Citrus Sinensis ID: 004674
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 738 | 2.2.26 [Sep-21-2011] | |||||||
| O81832 | 783 | G-type lectin S-receptor- | yes | no | 0.914 | 0.862 | 0.554 | 0.0 | |
| O81905 | 850 | Receptor-like serine/thre | no | no | 0.932 | 0.809 | 0.488 | 0.0 | |
| O81833 | 815 | G-type lectin S-receptor- | no | no | 0.924 | 0.836 | 0.530 | 0.0 | |
| Q09092 | 857 | Putative serine/threonine | N/A | no | 0.940 | 0.809 | 0.468 | 0.0 | |
| Q9ZT07 | 833 | G-type lectin S-receptor- | no | no | 0.928 | 0.822 | 0.481 | 0.0 | |
| Q9S972 | 847 | Receptor-like serine/thre | no | no | 0.910 | 0.793 | 0.481 | 0.0 | |
| Q39086 | 843 | Receptor-like serine/thre | no | no | 0.906 | 0.793 | 0.482 | 0.0 | |
| Q9LPZ3 | 845 | G-type lectin S-receptor- | no | no | 0.921 | 0.804 | 0.470 | 0.0 | |
| P0DH86 | 853 | G-type lectin S-receptor- | no | no | 0.921 | 0.797 | 0.467 | 1e-177 | |
| O81906 | 849 | G-type lectin S-receptor- | no | no | 0.917 | 0.797 | 0.451 | 1e-176 |
| >sp|O81832|Y4729_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290 OS=Arabidopsis thaliana GN=At4g27290 PE=3 SV=4 | Back alignment and function desciption |
|---|
Score = 807 bits (2084), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 400/721 (55%), Positives = 510/721 (70%), Gaps = 46/721 (6%)
Query: 23 MEGFNLL-IIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRY 81
ME N+L ++ LF I A+ D + Q++KDG+T+VS SFE+GFFSPG S++RY
Sbjct: 1 MEATNVLHLLIISLFSTILLAQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRY 60
Query: 82 LGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQ 141
LGIWYKKI+ TV WVANRD+PL D SG L+++ NG L L N N +WSS+SS S+Q
Sbjct: 61 LGIWYKKISLQTVVWVANRDSPLYDLSGTLKVS--ENGSLCLFNDRNHIIWSSSSSPSSQ 118
Query: 142 K-----PVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFL 196
K P+ ++++GNLVV++ D+ + +WQS DYP D LPGMK G+N TGLNRFL
Sbjct: 119 KASLRNPIVQILDTGNLVVRNSGDDQ--DYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFL 176
Query: 197 SSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTF 256
+SW++ DDP+ G++T +DP G+PQ L+KNS++ FR G WNGL +TG+P L+ NP+Y +
Sbjct: 177 TSWRAIDDPSTGNYTNKMDPNGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRY 236
Query: 257 EYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDS 316
EYV E+E +YTY L N SV +RM +NP G +QRYTW++ ++W + +D CD
Sbjct: 237 EYVFTEEEVYYTYKLENPSVLTRMQLNPNGALQRYTWVDNLQSWNFYL---SAMMDSCDQ 293
Query: 317 YALCGAYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHG-DGFLEH 375
Y LCG+Y SCNIN SP C CL+GFV + + W S GCVRR LDC G DGFL+
Sbjct: 294 YTLCGSYGSCNINE-SPACRCLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKI 352
Query: 376 KAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKEL 435
+KLPDTR SW DKN+ L ECK++C +NC+C+AY+ D+R G GC+LWF DLIDI+E
Sbjct: 353 SKLKLPDTRTSWYDKNMDLNECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREY 412
Query: 436 PESGQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQ 495
E+GQDL++R+A+SE++ ++R + S++
Sbjct: 413 NENGQDLYVRLASSEIETLQRESS-------------------------------RVSSR 441
Query: 496 GNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ 555
E+E++ELP DL ++ AT FS NKLG+GGFGPVYKG L GQE+AVKRLS+ S Q
Sbjct: 442 KQEEEDLELPFLDLDTVSEATSGFSAGNKLGQGGFGPVYKGTLACGQEVAVKRLSRTSRQ 501
Query: 556 GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW 615
G+EEFKNE+ LIAKLQHRNLVK+LG C +ERMLIYEY PNKSLD FIFD R + LDW
Sbjct: 502 GVEEFKNEIKLIAKLQHRNLVKILGYCVDEEERMLIYEYQPNKSLDSFIFDKERRRELDW 561
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
KR II GIARG+LYLH+DSRLRIIHRDLKASNVLLD+ MN KISDFGLAR+ G D+TE
Sbjct: 562 PKRVEIIKGIARGMLYLHEDSRLRIIHRDLKASNVLLDSDMNAKISDFGLARTLGGDETE 621
Query: 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH 735
ANT RVVGTYGYMSPEY IDG FS+KSDVFSFGVLVLEI+ G++NRGF + +H NLLGH
Sbjct: 622 ANTTRVVGTYGYMSPEYQIDGYFSLKSDVFSFGVLVLEIVSGRRNRGFRNEEHKLNLLGH 681
Query: 736 V 736
Sbjct: 682 A 682
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O81905|SD18_ARATH Receptor-like serine/threonine-protein kinase SD1-8 OS=Arabidopsis thaliana GN=SD18 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 704 bits (1817), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 357/731 (48%), Positives = 494/731 (67%), Gaps = 43/731 (5%)
Query: 37 YIISAARTLDTISLGQS--IKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTV 94
Y ISA +T+S +S I T+VS FELGFF PG YLGIWYK I++ T
Sbjct: 25 YSISA----NTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTY 80
Query: 95 TWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSN-SSISAQKP-VAALMESGN 152
WVANRD PLS G L+I+ LV+L+ ++ VWS+N + + P VA L+++GN
Sbjct: 81 VWVANRDTPLSSSIGTLKISDSN---LVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGN 137
Query: 153 LVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTY 212
V++D K++ PD +LWQSFD+P DTLLP MKLG + TG NRF+ SWKS DDP+ GDF++
Sbjct: 138 FVLRDSKNSAPDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSF 197
Query: 213 GLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLS 272
L+ G P++ L +R+G WNG+ ++GVP++Q F + ++++E Y++ ++
Sbjct: 198 KLETEGFPEIFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRIT 257
Query: 273 NSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNS 332
S V SR+ I+ +G +QR+TW+E + W ++F DQCD Y CG Y C+ N+ S
Sbjct: 258 KSDVYSRLSISSSGLLQRFTWIETAQNW---NQFWYAPKDQCDEYKECGVYGYCDSNT-S 313
Query: 333 PECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNI 392
P C C++GF P + + W ++ S GCVR+T L C GDGF+ K +KLPDT + VD+ I
Sbjct: 314 PVCNCIKGFKPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGI 373
Query: 393 TLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELD 452
+ EC++ C ++C+CTA+AN D+RG GSGC+ W +L DI+ + GQDL++R+AA++L+
Sbjct: 374 GVKECEQKCLRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLE 433
Query: 453 NVERRRQSK------------------------NKKQVMIIITSI---SLATAVIFIGGL 485
+ +R R +K +K+ ++I T I L + + + +
Sbjct: 434 D-KRNRSAKIIGSSIGVSVLLLLSFIIFFLWKRKQKRSILIETPIVDHQLRSRDLLMNEV 492
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIA 545
+ ++H ++ N +++ELP+ + + +A AT+NFS NKLG+GGFG VYKG L++GQE+A
Sbjct: 493 VISSRRHISRENNTDDLELPLMEFEEVAMATNNFSNANKLGQGGFGIVYKGKLLDGQEMA 552
Query: 546 VKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
VKRLSK S QG +EFKNEV LIA+LQH NLV+LL CC E+MLIYEYL N SLD +F
Sbjct: 553 VKRLSKTSVQGTDEFKNEVKLIARLQHINLVRLLACCVDAGEKMLIYEYLENLSLDSHLF 612
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
D +R+ L+W R II GIARGLLYLHQDSR RIIHRDLKASN+LLD M PKISDFG+
Sbjct: 613 DKSRNSKLNWQMRFDIINGIARGLLYLHQDSRFRIIHRDLKASNILLDKYMTPKISDFGM 672
Query: 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725
AR FG D+TEANT++VVGTYGYMSPEYA+DG+FS+KSDVFSFGVL+LEII K+N+GF +
Sbjct: 673 ARIFGRDETEANTRKVVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISSKRNKGFYN 732
Query: 726 ADHDHNLLGHV 736
+D D NLLG V
Sbjct: 733 SDRDLNLLGCV 743
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81833|SD11_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD1-1 OS=Arabidopsis thaliana GN=SD11 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 701 bits (1809), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 377/711 (53%), Positives = 484/711 (68%), Gaps = 29/711 (4%)
Query: 41 AARTLDTISLGQSIKDGETLVSAKESFELGFFS---PGNSKSRYLGIWYKKIAEGTVTWV 97
A + I+ + +KDG+TL S + F+LGFFS + R+LG+WY + V WV
Sbjct: 21 VALDYNVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWY--MEPFAVVWV 78
Query: 98 ANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISA-----QKPVAALMESGN 152
ANR+ PL SG L ++ G L L + + +WSS+SS + P+ + SGN
Sbjct: 79 ANRNNPLYGTSGFLNLSSL--GDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGN 136
Query: 153 LVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTY 212
L+ DG++ +LWQSFDYP +T+L GMKLG N T + LSSWK+ DP+ GDFT
Sbjct: 137 LISSDGEEA----VLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTL 192
Query: 213 GLDPRGIPQLVLRKN--SIITFRAGSWNGLHWTGVPQL-QLNPVYTFEYVSNEKEAFYTY 269
LD RG+PQL+LRKN S ++R GSWNGL +TG P + + N ++ +++ S+ +E Y++
Sbjct: 193 SLDTRGLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSW 252
Query: 270 NLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNIN 329
+ V SR+V+N G + R+ + W L + D+CD Y++CGAYA C IN
Sbjct: 253 TPRHRIV-SRLVLNNTGKLHRFI-QSKQNQWILANT---APEDECDYYSICGAYAVCGIN 307
Query: 330 S-NSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWV 388
S N+P C CLQGF P S R+W++ + GCV P +C+ D F++ +KLPDT +SW
Sbjct: 308 SKNTPSCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWY 367
Query: 389 D--KNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRM 446
D +TL +CK CS NCSCTAYAN D+R G GCLLWF DL+D++E GQD++IRM
Sbjct: 368 DAKNEMTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRM 427
Query: 447 AASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYR-RKKHSNQGNEKEEMELP 505
++++ + R ++ I + + F +M R R ++ +G E+E+++LP
Sbjct: 428 GFAKIE-FKGREVVGMVVGSVVAIAVVLVVVFACFRKKIMKRYRGENFRKGIEEEDLDLP 486
Query: 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVL 565
IFD K I+ ATD+FS N LG GGFGPVYKG L +GQEIAVKRLS SGQG+EEFKNEV
Sbjct: 487 IFDRKTISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVK 546
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
LIAKLQHRNLV+LLGCC Q +E MLIYEY+PNKSLD+FIFD RS LDW KR +II G+
Sbjct: 547 LIAKLQHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGV 606
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
ARG+LYLHQDSRLRIIHRDLKA NVLLDN MNPKISDFGLA+SFG DQ+E++T RVVGTY
Sbjct: 607 ARGILYLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTY 666
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
GYM PEYAIDG FSVKSDVFSFGVLVLEII GK NRGF HADHD NLLGHV
Sbjct: 667 GYMPPEYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHV 717
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q09092|SRK6_BRAOE Putative serine/threonine-protein kinase receptor OS=Brassica oleracea var. acephala GN=SRK6 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 680 bits (1755), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 351/750 (46%), Positives = 496/750 (66%), Gaps = 56/750 (7%)
Query: 26 FNLLIIYSFLFYIISAART-LDTISLGQS--IKDGETLVSAKESFELGFFSPGNSKSR-Y 81
+ L+++ + I A ++T+S +S I +TLVS FE+GFF + SR Y
Sbjct: 13 MSFLLVFVVMILIHPALSIYINTLSSTESLTISSNKTLVSPGSIFEVGFF---RTNSRWY 69
Query: 82 LGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQ 141
LG+WYKK+++ T WVANRD PLS+ G L+I+G LVLL+ +N VW +N + +
Sbjct: 70 LGMWYKKVSDRTYVWVANRDNPLSNAIGTLKISGNN---LVLLDHSNKPVWWTNLTRGNE 126
Query: 142 KP--VAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSW 199
+ VA L+ +GN V++D +N+ LWQSFDYP DTLLP MKLG NL TGLNRFL+SW
Sbjct: 127 RSPVVAELLANGNFVMRDSSNNDASEYLWQSFDYPTDTLLPEMKLGYNLKTGLNRFLTSW 186
Query: 200 KSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYV 259
+S+DDP+ G+F+Y L+ + +P+ L + + R+G WNG+ ++G+P+ Q + ++
Sbjct: 187 RSSDDPSSGNFSYKLETQSLPEFYLSRENFPMHRSGPWNGIRFSGIPEDQKLSYMVYNFI 246
Query: 260 SNEKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYAL 319
N +E YT+ ++N+S SR+ + G QR TW + W F +S QCD+Y +
Sbjct: 247 ENNEEVAYTFRMTNNSFYSRLTLISEGYFQRLTWYPSIRIWNRF--WSSPVDPQCDTYIM 304
Query: 320 CGAYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVK 379
CG YA C++N+ SP C C+QGF P + ++WD + +GGC+RRT L C GDGF K +K
Sbjct: 305 CGPYAYCDVNT-SPVCNCIQGFNPRNIQQWDQRVWAGGCIRRTQLSCS-GDGFTRMKKMK 362
Query: 380 LPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPES- 438
LP+T + VD++I + ECK+ C +C+CTA+ANAD+R GSGC++W L DI+
Sbjct: 363 LPETTMATVDRSIGVKECKKRCISDCNCTAFANADIRNGGSGCVIWTERLEDIRNYATDA 422
Query: 439 --GQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKH---- 492
GQDL++R+AA++ + ++R + K II ++ ++ ++ I +++RK+
Sbjct: 423 IDGQDLYVRLAAAD---IAKKRNASGK----IISLTVGVSVLLLLIMFCLWKRKQKRAKA 475
Query: 493 ------SNQGNEK--------------------EEMELPIFDLKIIANATDNFSEKNKLG 526
+ Q N+ EE+ELP+ +++ + AT+NFS NKLG
Sbjct: 476 SAISIANTQRNQNLPMNEMVLSSKREFSGEYKFEELELPLIEMETVVKATENFSSCNKLG 535
Query: 527 EGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586
+GGFG VYKG L++G+EIAVKRLSK S QG +EF NEV LIA+LQH NLV++LGCC + D
Sbjct: 536 QGGFGIVYKGRLLDGKEIAVKRLSKTSVQGTDEFMNEVTLIARLQHINLVQVLGCCIEGD 595
Query: 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646
E+MLIYEYL N SLD ++F TR L+W++R I G+ARGLLYLHQDSR RIIHRDLK
Sbjct: 596 EKMLIYEYLENLSLDSYLFGKTRRSKLNWNERFDITNGVARGLLYLHQDSRFRIIHRDLK 655
Query: 647 ASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFS 706
SN+LLD M PKISDFG+AR F D+TEANT +VVGTYGYMSPEYA+ G+FS KSDVFS
Sbjct: 656 VSNILLDKNMIPKISDFGMARIFERDETEANTMKVVGTYGYMSPEYAMYGIFSEKSDVFS 715
Query: 707 FGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
FGV+VLEI+ GKKNRGF + D++++LL +V
Sbjct: 716 FGVIVLEIVSGKKNRGFYNLDYENDLLSYV 745
|
Involved in sporophytic self-incompatibility system (the inability of flowering plants to achieve self-fertilization), probably acting in combination with S-locus-specific glycoproteins. Interaction with a ligand in the extracellular domain triggers the protein kinase activity of the cytoplasmic domain. Brassica oleracea var. acephala (taxid: 3713) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZT07|RKS1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RKS1 OS=Arabidopsis thaliana GN=RKS1 PE=2 SV=3 | Back alignment and function description |
|---|
Score = 672 bits (1733), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 347/721 (48%), Positives = 471/721 (65%), Gaps = 36/721 (4%)
Query: 44 TLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAP 103
++DTI QS++DGE ++SA + F GFFS G+S+ RY+GIWY +I++ T+ WVANRD P
Sbjct: 18 SVDTIMRRQSLRDGEVILSAGKRFAFGFFSLGDSELRYVGIWYAQISQQTIVWVANRDHP 77
Query: 104 LSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKP--VAALMESGNLVVKDGKDN 161
++D SG+++ + N + ++ + +WS+N S S +P VA L + GNLV+ D
Sbjct: 78 INDTSGMVKFSNRGNLSVYASDNETELIWSTNVSDSMLEPTLVATLSDLGNLVLFDPVTG 137
Query: 162 NPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQ 221
W+SFD+P DT LP M+LG GL+R L+SWKS DP GD ++ RG PQ
Sbjct: 138 RS---FWESFDHPTDTFLPFMRLGFTRKDGLDRSLTSWKSHGDPGSGDLILRMERRGFPQ 194
Query: 222 LVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMV 281
L+L K +R GSW G W+GVP++ + ++ +V+NE E +TY ++++SV +R +
Sbjct: 195 LILYKGVTPWWRMGSWTGHRWSGVPEMPIGYIFNNSFVNNEDEVSFTYGVTDASVITRTM 254
Query: 282 INPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCN-INSNSPECECLQG 340
+N GT+ R+TW+ R K W + F V +QCD+YA CG C+ +S + EC CL G
Sbjct: 255 VNETGTMHRFTWIARDKRW---NDFWSVPKEQCDNYAHCGPNGYCDSPSSKTFECTCLPG 311
Query: 341 FVPNSQREWDMQYKSGGCVRRTPLD-CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKE 399
F P R W ++ SGGC ++ C DGF++ K +K+PDT + VD NITL ECK+
Sbjct: 312 FEPKFPRHWFLRDSSGGCTKKKRASICSEKDGFVKLKRMKIPDTSDASVDMNITLKECKQ 371
Query: 400 LCSKNCSCTAYANA-DVRGRGS-GCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERR 457
C KNCSC AYA+A RG+ GCL W ++D + SGQD +IR+ EL R
Sbjct: 372 RCLKNCSCVAYASAYHESKRGAIGCLKWHGGMLDARTYLNSGQDFYIRVDKEELARWNRN 431
Query: 458 RQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSN----------------------Q 495
S ++ ++I+I+ I+ + I + R ++ SN +
Sbjct: 432 GLSGKRRVLLILISLIAAVMLLTVILFCVVRERRKSNRHRSSSANFAPVPFDFDESFRFE 491
Query: 496 GNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ 555
++ ELP+FDL I AT+NFS +NKLG GGFGPVYKG+L EIAVKRLS+ SGQ
Sbjct: 492 QDKARNRELPLFDLNTIVAATNNFSSQNKLGAGGFGPVYKGVLQNRMEIAVKRLSRNSGQ 551
Query: 556 GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW 615
GMEEFKNEV LI+KLQHRNLV++LGCC + +E+ML+YEYLPNKSLDYFIF + LDW
Sbjct: 552 GMEEFKNEVKLISKLQHRNLVRILGCCVELEEKMLVYEYLPNKSLDYFIFHEEQRAELDW 611
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
KR I+ GIARG+LYLHQDSRLRIIHRDLKASN+LLD+ M PKISDFG+AR FG +Q E
Sbjct: 612 PKRMEIVRGIARGILYLHQDSRLRIIHRDLKASNILLDSEMIPKISDFGMARIFGGNQME 671
Query: 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH 735
T RVVGT+GYM+PEYA++G FS+KSDV+SFGVL+LEII GKKN F+ + NL+GH
Sbjct: 672 GCTSRVVGTFGYMAPEYAMEGQFSIKSDVYSFGVLMLEIITGKKNSAFH--EESSNLVGH 729
Query: 736 V 736
+
Sbjct: 730 I 730
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9S972|SD16_ARATH Receptor-like serine/threonine-protein kinase SD1-6 OS=Arabidopsis thaliana GN=SD16 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 662 bits (1707), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/716 (48%), Positives = 475/716 (66%), Gaps = 44/716 (6%)
Query: 53 SIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLR 112
+I +T++S + FELGFF+P +S YLGIWYK I T WVANRD PLS +G L+
Sbjct: 37 TISSNKTIISPSQIFELGFFNPDSSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLK 96
Query: 113 INGERNGILVLLNSTNDTVWSSN-SSISAQKPVAA-LMESGNLVVKDGKDNNPDNILWQS 170
I+ LV+ + ++ VWS+N + + PVAA L++ GN V++D K+N P LWQS
Sbjct: 97 ISDNN---LVIFDQSDRPVWSTNITGGDVRSPVAAELLDYGNFVLRDSKNNKPSGFLWQS 153
Query: 171 FDYPCDTLLPGMKLGI-NLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSI 229
FD+P DTLL MK+G N G NR L SWK+TDDP+ GDF+ L G P+ +
Sbjct: 154 FDFPTDTLLSDMKMGWDNKSGGFNRILRSWKTTDDPSSGDFSTKLRTSGFPEFYIYNKES 213
Query: 230 ITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQ 289
IT+R+G W G ++ VP ++ + N ++ Y+Y ++ +++ S + ++ G +Q
Sbjct: 214 ITYRSGPWLGNRFSSVPGMKPVDYIDNSFTENNQQVVYSYRVNKTNIYSILSLSSTGLLQ 273
Query: 290 RYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGFVPNSQREW 349
R TWME ++W + D CD+Y CG Y C+ N+ SP C C++GF P +++
Sbjct: 274 RLTWMEAAQSW---KQLWYSPKDLCDNYKECGNYGYCDANT-SPICNCIKGFEPMNEQA- 328
Query: 350 DMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTA 409
++ S GCVR+T L C DGF+ K ++LPDT + VDK I L EC+E C K C+CTA
Sbjct: 329 ALRDDSVGCVRKTKLSCDGRDGFVRLKKMRLPDTTETSVDKGIGLKECEERCLKGCNCTA 388
Query: 410 YANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRRQSKNKK----- 464
+AN D+R GSGC++W L DI+ + GQDL++R+AA +L++ ++ K+KK
Sbjct: 389 FANTDIRNGGSGCVIWSGGLFDIRNYAKGGQDLYVRVAAGDLED----KRIKSKKIIGSS 444
Query: 465 ---QVMIIIT-------------SISLATAVI--------FIGGLMYRRKKHSNQGNEKE 500
++++++ SI++ T ++ + L+ + ++++ N+ +
Sbjct: 445 IGVSILLLLSFIIFHFWKRKQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTD 504
Query: 501 EMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEF 560
+ELP+ + K +A AT+NFS NKLG+GGFG VYKGML++G+EIAVKRLSK S QG +EF
Sbjct: 505 YLELPLMEWKALAMATNNFSTDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEF 564
Query: 561 KNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH 620
NEV LIAKLQH NLV+LLGCC + E+MLIYEYL N SLD +FD TRS L+W KR
Sbjct: 565 MNEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFD 624
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
II GIARGLLYLHQDSR RIIHRDLKASNVLLD M PKISDFG+AR FG ++TEANT+R
Sbjct: 625 IINGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRR 684
Query: 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
VVGTYGYMSPEYA+DG+FS+KSDVFSFGVL+LEII GK+N+GF +++ D NLLG V
Sbjct: 685 VVGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFV 740
|
Involved in the regulation of cellular expansion and differentiation. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39086|SD17_ARATH Receptor-like serine/threonine-protein kinase SD1-7 OS=Arabidopsis thaliana GN=SD17 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 658 bits (1698), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 345/715 (48%), Positives = 482/715 (67%), Gaps = 46/715 (6%)
Query: 53 SIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLR 112
+I +T++S + FELGFF+P +S YLGIWYK I T WVANRD PLS +G L+
Sbjct: 37 TISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNPLSSSNGTLK 96
Query: 113 INGERNGILVLLNSTNDTVWSSN-SSISAQKPVAA-LMESGNLVVKDGKDNNPDNILWQS 170
I+G LV+ + ++ VWS+N + + PVAA L+++GN +++D + +LWQS
Sbjct: 97 ISGNN---LVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDSNNR----LLWQS 149
Query: 171 FDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSII 230
FD+P DTLL MKLG + TG NR L SWK+TDDP+ G+F+ L+ P+ + I
Sbjct: 150 FDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPEFYICSKESI 209
Query: 231 TFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQR 290
+R+G WNG+ ++ VP + + ++++E Y+Y ++ +++ SR+ +N AG +QR
Sbjct: 210 LYRSGPWNGMRFSSVPGTIQVDYMVYNFTASKEEVTYSYRINKTNLYSRLYLNSAGLLQR 269
Query: 291 YTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGFVPNSQREWD 350
TW E T++W + D CD+Y +CG + C+ NS P C C++GF P +++ WD
Sbjct: 270 LTWFETTQSW---KQLWYSPKDLCDNYKVCGNFGYCDSNS-LPNCYCIKGFKPVNEQAWD 325
Query: 351 MQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAY 410
++ S GC+R+T L C DGF K +KLPDT + VD+ I L CKE C ++C+CTA+
Sbjct: 326 LRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKERCLEDCNCTAF 385
Query: 411 ANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRRQSKNKKQV--MI 468
ANAD+R GSGC++W +++D++ + GQDL++R+AA+EL++ ++ KN+K + I
Sbjct: 386 ANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELED----KRIKNEKIIGSSI 441
Query: 469 IITSISLATAVIF---------------------------IGGLMYRRKKHSNQGNEKEE 501
++ + L + VIF I ++ R+ ++++ + E
Sbjct: 442 GVSILLLLSFVIFHFWKRKQKRSITIQTPNVDQVRSQDSLINDVVVSRRGYTSKEKKSEY 501
Query: 502 MELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFK 561
+ELP+ +L+ +A AT+NFS NKLG+GGFG VYKG L++G+EIAVKRLSK S QG +EF
Sbjct: 502 LELPLLELEALATATNNFSNDNKLGQGGFGIVYKGRLLDGKEIAVKRLSKMSSQGTDEFM 561
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
NEV LIAKLQH NLV+LLGCC + E+MLIYEYL N SLD +FD TRS L+W KR I
Sbjct: 562 NEVRLIAKLQHINLVRLLGCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDI 621
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
I GIARGLLYLHQDSR RIIHRDLKASNVLLD M PKISDFG+AR FG ++TEANT+RV
Sbjct: 622 INGIARGLLYLHQDSRCRIIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRV 681
Query: 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
VGTYGYMSPEYA+DG+FS+KSDVFSFGVL+LEII GK+N+GF +++ D NLLG V
Sbjct: 682 VGTYGYMSPEYAMDGIFSMKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFV 736
|
Involved in the regulation of cellular expansion and differentiation. Mediates subcellular relocalization of PUB9 from nucleus to plasma membrane in a protein-phosphorylation-dependent manner. May be involved in the abscisic acid-mediated signaling pathway, at least during germination. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LPZ3|Y1141_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g11410 OS=Arabidopsis thaliana GN=At1g11410 PE=3 SV=3 | Back alignment and function description |
|---|
Score = 635 bits (1639), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 342/727 (47%), Positives = 461/727 (63%), Gaps = 47/727 (6%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+TI QS+KDG+ + S + F GFFS GNSK RY+GIWY +++E T+ WVANRD P++
Sbjct: 23 NTILRSQSLKDGDVIYSEGKRFAFGFFSLGNSKLRYVGIWYAQVSEQTIVWVANRDHPIN 82
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKP--VAALMESGNLVVKD---GKD 160
D SG+++ + N + + + +WS++ Q+P VA L + GNLV+ D GK
Sbjct: 83 DTSGLIKFSTRGNLCVYASGNGTEPIWSTDVIDMIQEPALVAKLSDLGNLVLLDPVTGKS 142
Query: 161 NNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIP 220
W+SF++P +TLLP MK G +G++R ++SW+S DP G+ TY ++ RG P
Sbjct: 143 ------FWESFNHPTNTLLPFMKFGFTRQSGVDRIMTSWRSPGDPGSGNITYRIERRGFP 196
Query: 221 QLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRM 280
Q+++ K + +R GSW G W+GVP++ ++ +V+N E TY + ++SV +RM
Sbjct: 197 QMMMYKGLTLWWRTGSWTGQRWSGVPEMTNKFIFNISFVNNPDEVSITYGVLDASVTTRM 256
Query: 281 VINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSP-ECECLQ 339
V+N GT+QR+ W R K W F D+CD Y CG C+ S EC CL
Sbjct: 257 VLNETGTLQRFRWNGRDKKWI---GFWSAPEDKCDIYNHCGFNGYCDSTSTEKFECSCLP 313
Query: 340 GFVPNSQREWDMQYKSGGCVR-RTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECK 398
G+ P + R+W ++ S GC R + C +GF + K VK+P+T VD NITL EC+
Sbjct: 314 GYEPKTPRDWFLRDASDGCTRIKADSICNGKEGFAKLKRVKIPNTSAVNVDMNITLKECE 373
Query: 399 ELCSKNCSCTAYANA--DVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVER 456
+ C KNCSC AYA+A + + GCL W +++D + SGQD ++R+ SEL
Sbjct: 374 QRCLKNCSCVAYASAYHESQDGAKGCLTWHGNMLDTRTYLSSGQDFYLRVDKSELARWNG 433
Query: 457 RRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQGNEK----------------- 499
S K+ V+I+I+ I++ ++ R+++ Q N
Sbjct: 434 NGASGKKRLVLILISLIAVVMLLLISFHCYLRKRRQRTQSNRLRKAPSSFAPSSFDLEDS 493
Query: 500 ---EEME-------LPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRL 549
EE+E LP+F+L IA AT+NF+ +NKLG GGFGPVYKG+L G EIAVKRL
Sbjct: 494 FILEELEDKSRSRELPLFELSTIATATNNFAFQNKLGAGGFGPVYKGVLQNGMEIAVKRL 553
Query: 550 SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR 609
SK SGQGMEEFKNEV LI+KLQHRNLV++LGCC + +E+ML+YEYLPNKSLDYFIF +
Sbjct: 554 SKSSGQGMEEFKNEVKLISKLQHRNLVRILGCCVEFEEKMLVYEYLPNKSLDYFIFHEEQ 613
Query: 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
LDW KR II GI RG+LYLHQDSRLRIIHRDLKASNVLLDN M PKI+DFGLAR F
Sbjct: 614 RAELDWPKRMGIIRGIGRGILYLHQDSRLRIIHRDLKASNVLLDNEMIPKIADFGLARIF 673
Query: 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
G +Q E +T RVVGTYGYMSPEYA+DG FS+KSDV+SFGVL+LEII GK+N F +
Sbjct: 674 GGNQIEGSTNRVVGTYGYMSPEYAMDGQFSIKSDVYSFGVLILEIITGKRNSAF--YEES 731
Query: 730 HNLLGHV 736
NL+ H+
Sbjct: 732 LNLVKHI 738
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|P0DH86|SRK_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SRK OS=Arabidopsis thaliana GN=SRK PE=2 SV=1 | Back alignment and function description |
|---|
Score = 623 bits (1607), Expect = e-177, Method: Compositional matrix adjust.
Identities = 339/725 (46%), Positives = 466/725 (64%), Gaps = 45/725 (6%)
Query: 44 TLDTISLGQS--IKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRD 101
+++T+S +S I +T+VS FELGFF S YLGIWYKKI++ T WVANRD
Sbjct: 31 SVNTLSATESLTISSNKTIVSPGGVFELGFFRILGD-SWYLGIWYKKISQRTYVWVANRD 89
Query: 102 APLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAA-LMESGNLVVKDGKD 160
PLS+ G+L+I+ N LV+L++++ VWS+N + + + V A L+++GN V++ K
Sbjct: 90 TPLSNPIGILKIS---NANLVILDNSDTHVWSTNLTGAVRSSVVAELLDNGNFVLRGSKI 146
Query: 161 NNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIP 220
N D LWQSFD+P DTLLP MKLG + GLNRF++SWKS+ DP+ G F + L+ G+P
Sbjct: 147 NESDEFLWQSFDFPTDTLLPQMKLGRDHKRGLNRFVTSWKSSFDPSSGSFMFKLETLGLP 206
Query: 221 QLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRM 280
+ + + +R+G W+GL ++G+ ++Q + + N +E YT+ +++ + SR+
Sbjct: 207 EFFGFTSFLEVYRSGPWDGLRFSGILEMQQWDDIIYNFTENREEVAYTFRVTDHNSYSRL 266
Query: 281 VINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQG 340
IN G ++ + W + W +F D CD Y +CG YA C++ S SP C C++G
Sbjct: 267 TINTVGRLEGFMWEPTQQEWNMFWFMPK---DTCDLYGICGPYAYCDM-STSPTCNCIKG 322
Query: 341 FVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKEL 400
F P S ++W +G C R+T L C D F +K+P T + VDK I L EC+E
Sbjct: 323 FQPLSPQDWASGDVTGRCRRKTQLTCGE-DRFFRLMNMKIPATTAAIVDKRIGLKECEEK 381
Query: 401 CSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERR--- 457
C +C+CTAYAN+D+R GSGC++W + DI+ GQDLF+R+AA+E ERR
Sbjct: 382 CKTHCNCTAYANSDIRNGGSGCIIWIGEFRDIRNYAADGQDLFVRLAAAEFG--ERRTIR 439
Query: 458 ---RQSKNKKQVMIIITSI-----------SLATA-----------VIFIGGLMYRRKKH 492
+M++++ I + ATA +I G++ +
Sbjct: 440 GKIIGLIIGISLMLVLSFIIYCFWKKKQKRARATAAPIGYRDRIQELIITNGVVMSSGRR 499
Query: 493 SNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG 552
E E+ L F+ ++ AT+NFS+ N LG GGFG VYKG L++GQEIAVKRLS+
Sbjct: 500 LLGEEEDLELPLTEFETVVM--ATENFSDSNILGRGGFGIVYKGRLLDGQEIAVKRLSEM 557
Query: 553 SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK- 611
S QG EFKNEV LIA+LQH NLV+LL CC DE++LIYEYL N SLD +F+TT+S
Sbjct: 558 SSQGTNEFKNEVRLIARLQHINLVRLLSCCIYADEKILIYEYLENGSLDSHLFETTQSSN 617
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
L+W R II GIARGLLYLHQDSR +IIHRDLKASNVLLD M PKISDFG+AR F
Sbjct: 618 KLNWQTRFSIINGIARGLLYLHQDSRFKIIHRDLKASNVLLDKNMTPKISDFGMARIFER 677
Query: 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHN 731
D+TEANT++VVGTYGYMSPEYA++G+FSVKSDVFSFGVLVLEI+ GK+NRGF+++ D+N
Sbjct: 678 DETEANTRKVVGTYGYMSPEYAMEGIFSVKSDVFSFGVLVLEIVSGKRNRGFHNSGQDNN 737
Query: 732 LLGHV 736
LLG+
Sbjct: 738 LLGYT 742
|
Female specificity determinant of self-incompatibility. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O81906|B120_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase B120 OS=Arabidopsis thaliana GN=B120 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 620 bits (1599), Expect = e-176, Method: Compositional matrix adjust.
Identities = 345/764 (45%), Positives = 473/764 (61%), Gaps = 87/764 (11%)
Query: 29 LIIYSFLFYIISAARTLDTISLGQSIKDG---ETLVSAKESFELGFFSPGNSKSRYLGIW 85
L +Y FL+ AA +TI G+S++DG + LVS +++FELGFFSPG+S R+LGIW
Sbjct: 13 LFLYFFLYESSMAA---NTIRRGESLRDGINHKPLVSPQKTFELGFFSPGSSTHRFLGIW 69
Query: 86 YKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSN---SSISAQK 142
Y I + V WVANR P+SD+SGVL I+ + N LVLL+ N TVWSSN S+ +
Sbjct: 70 YGNIEDKAVVWVANRATPISDQSGVLMISNDGN--LVLLDGKNITVWSSNIESSTTNNNN 127
Query: 143 PVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKST 202
V ++ ++GN V+ + + P +W+SF++P DT LP M++ +N TG N SW+S
Sbjct: 128 RVVSIHDTGNFVLSETDTDRP---IWESFNHPTDTFLPQMRVRVNPQTGDNHAFVSWRSE 184
Query: 203 DDPARGDFTYGLDPRGIPQLVL-RKNSIITFRAGSWNGLHWTGVPQLQL--NPVYTFEYV 259
DP+ G+++ G+DP G P++VL N +R+G WN +TG+P + L N +Y F+
Sbjct: 185 TDPSPGNYSLGVDPSGAPEIVLWEGNKTRKWRSGQWNSAIFTGIPNMSLLTNYLYGFKLS 244
Query: 260 SNEKE---AFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDS 316
S E ++TY S+ SV R + GT + W E K WT +F +CD
Sbjct: 245 SPPDETGSVYFTYVPSDPSVLLRFKVLYNGTEEELRWNETLKKWT---KFQSEPDSECDQ 301
Query: 317 YALCGAYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHG-----DG 371
Y CG + C++ ++ C C+ G+ S W S GC RRTPL C+ D
Sbjct: 302 YNRCGKFGICDMKGSNGICSCIHGYEQVSVGNW-----SRGCRRRTPLKCERNISVGEDE 356
Query: 372 FLEHKAVKLPDTRFSWVDKNITLWE-CKELCSKNCSCTAYANADVRGRGSGCLLWFHDLI 430
FL K+VKLPD F + N+ E C+E C +NCSC AY+ G GC++W DL+
Sbjct: 357 FLTLKSVKLPD--FEIPEHNLVDPEDCRERCLRNCSCNAYSLVG----GIGCMIWNQDLV 410
Query: 431 DIKELPESGQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLM---Y 487
D+++ G L IR+A SE+ +N+K + +I ++ + +I I L+ +
Sbjct: 411 DLQQFEAGGSSLHIRLADSEV--------GENRKTKIAVIVAVLVGVILIGIFALLLWRF 462
Query: 488 RRKKHSN-----------------------------------QGNEKEEMELPIFDLKII 512
+RKK + +G ELP+F L I
Sbjct: 463 KRKKDVSGAYCGKNTDTSVVVADLTKSKETTSAFSGSVDIMIEGKAVNTSELPVFSLNAI 522
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
A AT++F ++N+LG GGFGPVYKG+L +G+EIAVKRLS SGQG++EFKNE++LIAKLQH
Sbjct: 523 AIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSGQGVDEFKNEIILIAKLQH 582
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
RNLV+LLGCC + +E+ML+YEY+PNKSLD+F+FD T+ L+DW R II GIARGLLYL
Sbjct: 583 RNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALIDWKLRFSIIEGIARGLLYL 642
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H+DSRLRIIHRDLK SNVLLD MNPKISDFG+AR FG +Q EANT RVVGTYGYMSPEY
Sbjct: 643 HRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQNEANTVRVVGTYGYMSPEY 702
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
A++GLFSVKSDV+SFGVL+LEI+ GK+N ++H +L+G+
Sbjct: 703 AMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SLIGYA 745
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 738 | ||||||
| 224122978 | 831 | predicted protein [Populus trichocarpa] | 0.953 | 0.847 | 0.638 | 0.0 | |
| 224122958 | 812 | predicted protein [Populus trichocarpa] | 0.951 | 0.864 | 0.622 | 0.0 | |
| 147799241 | 818 | hypothetical protein VITISV_027305 [Viti | 0.945 | 0.853 | 0.607 | 0.0 | |
| 359493740 | 2422 | PREDICTED: uncharacterized protein LOC10 | 0.955 | 0.291 | 0.583 | 0.0 | |
| 224122858 | 831 | predicted protein [Populus trichocarpa] | 0.955 | 0.848 | 0.585 | 0.0 | |
| 359493715 | 1603 | PREDICTED: uncharacterized protein LOC10 | 0.944 | 0.434 | 0.615 | 0.0 | |
| 255569631 | 868 | S-locus-specific glycoprotein S13 precur | 0.949 | 0.807 | 0.593 | 0.0 | |
| 359493725 | 1593 | PREDICTED: uncharacterized protein LOC10 | 0.949 | 0.440 | 0.599 | 0.0 | |
| 359493721 | 804 | PREDICTED: G-type lectin S-receptor-like | 0.905 | 0.830 | 0.605 | 0.0 | |
| 359493727 | 1767 | PREDICTED: uncharacterized protein LOC10 | 0.945 | 0.395 | 0.589 | 0.0 |
| >gi|224122978|ref|XP_002330411.1| predicted protein [Populus trichocarpa] gi|222871796|gb|EEF08927.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 937 bits (2423), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 466/730 (63%), Positives = 562/730 (76%), Gaps = 26/730 (3%)
Query: 23 MEGFNLLIIYSFLFYIISAAR-TLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRY 81
+ GF +L +++FL +ISA R + DT++ GQSI+DG+ LVSA SFELGFFSPG SK RY
Sbjct: 5 ISGFIILFVHTFL--LISAIRASTDTLTPGQSIRDGDLLVSADGSFELGFFSPGISKGRY 62
Query: 82 LGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQ 141
LGIWY+KI+ GTV WVANR+ PL+D SG L + + GIL+LLNS+ D +WSSN+S +AQ
Sbjct: 63 LGIWYQKISAGTVVWVANRETPLNDSSGALIVTDQ--GILILLNSSKDAIWSSNASRTAQ 120
Query: 142 KPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKS 201
PV L++SGNLVVKD DN+ +N LWQSFDYP DTLLPGMK G N+ TGL+R+LSSWKS
Sbjct: 121 NPVMKLLDSGNLVVKDINDNS-ENFLWQSFDYPGDTLLPGMKWGRNMVTGLDRYLSSWKS 179
Query: 202 TDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSN 261
++DPA+G+FT+ +DPRG Q++L + I +R G+WNG WTG PQL+ N +YT+ ++S
Sbjct: 180 SNDPAQGEFTFRIDPRGNTQMLLMRGPKILYRTGTWNGYRWTGTPQLEPNMLYTYGFIST 239
Query: 262 EKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCG 321
E +Y ++L NSSV SR+V+N +G QR+TW+ RT +W +RFS V LDQCD YALCG
Sbjct: 240 ATEMYYKFDLINSSVASRIVMNSSGAAQRFTWITRTNSW---ARFSAVLLDQCDDYALCG 296
Query: 322 AYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLP 381
AY SCN+N P C CL+GF+P S ++W +Q S GCVRRT LDC GD FL+H VKLP
Sbjct: 297 AYGSCNVNKQ-PVCACLEGFIPKSPKDWSIQEWSDGCVRRTKLDCDKGDRFLQHGGVKLP 355
Query: 382 DTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQD 441
D SWVD + L ECK+LC KNCSC AYAN+D+RG GSGCLLWF +LID +EL GQD
Sbjct: 356 DMIKSWVDTSKGLKECKDLCLKNCSCVAYANSDIRGGGSGCLLWFDELIDTRELTTGGQD 415
Query: 442 LFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMY-RRKKHSNQGN--- 497
L+IR+AASEL N+E+ R S +KKQ+ II+ +I V+ + ++Y RRKK Q N
Sbjct: 416 LYIRIAASELYNIEKNRSS-DKKQLGIIVGTIITIVGVLVLAFILYARRKKLKKQANMKT 474
Query: 498 -----------EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAV 546
KE+MELP FDL IANATDNFS +NKLGEGGFG VYKG LIEGQE+AV
Sbjct: 475 SHLQNYEDEDQRKEDMELPTFDLSTIANATDNFSSRNKLGEGGFGSVYKGTLIEGQEVAV 534
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606
KRLSK SGQG+ EFKNEV+LIAKLQHRNLVKLLGCC + DER+LIYEY+PNKSLDYFIFD
Sbjct: 535 KRLSKNSGQGLTEFKNEVILIAKLQHRNLVKLLGCCIEGDERILIYEYMPNKSLDYFIFD 594
Query: 607 TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
DW +I+ GIARGLLYLHQDSRLRIIHRDLKA+NVLLDN MNPKISDFGLA
Sbjct: 595 KKTRNSSDWRIWINIVGGIARGLLYLHQDSRLRIIHRDLKAANVLLDNGMNPKISDFGLA 654
Query: 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726
R+FG DQTEANT ++VGTYGYMSPEYA+DG FSVKSDVFSFGVLVLEI+ GKKNRGFNH
Sbjct: 655 RTFGGDQTEANTNKIVGTYGYMSPEYAVDGFFSVKSDVFSFGVLVLEIVSGKKNRGFNHP 714
Query: 727 DHDHNLLGHV 736
DH HNLLGH
Sbjct: 715 DHHHNLLGHA 724
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122958|ref|XP_002330406.1| predicted protein [Populus trichocarpa] gi|222871791|gb|EEF08922.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 915 bits (2364), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 446/716 (62%), Positives = 542/716 (75%), Gaps = 14/716 (1%)
Query: 27 NLLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWY 86
+++ +YS F I+ + LD ++ QS++DGETLVS SFELGFF+P S SRYLG+WY
Sbjct: 5 DVIFVYSLFFSILKISSALDAMNTTQSLRDGETLVSTGGSFELGFFTPAGSTSRYLGLWY 64
Query: 87 KKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAA 146
KK + TV WVANR P+S++ G L + + GILVLLN TN+ VWSSN+S + Q PVA
Sbjct: 65 KKSPQ-TVVWVANRGIPISNKFGTLNVTSQ--GILVLLNGTNNIVWSSNTSTTVQNPVAQ 121
Query: 147 LMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPA 206
L++SGNLVV+DG DN DN LWQSFDYPCDTLLPGMKLG NL TGLN FLSSWK ++PA
Sbjct: 122 LLDSGNLVVRDGNDNKADNFLWQSFDYPCDTLLPGMKLGSNLVTGLNSFLSSWKGKENPA 181
Query: 207 RGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAF 266
G FT G+D +G PQL+LRK + I +R GSWNG ++TG P+L+ +P+YTFE+V N E +
Sbjct: 182 PGQFTLGIDVQGYPQLILRKETRIMYRVGSWNGQYFTGFPELKPDPIYTFEFVFNRNEVY 241
Query: 267 YTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASC 326
+ + L NSSV SR+ + P+G VQ +TW +T W +F+ +D+C++YALCGA A C
Sbjct: 242 FKFELQNSSVFSRLTVTPSGLVQLFTWSHQTNDWYVFAT---AVVDRCENYALCGANARC 298
Query: 327 NINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFS 386
+ NS SP C+CL GF+ S EW+ Q +GGC+RRTPLDC DGF + VKLPDT S
Sbjct: 299 DSNS-SPVCDCLDGFIHKSPTEWNSQNWTGGCIRRTPLDCTDKDGFQSYTGVKLPDTSSS 357
Query: 387 WVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRM 446
W D + +L EC+ LC +NCSC AYAN D RGRGSGCL WF DLID + L E GQD++IR+
Sbjct: 358 WYDDSFSLVECEGLCIQNCSCFAYANLDFRGRGSGCLRWFGDLIDTRRLAEGGQDIYIRL 417
Query: 447 AASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLM-YRRKKHSNQGN----EKEE 501
AAS+ V ++ K K +I ++ L ++++ +G + RR+KH GN ++EE
Sbjct: 418 AASQ-SGVTGEKKRKKKTHAGVIGGAVILGSSILILGIVFCIRRRKHRKNGNFEDRKEEE 476
Query: 502 MELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFK 561
MELP+ DL I +ATDNFS KLGEGGFG VYKG LIEGQEIAVKRLSK SGQG+ EFK
Sbjct: 477 MELPMLDLTTIEHATDNFSSSKKLGEGGFGAVYKGELIEGQEIAVKRLSKSSGQGLNEFK 536
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
NEVLLIAKLQHRNLVKLLGCC DE+MLIYEY+PN+SLD FIFD TR K LDWSKR+HI
Sbjct: 537 NEVLLIAKLQHRNLVKLLGCCIHEDEKMLIYEYMPNRSLDSFIFDPTRRKFLDWSKRTHI 596
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
I GIARGLLYLHQDSRLRIIHRD+KASN+LLDN +NPKISDFGLAR FG DQTEANTKRV
Sbjct: 597 IDGIARGLLYLHQDSRLRIIHRDIKASNILLDNELNPKISDFGLARMFGGDQTEANTKRV 656
Query: 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH-NLLGHV 736
VGTYGYMSPEYA+DG FSVKSDVFSFGVLVLEI+ GKKNRGF H D++ NLLGH
Sbjct: 657 VGTYGYMSPEYALDGHFSVKSDVFSFGVLVLEIVSGKKNRGFCHPDYNQKNLLGHA 712
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|147799241|emb|CAN77004.1| hypothetical protein VITISV_027305 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 890 bits (2301), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 439/723 (60%), Positives = 550/723 (76%), Gaps = 25/723 (3%)
Query: 28 LLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYK 87
L+ ++S++ I+ + +D+I+ Q IKDGET++SA +FELGF G SK++YLGIWYK
Sbjct: 7 LVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIWYK 66
Query: 88 KIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAAL 147
K+ TV WVANR+ P++D SG L++ + G LV+LN +N +WSSNSS SA+ P A L
Sbjct: 67 KVTPRTVVWVANRELPVTDSSGXLKVTDQ--GSLVILNGSNGLIWSSNSSRSARNPTAQL 124
Query: 148 MESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPAR 207
++SGNLV+K G D++PDN LWQSFDYP DTLLPGMK G N TGL+R+LSSWKS DDP++
Sbjct: 125 LDSGNLVIKSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDPSK 184
Query: 208 GDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFY 267
GDFTYGLDP G PQL LR S + FR+G WNG+ + G P+L+ NPV+ + +V NEKE ++
Sbjct: 185 GDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNEKEMYF 244
Query: 268 TYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCN 327
TY L NSSV SR+V+NP G VQR W+ RTK+W ++S D CDSYALCGAY++CN
Sbjct: 245 TYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYST---AYKDDCDSYALCGAYSTCN 301
Query: 328 INSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSW 387
I+ SP C C++GFVP +WD S GCVR+T LDC+ GDGF ++ VKLPDTR SW
Sbjct: 302 IH-RSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFAKYSGVKLPDTRNSW 360
Query: 388 VDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMA 447
++++ L EC LC +NCSC+AY N+D++G GSGCLLWF DLIDIKE E+GQD +IRMA
Sbjct: 361 FNESMNLKECASLCFRNCSCSAYTNSDIKGGGSGCLLWFGDLIDIKEFTENGQDFYIRMA 420
Query: 448 ASELDNVERRRQSKNKKQVMIIITSISLATAVIF-IGGLMYRRKKH---------SNQGN 497
ASELD + SK K+ +I++++S+A ++ + +Y KK +N+G
Sbjct: 421 ASELDAI-----SKVTKRRWVIVSTVSIAGMILLSLVVTLYLLKKRLKRKGTTELNNEGA 475
Query: 498 E----KEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS 553
E +E++ELP+F L I NAT NFS NKLGEGGFGPVYKGML +G+EIAVKRLSK S
Sbjct: 476 ETNERQEDLELPLFXLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKES 535
Query: 554 GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLL 613
QG++EFKNEV+ I+KLQHRNLVKLLGCC +E+MLIYEY+PNKSL++FIFD +S +L
Sbjct: 536 NQGLDEFKNEVIYISKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVL 595
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
DW KR II GIARGLLYLHQDSRLRIIHRDLKA NVLLDN MNP+ISDFG+ARSFG ++
Sbjct: 596 DWPKRFVIINGIARGLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNE 655
Query: 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733
T A TKRVVGTYGYMSPEYAIDG++SVKSDVFSFGVL LEII GK+NRGFNH DHD NLL
Sbjct: 656 TIARTKRVVGTYGYMSPEYAIDGVYSVKSDVFSFGVLXLEIISGKRNRGFNHPDHDLNLL 715
Query: 734 GHV 736
GH
Sbjct: 716 GHA 718
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493740|ref|XP_002280379.2| PREDICTED: uncharacterized protein LOC100262430 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 885 bits (2288), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 443/759 (58%), Positives = 554/759 (72%), Gaps = 54/759 (7%)
Query: 23 MEGFNLLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYL 82
MEGF L++ +F I+ + +DT+++ Q I DGET+ SA SFELGFFSP +S++RY+
Sbjct: 1 MEGFATLVL---VFSILRVSIAVDTLTVNQIITDGETITSAGGSFELGFFSPDSSRNRYV 57
Query: 83 GIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQK 142
GIWYKK+A TV WVANR PL+ SG+L++ G LV+LN TN T+WSSNSS AQ
Sbjct: 58 GIWYKKVATRTVVWVANRQIPLTASSGILKVTDR--GTLVILNGTNTTIWSSNSSRPAQN 115
Query: 143 PVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKST 202
P A L++SGNLV+K+G D++ +N LWQSFDYPC+TLLPGMK G N TGL+R+LSSWK+T
Sbjct: 116 PNAQLLDSGNLVMKNGNDSDSENFLWQSFDYPCNTLLPGMKFGRNRVTGLDRYLSSWKTT 175
Query: 203 DDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNE 262
DDP+ G+FTY LDP G PQL++R S +TFR+G WNGL ++G PQL+ N VY++ ++ N+
Sbjct: 176 DDPSIGNFTYRLDPGGSPQLLVRNGSTVTFRSGPWNGLRFSGFPQLRPNSVYSYAFIFND 235
Query: 263 KEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGA 322
KE +YT+ L NSSV +R+V++P G QR+TW++RT W L +S D CDSYALCG
Sbjct: 236 KETYYTFELVNSSVITRLVLSPEGYAQRFTWIDRTSDWIL---YSSAQTDDCDSYALCGV 292
Query: 323 YASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPD 382
Y C IN SP+CEC++GF P Q WDM S GCVR TP+ C+ +GFL++ VKLPD
Sbjct: 293 YGICEIN-RSPKCECMKGFEPKFQSNWDMADWSDGCVRSTPMVCQKSNGFLKYSGVKLPD 351
Query: 383 TRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDL 442
TR SW ++++ L EC LC NCSCTAY N+D+RG GSGCLLWF DLIDI+E E+GQD
Sbjct: 352 TRNSWFNESMNLKECASLCLGNCSCTAYTNSDIRGGGSGCLLWFGDLIDIREYTENGQDF 411
Query: 443 FIRMAASEL------------DNVE---------------RRRQSKNKKQVMIIITSISL 475
+IRMA SEL ++V+ SK K+ +I++++S+
Sbjct: 412 YIRMAKSELGMSLSVPYLRIINSVQVFNDKYCTCVYAFAMTNSGSKGAKRKWVIVSTVSI 471
Query: 476 ATAVIFIGGLM--------YRRK------KHSNQG---NEKEE-MELPIFDLKIIANATD 517
++ L RRK KH+ +G NE+EE +ELP+FDL I NATD
Sbjct: 472 VGIILLSLVLTLYVLRKKRLRRKGNNLYSKHNCKGAEINEREEDLELPLFDLDTILNATD 531
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
NFS NKLGEGGFGPVYKGML +G+EIAVKRLSK S QG++EFKNEV I+KLQHRNLVK
Sbjct: 532 NFSNDNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESRQGLDEFKNEVTHISKLQHRNLVK 591
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
LLGCC +E+MLIYEY+PNKSLD+FIFD +S +LDW KR II GIARGLLYLHQDSR
Sbjct: 592 LLGCCIHGEEKMLIYEYMPNKSLDFFIFDGMQSLVLDWPKRFVIINGIARGLLYLHQDSR 651
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL 697
LRIIHRDLKA NVLLDN MNP+ISDFG+ARSF +++EA TKRVVGTYGYMSPEYAIDG+
Sbjct: 652 LRIIHRDLKADNVLLDNEMNPRISDFGMARSFRGNESEARTKRVVGTYGYMSPEYAIDGV 711
Query: 698 FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
+S+KSDVFSFGVLVLEI+ GK+NRGFNH DH NLLGH
Sbjct: 712 YSIKSDVFSFGVLVLEIVTGKRNRGFNHPDHALNLLGHA 750
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224122858|ref|XP_002330381.1| predicted protein [Populus trichocarpa] gi|222871766|gb|EEF08897.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 885 bits (2288), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/733 (58%), Positives = 551/733 (75%), Gaps = 28/733 (3%)
Query: 23 MEGFNLLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYL 82
M G +L + S +F++ + +++I+ QS++DG+TLVS++ FELGFFSPGNS++RY+
Sbjct: 8 MGGQTILFLLSIVFFLSIPSTAIESINATQSLEDGDTLVSSEGHFELGFFSPGNSRNRYM 67
Query: 83 GIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQK 142
GIWYKKI+ TV WVANR+ PL+D SG+L+ +G L +NSTN T+WSSN S +A
Sbjct: 68 GIWYKKISSFTVVWVANRNTPLNDSSGMLKF--VDHGNLAFINSTNGTIWSSNISRAAIN 125
Query: 143 PVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKST 202
PVA L+++GNLVV+ DN+P+N LWQSFDYP D+ LPGMK GI+ TGLNR+L+SWKS
Sbjct: 126 PVAQLLDTGNLVVRAENDNDPENFLWQSFDYPGDSFLPGMKYGISFVTGLNRYLTSWKSP 185
Query: 203 DDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNE 262
DP+ G +T LDP G+PQ L + S+ FR+G WNGL ++G+ L+ NP+YTFE+V N+
Sbjct: 186 SDPSTGKYTNKLDPNGLPQYFLSQGSVDQFRSGPWNGLRFSGMINLKPNPIYTFEFVFNQ 245
Query: 263 KEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGA 322
+E +Y Y ++NSSV SRMV++P G +QR+TW++RT+ WTL+ +D CD +ALCGA
Sbjct: 246 EEIYYKYQIANSSVLSRMVLSPDGVLQRFTWIDRTQDWTLYLT---ANMDNCDRFALCGA 302
Query: 323 YASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPD 382
+ CNIN NSP C+CL+ F P S EW S GCVR+ PLDC +G+GF+++ +K+PD
Sbjct: 303 HGVCNIN-NSPACDCLKEFEPKSLEEWTAADWSQGCVRKAPLDCSNGEGFIKYTGIKVPD 361
Query: 383 TRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDL 442
TR SW +K I L EC+E+C KNCSCTAYAN DVR GSGC+LWF DLIDI++ E+GQD+
Sbjct: 362 TRKSWYNKTINLEECEEVCLKNCSCTAYANLDVRDGGSGCVLWFGDLIDIRQYNENGQDI 421
Query: 443 FIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYR------RKKHSNQG 496
+IR+AAS +D + +S+ KK+V II+ +SL + L R +++ + +G
Sbjct: 422 YIRIAASVID---KPVKSRGKKRVRIIVIPVSLVAFSLLALCLFLRFLRKNKQQQLTREG 478
Query: 497 N-------------EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE 543
N E++ELP+FDL + +AT+ FS NKLG+GGFGPVYKG+L +GQE
Sbjct: 479 NVVTNPEQDRTKESRNEDLELPLFDLATLTDATNCFSINNKLGQGGFGPVYKGILQDGQE 538
Query: 544 IAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF 603
IAVKRLSK S QG+ EF+NEV+ IAKLQHRNLVKLLGCC + +ERMLIYEY+PNKSLD F
Sbjct: 539 IAVKRLSKRSRQGINEFRNEVVCIAKLQHRNLVKLLGCCIELEERMLIYEYMPNKSLDSF 598
Query: 604 IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
IFD R+ LLDW+KR II GIARGLLYLHQDSRLRIIHRDLKASN+LLD MNPKISDF
Sbjct: 599 IFDKRRNMLLDWTKRFPIINGIARGLLYLHQDSRLRIIHRDLKASNILLDYEMNPKISDF 658
Query: 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723
G+ARSFG D+T ANT R+VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI+ G+KNRGF
Sbjct: 659 GMARSFGGDETSANTSRIVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIVSGRKNRGF 718
Query: 724 NHADHDHNLLGHV 736
HA+H NLLGH
Sbjct: 719 RHAEHKLNLLGHA 731
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493715|ref|XP_002280938.2| PREDICTED: uncharacterized protein LOC100246941 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 884 bits (2283), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 440/715 (61%), Positives = 539/715 (75%), Gaps = 18/715 (2%)
Query: 34 FLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGT 93
+F I + +DTI+L Q ++DGE L SA SFELGFFSP +S RYLGIWYKK++ T
Sbjct: 9 LVFSIFRISIAVDTIALNQVVRDGEILTSAGGSFELGFFSPDDSNRRYLGIWYKKVSTMT 68
Query: 94 VTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTV-WSSNSSISAQKPVAALMESGN 152
V WVANR+ PL+D SGVL++ + G L +LN +N + WSSNSS SA+ P A L++SGN
Sbjct: 69 VVWVANREIPLNDSSGVLKVTDQ--GTLAILNGSNTNILWSSNSSRSARNPTAQLLDSGN 126
Query: 153 LVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTY 212
LV+KDG D+NP+N LWQSFDYPC+TLLPGMKLG N TGL+R+LS+WKS DDP++G+FTY
Sbjct: 127 LVMKDGNDDNPENFLWQSFDYPCNTLLPGMKLGRNTVTGLDRYLSAWKSVDDPSKGNFTY 186
Query: 213 GLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLS 272
LDP G PQL+LRK S +TFR+G WNGL ++G P+L NPVYT+E+V NEKE ++ Y L
Sbjct: 187 RLDPSGYPQLILRKGSAVTFRSGPWNGLRFSGFPELGSNPVYTYEFVFNEKEMYFRYELV 246
Query: 273 NSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNS 332
NSSV SR+V+NP G+ QR W++RT W L+S +D CDSYALCG Y SCNIN S
Sbjct: 247 NSSVVSRLVLNPDGSKQRVNWIDRTHGWILYS---SAPMDSCDSYALCGVYGSCNIN-RS 302
Query: 333 PECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNI 392
P+CEC++GFVP +WDM S GCVR TPL C++G+GF++ VKLPDTR SW ++++
Sbjct: 303 PKCECMEGFVPKFPNDWDMADWSNGCVRSTPLGCQNGEGFVKFSGVKLPDTRNSWFNRSM 362
Query: 393 TLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELD 452
L EC +C NCSCTAY N D+R GSGCLLWF DLIDI+E E+GQ+L++RMAASEL
Sbjct: 363 DLKECAAVCLSNCSCTAYTNLDIRDGGSGCLLWFGDLIDIREFNENGQELYVRMAASELG 422
Query: 453 NVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKK-----------HSNQGNEKEE 501
R K KK+ +I+ S+S ++ L K ++ +G +KE+
Sbjct: 423 MHRRSGNFKGKKREWVIVGSVSSLGIILLCLLLTLYLLKKKKLRKKGTMGYNLEGGQKED 482
Query: 502 MELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFK 561
+ELP+FD ++ AT++FS NKLGEGGFG VYKG L E QEIAVKRLSK SGQG+ EFK
Sbjct: 483 VELPLFDFATVSKATNHFSIHNKLGEGGFGLVYKGTLQEEQEIAVKRLSKNSGQGLNEFK 542
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
NEV+ I+KLQHRNLV+LLG C +E+MLIYEY+PNKSLD FIFD TRS LDW+KR I
Sbjct: 543 NEVIYISKLQHRNLVRLLGGCIHDEEKMLIYEYMPNKSLDSFIFDKTRSMELDWNKRFLI 602
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
I GIARGLLYLHQDSRLRIIHRDLKA NVLLD M PKISDFG+ARSFG ++TEANTKRV
Sbjct: 603 INGIARGLLYLHQDSRLRIIHRDLKADNVLLDEEMTPKISDFGIARSFGGNETEANTKRV 662
Query: 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
VGTYGYMSPEYAIDGL+S KSDVFSFGVLVLEI+ GK+NRGF+H DH NLLGH
Sbjct: 663 VGTYGYMSPEYAIDGLYSTKSDVFSFGVLVLEIVSGKRNRGFSHPDHSLNLLGHA 717
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|255569631|ref|XP_002525781.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis] gi|223534931|gb|EEF36617.1| S-locus-specific glycoprotein S13 precursor, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 881 bits (2277), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 438/738 (59%), Positives = 554/738 (75%), Gaps = 37/738 (5%)
Query: 23 MEGFNLLIIY-SFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRY 81
M+ ++L+I+ S+L I+ + DTI++ QS+ DGETLVSA ESF+LGFFSPGNS++RY
Sbjct: 44 MDDTSILVIFCSYLLLSITTSTAADTINITQSVTDGETLVSAGESFKLGFFSPGNSRTRY 103
Query: 82 LGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQ 141
LGIWY K++ TV WVANR+ PL D SGVL+I R IL LLN +WSSN +++A+
Sbjct: 104 LGIWYNKVSVMTVVWVANRETPLIDSSGVLKITDHR--ILALLNHNGSKIWSSNVTMAAR 161
Query: 142 KPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKS 201
PVA L++SGNL+VKD D+NP+N LWQSFDYPC+TLLPGMKLG N+ TGL+R++SSWK+
Sbjct: 162 NPVAQLLDSGNLIVKDEGDDNPENFLWQSFDYPCNTLLPGMKLGRNIATGLDRYISSWKT 221
Query: 202 TDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSN 261
DP+RG+FTYGLDP G P+++LR+NSI FRAG WNG ++G QL +NP++ +E+V N
Sbjct: 222 PSDPSRGNFTYGLDPAGYPEMILRENSIERFRAGPWNGRSYSGTSQLNVNPIFKYEFVIN 281
Query: 262 EKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCG 321
E E +Y + L NSSV SRMVIN G +QR+ W ER + W L+ F+ + D CD YALCG
Sbjct: 282 ETEIYYDFQLLNSSVLSRMVINENGILQRFIWAERERKWRLY--FT-IQTDDCDQYALCG 338
Query: 322 AYASCNINSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLP 381
A+ASCNI SNS C CL GFVP +EWD SGGCVR+TPL+C DGF ++ A KLP
Sbjct: 339 AFASCNIKSNS-YCSCLNGFVPKFPKEWDQADWSGGCVRKTPLNCS-SDGFQKYLAFKLP 396
Query: 382 DTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQD 441
+TR SW ++++ L +CK +C KNCSCT YAN D+R SGCLLWF D+ID EL GQD
Sbjct: 397 ETRKSWFNRSMNLEDCKNMCVKNCSCTVYANLDIREGESGCLLWFSDVIDTTELDGDGQD 456
Query: 442 LFIRMAASEL-----DNVERRRQSKNKKQVMIIITSI------SLATAVIFIGGLMYRRK 490
++IRM+AS+L D+ + + +S KKQ+ II++S+ SL+ AVI ++R+K
Sbjct: 457 IYIRMSASQLGVAHDDDPKIQSKSNVKKQMRIILSSLLSAGMMSLSLAVIL---YVWRKK 513
Query: 491 KH------------SNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGML 538
+ +N EKEE++LP+FD IA AT NFS+ NKLGEGGFG G L
Sbjct: 514 QKKEGKAIGILEISANDKGEKEELKLPLFDFGTIACATCNFSDANKLGEGGFG---LGNL 570
Query: 539 IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598
+GQEIAV+RLSK S QG++EF NEVL IAKLQHRNLV+LLGCC Q +E++LIYE++PNK
Sbjct: 571 KDGQEIAVRRLSKNSNQGVDEFMNEVLHIAKLQHRNLVRLLGCCIQSEEKLLIYEFMPNK 630
Query: 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658
SLD+FIFD T+SKLLDW KR HII GIARGLLYLHQDSRLRIIHRDLKA N+LLD MNP
Sbjct: 631 SLDFFIFDQTKSKLLDWPKRYHIINGIARGLLYLHQDSRLRIIHRDLKAGNILLDYEMNP 690
Query: 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
KISDFG AR F ++TEA+T +VVGT+GYMSPEYAIDGL+S+KSDVFSFGV+VLEI+ GK
Sbjct: 691 KISDFGPARCFWGNETEASTDKVVGTHGYMSPEYAIDGLYSMKSDVFSFGVIVLEIVSGK 750
Query: 719 KNRGFNHADHDHNLLGHV 736
+NRGF H +H NLLGH
Sbjct: 751 RNRGFYHPEHQLNLLGHA 768
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493725|ref|XP_002280679.2| PREDICTED: uncharacterized protein LOC100260657 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 880 bits (2274), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 434/724 (59%), Positives = 535/724 (73%), Gaps = 23/724 (3%)
Query: 30 IIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKI 89
+I+S++ ++ + +DTI + Q+I DGET+ SA SFELGFFSPGNSK+RYLGIWYKK+
Sbjct: 9 VIFSYVLSLLRISVAVDTIIVNQNITDGETITSAGGSFELGFFSPGNSKNRYLGIWYKKV 68
Query: 90 AEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALME 149
A GTV WVANR++PL+D SGVL++ GILVL+N TN +W+SNSS A+ P A L+E
Sbjct: 69 ATGTVVWVANRESPLTDSSGVLKVT--EQGILVLVNGTNGILWNSNSSRFAEDPNAQLLE 126
Query: 150 SGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGD 209
SGNLV++ G D++ +N WQSFDYPCDTLLPGMK G N TGL+R+LSSWKS DDP++G+
Sbjct: 127 SGNLVMRSGNDSDSENFFWQSFDYPCDTLLPGMKFGRNRVTGLDRYLSSWKSDDDPSKGN 186
Query: 210 FTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTY 269
FTYG+D G PQL+LR + FRAG WNG+ ++G+PQL N VYTF +VSNEKE ++ Y
Sbjct: 187 FTYGIDLSGFPQLLLRNGLAVEFRAGPWNGVRYSGIPQLTNNSVYTFNFVSNEKEIYFIY 246
Query: 270 NLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNIN 329
+L NSSV R+V+ P G +R+TW ++ WTL+S D CD+YA+CG Y C I+
Sbjct: 247 SLVNSSVIMRLVLTPDGYSRRFTWTDQKNEWTLYST---TQKDDCDNYAICGVYGICKID 303
Query: 330 SNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVD 389
SP+CEC++GF P Q WDM S GCVR TPLDC+ GDGF+++ VKLPDTR SW D
Sbjct: 304 E-SPKCECMKGFRPKFQSNWDMADWSKGCVRSTPLDCQKGDGFVKYSGVKLPDTRNSWFD 362
Query: 390 KNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAAS 449
+++ L EC LC +NCSCTAYAN+D+RG GSGCLLWF DLIDI++ ++GQ+ + RMAAS
Sbjct: 363 ESMNLKECASLCLRNCSCTAYANSDIRGGGSGCLLWFDDLIDIRDFTQNGQEFYARMAAS 422
Query: 450 ELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRK-------------KHSNQG 496
E D + S KK+ I SIS+ V+ L +H+ +G
Sbjct: 423 ESDALSSLNSSSKKKKKQAIAISISITGVVLLSLVLTLCVLKKRKRRLKRRGYMEHNIEG 482
Query: 497 NE----KEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG 552
+E +E +E+P+FDL + NAT+NFS NKLGEGGFGPVYKG+L EGQEIAVK + K
Sbjct: 483 DETNEGQEHLEIPLFDLDTLLNATNNFSSDNKLGEGGFGPVYKGILQEGQEIAVKMMLKT 542
Query: 553 SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL 612
S QG+EE KNE IAKLQHRNLVKLLGCC ERMLIYEYLPNKSLD FIFD RS +
Sbjct: 543 SRQGLEELKNEAESIAKLQHRNLVKLLGCCIHGRERMLIYEYLPNKSLDLFIFDQMRSVV 602
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
LDW KR HII GIARGLLYLHQDSRLRIIHRDLKA N+LLDN M+PKISDFG+ARSFG +
Sbjct: 603 LDWPKRFHIINGIARGLLYLHQDSRLRIIHRDLKAENILLDNEMSPKISDFGIARSFGGN 662
Query: 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNL 732
+TEANT RV GT GYMSPEYA +GL+S KSDVFSFGVLVLEI+ GK+N GFNH D + NL
Sbjct: 663 ETEANTTRVAGTLGYMSPEYASEGLYSTKSDVFSFGVLVLEIVSGKRNIGFNHPDRNINL 722
Query: 733 LGHV 736
LGH
Sbjct: 723 LGHA 726
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493721|ref|XP_002280717.2| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At4g27290-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 877 bits (2265), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 429/709 (60%), Positives = 532/709 (75%), Gaps = 41/709 (5%)
Query: 28 LLIIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYK 87
L+ ++S++ I+ + +D+I+ Q IKDGET++SA +FELGF G SK++YLGIWYK
Sbjct: 37 LVFLFSYVISILRISTAVDSITANQHIKDGETIISAGGNFELGFVHLGTSKNQYLGIWYK 96
Query: 88 KIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAAL 147
K+ TV WVANR+ P++D SGVL++ + G LV+LN +N +WSSNSS SA+ P A L
Sbjct: 97 KVTPRTVVWVANRELPVTDSSGVLKVTDQ--GSLVILNGSNGLIWSSNSSRSARNPTAQL 154
Query: 148 MESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPAR 207
++SGNLV+K G D++PDN LWQSFDYP DTLLPGMK G N TGL+R+LSSWKS DDP++
Sbjct: 155 LDSGNLVIKSGNDSDPDNFLWQSFDYPGDTLLPGMKHGRNTVTGLDRYLSSWKSNDDPSK 214
Query: 208 GDFTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFY 267
GDFTYGLDP G PQL LR S + FR+G WNG+ + G P+L+ NPV+ + +V NEKE ++
Sbjct: 215 GDFTYGLDPSGCPQLFLRSGSTVIFRSGPWNGIRFNGFPELRPNPVFNYSFVFNEKEMYF 274
Query: 268 TYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCN 327
TY L NSSV SR+V+NP G VQR W+ RTK+W ++S D CDSYALCGAY++CN
Sbjct: 275 TYKLVNSSVLSRLVLNPNGNVQRLIWIGRTKSWNVYST---AYKDDCDSYALCGAYSTCN 331
Query: 328 INSNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSW 387
I+ SP C C++GFVP +WD S GCVR+T LDC+ GDGF++ VKLPDTR SW
Sbjct: 332 IH-RSPRCGCMKGFVPKFPYQWDTMDWSNGCVRKTSLDCQKGDGFVKCSGVKLPDTRNSW 390
Query: 388 VDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMA 447
++++ L EC LC +NCSC+AY N+D++G GSGCLLWF DLID+KE E+GQD +IRMA
Sbjct: 391 FNESMNLKECASLCLRNCSCSAYTNSDIKGGGSGCLLWFGDLIDVKEFTENGQDFYIRMA 450
Query: 448 ASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQGNEKEEMELPIF 507
ASEL+ + N++Q E++ELP+F
Sbjct: 451 ASELE-LNNEGAETNERQ----------------------------------EDLELPLF 475
Query: 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLI 567
DL I NAT NFS NKLGEGGFGPVYKGML +G+EIAVKRLSK S QG++EFKNEV+ I
Sbjct: 476 DLDTILNATHNFSRNNKLGEGGFGPVYKGMLQDGKEIAVKRLSKESNQGLDEFKNEVIYI 535
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+KLQHRNLVKLLGCC +E+MLIYEY+PNKSL++FIFD +S +LDW KR II GIAR
Sbjct: 536 SKLQHRNLVKLLGCCIHGEEKMLIYEYMPNKSLNFFIFDGIQSMVLDWPKRFVIINGIAR 595
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
GLLYLHQDSRLRIIHRDLKA NVLLDN MNP+ISDFG+ARSFG ++T+A TKRVVGTYGY
Sbjct: 596 GLLYLHQDSRLRIIHRDLKADNVLLDNEMNPRISDFGMARSFGGNETQARTKRVVGTYGY 655
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
MSPEYAIDG++SVKSDVFSFGVL+LEII GK+NRGFNH DHD NLLGH
Sbjct: 656 MSPEYAIDGVYSVKSDVFSFGVLLLEIISGKRNRGFNHPDHDLNLLGHA 704
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359493727|ref|XP_002280656.2| PREDICTED: uncharacterized protein LOC100243545 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 875 bits (2262), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 417/707 (58%), Positives = 527/707 (74%), Gaps = 9/707 (1%)
Query: 30 IIYSFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKI 89
+I+S++ ++ + +DTI + Q+I DGET+ SA SFELGFFSPGNSK+RYLGIWYKK
Sbjct: 9 VIFSYVLSLLRISVAVDTIIVNQNITDGETITSAGGSFELGFFSPGNSKNRYLGIWYKKA 68
Query: 90 AEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALME 149
++ V WVANR++P++D SGVL++ + GILVL+N TN +W+S SS SAQ P A L+E
Sbjct: 69 SKKPVVWVANRESPITDSSGVLKVT--QPGILVLVNGTNGILWNSTSSRSAQDPNAQLLE 126
Query: 150 SGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGD 209
SGNLV+++G D +P+N LWQSFDYPCDTLLPGMKLG N GL+R+LSSWKS DDP++G+
Sbjct: 127 SGNLVMRNGNDRDPENFLWQSFDYPCDTLLPGMKLGRNRVAGLDRYLSSWKSADDPSKGN 186
Query: 210 FTYGLDPRGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTY 269
FTY +DP G PQL+LR + FR G WNG+ ++G+PQL +NPVY++EYVSNEKE +Y Y
Sbjct: 187 FTYWIDPSGFPQLLLRNGLAVAFRPGPWNGIRFSGIPQLTINPVYSYEYVSNEKEIYYIY 246
Query: 270 NLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNIN 329
+L NSSV R+V+ P G QR W ++ WTL+S DQCD+YA+CG C I+
Sbjct: 247 SLVNSSVIMRLVLTPDGAAQRSIWTDKKNEWTLYST---AQRDQCDNYAICGVNGICKID 303
Query: 330 SNSPECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVD 389
SP CEC++GF P Q WDM+ S GCVR TPLDC+ GDGF+++ VKLPDTR SW +
Sbjct: 304 -QSPNCECMKGFRPKFQSNWDMEDWSNGCVRSTPLDCQKGDGFVKYSGVKLPDTRSSWFN 362
Query: 390 KNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAAS 449
+++ L EC LC NCSCTAYAN+D+RG GSGCLLWF DLIDI++ E+GQ+ ++RMAA+
Sbjct: 363 ESMNLKECASLCLSNCSCTAYANSDIRGGGSGCLLWFGDLIDIRDFTENGQEFYVRMAAA 422
Query: 450 ELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQGNEKEEMELPIFDL 509
+L+ + +R I + S+ L + ++ M K +E +ELP+FDL
Sbjct: 423 DLETTKEKRLGNRLNS--IFVNSLILHS-ILHFAAYMEHNSKGGENNEGQEHLELPLFDL 479
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK 569
+ NAT+NFS NKLGEGGFGPVYKG+L EGQEIAVK +SK S QG++EFKNEV IAK
Sbjct: 480 DTLLNATNNFSSDNKLGEGGFGPVYKGILQEGQEIAVKMMSKTSRQGLKEFKNEVESIAK 539
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
LQHRNLVKLLGCC ER+LIYE++PNKSLD FIFD R ++LDW KR II GIA+GL
Sbjct: 540 LQHRNLVKLLGCCIHGRERLLIYEHMPNKSLDLFIFDQMRRRVLDWPKRFLIINGIAQGL 599
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
LYLH+DSRLRIIHRDLKA N+LLDN M PKISDFG+ SFG ++ E NT RV T GYMS
Sbjct: 600 LYLHRDSRLRIIHRDLKAENILLDNEMIPKISDFGITGSFGGNEIETNTTRVARTLGYMS 659
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
PEYA +GL+S KSDVFSFGVLVLEI+ GK+N+GFNH HD +LLGH
Sbjct: 660 PEYAREGLYSTKSDVFSFGVLVLEIVSGKRNKGFNHPYHDLSLLGHA 706
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 738 | ||||||
| TAIR|locus:2131684 | 783 | AT4G27290 [Arabidopsis thalian | 0.563 | 0.531 | 0.516 | 9.9e-218 | |
| TAIR|locus:2131694 | 815 | AT4G27300 [Arabidopsis thalian | 0.917 | 0.830 | 0.539 | 2.9e-190 | |
| TAIR|locus:2141181 | 850 | RK3 "receptor kinase 3" [Arabi | 0.585 | 0.508 | 0.426 | 6.4e-190 | |
| TAIR|locus:2018546 | 843 | RK1 "receptor kinase 1" [Arabi | 0.581 | 0.508 | 0.401 | 7.8e-183 | |
| TAIR|locus:2018506 | 847 | RK2 "receptor kinase 2" [Arabi | 0.373 | 0.325 | 0.631 | 5e-179 | |
| TAIR|locus:2141176 | 849 | B120 [Arabidopsis thaliana (ta | 0.325 | 0.282 | 0.676 | 2.8e-165 | |
| TAIR|locus:2200908 | 842 | AT1G61610 [Arabidopsis thalian | 0.323 | 0.283 | 0.658 | 2.6e-160 | |
| TAIR|locus:2200151 | 830 | SD1-13 "S-domain-1 13" [Arabid | 0.319 | 0.284 | 0.618 | 2.5e-149 | |
| UNIPROTKB|O49974 | 848 | KIK1 "Serine/threonine-protein | 0.315 | 0.274 | 0.665 | 3e-144 | |
| TAIR|locus:2197729 | 805 | SD1-29 "S-domain-1 29" [Arabid | 0.880 | 0.807 | 0.442 | 8.6e-143 |
| TAIR|locus:2131684 AT4G27290 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1220 (434.5 bits), Expect = 9.9e-218, Sum P(2) = 9.9e-218
Identities = 223/432 (51%), Positives = 306/432 (70%)
Query: 42 ARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRD 101
A+ D + Q++KDG+T+VS SFE+GFFSPG S++RYLGIWYKKI+ TV WVANRD
Sbjct: 21 AQATDILIANQTLKDGDTIVSQGGSFEVGFFSPGGSRNRYLGIWYKKISLQTVVWVANRD 80
Query: 102 APLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQK-----PVAALMESGNLVVK 156
+PL D SG L+++ NG L L N N +WSS+SS S+QK P+ ++++GNLVV+
Sbjct: 81 SPLYDLSGTLKVS--ENGSLCLFNDRNHIIWSSSSSPSSQKASLRNPIVQILDTGNLVVR 138
Query: 157 DGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDP 216
+ D+ + +WQS DYP D LPGMK G+N TGLNRFL+SW++ DDP+ G++T +DP
Sbjct: 139 NSGDDQ--DYIWQSLDYPGDMFLPGMKYGLNFVTGLNRFLTSWRAIDDPSTGNYTNKMDP 196
Query: 217 RGIPQLVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSV 276
G+PQ L+KNS++ FR G WNGL +TG+P L+ NP+Y +EYV E+E +YTY L N SV
Sbjct: 197 NGVPQFFLKKNSVVVFRTGPWNGLRFTGMPNLKPNPIYRYEYVFTEEEVYYTYKLENPSV 256
Query: 277 PSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECE 336
+RM +NP G +QRYTW++ ++W + S + +D CD Y LCG+Y SCNIN SP C
Sbjct: 257 LTRMQLNPNGALQRYTWVDNLQSWNFY--LSAM-MDSCDQYTLCGSYGSCNINE-SPACR 312
Query: 337 CLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHG-DGFLEHKAVKLPDTRFSWVDKNITLW 395
CL+GFV + + W S GCVRR LDC G DGFL+ +KLPDTR SW DKN+ L
Sbjct: 313 CLKGFVAKTPQAWVAGDWSEGCVRRVKLDCGKGEDGFLKISKLKLPDTRTSWYDKNMDLN 372
Query: 396 ECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVE 455
ECK++C +NC+C+AY+ D+R G GC+LWF DLIDI+E E+GQDL++R+A+SE++ ++
Sbjct: 373 ECKKVCLRNCTCSAYSPFDIRDGGKGCILWFGDLIDIREYNENGQDLYVRLASSEIETLQ 432
Query: 456 RR--RQSKNKKQ 465
R R S K++
Sbjct: 433 RESSRVSSRKQE 444
|
|
| TAIR|locus:2131694 AT4G27300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1844 (654.2 bits), Expect = 2.9e-190, P = 2.9e-190
Identities = 381/706 (53%), Positives = 488/706 (69%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKS---RYLGIWYKKIAEGTVTWVANRDA 102
+ I+ + +KDG+TL S + F+LGFFS + R+LG+WY + V WVANR+
Sbjct: 26 NVITPKEFLKDGDTLSSPDQVFQLGFFSLDQEEQPQHRFLGLWYME--PFAVVWVANRNN 83
Query: 103 PLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSIS-----AQKPVAALMESGNLVVKD 157
PL SG L ++ G L L + + +WSS+SS + A P+ + SGNL+ D
Sbjct: 84 PLYGTSGFLNLSSL--GDLQLFDGEHKALWSSSSSSTKASKTANNPLLKISCSGNLISSD 141
Query: 158 GKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPR 217
G++ +LWQSFDYP +T+L GMKLG N T + LSSWK+ DP+ GDFT LD R
Sbjct: 142 GEEA----VLWQSFDYPMNTILAGMKLGKNFKTQMEWSLSSWKTLKDPSPGDFTLSLDTR 197
Query: 218 GIPQLVLRKN--SIITFRAGSWNGLHWTGVPQL-QLNPVYTFEYVSNEKEAFYTYNLSNS 274
G+PQL+LRKN S ++R GSWNGL +TG P + + N ++ +++ S+ +E Y++ +
Sbjct: 198 GLPQLILRKNGDSSYSYRLGSWNGLSFTGAPAMGRENSLFDYKFTSSAQEVNYSWTPRHR 257
Query: 275 SVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINS-NSP 333
V SR+V+N G + R+ ++ + W L + D+CD Y++CGAYA C INS N+P
Sbjct: 258 IV-SRLVLNNTGKLHRFIQSKQNQ-WILANT---APEDECDYYSICGAYAVCGINSKNTP 312
Query: 334 ECECLQGFVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVD-KN- 391
C CLQGF P S R+W++ + GCV P +C+ D F++ +KLPDT +SW D KN
Sbjct: 313 SCSCLQGFKPKSGRKWNISRGAYGCVHEIPTNCEKKDAFVKFPGLKLPDTSWSWYDAKNE 372
Query: 392 ITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASEL 451
+TL +CK CS NCSCTAYAN D+R G GCLLWF DL+D++E GQD++IRM +++
Sbjct: 373 MTLEDCKIKCSSNCSCTAYANTDIREGGKGCLLWFGDLVDMREYSSFGQDVYIRMGFAKI 432
Query: 452 DNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYR-RKKHSNQGNEKEEMELPIFDLK 510
+ R V+ I + + A F +M R R ++ +G E+E+++LPIFD K
Sbjct: 433 EFKGREVVGMVVGSVVAIAVVLVVVFAC-FRKKIMKRYRGENFRKGIEEEDLDLPIFDRK 491
Query: 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
I+ ATD+FS N LG GGFGPVYKG L +GQEIAVKRLS SGQG+EEFKNEV LIAKL
Sbjct: 492 TISIATDDFSYVNFLGRGGFGPVYKGKLEDGQEIAVKRLSANSGQGVEEFKNEVKLIAKL 551
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
QHRNLV+LLGCC Q +E MLIYEY+PNKSLD+FIFD RS LDW KR +II G+ARG+L
Sbjct: 552 QHRNLVRLLGCCIQGEECMLIYEYMPNKSLDFFIFDERRSTELDWKKRMNIINGVARGIL 611
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLHQDSRLRIIHRDLKA NVLLDN MNPKISDFGLA+SFG DQ+E++T RVVGTYGYM P
Sbjct: 612 YLHQDSRLRIIHRDLKAGNVLLDNDMNPKISDFGLAKSFGGDQSESSTNRVVGTYGYMPP 671
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
EYAIDG FSVKSDVFSFGVLVLEII GK NRGF HADHD NLLGHV
Sbjct: 672 EYAIDGHFSVKSDVFSFGVLVLEIITGKTNRGFRHADHDLNLLGHV 717
|
|
| TAIR|locus:2141181 RK3 "receptor kinase 3" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 998 (356.4 bits), Expect = 6.4e-190, Sum P(2) = 6.4e-190
Identities = 193/452 (42%), Positives = 294/452 (65%)
Query: 46 DTISLGQS--IKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAP 103
+T+S +S I T+VS FELGFF PG YLGIWYK I++ T WVANRD P
Sbjct: 30 NTLSASESLTISSNNTIVSPGNVFELGFFKPGLDSRWYLGIWYKAISKRTYVWVANRDTP 89
Query: 104 LSDRSGVLRINGERNGILVLLNSTNDTVWSSN-SSISAQKP-VAALMESGNLVVKDGKDN 161
LS G L+I+ + N LV+L+ ++ VWS+N + + P VA L+++GN V++D K++
Sbjct: 90 LSSSIGTLKIS-DSN--LVVLDQSDTPVWSTNLTGGDVRSPLVAELLDNGNFVLRDSKNS 146
Query: 162 NPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQ 221
PD +LWQSFD+P DTLLP MKLG + TG NRF+ SWKS DDP+ GDF++ L+ G P+
Sbjct: 147 APDGVLWQSFDFPTDTLLPEMKLGWDAKTGFNRFIRSWKSPDDPSSGDFSFKLETEGFPE 206
Query: 222 LVLRKNSIITFRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMV 281
+ L +R+G WNG+ ++GVP++Q F + ++++E Y++ ++ S V SR+
Sbjct: 207 IFLWNRESRMYRSGPWNGIRFSGVPEMQPFEYMVFNFTTSKEEVTYSFRITKSDVYSRLS 266
Query: 282 INPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGF 341
I+ +G +QR+TW+E + W ++F DQCD Y CG Y C+ N+ SP C C++GF
Sbjct: 267 ISSSGLLQRFTWIETAQNW---NQFWYAPKDQCDEYKECGVYGYCDSNT-SPVCNCIKGF 322
Query: 342 VPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELC 401
P + + W ++ S GCVR+T L C GDGF+ K +KLPDT + VD+ I + EC++ C
Sbjct: 323 KPRNPQVWGLRDGSDGCVRKTLLSCGGGDGFVRLKKMKLPDTTTASVDRGIGVKECEQKC 382
Query: 402 SKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRRQSK 461
++C+CTA+AN D+RG GSGC+ W +L DI+ + GQDL++R+AA++L++ +R R +K
Sbjct: 383 LRDCNCTAFANTDIRGSGSGCVTWTGELFDIRNYAKGGQDLYVRLAATDLED-KRNRSAK 441
Query: 462 NKKQVMIIITSISLATAVI--FIGGLMYRRKK 491
II +SI ++ ++ FI +++RK+
Sbjct: 442 ------IIGSSIGVSVLLLLSFIIFFLWKRKQ 467
|
|
| TAIR|locus:2018546 RK1 "receptor kinase 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 910 (325.4 bits), Expect = 7.8e-183, Sum P(2) = 7.8e-183
Identities = 181/451 (40%), Positives = 289/451 (64%)
Query: 46 DTISLGQS--IKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAP 103
+T+S +S I +T++S + FELGFF+P +S YLGIWYK I T WVANRD P
Sbjct: 28 NTLSATESLTISSNKTIISPSQIFELGFFNPASSSRWYLGIWYKIIPIRTYVWVANRDNP 87
Query: 104 LSDRSGVLRINGERNGILVLLNSTNDTVWSSN-SSISAQKPVAA-LMESGNLVVKDGKDN 161
LS +G L+I+G LV+ + ++ VWS+N + + PVAA L+++GN +++D N
Sbjct: 88 LSSSNGTLKISGNN---LVIFDQSDRPVWSTNITGGDVRSPVAAELLDNGNFLLRDS--N 142
Query: 162 NPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQ 221
N +LWQSFD+P DTLL MKLG + TG NR L SWK+TDDP+ G+F+ L+ P+
Sbjct: 143 N--RLLWQSFDFPTDTLLAEMKLGWDQKTGFNRILRSWKTTDDPSSGEFSTKLETSEFPE 200
Query: 222 LVLRKNSIITFRAGSWNGLHWTGVP-QLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRM 280
+ I +R+G WNG+ ++ VP +Q++ + + + ++++E Y+Y ++ +++ SR+
Sbjct: 201 FYICSKESILYRSGPWNGMRFSSVPGTIQVDYM-VYNFTASKEEVTYSYRINKTNLYSRL 259
Query: 281 VINPAGTVQRYTWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQG 340
+N AG +QR TW E T++W +S D CD+Y +CG + C+ NS P C C++G
Sbjct: 260 YLNSAGLLQRLTWFETTQSWKQLW-YS--PKDLCDNYKVCGNFGYCDSNS-LPNCYCIKG 315
Query: 341 FVPNSQREWDMQYKSGGCVRRTPLDCKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKEL 400
F P +++ WD++ S GC+R+T L C DGF K +KLPDT + VD+ I L CKE
Sbjct: 316 FKPVNEQAWDLRDGSAGCMRKTRLSCDGRDGFTRLKRMKLPDTTATIVDREIGLKVCKER 375
Query: 401 CSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRRQS 460
C ++C+CTA+ANAD+R GSGC++W +++D++ + GQDL++R+AA+EL++ ++
Sbjct: 376 CLEDCNCTAFANADIRNGGSGCVIWTREILDMRNYAKGGQDLYVRLAAAELED----KRI 431
Query: 461 KNKKQVMIIITSISLATAVIFIGGLMYRRKK 491
KN+K + I +S+ + F+ ++RK+
Sbjct: 432 KNEKIIGSSI-GVSILLLLSFVIFHFWKRKQ 461
|
|
| TAIR|locus:2018506 RK2 "receptor kinase 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 885 (316.6 bits), Expect = 5.0e-179, Sum P(2) = 5.0e-179
Identities = 175/277 (63%), Positives = 216/277 (77%)
Query: 461 KNKKQVMIIITSISLATAV-IFIGGLMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNF 519
K K+ + I + L + + L+ + ++++ N+ + +ELP+ + K +A AT+NF
Sbjct: 464 KQKRSITIQTPIVDLVRSQDSLMNELVKASRSYTSKENKTDYLELPLMEWKALAMATNNF 523
Query: 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
S NKLG+GGFG VYKGML++G+EIAVKRLSK S QG +EF NEV LIAKLQH NLV+LL
Sbjct: 524 STDNKLGQGGFGIVYKGMLLDGKEIAVKRLSKMSSQGTDEFMNEVRLIAKLQHINLVRLL 583
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
GCC + E+MLIYEYL N SLD +FD TRS L+W KR II GIARGLLYLHQDSR R
Sbjct: 584 GCCVDKGEKMLIYEYLENLSLDSHLFDQTRSSNLNWQKRFDIINGIARGLLYLHQDSRCR 643
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
IIHRDLKASNVLLD M PKISDFG+AR FG ++TEANT+RVVGTYGYMSPEYA+DG+FS
Sbjct: 644 IIHRDLKASNVLLDKNMTPKISDFGMARIFGREETEANTRRVVGTYGYMSPEYAMDGIFS 703
Query: 700 VKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
+KSDVFSFGVL+LEII GK+N+GF +++ D NLLG V
Sbjct: 704 MKSDVFSFGVLLLEIISGKRNKGFYNSNRDLNLLGFV 740
|
|
| TAIR|locus:2141176 B120 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 865 (309.6 bits), Expect = 2.8e-165, Sum P(2) = 2.8e-165
Identities = 163/241 (67%), Positives = 201/241 (83%)
Query: 495 QGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG 554
+G ELP+F L IA AT++F ++N+LG GGFGPVYKG+L +G+EIAVKRLS SG
Sbjct: 505 EGKAVNTSELPVFSLNAIAIATNDFCKENELGRGGFGPVYKGVLEDGREIAVKRLSGKSG 564
Query: 555 QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLD 614
QG++EFKNE++LIAKLQHRNLV+LLGCC + +E+ML+YEY+PNKSLD+F+FD T+ L+D
Sbjct: 565 QGVDEFKNEIILIAKLQHRNLVRLLGCCFEGEEKMLVYEYMPNKSLDFFLFDETKQALID 624
Query: 615 WSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
W R II GIARGLLYLH+DSRLRIIHRDLK SNVLLD MNPKISDFG+AR FG +Q
Sbjct: 625 WKLRFSIIEGIARGLLYLHRDSRLRIIHRDLKVSNVLLDAEMNPKISDFGMARIFGGNQN 684
Query: 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG 734
EANT RVVGTYGYMSPEYA++GLFSVKSDV+SFGVL+LEI+ GK+N ++H +L+G
Sbjct: 685 EANTVRVVGTYGYMSPEYAMEGLFSVKSDVYSFGVLLLEIVSGKRNTSLRSSEHG-SLIG 743
Query: 735 H 735
+
Sbjct: 744 Y 744
|
|
| TAIR|locus:2200908 AT1G61610 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 837 (299.7 bits), Expect = 2.6e-160, Sum P(2) = 2.6e-160
Identities = 158/240 (65%), Positives = 196/240 (81%)
Query: 496 GNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ 555
G++ + +LPIF +A+AT +F+E+NKLG+GGFG VYKG EG+EIAVKRLS S Q
Sbjct: 502 GDQVDTPDLPIFSFDSVASATGDFAEENKLGQGGFGTVYKGNFSEGREIAVKRLSGKSKQ 561
Query: 556 GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW 615
G+EEFKNE+LLIAKLQHRNLV+LLGCC + +E+ML+YEY+PNKSLD F+FD ++ LDW
Sbjct: 562 GLEEFKNEILLIAKLQHRNLVRLLGCCIEDNEKMLLYEYMPNKSLDRFLFDESKQGSLDW 621
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
KR +I GIARGLLYLH+DSRL+IIHRDLKASN+LLD MNPKISDFG+AR F Q
Sbjct: 622 RKRWEVIGGIARGLLYLHRDSRLKIIHRDLKASNILLDTEMNPKISDFGMARIFNYRQDH 681
Query: 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH 735
ANT RVVGTYGYM+PEYA++G+FS KSDV+SFGVL+LEI+ G+KN F DH +L+G+
Sbjct: 682 ANTIRVVGTYGYMAPEYAMEGIFSEKSDVYSFGVLILEIVSGRKNVSFRGTDHG-SLIGY 740
|
|
| TAIR|locus:2200151 SD1-13 "S-domain-1 13" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 774 (277.5 bits), Expect = 2.5e-149, Sum P(2) = 2.5e-149
Identities = 146/236 (61%), Positives = 189/236 (80%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG 556
N+ + ELP+F+ +++A AT+NFS NKLG+GGFG VYKG L EG +IAVKRLS+ SGQG
Sbjct: 490 NQYKLKELPLFEFQVLAVATNNFSITNKLGQGGFGAVYKGRLQEGLDIAVKRLSRTSGQG 549
Query: 557 MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
+EEF NEV++I+KLQHRNLV+LLG C + +ERML+YE++P LD ++FD + +LLDW
Sbjct: 550 VEEFVNEVVVISKLQHRNLVRLLGFCIEGEERMLVYEFMPENCLDAYLFDPVKQRLLDWK 609
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676
R +II GI RGL+YLH+DSRL+IIHRDLKASN+LLD +NPKISDFGLAR F ++ E
Sbjct: 610 TRFNIIDGICRGLMYLHRDSRLKIIHRDLKASNILLDENLNPKISDFGLARIFQGNEDEV 669
Query: 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNL 732
+T RVVGTYGYM+PEYA+ GLFS KSDVFS GV++LEI+ G++N F + + NL
Sbjct: 670 STVRVVGTYGYMAPEYAMGGLFSEKSDVFSLGVILLEIVSGRRNSSFYNDGQNPNL 725
|
|
| UNIPROTKB|O49974 KIK1 "Serine/threonine-protein kinase" [Zea mays (taxid:4577)] | Back alignment and assigned GO terms |
|---|
Score = 832 (297.9 bits), Expect = 3.0e-144, Sum P(2) = 3.0e-144
Identities = 155/233 (66%), Positives = 190/233 (81%)
Query: 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN 562
EL ++ L I AT NFS+ NKLGEGGFGPVY G L G+E+AVKRL + SGQG+EEFKN
Sbjct: 514 ELKVYSLDRIRTATSNFSDSNKLGEGGFGPVYMGTLPGGEEVAVKRLCRNSGQGLEEFKN 573
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
EV+LIAKLQHRNLV+LLGCC R+E++L+YEY+PNKSLD F+F+ + +LLDW KR II
Sbjct: 574 EVILIAKLQHRNLVRLLGCCIPREEKILVYEYMPNKSLDAFLFNPEKQRLLDWKKRFDII 633
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
GIARGLLYLH+DSRLR++HRDLKASN+LLD M PKISDFG+AR FG DQ + NT RVV
Sbjct: 634 EGIARGLLYLHRDSRLRVVHRDLKASNILLDADMKPKISDFGMARMFGGDQNQFNTNRVV 693
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH 735
GT+GYMSPEYA++G+FSVKSDV+ FGVL+LEII GK+ F+ + N+ G+
Sbjct: 694 GTFGYMSPEYAMEGIFSVKSDVYGFGVLILEIITGKRAVSFHCHEDSLNIAGY 746
|
|
| TAIR|locus:2197729 SD1-29 "S-domain-1 29" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1396 (496.5 bits), Expect = 8.6e-143, P = 8.6e-143
Identities = 310/700 (44%), Positives = 429/700 (61%)
Query: 58 ETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGER 117
+TL S +ELGFFSP N++++Y+GIW+KKI V WVANRD P++ + L I+
Sbjct: 33 QTLSSPGGFYELGFFSPNNTQNQYVGIWFKKIVPRVVVWVANRDTPVTSSAANLTISS-- 90
Query: 118 NGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDT 177
NG L+LL+ D +WS+ + ++ K A L+++GN VV D N LWQSF++ +T
Sbjct: 91 NGSLILLDGKQDVIWSTGKAFTSNKCHAELLDTGNFVVIDDVSGNK---LWQSFEHLGNT 147
Query: 178 LLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIP-QLVLRKNSIITFRAGS 236
+LP L + G R L++WKS DP+ G+F+ + P+ IP Q ++R+ S+ +R G
Sbjct: 148 MLPQSSLMYDTSNGKKRVLTTWKSNSDPSPGEFSLEITPQ-IPTQGLIRRGSVPYWRCGP 206
Query: 237 WNGLHWTGVPQLQLNPVYTFEYVSNEKEAF--YTYN-LSNSSVPSRMVINPAGTVQRYTW 293
W ++G+ + + V F V + ++Y+ L N ++ S + + P G + + W
Sbjct: 207 WAKTRFSGISGIDASYVSPFSVVQDTAAGTGSFSYSTLRNYNL-SYVTLTPEGKM-KILW 264
Query: 294 MERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGFVPNSQREWDMQY 353
+ W L + + CD Y CG Y C + S+ P+CECL+GFVP S EW
Sbjct: 265 -DDGNNWKLHL---SLPENPCDLYGRCGPYGLC-VRSDPPKCECLKGFVPKSDEEWGKGN 319
Query: 354 KSGGCVRRTPLDC----------KHGDGFLEHKAVKLPDT-RFSWVDKNITLWECKELCS 402
+ GCVRRT L C K D F VK PD +F+ + +C + C
Sbjct: 320 WTSGCVRRTKLSCQAKSSMKTQGKDTDIFYRMTDVKTPDLHQFA---SFLNAEQCYQGCL 376
Query: 403 KNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESGQDLFIRMAASELDNVERRRQSKN 462
NCSCTA+A G GCL+W +L D + SG+ LFIR+A+SEL RR+
Sbjct: 377 GNCSCTAFAYIS----GIGCLVWNGELADTVQFLSSGEFLFIRLASSELAGSSRRK---- 428
Query: 463 KKQVMIIITSISLATAVIFI-GGLM---YRRKKHS--NQGNEKEEME-LPIFDLKIIANA 515
+I+ T++SL+ +I + +M YR K++ G E++++ + F++ I A
Sbjct: 429 ----IIVGTTVSLSIFLILVFAAIMLWRYRAKQNDAWKNGFERQDVSGVNFFEMHTIRTA 484
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
T+NFS NKLG+GGFGPVYKG L++G+EI VKRL+ SGQG EEF NE+ LI+KLQHRNL
Sbjct: 485 TNNFSPSNKLGQGGFGPVYKGKLVDGKEIGVKRLASSSGQGTEEFMNEITLISKLQHRNL 544
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V+LLG C +E++LIYE++ NKSLD FIFD LDW KR +II GIARGLLYLH+D
Sbjct: 545 VRLLGYCIDGEEKLLIYEFMVNKSLDIFIFDPCLKFELDWPKRFNIIQGIARGLLYLHRD 604
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
SRLR+IHRDLK SN+LLD+ MNPKISDFGLAR F Q + NT+RVVGT GYMSPEYA
Sbjct: 605 SRLRVIHRDLKVSNILLDDRMNPKISDFGLARMFQGTQYQDNTRRVVGTLGYMSPEYAWA 664
Query: 696 GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH 735
GLFS KSD++SFGVL+LEII GK+ F + D LL +
Sbjct: 665 GLFSEKSDIYSFGVLMLEIISGKRISRFIYGDESKGLLAY 704
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O81832 | Y4729_ARATH | 2, ., 7, ., 1, 1, ., 1 | 0.5547 | 0.9146 | 0.8620 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.914 |
| 3rd Layer | 2.7.11 | 0.921 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | eugene3.01340036 | hypothetical protein (831 aa) | |||||||||
(Populus trichocarpa) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 738 | |||
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-52 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 2e-51 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 2e-49 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 4e-48 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-47 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 1e-46 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 9e-46 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-39 | |
| pfam00954 | 110 | pfam00954, S_locus_glycop, S-locus glycoprotein fa | 2e-37 | |
| pfam01453 | 109 | pfam01453, B_lectin, D-mannose binding lectin | 3e-37 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-34 | |
| cd00028 | 116 | cd00028, B_lectin, Bulb-type mannose-specific lect | 4e-34 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-33 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 2e-33 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-32 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 9e-32 | |
| smart00108 | 114 | smart00108, B_lectin, Bulb-type mannose-specific l | 4e-31 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 1e-30 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 2e-30 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-30 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 3e-30 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 5e-30 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 3e-29 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 7e-29 | |
| pfam08276 | 66 | pfam08276, PAN_2, PAN-like domain | 7e-29 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 8e-29 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 9e-29 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 6e-28 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 9e-28 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-27 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-27 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-27 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 8e-27 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-27 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-26 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-26 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 3e-26 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-26 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-26 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-25 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 4e-25 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-25 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 7e-25 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 2e-24 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-24 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 6e-24 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 9e-24 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-23 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 2e-23 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 2e-23 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-23 | |
| cd01098 | 84 | cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain | 2e-23 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 3e-23 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-23 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-23 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 6e-23 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 1e-22 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-22 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-22 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 2e-22 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 2e-22 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 2e-22 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 4e-22 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 5e-22 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 7e-22 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 1e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-21 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 2e-21 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-21 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 2e-21 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 2e-21 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 3e-21 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-21 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-21 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 4e-21 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 4e-21 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 7e-21 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 7e-21 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 9e-21 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 1e-20 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-20 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-20 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 1e-20 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-20 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-20 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 3e-20 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 3e-20 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-20 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 5e-20 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 5e-20 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 6e-20 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 9e-20 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 9e-20 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 9e-20 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-19 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 1e-19 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 1e-19 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 2e-19 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-19 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 2e-19 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-19 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-19 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-19 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 4e-19 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 5e-19 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 5e-19 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 5e-19 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 5e-19 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-19 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 6e-19 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 1e-18 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-18 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 1e-18 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 2e-18 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-18 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 2e-18 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 2e-18 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 3e-18 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 4e-18 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 4e-18 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 4e-18 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 4e-18 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 6e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-18 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-18 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 7e-18 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 7e-18 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-18 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-17 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-17 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 1e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-17 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-17 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-17 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 2e-17 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 2e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-17 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 3e-17 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 3e-17 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 4e-17 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 4e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 4e-17 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 5e-17 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 6e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-17 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 6e-17 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 8e-17 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 8e-17 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 9e-17 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 9e-17 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 1e-16 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 1e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-16 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-16 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 2e-16 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 2e-16 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 4e-16 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 5e-16 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-16 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-16 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-16 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 6e-16 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 9e-16 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 9e-16 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 1e-15 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-15 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-15 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-15 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-15 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 2e-15 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-15 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 4e-15 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 5e-15 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 5e-15 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-15 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 8e-15 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 8e-15 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-15 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-14 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-14 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 2e-14 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-14 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 5e-14 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 5e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 6e-14 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 7e-14 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 7e-14 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 7e-14 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 9e-14 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-13 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-13 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-13 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-13 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-13 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-13 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 3e-13 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-13 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 3e-13 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-13 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-13 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-13 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 9e-13 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 9e-13 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 1e-12 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-12 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 1e-12 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-12 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-12 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 3e-12 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-12 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 4e-12 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-12 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-12 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 6e-12 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 8e-12 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 8e-12 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-11 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 1e-11 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 1e-11 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-11 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 1e-11 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-11 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 1e-11 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 2e-11 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 2e-11 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 2e-11 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-11 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 4e-11 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 4e-11 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 4e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 4e-11 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-11 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 5e-11 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 7e-11 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 8e-11 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 9e-11 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 9e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 9e-11 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 1e-10 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 1e-10 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-10 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-10 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 2e-10 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 2e-10 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 3e-10 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-10 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 6e-10 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-10 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 8e-10 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 1e-09 | |
| smart00473 | 78 | smart00473, PAN_AP, divergent subfamily of APPLE d | 2e-09 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-09 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 3e-09 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-09 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-09 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 5e-09 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 6e-09 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 7e-09 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-08 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-08 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 1e-08 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 2e-08 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 2e-08 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-08 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-08 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-08 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 3e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 4e-08 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 5e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 6e-08 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-08 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-07 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-07 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 2e-07 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 2e-07 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-07 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-07 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 3e-07 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 4e-07 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-07 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 7e-07 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-06 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 2e-06 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 2e-06 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 3e-06 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-06 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 6e-06 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 7e-06 | |
| cd00129 | 80 | cd00129, PAN_APPLE, PAN/APPLE-like domain; present | 1e-05 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-05 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 1e-05 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 2e-05 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-05 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 2e-05 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 3e-05 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 4e-05 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 4e-05 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 6e-05 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 2e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 3e-04 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 4e-04 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 8e-04 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.002 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 0.004 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 0.004 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 181 bits (463), Expect = 2e-52
Identities = 84/200 (42%), Positives = 111/200 (55%), Gaps = 17/200 (8%)
Query: 524 KLGEGGFGPVYKGMLI-----EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVK 577
KLGEG FG VYKG L + E+AVK L + S Q +EEF E ++ KL H N+VK
Sbjct: 6 KLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNIVK 65
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
LLG CT+ + M++ EY+P L ++ R K L S IARG+ YL
Sbjct: 66 LLGVCTEEEPLMIVMEYMPGGDLLDYLRK-NRPKELSLSDLLSFALQIARGMEYLE---S 121
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEYAI 694
IHRDL A N L+ + KISDFGL+R D + + +V G +M+PE
Sbjct: 122 KNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYKVKGGKLPIRWMAPESLK 177
Query: 695 DGLFSVKSDVFSFGVLVLEI 714
+G F+ KSDV+SFGVL+ EI
Sbjct: 178 EGKFTSKSDVWSFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 179 bits (456), Expect = 2e-51
Identities = 80/202 (39%), Positives = 106/202 (52%), Gaps = 18/202 (8%)
Query: 522 KNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNL 575
KLGEG FG VYKG L + E+AVK L + S Q +EEF E ++ KL H N+
Sbjct: 4 GKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKEDASEQQIEEFLREARIMRKLDHPNV 63
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
VKLLG CT+ + ++ EY+ L ++ L S IARG+ YL
Sbjct: 64 VKLLGVCTEEEPLYIVMEYMEGGDLLSYL--RKNRPKLSLSDLLSFALQIARGMEYLE-- 119
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEY 692
IHRDL A N L+ + KISDFGL+R D + + R G +M+PE
Sbjct: 120 -SKNFIHRDLAARNCLVGENLVVKISDFGLSR----DLYDDDYYRKRGGKLPIRWMAPES 174
Query: 693 AIDGLFSVKSDVFSFGVLVLEI 714
+G F+ KSDV+SFGVL+ EI
Sbjct: 175 LKEGKFTSKSDVWSFGVLLWEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 174 bits (443), Expect = 2e-49
Identities = 75/204 (36%), Positives = 106/204 (51%), Gaps = 16/204 (7%)
Query: 523 NKLGEGGFGPVYKGMLIEGQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVK 577
KLGEG FG VYKG L E+AVK L + S + ++F E ++ KL H N+V+
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVR 60
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFI------FDTTRSKLLDWSKRSHIIAGIARGLLY 631
LLG CT+ + L+ EY+ L ++ F + L IA+G+ Y
Sbjct: 61 LLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEY 120
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKRVVGTYGYMSP 690
L + +HRDL A N L+ + KISDFGL+R + D T + +M+P
Sbjct: 121 LAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIR-WMAP 176
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEI 714
E DG+F+ KSDV+SFGVL+ EI
Sbjct: 177 ESLKDGIFTSKSDVWSFGVLLWEI 200
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 170 bits (433), Expect = 4e-48
Identities = 72/200 (36%), Positives = 103/200 (51%), Gaps = 14/200 (7%)
Query: 524 KLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFK---NEVLLIAKLQHRNLVKLL 579
KLG G FG VYK G+ +AVK L K + ++ + E+ ++ +L H N+V+L+
Sbjct: 6 KLGSGSFGTVYKAKHKGTGKIVAVKILKK-RSEKSKKDQTARREIRILRRLSHPNIVRLI 64
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
+D L+ EY L ++ +R L + I I RGL YLH
Sbjct: 65 DAFEDKDHLYLVMEYCEGGDLFDYL---SRGGPLSEDEAKKIALQILRGLEYLH---SNG 118
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-F 698
IIHRDLK N+LLD KI+DFGLA+ + T VGT YM+PE + G +
Sbjct: 119 IIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT--FVGTPWYMAPEVLLGGNGY 176
Query: 699 SVKSDVFSFGVLVLEIICGK 718
K DV+S GV++ E++ GK
Sbjct: 177 GPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 168 bits (428), Expect = 2e-47
Identities = 78/203 (38%), Positives = 108/203 (53%), Gaps = 17/203 (8%)
Query: 524 KLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVK 577
KLGEG FG VYKG L ++AVK L +G+ + EEF E ++ KL H N+V+
Sbjct: 6 KLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGASEEEREEFLEEASIMKKLSHPNIVR 65
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
LLG CTQ + ++ EY+P L F+ + L + IA+G+ YL
Sbjct: 66 LLGVCTQGEPLYIVTEYMPGGDLLDFL--RKHGEKLTLKDLLQMALQIAKGMEYLE---S 120
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG---YMSPEYAI 694
+HRDL A N L+ + KISDFGL+R + + + KR G +M+PE
Sbjct: 121 KNFVHRDLAARNCLVTENLVVKISDFGLSRD--IYEDDYYRKR-GGGKLPIKWMAPESLK 177
Query: 695 DGLFSVKSDVFSFGVLVLEIICG 717
DG F+ KSDV+SFGVL+ EI
Sbjct: 178 DGKFTSKSDVWSFGVLLWEIFTL 200
|
Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 164 bits (418), Expect = 1e-46
Identities = 72/194 (37%), Positives = 104/194 (53%), Gaps = 11/194 (5%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
LGEGGFG VY G+++A+K + K S +EE E+ ++ KL H N+VKL G
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVF 60
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+ L+ EY SL + + L + I+ I GL YLH IIH
Sbjct: 61 EDENHLYLVMEYCEGGSLKDLLKE--NEGKLSEDEILRILLQILEGLEYLHS---NGIIH 115
Query: 643 RDLKASNVLLDN-TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSV 700
RDLK N+LLD+ K++DFGL++ D++ T VGT YM+PE + G +S
Sbjct: 116 RDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTI--VGTPAYMAPEVLLGKGYYSE 173
Query: 701 KSDVFSFGVLVLEI 714
KSD++S GV++ E+
Sbjct: 174 KSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 163 bits (415), Expect = 9e-46
Identities = 63/202 (31%), Positives = 96/202 (47%), Gaps = 11/202 (5%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNLV 576
+ KLGEG FG VY + G+ +A+K + K + E E+ ++ KL+H N+V
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKKKIKKDRERILREIKILKKLKHPNIV 60
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+L D+ L+ EY L + + L + + I L YLH
Sbjct: 61 RLYDVFEDEDKLYLVMEYCEGGDLFDLL---KKRGRLSEDEARFYLRQILSALEYLHS-- 115
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
I+HRDLK N+LLD + K++DFGLAR VGT YM+PE +
Sbjct: 116 -KGIVHRDLKPENILLDEDGHVKLADFGLARQL---DPGEKLTTFVGTPEYMAPEVLLGK 171
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+ D++S GV++ E++ GK
Sbjct: 172 GYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 146 bits (372), Expect = 1e-39
Identities = 65/208 (31%), Positives = 101/208 (48%), Gaps = 25/208 (12%)
Query: 523 NKLGEGGFGPVYKGMLIE-GQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LG G FG VY + + G+ +AVK LS S + +E + E+ +++ LQH N+V+
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYY 65
Query: 580 GCCTQRDERML-IY-EYLPNKSLDYFI--F-----DTTRSKLLDWSKRSHIIAGIARGLL 630
G ++ L I+ EY+ SL + F R I GL
Sbjct: 66 GSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ----------ILEGLA 115
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH I+HRD+K +N+L+D+ K++DFG A+ G +T T V GT +M+P
Sbjct: 116 YLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAP 172
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + +D++S G V+E+ GK
Sbjct: 173 EVIRGEEYGRAADIWSLGCTVIEMATGK 200
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|201524 pfam00954, S_locus_glycop, S-locus glycoprotein family | Back alignment and domain information |
|---|
Score = 135 bits (341), Expect = 2e-37
Identities = 44/114 (38%), Positives = 77/114 (67%), Gaps = 4/114 (3%)
Query: 232 FRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQRY 291
+R+G WNG+ ++G+P++Q Y + + N +E +YTY ++N+S+ SR+ ++ G+++R+
Sbjct: 1 WRSGPWNGIRFSGIPEMQKLSYYVYNFTENNEEVYYTYRMTNNSIYSRLTLSSEGSLERF 60
Query: 292 TWMERTKTWTLFSRFSGVTLDQCDSYALCGAYASCNINSNSPECECLQGFVPNS 345
TW+ ++ W LF +S DQCD Y CG Y C++N SP+C C++GFVP +
Sbjct: 61 TWIPNSQDWNLF--WS-APKDQCDVYGRCGPYGYCDVN-TSPKCNCIKGFVPKN 110
|
In Brassicaceae, self-incompatible plants have a self/non-self recognition system. This is sporophytically controlled by multiple alleles at a single locus (S). S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles. Length = 110 |
| >gnl|CDD|216511 pfam01453, B_lectin, D-mannose binding lectin | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 3e-37
Identities = 56/116 (48%), Positives = 69/116 (59%), Gaps = 7/116 (6%)
Query: 91 EGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMES 150
TV WVANR PL+D S L + +G LVL + VWSSN+S VA L +
Sbjct: 1 NQTVVWVANRLNPLTDSSYTLILQS--DGNLVLYDGNGRVVWSSNTSGKGSGCVAVLQDD 58
Query: 151 GNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPA 206
GNLV+ D N +LWQSFD+P DTLLPG K G N+ G +R L+SWKS DP+
Sbjct: 59 GNLVLYD----NSGKVLWQSFDHPTDTLLPGQKDG-NVVIGGSRRLTSWKSNTDPS 109
|
These proteins include mannose-specific lectins from plants as well as bacteriocins from bacteria. Length = 109 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 1e-34
Identities = 64/201 (31%), Positives = 108/201 (53%), Gaps = 9/201 (4%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
F K+G+GGFG VYK G+E+A+K + S + E+ NE+ ++ K +H N+VK
Sbjct: 2 FEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVK 61
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
G ++DE ++ E+ SL + + ++ L S+ +++ + +GL YLH
Sbjct: 62 YYGSYLKKDELWIVMEFCSGGSLKDLL--KSTNQTLTESQIAYVCKELLKGLEYLHS--- 116
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL 697
IIHRD+KA+N+LL + K+ DFGL+ +VGT +M+PE
Sbjct: 117 NGIIHRDIKAANILLTSDGEVKLIDFGLSAQL---SDTKARNTMVGTPYWMAPEVINGKP 173
Query: 698 FSVKSDVFSFGVLVLEIICGK 718
+ K+D++S G+ +E+ GK
Sbjct: 174 YDYKADIWSLGITAIELAEGK 194
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|237995 cd00028, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 4e-34
Identities = 51/123 (41%), Positives = 64/123 (52%), Gaps = 8/123 (6%)
Query: 52 QSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVL 111
+ G+TLVS+ FELGFF Y I YK TV WVANRD P S S L
Sbjct: 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGS-SRTVVWVANRDNP-SGSSCTL 59
Query: 112 RINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSF 171
+ +G LV+ + + VWSSN++ V L++ GNLV+ D N LWQSF
Sbjct: 60 TLQ--SDGNLVIYDGSGTVVWSSNTTRVNGNYVLVLLDDGNLVLYDSD----GNFLWQSF 113
Query: 172 DYP 174
DYP
Sbjct: 114 DYP 116
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. Length = 116 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 130 bits (329), Expect = 1e-33
Identities = 78/217 (35%), Positives = 111/217 (51%), Gaps = 27/217 (12%)
Query: 519 FSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSK-GSGQGMEEFKNEVLLIAKLQ 571
F E+ LGEG FG VYKG L +A+K L + + +EF+ E L++ LQ
Sbjct: 9 FLEE--LGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQ 66
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-------------DTTRSKLLDWSKR 618
H N+V LLG CT+ +++EYL + L F+ D T LD S
Sbjct: 67 HPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF 126
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEAN 677
HI IA G+ YL S +HRDL A N L+ + KISDFGL+R + D
Sbjct: 127 LHIAIQIAAGMEYL---SSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQ 183
Query: 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+K ++ +M PE + G F+ +SD++SFGV++ EI
Sbjct: 184 SKSLLPVR-WMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 128 bits (324), Expect = 2e-33
Identities = 71/201 (35%), Positives = 105/201 (52%), Gaps = 24/201 (11%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM--EEFKNEVLLIAKLQHRNLVKLLGC 581
KLG G FG V+ G ++AVK L G+ M E F E ++ KL+H LV+L
Sbjct: 13 KLGAGQFGEVWMGTWNGTTKVAVKTLKPGT---MSPEAFLQEAQIMKKLRHDKLVQLYAV 69
Query: 582 CTQRDERMLIYEYLPNKSL-DYFIFDTTRS----KLLDWSKRSHIIAGIARGLLYLHQDS 636
C++ + ++ EY+ SL D+ + +L+D + A IA G+ YL
Sbjct: 70 CSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMA------AQIAEGMAYLE--- 120
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA--NTKRVVGTYGYMSPEYAI 694
IHRDL A N+L+ + KI+DFGLAR D+ A K + + +PE A
Sbjct: 121 SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYTAREGAKFPI---KWTAPEAAN 177
Query: 695 DGLFSVKSDVFSFGVLVLEII 715
G F++KSDV+SFG+L+ EI+
Sbjct: 178 YGRFTIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 3e-32
Identities = 72/221 (32%), Positives = 103/221 (46%), Gaps = 32/221 (14%)
Query: 523 NKLGEGGFGPVYKGMLI-----EGQEIAVKRLSK-GSGQGMEEFKNEVLLIAKLQHRNLV 576
+LGEG FG V G+++AVK L+ G Q +F+ E+ ++ L H N+V
Sbjct: 10 KQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIV 69
Query: 577 KLLGCCTQRDER--MLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIAGIARGLL 630
K G C + R LI EYLP+ SL ++ +LL +S + I +G+
Sbjct: 70 KYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQ------ICKGMD 123
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR--SFGLDQTEANTKRVVGTYGYM 688
YL R IHRDL A N+L+++ KISDFGLA+ D + Y
Sbjct: 124 YLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWY- 179
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
+PE FS SDV+SFGV + E+ F + D
Sbjct: 180 APECLRTSKFSSASDVWSFGVTLYEL--------FTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (312), Expect = 9e-32
Identities = 66/204 (32%), Positives = 106/204 (51%), Gaps = 11/204 (5%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS--KGSGQGMEEFKNEVLLIAKLQHRN 574
N+ + +G G FG VYKG+ +E G +A+K++S K + ++ E+ L+ L+H N
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPN 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VK +G D +I EY N SL I + S + + + +GL YLH+
Sbjct: 61 IVKYIGSIETSDSLYIILEYAENGSLRQII---KKFGPFPESLVAVYVYQVLQGLAYLHE 117
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+IHRD+KA+N+L K++DFG+A L+ + VVGT +M+PE
Sbjct: 118 QG---VIHRDIKAANILTTKDGVVKLADFGVATK--LNDVSKDDASVVGTPYWMAPEVIE 172
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
S SD++S G V+E++ G
Sbjct: 173 MSGASTASDIWSLGCTVIELLTGN 196
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|214519 smart00108, B_lectin, Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 4e-31
Identities = 52/122 (42%), Positives = 67/122 (54%), Gaps = 9/122 (7%)
Query: 52 QSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVL 111
++ G+TLVS FELGFF+ Y I YK TV WVANRD P+SD S L
Sbjct: 2 NTLSSGQTLVSGNSLFELGFFTLIMQN-DYNLILYKSS-SRTVVWVANRDNPVSD-SCTL 58
Query: 112 RINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSF 171
+ +G LVL + VWSSN++ + V L++ GNLV+ D + N LWQSF
Sbjct: 59 TLQ--SDGNLVLYDGDGRVVWSSNTTGANGNYVLVLLDDGNLVIYD----SDGNFLWQSF 112
Query: 172 DY 173
DY
Sbjct: 113 DY 114
|
Length = 114 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 1e-30
Identities = 67/202 (33%), Positives = 114/202 (56%), Gaps = 22/202 (10%)
Query: 525 LGEGGFGPVYKGMLI-EGQ----EIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG VYKG+ I EG+ +A+K L + + + +E +E ++A + H ++V+L
Sbjct: 15 LGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRL 74
Query: 579 LGCC-TQRDERMLIYEYLPNKSLDYFIF---DTTRSK-LLDWSKRSHIIAGIARGLLYLH 633
LG C + + LI + +P L ++ D S+ LL+W + IA+G+ YL
Sbjct: 75 LGICLSSQ--VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQ------IAKGMSYLE 126
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
+ R++HRDL A NVL+ + KI+DFGLA+ +D+ E + + +M+ E
Sbjct: 127 EK---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESI 183
Query: 694 IDGLFSVKSDVFSFGVLVLEII 715
+ +++ KSDV+S+GV V E++
Sbjct: 184 LHRIYTHKSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 2e-30
Identities = 63/196 (32%), Positives = 107/196 (54%), Gaps = 6/196 (3%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
F+ + KLG G FG V++G+ +A+K L ++F+ EV + +L+H++L+ L
Sbjct: 8 FTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISL 67
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
C+ + +I E + SL F+ + ++L + + +A G+ YL +
Sbjct: 68 FAVCSVGEPVYIITELMEKGSLLAFL-RSPEGQVLPVASLIDMACQVAEGMAYLEEQ--- 123
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
IHRDL A N+L+ + K++DFGLAR D ++ K++ Y + +PE A G F
Sbjct: 124 NSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTF 181
Query: 699 SVKSDVFSFGVLVLEI 714
S KSDV+SFG+L+ E+
Sbjct: 182 STKSDVWSFGILLYEM 197
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 2e-30
Identities = 71/241 (29%), Positives = 112/241 (46%), Gaps = 41/241 (17%)
Query: 517 DNFSEKNKLGEGGFGPVYKG---MLIEGQE---IAVKRLSKGSGQGMEE-FKNEVLLIAK 569
D K +LGEG FG V+ G L + +AVK L + + + F+ E L+
Sbjct: 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTN 64
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI-----------------FDTTRSKL 612
QH N+VK G CT+ D ++++EY+ + L+ F+ + T S+L
Sbjct: 65 FQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL 124
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
L I IA G++YL + +HRDL N L+ + KI DFG++R D
Sbjct: 125 L------QIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----D 171
Query: 673 QTEANTKRVVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728
+ RV G +M PE + F+ +SDV+SFGV++ EI K + ++
Sbjct: 172 VYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNE 231
Query: 729 D 729
+
Sbjct: 232 E 232
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 3e-30
Identities = 66/228 (28%), Positives = 110/228 (48%), Gaps = 27/228 (11%)
Query: 500 EEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGME 558
EE++ + D+ + + + K+GEG G VYK G+E+A+K++ + Q E
Sbjct: 2 EELKAALKDIVSEGDPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKM-RLRKQNKE 60
Query: 559 EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR 618
NE+L++ +H N+V DE ++ EY+ SL ++ +
Sbjct: 61 LIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTD---------IITQNFV 111
Query: 619 S---HIIAGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
IA + R GL YLH +IHRD+K+ N+LL + K++DFG A
Sbjct: 112 RMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQL-- 166
Query: 672 DQTEANTKR--VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
T+ +KR VVGT +M+PE + K D++S G++ +E+ G
Sbjct: 167 --TKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEG 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 119 bits (300), Expect = 5e-30
Identities = 64/202 (31%), Positives = 101/202 (50%), Gaps = 19/202 (9%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
LG+G G VYK G+ A+K++ G + ++ E+ + + +VK G
Sbjct: 8 VLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGA 67
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR----GLLYLHQDSR 637
+ E ++ EY+ SL + K+ + ++A IAR GL YLH
Sbjct: 68 FYKEGEISIVLEYMDGGSLADLL-----KKVGKIPEP--VLAYIARQILKGLDYLHTK-- 118
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG- 696
IIHRD+K SN+L+++ KI+DFG+++ L+ T VGT YMSPE I G
Sbjct: 119 RHIIHRDIKPSNLLINSKGEVKIADFGISKV--LENTLDQCNTFVGTVTYMSPE-RIQGE 175
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+S +D++S G+ +LE GK
Sbjct: 176 SYSYAADIWSLGLTLLECALGK 197
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 3e-29
Identities = 68/198 (34%), Positives = 102/198 (51%), Gaps = 14/198 (7%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
KLG G FG V++G+ +AVK L G+ ++F E ++ KL+H L++L
Sbjct: 11 LRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD-PKDFLAEAQIMKKLRHPKLIQLYAV 69
Query: 582 CTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
CT + ++ E + SL +Y R+ L + + A +A G+ YL +
Sbjct: 70 CTLEEPIYIVTELMKYGSLLEYLQGGAGRA--LKLPQLIDMAAQVASGMAYLEAQN---Y 124
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGL 697
IHRDL A NVL+ K++DFGLAR D EA G + +PE A+
Sbjct: 125 IHRDLAARNVLVGENNICKVADFGLARVIKEDIYEARE----GAKFPIKWTAPEAALYNR 180
Query: 698 FSVKSDVFSFGVLVLEII 715
FS+KSDV+SFG+L+ EI+
Sbjct: 181 FSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 119 bits (297), Expect = 7e-29
Identities = 69/213 (32%), Positives = 103/213 (48%), Gaps = 17/213 (7%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH-R 573
++ KLGEG FG VY + +A+K L+K + +E F E+ ++A L H
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPP 58
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+VKL L+ EY+ SL+ + R L S+ I+A I L YLH
Sbjct: 59 NIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLH 118
Query: 634 QDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEAN----TKRVVGTYGYM 688
IIHRD+K N+LLD + K+ DFGLA+ + ++ VGT GYM
Sbjct: 119 ---SKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYM 175
Query: 689 SPEYAIDGLF---SVKSDVFSFGVLVLEIICGK 718
+PE + S SD++S G+ + E++ G
Sbjct: 176 APEVLLGLSLAYASSSSDIWSLGITLYELLTGL 208
|
Length = 384 |
| >gnl|CDD|219774 pfam08276, PAN_2, PAN-like domain | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-29
Identities = 38/67 (56%), Positives = 49/67 (73%), Gaps = 1/67 (1%)
Query: 366 CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLW 425
C GDGFL +KLPDT + VD++I L EC++ C NCSCTAYA AD+RG GSGCL+W
Sbjct: 1 CGGGDGFLRLPNMKLPDTTAAIVDRSIGLKECEQRCLSNCSCTAYAYADIRG-GSGCLIW 59
Query: 426 FHDLIDI 432
+L+D+
Sbjct: 60 TGELVDM 66
|
Length = 66 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 8e-29
Identities = 75/212 (35%), Positives = 105/212 (49%), Gaps = 28/212 (13%)
Query: 525 LGEGGFGPVYKGMLI-------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLV 576
LG G FG VY+G +AVK L KG+ Q +EF E L++ H N+V
Sbjct: 3 LGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIV 62
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLYL 632
KLLG C + + +I E + L ++ D LL + I +A+G +YL
Sbjct: 63 KLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYL 122
Query: 633 HQDSRLRIIHRDLKASNVLL-----DNTMNPKISDFGLARSFGLDQTEANTKRVVGT--- 684
Q + IHRDL A N L+ D KI DFGLAR D +++ R G
Sbjct: 123 EQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLAR----DIYKSDYYRKEGEGLL 175
Query: 685 -YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+PE +DG F+ +SDV+SFGVL+ EI+
Sbjct: 176 PVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 9e-29
Identities = 62/218 (28%), Positives = 100/218 (45%), Gaps = 33/218 (15%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKR--LSKGSGQGMEEFKNEVLLIAKLQHRN 574
+ ++G+G FG VY ++ +K LS S + E+ NEV ++ KL H N
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPN 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS-------KLLDWSKRSHIIAGIAR 627
++K ++ + ++ EY L I + ++LDW +
Sbjct: 61 IIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW------FVQLCL 114
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
L YLH SR +I+HRD+K N+ L + K+ DFG+++ L T K VVGT Y
Sbjct: 115 ALKYLH--SR-KILHRDIKPQNIFLTSNGLVKLGDFGISKV--LSSTVDLAKTVVGTPYY 169
Query: 688 MSPE------YAIDGLFSVKSDVFSFGVLVLEIICGKK 719
+SPE Y + KSD++S G ++ E+ K
Sbjct: 170 LSPELCQNKPY------NYKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 6e-28
Identities = 69/204 (33%), Positives = 101/204 (49%), Gaps = 27/204 (13%)
Query: 523 NKLGEGGFGPVYKGMLIE--GQEI--AVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVK 577
+LG G FG V KG+ + G+E+ AVK L + G +EF E ++A+L H +V+
Sbjct: 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVR 60
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFD---TTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
L+G C + + ML+ E P L ++ S L + + + +A G+ YL
Sbjct: 61 LIGVC-KGEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQ------VAMGMAYLES 113
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YMS 689
+HRDL A NVLL N KISDFG++R+ G T G + +
Sbjct: 114 K---HFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRAT----TAGRWPLKWYA 166
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLE 713
PE G FS KSDV+S+GV + E
Sbjct: 167 PECINYGKFSSKSDVWSYGVTLWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 9e-28
Identities = 67/197 (34%), Positives = 100/197 (50%), Gaps = 19/197 (9%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+G+G FG V G GQ++AVK L K + F E ++ L+H NLV+LLG
Sbjct: 11 GATIGKGEFGDVMLGDY-RGQKVAVKCL-KDDSTAAQAFLAEASVMTTLRHPNLVQLLGV 68
Query: 582 CTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIA-GIARGLLYLHQDSRLR 639
Q + ++ EY+ SL DY +R + + + A + G+ YL +
Sbjct: 69 VLQGNPLYIVTEYMAKGSLVDYL---RSRGRAVITLAQQLGFALDVCEGMEYLEEK---N 122
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDGL 697
+HRDL A NVL+ + K+SDFGLA+ EA+ + G + +PE +
Sbjct: 123 FVHRDLAARNVLVSEDLVAKVSDFGLAK-------EASQGQDSGKLPVKWTAPEALREKK 175
Query: 698 FSVKSDVFSFGVLVLEI 714
FS KSDV+SFG+L+ EI
Sbjct: 176 FSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 75/199 (37%), Positives = 109/199 (54%), Gaps = 21/199 (10%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG G FG V+ G ++A+K L +GS E F E L+ +LQH LV+L T
Sbjct: 13 KLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT 71
Query: 584 QRDERMLIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
Q + +I EY+ N SL F+ T +KL+D + A IA G+ ++ R
Sbjct: 72 Q-EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMA------AQIAEGMAFIE---RK 121
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDG 696
IHRDL+A+N+L+ T+ KI+DFGLAR L + T R + + +PE G
Sbjct: 122 NYIHRDLRAANILVSETLCCKIADFGLAR---LIEDNEYTAREGAKFPIKWTAPEAINYG 178
Query: 697 LFSVKSDVFSFGVLVLEII 715
F++KSDV+SFG+L+ EI+
Sbjct: 179 TFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 3e-27
Identities = 80/241 (33%), Positives = 122/241 (50%), Gaps = 40/241 (16%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLS-KGSGQGMEEFKNEV 564
I +T F E+ LGE FG VYKG L + Q +A+K L K G EEFK+E
Sbjct: 2 INLSTVRFMEE--LGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEA 59
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-------------DTTRSK 611
++ ++LQH N+V LLG T+ +I+ Y + L F+ D T
Sbjct: 60 MMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKS 119
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
L+ + HI+ IA G+ +L S ++H+DL NVL+ + +N KISD GL R
Sbjct: 120 TLEPADFVHIVTQIAAGMEFL---SSHHVVHKDLATRNVLVFDKLNVKISDLGLFR---- 172
Query: 672 DQTEANTKRVVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII-------CGKKN 720
+ A+ +++G +MSPE + G FS+ SD++S+GV++ E+ CG N
Sbjct: 173 EVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSN 232
Query: 721 R 721
+
Sbjct: 233 Q 233
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 68/234 (29%), Positives = 100/234 (42%), Gaps = 47/234 (20%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-Q 571
D+F +GEG F V E +E A+K L K + ++ K E ++ +L
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 572 HRNLVKLLGCCTQRDERML--IYEYLPNKSLDYFI-------FDTTRSKLLDWSKRSHII 622
H ++KL T +DE L + EY PN L +I TR
Sbjct: 61 HPGIIKLY--YTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTR----------FYA 108
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV- 681
A I L YLH IIHRDLK N+LLD M+ KI+DFG A+ + + + K
Sbjct: 109 AEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDA 165
Query: 682 -----------------VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
VGT Y+SPE + SD+++ G ++ +++ GK
Sbjct: 166 TNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 8e-27
Identities = 67/216 (31%), Positives = 105/216 (48%), Gaps = 21/216 (9%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRL-SKGSGQGMEEFKNEVLLI 567
D+ + LG G FG VY+G+ ++AVK L S Q +F E L++
Sbjct: 4 PRDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIM 63
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIA 623
+K H+N+V+L+G +R R ++ E + L F+ + R L
Sbjct: 64 SKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCAR 123
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARS-FGLDQTEANT 678
+A+G YL ++ IHRD+ A N LL P KI+DFG+AR +
Sbjct: 124 DVAKGCKYLEEN---HFIHRDIAARNCLL-TCKGPGRVAKIADFGMARDIYRASYYRKGG 179
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+ ++ +M PE +DG+F+ K+DV+SFGVL+ EI
Sbjct: 180 RAML-PIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-27
Identities = 62/196 (31%), Positives = 103/196 (52%), Gaps = 10/196 (5%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKGSGQGME-EFKNEVLLIAKLQHRNLVKLL 579
+G G FG V +G L + G++ +A+K L GS +F E ++ + H N+++L
Sbjct: 12 IGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLE 71
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
G T+ M+I EY+ N SLD F+ + ++ GIA G+ YL S +
Sbjct: 72 GVVTKSRPVMIITEYMENGSLDKFL--RENDGKFTVGQLVGMLRGIASGMKYL---SEMN 126
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
+HRDL A N+L+++ + K+SDFGL+R + TK + +PE F+
Sbjct: 127 YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFT 186
Query: 700 VKSDVFSFGVLVLEII 715
SDV+SFG+++ E++
Sbjct: 187 SASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 64/204 (31%), Positives = 99/204 (48%), Gaps = 24/204 (11%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG+G FG V + G+ A+K L K + +E E +++++ H +VKL
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLH- 59
Query: 581 CCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
Q +E++ L+ EY P L + F R++ A I L YLH
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARF--------YAAEIVLALEYLH- 110
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
L II+RDLK N+LLD + K++DFGLA+ + + NT GT Y++PE +
Sbjct: 111 --SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNT--FCGTPEYLAPEVLL 166
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+ D +S GVL+ E++ GK
Sbjct: 167 GKGYGKAVDWWSLGVLLYEMLTGK 190
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 2e-26
Identities = 71/201 (35%), Positives = 103/201 (51%), Gaps = 19/201 (9%)
Query: 525 LGEGGFGPV----YKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LG+G FG V Y + G+ +AVK+L + + + +F+ E+ ++ LQH N+VK
Sbjct: 12 LGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYK 71
Query: 580 GCCTQRDER--MLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
G C R L+ EYLP SL DY R LD K + I +G+ YL
Sbjct: 72 GVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRER---LDHRKLLLYASQICKGMEYL---G 125
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG---TYGYMSPEYA 693
R +HRDL N+L+++ KI DFGL + D+ E R G + Y +PE
Sbjct: 126 SKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDK-EYYKVREPGESPIFWY-APESL 183
Query: 694 IDGLFSVKSDVFSFGVLVLEI 714
+ FSV SDV+SFGV++ E+
Sbjct: 184 TESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 3e-26
Identities = 61/201 (30%), Positives = 104/201 (51%), Gaps = 10/201 (4%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
F KLGEG +G VYK + E GQ +A+K + + ++E E+ ++ + +VK
Sbjct: 5 FDILEKLGEGSYGSVYKAIHKETGQVVAIKVVP--VEEDLQEIIKEISILKQCDSPYIVK 62
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
G + + ++ EY S+ + +K L + + I+ +GL YLH
Sbjct: 63 YYGSYFKNTDLWIVMEYCGAGSVSDIM--KITNKTLTEEEIAAILYQTLKGLEYLHS--- 117
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL 697
+ IHRD+KA N+LL+ K++DFG+ S L T A V+GT +M+PE +
Sbjct: 118 NKKIHRDIKAGNILLNEEGQAKLADFGV--SGQLTDTMAKRNTVIGTPFWMAPEVIQEIG 175
Query: 698 FSVKSDVFSFGVLVLEIICGK 718
++ K+D++S G+ +E+ GK
Sbjct: 176 YNNKADIWSLGITAIEMAEGK 196
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 6e-26
Identities = 62/193 (32%), Positives = 105/193 (54%), Gaps = 11/193 (5%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
++G G FG V+ G +E +++A+K + +G+ E+F E ++ KL H LV+L G CT
Sbjct: 11 EIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCT 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS--HIIAGIARGLLYLHQDSRLRII 641
+R L++E++ + L ++ R++ +S+ + + + G+ YL + +I
Sbjct: 70 ERSPICLVFEFMEHGCLSDYL----RAQRGKFSQETLLGMCLDVCEGMAYLESSN---VI 122
Query: 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVK 701
HRDL A N L+ K+SDFG+ R F LD ++ + SPE +S K
Sbjct: 123 HRDLAARNCLVGENQVVKVSDFGMTR-FVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSK 181
Query: 702 SDVFSFGVLVLEI 714
SDV+SFGVL+ E+
Sbjct: 182 SDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 107 bits (268), Expect = 7e-26
Identities = 70/192 (36%), Positives = 102/192 (53%), Gaps = 6/192 (3%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG G FG V+ G ++AVK L G+ ++ F E L+ LQH LV+L T
Sbjct: 13 KLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVT 71
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ + +I EY+ SL F+ K+L K A IA G+ Y+ R IHR
Sbjct: 72 KEEPIYIITEYMAKGSLLDFLKSDEGGKVL-LPKLIDFSAQIAEGMAYIE---RKNYIHR 127
Query: 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSD 703
DL+A+NVL+ ++ KI+DFGLAR ++ A + +PE G F++KSD
Sbjct: 128 DLRAANVLVSESLMCKIADFGLARVIEDNEYTAREGAKF-PIKWTAPEAINFGSFTIKSD 186
Query: 704 VFSFGVLVLEII 715
V+SFG+L+ EI+
Sbjct: 187 VWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 106 bits (265), Expect = 2e-25
Identities = 66/216 (30%), Positives = 104/216 (48%), Gaps = 29/216 (13%)
Query: 518 NFSEKNKLGEGGFGPVY----KGMLIEGQE--IAVKRLSKGSGQGME-EFKNEVLLIAKL 570
N E LG G FG V+ KG+ EG E + VK L K + ++ EF+ E+ + KL
Sbjct: 6 NLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKL 65
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI------FDTTRSKLLDWSKRSHIIAG 624
H+N+V+LLG C + + +I EY L F+ + + L ++ +
Sbjct: 66 SHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQ 125
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS------FGLDQTEANT 678
IA G+ +L S R +HRDL A N L+ + K+S L++ + L
Sbjct: 126 IALGMDHL---SNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPL 182
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+ +++PE + FS KSDV+SFGVL+ E+
Sbjct: 183 R-------WLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 4e-25
Identities = 66/198 (33%), Positives = 98/198 (49%), Gaps = 14/198 (7%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584
LG G FG V+ G ++A+K + +G+ ++F E ++ KL H NLV+L G CT+
Sbjct: 12 LGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTK 70
Query: 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRD 644
+ ++ EY+ N L ++ R L + + + + YL + IHRD
Sbjct: 71 QRPIFIVTEYMANGCLLNYL--RERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRD 125
Query: 645 LKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGLFSVK 701
L A N L+ K+SDFGLAR DQ ++ GT + PE FS K
Sbjct: 126 LAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQ----GTKFPVKWAPPEVFDYSRFSSK 181
Query: 702 SDVFSFGVLVLEII-CGK 718
SDV+SFGVL+ E+ GK
Sbjct: 182 SDVWSFGVLMWEVFSEGK 199
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 5e-25
Identities = 69/213 (32%), Positives = 110/213 (51%), Gaps = 30/213 (14%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKR--LSKGSGQG-------MEEFKNEVLLIAKLQHRN 574
+G G FG VY GM G+ +AVK+ L S ++ E+ L+ +LQH N
Sbjct: 8 IGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHEN 67
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
+V+ LG D + EY+P S+ +Y F+ T + + + I +GL
Sbjct: 68 IVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVR--------NFVRQILKGL 119
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD--QTEANTKR--VVGTY 685
YLH IIHRD+K +N+L+DN KISDFG+++ + T+ N R + G+
Sbjct: 120 NYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSV 176
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
+M+PE ++ K+D++S G LV+E++ GK
Sbjct: 177 FWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGK 209
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 7e-25
Identities = 64/196 (32%), Positives = 105/196 (53%), Gaps = 11/196 (5%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
K+KLG G +G VY+G+ + +AVK L K +EEF E ++ +++H NLV+LLG
Sbjct: 11 KHKLGGGQYGEVYEGVWKKYSLTVAVKTL-KEDTMEVEEFLKEAAVMKEIKHPNLVQLLG 69
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
CT+ +I E++ +L ++ + R ++ ++ I+ + YL + +
Sbjct: 70 VCTREPPFYIITEFMTYGNLLDYLRECNRQ-EVNAVVLLYMATQISSAMEYLEKKN---F 125
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDGLF 698
IHRDL A N L+ K++DFGL+R L + T + + +PE F
Sbjct: 126 IHRDLAARNCLVGENHLVKVADFGLSR---LMTGDTYTAHAGAKFPIKWTAPESLAYNKF 182
Query: 699 SVKSDVFSFGVLVLEI 714
S+KSDV++FGVL+ EI
Sbjct: 183 SIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 103 bits (260), Expect = 2e-24
Identities = 69/217 (31%), Positives = 108/217 (49%), Gaps = 38/217 (17%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN--------EVLLIAK 569
+ + KLGEG +G VYK + EI A+K++ ++ + E+ L+ +
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIR------LDNEEEGIPSTALREISLLKE 54
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARG 628
L+H N+VKLL + L++EY + L ++ D L + K I+ + RG
Sbjct: 55 LKHPNIVKLLDVIHTERKLYLVFEYC-DMDLKKYL-DKRPGPLSPNLIK--SIMYQLLRG 110
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
L Y H RI+HRDLK N+L++ K++DFGLAR+FG+ T VV T Y
Sbjct: 111 LAYCHSH---RILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR-TYTHEVV-TLWYR 165
Query: 689 SPE-------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+PE Y+ +V D++S G + E+I GK
Sbjct: 166 APEILLGSKHYST----AV--DIWSVGCIFAEMITGK 196
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 3e-24
Identities = 66/194 (34%), Positives = 106/194 (54%), Gaps = 11/194 (5%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG G FG V+ G ++AVK L G+ E F E ++ KL+H LV+L +
Sbjct: 13 KLGNGQFGEVWMGTWNGNTKVAVKTLKPGT-MSPESFLEEAQIMKKLRHDKLVQLYAVVS 71
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ ++ EY+ SL F+ D + L + A +A G+ Y+ R+ IHR
Sbjct: 72 EE-PIYIVTEYMSKGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIE---RMNYIHR 126
Query: 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDGLFSVK 701
DL+++N+L+ + + KI+DFGLAR L + T R + + +PE A+ G F++K
Sbjct: 127 DLRSANILVGDGLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 702 SDVFSFGVLVLEII 715
SDV+SFG+L+ E++
Sbjct: 184 SDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 102 bits (254), Expect = 6e-24
Identities = 74/212 (34%), Positives = 104/212 (49%), Gaps = 25/212 (11%)
Query: 524 KLGEGGFGPVYKGMLI-----EGQEIAVKRLSK-GSGQGMEEFKNEVLLIAKLQHRNLVK 577
+LGE FG +YKG L Q +A+K L + Q EF+ E L+A+L H N+V
Sbjct: 12 ELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVC 71
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIF--------------DTTRSKLLDWSKRSHIIA 623
LLG TQ +++EYL L F+ D T LD HI
Sbjct: 72 LLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKRVV 682
IA G+ YL S +H+DL A N+L+ ++ KISD GL+R + D K ++
Sbjct: 132 QIAAGMEYL---SSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLL 188
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M PE + G FS SD++SFGV++ EI
Sbjct: 189 PIR-WMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 9e-24
Identities = 65/207 (31%), Positives = 105/207 (50%), Gaps = 15/207 (7%)
Query: 518 NFSEKNKLGEGGFGPVYKGML-IEGQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRN 574
+F NK+G+G FG V+K + + + A+K+ LSK + + EE +E ++AKL
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSY 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLD---WSKRSHIIAGIARGLLY 631
+++ + + ++ EY N L + L + W I GL +
Sbjct: 61 IIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVW----RFFIQILLGLAH 116
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH +I+HRD+K+ N+ LD N KI D G+A+ + ANT +VGT Y+SPE
Sbjct: 117 LHSK---KILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFANT--IVGTPYYLSPE 171
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
D ++ KSDV++ GV++ E GK
Sbjct: 172 LCEDKPYNEKSDVWALGVVLYECCTGK 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 1e-23
Identities = 66/209 (31%), Positives = 94/209 (44%), Gaps = 35/209 (16%)
Query: 524 KLGEGGFGPVYKG----MLIEGQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVKL 578
KLG+G FG V +G + +AVK L M++F E ++ L H NL++L
Sbjct: 2 KLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRL 61
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTR---------SKLLDWSKRSHIIAGIARGL 629
G M++ E P SL D R S L D++ + IA G+
Sbjct: 62 YGVVLT-HPLMMVTELAPLGSL----LDRLRKDALGHFLISTLCDYAVQ------IANGM 110
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ----TEANTKRVVGTY 685
YL R IHRDL A N+LL + KI DFGL R+ ++ E + K +
Sbjct: 111 RYLESK---RFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKV---PF 164
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+ +PE FS SDV+ FGV + E+
Sbjct: 165 AWCAPESLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 2e-23
Identities = 68/221 (30%), Positives = 110/221 (49%), Gaps = 35/221 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQ------EIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVK 577
LGEG FG V K + +AVK L + + + + +E L+ ++ H +++K
Sbjct: 8 LGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIK 67
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAG 624
L G C+Q +LI EY SL F+ ++ + S LD + G
Sbjct: 68 LYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127
Query: 625 --------IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676
I+RG+ YL + ++++HRDL A NVL+ KISDFGL+R + + ++
Sbjct: 128 DLISFAWQISRGMQYL---AEMKLVHRDLAARNVLVAEGRKMKISDFGLSRD--VYEEDS 182
Query: 677 NTKRVVG--TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
KR G +M+ E D +++ +SDV+SFGVL+ EI+
Sbjct: 183 YVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 12/199 (6%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQHRNLVKLLG 580
K+GEG +G VYK + G+ +A+K++ E+ L+ +L H N++KLL
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLD 65
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
+ + L++E++ D + R + L S + + +GL + H I
Sbjct: 66 VFRHKGDLYLVFEFM---DTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSH---GI 119
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-DGLFS 699
+HRDLK N+L++ K++DFGLARSFG T VV T Y +PE + D +S
Sbjct: 120 LHRDLKPENLLINTEGVLKLADFGLARSFGSPV-RPYTHYVV-TRWYRAPELLLGDKGYS 177
Query: 700 VKSDVFSFGVLVLEIICGK 718
D++S G + E++ +
Sbjct: 178 TPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 99.8 bits (249), Expect = 2e-23
Identities = 60/192 (31%), Positives = 93/192 (48%), Gaps = 6/192 (3%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQHRNLVKLLGCC 582
K+G+G FG VYKG+L E+AVK + +F E ++ + H N+VKL+G C
Sbjct: 2 KIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVC 61
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
Q+ ++ E +P SL F+ + L K + A G+ YL + IH
Sbjct: 62 VQKQPIYIVMELVPGGSLLTFL--RKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIH 116
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKS 702
RDL A N L+ KISDFG++R + + +PE G ++ +S
Sbjct: 117 RDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSES 176
Query: 703 DVFSFGVLVLEI 714
DV+S+G+L+ E
Sbjct: 177 DVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|238531 cd01098, PAN_AP_plant, Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Score = 94.0 bits (234), Expect = 2e-23
Identities = 38/89 (42%), Positives = 50/89 (56%), Gaps = 8/89 (8%)
Query: 362 TPLDCKHG---DGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGR 418
TPL+C DGFL+ VKLPD + I+L EC+E C NCSCTAYA +
Sbjct: 1 TPLNCGGDGSTDGFLKLPDVKLPDN--ASAITAISLEECREACLSNCSCTAYAYNNG--- 55
Query: 419 GSGCLLWFHDLIDIKELPESGQDLFIRMA 447
GCLLW L +++ L G L++R+A
Sbjct: 56 SGGCLLWNGLLNNLRSLSSGGGTLYLRLA 84
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. Length = 84 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 99.7 bits (248), Expect = 3e-23
Identities = 65/193 (33%), Positives = 105/193 (54%), Gaps = 11/193 (5%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG+G FG V+ G +A+K L G+ E F E ++ KL+H LV+L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS 71
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ + ++ EY+ SL F+ K L + + A IA G+ Y+ R+ +HR
Sbjct: 72 E-EPIYIVTEYMSKGSLLDFLKGEM-GKYLRLPQLVDMAAQIASGMAYVE---RMNYVHR 126
Query: 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDGLFSVK 701
DL+A+N+L+ + K++DFGLAR L + T R + + +PE A+ G F++K
Sbjct: 127 DLRAANILVGENLVCKVADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 702 SDVFSFGVLVLEI 714
SDV+SFG+L+ E+
Sbjct: 184 SDVWSFGILLTEL 196
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 3e-23
Identities = 66/215 (30%), Positives = 110/215 (51%), Gaps = 29/215 (13%)
Query: 522 KNKLGEGGFGPVYKG---MLIEGQE---IAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
K +LGEG FG V+ L+ Q+ +AVK L + S ++F+ E L+ LQH+++
Sbjct: 10 KWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHI 69
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFI-FDTTRSKLLDWSKRS-----------HIIA 623
V+ G CT+ ++++EY+ + L+ F+ +K+L + I +
Sbjct: 70 VRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIAS 129
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
IA G++YL + L +HRDL N L+ + KI DFG++R D + RV G
Sbjct: 130 QIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----DIYSTDYYRVGG 182
Query: 684 ----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M PE + F+ +SD++SFGV++ EI
Sbjct: 183 RTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 99.5 bits (249), Expect = 6e-23
Identities = 62/220 (28%), Positives = 107/220 (48%), Gaps = 41/220 (18%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIAK 569
+ + ++GEG +G VYK G+ +A+K++ ME K E+ L+ K
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIR------MENEKEGFPITAIREIKLLQK 54
Query: 570 LQHRNLVKLLGCCTQRDER--MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
L+H N+V+L T + + +++EY+ + L + D+ K + S+ + +
Sbjct: 55 LRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLL-DSPEVKFTE-SQIKCYMKQLLE 111
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
GL YLH + I+HRD+K SN+L++N K++DFGLAR + + T RV+ T Y
Sbjct: 112 GLQYLHSN---GILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSADYTNRVI-TLWY 167
Query: 688 MSPE---------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
PE + D++S G ++ E+ GK
Sbjct: 168 RPPELLLGATRYGPEV--------DMWSVGCILAELFLGK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 6e-23
Identities = 69/208 (33%), Positives = 112/208 (53%), Gaps = 30/208 (14%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLS-----KGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG VY+G+ L +G AVK +S + + +++ + E+ L++KLQH N+V+
Sbjct: 8 LGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQY 67
Query: 579 LGCCTQRDERML-IY-EYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
LG T+R+E L I+ E +P SL Y F +L ++++ I GL Y
Sbjct: 68 LG--TEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRL--YTRQ------ILLGLEY 117
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH +HRD+K +N+L+D K++DFG+A+ + K G+ +M+PE
Sbjct: 118 LHDR---NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPE 171
Query: 692 Y-AIDGLFSVKSDVFSFGVLVLEIICGK 718
A G + + +D++S G VLE+ GK
Sbjct: 172 VIAQQGGYGLAADIWSLGCTVLEMATGK 199
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 98.6 bits (245), Expect = 1e-22
Identities = 70/201 (34%), Positives = 115/201 (57%), Gaps = 20/201 (9%)
Query: 525 LGEGGFGPVYKGMLI-EGQEI----AVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG VYKG+ + EG+ + A+K L++ +G + EF +E L++A + H +LV+L
Sbjct: 15 LGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRL 74
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIF---DTTRSKLL-DWSKRSHIIAGIARGLLYLHQ 634
LG C + L+ + +P+ L ++ D S+LL +W + IA+G++YL +
Sbjct: 75 LGVCLSPTIQ-LVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQ------IAKGMMYLEE 127
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
R++HRDL A NVL+ + + KI+DFGLAR D+ E N +M+ E
Sbjct: 128 R---RLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIH 184
Query: 695 DGLFSVKSDVFSFGVLVLEII 715
F+ +SDV+S+GV + E++
Sbjct: 185 YRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.1 bits (245), Expect = 1e-22
Identities = 56/203 (27%), Positives = 103/203 (50%), Gaps = 13/203 (6%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRNL 575
F+ +G+G FG VYK + Q +A+K L + + +E+ + E+ +++ + +
Sbjct: 3 FTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDE-IEDIQQEIQFLSQCRSPYI 61
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
K G + + +I EY S D + LD + + I+ + GL YLH++
Sbjct: 62 TKYYGSFLKGSKLWIIMEYCGGGS----CLDLLKPGKLDETYIAFILREVLLGLEYLHEE 117
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
IHRD+KA+N+LL + K++DFG++ ++ NT VGT +M+PE
Sbjct: 118 ---GKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSKRNT--FVGTPFWMAPEVIKQ 172
Query: 696 GLFSVKSDVFSFGVLVLEIICGK 718
+ K+D++S G+ +E+ G+
Sbjct: 173 SGYDEKADIWSLGITAIELAKGE 195
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 97.7 bits (243), Expect = 2e-22
Identities = 74/209 (35%), Positives = 104/209 (49%), Gaps = 34/209 (16%)
Query: 525 LGEGGFG--------PVYKGMLIEGQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNL 575
LGEG FG P G G+ +AVK L + GQ +K E+ ++ L H N+
Sbjct: 12 LGEGHFGKVSLYCYDPANDGT---GEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENI 68
Query: 576 VKLLGCCTQRDER--MLIYEYLPNKSL-DYFI-FDTTRSKLLDWSKRSHIIAGIARGLLY 631
VK GCC+++ + LI EY+P SL DY ++LL ++++ I G+ Y
Sbjct: 69 VKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLLFAQQ------ICEGMAY 122
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG----- 686
LH IHRDL A NVLLDN KI DFGLA++ E + V G
Sbjct: 123 LHSQ---HYIHRDLAARNVLLDNDRLVKIGDFGLAKAV----PEGHEYYRVREDGDSPVF 175
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ + E + FS SDV+SFGV + E++
Sbjct: 176 WYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 97.9 bits (244), Expect = 2e-22
Identities = 72/224 (32%), Positives = 100/224 (44%), Gaps = 48/224 (21%)
Query: 525 LGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG---------QGMEEFKNEVLLIAK 569
LGEG FG V K + E +AVK L K ME K +I K
Sbjct: 20 LGEGAFGQVVKAEAVGLDNPNETSTVAVKML-KDDATEKDLSDLVSEMEMMK----MIGK 74
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAG----- 624
H+N++ LLG CTQ ++ EY + +L F+ R S
Sbjct: 75 --HKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRAR-RPPGEYASPDDPRPPEETLTQ 131
Query: 625 ---------IARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLARSFGLDQ 673
+ARG+ +L + IHRDL A NVL+ D+ M KI+DFGLAR +
Sbjct: 132 KDLVSFAYQVARGMEFLASK---KCIHRDLAARNVLVTEDHVM--KIADFGLAR--DIHH 184
Query: 674 TEANTKRVVG--TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ K G +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 185 IDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 2e-22
Identities = 68/215 (31%), Positives = 103/215 (47%), Gaps = 25/215 (11%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQ-EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
D E+ LG+G +G VY + Q IA+K + + + ++ E+ L + L+HRN
Sbjct: 7 YDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRN 66
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW----SKRSHII---AGIAR 627
+V+ LG ++ + E +P SL RSK W II I
Sbjct: 67 IVQYLGSDSENGFFKIFMEQVPGGSLS----ALLRSK---WGPLKDNEQTIIFYTKQILE 119
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGTY 685
GL YLH +I+HRD+K NVL+ NT + KISDFG ++ L T+ GT
Sbjct: 120 GLKYLHD---NQIVHRDIKGDNVLV-NTYSGVVKISDFGTSKR--LAGINPCTETFTGTL 173
Query: 686 GYMSPEYAIDGL--FSVKSDVFSFGVLVLEIICGK 718
YM+PE G + +D++S G ++E+ GK
Sbjct: 174 QYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGK 208
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 96.9 bits (242), Expect = 2e-22
Identities = 62/207 (29%), Positives = 96/207 (46%), Gaps = 16/207 (7%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAV-KRLSKGSGQGMEEFK-----NEVLLIAKLQH 572
+ +G+G FG V K +I V K + G+ M E + +EV ++ +L+H
Sbjct: 2 YEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGN---MTEKEKQQLVSEVNILRELKH 58
Query: 573 RNLVKLLGCCTQRD-ERMLIY-EYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARGL 629
N+V+ R + + I EY L I + + ++ I+ + L
Sbjct: 59 PNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118
Query: 630 LYLH--QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
H D ++HRDLK +N+ LD N K+ DFGLA+ G D + A T VGT Y
Sbjct: 119 YECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFAKT--YVGTPYY 176
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEI 714
MSPE + KSD++S G L+ E+
Sbjct: 177 MSPEQLNHMSYDEKSDIWSLGCLIYEL 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 4e-22
Identities = 62/200 (31%), Positives = 112/200 (56%), Gaps = 17/200 (8%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G FG V++G+L + G++ +A+K L G + + ++F +E ++ + H N+++L
Sbjct: 13 IGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLE 72
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS--KRSHIIAGIARGLLYLHQDSR 637
G T+ M+I EY+ N +LD ++ R ++S + ++ GIA G+ YL S
Sbjct: 73 GVVTKFKPAMIITEYMENGALDKYL----RDHDGEFSSYQLVGMLRGIAAGMKYL---SD 125
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG--YMSPEYAID 695
+ +HRDL A N+L+++ + K+SDFGL+R D E G + +PE
Sbjct: 126 MNYVHRDLAARNILVNSNLECKVSDFGLSRVLE-DDPEGTYTTSGGKIPIRWTAPEAIAY 184
Query: 696 GLFSVKSDVFSFGVLVLEII 715
F+ SDV+SFG+++ E++
Sbjct: 185 RKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 5e-22
Identities = 60/206 (29%), Positives = 102/206 (49%), Gaps = 10/206 (4%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQ 571
NF + K+G+G F VYK + L++G+ +A+K++ + ++ E+ L+ +L
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLD 60
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLL 630
H N++K L + +E ++ E L I + K L+ + L
Sbjct: 61 HPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALE 120
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
++H RI+HRD+K +NV + T K+ D GL R F T A++ VGT YMSP
Sbjct: 121 HMHSK---RIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSP 175
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIIC 716
E + ++ KSD++S G L+ E+
Sbjct: 176 ERIHENGYNFKSDIWSLGCLLYEMAA 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 96.0 bits (239), Expect = 7e-22
Identities = 64/200 (32%), Positives = 95/200 (47%), Gaps = 15/200 (7%)
Query: 525 LGEGGFGPVY------KGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+GGFG V G + +++ KRL K G+ M NE ++ K+ R +V L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMA--LNEKKILEKVSSRFIVSL 58
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+D+ L+ + L Y I++ ++ A I GL +LHQ
Sbjct: 59 AYAFETKDDLCLVMTLMNGGDLKYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQ---R 114
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
RI++RDLK NVLLD+ N +ISD GLA + K GT GYM+PE ++
Sbjct: 115 RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMAPEVLQGEVY 171
Query: 699 SVKSDVFSFGVLVLEIICGK 718
D F+ G + E+I G+
Sbjct: 172 DFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.3 bits (237), Expect = 1e-21
Identities = 61/209 (29%), Positives = 98/209 (46%), Gaps = 26/209 (12%)
Query: 525 LGEGGFGPVYKGMLIEG----QEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LGEG FG V +G L + ++AVK +L + +EEF +E + H N++KL
Sbjct: 7 LGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKL 66
Query: 579 LGCCTQRDER------MLIYEYLPNKSLDYFIFDT---TRSKLLDWSKRSHIIAGIARGL 629
+G C + M+I ++ + L F+ + + L + IA G+
Sbjct: 67 IGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLD---QTEANTKRVVGTY 685
YL S IHRDL A N +L M ++DFGL++ + D Q V
Sbjct: 127 EYL---SNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPV---- 179
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+++ E D +++ KSDV++FGV + EI
Sbjct: 180 KWIAIESLADRVYTSKSDVWAFGVTMWEI 208
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 95.1 bits (237), Expect = 1e-21
Identities = 59/214 (27%), Positives = 99/214 (46%), Gaps = 37/214 (17%)
Query: 525 LGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGME-EFKNEVLLIAKLQHRNLVK 577
LG+G FG VY+G+ +A+K +++ + EF NE ++ + ++V+
Sbjct: 14 LGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVR 73
Query: 578 LLGCCTQRDERMLIYEYL-------------PNKSLDYFIFDTTRSKLLDWSKRSHIIAG 624
LLG + +++ E + P + + T K + + A
Sbjct: 74 LLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA------AE 127
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
IA G+ YL + +HRDL A N ++ + KI DFG+ R D E + R G
Sbjct: 128 IADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTR----DIYETDYYRKGGK 180
Query: 685 ----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE DG+F+ KSDV+SFGV++ E+
Sbjct: 181 GLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEM 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.5 bits (235), Expect = 2e-21
Identities = 63/204 (30%), Positives = 101/204 (49%), Gaps = 19/204 (9%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKR-----LSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG VY ++ G+E+AVK+ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQY 69
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
GC + + EY+P S+ + L + R + I G+ YLH +
Sbjct: 70 YGCLRDDETLSIFMEYMPGGSVKDQL--KAYGALTETVTRKYT-RQILEGVEYLHSN--- 123
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT----EANTKRVVGTYGYMSPEYAI 694
I+HRD+K +N+L D+ N K+ DFG ++ QT K V GT +MSPE
Sbjct: 124 MIVHRDIKGANILRDSAGNVKLGDFGASKRL---QTICSSGTGMKSVTGTPYWMSPEVIS 180
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+ K+DV+S G V+E++ K
Sbjct: 181 GEGYGRKADVWSVGCTVVEMLTEK 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 95.4 bits (237), Expect = 2e-21
Identities = 76/225 (33%), Positives = 114/225 (50%), Gaps = 34/225 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYK----GMLIEGQE----IAVKRLS-KGSGQGMEEFKNEVLLI 567
D LGEG FG V + G+ + +AVK L + + + + +E+ L+
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELM 71
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI-----------FDTTRS--KLL 613
+ +H+N++ LLG CTQ +I EY +L F+ FD T+ + L
Sbjct: 72 KLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQL 131
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLARSFGL 671
+ +ARG+ YL +SR R IHRDL A NVL+ DN M KI+DFGLAR G+
Sbjct: 132 SFKDLVSCAYQVARGMEYL--ESR-RCIHRDLAARNVLVTEDNVM--KIADFGLAR--GV 184
Query: 672 DQTEANTKRVVGTY--GYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+ K G +M+PE D +++ +SDV+SFG+L+ EI
Sbjct: 185 HDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 94.8 bits (236), Expect = 2e-21
Identities = 67/207 (32%), Positives = 107/207 (51%), Gaps = 14/207 (6%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRL---SKGSGQGMEEFKNEVLLIAKLQHR 573
++++ K+GEG +G VYKG GQ +A+K++ S+ G + E+ L+ +LQH
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIR-EISLLKELQHP 59
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYL 632
N+V L Q LI+E+L Y D+ + +D + I +G+L+
Sbjct: 60 NIVCLQDVLMQESRLYLIFEFLSMDLKKYL--DSLPKGQYMDAELVKSYLYQILQGILFC 117
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H R++HRDLK N+L+DN K++DFGLAR+FG+ T VV T Y +PE
Sbjct: 118 H---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGI-PVRVYTHEVV-TLWYRAPEV 172
Query: 693 AIDG-LFSVKSDVFSFGVLVLEIICGK 718
+ +S D++S G + E+ K
Sbjct: 173 LLGSPRYSTPVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 2e-21
Identities = 66/194 (34%), Positives = 108/194 (55%), Gaps = 11/194 (5%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG+G FG V+ G ++A+K L G+ E F E ++ KL+H LV L +
Sbjct: 13 KLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS 71
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ + ++ E++ SL F+ + K L + + A IA G+ Y+ R+ IHR
Sbjct: 72 E-EPIYIVTEFMGKGSLLDFLKEGD-GKYLKLPQLVDMAAQIADGMAYIE---RMNYIHR 126
Query: 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDGLFSVK 701
DL+A+N+L+ + + KI+DFGLAR L + T R + + +PE A+ G F++K
Sbjct: 127 DLRAANILVGDNLVCKIADFGLAR---LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIK 183
Query: 702 SDVFSFGVLVLEII 715
SDV+SFG+L+ E++
Sbjct: 184 SDVWSFGILLTELV 197
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 3e-21
Identities = 70/199 (35%), Positives = 109/199 (54%), Gaps = 21/199 (10%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
KLG G FG V+ + ++AVK + GS +E F E ++ LQH LVKL T
Sbjct: 13 KLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVT 71
Query: 584 QRDERMLIYEYLPNKSL-DYFIFDTTRS----KLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ +I E++ SL D+ D KL+D+S A IA G+ ++ Q +
Sbjct: 72 -KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFS------AQIAEGMAFIEQRN-- 122
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDG 696
IHRDL+A+N+L+ ++ KI+DFGLAR + + T R + + +PE G
Sbjct: 123 -YIHRDLRAANILVSASLVCKIADFGLAR---VIEDNEYTAREGAKFPIKWTAPEAINFG 178
Query: 697 LFSVKSDVFSFGVLVLEII 715
F++KSDV+SFG+L++EI+
Sbjct: 179 SFTIKSDVWSFGILLMEIV 197
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-21
Identities = 69/223 (30%), Positives = 107/223 (47%), Gaps = 39/223 (17%)
Query: 518 NFSEKNKLGEGGFGPVYKGM---LIEGQE---IAVKRLSKGSGQGMEEFKNEVLLIAKLQ 571
N K +LGEG FG V+ L Q+ +AVK L S ++F E L+ LQ
Sbjct: 6 NIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQ 65
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----------------FDTTRSKLLDW 615
H ++VK G C + D ++++EY+ + L+ F+ + T+S++L
Sbjct: 66 HEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML-- 123
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
HI IA G++YL + +HRDL N L+ + KI DFG++R D
Sbjct: 124 ----HIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR----DVYS 172
Query: 676 ANTKRVVG----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+ RV G +M PE + F+ +SDV+S GV++ EI
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 4e-21
Identities = 64/218 (29%), Positives = 106/218 (48%), Gaps = 28/218 (12%)
Query: 522 KNKLGEGGFGPVY----KGML---------IEGQE--IAVKRL-SKGSGQGMEEFKNEVL 565
K KLGEG FG V+ +G+ +GQ +AVK L + + +F E+
Sbjct: 10 KEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIK 69
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD-TTRSKL--------LDWS 616
++++L++ N+++LLG C D +I EY+ N L+ F+ S + +
Sbjct: 70 IMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIA 129
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676
++ IA G+ YL + L +HRDL N L+ N KI+DFG++R+
Sbjct: 130 NLLYMAVQIASGMKYL---ASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYR 186
Query: 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
R V +M+ E + G F+ SDV++FGV + E+
Sbjct: 187 IQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM 224
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 94.0 bits (233), Expect = 4e-21
Identities = 58/208 (27%), Positives = 111/208 (53%), Gaps = 10/208 (4%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
I + ++ K+G+G G V+ + + GQE+A+K+++ E NE+L++ +L
Sbjct: 14 IGDPKKKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKEL 73
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
++ N+V L DE ++ EYL SL D +D ++ + + + L
Sbjct: 74 KNPNIVNFLDSFLVGDELFVVMEYLAGGSLT----DVVTETCMDEAQIAAVCRECLQALE 129
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LH + ++IHRD+K+ NVLL + K++DFG +Q++ +T +VGT +M+P
Sbjct: 130 FLHAN---QVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAP 184
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + K D++S G++ +E++ G+
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 93.7 bits (233), Expect = 4e-21
Identities = 61/222 (27%), Positives = 103/222 (46%), Gaps = 41/222 (18%)
Query: 525 LGEGGFGPVYKGM---LIEGQE---IAVKRLSKGSGQGME-EFKNEVLLIAKLQHRNLVK 577
+G+G FG V++ L+ + +AVK L + + M+ +F+ E L+A+ H N+VK
Sbjct: 13 IGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVK 72
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH----------------- 620
LLG C L++EY+ L+ F+ + S +
Sbjct: 73 LLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQ 132
Query: 621 --IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS------FGLD 672
I +A G+ YL S + +HRDL N L+ M KI+DFGL+R+ +
Sbjct: 133 LCIAKQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKAS 189
Query: 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+ +A R +M PE ++ +SDV+++GV++ EI
Sbjct: 190 ENDAIPIR------WMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 93.5 bits (232), Expect = 7e-21
Identities = 67/225 (29%), Positives = 105/225 (46%), Gaps = 30/225 (13%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
K +LGEG FG V+ + +AVK L + ++F+ E L+ LQH ++
Sbjct: 10 KRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHI 69
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-------------LDWSKRSHII 622
VK G C D ++++EY+ + L+ F+ + L S+ HI
Sbjct: 70 VKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIA 129
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+ IA G++YL + +HRDL N L+ + KI DFG++R D + RV
Sbjct: 130 SQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----DVYSTDYYRVG 182
Query: 683 G----TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723
G +M PE + F+ +SDV+SFGV++ EI K F
Sbjct: 183 GHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWF 227
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 7e-21
Identities = 61/202 (30%), Positives = 97/202 (48%), Gaps = 18/202 (8%)
Query: 523 NKLGEGGFGPVYKGMLI--EGQEIAVKRLSKGSGQGMEEFKN---EVLLIAKLQHRNLVK 577
+LG G G V K +L G+ +AVK + K E+ ++ K +V
Sbjct: 7 GELGAGNSGVVSK-VLHRPTGKIMAVKTIR--LEINEAIQKQILRELDILHKCNSPYIVG 63
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
G + + EY+ SLD + + I + +GL YLH +
Sbjct: 64 FYGAFYNNGDISICMEYMDGGSLDKIL--KEVQGRIPERILGKIAVAVLKGLTYLH--EK 119
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL 697
+IIHRD+K SN+L+++ K+ DFG++ L + A T VGT YM+PE I G
Sbjct: 120 HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQ--LVNSLAKT--FVGTSSYMAPE-RIQGN 174
Query: 698 -FSVKSDVFSFGVLVLEIICGK 718
+SVKSD++S G+ ++E+ G+
Sbjct: 175 DYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 9e-21
Identities = 63/193 (32%), Positives = 101/193 (52%), Gaps = 11/193 (5%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+LG G FG V+ G ++A+K +++G+ E+F E ++ KL H LV+L G CT
Sbjct: 11 ELGSGQFGVVHLGKWRAQIKVAIKAINEGA-MSEEDFIEEAKVMMKLSHPKLVQLYGVCT 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS--HIIAGIARGLLYLHQDSRLRII 641
Q+ ++ E++ N L ++ R + SK + + G+ YL ++S I
Sbjct: 70 QQKPLYIVTEFMENGCLLNYL----RQRQGKLSKDMLLSMCQDVCEGMEYLERNS---FI 122
Query: 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVK 701
HRDL A N L+ +T K+SDFG+ R + LD ++ + PE +S K
Sbjct: 123 HRDLAARNCLVSSTGVVKVSDFGMTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSK 181
Query: 702 SDVFSFGVLVLEI 714
SDV+SFGVL+ E+
Sbjct: 182 SDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 1e-20
Identities = 66/206 (32%), Positives = 103/206 (50%), Gaps = 16/206 (7%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLS------KGSGQGMEEFKNEVLLIAKLQHRNLV 576
LG+G +G VY G+ +GQ IAVK++ + + E+ + EV L+ L+H N+V
Sbjct: 6 EVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIV 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ LG C + + E++P S+ + R L I G+ YLH +
Sbjct: 66 QYLGTCLDDNTISIFMEFVPGGSISSIL---NRFGPLPEPVFCKYTKQILDGVAYLHNNC 122
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSF---GLDQTEANT-KRVVGTYGYMSPEY 692
++HRD+K +NV+L K+ DFG AR GL T +N K + GT +M+PE
Sbjct: 123 ---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEV 179
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ + KSD++S G V E+ GK
Sbjct: 180 INESGYGRKSDIWSIGCTVFEMATGK 205
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 91.9 bits (228), Expect = 1e-20
Identities = 67/198 (33%), Positives = 105/198 (53%), Gaps = 21/198 (10%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+LG G FG V G ++A+K + +GS +EF E ++ KL H LV+L G CT
Sbjct: 11 ELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCT 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
++ ++ EY+ N L ++ + + S+LL+ K + G+ YL +
Sbjct: 70 KQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCK------DVCEGMAYLESK---Q 120
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEYAIDG 696
IHRDL A N L+D+ K+SDFGL+R + LD ++ VG+ + PE +
Sbjct: 121 FIHRDLAARNCLVDDQGCVKVSDFGLSR-YVLDDEYTSS---VGSKFPVRWSPPEVLLYS 176
Query: 697 LFSVKSDVFSFGVLVLEI 714
FS KSDV++FGVL+ E+
Sbjct: 177 KFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 1e-20
Identities = 59/211 (27%), Positives = 102/211 (48%), Gaps = 25/211 (11%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLS---------KGSGQGM-EEFKNEVLLIAKLQHR 573
+G+G +G VY + + G+ +AVK++ + M + ++E+ + L H
Sbjct: 9 IGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHL 68
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V+ LG T + + EY+P S+ + R + + GL YLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQVLEGLAYLH 125
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG--LDQTEANTKRVVGTYGYMSPE 691
I+HRDLKA N+L+D KISDFG+++ D + + + G+ +M+PE
Sbjct: 126 SKG---ILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQ--GSVFWMAPE 180
Query: 692 YAIDGL---FSVKSDVFSFGVLVLEIICGKK 719
I +S K D++S G +VLE+ G++
Sbjct: 181 -VIHSYSQGYSAKVDIWSLGCVVLEMFAGRR 210
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 1e-20
Identities = 64/198 (32%), Positives = 97/198 (48%), Gaps = 23/198 (11%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGME-EFKNEVLLIAKLQHRNLVKLLGCCT 583
LG+G FG V+KG L + +AVK + Q ++ +F +E ++ + H N+VKL+G CT
Sbjct: 3 LGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCT 62
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
QR ++ E +P D+ F + L + A G+ YL + IHR
Sbjct: 63 QRQPIYIVMELVPGG--DFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESKN---CIHR 117
Query: 644 DLKASNVLLDNTMNPKISDFGLAR--------SFGLDQTEANTKRVVGTYGYMSPEYAID 695
DL A N L+ KISDFG++R S GL Q + +PE
Sbjct: 118 DLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIK---------WTAPEALNY 168
Query: 696 GLFSVKSDVFSFGVLVLE 713
G +S +SDV+S+G+L+ E
Sbjct: 169 GRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 92.3 bits (229), Expect = 2e-20
Identities = 59/212 (27%), Positives = 110/212 (51%), Gaps = 18/212 (8%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + ++ K+G+G G VY + + GQE+A+K+++ E NE+L++ +
Sbjct: 14 VGDPKKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMREN 73
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H N+V L DE ++ EYL SL + +T + IA + R L
Sbjct: 74 KHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDE--------GQIAAVCRECL 125
Query: 631 ----YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
+LH + ++IHRD+K+ N+LL + K++DFG +Q++ +T +VGT
Sbjct: 126 QALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPY 180
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
+M+PE + K D++S G++ +E++ G+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 72/238 (30%), Positives = 108/238 (45%), Gaps = 39/238 (16%)
Query: 518 NFSEKNKLGEGGFGPVY-----------------KGMLIEGQEIAVKRLSKG-SGQGMEE 559
NF EK LGEG FG V+ +AVK L S E+
Sbjct: 8 NFVEK--LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNARED 65
Query: 560 FKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI--------FDTTRSK 611
F EV ++++L N+ +LLG CT +I EY+ N L+ F+ SK
Sbjct: 66 FLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSK 125
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
L +S ++ IA G+ YL L +HRDL N L+ KI+DFG++R+
Sbjct: 126 SLSFSTLLYMATQIASGMRYL---ESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNL-- 180
Query: 672 DQTEANTKRVVGT----YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725
++ RV G +M+ E + G F+ KSDV++FGV + EI+ + + + H
Sbjct: 181 --YSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 91.8 bits (228), Expect = 3e-20
Identities = 66/209 (31%), Positives = 99/209 (47%), Gaps = 18/209 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM---LIEGQ---EIAVKRL-SKGSGQGMEEFKNEVLLIAK 569
+N S LG G FG V + L + ++AVK L E +E+ +++
Sbjct: 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSH 94
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG 628
L H N+V LLG CT ++I EY L F+ R L +A+G
Sbjct: 95 LGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFL-RRKRESFLTLEDLLSFSYQVAKG 153
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ---TEANTKRVVGTY 685
+ +L + IHRDL A NVLL + KI DFGLAR D + N + V
Sbjct: 154 MAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPV--- 207
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE + +++ +SDV+S+G+L+ EI
Sbjct: 208 KWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 3e-20
Identities = 67/207 (32%), Positives = 112/207 (54%), Gaps = 20/207 (9%)
Query: 519 FSEKNKLGEGGFGPVYKGMLI-EGQEI----AVKRLSKG-SGQGMEEFKNEVLLIAKLQH 572
F + LG G FG VYKG+ I EG+++ A+K L + S + +E +E ++A + +
Sbjct: 9 FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDN 68
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTR---SKLLDWSKRSHIIAGIARG 628
++ +LLG C + LI + +P L DY LL+W + IA+G
Sbjct: 69 PHVCRLLGICLTSTVQ-LITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ------IAKG 121
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
+ YL + R++HRDL A NVL+ + KI+DFGLA+ G D+ E + + +M
Sbjct: 122 MNYLEER---RLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWM 178
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ E + +++ +SDV+S+GV V E++
Sbjct: 179 ALESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.6 bits (225), Expect = 4e-20
Identities = 59/211 (27%), Positives = 108/211 (51%), Gaps = 19/211 (9%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQH---RNLVKLL 579
+G G +G VY+G + G+ +A+K ++ + + + + EV L+++L+ N+ K
Sbjct: 9 IGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYY 68
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
G + +I EY S+ + ++ + S II + L Y+H+
Sbjct: 69 GSYLKGPRLWIIMEYAEGGSVRTLM----KAGPIAEKYISVIIREVLVALKYIHKVG--- 121
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LF 698
+IHRD+KA+N+L+ NT N K+ DFG+A L+Q + VGT +M+PE +G +
Sbjct: 122 VIHRDIKAANILVTNTGNVKLCDFGVAAL--LNQNSSKRSTFVGTPYWMAPEVITEGKYY 179
Query: 699 SVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
K+D++S G+ + E+ G ++D D
Sbjct: 180 DTKADIWSLGITIYEMATGNP----PYSDVD 206
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 5e-20
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 29/212 (13%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-----EVLLIAKLQ 571
+ + KLGEG + VYK E G+ +A+K++ G + ++ N E+ L+ +L+
Sbjct: 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELK 60
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI---IAGIARG 628
H N++ LL + L++E++ L+ I + K + + + I + RG
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-DLEKVI----KDKSIVLTP-ADIKSYMLMTLRG 114
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
L YLH I+HRDLK +N+L+ + K++DFGLARSFG T +VV T Y
Sbjct: 115 LEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARSFG-SPNRKMTHQVV-TRWYR 169
Query: 689 SPEYAIDGLFSVKS-----DVFSFGVLVLEII 715
+PE LF + D++S G + E++
Sbjct: 170 APEL----LFGARHYGVGVDMWSVGCIFAELL 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.4 bits (225), Expect = 5e-20
Identities = 61/223 (27%), Positives = 99/223 (44%), Gaps = 28/223 (12%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QH 572
+ T F +GEG +G VYK + ++ ++ EE K E ++ K H
Sbjct: 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIEDEEEEIKEEYNILRKYSNH 62
Query: 573 RNLVKLLGCCTQR------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR------SH 620
N+ G ++ D+ L+ E S + D + L KR ++
Sbjct: 63 PNIATFYGAFIKKNPPGNDDQLWLVMELCGGGS----VTDLVK-GLRKKGKRLKEEWIAY 117
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
I+ RGL YLH++ ++IHRD+K N+LL K+ DFG++ LD T
Sbjct: 118 ILRETLRGLAYLHEN---KVIHRDIKGQNILLTKNAEVKLVDFGVSAQ--LDSTLGRRNT 172
Query: 681 VVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+GT +M+PE D + +SDV+S G+ +E+ GK
Sbjct: 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGK 215
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 90.1 bits (224), Expect = 6e-20
Identities = 67/222 (30%), Positives = 110/222 (49%), Gaps = 16/222 (7%)
Query: 523 NKLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
NK+G G FG VY + L G+ +AVK R+ + ++E +E+ ++ L+H NLVK
Sbjct: 6 NKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYY 65
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
G R++ + EY +L+ + ++LD + GL YLH
Sbjct: 66 GVEVHREKVYIFMEYCSGGTLEELLEHG---RILDEHVIRVYTLQLLEGLAYLHSH---G 119
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT--KRVVGTYGYMSPEYAIDGL 697
I+HRD+K +N+ LD+ K+ DFG A + T + + GT YM+PE G
Sbjct: 120 IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGK 179
Query: 698 FSVK---SDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
+D++S G +VLE+ GK R ++ D++ ++ HV
Sbjct: 180 GKGHGRAADIWSLGCVVLEMATGK--RPWSELDNEFQIMFHV 219
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 9e-20
Identities = 63/202 (31%), Positives = 102/202 (50%), Gaps = 10/202 (4%)
Query: 523 NKLGEGGFGPVYKGMLIEGQE-IAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G VY + + E +A+KR L K ++E + EV +++ H N+VK
Sbjct: 7 EVIGVGATAVVYAAICLPNNEKVAIKRIDLEK-CQTSVDELRKEVQAMSQCNHPNVVKYY 65
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
DE L+ YL SL + + LD + + ++ + +GL YLH + +
Sbjct: 66 TSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQ-- 123
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSF--GLDQTEANTKRVVGTYGYMSPEYAIDGL 697
IHRD+KA N+LL + KI+DFG++ S G D+T K VGT +M+PE
Sbjct: 124 -IHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVH 182
Query: 698 -FSVKSDVFSFGVLVLEIICGK 718
+ K+D++SFG+ +E+ G
Sbjct: 183 GYDFKADIWSFGITAIELATGA 204
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 89.5 bits (222), Expect = 9e-20
Identities = 57/220 (25%), Positives = 103/220 (46%), Gaps = 27/220 (12%)
Query: 525 LGEGGFGPVYK------GMLIEGQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVK 577
LG G F Y+ G L+ +++ R + + +E + E+ L+A+L H ++++
Sbjct: 8 LGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIR 67
Query: 578 LLGCCTQRDERMLIYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
+LG + L E++ S+ Y F + + RGL YL
Sbjct: 68 MLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVI--------INYTEQLLRGLSYL 119
Query: 633 HQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLARSFGLDQTEAN--TKRVVGTYGYMS 689
H++ +IIHRD+K +N+L+D+T +I+DFG A T A +++GT +M+
Sbjct: 120 HEN---QIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMA 176
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRG-FNHADH 728
PE + DV+S G +++E+ K H++H
Sbjct: 177 PEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH 216
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 90.2 bits (223), Expect = 9e-20
Identities = 57/208 (27%), Positives = 109/208 (52%), Gaps = 10/208 (4%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + ++ K+G+G G VY + I GQE+A+K+++ E NE+L++ +
Sbjct: 14 VGDPKKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMREN 73
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
++ N+V L DE ++ EYL SL D +D + + + + L
Sbjct: 74 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALD 129
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LH + ++IHRD+K+ N+LL + K++DFG +Q++ +T +VGT +M+P
Sbjct: 130 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAP 184
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + K D++S G++ +E++ G+
Sbjct: 185 EVVTRKAYGPKVDIWSLGIMAIEMVEGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 1e-19
Identities = 66/198 (33%), Positives = 101/198 (51%), Gaps = 27/198 (13%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+GEG FG V +G GQ++AVK + + F E ++ KL H+NLV+LLG
Sbjct: 13 IIGEGEFGAVLQGEYT-GQKVAVKNIK--CDVTAQAFLEETAVMTKLHHKNLVRLLGVIL 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFDTTRS-----KLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ E + +L F+ R+ +LL +S +A G+ YL
Sbjct: 70 HNG-LYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFS------LDVAEGMEYLESK--- 119
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLAR--SFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
+++HRDL A N+L+ K+SDFGLAR S G+D ++ K + +PE
Sbjct: 120 KLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGVDNSKLPVK-------WTAPEALKHK 172
Query: 697 LFSVKSDVFSFGVLVLEI 714
FS KSDV+S+GVL+ E+
Sbjct: 173 KFSSKSDVWSYGVLLWEV 190
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 1e-19
Identities = 60/202 (29%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLV 576
F++ ++G+G FG VYKG+ +E+ A+K + + +E+ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYIT 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ G + + +I EYL S D + L+ + + I+ I +GL YLH +
Sbjct: 66 RYYGSYLKGTKLWIIMEYLGGGS----ALDLLKPGPLEETYIATILREILKGLDYLHSE- 120
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
R IHRD+KA+NVLL + K++DFG+A Q + NT VGT +M+PE
Sbjct: 121 --RKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIKQS 176
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+ K+D++S G+ +E+ G+
Sbjct: 177 AYDFKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 1e-19
Identities = 67/199 (33%), Positives = 95/199 (47%), Gaps = 10/199 (5%)
Query: 525 LGEGGFGPVYK-GMLIEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG+GGFG V M G+ A K+L+K +G E E ++AK+ R +V L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAY 60
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARGLLYLHQDSRLR 639
+ + L+ + L Y I++ + A I GL +LHQ R
Sbjct: 61 AFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR---R 117
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
II+RDLK NVLLDN N +ISD GLA Q++ TK GT G+M+PE +
Sbjct: 118 IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSK--TKGYAGTPGFMAPELLQGEEYD 175
Query: 700 VKSDVFSFGVLVLEIICGK 718
D F+ GV + E+I +
Sbjct: 176 FSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 88.7 bits (220), Expect = 2e-19
Identities = 66/202 (32%), Positives = 108/202 (53%), Gaps = 19/202 (9%)
Query: 525 LGEGGFGPVYKGMLI--EGQEI--AVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLL 579
+G+G FG VY G LI +GQ+I AVK L++ + + +E+F E +++ H N++ LL
Sbjct: 3 IGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLL 62
Query: 580 GCCTQRD-ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAG--IARGLLYLHQDS 636
G C + +++ Y+ + L FI T + + + I G +A+G+ YL
Sbjct: 63 GICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTV----KDLIGFGLQVAKGMEYLASK- 117
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ---TEANTKRVVGTYGYMSPEYA 693
+ +HRDL A N +LD + K++DFGLAR D+ + N +M+ E
Sbjct: 118 --KFVHRDLAARNCMLDESFTVKVADFGLARDI-YDKEYYSVHNHTGAKLPVKWMALESL 174
Query: 694 IDGLFSVKSDVFSFGVLVLEII 715
F+ KSDV+SFGVL+ E++
Sbjct: 175 QTQKFTTKSDVWSFGVLLWELM 196
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 2e-19
Identities = 67/201 (33%), Positives = 108/201 (53%), Gaps = 20/201 (9%)
Query: 525 LGEGGFGPVYKGMLIEGQE-----IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG VYKG+ I E +A+K L + S + +E +E ++A + + +L
Sbjct: 15 LGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRL 74
Query: 579 LGCCTQRDERMLIYEYLPNKSL-DYFIFDTTR---SKLLDWSKRSHIIAGIARGLLYLHQ 634
LG C + L+ + +P L DY + R LL+W + IA+G+ YL +
Sbjct: 75 LGICLTSTVQ-LVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQ------IAKGMSYLEE 127
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+R++HRDL A NVL+ + + KI+DFGLAR +D+TE + +M+ E +
Sbjct: 128 ---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESIL 184
Query: 695 DGLFSVKSDVFSFGVLVLEII 715
F+ +SDV+S+GV V E++
Sbjct: 185 HRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.0 bits (220), Expect = 2e-19
Identities = 56/208 (26%), Positives = 108/208 (51%), Gaps = 10/208 (4%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + ++ K+G+G G VY M + GQE+A+++++ E NE+L++ +
Sbjct: 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN 74
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
++ N+V L DE ++ EYL SL D +D + + + + L
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETCMDEGQIAAVCRECLQALE 130
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LH + ++IHRD+K+ N+LL + K++DFG +Q++ + +VGT +M+P
Sbjct: 131 FLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRS--TMVGTPYWMAP 185
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + K D++S G++ +E+I G+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (218), Expect = 2e-19
Identities = 64/206 (31%), Positives = 104/206 (50%), Gaps = 20/206 (9%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCT 583
+G G +G VYKG ++ ++A ++ +G EE K E+ ++ K HRN+ G
Sbjct: 14 VGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEIKQEINMLKKYSHHRNIATYYGAFI 73
Query: 584 QR------DERMLIYEYLPNKSLDYFIFDTTRSKLL-DWSKRSHIIAGIARGLLYLHQDS 636
++ D+ L+ E+ S+ I +T + L +W ++I I RGL +LHQ
Sbjct: 74 KKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWI--AYICREILRGLSHLHQH- 130
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-- 694
++IHRD+K NVLL K+ DFG+ S LD+T +GT +M+PE
Sbjct: 131 --KVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRNTFIGTPYWMAPEVIACD 186
Query: 695 ---DGLFSVKSDVFSFGVLVLEIICG 717
D + KSD++S G+ +E+ G
Sbjct: 187 ENPDATYDFKSDLWSLGITAIEMAEG 212
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 2e-19
Identities = 62/205 (30%), Positives = 102/205 (49%), Gaps = 19/205 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+++ ++G G +G VYK I E+ A+K + G E + E+ ++ + +H N+
Sbjct: 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNI 62
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR----GLLY 631
V G +RD+ ++ EY SL I+ TR L IA + R GL Y
Sbjct: 63 VAYFGSYLRRDKLWIVMEYCGGGSLQD-IYQVTRGPL-----SELQIAYVCRETLKGLAY 116
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH+ IHRD+K +N+LL + K++DFG++ L T A K +GT +M+PE
Sbjct: 117 LHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQ--LTATIAKRKSFIGTPYWMAPE 171
Query: 692 YA---IDGLFSVKSDVFSFGVLVLE 713
A G + K D+++ G+ +E
Sbjct: 172 VAAVERKGGYDGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 60/205 (29%), Positives = 105/205 (51%), Gaps = 23/205 (11%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIAKLQHRN 574
K+GEG +G VYK + G+ +A+K++ +E E+ L+ +L H N
Sbjct: 6 KIGEGTYGVVYKARDKLTGEIVALKKIR------LETEDEGVPSTAIREISLLKELNHPN 59
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+V+LL ++ L++E+L + L ++ D++ LD + + +G+ Y H
Sbjct: 60 IVRLLDVVHSENKLYLVFEFL-DLDLKKYM-DSSPLTGLDPPLIKSYLYQLLQGIAYCHS 117
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
R++HRDLK N+L+D K++DFGLAR+FG+ T VV T Y +PE +
Sbjct: 118 H---RVLHRDLKPQNLLIDREGALKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILL 172
Query: 695 DG-LFSVKSDVFSFGVLVLEIICGK 718
+S D++S G + E++ +
Sbjct: 173 GSRQYSTPVDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 3e-19
Identities = 67/214 (31%), Positives = 106/214 (49%), Gaps = 28/214 (13%)
Query: 522 KNKLGEGGFGPVYKGMLIEG---QEIAVKRLSK-GSGQGMEEFKNEVLLIAKL-QHRNLV 576
++ +GEG FG V K + + + A+KR+ + S +F E+ ++ KL H N++
Sbjct: 12 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 71
Query: 577 KLLGCCTQRDERMLIYEYLPNKSL-DY------------FIFDTTRSKLLDWSKRSHIIA 623
LLG C R L EY P+ +L D+ F + + L + H A
Sbjct: 72 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 131
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
+ARG+ YL Q + IHRDL A N+L+ KI+DFGL+R E K+ +G
Sbjct: 132 DVARGMDYLSQK---QFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMG 183
Query: 684 TYG--YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+ E +++ SDV+S+GVL+ EI+
Sbjct: 184 RLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 88.3 bits (219), Expect = 4e-19
Identities = 58/204 (28%), Positives = 91/204 (44%), Gaps = 14/204 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQG-MEEFKNEVLLIAKLQHRN 574
+ E ++LGEG G V K L I A+K ++ ++ E+ + +
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPY 60
Query: 575 LVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSKLLDWSKR--SHIIAGIARGLL 630
+VK G + EY SLD I+ + + ++ I + +GL
Sbjct: 61 IVKYYGAFLDESSSSIGIAMEYCEGGSLDS-IYKKVKKRGGRIGEKVLGKIAESVLKGLS 119
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH +IIHRD+K SN+LL K+ DFG++ A T GT YM+P
Sbjct: 120 YLHSR---KIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL--AGT--FTGTSFYMAP 172
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEI 714
E +S+ SDV+S G+ +LE+
Sbjct: 173 ERIQGKPYSITSDVWSLGLTLLEV 196
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 5e-19
Identities = 59/202 (29%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLV 576
F++ ++G+G FG V+KG+ Q++ A+K + + +E+ + E+ ++++ +
Sbjct: 6 FTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
K G + + +I EYL S D R+ D + + ++ I +GL YLH +
Sbjct: 66 KYYGSYLKGTKLWIIMEYLGGGS----ALDLLRAGPFDEFQIATMLKEILKGLDYLHSEK 121
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
+ IHRD+KA+NVLL + K++DFG+A Q + NT VGT +M+PE
Sbjct: 122 K---IHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAPEVIQQS 176
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+ K+D++S G+ +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 5e-19
Identities = 57/207 (27%), Positives = 102/207 (49%), Gaps = 13/207 (6%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
N D + +LG+G FG VYK E G A K + S + +E+F E+ ++++ +H
Sbjct: 2 NPNDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKH 61
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
N+V L ++ ++ E+ +LD + + R L + ++ + L +L
Sbjct: 62 PNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERG--LTEPQIRYVCRQMLEALNFL 119
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H ++IHRDLKA N+LL + K++DFG+ S T +GT +M+PE
Sbjct: 120 HSH---KVIHRDLKAGNILLTLDGDVKLADFGV--SAKNKSTLQKRDTFIGTPYWMAPEV 174
Query: 693 AI-----DGLFSVKSDVFSFGVLVLEI 714
D + K+D++S G+ ++E+
Sbjct: 175 VACETFKDNPYDYKADIWSLGITLIEL 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 5e-19
Identities = 62/213 (29%), Positives = 93/213 (43%), Gaps = 27/213 (12%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQHR 573
+F +G+G FG V + +++ A+K ++K +N E ++ +L H
Sbjct: 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHP 60
Query: 574 NLVKLLGCCT-QRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
LV L + Q +E M L+ + L L Y + F + K I I
Sbjct: 61 FLVNL--WYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKF--------WICEIV 110
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
L YLH IIHRD+K N+LLD + I+DF +A + T GT G
Sbjct: 111 LALEYLHSK---GIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPG 164
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
YM+PE +SV D +S GV E + GK+
Sbjct: 165 YMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKR 197
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 5e-19
Identities = 60/202 (29%), Positives = 106/202 (52%), Gaps = 11/202 (5%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLV 576
F++ K+G+G FG V+KG+ Q++ A+K + + +E+ + E+ ++++ +
Sbjct: 6 FTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVT 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
K G + + +I EYL S D LD ++ + I+ I +GL YLH +
Sbjct: 66 KYYGSYLKDTKLWIIMEYLGGGS----ALDLLEPGPLDETQIATILREILKGLDYLHSEK 121
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
+ IHRD+KA+NVLL K++DFG+A L T+ VGT +M+PE
Sbjct: 122 K---IHRDIKAANVLLSEHGEVKLADFGVAGQ--LTDTQIKRNTFVGTPFWMAPEVIKQS 176
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+ K+D++S G+ +E+ G+
Sbjct: 177 AYDSKADIWSLGITAIELAKGE 198
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 5e-19
Identities = 67/216 (31%), Positives = 101/216 (46%), Gaps = 33/216 (15%)
Query: 518 NFSEKNKLGEGGFGPVYK-GMLIEGQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRN 574
+F KLG+G +G VYK L + Q A+K L S + E+ NE+ ++A + H N
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 575 LVK-----LLGC--CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLL-----DWSKRSHII 622
++ L G C + EY P L I + + L W I
Sbjct: 61 IISYKEAFLDGNKLCI-------VMEYAPFGDLSKAISKRKKKRKLIPEQEIWR----IF 109
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+ RGL LH+ +I+HRDLK++N+LL KI D G+++ L + A T +
Sbjct: 110 IQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKV--LKKNMAKT--QI 162
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
GT YM+PE +S KSD++S G L+ E+
Sbjct: 163 GTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFA 198
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 6e-19
Identities = 67/216 (31%), Positives = 114/216 (52%), Gaps = 14/216 (6%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFK-NEVLLIAKLQHRNL 575
NF + KLGEG + VYKG EI A+K + + +G E+ L+ +L+H N+
Sbjct: 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENI 60
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V+L ++ ML++EY+ +K L ++ LD + + +G+ + H++
Sbjct: 61 VRLHDVIHTENKLMLVFEYM-DKDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHEN 119
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT--KRVVGTYGYMSPEYA 693
R++HRDLK N+L++ K++DFGLAR+FG+ NT VV T Y +P+
Sbjct: 120 ---RVLHRDLKPQNLLINKRGELKLADFGLARAFGI---PVNTFSNEVV-TLWYRAPDVL 172
Query: 694 IDG-LFSVKSDVFSFGVLVLEIICGKK-NRGFNHAD 727
+ +S D++S G ++ E+I G+ G N+ D
Sbjct: 173 LGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 1e-18
Identities = 64/206 (31%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 519 FSEKNKLGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
F + LG+GGFG V G + +++ KR+ K G+ M NE ++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
R +V L +D L+ + L + I+ + + + A I GL L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGF-EEGRAVFYAAEICCGLEDL 118
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
HQ+ RI++RDLK N+LLD+ + +ISD GLA QT K VGT GYM+PE
Sbjct: 119 HQE---RIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMAPEV 172
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ ++ D ++ G L+ E+I G+
Sbjct: 173 VKNERYTFSPDWWALGCLLYEMIAGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 54/201 (26%), Positives = 101/201 (50%), Gaps = 15/201 (7%)
Query: 525 LGEGGFGP--VYK----GMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG +Y+ L+ +E+ + RLS+ + + NE+++++ LQH N++
Sbjct: 8 LGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSE---KERRDALNEIVILSLLQHPNIIAY 64
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+ ++ EY +L Y + +L + + I + Y+H+
Sbjct: 65 YNHFMDDNTLLIEMEYANGGTL-YDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAG-- 121
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
I+HRD+K N+ L K+ DFG+++ G + + A T VVGT YMSPE +
Sbjct: 122 -ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAET--VVGTPYYMSPELCQGVKY 178
Query: 699 SVKSDVFSFGVLVLEIICGKK 719
+ KSD+++ G ++ E++ K+
Sbjct: 179 NFKSDIWALGCVLYELLTLKR 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.5 bits (215), Expect = 1e-18
Identities = 65/213 (30%), Positives = 108/213 (50%), Gaps = 31/213 (14%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KGSGQGMEEFK-NEVLLIAKLQ---H 572
+ E ++GEG +G VYK L G+ +A+K++ S +G+ E+ L+ +L+ H
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEH 60
Query: 573 RNLVKLLGCC-TQRDER----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
N+V+LL C R +R L++E++ ++ L ++ L ++ + R
Sbjct: 61 PNIVRLLDVCHGPRTDRELKLTLVFEHV-DQDLATYL-SKCPKPGLPPETIKDLMRQLLR 118
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
G+ +LH RI+HRDLK N+L+ + KI+DFGLAR + + A T VV T Y
Sbjct: 119 GVDFLHSH---RIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM--ALTSVVV-TLWY 172
Query: 688 MSPE------YAIDGLFSVKSDVFSFGVLVLEI 714
+PE YA V D++S G + E+
Sbjct: 173 RAPEVLLQSSYA----TPV--DMWSVGCIFAEL 199
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 2e-18
Identities = 63/200 (31%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 525 LGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+GGFG V G + +++ KRL K SG+ M + E+L K+ +V L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEIL--EKVNSPFIVNL 58
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+ L+ + L Y I++ + L+ + H A I G+L+LH +
Sbjct: 59 AYAFESKTHLCLVMSLMNGGDLKYHIYNVG-ERGLEMERVIHYSAQITCGILHLHS---M 114
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
I++RD+K NVLLD+ N ++SD GLA L + T+R GT GYM+PE + +
Sbjct: 115 DIVYRDMKPENVLLDDQGNCRLSDLGLAVE--LKDGKTITQR-AGTNGYMAPEILKEEPY 171
Query: 699 SVKSDVFSFGVLVLEIICGK 718
S D F+ G + E++ G+
Sbjct: 172 SYPVDWFAMGCSIYEMVAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 2e-18
Identities = 70/202 (34%), Positives = 106/202 (52%), Gaps = 18/202 (8%)
Query: 525 LGEGGFGPVY------KGMLIEGQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVK 577
LGEG FG V +G G+++AVK L SG + + K E+ ++ L H N+VK
Sbjct: 12 LGEGHFGKVELCRYDPEGDNT-GEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVK 70
Query: 578 LLGCCTQRDER--MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIA-GIARGLLYLHQ 634
G CT+ LI E+LP+ SL ++ R+K K+ A I +G+ YL
Sbjct: 71 YKGICTEDGGNGIKLIMEFLPSGSLKEYL---PRNKNKINLKQQLKYAVQICKGMDYL-- 125
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT-YGYMSPEYA 693
SR + +HRDL A NVL+++ KI DFGL ++ D+ K + + + +PE
Sbjct: 126 GSR-QYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECL 184
Query: 694 IDGLFSVKSDVFSFGVLVLEII 715
I F + SDV+SFGV + E++
Sbjct: 185 IQSKFYIASDVWSFGVTLYELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 60/202 (29%), Positives = 94/202 (46%), Gaps = 21/202 (10%)
Query: 525 LGEGGFGPVYKGML-IEGQEIAVKRLSKGS--GQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LG GGFG V + + + A+K + K G +E +E ++ + H +VKL
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLY- 59
Query: 581 CCTQRDER---MLIYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLLYLHQDS 636
T +D++ ML+ EY L + R + L D IA + YLH
Sbjct: 60 -RTFKDKKYIYMLM-EYCLGGEL----WTILRDRGLFDEYTARFYIACVVLAFEYLH--- 110
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
II+RDLK N+LLD+ K+ DFG A+ Q T GT Y++PE ++
Sbjct: 111 NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPEIILNK 167
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+ D +S G+L+ E++ G+
Sbjct: 168 GYDFSVDYWSLGILLYELLTGR 189
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 2e-18
Identities = 60/203 (29%), Positives = 108/203 (53%), Gaps = 21/203 (10%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G FG V +G L + G+ +A+K L G + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIAGIARGLLYLHQD 635
G T+ M+I E++ N +LD F+ T +L+ ++ GIA G+ YL
Sbjct: 72 GVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVG------MLRGIAAGMKYL--- 122
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG---TYGYMSPEY 692
S + +HRDL A N+L+++ + K+SDFGL+R D ++ +G + +PE
Sbjct: 123 SEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEA 182
Query: 693 AIDGLFSVKSDVFSFGVLVLEII 715
F+ SDV+S+G+++ E++
Sbjct: 183 IAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 85.8 bits (212), Expect = 3e-18
Identities = 66/231 (28%), Positives = 104/231 (45%), Gaps = 43/231 (18%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQE-----------------IAVKRL-SKGSGQGMEEFKNE 563
K KLGEG FG V+ ++ Q+ +AVK L + +F E
Sbjct: 10 KEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKE 69
Query: 564 VLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---- 619
V ++++L+ N+++LLG C D +I EY+ N L+ F+ + L D +
Sbjct: 70 VKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFL---SSHHLDDKEENGNDAV 126
Query: 620 ---------------HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
H+ IA G+ YL S L +HRDL N L+ + KI+DFG
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYL---SSLNFVHRDLATRNCLVGENLTIKIADFG 183
Query: 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
++R+ R V +M+ E + G F+ SDV++FGV + EI+
Sbjct: 184 MSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-18
Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 43/213 (20%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G FG V G L + G+ +A+K L G + + +F +E ++ + H N++ L
Sbjct: 12 IGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLE 71
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH-----------IIAGIARG 628
G T+ M++ EY+ N SLD F+ R H ++ GIA G
Sbjct: 72 GVVTKSKPVMIVTEYMENGSLDAFL-------------RKHDGQFTVIQLVGMLRGIASG 118
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG-- 686
+ YL S + +HRDL A N+L+++ + K+SDFGL+R D A T R G
Sbjct: 119 MKYL---SDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTR-----GGK 170
Query: 687 ----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ +PE F+ SDV+S+G+++ E++
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 203
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 3e-18
Identities = 63/202 (31%), Positives = 108/202 (53%), Gaps = 11/202 (5%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRN 574
NF + K+GEG +G VYK + G+ +A+K RL + E+ L+ +L H N
Sbjct: 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPN 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VKLL ++ L++E+L ++ L F+ + S + +S++ + +GL + H
Sbjct: 61 IVKLLDVIHTENKLYLVFEFL-HQDLKKFMDASPLSGIPLPLIKSYLFQ-LLQGLAFCHS 118
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
R++HRDLK N+L++ K++DFGLAR+FG+ T VV T Y +PE +
Sbjct: 119 H---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGV-PVRTYTHEVV-TLWYRAPEILL 173
Query: 695 DG-LFSVKSDVFSFGVLVLEII 715
+S D++S G + E++
Sbjct: 174 GCKYYSTAVDIWSLGCIFAEMV 195
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 4e-18
Identities = 63/204 (30%), Positives = 103/204 (50%), Gaps = 17/204 (8%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRL-----SKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG VY ++ G+E+A K++ S + + + + E+ L+ LQH +V+
Sbjct: 10 LGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQY 69
Query: 579 LGCCTQRDERML--IYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYLHQD 635
GC R E+ L EY+P S+ D ++ L S I G+ YLH +
Sbjct: 70 YGCLRDRAEKTLTIFMEYMPGGSVK----DQLKAYGALTESVTRKYTRQILEGMSYLHSN 125
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-GLDQTEANTKRVVGTYGYMSPEYAI 694
I+HRD+K +N+L D+ N K+ DFG ++ + + + V GT +MSPE
Sbjct: 126 ---MIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVIS 182
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+ K+DV+S G V+E++ K
Sbjct: 183 GEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 66/209 (31%), Positives = 108/209 (51%), Gaps = 22/209 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KGSGQGMEEFK-NEVLLIAKLQHR 573
D + + K+GEG +G VYK + + IA+K++ + +G+ E+ L+ ++QH
Sbjct: 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHG 61
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-DTTRSKLLDWSKRSHIIAG----IARG 628
N+V+L L++EYL LD D++ D++K +I I RG
Sbjct: 62 NIVRLQDVVHSEKRLYLVFEYL---DLDLKKHMDSSP----DFAKNPRLIKTYLYQILRG 114
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNP-KISDFGLARSFGLDQTEANTKRVVGTYGY 687
+ Y H R++HRDLK N+L+D N K++DFGLAR+FG+ T VV T Y
Sbjct: 115 IAYCHSH---RVLHRDLKPQNLLIDRRTNALKLADFGLARAFGI-PVRTFTHEVV-TLWY 169
Query: 688 MSPEYAIDGL-FSVKSDVFSFGVLVLEII 715
+PE + +S D++S G + E++
Sbjct: 170 RAPEILLGSRHYSTPVDIWSVGCIFAEMV 198
|
Length = 294 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 4e-18
Identities = 64/225 (28%), Positives = 102/225 (45%), Gaps = 29/225 (12%)
Query: 517 DNFSEKNKLGEGGFGPVY----KGMLIEGQE-------------IAVKRL-SKGSGQGME 558
+ K KLGEG FG V+ +GM + +AVK L +
Sbjct: 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARN 64
Query: 559 EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI--------FDTTRS 610
+F E+ ++++L+ N+++LL C D +I EY+ N L+ F+ +
Sbjct: 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADV 124
Query: 611 KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
+ +S + IA G+ YL S L +HRDL N L+ KI+DFG++R+
Sbjct: 125 VTISYSTLIFMATQIASGMKYL---SSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLY 181
Query: 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
R V +MS E + G F+ SDV++FGV + EI+
Sbjct: 182 SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEIL 226
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 4e-18
Identities = 58/215 (26%), Positives = 108/215 (50%), Gaps = 15/215 (6%)
Query: 509 LKIIANATD---NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEV 564
L+++ + D K+GEG G V G+++AVK++ Q E NEV
Sbjct: 8 LQLVVDPGDPRSYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEV 67
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIA 623
+++ QH N+V++ DE ++ E+L +L D I TR ++ + + +
Sbjct: 68 VIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD--IVTHTR---MNEEQIATVCL 122
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
+ + L +LH +IHRD+K+ ++LL + K+SDFG + + K +VG
Sbjct: 123 AVLKALSFLHAQ---GVIHRDIKSDSILLTSDGRVKLSDFGFCAQ--VSKEVPRRKSLVG 177
Query: 684 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
T +M+PE + + D++S G++V+E++ G+
Sbjct: 178 TPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGE 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 6e-18
Identities = 60/204 (29%), Positives = 100/204 (49%), Gaps = 17/204 (8%)
Query: 525 LGEGGFGPVYKGMLIEGQEI---AVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LGEG FG V +G L + I AVK +++ + ME+F +E + + + H N+++L+
Sbjct: 7 LGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLI 66
Query: 580 GCCTQRDER------MLIYEYLPNKSLDYFIFDT---TRSKLLDWSKRSHIIAGIARGLL 630
G C Q E ++I ++ + L F+ + + L + IA G+
Sbjct: 67 GVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGME 126
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YL S IHRDL A N +L+ MN ++DFGL++ + +++
Sbjct: 127 YL---SSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAI 183
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEI 714
E D +++ KSDV+SFGV + EI
Sbjct: 184 ESLADRVYTTKSDVWSFGVTMWEI 207
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-18
Identities = 69/214 (32%), Positives = 108/214 (50%), Gaps = 34/214 (15%)
Query: 525 LGEGGFGPVYKGMLI-EGQEI--AVKRLSK-GSGQGMEEFKNEVLLIAKL-QHRNLVKLL 579
+GEG FG V + M+ +G ++ A+K L + S +F E+ ++ KL H N++ LL
Sbjct: 10 IGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLL 69
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS---KRSHIIAG------------ 624
G C R + EY P +L F+ +S++L+ + H A
Sbjct: 70 GACENRGYLYIAIEYAPYGNLLDFL---RKSRVLETDPAFAKEHGTASTLTSQQLLQFAS 126
Query: 625 -IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
+A G+ YL S + IHRDL A NVL+ + KI+DFGL+R E K+ +G
Sbjct: 127 DVATGMQYL---SEKQFIHRDLAARNVLVGENLASKIADFGLSRG-----EEVYVKKTMG 178
Query: 684 TYG--YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+ E +++ KSDV+SFGVL+ EI+
Sbjct: 179 RLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 84.8 bits (209), Expect = 7e-18
Identities = 61/203 (30%), Positives = 103/203 (50%), Gaps = 19/203 (9%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQHRN 574
F++ ++G G FG VY + E+ A+K++S Q E++++ EV + +++H N
Sbjct: 27 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPN 86
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
++ GC + L+ EY + D K L + + I G +GL YLH
Sbjct: 87 SIEYKGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 143
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+ +IHRD+KA N+LL K++DFG A + AN+ VGT +M+PE +
Sbjct: 144 HN---MIHRDIKAGNILLTEPGQVKLADFGSASI----ASPANS--FVGTPYWMAPEVIL 194
Query: 695 ---DGLFSVKSDVFSFGVLVLEI 714
+G + K DV+S G+ +E+
Sbjct: 195 AMDEGQYDGKVDVWSLGITCIEL 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 84.2 bits (208), Expect = 7e-18
Identities = 64/201 (31%), Positives = 102/201 (50%), Gaps = 20/201 (9%)
Query: 525 LGEGGFGPVYKGMLI-EGQEI----AVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKL 578
LG G FG V+KG+ I EG I A+K + SG Q +E + +L + L H +V+L
Sbjct: 15 LGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRL 74
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS----KLLDWSKRSHIIAGIARGLLYLHQ 634
LG C L+ + P SL + S +LL+W + IA+G+ YL +
Sbjct: 75 LGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQ------IAKGMYYLEE 127
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
R++HR+L A N+LL + +I+DFG+A D + +M+ E +
Sbjct: 128 H---RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESIL 184
Query: 695 DGLFSVKSDVFSFGVLVLEII 715
G ++ +SDV+S+GV V E++
Sbjct: 185 FGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 7e-18
Identities = 63/203 (31%), Positives = 100/203 (49%), Gaps = 19/203 (9%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQHRN 574
FS+ ++G G FG VY + E+ A+K++S Q E++++ EV + KL+H N
Sbjct: 17 FSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPN 76
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
++ GC + L+ EY + D K L + + + G +GL YLH
Sbjct: 77 TIQYRGCYLREHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAVTHGALQGLAYLHS 133
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+ +IHRD+KA N+LL K+ DFG A AN VGT +M+PE +
Sbjct: 134 HN---MIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANX--FVGTPYWMAPEVIL 184
Query: 695 ---DGLFSVKSDVFSFGVLVLEI 714
+G + K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 7e-18
Identities = 61/191 (31%), Positives = 94/191 (49%), Gaps = 13/191 (6%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ 584
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV+LLG +
Sbjct: 14 IGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVE 70
Query: 585 RDERMLIY-EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
+ I EY+ SL ++ RS +L + + YL ++ +HR
Sbjct: 71 EKGGLYIVTEYMAKGSLVDYLRSRGRS-VLGGDCLLKFSLDVCEAMEYLEANN---FVHR 126
Query: 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSD 703
DL A NVL+ K+SDFGL + T+ K V + +PE + FS KSD
Sbjct: 127 DLAARNVLVSEDNVAKVSDFGLTKE--ASSTQDTGKLPV---KWTAPEALREKKFSTKSD 181
Query: 704 VFSFGVLVLEI 714
V+SFG+L+ EI
Sbjct: 182 VWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-17
Identities = 59/206 (28%), Positives = 101/206 (49%), Gaps = 18/206 (8%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHR 573
NF + K+G G F VY+ L++ + +A+K++ + ++ E+ L+ +L H
Sbjct: 3 NFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHP 62
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLD-----WSKRSHIIAGIARG 628
N++K L + +E ++ E L I + K L W + + +
Sbjct: 63 NVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVE-- 120
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
H SR R++HRD+K +NV + T K+ D GL R F T A++ +VGT YM
Sbjct: 121 ----HMHSR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYM 173
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEI 714
SPE + ++ KSD++S G L+ E+
Sbjct: 174 SPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 83.5 bits (206), Expect = 1e-17
Identities = 60/199 (30%), Positives = 102/199 (51%), Gaps = 17/199 (8%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
+LG+G FG VYK E G A K + S + +E++ E+ ++A H +VKLLG
Sbjct: 19 ELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAF 78
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+ ++ E+ P ++D + + R L + I + L YLH ++IIH
Sbjct: 79 YWDGKLWIMIEFCPGGAVDAIMLELDRG--LTEPQIQVICRQMLEALQYLHS---MKIIH 133
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR--VVGTYGYMSPEYAI-----D 695
RDLKA NVLL + K++DFG++ + +R +GT +M+PE + D
Sbjct: 134 RDLKAGNVLLTLDGDIKLADFGVSAK----NVKTLQRRDSFIGTPYWMAPEVVMCETMKD 189
Query: 696 GLFSVKSDVFSFGVLVLEI 714
+ K+D++S G+ ++E+
Sbjct: 190 TPYDYKADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 83.9 bits (208), Expect = 1e-17
Identities = 59/209 (28%), Positives = 90/209 (43%), Gaps = 50/209 (23%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVL 565
++ KLGEG FG VYK I+ G+ +A+K++ M K+ E+
Sbjct: 6 KLRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKIL------MHNEKDGFPITALREIK 59
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD----YFIF---DTTRSKLLDWSK- 617
++ KL+H N+V L+ + E Y + D S LL+
Sbjct: 60 ILKKLKHPNVVPLID---------MAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSV 110
Query: 618 ---RSHI---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-- 669
S I + + G+ YLH++ I+HRD+KA+N+L+DN KI+DFGLAR +
Sbjct: 111 KLTESQIKCYMLQLLEGINYLHEN---HILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 670 -------GLDQTEANTKRVVGTYGYMSPE 691
G +V T Y PE
Sbjct: 168 PPPNPKGGGGGGTRKYTNLVVTRWYRPPE 196
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 2e-17
Identities = 69/216 (31%), Positives = 109/216 (50%), Gaps = 32/216 (14%)
Query: 525 LGEGGFGPVYKGMLI--------EGQEIAVKRLSK-GSGQGMEEFKNEVLLIAKL-QHRN 574
LGEG FG V I + +AVK L + + + + +E+ ++ + +H+N
Sbjct: 20 LGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKN 79
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFI-----------FDTTR--SKLLDWSKRSHI 621
++ LLG CTQ ++ EY +L ++ FDT + + L +
Sbjct: 80 IINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSC 139
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLARSF-GLDQTEANT 678
+ARG+ YL + + IHRDL A NVL+ DN M KI+DFGLAR +D + T
Sbjct: 140 AYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVM--KIADFGLARDVHNIDYYKKTT 194
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+ +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 195 NGRLPV-KWMAPEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 62/212 (29%), Positives = 104/212 (49%), Gaps = 23/212 (10%)
Query: 525 LGEGGFGPVY--------KGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+G G FG V+ K ++I ++I V++++K + NE ++ L H N++
Sbjct: 8 VGRGAFGIVHLCRRKADQKLVII--KQIPVEQMTKDERLAAQ---NECQVLKLLSHPNII 62
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ + M++ EY P +L +I S LLD H I L ++H
Sbjct: 63 EYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNS-LLDEDTILHFFVQILLALHHVHTKL 121
Query: 637 RLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
I+HRDLK N+LLD + M KI DFG+++ +++ VVGT Y+SPE
Sbjct: 122 ---ILHRDLKTQNILLDKHKMVVKIGDFGISKILS---SKSKAYTVVGTPCYISPELCEG 175
Query: 696 GLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727
++ KSD+++ G ++ E+ K R F A+
Sbjct: 176 KPYNQKSDIWALGCVLYELASLK--RAFEAAN 205
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 83.0 bits (206), Expect = 2e-17
Identities = 63/200 (31%), Positives = 96/200 (48%), Gaps = 22/200 (11%)
Query: 524 KLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN--EVLLIAKLQ-HRNLVKLL 579
+LG+G FG VY E E+ A+K++ K EE N EV + KL H N+VKL
Sbjct: 6 QLGDGTFGSVYLARNKETGELVAIKKM-KKKFYSWEECMNLREVKSLRKLNEHPNIVKLK 64
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
+ DE ++EY+ +L Y + + K S II I +GL ++H +
Sbjct: 65 EVFRENDELYFVFEYM-EGNL-YQLMKDRKGKPFSESVIRSIIYQILQGLAHIH---KHG 119
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV----VGTYGYMSPEYAI- 694
HRDLK N+L+ KI+DFGLAR E ++ V T Y +PE +
Sbjct: 120 FFHRDLKPENLLVSGPEVVKIADFGLAR-------EIRSRPPYTDYVSTRWYRAPEILLR 172
Query: 695 DGLFSVKSDVFSFGVLVLEI 714
+S D+++ G ++ E+
Sbjct: 173 STSYSSPVDIWALGCIMAEL 192
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 64/211 (30%), Positives = 106/211 (50%), Gaps = 28/211 (13%)
Query: 525 LGEGGFGPVYKGMLIEG---QEIAVKRLSK-GSGQGMEEFKNEVLLIAKL-QHRNLVKLL 579
+GEG FG V K + + + A+KR+ + S +F E+ ++ KL H N++ LL
Sbjct: 3 IGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLL 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS---KRSHIIAGI--ARGLLYLHQ 634
G C R L EY P+ +L F+ +S++L+ ++ A ++ LL+
Sbjct: 63 GACEHRGYLYLAIEYAPHGNLLDFL---RKSRVLETDPAFAIANSTASTLSSQQLLHFAA 119
Query: 635 D--------SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
D S+ + IHRDL A N+L+ KI+DFGL+R E K+ +G
Sbjct: 120 DVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRG-----QEVYVKKTMGRLP 174
Query: 687 --YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+ E +++ SDV+S+GVL+ EI+
Sbjct: 175 VRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 82.7 bits (204), Expect = 2e-17
Identities = 69/222 (31%), Positives = 102/222 (45%), Gaps = 19/222 (8%)
Query: 522 KNKLGEGGFGPVY---KGMLIEGQEIAV-KRLSKGSGQGMEEFKN--EVLLIAKLQHRNL 575
+ +LG+G FG VY + + + V K + G E + E L++KL H +
Sbjct: 5 QQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAI 64
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYLHQ 634
VK +RD +I EY + LD + + + K L ++ + G+ Y+HQ
Sbjct: 65 VKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
RI+HRDLKA N+ L N + KI DFG++R A T GT YMSPE
Sbjct: 125 R---RILHRDLKAKNIFLKNNL-LKIGDFGVSRLLMGSCDLATT--FTGTPYYMSPEALK 178
Query: 695 DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
+ KSD++S G ++ E+ C HA N L V
Sbjct: 179 HQGYDSKSDIWSLGCILYEMCC------LAHAFEGQNFLSVV 214
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 3e-17
Identities = 65/221 (29%), Positives = 103/221 (46%), Gaps = 26/221 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLS-KGSGQGMEEFKNEVLLI 567
D + LGEG FG V + E +AVK L + + + + +E+ ++
Sbjct: 15 DKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 74
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI-----------FDTTR--SKLL 613
+ +H+N++ LLG CTQ +I EY +L ++ +D R + +
Sbjct: 75 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQM 134
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+ +ARG+ YL + + IHRDL A NVL+ KI+DFGLAR
Sbjct: 135 TFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNID 191
Query: 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
T +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 192 YYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 3e-17
Identities = 65/203 (32%), Positives = 106/203 (52%), Gaps = 19/203 (9%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---EVLLIAKLQHRN 574
F++ ++G G FG VY + + +A+K++S Q E++++ EV + +L+H N
Sbjct: 17 FTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPN 76
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
++ GC + L+ EY + D I + + K L + + I G +GL YLH
Sbjct: 77 TIEYKGCYLREHTAWLVMEYCLGSASD--ILEVHK-KPLQEVEIAAICHGALQGLAYLHS 133
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE--Y 692
R IHRD+KA N+LL K++DFG A + AN+ VGT +M+PE
Sbjct: 134 HER---IHRDIKAGNILLTEPGTVKLADFGSASL----VSPANS--FVGTPYWMAPEVIL 184
Query: 693 AID-GLFSVKSDVFSFGVLVLEI 714
A+D G + K DV+S G+ +E+
Sbjct: 185 AMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 82.3 bits (204), Expect = 3e-17
Identities = 53/171 (30%), Positives = 87/171 (50%), Gaps = 10/171 (5%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
++GEG G V+K E G+ +A+K+ L + G + E+ + QH +VKLL
Sbjct: 7 RIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLD 66
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
+L+ EY+P+ L + D R L + +S + + +G+ Y+H I
Sbjct: 67 VFPHGSGFVLVMEYMPS-DLSEVLRDEERP-LPEAQVKS-YMRMLLKGVAYMHA---NGI 120
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
+HRDLK +N+L+ KI+DFGLAR F ++ + + V T Y +PE
Sbjct: 121 MHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQ-VATRWYRAPE 170
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 81.6 bits (201), Expect = 4e-17
Identities = 64/205 (31%), Positives = 103/205 (50%), Gaps = 19/205 (9%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRL-----SKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG VY + G+E+AVK++ S + + + + E+ L+ L H +V+
Sbjct: 10 LGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQY 69
Query: 579 LGCCTQRDERML--IYEYLPNKSLDYFIFDTTRS--KLLDWSKRSHIIAGIARGLLYLHQ 634
GC ER L E++P S I D +S L + R + I G+ YLH
Sbjct: 70 YGCLRDPMERTLSIFMEHMPGGS----IKDQLKSYGALTENVTRKYT-RQILEGVSYLHS 124
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-GLDQTEANTKRVVGTYGYMSPEYA 693
+ I+HRD+K +N+L D+ N K+ DFG ++ + + K V GT +MSPE
Sbjct: 125 N---MIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVI 181
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGK 718
+ K+D++S G V+E++ K
Sbjct: 182 SGEGYGRKADIWSVGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 81.5 bits (201), Expect = 4e-17
Identities = 59/202 (29%), Positives = 99/202 (49%), Gaps = 12/202 (5%)
Query: 518 NFSEKNKLGEGGFGPVY--KGMLIEGQEIAVKR--LSKGSGQGMEEFKNEVLLIAKLQHR 573
+ K+GEG FG +Y K + + +K L+K + E K EV+L+AK++H
Sbjct: 1 RYEIIKKIGEGSFGKIYLAKAK-SDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHP 59
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V + ++ EY L I + R L + I+ GL ++H
Sbjct: 60 NIVTFFASFQENGRLFIVMEYCDGGDLMKRI-NRQRGVLFSEDQILSWFVQISLGLKHIH 118
Query: 634 QDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
+I+HRD+K+ N+ L N M K+ DFG+AR L+ + VGT Y+SPE
Sbjct: 119 DR---KILHRDIKSQNIFLSKNGMVAKLGDFGIARQ--LNDSMELAYTCVGTPYYLSPEI 173
Query: 693 AIDGLFSVKSDVFSFGVLVLEI 714
+ ++ K+D++S G ++ E+
Sbjct: 174 CQNRPYNNKTDIWSLGCVLYEL 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 4e-17
Identities = 64/223 (28%), Positives = 107/223 (47%), Gaps = 20/223 (8%)
Query: 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLI 567
DL + + F +G G +G VYKG ++ ++A ++ + EE K E+ ++
Sbjct: 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTEDEEEEIKLEINML 66
Query: 568 AKL-QHRNLVKLLGCCTQR------DERMLIYEYLPNKSLDYFIFDTTRSKLL-DWSKRS 619
K HRN+ G ++ D+ L+ E+ S+ + +T + L DW +
Sbjct: 67 KKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWI--A 124
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
+I I RGL +LH ++IHRD+K NVLL K+ DFG+ S LD+T
Sbjct: 125 YICREILRGLAHLHAH---KVIHRDIKGQNVLLTENAEVKLVDFGV--SAQLDRTVGRRN 179
Query: 680 RVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICG 717
+GT +M+PE D + +SD++S G+ +E+ G
Sbjct: 180 TFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEG 222
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 81.5 bits (202), Expect = 5e-17
Identities = 60/210 (28%), Positives = 94/210 (44%), Gaps = 36/210 (17%)
Query: 528 GGFGPVY---KGMLIEGQEIAVKRLSKGSGQG---MEEFKNEVLLIAKLQHRNLVKLLGC 581
G +G V+ K G A+K + K +++ E ++++ Q +VKL
Sbjct: 4 GAYGRVFLAKKK--STGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLY-Y 60
Query: 582 CTQRDERM-LIYEYLPN-------KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
Q + + L+ EYLP +++ D R IA I L YLH
Sbjct: 61 SFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVAR----------IYIAEIVLALEYLH 110
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA------RSFGLDQTEANTKRVVGTYGY 687
IIHRDLK N+L+D+ + K++DFGL+ R L+ E KR+VGT Y
Sbjct: 111 S---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDY 167
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
++PE + S D +S G ++ E + G
Sbjct: 168 IAPEVILGQGHSKTVDWWSLGCILYEFLVG 197
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 85.3 bits (211), Expect = 6e-17
Identities = 68/273 (24%), Positives = 119/273 (43%), Gaps = 28/273 (10%)
Query: 457 RRQSKNKKQVMIIITSISLATAVIFIG-GLMYRRKKHSNQ----GNEKEEMELPIFDLKI 511
+R K I ++ + + G ++ R +++ + NE EL FD K+
Sbjct: 620 KRVRKTPSWWFYITCTLGAFLVLALVAFGFVFIRGRNNLELKRVENEDGTWELQFFDSKV 679
Query: 512 IANATDN-----FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVL 565
+ T N E+N + G G YKG I+ G + VK ++ + E +
Sbjct: 680 SKSITINDILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIPSSEIAD--- 736
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+ KLQH N+VKL+G C LI+EY+ K+L + + L W +R I GI
Sbjct: 737 -MGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLRN------LSWERRRKIAIGI 789
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
A+ L +LH ++ +L +++D P + L D +
Sbjct: 790 AKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFISS------ 842
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y++PE + KSD++ FG++++E++ GK
Sbjct: 843 AYVAPETRETKDITEKSDIYGFGLILIELLTGK 875
|
Length = 968 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 6e-17
Identities = 66/220 (30%), Positives = 103/220 (46%), Gaps = 34/220 (15%)
Query: 515 ATDNFSE---KNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN----EVLL 566
A + SE N++G G G VYK + G+ A+K + G + + E+ +
Sbjct: 69 AAKSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIY---GNHEDTVRRQICREIEI 125
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+ + H N+VK E ++ E++ SL+ + + D + + I
Sbjct: 126 LRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLE-------GTHIADEQFLADVARQIL 178
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
G+ YLH R I+HRD+K SN+L+++ N KI+DFG++R L QT VGT
Sbjct: 179 SGIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRI--LAQTMDPCNSSVGTIA 233
Query: 687 YMSPEY--------AIDGLFSVKSDVFSFGVLVLEIICGK 718
YMSPE A DG D++S GV +LE G+
Sbjct: 234 YMSPERINTDLNHGAYDGY---AGDIWSLGVSILEFYLGR 270
|
Length = 353 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 6e-17
Identities = 62/219 (28%), Positives = 110/219 (50%), Gaps = 21/219 (9%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIEG-----QEIAVKRLSKGSGQ-GMEEFKNEVL 565
IA + D + + L EG FG ++ G+LI+ +E+ VK + + + + E
Sbjct: 1 IAISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESC 60
Query: 566 LIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYF-----IFDTTRSKLLDWSKRS 619
L+ L H+N++ +L C + E ++Y Y+ +L F + + + L +
Sbjct: 61 LLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLV 120
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQ--TEA 676
H+ IA G+ YLH + +IH+D+ A N ++D + KI+D L+R F +D
Sbjct: 121 HMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGD 177
Query: 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
N R V +M+ E ++ +S SDV+SFGVL+ E++
Sbjct: 178 NENRPV---KWMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 8e-17
Identities = 44/110 (40%), Positives = 66/110 (60%), Gaps = 6/110 (5%)
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
I + GL YL+ + RI+HRD+K SN+L+++ K+ DFG+ S L + A+T
Sbjct: 107 KIAVAVVEGLTYLY--NVHRIMHRDIKPSNILVNSRGQIKLCDFGV--SGELINSIADT- 161
Query: 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
VGT YMSPE G ++VKSDV+S G+ ++E+ GK F++ D D
Sbjct: 162 -FVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDD 210
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 8e-17
Identities = 64/210 (30%), Positives = 105/210 (50%), Gaps = 27/210 (12%)
Query: 524 KLGEGGFGPVY----KGMLIEGQE--IAVKRLSK-GSGQGMEEFKNEVLLIAKLQHRNLV 576
+LG+G FG VY KG++ + E +A+K +++ S + EF NE ++ + ++V
Sbjct: 13 ELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVV 72
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK--------LLDWSKRSHIIAGIARG 628
+LLG +Q ++I E + L ++ + R + K + IA G
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYL-RSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---- 684
+ YL+ + + +HRDL A N ++ KI DFG+ R D E + R G
Sbjct: 132 MAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYRKGGKGLLP 184
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+MSPE DG+F+ SDV+SFGV++ EI
Sbjct: 185 VRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 9e-17
Identities = 56/205 (27%), Positives = 105/205 (51%), Gaps = 12/205 (5%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
N ++F ++G G +G VYK + G+ A+K + G+ + E++++ +H
Sbjct: 6 NPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKH 65
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
N+V G +RD+ + E+ SL I+ T L S+ +++ +GL YL
Sbjct: 66 SNIVAYFGSYLRRDKLWICMEFCGGGSLQD-IYHVTGP--LSESQIAYVSRETLQGLYYL 122
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H + +HRD+K +N+LL + + K++DFG+ S + T A K +GT +M+PE
Sbjct: 123 HSKGK---MHRDIKGANILLTDNGHVKLADFGV--SAQITATIAKRKSFIGTPYWMAPEV 177
Query: 693 AI---DGLFSVKSDVFSFGVLVLEI 714
A G ++ D+++ G+ +E+
Sbjct: 178 AAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 9e-17
Identities = 68/213 (31%), Positives = 107/213 (50%), Gaps = 20/213 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQH- 572
++ + ++G G FG V K ML + G +AVKR+ S + + ++ ++ +
Sbjct: 4 EDLKDLGEIGRGAFGTVNK-MLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDC 62
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYF---IFDTTRSKLLDWSKRSHIIAGIARGL 629
+VK G R+ I L + SLD F +++ +S + I + L
Sbjct: 63 PYIVKFYGA-LFREGDCWICMELMDISLDKFYKYVYEVLKSVI-PEEILGKIAVATVKAL 120
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
YL ++ L+IIHRD+K SN+LLD N K+ DFG+ S L + A T R G YM+
Sbjct: 121 NYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGI--SGQLVDSIAKT-RDAGCRPYMA 175
Query: 690 PE----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
PE A DG + V+SDV+S G+ + E+ GK
Sbjct: 176 PERIDPSARDG-YDVRSDVWSLGITLYEVATGK 207
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 81.2 bits (200), Expect = 1e-16
Identities = 63/203 (31%), Positives = 101/203 (49%), Gaps = 19/203 (9%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQHRN 574
F +++G G FG VY E+ AVK++S Q E++++ EV + +L+H N
Sbjct: 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPN 82
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
++ GC + L+ EY + D K L + + I G +GL YLH
Sbjct: 83 TIEYKGCYLKEHTAWLVMEYCLGSASDLL---EVHKKPLQEVEIAAITHGALQGLAYLHS 139
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+ +IHRD+KA N+LL K++DFG A + AN+ VGT +M+PE +
Sbjct: 140 HN---MIHRDIKAGNILLTEPGQVKLADFGSASK----SSPANS--FVGTPYWMAPEVIL 190
Query: 695 ---DGLFSVKSDVFSFGVLVLEI 714
+G + K DV+S G+ +E+
Sbjct: 191 AMDEGQYDGKVDVWSLGITCIEL 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 80.8 bits (199), Expect = 1e-16
Identities = 67/218 (30%), Positives = 104/218 (47%), Gaps = 36/218 (16%)
Query: 525 LGEGGFGPVYKGMLIEG-----------QEIAVKRL-SKGSGQGMEEFKNEVLLIAKL-Q 571
LGEG FG V ++ E ++AVK L S + + + + +E+ ++ + +
Sbjct: 26 LGEGCFGQV---VMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 82
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-------------DTTRSKLLDWSKR 618
H+N++ LLG CTQ +I EY +L ++ + L +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLARSFGLDQTEA 676
+ARG+ YL + + IHRDL A NVL+ DN M KI+DFGLAR
Sbjct: 143 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVM--KIADFGLARDIHHIDYYK 197
Query: 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
T +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 198 KTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 80.0 bits (197), Expect = 1e-16
Identities = 58/196 (29%), Positives = 102/196 (52%), Gaps = 13/196 (6%)
Query: 524 KLGEGGFGPVYKG---MLIEGQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQHRNLVKLL 579
+LG G FG V KG M + ++A+K L + + + +E E ++ +L + +V+++
Sbjct: 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMI 61
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
G C + + ML+ E L+ F+ + + + S ++ ++ G+ YL +
Sbjct: 62 GVC-EAEALMLVMEMASGGPLNKFL--SGKKDEITVSNVVELMHQVSMGMKYLEGKN--- 115
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY--GYMSPEYAIDGL 697
+HRDL A NVLL N KISDFGL+++ G D + R G + + +PE
Sbjct: 116 FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYY-KARSAGKWPLKWYAPECINFRK 174
Query: 698 FSVKSDVFSFGVLVLE 713
FS +SDV+S+G+ + E
Sbjct: 175 FSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 2e-16
Identities = 64/212 (30%), Positives = 107/212 (50%), Gaps = 19/212 (8%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRL-----SKGSGQGMEEFKNEVLLIAKLQ 571
N+ LG G FG VY + G+E+AVK++ S+ + + + + E+ L+ L+
Sbjct: 3 NWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLR 62
Query: 572 HRNLVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRS--KLLDWSKRSHIIAGIAR 627
H +V+ GC +E+ L EY+P S I D ++ L + R + I +
Sbjct: 63 HDRIVQYYGCLRDPEEKKLSIFVEYMPGGS----IKDQLKAYGALTENVTRRYT-RQILQ 117
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-GLDQTEANTKRVVGTYG 686
G+ YLH + I+HRD+K +N+L D+ N K+ DFG ++ + + K V GT
Sbjct: 118 GVSYLHSN---MIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
+MSPE + K+DV+S V+E++ K
Sbjct: 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 2e-16
Identities = 66/213 (30%), Positives = 113/213 (53%), Gaps = 24/213 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRL---SKGSGQGMEEFKNEVLLIAKLQH 572
D + + N++ EG +G VY+ + EI A+K+L + G + + E+ ++ KLQH
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLR-EINILLKLQH 63
Query: 573 RNLVKL----LGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
N+V + +G + D+ ++ EY+ + KSL +T + L S+ ++ +
Sbjct: 64 PNIVTVKEVVVG--SNLDKIYMVMEYVEHDLKSL----METMKQPFLQ-SEVKCLMLQLL 116
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
G+ +LH + I+HRDLK SN+LL+N KI DFGLAR +G + T+ VV T
Sbjct: 117 SGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYG-SPLKPYTQLVV-TLW 171
Query: 687 YMSPEYAID-GLFSVKSDVFSFGVLVLEIICGK 718
Y +PE + +S D++S G + E++ K
Sbjct: 172 YRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 80.5 bits (199), Expect = 2e-16
Identities = 65/224 (29%), Positives = 105/224 (46%), Gaps = 48/224 (21%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIA 568
F + N++GEG +G VY+ G+ +A+K++ M+ ++ E+ L+
Sbjct: 8 EFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVR------MDNERDGIPISSLREITLLL 61
Query: 569 KLQHRNLVKLLGCCT--QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
L+H N+V+L D L+ EY + + LLD + +
Sbjct: 62 NLRHPNIVELKEVVVGKHLDSIFLVMEYC----------EQDLASLLDNMPTPFSESQVK 111
Query: 627 -------RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
RGL YLH++ IIHRDLK SN+LL + KI+DFGLAR++GL T
Sbjct: 112 CLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM-TP 167
Query: 680 RVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIICGK 718
+VV T Y +PE L + D+++ G ++ E++ K
Sbjct: 168 KVV-TLWYRAPEL----LLGCTTYTTAIDMWAVGCILAELLAHK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 4e-16
Identities = 59/204 (28%), Positives = 98/204 (48%), Gaps = 13/204 (6%)
Query: 522 KNKLGEGGFGPVYKGMLI--EGQEI--AVKRLSKGSGQGM-EEFKNEVLLIAKLQHRNLV 576
+GEG FG VY+G+ + E ++I AVK + + E+F E ++ + H ++V
Sbjct: 11 GRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIV 70
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
KL+G T+ + ++ E P L ++ LD + ++ L YL
Sbjct: 71 KLIGVITE-NPVWIVMELAPLGELRSYL--QVNKYSLDLASLILYSYQLSTALAYLES-- 125
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
R +HRD+ A NVL+ + K+ DFGL+R D++ + +M+PE
Sbjct: 126 -KRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE-DESYYKASKGKLPIKWMAPESINFR 183
Query: 697 LFSVKSDVFSFGVLVLEIIC-GKK 719
F+ SDV+ FGV + EI+ G K
Sbjct: 184 RFTSASDVWMFGVCMWEILMLGVK 207
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 79.1 bits (195), Expect = 5e-16
Identities = 64/221 (28%), Positives = 112/221 (50%), Gaps = 31/221 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFK----NEVLLIAKLQ 571
D F ++GEG +G VYK G+ +A+K++ + + E F E+ ++ +L
Sbjct: 7 DKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK--EGFPITAIREIKILRQLN 64
Query: 572 HRNLVKLLGCCTQRDERM----------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
HRN+V L T + + + L++EY+ D+ + S L+ +S+ HI
Sbjct: 65 HRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-----DHDLMGLLESGLVHFSE-DHI 118
Query: 622 ---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+ + GL Y H+ + L HRD+K SN+LL+N K++DFGLAR + +++ T
Sbjct: 119 KSFMKQLLEGLNYCHKKNFL---HRDIKCSNILLNNKGQIKLADFGLARLYNSEESRPYT 175
Query: 679 KRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIICGK 718
+V+ T Y PE + + + DV+S G ++ E+ K
Sbjct: 176 NKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 5e-16
Identities = 60/202 (29%), Positives = 100/202 (49%), Gaps = 10/202 (4%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHR 573
NF + K+G G F VY+ L++G +A+K++ + + E+ L+ +L H
Sbjct: 3 NFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHP 62
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS-HIIAGIARGLLYL 632
N++K + +E ++ E L I + K L K + L ++
Sbjct: 63 NVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H SR R++HRD+K +NV + T K+ D GL R F T A++ +VGT YMSPE
Sbjct: 123 H--SR-RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPER 177
Query: 693 AIDGLFSVKSDVFSFGVLVLEI 714
+ ++ KSD++S G L+ E+
Sbjct: 178 IHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 78.6 bits (194), Expect = 6e-16
Identities = 58/195 (29%), Positives = 100/195 (51%), Gaps = 12/195 (6%)
Query: 524 KLGEGGFGPVYKGMLIEGQEI-AVKRLS-KGSGQGMEEFK-NEVLLIAKLQHRNLVKLLG 580
K+GEG +G V+K E EI A+KR+ +G+ E+ L+ +L+H+N+V+L
Sbjct: 7 KIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYD 66
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
+ L++EY ++ L + FD+ + D + + +GL + H +
Sbjct: 67 VLHSDKKLTLVFEYC-DQDLKKY-FDSCNGDI-DPEIVKSFMFQLLKGLAFCHSH---NV 120
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFS 699
+HRDLK N+L++ K++DFGLAR+FG+ + VV T Y P+ L+S
Sbjct: 121 LHRDLKPQNLLINKNGELKLADFGLARAFGI-PVRCYSAEVV-TLWYRPPDVLFGAKLYS 178
Query: 700 VKSDVFSFGVLVLEI 714
D++S G + E+
Sbjct: 179 TSIDMWSAGCIFAEL 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 6e-16
Identities = 55/196 (28%), Positives = 98/196 (50%), Gaps = 10/196 (5%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
K+GEG G V G+++AVK + Q E NEV+++ QH+N+V++
Sbjct: 28 KIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSY 87
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+E ++ E+L +L D L+ + + + + + L YLH +IH
Sbjct: 88 LVGEELWVLMEFLQGGALT----DIVSQTRLNEEQIATVCESVLQALCYLHSQG---VIH 140
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKS 702
RD+K+ ++LL K+SDFG D + K +VGT +M+PE + +
Sbjct: 141 RDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEVISRTPYGTEV 198
Query: 703 DVFSFGVLVLEIICGK 718
D++S G++V+E++ G+
Sbjct: 199 DIWSLGIMVIEMVDGE 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 78.5 bits (193), Expect = 6e-16
Identities = 57/197 (28%), Positives = 99/197 (50%), Gaps = 13/197 (6%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAV-KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
+LG+G FG VYK E +A K + S + +E++ E+ ++A H N+VKLL
Sbjct: 12 ELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAF 71
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+ ++ E+ ++D + + R L + + L YLH++ +IIH
Sbjct: 72 YYENNLWILIEFCAGGAVDAVMLELERP--LTEPQIRVVCKQTLEALNYLHEN---KIIH 126
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-----DGL 697
RDLKA N+L + K++DFG+ S +T +GT +M+PE + D
Sbjct: 127 RDLKAGNILFTLDGDIKLADFGV--SAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRP 184
Query: 698 FSVKSDVFSFGVLVLEI 714
+ K+DV+S G+ ++E+
Sbjct: 185 YDYKADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 9e-16
Identities = 55/196 (28%), Positives = 97/196 (49%), Gaps = 10/196 (5%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
K+GEG G V G+++AVK++ Q E NEV+++ H N+V +
Sbjct: 29 KIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSY 88
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
DE ++ E+L +L D ++ + + + + R L YLH +IH
Sbjct: 89 LVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIATVCLSVLRALSYLHNQG---VIH 141
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKS 702
RD+K+ ++LL + K+SDFG + + K +VGT +M+PE + +
Sbjct: 142 RDIKSDSILLTSDGRIKLSDFGFCAQ--VSKEVPKRKSLVGTPYWMAPEVISRLPYGTEV 199
Query: 703 DVFSFGVLVLEIICGK 718
D++S G++V+E+I G+
Sbjct: 200 DIWSLGIMVIEMIDGE 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 9e-16
Identities = 56/203 (27%), Positives = 101/203 (49%), Gaps = 13/203 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
DNF K+GEG G V + G+ +AVK++ Q E NEV+++ QH N+
Sbjct: 23 DNFI---KIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENV 79
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V++ DE ++ E+L +L D ++ + + + + + L LH
Sbjct: 80 VEMYNSYLVGDELWVVMEFLEGGALT----DIVTHTRMNEEQIAAVCLAVLKALSVLHAQ 135
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
+IHRD+K+ ++LL + K+SDFG + + K +VGT +M+PE
Sbjct: 136 G---VIHRDIKSDSILLTHDGRVKLSDFGFCAQ--VSKEVPRRKSLVGTPYWMAPELISR 190
Query: 696 GLFSVKSDVFSFGVLVLEIICGK 718
+ + D++S G++V+E++ G+
Sbjct: 191 LPYGPEVDIWSLGIMVIEMVDGE 213
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 58/194 (29%), Positives = 97/194 (50%), Gaps = 11/194 (5%)
Query: 524 KLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGME-EFKNEVLLIAKLQHRNLVKLLGC 581
++G G FG V+ G L + +AVK + ++ +F E ++ + H N+V+L+G
Sbjct: 2 RIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGV 61
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRII 641
CTQ+ ++ E + + D+ F T L + ++ A G+ YL I
Sbjct: 62 CTQKQPIYIVMELV--QGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKH---CI 116
Query: 642 HRDLKASNVLLDNTMNPKISDFGLAR--SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
HRDL A N L+ KISDFG++R G+ + K++ + +PE G +S
Sbjct: 117 HRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQI--PVKWTAPEALNYGRYS 174
Query: 700 VKSDVFSFGVLVLE 713
+SDV+SFG+L+ E
Sbjct: 175 SESDVWSFGILLWE 188
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-15
Identities = 63/200 (31%), Positives = 96/200 (48%), Gaps = 15/200 (7%)
Query: 525 LGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+GGFG V G + +++ KR+ K G+ M NE ++ K+ R +V L
Sbjct: 8 LGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKQILEKVNSRFVVSL 65
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+D L+ + L + I++ D + A I GL LH R
Sbjct: 66 AYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGF-DEERAVFYAAEITCGLEDLH---RE 121
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
RI++RDLK N+LLD+ + +ISD GLA +T + VGT GYM+PE + +
Sbjct: 122 RIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMAPEVVKNERY 178
Query: 699 SVKSDVFSFGVLVLEIICGK 718
+ D + G L+ E+I GK
Sbjct: 179 TFSPDWWGLGCLIYEMIEGK 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 78.2 bits (193), Expect = 1e-15
Identities = 66/204 (32%), Positives = 96/204 (47%), Gaps = 23/204 (11%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKG---SGQGMEEFKNE--VLLIAKLQHRNL 575
LG+G FG V +L E + AVK L K +E E VL +A +H L
Sbjct: 3 LGKGSFGKV---LLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAG-KHPFL 58
Query: 576 VKLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+L C Q +R+ + EY+ L + I RS D + A I GL +LH+
Sbjct: 59 TQLH-SCFQTKDRLFFVMEYVNGGDLMFHI---QRSGRFDEPRARFYAAEIVLGLQFLHE 114
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
II+RDLK NVLLD+ + KI+DFG+ + L T GT Y++PE
Sbjct: 115 RG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILG--GVTTSTFCGTPDYIAPEILS 169
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++ GVL+ E++ G+
Sbjct: 170 YQPYGPAVDWWALGVLLYEMLAGQ 193
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 60/206 (29%), Positives = 97/206 (47%), Gaps = 15/206 (7%)
Query: 519 FSEKNKLGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
F LG+GGFG V G + +++ KR+ K G+ M NE ++ K+
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMA--LNEKRILEKVNS 59
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
R +V L +D L+ + L + I++ D + A + GL L
Sbjct: 60 RFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-DEQRAIFYAAELCCGLEDL 118
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
++ RI++RDLK N+LLD+ + +ISD GLA +T + VGT GYM+PE
Sbjct: 119 QRE---RIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMAPEV 172
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ ++ D + G L+ E+I G+
Sbjct: 173 INNEKYTFSPDWWGLGCLIYEMIQGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.0 bits (189), Expect = 1e-15
Identities = 55/206 (26%), Positives = 103/206 (50%), Gaps = 14/206 (6%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
N ++ ++G G +G VYK + G+ AVK + G + E+ ++ + +H
Sbjct: 6 NPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKH 65
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
N+V G R++ + EY SL D + S+L + +++ +GL Y
Sbjct: 66 CNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSEL----QIAYVCRETLQGLAY 121
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH ++ HRD+K +N+LL + + K++DFG+A + T A K +GT +M+PE
Sbjct: 122 LHSKGKM---HRDIKGANILLTDNGDVKLADFGVAAK--ITATIAKRKSFIGTPYWMAPE 176
Query: 692 YAI---DGLFSVKSDVFSFGVLVLEI 714
A +G ++ D+++ G+ +E+
Sbjct: 177 VAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 58/198 (29%), Positives = 93/198 (46%), Gaps = 15/198 (7%)
Query: 524 KLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFK---NEVLLIAKLQHRNLVKLL 579
++G+GG+G V+ + EI A+KR+ K + E + E ++ + LVKLL
Sbjct: 8 QVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLL 67
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
+ L EY+P D+ L + R ++ + LH L
Sbjct: 68 YAFQDDEYLYLAMEYVPGG--DFRTLLNNLGVLSEDHARFYMAEMFE-AVDALH---ELG 121
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
IHRDLK N L+D + + K++DFGL++ T AN+ VVG+ YM+PE +
Sbjct: 122 YIHRDLKPENFLIDASGHIKLTDFGLSKGI---VTYANS--VVGSPDYMAPEVLRGKGYD 176
Query: 700 VKSDVFSFGVLVLEIICG 717
D +S G ++ E +CG
Sbjct: 177 FTVDYWSLGCMLYEFLCG 194
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 4e-15
Identities = 58/202 (28%), Positives = 100/202 (49%), Gaps = 23/202 (11%)
Query: 525 LGEGGFGPVYKGML-IEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LG G FG + +G L + + +A+ L G S + F E L + + H N+V+L
Sbjct: 13 LGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLE 72
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIF----DTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
G T+ + M++ EY+ N +LD F+ +L+ ++ G+A G+ YL
Sbjct: 73 GVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG------MLPGLASGMKYL--- 123
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA--NTKRVVGTYGYMSPEYA 693
S + +H+ L A VL+++ + KIS F + D++EA T + +PE
Sbjct: 124 SEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQE---DKSEAIYTTMSGKSPVLWAAPEAI 180
Query: 694 IDGLFSVKSDVFSFGVLVLEII 715
FS SDV+SFG+++ E++
Sbjct: 181 QYHHFSSASDVWSFGIVMWEVM 202
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 4e-15
Identities = 63/196 (32%), Positives = 94/196 (47%), Gaps = 19/196 (9%)
Query: 528 GGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN----EVLLIAKLQHRNLVKLLGCC 582
G FG VY G A+K L K + N +++ + + + KL
Sbjct: 7 GAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSF 66
Query: 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642
+D L+ EYL I T DW+K+ IA + G+ LHQ IIH
Sbjct: 67 QSKDYLYLVMEYLNGGDCASLI-KTLGGLPEDWAKQ--YIAEVVLGVEDLHQRG---IIH 120
Query: 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVK- 701
RD+K N+L+D T + K++DFGL+R+ GL+ K+ VGT Y++PE I G+ K
Sbjct: 121 RDIKPENLLIDQTGHLKLTDFGLSRN-GLEN-----KKFVGTPDYLAPE-TILGVGDDKM 173
Query: 702 SDVFSFGVLVLEIICG 717
SD +S G ++ E + G
Sbjct: 174 SDWWSLGCVIFEFLFG 189
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 5e-15
Identities = 60/209 (28%), Positives = 105/209 (50%), Gaps = 25/209 (11%)
Query: 524 KLGEGGFGPVYKGM---LIEGQ---EIAVKRLSK-GSGQGMEEFKNEVLLIAKLQHRNLV 576
+LG+G FG VY+G +I+G+ +AVK +++ S + EF NE ++ ++V
Sbjct: 13 ELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVV 72
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIF-------DTTRSKLLDWSKRSHIIAGIARGL 629
+LLG ++ +++ E + + L ++ + + + A IA G+
Sbjct: 73 RLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT----Y 685
YL+ + +HRDL A N ++ + KI DFG+ R D E + R G
Sbjct: 133 AYLNAK---KFVHRDLAARNCMVAHDFTVKIGDFGMTR----DIYETDYYRKGGKGLLPV 185
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE DG+F+ SD++SFGV++ EI
Sbjct: 186 RWMAPESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 5e-15
Identities = 65/202 (32%), Positives = 102/202 (50%), Gaps = 25/202 (12%)
Query: 524 KLGEGGFGPVYKG---MLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK----LQHRNLV 576
+LG G FG V KG M + +AVK L + K+E+L A L + +V
Sbjct: 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNND--PALKDELLREANVMQQLDNPYIV 59
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+++G C + + ML+ E L+ F+ ++K + + ++ ++ G+ YL + +
Sbjct: 60 RMIGIC-EAESWMLVMELAELGPLNKFL---QKNKHVTEKNITELVHQVSMGMKYLEETN 115
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YMSPE 691
+HRDL A NVLL KISDFGL+++ G D+ K T+G + +PE
Sbjct: 116 ---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK----THGKWPVKWYAPE 168
Query: 692 YAIDGLFSVKSDVFSFGVLVLE 713
FS KSDV+SFGVL+ E
Sbjct: 169 CMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 8e-15
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 519 FSEKNKLGEGGFGPV------YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
F + LG+GGFG V G + + + KR+ K G+ M NE ++ K+
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMA--LNEKQILEKVNS 59
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
+ +V L +D L+ + L + I++ + + A I GL L
Sbjct: 60 QFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGF-EEERALFYAAEILCGLEDL 118
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H+++ ++RDLK N+LLD+ + +ISD GLA + + E+ R VGT GYM+PE
Sbjct: 119 HREN---TVYRDLKPENILLDDYGHIRISDLGLA--VKIPEGESIRGR-VGTVGYMAPEV 172
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ +++ D + G L+ E+I G+
Sbjct: 173 LNNQRYTLSPDYWGLGCLIYEMIEGQ 198
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 56/204 (27%), Positives = 98/204 (48%), Gaps = 19/204 (9%)
Query: 525 LGEGGFGPVYK-------GMLIEGQEIAVKRLSKGSG-----QGMEEFKNEVLLIAK-LQ 571
LG G FG VYK L+ +EI V + G + + + +EV +I + L+
Sbjct: 8 LGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLR 67
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
H N+V+ + D ++ + + L ++F + + + +I + L
Sbjct: 68 HPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALR 127
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH++ R I+HRDL +N++L I+DFGLA+ Q E+ VVGT Y P
Sbjct: 128 YLHKEKR--IVHRDLTPNNIMLGEDDKVTITDFGLAKQ---KQPESKLTSVVGTILYSCP 182
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEI 714
E + + K+DV++FG ++ ++
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQM 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 8e-15
Identities = 54/200 (27%), Positives = 91/200 (45%), Gaps = 15/200 (7%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN----EVLLIAKLQHRNLVKL 578
+GEG +G V K G+ +A+K+ K S + E+ K EV ++ +L+H N+V L
Sbjct: 8 VVGEGAYGVVLKCRNKATGEIVAIKKF-KES-EDDEDVKKTALREVKVLRQLRHENIVNL 65
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ L++EY+ L+ L I + + + Y H
Sbjct: 66 KEAFRRKGRLYLVFEYVERTLLELL---EASPGGLPPDAVRSYIWQLLQAIAYCH---SH 119
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-DGL 697
IIHRD+K N+L+ + K+ DFG AR+ T V T Y +PE + D
Sbjct: 120 NIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVA-TRWYRAPELLVGDTN 178
Query: 698 FSVKSDVFSFGVLVLEIICG 717
+ DV++ G ++ E++ G
Sbjct: 179 YGKPVDVWAIGCIMAELLDG 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 9e-15
Identities = 60/225 (26%), Positives = 109/225 (48%), Gaps = 23/225 (10%)
Query: 524 KLGEGGFGPVYKGMLIE--GQEIAVKRLS-KGSGQGME-EFKNEVLLIAKLQ---HRNLV 576
++GEG +G V+K ++ G+ +A+KR+ + +GM EV ++ L+ H N+V
Sbjct: 8 EIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVV 67
Query: 577 KLLGCCT-QRDER----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
+L CT R +R L++E++ Y D + ++ + RGL +
Sbjct: 68 RLFDVCTVSRTDRETKLTLVFEHVDQDLTTYL--DKVPEPGVPTETIKDMMFQLLRGLDF 125
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH R++HRDLK N+L+ ++ K++DFGLAR + + VV T Y +PE
Sbjct: 126 LHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSF---QMALTSVVVTLWYRAPE 179
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
+ ++ D++S G + E+ + + D + LG +
Sbjct: 180 VLLQSSYATPVDLWSVGCIFAEMF---RRKPLFRGSSDVDQLGKI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 75.5 bits (186), Expect = 1e-14
Identities = 57/191 (29%), Positives = 89/191 (46%), Gaps = 37/191 (19%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN--------EVLLIAKLQHR 573
K+G+G FG V+K + ++I A+K++ ME K E+ ++ L+H
Sbjct: 18 AKIGQGTFGEVFKARHKKTKQIVALKKVL------MENEKEGFPITALREIKILQLLKHE 71
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL----------LDWSKRSHIIA 623
N+V L+ C R Y K Y +F+ L S+ ++
Sbjct: 72 NVVNLIEIC-----RTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMK 126
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN---TKR 680
+ GL Y+H R +I+HRD+KA+N+L+ K++DFGLAR+F L + T R
Sbjct: 127 MLLNGLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNR 183
Query: 681 VVGTYGYMSPE 691
VV T Y PE
Sbjct: 184 VV-TLWYRPPE 193
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 75.3 bits (185), Expect = 1e-14
Identities = 64/200 (32%), Positives = 101/200 (50%), Gaps = 17/200 (8%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNE--VLLIAKLQHRNLVKL 578
LG+G FG V L E G+ AVK L K +E E +L +A+ H L +L
Sbjct: 3 LGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 61
Query: 579 LGCCTQRDERML-IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
CC Q +R+ + E++ L +F +S+ D ++ A I L++LH
Sbjct: 62 Y-CCFQTPDRLFFVMEFVNGGDL---MFHIQKSRRFDEARARFYAAEITSALMFLHDKG- 116
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL 697
II+RDLK NVLLD+ + K++DFG+ + + +T GT Y++PE + L
Sbjct: 117 --IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTST--FCGTPDYIAPEILQEML 172
Query: 698 FSVKSDVFSFGVLVLEIICG 717
+ D ++ GVL+ E++CG
Sbjct: 173 YGPSVDWWAMGVLLYEMLCG 192
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (185), Expect = 2e-14
Identities = 59/210 (28%), Positives = 99/210 (47%), Gaps = 16/210 (7%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---EVLLIAKLQHRNLVKLLG 580
+G G +G V + G+++A+K+LS+ Q K E+ L+ + H N++ LL
Sbjct: 23 VGSGAYGQVCSAFDTKTGRKVAIKKLSR-PFQSAIHAKRTYRELRLLKHMDHENVIGLLD 81
Query: 581 CCTQRDERMLIYE-YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
T + YL + + + + + L ++ I RGL Y+H
Sbjct: 82 VFTPASSLEDFQDVYLVTHLMGADLNNIVKCQKLSDDHIQFLVYQILRGLKYIHS---AG 138
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
IIHRDLK SN+ ++ KI DFGLAR T+ V T Y +PE ++ +
Sbjct: 139 IIHRDLKPSNIAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHY 193
Query: 700 VKS-DVFSFGVLVLEIICGKK-NRGFNHAD 727
++ D++S G ++ E++ GK G +H D
Sbjct: 194 NQTVDIWSVGCIMAELLTGKTLFPGSDHID 223
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 74.4 bits (183), Expect = 2e-14
Identities = 59/199 (29%), Positives = 99/199 (49%), Gaps = 14/199 (7%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE--FKNEVLLIAKLQHRNLVKLLG 580
+GEG +G V K E GQ +A+K+ + M + E+ ++ +L+H NLV L+
Sbjct: 8 LVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIE 67
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARGLLYLHQDSRLR 639
++ L++E++ + LD D + LD S+ + I RG+ + H +
Sbjct: 68 VFRRKKRLYLVFEFVDHTVLD----DLEKYPNGLDESRVRKYLFQILRGIEFCHSHN--- 120
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-DGLF 698
IIHRD+K N+L+ + K+ DFG AR+ E T V T Y +PE + D +
Sbjct: 121 IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG-EVYTD-YVATRWYRAPELLVGDTKY 178
Query: 699 SVKSDVFSFGVLVLEIICG 717
D+++ G LV E++ G
Sbjct: 179 GRAVDIWAVGCLVTEMLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 73.1 bits (179), Expect = 5e-14
Identities = 61/203 (30%), Positives = 99/203 (48%), Gaps = 19/203 (9%)
Query: 523 NKLGEGGFGPVYKGM------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+KLGEG + VYKG L+ +EI RL G + EV L+ L+H N+V
Sbjct: 12 DKLGEGTYATVYKGRSKLTDNLVALKEI---RLEHEEGAPCTAIR-EVSLLKDLKHANIV 67
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
L L++EYL +K L ++ D ++ + + RGL Y H
Sbjct: 68 TLHDIIHTEKSLTLVFEYL-DKDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCH--- 121
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
R +++HRDLK N+L++ K++DFGLAR+ + T+ + VV T Y P+ +
Sbjct: 122 RRKVLHRDLKPQNLLINERGELKLADFGLARAKSI-PTKTYSNEVV-TLWYRPPDILLGS 179
Query: 697 L-FSVKSDVFSFGVLVLEIICGK 718
+S + D++ G + E+ G+
Sbjct: 180 TDYSTQIDMWGVGCIFYEMSTGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 72.8 bits (179), Expect = 5e-14
Identities = 67/229 (29%), Positives = 98/229 (42%), Gaps = 52/229 (22%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
D+ +LG G +G V K M G +AVKR+ + + E Q R
Sbjct: 1 DDLEVIEELGRGAYGVVDK-MRHVPTGTIMAVKRI-RATVNSQE------------QKRL 46
Query: 575 LVKL-----LGCCTQ---------RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR-- 618
L+ L C R+ + I + + SLD F K+ D
Sbjct: 47 LMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMDTSLDKFY-----KKVYDKGLTIP 101
Query: 619 ----SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
I I + L YLH S+L +IHRD+K SNVL++ K+ DFG+ S L +
Sbjct: 102 EDILGKIAVSIVKALEYLH--SKLSVIHRDVKPSNVLINRNGQVKLCDFGI--SGYLVDS 157
Query: 675 EANTKRVVGTYGYMSPEYAIDGL-----FSVKSDVFSFGVLVLEIICGK 718
A T G YM+PE I+ + VKSDV+S G+ ++E+ G+
Sbjct: 158 VAKTID-AGCKPYMAPE-RINPELNQKGYDVKSDVWSLGITMIELATGR 204
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 5e-14
Identities = 56/208 (26%), Positives = 104/208 (50%), Gaps = 27/208 (12%)
Query: 519 FSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRL--SKGSGQGMEEFKNEVLLIAKLQH 572
+ + K+GEG FG K +L+ +G++ +K + SK S + EE + EV +++ ++H
Sbjct: 2 YVKVKKIGEGSFG---KAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKH 58
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS------KLLDWSKRSHIIAGIA 626
N+V+ + ++ +Y L Y + R ++LDW I
Sbjct: 59 PNIVQYQESFEENGNLYIVMDYCEGGDL-YKKINAQRGVLFPEDQILDW------FVQIC 111
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
L ++H +I+HRD+K+ N+ L K+ DFG+AR L+ T + +GT
Sbjct: 112 LALKHVHDR---KILHRDIKSQNIFLTKDGTIKLGDFGIARV--LNSTVELARTCIGTPY 166
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
Y+SPE + ++ KSD+++ G ++ E+
Sbjct: 167 YLSPEICENRPYNNKSDIWALGCVLYEM 194
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.3 bits (177), Expect = 6e-14
Identities = 61/216 (28%), Positives = 100/216 (46%), Gaps = 38/216 (17%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG V + L Q++AVK L S +EEF E + + H N++KL
Sbjct: 7 LGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKL 66
Query: 579 LGCCTQRDER------MLIYEYLPNKSLDYFI---------FDTTRSKLLDWSKRSHIIA 623
+G + + M+I ++ + L F+ F L+ + +
Sbjct: 67 IGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRF------MI 120
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLD---QTEANTK 679
IA G+ YL S IHRDL A N +L+ M ++DFGL++ + D Q A+
Sbjct: 121 DIASGMEYL---SSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKL 177
Query: 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
V +++ E D +++ SDV++FGV + EI+
Sbjct: 178 PV----KWLALESLADNVYTTHSDVWAFGVTMWEIM 209
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 72.8 bits (178), Expect = 7e-14
Identities = 62/206 (30%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHR 573
D++ + KLGEG + VYKG + G+ +A+K RL + G + E L+ L+H
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIR-EASLLKGLKHA 63
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V L ++ L++EY+ Y L + + RGL Y+H
Sbjct: 64 NIVLLHDIIHTKETLTLVFEYVHTDLCQYM---DKHPGGLHPENVKLFLFQLLRGLSYIH 120
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL-DQTEANTKRVVGTYGYMSPEY 692
Q I+HRDLK N+L+ +T K++DFGLAR+ + T +N V T Y P+
Sbjct: 121 QRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTYSNE---VVTLWYRPPDV 174
Query: 693 AIDGL-FSVKSDVFSFGVLVLEIICG 717
+ +S D++ G + +E+I G
Sbjct: 175 LLGSTEYSTCLDMWGVGCIFVEMIQG 200
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 7e-14
Identities = 62/218 (28%), Positives = 97/218 (44%), Gaps = 41/218 (18%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG----SGQGMEEFKNEVLLIAKLQ 571
D+F LG G FG V + A+K LSK Q +E NE ++ ++
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQ-VEHVLNEKRILQSIR 59
Query: 572 HRNLVKLLGCCTQRDERML--IYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAG 624
H LV L G + +D+ L + EY+P L + F ++ A
Sbjct: 60 HPFLVNLYG--SFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFY--------AAQ 109
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ L YLH L I++RDLK N+LLD+ KI+DFG A+ + + T + GT
Sbjct: 110 VVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAK-----RVKGRTYTLCGT 161
Query: 685 YGYMSPEYAIDGLFSVK-----SDVFSFGVLVLEIICG 717
Y++PE + K D ++ G+L+ E++ G
Sbjct: 162 PEYLAPE-----IILSKGYGKAVDWWALGILIYEMLAG 194
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 73.2 bits (180), Expect = 7e-14
Identities = 62/208 (29%), Positives = 90/208 (43%), Gaps = 32/208 (15%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKG---SGQGMEEFKNE--VLLIA-KLQHRN 574
LG G FG V +L E G+ A+K L KG + +E E + A +H
Sbjct: 7 LGRGHFGKV---LLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPF 63
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLL 630
LV L C D + EY L I F R+ A + GL
Sbjct: 64 LVNLFACFQTEDHVCFVMEYAAGGDLMMHIHTDVFSEPRAVFY--------AACVVLGLQ 115
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKRVVGTYGYMS 689
YLH++ +I++RDLK N+LLD KI+DFGL + G T GT +++
Sbjct: 116 YLHEN---KIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDR---TSTFCGTPEFLA 169
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEIICG 717
PE + ++ D + GVL+ E++ G
Sbjct: 170 PEVLTETSYTRAVDWWGLGVLIYEMLVG 197
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 9e-14
Identities = 65/205 (31%), Positives = 99/205 (48%), Gaps = 25/205 (12%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEEFKNEVLLIAK------LQHRN 574
LG+G FG V ML E + A+K L K +E+ E ++ + +H
Sbjct: 3 LGKGSFGKV---MLAELKGTNEFFAIKALKKDVV--LEDDDVECTMVERRVLALAWEHPF 57
Query: 575 LVKLLGCCTQRDERML-IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
L L C Q E + + EYL L + I + R D ++ A I GL +LH
Sbjct: 58 LTHLF-CTFQTKEHLFFVMEYLNGGDLMFHIQSSGR---FDEARARFYAAEIICGLQFLH 113
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
+ II+RDLK NVLLD + KI+DFG+ + + +A+T GT Y++PE
Sbjct: 114 KKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKAST--FCGTPDYIAPEIL 168
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGK 718
++ D +SFGVL+ E++ G+
Sbjct: 169 KGQKYNESVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 73.0 bits (179), Expect = 1e-13
Identities = 39/153 (25%), Positives = 72/153 (47%), Gaps = 9/153 (5%)
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
E +L+ + H +++++ ++ LP+ S D + + T RS+ L + I
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMV---LPHYSSDLYTYLTKRSRPLPIDQALIIE 163
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
I GL YLH RIIHRD+K N+ +++ I D G A+ +
Sbjct: 164 KQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQ---FPVVAPAFLGLA 217
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
GT +PE ++ K+D++S G+++ E++
Sbjct: 218 GTVETNAPEVLARDKYNSKADIWSAGIVLFEML 250
|
Length = 357 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 1e-13
Identities = 56/236 (23%), Positives = 107/236 (45%), Gaps = 38/236 (16%)
Query: 513 ANATDNFSEKNK-LGEGGFGPVYKGM-LIEGQEIAVKR--LSKGSGQGMEEFKN------ 562
+ ++ + +K LGEG +G V K + G+ +A+K+ + + S ++ +
Sbjct: 4 FSISERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGI 63
Query: 563 ------EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
E+ ++ +++H N++ L+ + D L+ + + L + R L S
Sbjct: 64 HFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIM-ASDLKKVVDRKIR---LTES 119
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD---- 672
+ I+ I GL LH+ +HRDL +N+ +++ KI+DFGLAR +G
Sbjct: 120 QVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSD 176
Query: 673 ---------QTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGK 718
+ E T +VV T Y +PE + + D++S G + E++ GK
Sbjct: 177 TLSKDETMQRREEMTSKVV-TLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGK 231
|
Length = 335 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 1e-13
Identities = 68/228 (29%), Positives = 111/228 (48%), Gaps = 60/228 (26%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---------EVLLIAKL- 570
KLG+G +G V+K + +E+ A+K++ + F+N E++ + +L
Sbjct: 12 LQKLGKGAYGIVWKAIDRRTKEVVALKKI-------FDAFRNATDAQRTFREIMFLQELG 64
Query: 571 QHRNLVKLLGCCTQRDERM----LIYEYLPNKSLDYFIFDT-----TRSKLL-DWSKRSH 620
H N+VKLL + E L++EY+ +T R+ +L D KR +
Sbjct: 65 DHPNIVKLLN--VIKAENDKDIYLVFEYM----------ETDLHAVIRANILEDVHKR-Y 111
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
I+ + + L Y+H S +IHRDLK SN+LL++ K++DFGLARS L + E N +
Sbjct: 112 IMYQLLKALKYIH--SG-NVIHRDLKPSNILLNSDCRVKLADFGLARS--LSELEENPEN 166
Query: 681 -----VVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIICGK 718
V T Y +PE L D++S G ++ E++ GK
Sbjct: 167 PVLTDYVATRWYRAPEI----LLGSTRYTKGVDMWSVGCILGEMLLGK 210
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 1e-13
Identities = 60/199 (30%), Positives = 101/199 (50%), Gaps = 13/199 (6%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFK--NEVLLIAKLQHRNLVKLLG 580
KLGEG + VYKG+ I GQ +A+K +S + +G+ F E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGISRINGQLVALKVISMKTEEGVP-FTAIREASLLKGLKHANIVLLHD 70
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
++ ++EY+ Y I L ++ R + + RGL Y+H I
Sbjct: 71 IIHTKETLTFVFEYMHTDLAQYMI--QHPGGLHPYNVRLFMFQ-LLRGLAYIH---GQHI 124
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FS 699
+HRDLK N+L+ K++DFGLAR+ + ++ + VV T Y P+ + +S
Sbjct: 125 LHRDLKPQNLLISYLGELKLADFGLARAKSI-PSQTYSSEVV-TLWYRPPDVLLGATDYS 182
Query: 700 VKSDVFSFGVLVLEIICGK 718
D++ G + +E++ G+
Sbjct: 183 SALDIWGAGCIFIEMLQGQ 201
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (178), Expect = 1e-13
Identities = 60/225 (26%), Positives = 97/225 (43%), Gaps = 59/225 (26%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVLLIAKLQHRN 574
+G G +G V + G+++A+K++S F + E+ L+ L+H N
Sbjct: 8 IGSGAYGVVCSAVDKRTGRKVAIKKISN-------VFDDLIDAKRILREIKLLRHLRHEN 60
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD----------TTRSKLLDWSKRSHIIAG 624
++ LL +L + + Y + + + L D + +
Sbjct: 61 IIGLL--------DILRPPSPEDFNDVYIVTELMETDLHKVIKSPQPLTD-DHIQYFLYQ 111
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN--TKRVV 682
I RGL YLH +IHRDLK SN+L+++ + KI DFGLAR D+ E T+ VV
Sbjct: 112 ILRGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVV 168
Query: 683 GTYGYMSPE---------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
T Y +PE AI D++S G + E++ K
Sbjct: 169 -TRWYRAPELLLSSSRYTKAI--------DIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 1e-13
Identities = 56/202 (27%), Positives = 95/202 (47%), Gaps = 19/202 (9%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQ---HRNLVK 577
++G G +G VYK G +A+K + + + EV L+ +L+ H N+V+
Sbjct: 7 EIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVR 66
Query: 578 LLG-CCTQRDER----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
L+ C T R +R L++E++ Y D L ++ RGL +L
Sbjct: 67 LMDVCATSRTDRETKVTLVFEHVDQDLRTYL--DKVPPPGLPAETIKDLMRQFLRGLDFL 124
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H + I+HRDLK N+L+ + K++DFGLAR + + VV T Y +PE
Sbjct: 125 HAN---CIVHRDLKPENILVTSGGQVKLADFGLARIY---SCQMALTPVVVTLWYRAPEV 178
Query: 693 AIDGLFSVKSDVFSFGVLVLEI 714
+ ++ D++S G + E+
Sbjct: 179 LLQSTYATPVDMWSVGCIFAEM 200
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 3e-13
Identities = 64/202 (31%), Positives = 97/202 (48%), Gaps = 19/202 (9%)
Query: 525 LGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEE------FKNEVLLIAKLQHRNLVK 577
LG+G FG V+ L Q A+K L K M++ + VL +A +H L
Sbjct: 3 LGKGSFGKVFLAELKGTNQFFAIKALKKDVVL-MDDDVECTMVEKRVLSLA-WEHPFLTH 60
Query: 578 LLGCCTQRDERML-IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
L C Q E + + EYL L + I + D + + A I GL +LH
Sbjct: 61 LY-CTFQTKENLFFVMEYLNGGDLMFHIQSCHK---FDLPRATFYAAEIICGLQFLHSKG 116
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
I++RDLK N+LLD + KI+DFG+ + L +A T GT Y++PE +
Sbjct: 117 ---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLG--DAKTCTFCGTPDYIAPEILLGQ 171
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
++ D +SFGVL+ E++ G+
Sbjct: 172 KYNTSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 3e-13
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 19/209 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + + KLGEG + V+KG L+ +EI RL G + EV L+ L
Sbjct: 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEI---RLEHEEGAPCTAIR-EVSLLKDL 61
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H N+V L L++EYL +K L ++ D ++ + I RGL
Sbjct: 62 KHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDC--GNIMSMHNVKIFLYQILRGLA 118
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
Y H R +++HRDLK N+L++ K++DFGLAR+ + T+ + VV T Y P
Sbjct: 119 YCH---RRKVLHRDLKPQNLLINERGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPP 173
Query: 691 EYAI-DGLFSVKSDVFSFGVLVLEIICGK 718
+ + +S + D++ G + E+ G+
Sbjct: 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGR 202
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 3e-13
Identities = 53/190 (27%), Positives = 83/190 (43%), Gaps = 33/190 (17%)
Query: 524 KLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQGMEEFK----NEVLLIAKLQHRNLV 576
+G G +G VYK G+E A+K+ KG + E+ L+ +L+H N+V
Sbjct: 7 CIGRGTYGRVYKAKRKNGKDGKEYAIKKF-KGDKEQYTGISQSACREIALLRELKHENVV 65
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFD---------TTRSKLLDWSKRSHIIAGIAR 627
L+ + ++ + YL DY D + + S ++ I
Sbjct: 66 SLVEVFLEHADKSV---YL---LFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQILN 119
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFG--LDQTEANTKRV 681
G+ YLH + ++HRDLK +N+L+ KI D GLAR F L + A+ V
Sbjct: 120 GVHYLHSN---WVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPL-KPLADLDPV 175
Query: 682 VGTYGYMSPE 691
V T Y +PE
Sbjct: 176 VVTIWYRAPE 185
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 5e-13
Identities = 56/215 (26%), Positives = 98/215 (45%), Gaps = 31/215 (14%)
Query: 522 KNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+ LG G G VYK L+ + +AVK + + + ++ +E+ ++ K ++
Sbjct: 6 QEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFY 65
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA----RGLLYLHQD 635
G + + E++ SLD + H++ IA +GL YL
Sbjct: 66 GAFFVENRISICTEFMDGGSLDVY-----------RKIPEHVLGRIAVAVVKGLTYLWS- 113
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
L+I+HRD+K SN+L++ K+ DFG++ + K VGT YM+PE
Sbjct: 114 --LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQL----VNSIAKTYVGTNAYMAPERISG 167
Query: 696 GLFSVKSDVFSFGVLVLEIICGK-------KNRGF 723
+ + SDV+S G+ +E+ G+ KN+G
Sbjct: 168 EQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGS 202
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 70.2 bits (172), Expect = 6e-13
Identities = 65/201 (32%), Positives = 102/201 (50%), Gaps = 18/201 (8%)
Query: 525 LGEGGFGPVYKGMLI----EGQEIAVKRLSKGSGQGMEEF--KNEVLLIAKLQHRNLVKL 578
LG+G FG V+ I GQ A+K L K + + + K E ++A++ H +VKL
Sbjct: 4 LGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKL 63
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR--SHIIAGIARGLLYLHQDS 636
+ LI ++L + D F T SK + +++ +A +A L +LH
Sbjct: 64 HYAFQTEGKLYLILDFL--RGGDLF---TRLSKEVMFTEEDVKFYLAELALALDHLH--- 115
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
L II+RDLK N+LLD + K++DFGL++ +D E GT YM+PE
Sbjct: 116 SLGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDH-EKKAYSFCGTVEYMAPEVVNRR 173
Query: 697 LFSVKSDVFSFGVLVLEIICG 717
+ +D +SFGVL+ E++ G
Sbjct: 174 GHTQSADWWSFGVLMFEMLTG 194
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 8e-13
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 30/214 (14%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVL--------- 565
T+ + + +G G FG V + GQ +A+K++ M+ F VL
Sbjct: 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKI-------MKPFSTPVLAKRTYRELK 61
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
L+ L+H N++ L E + L L + S+ L+ + + I
Sbjct: 62 LLKHLRHENIISLSDIFISPLEDIYFVTELLGTDLHRLL----TSRPLEKQFIQYFLYQI 117
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
RGL Y+H ++HRDLK SN+L++ + KI DFGLAR + V T
Sbjct: 118 LRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARI-----QDPQMTGYVSTR 169
Query: 686 GYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGK 718
Y +PE + + V+ D++S G + E++ GK
Sbjct: 170 YYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGK 203
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 70.0 bits (172), Expect = 9e-13
Identities = 58/228 (25%), Positives = 102/228 (44%), Gaps = 45/228 (19%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQ-----GMEEFKNEVLLI 567
+ + + +GEG +G V G ++A+K++S Q + E K ++
Sbjct: 2 DVGPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIK----IL 57
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF--------IFDTTRSKLLDWSKRS 619
+ +H N++ I + + S + F + +T KL+ S
Sbjct: 58 RRFKHENIIG-------------ILDIIRPPSFESFNDVYIVQELMETDLYKLIKTQHLS 104
Query: 620 --HI---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
HI + I RGL Y+H + ++HRDLK SN+LL+ + KI DFGLAR D
Sbjct: 105 NDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI--ADPE 159
Query: 675 EANTKRV---VGTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIICGK 718
+T + V T Y +PE ++ K+ D++S G ++ E++ +
Sbjct: 160 HDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 9e-13
Identities = 57/189 (30%), Positives = 95/189 (50%), Gaps = 28/189 (14%)
Query: 542 QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601
+ +A+K+LS+ F+N+ AK +R LV L+ C ++ L+ + P KSL+
Sbjct: 50 RNVAIKKLSR-------PFQNQTH--AKRAYRELV-LMKCVNHKNIIGLLNVFTPQKSLE 99
Query: 602 -----YFIFDTTRSKL-------LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649
Y + + + L LD + S+++ + G+ +LH IIHRDLK SN
Sbjct: 100 EFQDVYIVMELMDANLCQVIQMELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSN 156
Query: 650 VLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGV 709
+++ + KI DFGLAR+ G + T VV Y Y +PE + + D++S G
Sbjct: 157 IVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRAPEVILGMGYKENVDIWSVGC 213
Query: 710 LVLEIICGK 718
++ E+I G
Sbjct: 214 IMGEMIKGG 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 1e-12
Identities = 65/219 (29%), Positives = 104/219 (47%), Gaps = 19/219 (8%)
Query: 509 LKIIANATDNFSEKNKLGEGGFGPVYK-GMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLI 567
L+ + + TD + +G+G +G VYK +G AVK L S EE + E ++
Sbjct: 14 LESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDVD-EEIEAEYNIL 72
Query: 568 AKL-QHRNLVKLLGCCTQRDERM-----LIYEYLPNKSLDYFIFDTTR-SKLLDWSKRSH 620
L H N+VK G + D+ + L+ E S+ + + LD + S+
Sbjct: 73 QSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISY 132
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
I+ G GL +LH + RIIHRD+K +N+LL K+ DFG++ + NT
Sbjct: 133 ILYGALLGLQHLHNN---RIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTS- 188
Query: 681 VVGTYGYMSPEY-----AIDGLFSVKSDVFSFGVLVLEI 714
VGT +M+PE D + + DV+S G+ +E+
Sbjct: 189 -VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 69.2 bits (169), Expect = 1e-12
Identities = 62/199 (31%), Positives = 93/199 (46%), Gaps = 13/199 (6%)
Query: 525 LGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG+G FG V L +G+ AVK L K +E E ++A + L
Sbjct: 3 LGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLY 62
Query: 581 CCTQ-RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
C Q ++ + E+L L + I D R D + + A I GL +LH
Sbjct: 63 CTFQTKEHLFFVMEFLNGGDLMFHIQDKGR---FDLYRATFYAAEIVCGLQFLHSKG--- 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
II+RDLK NV+LD + KI+DFG+ + A+T GT Y++PE ++
Sbjct: 117 IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRAST--FCGTPDYIAPEILQGLKYT 174
Query: 700 VKSDVFSFGVLVLEIICGK 718
D +SFGVL+ E++ G+
Sbjct: 175 FSVDWWSFGVLLYEMLIGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 16/209 (7%)
Query: 525 LGEGGFGPVYKGMLI----EGQEIAVKRLS--KGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
+G+G +G V L+ +G++ +K+L+ S + + + E L+++L+H N+V
Sbjct: 8 VGKGSYGEV---SLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAY 64
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
D + I Y + KLL ++ IA L YLH+
Sbjct: 65 RESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK--- 121
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
I+HRDLK NV L T K+ D G+AR A+T ++GT YMSPE + +
Sbjct: 122 HILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMAST--LIGTPYYMSPELFSNKPY 179
Query: 699 SVKSDVFSFGVLVLEIICGKKNRGFNHAD 727
+ KSDV++ G V E+ K FN D
Sbjct: 180 NYKSDVWALGCCVYEMATLK--HAFNAKD 206
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 69.4 bits (170), Expect = 1e-12
Identities = 60/203 (29%), Positives = 97/203 (47%), Gaps = 48/203 (23%)
Query: 538 LIEGQEIAVKRLSKGSGQGMEEFKN---------EVLLIAKLQHRNLVKLLGCCTQRDER 588
+ GQ +A+K+LS+ F+N E++L+ + H+N++ LL T
Sbjct: 38 TVTGQNVAIKKLSR-------PFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFT----- 85
Query: 589 MLIYEYLPNKSLD-----YFIFDTTRSKL-------LDWSKRSHIIAGIARGLLYLHQDS 636
P KSL+ Y + + + L LD + S+++ + G+ +LH
Sbjct: 86 -------PQKSLEEFQDVYLVMELMDANLCQVIQMDLDHERMSYLLYQMLCGIKHLHSAG 138
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
IIHRDLK SN+++ + KI DFGLAR+ G T VV Y Y +PE I G
Sbjct: 139 ---IIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM--TPYVVTRY-YRAPE-VILG 191
Query: 697 L-FSVKSDVFSFGVLVLEIICGK 718
+ + D++S G ++ E+I G
Sbjct: 192 MGYKENVDIWSVGCIMGEMIRGT 214
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 69.1 bits (169), Expect = 2e-12
Identities = 38/90 (42%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ARG+ +L SR + IHRDL A N+LL KI DFGLAR D
Sbjct: 182 VARGMEFL--ASR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 238
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 239 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 2e-12
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 34/219 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL--------------IAKL 570
LG+G FG V I V+ + G M+ K EV++ +
Sbjct: 3 LGKGTFGKV----------ILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNT 52
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H L L +D + EY+ L F +R ++ + A I L
Sbjct: 53 RHPFLTSLKYSFQTKDRLCFVMEYVNGGEL---FFHLSRERVFSEDRTRFYGAEIVSALD 109
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH +I++RDLK N++LD + KI+DFGL + D A K GT Y++P
Sbjct: 110 YLHSG---KIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMKTFCGTPEYLAP 164
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
E D + D + GV++ E++CG+ F + DH+
Sbjct: 165 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 68.5 bits (167), Expect = 3e-12
Identities = 65/224 (29%), Positives = 107/224 (47%), Gaps = 30/224 (13%)
Query: 519 FSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
+ + +G G G V + G +AVK+LS+ F+N+ AK +R LV
Sbjct: 23 YQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSR-------PFQNQTH--AKRAYRELV- 72
Query: 578 LLGCCTQRDERMLIYEYLPNKSLD-----YFIFDTTRSKL-------LDWSKRSHIIAGI 625
LL C ++ L+ + P KSL+ Y + + + L LD + S+++ +
Sbjct: 73 LLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIHMELDHERMSYLLYQM 132
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
G+ +LH IIHRDLK SN+++ + KI DFGLAR+ + T VV Y
Sbjct: 133 LCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTACTNFMM--TPYVVTRY 187
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK-NRGFNHADH 728
Y +PE + + D++S G ++ E++ G +G +H D
Sbjct: 188 -YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQ 230
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 3e-12
Identities = 36/94 (38%), Positives = 60/94 (63%), Gaps = 6/94 (6%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ RGL YL + + +I+HRD+K SN+L+++ K+ DFG+ S L + AN+ VGT
Sbjct: 108 VLRGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANS--FVGT 161
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
YMSPE ++V+SD++S G+ ++E+ G+
Sbjct: 162 RSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 67.2 bits (164), Expect = 4e-12
Identities = 58/213 (27%), Positives = 102/213 (47%), Gaps = 32/213 (15%)
Query: 523 NKLGEGGFGPVYK------GMLIEGQEIAVKRLSKGSGQGMEEFK-NEVLLIAKLQHR-- 573
++LG+G +G VYK G+ + +EI RL ++E K N++++ + H+
Sbjct: 7 DELGKGNYGSVYKVLHRPTGVTMAMKEI---RLE------LDESKFNQIIMELDILHKAV 57
Query: 574 --NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
+V G + EY+ SLD ++ + I + +GL +
Sbjct: 58 SPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKF 117
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
L ++ IIHRD+K +NVL++ K+ DFG+ S L + A T +G YM+PE
Sbjct: 118 LKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGV--SGNLVASLAKTN--IGCQSYMAPE 171
Query: 692 Y------AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ ++V+SDV+S G+ +LE+ G+
Sbjct: 172 RIKSGGPNQNPTYTVQSDVWSLGLSILEMALGR 204
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 69.9 bits (171), Expect = 4e-12
Identities = 50/195 (25%), Positives = 85/195 (43%), Gaps = 28/195 (14%)
Query: 541 GQEIAVKRLSKGSGQGMEE---FKNEVLLIAKLQHRNLVKLLGCCTQRDERML-IYEYLP 596
G E+A+K L + + + F+ E L A+L H N+V LL + ++EY+P
Sbjct: 3 GHEVAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVP 62
Query: 597 NKSLDYFIFDTTRSKL-----LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
++L R L L + ++ + L H I+HRDLK N++
Sbjct: 63 GRTL--------REVLAADGALPAGETGRLMLQVLDALACAHNQG---IVHRDLKPQNIM 111
Query: 652 L---DNTMNPKISDFG---LARSFG--LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSD 703
+ + K+ DFG L T T V+GT Y +PE + SD
Sbjct: 112 VSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSD 171
Query: 704 VFSFGVLVLEIICGK 718
++++G++ LE + G+
Sbjct: 172 LYAWGLIFLECLTGQ 186
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 4e-12
Identities = 54/197 (27%), Positives = 101/197 (51%), Gaps = 10/197 (5%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRL--SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+GEG +G V K E +EI A+K+ S+ + + E E+ ++ L+ N+V+L
Sbjct: 9 VGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEA 68
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRII 641
+R + L++EY+ L+ + + + + RS+I I + + + H++ I+
Sbjct: 69 FRRRGKLYLVFEYVEKNMLE--LLEEMPNGVPPEKVRSYIYQLI-KAIHWCHKND---IV 122
Query: 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVK 701
HRD+K N+L+ + K+ DFG AR+ + + AN V T Y SPE + +
Sbjct: 123 HRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRWYRSPELLLGAPYGKA 181
Query: 702 SDVFSFGVLVLEIICGK 718
D++S G ++ E+ G+
Sbjct: 182 VDMWSVGCILGELSDGQ 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 67.0 bits (163), Expect = 6e-12
Identities = 62/220 (28%), Positives = 93/220 (42%), Gaps = 36/220 (16%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK------------LQ- 571
LG+G FG V I V+ + G M+ + EV+ IAK LQ
Sbjct: 3 LGKGTFGKV----------ILVREKATGRYYAMKILRKEVI-IAKDEVAHTVTESRVLQN 51
Query: 572 --HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H L L D + EY L F +R ++ + A I L
Sbjct: 52 TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---FFHLSRERVFTEERARFYGAEIVSAL 108
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
YLH +++RD+K N++LD + KI+DFGL + D A K GT Y++
Sbjct: 109 EYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISD--GATMKTFCGTPEYLA 163
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
PE D + D + GV++ E++CG+ F + DH+
Sbjct: 164 PEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.9 bits (163), Expect = 8e-12
Identities = 65/237 (27%), Positives = 109/237 (45%), Gaps = 38/237 (16%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKNEVLL 566
K I D + + ++G G +G V + G ++A+K+L + S + E+ L
Sbjct: 8 KTIWEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRL 67
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF--------IFDTTRSKLLDWSKR 618
+ ++H N++ LL T P+ SLD F T KL+ K
Sbjct: 68 LKHMKHENVIGLLDVFT------------PDLSLDRFHDFYLVMPFMGTDLGKLMKHEKL 115
Query: 619 S-----HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
S ++ + +GL Y+H IIHRDLK N+ ++ KI DFGLAR Q
Sbjct: 116 SEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLAR-----Q 167
Query: 674 TEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKK-NRGFNHADH 728
T++ V T Y +PE ++ + ++ D++S G ++ E++ GK +G +H D
Sbjct: 168 TDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 8e-12
Identities = 58/200 (29%), Positives = 95/200 (47%), Gaps = 13/200 (6%)
Query: 523 NKLGEGGFGPVYKGML-IEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
+KLGEG + V+KG + +A+K RL G + EV L+ L+H N+V L
Sbjct: 11 DKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIR-EVSLLKNLKHANIVTLH 69
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
L++EYL + Y L+ + + RGL Y H + +
Sbjct: 70 DIIHTERCLTLVFEYLDSDLKQYL---DNCGNLMSMHNVKIFMFQLLRGLSYCH---KRK 123
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-F 698
I+HRDLK N+L++ K++DFGLAR+ + T+ + VV T Y P+ + +
Sbjct: 124 ILHRDLKPQNLLINEKGELKLADFGLARAKSV-PTKTYSNEVV-TLWYRPPDVLLGSTEY 181
Query: 699 SVKSDVFSFGVLVLEIICGK 718
S D++ G ++ E+ G+
Sbjct: 182 STPIDMWGVGCILYEMATGR 201
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 63/205 (30%), Positives = 93/205 (45%), Gaps = 25/205 (12%)
Query: 525 LGEGGFGPVYKGMLIE--GQE--IAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVK 577
LG+G FG V ML E G + A+K L K +E E ++A +
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLT 64
Query: 578 LLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII---AGIARGLLYLH 633
L C Q +R+ + EY+ L Y I + K H + A IA GL +LH
Sbjct: 65 QLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFK------EPHAVFYAAEIAIGLFFLH 118
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
II+RDLK NV+LD + KI+DFG+ + T+ GT Y++PE
Sbjct: 119 SKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG--GKTTRTFCGTPDYIAPEII 173
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++FGVL+ E++ G+
Sbjct: 174 AYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 52/210 (24%), Positives = 96/210 (45%), Gaps = 22/210 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-------EVLLIA 568
+ + + +K+GEG +G V+K E GQ +A+K+ + E+ E+ ++
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVES-----EDDPVIKKIALREIRMLK 55
Query: 569 KLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG 628
+L+H NLV L+ ++ + L++EY + L+ + + II +
Sbjct: 56 QLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNEL---EKNPRGVPEHLIKKIIWQTLQA 112
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
+ + H+ IHRD+K N+L+ K+ DFG AR L + V T Y
Sbjct: 113 VNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARI--LTGPGDDYTDYVATRWYR 167
Query: 689 SPEYAI-DGLFSVKSDVFSFGVLVLEIICG 717
+PE + D + DV++ G + E++ G
Sbjct: 168 APELLVGDTQYGPPVDVWAIGCVFAELLTG 197
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 1e-11
Identities = 57/196 (29%), Positives = 94/196 (47%), Gaps = 16/196 (8%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
+GEG FG + +L++ Q+ A+K RL K S +E+ + E +L+AK++H N+V
Sbjct: 8 VGEGSFG---RALLVQHVNSDQKYAMKEIRLPK-SSSAVEDSRKEAVLLAKMKHPNIVAF 63
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ EY L I R KL + G+ ++H+
Sbjct: 64 KESFEADGHLYIVMEYCDGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEK--- 119
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
R++HRD+K+ N+ L K+ DFG AR A T VGT Y+ PE + +
Sbjct: 120 RVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACT--YVGTPYYVPPEIWENMPY 177
Query: 699 SVKSDVFSFGVLVLEI 714
+ KSD++S G ++ E+
Sbjct: 178 NNKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 49/147 (33%), Positives = 70/147 (47%), Gaps = 14/147 (9%)
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII---AGIARGLLY 631
L +L C D + EY+ L Y I R K H + A IA GL +
Sbjct: 63 LTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFK------EPHAVFYAAEIAIGLFF 116
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH II+RDLK NV+LD+ + KI+DFG+ + D TK GT Y++PE
Sbjct: 117 LHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGV--TTKTFCGTPDYIAPE 171
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++FGVL+ E++ G+
Sbjct: 172 IIAYQPYGKSVDWWAFGVLLYEMLAGQ 198
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 1e-11
Identities = 64/228 (28%), Positives = 103/228 (45%), Gaps = 41/228 (17%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---EVL 565
K I + + + +G G +G V + G +AVK+LS+ Q + K E+
Sbjct: 10 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-PFQSIIHAKRTYRELR 68
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF--IFDTTR------------SK 611
L+ ++H N++ LL T P +SL+ F ++ T K
Sbjct: 69 LLKHMKHENVIGLLDVFT------------PARSLEEFNDVYLVTHLMGADLNNIVKCQK 116
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
L D +I I RGL Y+H IIHRDLK SN+ ++ KI DFGLAR
Sbjct: 117 LTD-DHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLAR---- 168
Query: 672 DQTEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGK 718
T+ V T Y +PE ++ + ++ D++S G ++ E++ G+
Sbjct: 169 -HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 66.0 bits (161), Expect = 1e-11
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG+G FG V L E+ A+K L K ++ E ++A + L
Sbjct: 3 LGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALH 62
Query: 581 CCTQRDERML-IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
CC Q +R+ + EY+ L +F RS+ D + A + L++LH+
Sbjct: 63 CCFQTKDRLFFVMEYVNGGDL---MFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG--- 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
+I+RDLK N+LLD + K++DFG+ + G+ T GT Y++PE + +
Sbjct: 117 VIYRDLKLDNILLDAEGHCKLADFGMCKE-GILN-GVTTTTFCGTPDYIAPEILQELEYG 174
Query: 700 VKSDVFSFGVLVLEIICGK 718
D ++ GVL+ E++ G+
Sbjct: 175 PSVDWWALGVLMYEMMAGQ 193
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 65.3 bits (159), Expect = 1e-11
Identities = 52/206 (25%), Positives = 84/206 (40%), Gaps = 18/206 (8%)
Query: 523 NKLGEGGFGPVYKG---MLIEGQEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578
+++G G FG V G + + VK L + + F EV +L H N+++
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQC 60
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS--HIIAGIARGLLYLHQDS 636
LG C + +L+ E+ P L ++ K + +A GLL+LHQ
Sbjct: 61 LGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKRVVGTYGYMSPEYAI- 694
IH DL N L ++ KI D+GLA + D V +++PE
Sbjct: 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAV-PLRWLAPELVEI 176
Query: 695 --DGLFSVK----SDVFSFGVLVLEI 714
L S+++S GV + E+
Sbjct: 177 RGQDLLPKDQTKKSNIWSLGVTMWEL 202
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 65/221 (29%), Positives = 97/221 (43%), Gaps = 55/221 (24%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+G G G VYK + G +AVK++ + + EE K R L+ L
Sbjct: 23 IGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNK--EENK-----------RILMDLDVVLK 69
Query: 584 QRDERMLIYEYLPNKSLDYFIFD-----------TTRSKLLDWSKRS----------HII 622
D ++ K YFI D T KLL KR +
Sbjct: 70 SHDCPYIV------KCYGYFITDSDVFICMELMSTCLDKLL---KRIQGPIPEDILGKMT 120
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
I + L YL + +IHRD+K SN+LLD + N K+ DFG+ S L ++A T R
Sbjct: 121 VAIVKALHYLKEKHG--VIHRDVKPSNILLDASGNVKLCDFGI--SGRLVDSKAKT-RSA 175
Query: 683 GTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGK 718
G YM+PE ID + +++DV+S G+ ++E+ G+
Sbjct: 176 GCAAYMAPE-RIDPPDPNPKYDIRADVWSLGISLVELATGQ 215
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 65.1 bits (159), Expect = 2e-11
Identities = 51/155 (32%), Positives = 73/155 (47%), Gaps = 24/155 (15%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
KLGEG + VYKG + GQ +A+K RL G + E L+ L+H N+V L
Sbjct: 12 KLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIR-EASLLKDLKHANIVTLHD 70
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH-------IIAGIARGLLYLH 633
+ L++EYL DT + +D + + RGL Y H
Sbjct: 71 IIHTKKTLTLVFEYL----------DTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCH 120
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
Q R++HRDLK N+L+ K++DFGLAR+
Sbjct: 121 QR---RVLHRDLKPQNLLISERGELKLADFGLARA 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 2e-11
Identities = 60/219 (27%), Positives = 94/219 (42%), Gaps = 33/219 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL--------------IAKL 570
LG+G FG V I VK + G M+ K EV++ +
Sbjct: 3 LGKGTFGKV----------ILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNS 52
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H L L D + EY L F +R ++ + A I L
Sbjct: 53 RHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSALD 109
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH + +++RDLK N++LD + KI+DFGL + G+ + A K GT Y++P
Sbjct: 110 YLHSEKN--VVYRDLKLENLMLDKDGHIKITDFGLCKE-GI-KDGATMKTFCGTPEYLAP 165
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
E D + D + GV++ E++CG+ F + DH+
Sbjct: 166 EVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 202
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 3e-11
Identities = 38/90 (42%), Positives = 51/90 (56%), Gaps = 3/90 (3%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ARG+ +L SR + IHRDL A N+LL KI DFGLAR D
Sbjct: 183 VARGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLP 239
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 240 LKWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 65.2 bits (159), Expect = 4e-11
Identities = 34/95 (35%), Positives = 54/95 (56%), Gaps = 5/95 (5%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
I RGL YLH I+HRD+K N+L+++ KI DFGLAR D+++ T+ VV
Sbjct: 112 ILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQ 168
Query: 685 YGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGK 718
Y Y +PE + ++ D++S G + E++ +
Sbjct: 169 Y-YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 4e-11
Identities = 63/213 (29%), Positives = 99/213 (46%), Gaps = 21/213 (9%)
Query: 525 LGEGGFGPVYKGMLIE----GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVK 577
LG+G FG V ML E + A+K L K +E E ++A +
Sbjct: 8 LGKGSFGKV---MLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLT 64
Query: 578 LLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
L C Q +R+ + EY+ L Y I + K + A I+ GL +LH+
Sbjct: 65 QLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFK---EPQAVFYAAEISVGLFFLHRRG 121
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
II+RDLK NV+LD+ + KI+DFG+ + +D T+ GT Y++PE
Sbjct: 122 ---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAPEIIAYQ 176
Query: 697 LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
+ D +++GVL+ E++ G+ F+ D D
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPP--FDGEDED 207
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 4e-11
Identities = 59/219 (26%), Positives = 101/219 (46%), Gaps = 33/219 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEE------FKNEVLLI 567
D + + K+GEG +G VYK G+ +A+K RL M+E E+ L+
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLE------MDEEGIPPTALREISLL 54
Query: 568 AKLQHRN-LVKLLGCCTQRDERM------LIYEYLPNKSLDYFIFDTTR--SKLLDWSKR 618
L +V+LL +E+ L++EYL + L F+ R + L
Sbjct: 55 QMLSESIYIVRLL-DVEHVEEKNGKPSLYLVFEYL-DSDLKKFMDSNGRGPGRPLPAKTI 112
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-KISDFGLARSFGLDQTEAN 677
+ + +G+ + H + ++HRDLK N+L+D KI+D GL R+F + ++
Sbjct: 113 KSFMYQLLKGVAHCH---KHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSI-PVKSY 168
Query: 678 TKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEII 715
T +V T Y +PE + +S D++S G + E+
Sbjct: 169 THEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMS 206
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 64.7 bits (157), Expect = 4e-11
Identities = 61/206 (29%), Positives = 102/206 (49%), Gaps = 33/206 (16%)
Query: 525 LGEGGFGPV---YKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+G G G V Y +L + +A+K+LS+ F+N+ AK +R LV L+ C
Sbjct: 25 IGSGAQGIVCAAYDAVL--DRNVAIKKLSR-------PFQNQTH--AKRAYRELV-LMKC 72
Query: 582 CTQRDERMLIYEYLPNKSLD-----YFIFDTTRSKL-------LDWSKRSHIIAGIARGL 629
++ L+ + P KSL+ Y + + + L LD + S+++ + G+
Sbjct: 73 VNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDANLCQVIQMELDHERMSYLLYQMLCGI 132
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
+LH IIHRDLK SN+++ + KI DFGLAR+ G + T VV Y Y +
Sbjct: 133 KHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLARTAG--TSFMMTPYVVTRY-YRA 186
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEII 715
PE + + D++S G ++ E++
Sbjct: 187 PEVILGMGYKENVDIWSVGCIMGEMV 212
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 64.5 bits (157), Expect = 5e-11
Identities = 56/214 (26%), Positives = 101/214 (47%), Gaps = 20/214 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSK---GSGQGMEEFKNEVLLIAKL 570
+F K+ +G G FG V ++ E G A+K + K + + + F+ E +++
Sbjct: 1 KDFDVKSLVGRGHFGEVQ--VVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSIS 58
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+ +L +D L+ EY P L + ++ D +A +L
Sbjct: 59 NSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLL-----NRYEDQFDEDMAQFYLAELVL 113
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+H ++ +HRD+K NVL+D T + K++DFG A ++ N+K VGT Y++P
Sbjct: 114 AIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM-VNSKLPVGTPDYIAP 172
Query: 691 EY--AIDG----LFSVKSDVFSFGVLVLEIICGK 718
E ++G + V+ D +S GV+ E+I G+
Sbjct: 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGR 206
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 65.4 bits (159), Expect = 5e-11
Identities = 65/240 (27%), Positives = 112/240 (46%), Gaps = 24/240 (10%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE-IAVKR 548
+ H+N E E+ E I D I + ++ N +G G FG VY+ + I+ E +A+K+
Sbjct: 40 RSHNNNAGEDEDEEKMI-DNDINRSPNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKK 98
Query: 549 LSKGSGQGMEEFKNEVLLIAK-LQHRNLVKLLGC----CTQRDERML----IYEYLPNKS 599
+ + ++KN LLI K L H N++ L C +++E+ + + E++P
Sbjct: 99 VLQDP-----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTV 153
Query: 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNP 658
Y + L + R L Y+H I HRDLK N+L+D NT
Sbjct: 154 HKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTL 210
Query: 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICG 717
K+ DFG A++ Q + + + Y +PE + ++ D++S G ++ E+I G
Sbjct: 211 KLCDFGSAKNLLAGQRSVS---YICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILG 267
|
Length = 440 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 64.3 bits (156), Expect = 7e-11
Identities = 37/90 (41%), Positives = 52/90 (57%), Gaps = 3/90 (3%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+A+G+ +L SR + IHRDL A N+LL KI DFGLAR D
Sbjct: 188 VAKGMEFLA--SR-KCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLP 244
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE D +++++SDV+SFGVL+ EI
Sbjct: 245 LKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 8e-11
Identities = 59/214 (27%), Positives = 98/214 (45%), Gaps = 31/214 (14%)
Query: 525 LGEGGFGPVYKGMLIE---------GQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQHRN 574
LG+G F +YKG+L GQE++V GS F L+++L H++
Sbjct: 3 LGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRDSLAFFETASLMSQLSHKH 62
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
LVKL G C RDE +++ EY+ LD F+ + L W + + +A L YL
Sbjct: 63 LVKLYGVCV-RDENIMVEEYVKFGPLDVFLHREKNNVSLHW--KLDVAKQLASALHYLED 119
Query: 635 DSRLRIIHRDLKASNVLL----DNTMNP---KISDFGLARSFGLDQTEANTKRVVGTYGY 687
+++H ++ N+L+ N K+SD G+ + E +R+ +
Sbjct: 120 K---KLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVL--SREERVERI----PW 170
Query: 688 MSPEYAIDGLFSVKS--DVFSFGVLVLEIICGKK 719
++PE +G S+ D +SFG +LEI +
Sbjct: 171 IAPECIRNGQASLTIAADKWSFGTTLLEICSNGE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 9e-11
Identities = 56/199 (28%), Positives = 94/199 (47%), Gaps = 13/199 (6%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQHRNLVKLLGC 581
+G G +G V Q++AVK+LS+ + + E+ L+ ++H N++ LL
Sbjct: 23 VGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDV 82
Query: 582 CTQRDERMLIYE-YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
T E YL + + + + + L +I + RGL Y+H I
Sbjct: 83 FTPATSIENFNEVYLVTNLMGADLNNIVKCQKLSDEHVQFLIYQLLRGLKYIHSAG---I 139
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FS 699
IHRDLK SNV ++ +I DFGLAR Q + V T Y +PE ++ + ++
Sbjct: 140 IHRDLKPSNVAVNEDCELRILDFGLAR-----QADDEMTGYVATRWYRAPEIMLNWMHYN 194
Query: 700 VKSDVFSFGVLVLEIICGK 718
D++S G ++ E++ GK
Sbjct: 195 QTVDIWSVGCIMAELLKGK 213
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 9e-11
Identities = 53/208 (25%), Positives = 96/208 (46%), Gaps = 19/208 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGM---EEFKNEVLLIAKLQH 572
D+ +G G FG V+ I A+K ++ + + NE ++ ++ H
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSH 60
Query: 573 RNLVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+++L T+ D+R L + EY+P L F + + + + + + I L
Sbjct: 61 PFIIRLF--WTEHDQRFLYMLMEYVPGGEL--FSYLRNSGRFSNSTGLFYA-SEIVCALE 115
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH I++RDLK N+LLD + K++DFG A+ D+T + GT Y++P
Sbjct: 116 YLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKL-RDRTWT----LCGTPEYLAP 167
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + D ++ G+L+ E++ G
Sbjct: 168 EVIQSKGHNKAVDWWALGILIYEMLVGY 195
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 9e-11
Identities = 41/112 (36%), Positives = 61/112 (54%), Gaps = 9/112 (8%)
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
DT S LD + +A+G+ +L + IHRD+ A NVLL + KI DFGL
Sbjct: 202 DTEDSWPLDLDDLLRFSSQVAQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGL 258
Query: 666 ARSFGLDQT---EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
AR D + N + V +M+PE D +++V+SDV+S+G+L+ EI
Sbjct: 259 ARDIMNDSNYVVKGNARLPV---KWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 1e-10
Identities = 59/206 (28%), Positives = 100/206 (48%), Gaps = 15/206 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR--- 573
D+F ++LG G G V K I ++L + +N+++ ++ H
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 574 -NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
+V G E + E++ SLD + + R K S + RGL YL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVS---IAVLRGLAYL 119
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
+ + +I+HRD+K SN+L+++ K+ DFG+ S L + AN+ VGT YMSPE
Sbjct: 120 RE--KHQIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANS--FVGTRSYMSPER 173
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+SV+SD++S G+ ++E+ G+
Sbjct: 174 LQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 1e-10
Identities = 57/201 (28%), Positives = 94/201 (46%), Gaps = 18/201 (8%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK--GSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+G G +G V + G+++A+K+LS+ S + E+ L+ +QH N++ LL
Sbjct: 23 VGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDV 82
Query: 582 CTQR---DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
T DE Y +P D L K +++ + GL Y+H
Sbjct: 83 FTSAVSGDEFQDFYLVMPYMQTD---LQKIMGHPLSEDKVQYLVYQMLCGLKYIHSAG-- 137
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
IIHRDLK N+ ++ KI DFGLAR +A V T Y +PE ++ +
Sbjct: 138 -IIHRDLKPGNLAVNEDCELKILDFGLARH-----ADAEMTGYVVTRWYRAPEVILNWMH 191
Query: 699 SVKS-DVFSFGVLVLEIICGK 718
++ D++S G ++ E++ GK
Sbjct: 192 YNQTVDIWSVGCIMAEMLTGK 212
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 62.6 bits (152), Expect = 1e-10
Identities = 48/149 (32%), Positives = 75/149 (50%), Gaps = 9/149 (6%)
Query: 524 KLGEGGFGPVYKGMLIEG---QEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
++G G FG V G + G ++ VK L S Q +F E LQH NL++ L
Sbjct: 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCL 61
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLL--DWSKRSHIIAGIARGLLYLHQDSR 637
G CT+ +L+ E+ P L ++ +++L+ D + + IA GLL+LH+++
Sbjct: 62 GQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN- 120
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLA 666
IH DL N LL + KI D+GL+
Sbjct: 121 --FIHSDLALRNCLLTADLTVKIGDYGLS 147
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 2e-10
Identities = 52/208 (25%), Positives = 95/208 (45%), Gaps = 34/208 (16%)
Query: 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQ-HRNLVKL 578
K+GEG F V K + G+ A+K + K + +E+ N E+ + +L H N+++L
Sbjct: 5 GKIGEGTFSEVLKAQSRKTGKYYAIKCM-KKHFKSLEQVNNLREIQALRRLSPHPNILRL 63
Query: 579 L--------GCCTQRDE--RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG 628
+ G E M +YE + R + L + + + +
Sbjct: 64 IEVLFDRKTGRLALVFELMDMNLYELIKG-----------RKRPLPEKRVKSYMYQLLKS 112
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
L ++H++ I HRD+K N+L+ + K++DFG R G+ T+ + T Y
Sbjct: 113 LDHMHRNG---IFHRDIKPENILIKDD-ILKLADFGSCR--GIYSKPPYTE-YISTRWYR 165
Query: 689 SPEYAI-DGLFSVKSDVFSFGVLVLEII 715
+PE + DG + K D+++ G + EI+
Sbjct: 166 APECLLTDGYYGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 2e-10
Identities = 65/223 (29%), Positives = 94/223 (42%), Gaps = 42/223 (18%)
Query: 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK------------LQ- 571
LG+G FG V I V+ + G M+ K EV+ IAK LQ
Sbjct: 3 LGKGTFGKV----------ILVREKATGKYYAMKILKKEVI-IAKDEVAHTLTESRVLQN 51
Query: 572 --HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H L L D + EY L F +R ++ + A I L
Sbjct: 52 TRHPFLTALKYSFQTHDRLCFVMEYANGGEL---FFHLSRERVFSEDRARFYGAEIVSAL 108
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR---SFGLDQTEANTKRVVGTYG 686
YLH +++RDLK N++LD + KI+DFGL + S G A K GT
Sbjct: 109 GYLH---SCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG-----ATMKTFCGTPE 160
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
Y++PE D + D + GV++ E++CG+ F + DH+
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR--LPFYNQDHE 201
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 2e-10
Identities = 58/211 (27%), Positives = 98/211 (46%), Gaps = 18/211 (8%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQE----IAVKRLSKGS----GQGMEEFKNEVLLIAK 569
NF LG G +G V+ + G + A+K L K + + E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 570 LQHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARG 628
++ + L Q D ++ LI +Y+ L F + R + + + + I
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGEL--FTHLSQRERFKEQEVQIYS-GEIVLA 117
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
L +LH +L II+RD+K N+LLD+ + ++DFGL++ F D+ E GT YM
Sbjct: 118 LEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIEYM 173
Query: 689 SPEYAI--DGLFSVKSDVFSFGVLVLEIICG 717
+P+ DG D +S GVL+ E++ G
Sbjct: 174 APDIVRGGDGGHDKAVDWWSMGVLMYELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 62.4 bits (151), Expect = 2e-10
Identities = 57/208 (27%), Positives = 103/208 (49%), Gaps = 19/208 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR--- 573
D+F + ++LG G G V+K I ++L + +N+++ ++ H
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNS 62
Query: 574 -NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR--SKLLDWSKRSHIIAGIARGLL 630
+V G E + E++ SLD + R ++L + + +GL
Sbjct: 63 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQIL-----GKVSIAVIKGLT 117
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YL + + +I+HRD+K SN+L+++ K+ DFG+ S L + AN+ VGT YMSP
Sbjct: 118 YLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANS--FVGTRSYMSP 171
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E +SV+SD++S G+ ++E+ G+
Sbjct: 172 ERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.3 bits (151), Expect = 3e-10
Identities = 35/90 (38%), Positives = 49/90 (54%), Gaps = 3/90 (3%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ARG+ +L + +HRDL A NVLL KI DFGLAR D +
Sbjct: 246 VARGMEFLASKN---CVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLP 302
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE D L++ SDV+S+G+L+ EI
Sbjct: 303 VKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 61.9 bits (151), Expect = 3e-10
Identities = 53/231 (22%), Positives = 91/231 (39%), Gaps = 51/231 (22%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEE---FKNEVLLIAKLQHRNLVKLLG 580
+G G FG V+ + ++ A+K L K + + E ++A +VKL
Sbjct: 9 IGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLY- 67
Query: 581 CCTQRDERML--IYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
+ +DE L + EY+P L +F ++ IA + L +H
Sbjct: 68 -YSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFY--------IAELVLALDSVH 118
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG----------------------- 670
+ L IHRD+K N+L+D + K++DFGL +
Sbjct: 119 K---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLV 175
Query: 671 ----LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
Q VGT Y++PE + ++ D +S GV++ E++ G
Sbjct: 176 RRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYG 226
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 6e-10
Identities = 36/96 (37%), Positives = 58/96 (60%), Gaps = 8/96 (8%)
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
A I GL ++H +R +++RDLK +N+LLD + +ISD GLA F + A+ V
Sbjct: 104 AEIILGLEHMH--NRF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----V 156
Query: 683 GTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICG 717
GT+GYM+PE G+ + +D FS G ++ +++ G
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 58/202 (28%), Positives = 96/202 (47%), Gaps = 20/202 (9%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLG 580
+G GGFG VY + G+ A+K L K QG NE ++++ L +
Sbjct: 2 IGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLS-LVSTGDCPFIV 60
Query: 581 CCT----QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
C T D+ I + + L Y + ++ + + I GL ++H +
Sbjct: 61 CMTYAFHTPDKLCFILDLMNGGDLHYHL---SQHGVFSEKEMRFYATEIILGLEHMH--N 115
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
R +++RDLK +N+LLD + +ISD GLA F + A+ VGT+GYM+PE G
Sbjct: 116 RF-VVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHAS----VGTHGYMAPEVLQKG 170
Query: 697 L-FSVKSDVFSFGVLVLEIICG 717
+ +D FS G ++ +++ G
Sbjct: 171 TAYDSSADWFSLGCMLFKLLRG 192
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 8e-10
Identities = 38/98 (38%), Positives = 53/98 (54%), Gaps = 6/98 (6%)
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
IA I L +LHQ L II+RD+K N+LLD+ + ++DFGL++ F L + E
Sbjct: 111 IAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEF-LAEEEERAYSF 166
Query: 682 VGTYGYMSPEY--AIDGLFSVKSDVFSFGVLVLEIICG 717
GT YM+PE G D +S GVL E++ G
Sbjct: 167 CGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTG 204
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 58/210 (27%), Positives = 98/210 (46%), Gaps = 28/210 (13%)
Query: 525 LGEGGFGPVYKGMLIE----GQ----EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
LG+G F ++KG+ E G+ E+ +K L K E F ++++L H++LV
Sbjct: 3 LGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLV 62
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
G C DE +++ EY+ SLD ++ L++ S + + +A L +L
Sbjct: 63 LNYGVCVCGDESIMVQEYVKFGSLDTYL--KKNKNLINISWKLEVAKQLAWALHFLEDKG 120
Query: 637 RLRIIHRDLKASNVLL-----DNTMNP---KISDFGLARSFGLDQTEANTKRVVGTYGYM 688
+ H ++ A NVLL T NP K+SD G+ S + E +R+ ++
Sbjct: 121 ---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGI--SITVLPKEILLERI----PWV 171
Query: 689 SPEYAIDGL-FSVKSDVFSFGVLVLEIICG 717
PE + S+ +D +SFG + EI G
Sbjct: 172 PPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|214680 smart00473, PAN_AP, divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Score = 54.5 bits (131), Expect = 2e-09
Identities = 25/81 (30%), Positives = 33/81 (40%), Gaps = 6/81 (7%)
Query: 367 KHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSK-NCSCTAYANADVRGRGSGCLLW 425
K D F+ KLP + +L EC C NCSC ++ GCLLW
Sbjct: 1 KSDDCFVRLPNTKLPGFSRIVIS-VASLEECASKCLNSNCSCRSFTY---NNGTKGCLLW 56
Query: 426 -FHDLIDIKELPESGQDLFIR 445
L D + P G DL+ +
Sbjct: 57 SESSLGDARLFPSGGVDLYEK 77
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. Length = 78 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 59.6 bits (144), Expect = 2e-09
Identities = 62/209 (29%), Positives = 96/209 (45%), Gaps = 32/209 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT 583
+G+G FG VY+ + + I A+K LSK +E + + RN++ T
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTI------GERNILV----RT 50
Query: 584 QRDERMLI----YEYLPNKSLDYFIFDTTRSKLLDW---------SKRSHI-IAGIARGL 629
DE I + + + L Y + D L W R+ IA + L
Sbjct: 51 LLDESPFIVGLKFSFQTDSDL-YLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLAL 109
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
+LH+ I++RDLK N+LLD T + + DFGL+++ D NT GT Y++
Sbjct: 110 EHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNT--FCGTTEYLA 164
Query: 690 PEYAIDGL-FSVKSDVFSFGVLVLEIICG 717
PE +D ++ D +S GVLV E+ CG
Sbjct: 165 PEVLLDEKGYTKHVDFWSLGVLVFEMCCG 193
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 3e-09
Identities = 62/211 (29%), Positives = 96/211 (45%), Gaps = 29/211 (13%)
Query: 518 NFSEKNKLGEGGFGPV----YKGMLIEGQEIAVKRLSKGSGQGMEEFKN---EVLLIAKL 570
+F LG G FG V +KG G+ A+K L K M++ ++ E ++ +L
Sbjct: 19 DFEMGETLGTGSFGRVRIAKHKG---TGEYYAIKCLKKREILKMKQVQHVAQEKSILMEL 75
Query: 571 QHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLL---DWSKRSHIIAGIA 626
H +V ++ C Q + R+ + E++ L F R D +K H A +
Sbjct: 76 SHPFIVNMM-CSFQDENRVYFLLEFVVGGEL----FTHLRKAGRFPNDVAKFYH--AELV 128
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
YLH II+RDLK N+LLDN + K++DFG A+ + T + GT
Sbjct: 129 LAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----KVPDRTFTLCGTPE 180
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
Y++PE D ++ GVL+ E I G
Sbjct: 181 YLAPEVIQSKGHGKAVDWWTMGVLLYEFIAG 211
|
Length = 329 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 58.9 bits (143), Expect = 3e-09
Identities = 60/232 (25%), Positives = 94/232 (40%), Gaps = 63/232 (27%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+ +G G +G V + G+++A+K++ +V +AK R L
Sbjct: 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAF---------DVPTLAKRTLREL 55
Query: 576 VKLLGCCTQR----DERMLIYEYL-PNKSLD---YFIFDTTRSKLLDWSKRSHIIAG--- 624
K+L R D + I + L P + Y + D S L HII
Sbjct: 56 -KIL-----RHFKHDNIIAIRDILRPPGADFKDVYVVMDLMESDL------HHIIHSDQP 103
Query: 625 ------------IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+ RGL Y+H + +IHRDLK SN+L++ +I DFG+AR GL
Sbjct: 104 LTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMAR--GLS 158
Query: 673 QTEANTKRV----VGTYGYMSPEYAIDGLFSV-----KSDVFSFGVLVLEII 715
+ K V T Y +PE L S+ D++S G + E++
Sbjct: 159 SSPTEHKYFMTEYVATRWYRAPEL----LLSLPEYTTAIDMWSVGCIFAEML 206
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 4e-09
Identities = 45/147 (30%), Positives = 69/147 (46%), Gaps = 8/147 (5%)
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H LV L C + EY+ L +F R + L A I+ L Y
Sbjct: 55 HPFLVGLHSCFQTESRLFFVIEYVNGGDL---MFHMQRQRKLPEEHARFYSAEISLALNY 111
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH+ II+RDLK NVLLD+ + K++D+G+ + GL + T GT Y++PE
Sbjct: 112 LHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGD-TTSTFCGTPNYIAPE 166
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++ GVL+ E++ G+
Sbjct: 167 ILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 5e-09
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 21/211 (9%)
Query: 521 EKNKLGEGGFGPVYKGMLIEGQ---EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
E K+G G +G VYK +G+ E A+K++ +G+G M + E+ L+ +L+H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDEKEYALKQI-EGTGISMSACR-EIALLRELKHPNVIA 62
Query: 578 LLGCCTQRDERM--LIYEYLPNKSLDYFIFD-----TTRSKLLDWSKRSHIIAGIARGLL 630
L +R L+++Y + F + L S ++ I G+
Sbjct: 63 LQKVFLSHSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIH 122
Query: 631 YLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSFGLD-QTEANTKRVVGTY 685
YLH + ++HRDLK +N+L+ KI+D G AR F + A+ VV T+
Sbjct: 123 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 686 GYMSPEYAIDGLFSVKS-DVFSFGVLVLEII 715
Y +PE + K+ D+++ G + E++
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 6e-09
Identities = 60/222 (27%), Positives = 103/222 (46%), Gaps = 21/222 (9%)
Query: 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEV 564
IFD + +D + +G+G +G V+K + G + AVK L EE + E
Sbjct: 9 IFD--SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDID-EEIEAEY 65
Query: 565 LLIAKLQ-HRNLVKLLGCCTQRDER-----MLIYEYLPNKSL-DYFIFDTTRSKLLDWSK 617
++ L H N+VK G ++D + L+ E S+ D R + ++
Sbjct: 66 NILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPI 125
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
++I+ GL +LH + + IHRD+K +N+LL K+ DFG++ + N
Sbjct: 126 IAYILHEALMGLQHLHVN---KTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRN 182
Query: 678 TKRVVGTYGYMSPEY-----AIDGLFSVKSDVFSFGVLVLEI 714
T VGT +M+PE +D + + DV+S G+ +E+
Sbjct: 183 TS--VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 52/172 (30%), Positives = 81/172 (47%), Gaps = 13/172 (7%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEV----LLIAKLQHRNLVKLL 579
+G+G FG V +G+ AVK L K + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
D+ + +Y+ L F R + + A IA L YLH L
Sbjct: 63 YSFQTADKLYFVLDYVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---LN 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
II+RDLK N+LLD+ + ++DFGL + G+ + T GT Y++PE
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GI-EHSKTTSTFCGTPEYLAPE 166
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 1e-08
Identities = 34/93 (36%), Positives = 54/93 (58%), Gaps = 9/93 (9%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT---EANTKRV 681
+A+G+ +L + IHRDL A N+LL + KI DFGLAR D + N +
Sbjct: 223 VAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLP 279
Query: 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
V +M+PE + +++ +SDV+S+G+L+ EI
Sbjct: 280 V---KWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 56/213 (26%), Positives = 99/213 (46%), Gaps = 38/213 (17%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---------EVLLIAKLQHRN 574
+G G +G V E +++A+K+++ F N E+ L+ L H N
Sbjct: 13 IGRGAYGIVCSAKNSETNEKVAIKKIANA-------FDNRIDAKRTLREIKLLRHLDHEN 65
Query: 575 LVKLLGCC--TQRDERMLIYEYLPNKSLDYFIFDT------TRSKLLDWSKRSHIIAGIA 626
++ + R+ +Y + Y + DT S+ L + + +
Sbjct: 66 VIAIKDIMPPPHREAFNDVY-------IVYELMDTDLHQIIRSSQTLSDDHCQYFLYQLL 118
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
RGL Y+H + ++HRDLK SN+LL+ + KI DFGLAR+ ++ + T+ VV T
Sbjct: 119 RGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLART-TSEKGDFMTEYVV-TRW 173
Query: 687 YMSPEYAID-GLFSVKSDVFSFGVLVLEIICGK 718
Y +PE ++ ++ DV+S G + E++ K
Sbjct: 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 1e-08
Identities = 57/218 (26%), Positives = 99/218 (45%), Gaps = 33/218 (15%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQE----IAVKRLSKGS----GQGMEEFKNEVLLIAK 569
NF LG G +G V+ + G + A+K L K + + +E + E ++
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 570 LQHRNLVKLLGCCTQRDERM-LIYEYLPNKSL-------DYFIFDTTRSKLLDWSKRSHI 621
++ + L Q + ++ LI +Y+ + D F D R
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVR-----------F 109
Query: 622 IAG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
+G I L +LH +L I++RD+K N+LLD+ + ++DFGL++ F L + + T
Sbjct: 110 YSGEIILALEHLH---KLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF-LSEEKERTYS 165
Query: 681 VVGTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIICG 717
GT YM+PE K+ D +S G+L+ E++ G
Sbjct: 166 FCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 2e-08
Identities = 58/209 (27%), Positives = 92/209 (44%), Gaps = 32/209 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQE----IAVKRLSKG----SGQGMEEFKNEVLLIAKLQHRNLV 576
LG+GG+G V++ + G + A+K L K + + K E ++ ++H +V
Sbjct: 4 LGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIV 63
Query: 577 KLLGCCTQRDERMLIYEYLPNKSL-------DYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
L+ + LI EYL L F+ DT ++ I+ L
Sbjct: 64 DLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTA----------CFYLSEISLAL 113
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR-SFGLDQTEANTKRVVGTYGYM 688
+LHQ II+RDLK N+LLD + K++DFGL + S T GT YM
Sbjct: 114 EHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTV---THTFCGTIEYM 167
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
+PE + D +S G L+ +++ G
Sbjct: 168 APEILMRSGHGKAVDWWSLGALMYDMLTG 196
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 56.9 bits (137), Expect = 2e-08
Identities = 33/90 (36%), Positives = 48/90 (53%), Gaps = 3/90 (3%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+A G+ +L + +HRDL A NVL+ KI DFGLAR D +
Sbjct: 248 VANGMEFLASKN---CVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLP 304
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
+M+PE + L++ SDV+SFG+L+ EI
Sbjct: 305 LKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 57.2 bits (138), Expect = 2e-08
Identities = 32/99 (32%), Positives = 56/99 (56%), Gaps = 2/99 (2%)
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
LL +H +IHRD+K++N+LL + K+ DFG ++ + ++ + GT Y+
Sbjct: 153 LLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYV 212
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727
+PE +S K+D+FS GVL+ E++ K R F+ +
Sbjct: 213 APEIWRRKPYSKKADMFSLGVLLYELLTLK--RPFDGEN 249
|
Length = 496 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 53/198 (26%), Positives = 93/198 (46%), Gaps = 13/198 (6%)
Query: 525 LGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEV----LLIAKLQHRNLVKLL 579
+G+G FG V ++G+ AVK L K +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLH 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
++ + +++ L F R + + A IA L YLH +
Sbjct: 63 YSFQTTEKLYFVLDFVNGGEL---FFHLQRERSFPEPRARFYAAEIASALGYLHS---IN 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
I++RDLK N+LLD+ + ++DFGL + G+ Q++ T GT Y++PE +
Sbjct: 117 IVYRDLKPENILLDSQGHVVLTDFGLCKE-GIAQSDTTTT-FCGTPEYLAPEVIRKQPYD 174
Query: 700 VKSDVFSFGVLVLEIICG 717
D + G ++ E++ G
Sbjct: 175 NTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 2e-08
Identities = 44/144 (30%), Positives = 67/144 (46%), Gaps = 8/144 (5%)
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
LV L C L+ EY+ L +F R + L A I L +LH+
Sbjct: 58 LVGLHSCFQTTSRLFLVIEYVNGGDL---MFHMQRQRKLPEEHARFYAAEICIALNFLHE 114
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
II+RDLK NVLLD + K++D+G+ + GL + T GT Y++PE
Sbjct: 115 RG---IIYRDLKLDNVLLDADGHIKLTDYGMCKE-GLGPGD-TTSTFCGTPNYIAPEILR 169
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++ GVL+ E++ G+
Sbjct: 170 GEEYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 3e-08
Identities = 55/217 (25%), Positives = 99/217 (45%), Gaps = 36/217 (16%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL---LG 580
LG G G V+ + + + +AVK++ Q ++ E+ +I +L H N+VK+ LG
Sbjct: 13 LGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLG 72
Query: 581 CCTQRDERMLIYEYLPNKSLDYF--------IFDTTRSKLLDWSKRS--HI---IAGIAR 627
+ SL +T + +L+ S H + + R
Sbjct: 73 PSGSDLTEDV-------GSLTELNSVYIVQEYMETDLANVLEQGPLSEEHARLFMYQLLR 125
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEAN----TKRVV 682
GL Y+H + ++HRDLK +NV ++ + KI DFGLAR +D ++ ++ +V
Sbjct: 126 GLKYIHSAN---VLHRDLKPANVFINTEDLVLKIGDFGLARI--VDPHYSHKGYLSEGLV 180
Query: 683 GTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIICGK 718
+ Y SP + K+ D+++ G + E++ GK
Sbjct: 181 TKW-YRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 216
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 56.2 bits (135), Expect = 4e-08
Identities = 47/176 (26%), Positives = 85/176 (48%), Gaps = 18/176 (10%)
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606
KR+ GS + + +NE+L + +L H N++K+ + R Y+ + D+ ++
Sbjct: 198 KRVKAGS-RAAIQLENEILALGRLNHENILKI-----EEILRSEANTYMITQKYDFDLYS 251
Query: 607 TTRSKLLDWSKR------SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
+ DW R I+ + + Y+H ++IHRD+K N+ L+ +
Sbjct: 252 FMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDK---KLIHRDIKLENIFLNCDGKIVL 308
Query: 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPE-YAIDGLFSVKSDVFSFGVLVLEII 715
DFG A F + EA VGT SPE A DG + +D++S G+++L+++
Sbjct: 309 GDFGTAMPFE-KEREAFDYGWVGTVATNSPEILAGDGYCEI-TDIWSCGLILLDML 362
|
Length = 501 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 56.3 bits (136), Expect = 5e-08
Identities = 55/229 (24%), Positives = 98/229 (42%), Gaps = 49/229 (21%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKG-SGQGM--EEFKNEVLLIAKLQHRNLVKLL 579
+G+GG G VY + + +A+K++ + S + + F E + A L H +V +
Sbjct: 9 LIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVY 68
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLD--WSKRS---------------HII 622
C+ D +Y +P +I T LL W K S I
Sbjct: 69 SICSDGD---PVYYTMP------YIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIF 119
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE-----AN 677
I + Y+H S+ ++HRDLK N+LL I D+G A L++ + +
Sbjct: 120 HKICATIEYVH--SK-GVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVD 176
Query: 678 TK-----------RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ ++VGT YM+PE + S +D+++ GV++ +++
Sbjct: 177 ERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQML 225
|
Length = 932 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 6e-08
Identities = 56/211 (26%), Positives = 103/211 (48%), Gaps = 21/211 (9%)
Query: 521 EKNKLGEGGFGPVYKGMLIEGQE---IAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
E K+G G +G VYK +G++ A+K++ +G+G M + E+ L+ +L+H N++
Sbjct: 5 EGCKVGRGTYGHVYKAKRKDGKDDRDYALKQI-EGTGISMSACR-EIALLRELKHPNVIS 62
Query: 578 LLGCCTQRDERM--LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY---- 631
L +R L+++Y + + I R+ + K + G+ + LLY
Sbjct: 63 LQKVFLSHADRKVWLLFDYAEHDL--WHIIKFHRASKAN-KKPVQLPRGMVKSLLYQILD 119
Query: 632 -LHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSFGLD-QTEANTKRVVGTY 685
+H ++HRDLK +N+L+ KI+D G AR F + A+ VV T+
Sbjct: 120 GIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 179
Query: 686 GYMSPEYAIDGLFSVKS-DVFSFGVLVLEII 715
Y +PE + K+ D+++ G + E++
Sbjct: 180 WYRAPELLLGARHYTKAIDIWAIGCIFAELL 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 8e-08
Identities = 43/149 (28%), Positives = 65/149 (43%), Gaps = 15/149 (10%)
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLL 630
+ N +KL T +LI +Y+ + L FD + + L ++ II + L
Sbjct: 68 NPNFIKLYYSVTTLKGHVLIMDYIKDGDL----FDLLKKEGKLSEAEVKKIIRQLVEALN 123
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNP-KISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
LH + IIH D+K NVL D + + D+GL + G GT Y S
Sbjct: 124 DLH---KHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTPSCYD------GTLDYFS 174
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
PE + V D ++ GVL E++ GK
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGK 203
|
Length = 267 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 33/113 (29%), Positives = 54/113 (47%), Gaps = 13/113 (11%)
Query: 605 FDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
FD +R++ A L L + +I+RDLK N+LLD + + DFG
Sbjct: 90 FDLSRARFY-----------TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFG 138
Query: 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
L + D + NT GT Y++PE + ++ D ++ GVL+ E++ G
Sbjct: 139 LCKLNMKDDDKTNT--FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTG 189
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 54.1 bits (130), Expect = 1e-07
Identities = 45/143 (31%), Positives = 72/143 (50%), Gaps = 13/143 (9%)
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
L C Q + R+ + E++ L +F R + L A I+ L +LH+
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL---MFHMQRQRKLPEEHARFYSAEISLALNFLHERG- 116
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY--AID 695
II+RDLK NVLLD + K++D+G+ + G+ + T GT Y++PE D
Sbjct: 117 --IIYRDLKLDNVLLDAEGHIKLTDYGMCKE-GIRPGDT-TSTFCGTPNYIAPEILRGED 172
Query: 696 GLFSVKSDVFSFGVLVLEIICGK 718
FSV D ++ GVL+ E++ G+
Sbjct: 173 YGFSV--DWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 53.2 bits (128), Expect = 2e-07
Identities = 33/97 (34%), Positives = 49/97 (50%), Gaps = 6/97 (6%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF--GLDQTEANTKRVV 682
I GL Y+H + ++HRDLK N+L++ KI DFGLAR F + V
Sbjct: 114 ILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170
Query: 683 GTYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIICGK 718
T Y +PE + K+ DV+S G ++ E++ K
Sbjct: 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 63/239 (26%), Positives = 103/239 (43%), Gaps = 22/239 (9%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKR 548
+K+ N N E + ++ + +++ +G G FG V Q++ A+K
Sbjct: 16 RKNKNIDNFLNRYEKIVRKIRKLQMKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKL 75
Query: 549 LSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI- 604
LSK + F E I + V L C Q D+ + ++ EY+P L +
Sbjct: 76 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMS 135
Query: 605 -FDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
+D W+K A +L L + +IHRD+K N+LLD + K++DF
Sbjct: 136 NYDVPEK----WAKFY-----TAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADF 186
Query: 664 GLARSFGLDQT-EANTKRVVGTYGYMSPEY----AIDGLFSVKSDVFSFGVLVLEIICG 717
G +D+T VGT Y+SPE DG + + D +S GV + E++ G
Sbjct: 187 GTC--MKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 2e-07
Identities = 54/198 (27%), Positives = 90/198 (45%), Gaps = 13/198 (6%)
Query: 525 LGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEV----LLIAKLQHRNLVKLL 579
+G+G FG V +G AVK L K + +E + + +L+ L+H LV L
Sbjct: 3 IGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLH 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
++ + +Y+ L F R + + A +A + YLH L
Sbjct: 63 YSFQTAEKLYFVLDYVNGGEL---FFHLQRERCFLEPRARFYAAEVASAIGYLHS---LN 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
II+RDLK N+LLD+ + ++DFGL + G++ E T GT Y++PE +
Sbjct: 117 IIYRDLKPENILLDSQGHVVLTDFGLCKE-GVEP-EETTSTFCGTPEYLAPEVLRKEPYD 174
Query: 700 VKSDVFSFGVLVLEIICG 717
D + G ++ E++ G
Sbjct: 175 RTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 53.1 bits (127), Expect = 3e-07
Identities = 59/245 (24%), Positives = 101/245 (41%), Gaps = 31/245 (12%)
Query: 481 FIGGLMYRRKKHSN---QGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM 537
F+ L +KK S+ + K +M+ ++F+ LG G FG V
Sbjct: 3 FLKNLQLHKKKDSDSTKEPKRKNKMKY------------EDFNFIRTLGTGSFGRVILAT 50
Query: 538 LIEGQ--EIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592
+A+KR K + ++ +E ++ + H V L G L+
Sbjct: 51 YKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVL 110
Query: 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652
E++ ++F F R+K A I YL L I++RDLK N+LL
Sbjct: 111 EFVIGG--EFFTF-LRRNKRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLL 164
Query: 653 DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVL 712
D K++DFG A+ + T + GT Y++PE ++ +D ++ G+ +
Sbjct: 165 DKDGFIKMTDFGFAKV-----VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIY 219
Query: 713 EIICG 717
EI+ G
Sbjct: 220 EILVG 224
|
Length = 340 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 55/200 (27%), Positives = 91/200 (45%), Gaps = 17/200 (8%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKNEV----LLIAKLQHRNLVKLL 579
+G+G FG V ++ AVK L K + +E K+ + +L+ ++H LV L
Sbjct: 3 IGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLH 62
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
D+ + +Y+ L Y + R + + A IA L YLH L
Sbjct: 63 FSFQTADKLYFVLDYINGGELFYHL---QRERCFLEPRARFYAAEIASALGYLHS---LN 116
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN--TKRVVGTYGYMSPEYAIDGL 697
I++RDLK N+LLD+ + ++DFGL + + E N T GT Y++PE
Sbjct: 117 IVYRDLKPENILLDSQGHIVLTDFGLCK----ENIEHNGTTSTFCGTPEYLAPEVLHKQP 172
Query: 698 FSVKSDVFSFGVLVLEIICG 717
+ D + G ++ E++ G
Sbjct: 173 YDRTVDWWCLGAVLYEMLYG 192
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 4e-07
Identities = 38/156 (24%), Positives = 70/156 (44%), Gaps = 8/156 (5%)
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
E ++ + H ++++L G T LI LP D + + + + + I
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLI---LPRYKTDLYCYLAAKRNIAICDILA-IE 188
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+ R + YLH++ RIIHRD+KA N+ +++ + + DFG A F +D
Sbjct: 189 RSVLRAIQYLHEN---RIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINANKYYGWA 244
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
GT +PE + D++S G+++ E+
Sbjct: 245 GTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 7e-07
Identities = 57/217 (26%), Positives = 96/217 (44%), Gaps = 32/217 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEE---FKNEVLLIAKLQH 572
++F +G G FG V +++ A+K LSK + F E ++A
Sbjct: 43 EDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANS 102
Query: 573 RNLVKLLGCCTQRDERML--IYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGI 625
+V+L +D++ L + EY+P L +Y I + W++ A +
Sbjct: 103 EWIVQL--HYAFQDDKYLYMVMEYMPGGDLVNLMSNYDIPE-------KWAR--FYTAEV 151
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD-QTEANTKRVVGT 684
L +H + IHRD+K N+LLD + + K++DFG + +T VGT
Sbjct: 152 VLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDT--AVGT 206
Query: 685 YGYMSPEY----AIDGLFSVKSDVFSFGVLVLEIICG 717
Y+SPE DG + + D +S GV + E++ G
Sbjct: 207 PDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 51.8 bits (124), Expect = 7e-07
Identities = 45/186 (24%), Positives = 76/186 (40%), Gaps = 18/186 (9%)
Query: 546 VKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
VK ++ G G E+ ++ + HR ++ L+ + ++ +P D F +
Sbjct: 124 VKAVTGGKTPG-----REIDILKTISHRAIINLIHAYRWKSTVCMV---MPKYKCDLFTY 175
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
RS L + I + L YLH IIHRD+K N+ LD N + DFG
Sbjct: 176 -VDRSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGA 231
Query: 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI------ICGKK 719
A GT SPE + K+D++S G+++ E+ + GK+
Sbjct: 232 ACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291
Query: 720 NRGFNH 725
+ +
Sbjct: 292 VKSSSS 297
|
Length = 392 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 34/99 (34%), Positives = 54/99 (54%), Gaps = 6/99 (6%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
IA +L +H +L +HRD+K NVLLD + +++DFG D T + VGT
Sbjct: 108 IAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGT 166
Query: 685 YGYMSPEY--AID---GLFSVKSDVFSFGVLVLEIICGK 718
Y+SPE A++ G + + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 50/210 (23%), Positives = 91/210 (43%), Gaps = 29/210 (13%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIA---VKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
++G G FG V + +A VK L + S + EF + LQH N+++ L
Sbjct: 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCL 61
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS-------HIIAGIARGLLYL 632
G C + +L++EY L ++ W +R+ + IA G+ ++
Sbjct: 62 GQCVEAIPYLLVFEYCELGDLKSYLSQE------QWHRRNSQLLLLQRMACEIAAGVTHM 115
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKRVVGTYGYMSPE 691
H + +H DL N L + + K+ D+G+ S + D E + V +++PE
Sbjct: 116 H---KHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCV-PLRWLAPE 171
Query: 692 YAI---DGLFSVK----SDVFSFGVLVLEI 714
GL + + S+V++ GV + E+
Sbjct: 172 LVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 50.5 bits (121), Expect = 2e-06
Identities = 35/97 (36%), Positives = 47/97 (48%), Gaps = 10/97 (10%)
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR-SFGLDQTEANTKRVVGTY 685
R L Y+H + + HRDLK N+L + KI DFGLAR +F T V T
Sbjct: 114 RALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170
Query: 686 GYMSPEYAIDGLFSVKS----DVFSFGVLVLEIICGK 718
Y +PE G F K D++S G + E++ GK
Sbjct: 171 WYRAPELC--GSFFSKYTPAIDIWSIGCIFAEVLTGK 205
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 3e-06
Identities = 42/156 (26%), Positives = 75/156 (48%), Gaps = 4/156 (2%)
Query: 561 KNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRS 619
++E+ +A H +VK D+ +LI EY L+ I + L +
Sbjct: 113 RSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVG 172
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
+ I L +H SR +++HRDLK++N+ L T K+ DFG ++ + +
Sbjct: 173 LLFYQIVLALDEVH--SR-KMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVAS 229
Query: 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
GT Y++PE +S K+D++S GV++ E++
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELL 265
|
Length = 478 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 50.1 bits (119), Expect = 4e-06
Identities = 62/229 (27%), Positives = 100/229 (43%), Gaps = 42/229 (18%)
Query: 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN-----EVLLIAKLQHRNLVKL 578
K+G G FG V+ QE + S +G++E + EV ++ +L+H+N+V+
Sbjct: 20 KIGNGRFGEVFLVKHKRTQEFFCWKAI--SYRGLKEREKSQLVIEVNVMRELKHKNIVRY 77
Query: 579 LGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL----YL 632
+ + + L + E+ L I + + H I I R LL Y
Sbjct: 78 IDRFLNKANQKLYILMEFCDAGDLSRNI---QKCYKMFGKIEEHAIVDITRQLLHALAYC 134
Query: 633 HQ----DSRLRIIHRDLKASNVLLD-------------NTMN----PKISDFGLARSFGL 671
H + R++HRDLK N+ L N +N KI DFGL+++ G+
Sbjct: 135 HNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGI 194
Query: 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSV--KSDVFSFGVLVLEIICGK 718
E+ VGT Y SPE + S KSD+++ G ++ E+ GK
Sbjct: 195 ---ESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGK 240
|
Length = 1021 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.5 bits (116), Expect = 6e-06
Identities = 60/243 (24%), Positives = 94/243 (38%), Gaps = 66/243 (27%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLVKLL 579
+G G FG V + I A+K+L K Q + + E ++A+ + +VKL
Sbjct: 9 IGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQ-VAHVRAERDILAEADNPWVVKLY 67
Query: 580 GCCTQRDER--MLIYEYLPNKSL-------DYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+ +DE LI EYLP + D F + TR IA +L
Sbjct: 68 --YSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFY-------------IAETIL 112
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG----------LDQTEANTKR 680
+ +L IHRD+K N+LLD + K+SDFGL L +
Sbjct: 113 AIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFL 172
Query: 681 --------------------------VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
VGT Y++PE + ++ + D +S GV++ E+
Sbjct: 173 DFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEM 232
Query: 715 ICG 717
+ G
Sbjct: 233 LVG 235
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 7e-06
Identities = 32/150 (21%), Positives = 54/150 (36%), Gaps = 15/150 (10%)
Query: 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV--K 577
S L G VY + + +K S + + + EV ++ L + L K
Sbjct: 1 SSIKLLKGGLTNRVYLLGTKDE-DYVLKI--NPSREKGADREREVAILQLLARKGLPVPK 57
Query: 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
+L L+ E++ ++LD + +A L LHQ
Sbjct: 58 VLASGESDGWSYLLMEWIEGETLDEVSEEEKEDIAEQ----------LAELLAKLHQLPL 107
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
L + H DL N+L+D+ I D+ A
Sbjct: 108 LVLCHGDLHPGNILVDDGKILGIIDWEYAG 137
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
| >gnl|CDD|238074 cd00129, PAN_APPLE, PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 1e-05
Identities = 23/84 (27%), Positives = 34/84 (40%), Gaps = 13/84 (15%)
Query: 366 CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKN---CSCTAYANADVRGRGSGC 422
CK L A+K+ T+ T EC C KN SC A+ A R C
Sbjct: 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKARK---QC 55
Query: 423 LLW-FHDLIDIKELPESGQDLFIR 445
L + F+ + +++ G DL+
Sbjct: 56 LWFPFNSMSGVRKEFSHGFDLYEN 79
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. Length = 80 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 1e-05
Identities = 21/46 (45%), Positives = 31/46 (67%), Gaps = 3/46 (6%)
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
I+ +A L YLH+ IIHRDLK N+L+ N + K++DFGL++
Sbjct: 110 ISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 28/81 (34%), Positives = 42/81 (51%), Gaps = 5/81 (6%)
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY----AIDG 696
IHRD+K N+LLD + + K++DFG + VGT Y+SPE DG
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDG 222
Query: 697 LFSVKSDVFSFGVLVLEIICG 717
+ + D +S GV + E++ G
Sbjct: 223 YYGRECDWWSVGVFLYEMLVG 243
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 2e-05
Identities = 32/99 (32%), Positives = 53/99 (53%), Gaps = 6/99 (6%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+A +L + +L +HRD+K NVLLD + +++DFG D T + VGT
Sbjct: 108 LAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT-VQSNVAVGT 166
Query: 685 YGYMSPEY--AID---GLFSVKSDVFSFGVLVLEIICGK 718
Y+SPE A++ G + + D +S GV + E++ G+
Sbjct: 167 PDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-05
Identities = 42/184 (22%), Positives = 78/184 (42%), Gaps = 21/184 (11%)
Query: 544 IAVKRLSKGSGQGMEEFK---NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600
+AVK+++ S E+ K E++ +LQH N++ + E ++ + S
Sbjct: 28 VAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSC 86
Query: 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
+ + T + L + I+ + L Y+H IHR +KAS++LL +
Sbjct: 87 EDLL-KTHFPEGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVL 142
Query: 661 SDFGLARSFGLDQTEANTKRVVGTYG--------YMSPEYAIDGL--FSVKSDVFSFGVL 710
S + S +RVV + ++SPE L ++ KSD++S G+
Sbjct: 143 SGLRYSVSM---IKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGIT 199
Query: 711 VLEI 714
E+
Sbjct: 200 ACEL 203
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 18/103 (17%)
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL--------------DQT 674
L YLH I+HRDLK N+L+ + + K++DFGL++ GL D
Sbjct: 114 LEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSK-IGLMSLTTNLYEGHIEKDTR 169
Query: 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
E K+V GT Y++PE + + D ++ G+++ E + G
Sbjct: 170 EFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVG 212
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 3e-05
Identities = 64/265 (24%), Positives = 97/265 (36%), Gaps = 85/265 (32%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
++F +G+G FG V L++ G+ A+K L K E FK + L K +
Sbjct: 1 EDFHTVKVIGKGAFGEV---RLVQKKDTGKIYAMKTLLKS-----EMFKKDQLAHVKAER 52
Query: 573 RNL--------VKLLGCCTQRDERMLIYEYLPNKSL-------DYFIFDTTRSKLLDWSK 617
L V L LI E+LP L D F D TR
Sbjct: 53 DVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFY------ 106
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-------- 669
+A +L + +L IHRD+K N+L+D + K+SDFGL+ F
Sbjct: 107 -------MAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAY 159
Query: 670 --GLDQTEANTKRV-----------------------------------VGTYGYMSPEY 692
L Q ++N R+ VGT Y++PE
Sbjct: 160 YQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEI 219
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICG 717
+ + + D +S G ++ E + G
Sbjct: 220 FLQQGYGQECDWWSLGAIMFECLIG 244
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 60/241 (24%), Positives = 97/241 (40%), Gaps = 49/241 (20%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEE---FKNEVLLIAK 569
++F +G G FG V L++ G A+K L K E+ + E ++ +
Sbjct: 1 EDFESLKVIGRGAFGEV---RLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVE 57
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
+VK+ + LI E+LP + + + L + IA +
Sbjct: 58 ADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLM---KKDTLTEEETQFYIAETVLAI 114
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA----------------RSFGLDQ 673
+HQ L IHRD+K N+LLD+ + K+SDFGL S D
Sbjct: 115 DSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDF 171
Query: 674 T--EANTKR---------------VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC 716
T N+KR VGT Y++PE + ++ D +S GV++ E++
Sbjct: 172 TFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 717 G 717
G
Sbjct: 232 G 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 4e-05
Identities = 60/241 (24%), Positives = 95/241 (39%), Gaps = 49/241 (20%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEE---FKNEVLLIAK 569
D+F +G G FG V L++ G A+K L K E+ + E ++ +
Sbjct: 1 DDFESLKVIGRGAFGEV---RLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVE 57
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
+VK+ + LI E+LP + + + L IA +
Sbjct: 58 ADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLM---KKDTLSEEATQFYIAETVLAI 114
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-GLDQTE------------- 675
+HQ L IHRD+K N+LLD + K+SDFGL +TE
Sbjct: 115 DAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDF 171
Query: 676 ----ANTKR---------------VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC 716
N+KR VGT Y++PE + ++ D +S GV++ E++
Sbjct: 172 SFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLI 231
Query: 717 G 717
G
Sbjct: 232 G 232
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 64/296 (21%), Positives = 109/296 (36%), Gaps = 43/296 (14%)
Query: 452 DNVERRRQSKNKKQVMIIITSISLATAVIFIGGLMYRRKKHSNQGNEKEEMELPIFDLKI 511
+ + K T + T + +KK + E F + +
Sbjct: 61 ETATSTDSGRTKSHEGAATTKQATTTPTTNVEVAPPPKKKKVTYALPNQSREEGHFYVVL 120
Query: 512 ---IANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIA 568
I +T F + LGEG FG V + + +E ++ + + + K E+ +
Sbjct: 121 GEDIDVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFME 180
Query: 569 KLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK-LLDW-------SKR-- 618
K++ + R M I Y N++ I LLDW S R
Sbjct: 181 KVRQADP-------ADRFPLMKIQRYFQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHL 233
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNP-------------KISD 662
+ II L Y H + L ++H DLK N+L+ D ++P +I D
Sbjct: 234 AQIIFQTGVALDYFH--TELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICD 291
Query: 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
G D+ + T +V T Y SPE + + +D++S G ++ E+ GK
Sbjct: 292 LGGC----CDERHSRTA-IVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGK 342
|
Length = 467 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 28/87 (32%), Positives = 48/87 (55%), Gaps = 6/87 (6%)
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY--AI 694
+L +HRD+K N+L+D + +++DFG D T + VGT Y+SPE A+
Sbjct: 120 QLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTPDYISPEILQAM 178
Query: 695 D---GLFSVKSDVFSFGVLVLEIICGK 718
+ G + + D +S GV + E++ G+
Sbjct: 179 EDGKGKYGPECDWWSLGVCMYEMLYGE 205
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 3e-04
Identities = 39/181 (21%), Positives = 78/181 (43%), Gaps = 22/181 (12%)
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG----CCTQRDERMLIYEYLPNKSLDY 602
K+ KG ++ +NE+ + ++ N++K+ G LI EY L
Sbjct: 52 KKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLRE 111
Query: 603 FIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKIS 661
+ + K L + + + +GL L++ ++ +++L + + L+ KI
Sbjct: 112 VL---DKEKDLSFKTKLDMAIDCCKGLYNLYKYTNK---PYKNLTSVSFLVTENYKLKII 165
Query: 662 DFGLARSFGLDQTEANTK-RVVGTYGYMSPEYAIDGLFS---VKSDVFSFGVLVLEIICG 717
GL++ ++ + V Y S + D +FS +K D++S GV++ EI G
Sbjct: 166 ------CHGLEKILSSPPFKNVNFMVYFSYKMLND-IFSEYTIKDDIYSLGVVLWEIFTG 218
Query: 718 K 718
K
Sbjct: 219 K 219
|
Length = 283 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-04
Identities = 36/113 (31%), Positives = 54/113 (47%), Gaps = 26/113 (23%)
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA---N 677
I+ G RGL YLHQ+ IHR++KAS++L IS GL GL + N
Sbjct: 106 ILFGALRGLNYLHQNG---YIHRNIKASHIL--------ISGDGLVSLSGLSHLYSLVRN 154
Query: 678 TKRVVGTYGY----------MSPEYAIDGL--FSVKSDVFSFGVLVLEIICGK 718
++ Y + +SPE L ++VKSD++S G+ E+ G+
Sbjct: 155 GQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 8e-04
Identities = 44/179 (24%), Positives = 73/179 (40%), Gaps = 36/179 (20%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSGQGMEEFKNEVLL----- 566
D+F KLGEG FG VYK L+ + +K+ + G +E + NE +
Sbjct: 132 DDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKK-ATEYGA-VEIWMNERVRRACPN 189
Query: 567 -IAKLQHRNLVKLLGCCTQRDERMLIYEY---------LPNKSLDY----FIFDTTRSKL 612
A + L + + DE L++ Y + +K Y ++ +
Sbjct: 190 SCADFVYGFLEPVSS--KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLP 247
Query: 613 LDWSKRSHIIAGIARGLLY----LHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLA 666
+ + II I R +L+ LH I+HRD+K N++ + + KI D G A
Sbjct: 248 KGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVKPQNIIFSEGSGSFKIIDLGAA 303
|
Length = 566 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.1 bits (97), Expect = 0.001
Identities = 57/236 (24%), Positives = 90/236 (38%), Gaps = 57/236 (24%)
Query: 524 KLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEE--------FKNEVLLIAKLQ 571
LG+G G V+ L+ G+ A+K L K M + + E+L A L
Sbjct: 8 LLGKGDVGRVF---LVRLKGTGKLFALKVLDKKE---MIKRNKVKRVLTEQEIL--ATLD 59
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H L L L+ +Y P L + + K L A + L Y
Sbjct: 60 HPFLPTLYASFQTETYLCLVMDYCPGGEL-FRLLQRQPGKCLSEEVARFYAAEVLLALEY 118
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS----------------------- 668
LH L I++RDLK N+LL + + +SDF L++
Sbjct: 119 LHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNS 175
Query: 669 ----FGLDQTEANTKRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIICG 717
++ + VGT Y++PE I G +V D ++ G+L+ E++ G
Sbjct: 176 IPSETFSEEPSFRSNSFVGTEEYIAPE-VISGDGHGSAV--DWWTLGILLYEMLYG 228
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 32/123 (26%), Positives = 56/123 (45%), Gaps = 11/123 (8%)
Query: 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL----YLHQDSRLRIIHRDLKASNV 650
LP D + + R + L ++ + +AR LL Y+H + IIHRD+K NV
Sbjct: 239 LPKYRSDLYTYLGARLRPLGLAQ----VTAVARQLLSAIDYIHGEG---IIHRDIKTENV 291
Query: 651 LLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
L++ + + DFG A + + GT +PE ++ D++S G++
Sbjct: 292 LVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLV 351
Query: 711 VLE 713
+ E
Sbjct: 352 IFE 354
|
Length = 461 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 0.004
Identities = 40/158 (25%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
L++++ H +L + G C + E +++ E++ + LD + + W + + +
Sbjct: 69 LMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAW--KITVAQQL 126
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLL------DNTMNP--KISDFGLARSFGLDQTEAN 677
A L YL + ++H ++ A N+LL + T P K+SD G+ SF E
Sbjct: 127 ASALSYLEDKN---LVHGNVCAKNILLARLGLAEGTS-PFIKLSDPGV--SFTALSREER 180
Query: 678 TKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEI 714
+R+ +++PE G S +D +SFG +LEI
Sbjct: 181 VERI----PWIAPECVPGGNSLSTAADKWSFGTTLLEI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 39.6 bits (92), Expect = 0.004
Identities = 52/249 (20%), Positives = 96/249 (38%), Gaps = 55/249 (22%)
Query: 519 FSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNEVLLIAKLQHRN 574
F + LG G FG V ++ + A+K L K + + K E ++A+ +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEW 62
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VKL +D + +Y+P + + R ++ IA + + +H
Sbjct: 63 VVKLYYSFQDKDNLYFVMDYIPGGDMMSLLI---RMEVFPEVLARFYIAELTLAIESVH- 118
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF------------------------- 669
++ IHRD+K N+L+D + K++DFGL F
Sbjct: 119 --KMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDL 176
Query: 670 -----------GLDQTEANTKR---------VVGTYGYMSPEYAIDGLFSVKSDVFSFGV 709
L E + +VGT Y++PE + ++ D +S GV
Sbjct: 177 WDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236
Query: 710 LVLEIICGK 718
++ E++ G+
Sbjct: 237 ILFEMLVGQ 245
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 738 | |||
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.98 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.98 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.98 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.98 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.98 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.98 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.98 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.98 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.98 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.98 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.98 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.98 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.98 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.98 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.98 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.98 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.98 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.98 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.98 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.97 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.97 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.97 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.97 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.97 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.97 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.97 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.97 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.97 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.97 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.97 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.97 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.97 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.97 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.97 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.97 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.97 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.97 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.97 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.97 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.97 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.97 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.97 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.97 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.97 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.97 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.97 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.97 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.97 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.97 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.97 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.97 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.97 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.97 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.97 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.97 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.97 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.97 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.97 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.97 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.97 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.97 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.97 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.97 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.97 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.97 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.97 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.97 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.97 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.97 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.97 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.97 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.97 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.97 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.97 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.97 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.97 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.97 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.97 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.97 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.97 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.97 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.97 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.97 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.97 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.96 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.96 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.96 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.96 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.96 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.96 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.96 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.96 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.96 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.96 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.96 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.96 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.96 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.96 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.96 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.96 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.96 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.96 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.96 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.96 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.96 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.96 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.96 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.96 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.96 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.96 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.96 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.96 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.96 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.96 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.96 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.96 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.96 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.96 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.96 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.96 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.96 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.96 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.96 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.96 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.96 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.96 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.96 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.96 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.96 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.96 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.96 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.96 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.96 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.96 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.96 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.96 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.96 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.96 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.96 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.96 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.96 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.95 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.95 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.95 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.95 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.95 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 99.95 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.95 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.95 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.95 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.95 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.95 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.95 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.95 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.95 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.95 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.95 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.95 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.95 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.95 | |
| PF00954 | 110 | S_locus_glycop: S-locus glycoprotein family; Inter | 99.95 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.95 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.95 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.95 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.95 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.95 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.95 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.95 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.94 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.94 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.94 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.94 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.94 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.94 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.94 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.93 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.93 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.92 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.92 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 99.92 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.91 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.91 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.89 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.89 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.89 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.89 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.88 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.87 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.87 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.87 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.84 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.82 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.82 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.81 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.79 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.79 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.76 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.76 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.74 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.73 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.72 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.7 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.69 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.68 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.68 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.66 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.66 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.66 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.65 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.64 | |
| PF08276 | 66 | PAN_2: PAN-like domain; InterPro: IPR013227 PAN do | 99.62 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.6 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.57 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.56 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.5 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.5 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.5 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.49 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.43 | |
| cd00129 | 80 | PAN_APPLE PAN/APPLE-like domain; present in N-term | 99.4 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.39 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.39 | |
| cd01098 | 84 | PAN_AP_plant Plant PAN/APPLE-like domain; present | 99.27 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.24 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.18 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.08 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.07 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.06 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.02 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.01 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.86 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.76 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.75 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.72 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 98.71 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.7 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.48 | |
| smart00108 | 114 | B_lectin Bulb-type mannose-specific lectin. | 98.46 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.46 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.45 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.44 | |
| cd00028 | 116 | B_lectin Bulb-type mannose-specific lectin. The do | 98.4 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.32 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.29 | |
| smart00473 | 78 | PAN_AP divergent subfamily of APPLE domains. Apple | 98.25 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.1 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.06 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.01 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 98.01 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.01 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.99 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.94 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.82 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 97.8 | |
| PF01453 | 114 | B_lectin: D-mannose binding lectin; InterPro: IPR0 | 97.75 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.72 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.72 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.67 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.62 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.61 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.58 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 97.55 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.4 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.29 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.27 | |
| PLN02236 | 344 | choline kinase | 96.82 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 96.71 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 96.71 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.62 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 96.38 | |
| cd01100 | 73 | APPLE_Factor_XI_like Subfamily of PAN/APPLE-like d | 96.32 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.28 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 96.23 | |
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.23 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 96.1 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.97 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 95.89 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.87 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 95.86 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.82 |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-45 Score=390.08 Aligned_cols=230 Identities=48% Similarity=0.808 Sum_probs=201.1
Q ss_pred ccCccCHHHHHHhcCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEE
Q 004674 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (738)
Q Consensus 503 ~~~~~~~~~l~~~~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~ 582 (738)
....|++.++..+|++|+..+.||+|+||.||+|.+.++..||||++.....+..++|.+|+.++.+++|||+|+|+|||
T Consensus 61 ~~~~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 61 PLRSFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQGEREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred CcceeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcchhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 45679999999999999999999999999999999999999999988765443156699999999999999999999999
Q ss_pred ecCC-cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEE
Q 004674 583 TQRD-ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (738)
Q Consensus 583 ~~~~-~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~ 661 (738)
.+.+ +++||||||++|+|.++++..... +++|.+|++||.++|+||+|||+...++||||||||+|||||+++++||+
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~-~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKls 219 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE-PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLS 219 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC-CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEcc
Confidence 9999 599999999999999999875444 89999999999999999999999988899999999999999999999999
Q ss_pred eecCccccCCCccccccccc-ccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCCccccc
Q 004674 662 DFGLARSFGLDQTEANTKRV-VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGH 735 (738)
Q Consensus 662 DFGla~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~ 735 (738)
|||+|+..... ....... .||.+|+|||++..+..+.|+|||||||+|+||++|+++.+...+....+++.+
T Consensus 220 DFGLa~~~~~~--~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w 292 (361)
T KOG1187|consen 220 DFGLAKLGPEG--DTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEW 292 (361)
T ss_pred CccCcccCCcc--ccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHH
Confidence 99999654321 1111112 799999999999999999999999999999999999999887654444455544
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=355.04 Aligned_cols=202 Identities=31% Similarity=0.525 Sum_probs=180.8
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
..+|...+.||+|+||+||+|++.. +.+||||.+.+. .....+.+..|+++|+.++|||||++++++...+..+|||
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVM 88 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVM 88 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEE
Confidence 3678888889999999999999865 789999998765 4556677889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC------CceEEEeecCc
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT------MNPKISDFGLA 666 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~------~~vkL~DFGla 666 (738)
|||.+|+|.+++.. .+.+++...+.++.|||.||++||+++ ||||||||+||||+.. -.+||+|||+|
T Consensus 89 EyC~gGDLs~yi~~---~~~l~e~t~r~Fm~QLA~alq~L~~~~---IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 89 EYCNGGDLSDYIRR---RGRLPEATARHFMQQLASALQFLHENN---IIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EeCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999954 446999999999999999999999998 9999999999999754 46899999999
Q ss_pred cccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
+.+.. .......||++-|||||++....|+.|+|+||+|+||||+++|+.||+....
T Consensus 163 R~L~~---~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 163 RFLQP---GSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhCCc---hhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 98763 3334558999999999999999999999999999999999999999985543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=331.63 Aligned_cols=204 Identities=30% Similarity=0.451 Sum_probs=182.8
Q ss_pred hcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
..++|+.++.||+|+||.||.++..+ ++.+|+|++++.. ....+..++|..+|.+++||.||+++-.+++++..||
T Consensus 23 ~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLyl 102 (357)
T KOG0598|consen 23 GPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYL 102 (357)
T ss_pred ChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEE
Confidence 35789999999999999999999765 7889999997652 2346778999999999999999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
|+||+.||.|..+|. +++.+++..+.-++.+|+.||.|||+.+ ||||||||+|||||++|+++|+|||+++...
T Consensus 103 Vld~~~GGeLf~hL~---~eg~F~E~~arfYlaEi~lAL~~LH~~g---IiyRDlKPENILLd~~GHi~LtDFgL~k~~~ 176 (357)
T KOG0598|consen 103 VLDYLNGGELFYHLQ---REGRFSEDRARFYLAEIVLALGYLHSKG---IIYRDLKPENILLDEQGHIKLTDFGLCKEDL 176 (357)
T ss_pred EEeccCCccHHHHHH---hcCCcchhHHHHHHHHHHHHHHHHHhCC---eeeccCCHHHeeecCCCcEEEeccccchhcc
Confidence 999999999999984 4567999999999999999999999998 9999999999999999999999999998643
Q ss_pred CCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
.. ...+..++||+.|||||++.+..|+..+|.||+|+++|||++|.+||...+.
T Consensus 177 ~~--~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 177 KD--GDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred cC--CCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 32 2234458999999999999999999999999999999999999999987653
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=347.83 Aligned_cols=202 Identities=30% Similarity=0.457 Sum_probs=184.1
Q ss_pred CCCCccceecccccEeEEEeee-ccccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~-~~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
..|+..+.||+|+|+.||+++. ..|..||+|++.+. .....+...+||++.+.|+|||||+++++|++.+..|||.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5688899999999999999997 67999999999763 3345678899999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
|.|++++|..++. +.+++++.+++.++.||+.||.|||+++ |+|||||..|++|+++.++||+|||+|..+..+
T Consensus 98 ELC~~~sL~el~K---rrk~ltEpEary~l~QIv~GlkYLH~~~---IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~ 171 (592)
T KOG0575|consen 98 ELCHRGSLMELLK---RRKPLTEPEARYFLRQIVEGLKYLHSLG---IIHRDLKLGNLFLNENMNVKIGDFGLATQLEYD 171 (592)
T ss_pred EecCCccHHHHHH---hcCCCCcHHHHHHHHHHHHHHHHHHhcC---ceecccchhheeecCcCcEEecccceeeeecCc
Confidence 9999999998883 5678999999999999999999999998 999999999999999999999999999988654
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
.. .....|||+.|+|||++....++..+||||+|||+|-|++|++||+...-
T Consensus 172 ~E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~v 223 (592)
T KOG0575|consen 172 GE--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTV 223 (592)
T ss_pred cc--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchH
Confidence 33 34458999999999999999999999999999999999999999987543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=342.59 Aligned_cols=201 Identities=36% Similarity=0.596 Sum_probs=175.1
Q ss_pred ccceecccccEeEEEeeeccccEEEEEEccCCCCc--chHHHHHHHHHHhHhcCCCeeeEEeEEecCC-cceEEEeeCCC
Q 004674 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ--GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-ERMLIYEYLPN 597 (738)
Q Consensus 521 ~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-~~~lV~Ey~~~ 597 (738)
..+.||+|+||+||+|.+.....||+|++...... ..++|.+|+.+|.+++|||||+++|+|.+.. ..++|||||++
T Consensus 45 ~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~ 124 (362)
T KOG0192|consen 45 IEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDESRKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPG 124 (362)
T ss_pred hhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCC
Confidence 34569999999999999965555999999754322 2569999999999999999999999999988 79999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-ceEEEeecCccccCCCcccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGla~~~~~~~~~~ 676 (738)
|+|..+++.. +...+++..+++++.+||+||.|||+++. ||||||||+|||++.+. ++||+|||+++...... .
T Consensus 125 GsL~~~l~~~-~~~~l~~~~~l~~aldiArGm~YLH~~~~--iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~ 199 (362)
T KOG0192|consen 125 GSLSVLLHKK-RKRKLPLKVRLRIALDIARGMEYLHSEGP--IIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--T 199 (362)
T ss_pred CcHHHHHhhc-ccCCCCHHHHHHHHHHHHHHHHHHhcCCC--eeecccChhhEEEcCCCCEEEECCCccceeecccc--c
Confidence 9999999764 45689999999999999999999999873 99999999999999997 99999999998764322 2
Q ss_pred cccccccccCccchhccc--CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAI--DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~--~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
......||+.|||||++. ...|+.|+||||||++||||+||+.||....+
T Consensus 200 ~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 200 SMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred cccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 233368999999999999 56999999999999999999999999986553
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=324.17 Aligned_cols=198 Identities=30% Similarity=0.410 Sum_probs=175.8
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCC-CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC-cceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-ERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-~~~lV~Ey 594 (738)
+++..+.||+|..|+|||+.++. ++.+|+|.+... .....+++.+|++++++.+||+||+++|.|..+. ...|+|||
T Consensus 80 dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEY 159 (364)
T KOG0581|consen 80 DLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEY 159 (364)
T ss_pred HhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhh
Confidence 44556789999999999999875 778999998544 3445678999999999999999999999999998 49999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
|++|+|+.++... +.+++...-+++.+|++||.|||+.. +||||||||+|||++..|+|||+|||.+..+...
T Consensus 160 MDgGSLd~~~k~~---g~i~E~~L~~ia~~VL~GL~YLh~~~--~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS-- 232 (364)
T KOG0581|consen 160 MDGGSLDDILKRV---GRIPEPVLGKIARAVLRGLSYLHEER--KIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS-- 232 (364)
T ss_pred cCCCCHHHHHhhc---CCCCHHHHHHHHHHHHHHHHHHhhcc--CeeeccCCHHHeeeccCCCEEeccccccHHhhhh--
Confidence 9999999998543 56899999999999999999999632 4999999999999999999999999999876533
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.....+||..|||||.+.+..|+.++||||||+.++|+.+|+-|+...
T Consensus 233 --~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 233 --IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred --hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 344589999999999999999999999999999999999999999775
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=325.60 Aligned_cols=204 Identities=28% Similarity=0.441 Sum_probs=174.2
Q ss_pred hcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCc-------chHHHHHHHHHHhHhcCCCeeeEEeEEecCC
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ-------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~-------~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~ 586 (738)
..+.|.+.+.||+|+||.|-+|... .++.||||+++++... ......+|+++|++++|||||++.+++...+
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 3456778899999999999999865 4899999999765211 2234579999999999999999999999999
Q ss_pred cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC---CceEEEee
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDF 663 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~---~~vkL~DF 663 (738)
..|||||||++|.|-+.+.. .+.+.+..-..++.|++.|+.|||++| |+||||||+|||+..+ ..+||+||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~---nk~l~ed~~K~~f~Qll~avkYLH~~G---I~HRDiKPeNILl~~~~e~~llKItDF 323 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVA---NKYLREDLGKLLFKQLLTAVKYLHSQG---IIHRDIKPENILLSNDAEDCLLKITDF 323 (475)
T ss_pred ceEEEEEEecCccHHHHHHh---ccccccchhHHHHHHHHHHHHHHHHcC---cccccCCcceEEeccCCcceEEEeccc
Confidence 99999999999999998843 455778888899999999999999998 9999999999999755 78999999
Q ss_pred cCccccCCCcccccccccccccCccchhcccCCC--C-CchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 004674 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL--F-SVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (738)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~-t~ksDVwS~Gvil~elltG~~p~~~~~~~ 727 (738)
|+|+..+ ....++..|||+.|.|||++.+.. + ..|+|+||+|||||-+++|..||.....+
T Consensus 324 GlAK~~g---~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~ 387 (475)
T KOG0615|consen 324 GLAKVSG---EGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD 387 (475)
T ss_pred chhhccc---cceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence 9999865 334566799999999999997654 3 34889999999999999999999755443
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=302.94 Aligned_cols=200 Identities=30% Similarity=0.400 Sum_probs=180.5
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC---cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|+..+.||.|+||.|.+++.+. |..+|+|++++..- ...+...+|..+|+.+.||.++++.+.+.+.+..+|||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 678889999999999999999765 77899999976532 23456789999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++|.|..+++. .+.+++..++-++.||+.||+|||+.+ |++|||||+|||||.+|.+||+|||+|+.+..
T Consensus 124 eyv~GGElFS~Lrk---~~rF~e~~arFYAAeivlAleylH~~~---iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~- 196 (355)
T KOG0616|consen 124 EYVPGGELFSYLRK---SGRFSEPHARFYAAEIVLALEYLHSLD---IIYRDLKPENLLLDQNGHIKITDFGFAKRVSG- 196 (355)
T ss_pred eccCCccHHHHHHh---cCCCCchhHHHHHHHHHHHHHHHHhcC---eeeccCChHHeeeccCCcEEEEeccceEEecC-
Confidence 99999999999943 456999999999999999999999988 99999999999999999999999999997632
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~ 727 (738)
.+-..|||+.|+|||++....+..++|.|||||++|||+.|..||....+.
T Consensus 197 ----rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~ 247 (355)
T KOG0616|consen 197 ----RTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI 247 (355)
T ss_pred ----cEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH
Confidence 245589999999999999999999999999999999999999999876553
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=309.87 Aligned_cols=204 Identities=27% Similarity=0.430 Sum_probs=176.6
Q ss_pred CCCccceecccccEeEEEee-eccccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEe-EEecCCc-ceEEE
Q 004674 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLG-CCTQRDE-RMLIY 592 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~-~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g-~~~~~~~-~~lV~ 592 (738)
+|+++++||+|.||.|||+. +.+|..+|.|.+.-. +....+.+..|+.+|++++|||||+.++ -+.+..+ .+|||
T Consensus 20 ~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivm 99 (375)
T KOG0591|consen 20 DYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVM 99 (375)
T ss_pred HHHHHHHHcCCcchheEEeeeccCcchhhhhhcchhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHH
Confidence 46778899999999999998 457899999988643 3445677899999999999999999998 4444455 89999
Q ss_pred eeCCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCC-CCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 593 EYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSR-LRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~-~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
||+..|+|..++....+ .+.+++..+++++.|++.||.++|..-+ ..|+||||||.||+|+.+|.+||+|||+++.+.
T Consensus 100 E~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~ 179 (375)
T KOG0591|consen 100 ELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLS 179 (375)
T ss_pred HhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhc
Confidence 99999999999876443 4579999999999999999999998431 249999999999999999999999999999886
Q ss_pred CCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
...+ .....+|||.||+||.+.+..|++|+||||+||++|||..=+.||..
T Consensus 180 s~~t--fA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g 230 (375)
T KOG0591|consen 180 SKTT--FAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYG 230 (375)
T ss_pred chhH--HHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccc
Confidence 5433 34458999999999999999999999999999999999999999975
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=327.64 Aligned_cols=197 Identities=38% Similarity=0.564 Sum_probs=172.2
Q ss_pred ccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCCh
Q 004674 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 521 ~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (738)
..+.||+|.||.|+.|.+.....||+|.+... ....++|.+|+++|++|+|+|||+++|+|..++..+||||||+.|+|
T Consensus 210 l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~-~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsL 288 (468)
T KOG0197|consen 210 LIRELGSGQFGEVWLGKWNGSTKVAVKTIKEG-SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSL 288 (468)
T ss_pred HHHHhcCCccceEEEEEEcCCCcccceEEecc-ccChhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcH
Confidence 45789999999999999987889999998655 34568899999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccc
Q 004674 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (738)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 680 (738)
.++|.. .....+...+.+.++.|||+||+||++++ +|||||.++||||+++..+||+|||||+....+.......
T Consensus 289 l~yLr~-~~~~~l~~~~Ll~~a~qIaeGM~YLes~~---~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~~~- 363 (468)
T KOG0197|consen 289 LDYLRT-REGGLLNLPQLLDFAAQIAEGMAYLESKN---YIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTASEG- 363 (468)
T ss_pred HHHhhh-cCCCccchHHHHHHHHHHHHHHHHHHhCC---ccchhhhhhheeeccCceEEEcccccccccCCCceeecCC-
Confidence 999975 34567899999999999999999999988 9999999999999999999999999999655443322221
Q ss_pred cccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
..-+..|.|||.+....++.|||||||||+||||+| |+.|+..
T Consensus 364 ~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~ 407 (468)
T KOG0197|consen 364 GKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPG 407 (468)
T ss_pred CCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCC
Confidence 234678999999999999999999999999999998 5556543
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=300.44 Aligned_cols=202 Identities=23% Similarity=0.389 Sum_probs=174.9
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
++|+.+.++|+|+||+|||++.++ |+.||||++.+... ...+-..+|+++|++++|+|+|.++.+|......+||+|
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esedd~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE 81 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESEDDPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFE 81 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCccHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEee
Confidence 467888899999999999999876 89999999965533 234456899999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|++..-|++.-. ....++...+.+++.|+++|+.|+|+++ +|||||||+|||++.++.+||+|||+|+.+..+
T Consensus 82 ~~dhTvL~eLe~---~p~G~~~~~vk~~l~Q~l~ai~~cHk~n---~IHRDIKPENILit~~gvvKLCDFGFAR~L~~p- 154 (396)
T KOG0593|consen 82 YCDHTVLHELER---YPNGVPSELVKKYLYQLLKAIHFCHKNN---CIHRDIKPENILITQNGVVKLCDFGFARTLSAP- 154 (396)
T ss_pred ecchHHHHHHHh---ccCCCCHHHHHHHHHHHHHHhhhhhhcC---eecccCChhheEEecCCcEEeccchhhHhhcCC-
Confidence 999877766542 2345889999999999999999999998 999999999999999999999999999987532
Q ss_pred ccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
.......+.|..|+|||.+.+ ..|...+||||+||++.||++|...|-...+
T Consensus 155 -gd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SD 207 (396)
T KOG0593|consen 155 -GDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSD 207 (396)
T ss_pred -cchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcch
Confidence 223334678999999999987 7899999999999999999999999865443
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=316.10 Aligned_cols=203 Identities=28% Similarity=0.447 Sum_probs=172.9
Q ss_pred cCCCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecC--CcceE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERML 590 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~l 590 (738)
.+.|+.+++||+|.||.|||++.. .|+.||+|+++... .....-..+||.+|++|+||||++|.+...+. ...||
T Consensus 116 ~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYl 195 (560)
T KOG0600|consen 116 ADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDNEKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYL 195 (560)
T ss_pred hHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeecccCCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEE
Confidence 456777889999999999999964 58999999986553 44556678999999999999999999999887 57999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
|+|||++ +|.-++. ...-.+++.++..++.|++.||.|+|..+ |+|||||.+|||||++|.+||+|||+|+.+.
T Consensus 196 VFeYMdh-DL~GLl~--~p~vkft~~qIKc~mkQLl~Gl~~cH~~g---vlHRDIK~SNiLidn~G~LKiaDFGLAr~y~ 269 (560)
T KOG0600|consen 196 VFEYMDH-DLSGLLS--SPGVKFTEPQIKCYMKQLLEGLEYCHSRG---VLHRDIKGSNILIDNNGVLKIADFGLARFYT 269 (560)
T ss_pred EEecccc-hhhhhhc--CCCcccChHHHHHHHHHHHHHHHHHhhcC---eeeccccccceEEcCCCCEEeccccceeecc
Confidence 9999986 4444442 22346999999999999999999999998 9999999999999999999999999999876
Q ss_pred CCcccccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.......+ ..+-|+.|+|||.+.+. .|+.++|+||.||||.||+.|+..|....
T Consensus 270 ~~~~~~~T-~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~t 324 (560)
T KOG0600|consen 270 PSGSAPYT-SRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRT 324 (560)
T ss_pred CCCCcccc-cceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCcc
Confidence 55443333 35679999999999874 69999999999999999999999987644
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-36 Score=316.04 Aligned_cols=206 Identities=30% Similarity=0.423 Sum_probs=180.1
Q ss_pred HhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcc
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 588 (738)
....+|...+.||+|+|.+|++++... ++++|||++.+.. ....+-...|-.+|.+| .||.|++|+-.|.++..+
T Consensus 70 k~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sL 149 (604)
T KOG0592|consen 70 KTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESL 149 (604)
T ss_pred CChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccce
Confidence 344688899999999999999999655 8899999987652 23345567888899999 899999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
|+|+||+++|.|.++|.. -+.+++...+.++.+|+.||+|||+.| ||||||||+|||||+|+++||+|||.|+.
T Consensus 150 YFvLe~A~nGdll~~i~K---~Gsfde~caR~YAAeIldAleylH~~G---IIHRDlKPENILLd~dmhikITDFGsAK~ 223 (604)
T KOG0592|consen 150 YFVLEYAPNGDLLDLIKK---YGSFDETCARFYAAEILDALEYLHSNG---IIHRDLKPENILLDKDGHIKITDFGSAKI 223 (604)
T ss_pred EEEEEecCCCcHHHHHHH---hCcchHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeEcCCCcEEEeecccccc
Confidence 999999999999999954 356999999999999999999999998 99999999999999999999999999988
Q ss_pred cCCCccc---------cc--ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 669 FGLDQTE---------AN--TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 669 ~~~~~~~---------~~--~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
+...... .. ...++||..|.+||++.+...+..+|+|+||||||+|+.|+.||....
T Consensus 224 l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~N 291 (604)
T KOG0592|consen 224 LSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAAN 291 (604)
T ss_pred CChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCcccc
Confidence 7532221 11 144899999999999999999999999999999999999999997644
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=312.11 Aligned_cols=209 Identities=26% Similarity=0.378 Sum_probs=182.3
Q ss_pred hcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
..++|+.+..||+|+||.||+++.++ |..+|+|++.+.. ....+..+.|-.+|...++|.||+|+-.|.+.+.+||
T Consensus 139 ~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYL 218 (550)
T KOG0605|consen 139 SLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYL 218 (550)
T ss_pred CcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEE
Confidence 45789999999999999999999765 8899999997753 3456778999999999999999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
||||++||++..+| .+.+.|++..+..++.+++-|+.-||+.| +|||||||+|+|||..|++||+|||++..+.
T Consensus 219 iMEylPGGD~mTLL---~~~~~L~e~~arfYiaE~vlAI~~iH~~g---yIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~ 292 (550)
T KOG0605|consen 219 IMEYLPGGDMMTLL---MRKDTLTEDWARFYIAETVLAIESIHQLG---YIHRDIKPDNLLIDAKGHIKLSDFGLSTGLD 292 (550)
T ss_pred EEEecCCccHHHHH---HhcCcCchHHHHHHHHHHHHHHHHHHHcC---cccccCChhheeecCCCCEeeccccccchhh
Confidence 99999999999998 35678999999999999999999999998 9999999999999999999999999985431
Q ss_pred CC---------------------cccc------------------------cccccccccCccchhcccCCCCCchhHHH
Q 004674 671 LD---------------------QTEA------------------------NTKRVVGTYGYMSPEYAIDGLFSVKSDVF 705 (738)
Q Consensus 671 ~~---------------------~~~~------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVw 705 (738)
.. .... .....+|||.|||||++.+..|+..+|.|
T Consensus 293 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwW 372 (550)
T KOG0605|consen 293 KKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWW 372 (550)
T ss_pred hhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHH
Confidence 10 0000 00125799999999999999999999999
Q ss_pred HHHHHHHHHHcCCCCCCCCCCCCC
Q 004674 706 SFGVLVLEIICGKKNRGFNHADHD 729 (738)
Q Consensus 706 S~Gvil~elltG~~p~~~~~~~~~ 729 (738)
|+|||+|||+.|.+||..+++.+.
T Consensus 373 SLG~ImyEmLvGyPPF~s~tp~~T 396 (550)
T KOG0605|consen 373 SLGCIMYEMLVGYPPFCSETPQET 396 (550)
T ss_pred HHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999999998777543
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=334.99 Aligned_cols=208 Identities=34% Similarity=0.520 Sum_probs=177.0
Q ss_pred CCCCccceecccccEeEEEeeecc------ccEEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcce
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 589 (738)
.+.+..+.||+|+||.||+|.... ...||||.+++.... ..++|++|++++..++|||||+|+|+|.++++.+
T Consensus 486 ~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~ 565 (774)
T KOG1026|consen 486 SDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLC 565 (774)
T ss_pred hheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhcccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeE
Confidence 455667899999999999998532 356999999877655 7889999999999999999999999999999999
Q ss_pred EEEeeCCCCChhHHHhhcCC-----------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCce
Q 004674 590 LIYEYLPNKSLDYFIFDTTR-----------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~-----------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~v 658 (738)
||+|||..|+|.++|..... ..+++..+.+.||.|||.||+||-++. .|||||..+|+||.++..|
T Consensus 566 MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~---FVHRDLATRNCLVge~l~V 642 (774)
T KOG1026|consen 566 MVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHH---FVHRDLATRNCLVGENLVV 642 (774)
T ss_pred EEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCc---ccccchhhhhceeccceEE
Confidence 99999999999999974321 223889999999999999999999886 9999999999999999999
Q ss_pred EEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCC
Q 004674 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHAD 727 (738)
Q Consensus 659 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~~~ 727 (738)
||+||||++.+.....-.......-..+|||||.+..+.||.+||||||||+|||+++ |+.|+.....+
T Consensus 643 KIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~ 712 (774)
T KOG1026|consen 643 KISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQ 712 (774)
T ss_pred EecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchH
Confidence 9999999997654333222212234679999999999999999999999999999996 77888765443
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-36 Score=315.00 Aligned_cols=198 Identities=28% Similarity=0.463 Sum_probs=176.9
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
++|.+.+.||+|.||.||||+.+. .+.||+|.+.+..+ ...+.+++|++++++++|||||.+++.|+...+.++|.|
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte 81 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGRNEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTE 81 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCCchHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEeh
Confidence 467778899999999999999765 78899999876533 345678999999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+.+ +|..++.. .+.++++.+..++.++..||.|||+.+ |.|||+||+|||++..+.+|++|||+|+.+....
T Consensus 82 ~a~g-~L~~il~~---d~~lpEe~v~~~a~~LVsaL~yLhs~r---ilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t 154 (808)
T KOG0597|consen 82 YAVG-DLFTILEQ---DGKLPEEQVRAIAYDLVSALYYLHSNR---ILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT 154 (808)
T ss_pred hhhh-hHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHhcC---cccccCCcceeeecCCCceeechhhhhhhcccCc
Confidence 9987 99999843 456999999999999999999999987 9999999999999999999999999999875432
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.....+.||+-|||||+..+.+|+..+|.||+||||||+++|++||..
T Consensus 155 --~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a 202 (808)
T KOG0597|consen 155 --SVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYA 202 (808)
T ss_pred --eeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchH
Confidence 223447899999999999999999999999999999999999999965
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=316.70 Aligned_cols=209 Identities=29% Similarity=0.472 Sum_probs=186.0
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
..|...++||+|+.|.||.+... .++.||||++........+-+.+|+.+|+..+|+|||.++..+...++.++|||||
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym 352 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYM 352 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeec
Confidence 45667789999999999999854 47889999998777667778899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++|+|.+++.. ..+++.++..|+.++++||+|||.++ |+|||||.+|||++.++.+||+|||++..+...+..
T Consensus 353 ~ggsLTDvVt~----~~~~E~qIA~Icre~l~aL~fLH~~g---IiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K 425 (550)
T KOG0578|consen 353 EGGSLTDVVTK----TRMTEGQIAAICREILQGLKFLHARG---IIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK 425 (550)
T ss_pred CCCchhhhhhc----ccccHHHHHHHHHHHHHHHHHHHhcc---eeeeccccceeEeccCCcEEEeeeeeeeccccccCc
Confidence 99999998843 34899999999999999999999998 999999999999999999999999999887655443
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCCcccc
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLG 734 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~~~~~l~~ 734 (738)
....+||+.|||||++....|++|+||||||++++||+.|+.||-.+.+-....||+
T Consensus 426 --R~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa 482 (550)
T KOG0578|consen 426 --RSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIA 482 (550)
T ss_pred --cccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHh
Confidence 334799999999999999999999999999999999999999998776655555554
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.87 Aligned_cols=202 Identities=27% Similarity=0.446 Sum_probs=177.5
Q ss_pred hcCCCCccceecccccEeEEEeeec-cccEEEEEEccCC----CC-cchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCc
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG----SG-QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDE 587 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~----~~-~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~ 587 (738)
...+|...+.||+|+||.|+.+... .+..||+|++.+. .. ...+.+.+|+.++++++ ||||++++.++.....
T Consensus 15 ~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~ 94 (370)
T KOG0583|consen 15 SIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTK 94 (370)
T ss_pred ccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCe
Confidence 4568889999999999999999865 4799999977553 12 23556778999999999 9999999999999999
Q ss_pred ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-CceEEEeecCc
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLA 666 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~vkL~DFGla 666 (738)
.++||||+.+|.|.+++.+ .+.+.+.++.+++.|++.|++|||+.+ |+||||||+|||++.+ +++||+|||++
T Consensus 95 ~~ivmEy~~gGdL~~~i~~---~g~l~E~~ar~~F~Qlisav~y~H~~g---i~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 95 IYIVMEYCSGGDLFDYIVN---KGRLKEDEARKYFRQLISAVAYCHSRG---IVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred EEEEEEecCCccHHHHHHH---cCCCChHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999954 456888999999999999999999998 9999999999999999 99999999999
Q ss_pred cccCCCcccccccccccccCccchhcccCCC-CC-chhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FS-VKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.... .........+||+.|+|||++.+.. |+ .++||||+||+||.|++|+.||+..
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~ 226 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDS 226 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCc
Confidence 8763 2233445589999999999999977 86 7899999999999999999999863
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-35 Score=282.41 Aligned_cols=201 Identities=28% Similarity=0.476 Sum_probs=172.8
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
+.|...+.||+|.||.||+|+.. .|+.||||++..... .......+||+.|+.++|+||+.+++++...+...||+|
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfE 81 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFE 81 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeeccccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEE
Confidence 45777889999999999999965 489999999865532 224567899999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
||+ .+|...+.+ +...++..++..++.++++|++|||.+. |+||||||+|+|+++++.+||+|||+|+.+..+.
T Consensus 82 fm~-tdLe~vIkd--~~i~l~pa~iK~y~~m~LkGl~y~H~~~---IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 82 FMP-TDLEVVIKD--KNIILSPADIKSYMLMTLKGLAYCHSKW---ILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred ecc-ccHHHHhcc--cccccCHHHHHHHHHHHHHHHHHHHhhh---hhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 997 478888754 3457999999999999999999999998 9999999999999999999999999999987654
Q ss_pred ccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
..... .+-|..|+|||.+.+ ..|+..+|+||.|||+.||+-|.+-|....
T Consensus 156 ~~~~~--~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~s 206 (318)
T KOG0659|consen 156 RIQTH--QVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDS 206 (318)
T ss_pred ccccc--ceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCc
Confidence 43322 367999999999987 469999999999999999999887775443
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=302.44 Aligned_cols=202 Identities=32% Similarity=0.513 Sum_probs=172.2
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC--cceEEEe
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD--ERMLIYE 593 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~--~~~lV~E 593 (738)
.+|...+.||+|+||.||++...+ |...|||..........+.+.+|+.+|.+++|||||+.+|.....+ .++++||
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mE 96 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPTSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFME 96 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchhHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeee
Confidence 456778899999999999999865 8899999886654334677899999999999999999999855544 5899999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCceEEEeecCccccCC-
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFGL- 671 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla~~~~~- 671 (738)
|+++|+|.+++..... .+++..+.++..||++||+|||+++ |+||||||+|||++. ++.+||+|||++.....
T Consensus 97 y~~~GsL~~~~~~~g~--~l~E~~v~~ytr~iL~GL~ylHs~g---~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~ 171 (313)
T KOG0198|consen 97 YAPGGSLSDLIKRYGG--KLPEPLVRRYTRQILEGLAYLHSKG---IVHCDIKPANILLDPSNGDVKLADFGLAKKLESK 171 (313)
T ss_pred ccCCCcHHHHHHHcCC--CCCHHHHHHHHHHHHHHHHHHHhCC---EeccCcccceEEEeCCCCeEEeccCccccccccc
Confidence 9999999999965332 6999999999999999999999998 999999999999999 79999999999987653
Q ss_pred CcccccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
...........||+.|||||++.++ ...+++|||||||++.||+||++||..
T Consensus 172 ~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 172 GTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred cccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 1112223347899999999999953 344599999999999999999999975
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=313.61 Aligned_cols=205 Identities=31% Similarity=0.522 Sum_probs=174.0
Q ss_pred cCCCCccceecccccEeEEEeeeccccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
.+.+...+.||+|.||+||+|.+. ..||||++.... .+..+.|++|+..+++-+|.||+-++|+|..... .||..
T Consensus 391 ~~ev~l~~rIGsGsFGtV~Rg~wh--GdVAVK~Lnv~~pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTq 467 (678)
T KOG0193|consen 391 PEEVLLGERIGSGSFGTVYRGRWH--GDVAVKLLNVDDPTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQ 467 (678)
T ss_pred HHHhhccceeccccccceeecccc--cceEEEEEecCCCCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeeh
Confidence 344566789999999999999984 369999986553 3356789999999999999999999999998777 99999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
++++-+|..+++.. +..++..+.+.|+.||++||.|||.++ |||||||..||+|.++++|||+|||++..-..-.
T Consensus 468 wCeGsSLY~hlHv~--etkfdm~~~idIAqQiaqGM~YLHAK~---IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~ 542 (678)
T KOG0193|consen 468 WCEGSSLYTHLHVQ--ETKFDMNTTIDIAQQIAQGMDYLHAKN---IIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWS 542 (678)
T ss_pred hccCchhhhhccch--hhhhhHHHHHHHHHHHHHhhhhhhhhh---hhhhhccccceEEccCCcEEEecccceeeeeeec
Confidence 99999999998653 356999999999999999999999998 9999999999999999999999999987543322
Q ss_pred ccccccccccccCccchhcccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~~ 728 (738)
.......-.|...|||||++.. .+|++.+||||||+|+|||++|..||..+..|.
T Consensus 543 g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq 600 (678)
T KOG0193|consen 543 GEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ 600 (678)
T ss_pred cccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh
Confidence 2222333457789999999864 579999999999999999999999998655543
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=314.55 Aligned_cols=207 Identities=27% Similarity=0.419 Sum_probs=181.7
Q ss_pred HhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcc
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 588 (738)
...++|..++.||+|.||+|+++.++. ++.+|||.+++.. ....+..+.|.+++... +||.++.++.++..+++.
T Consensus 365 ~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l 444 (694)
T KOG0694|consen 365 LTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHL 444 (694)
T ss_pred ccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeE
Confidence 345789999999999999999999875 6789999998763 44567788898888887 499999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
++||||+.||++..+ ...+.+++..+.-++..|+-||.|||+++ ||+||||.+|||||.+|.+||+||||++.
T Consensus 445 ~fvmey~~Ggdm~~~----~~~~~F~e~rarfyaAev~l~L~fLH~~~---IIYRDlKLdNiLLD~eGh~kiADFGlcKe 517 (694)
T KOG0694|consen 445 FFVMEYVAGGDLMHH----IHTDVFSEPRARFYAAEVVLGLQFLHENG---IIYRDLKLDNLLLDTEGHVKIADFGLCKE 517 (694)
T ss_pred EEEEEecCCCcEEEE----EecccccHHHHHHHHHHHHHHHHHHHhcC---ceeeecchhheEEcccCcEEecccccccc
Confidence 999999999994333 34467999999999999999999999998 99999999999999999999999999986
Q ss_pred cCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 004674 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729 (738)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~~~ 729 (738)
... ....+.++|||+.|||||++.+..|+.++|.|||||+||||+.|+.||..+++++.
T Consensus 518 ~m~--~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~ 576 (694)
T KOG0694|consen 518 GMG--QGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEV 576 (694)
T ss_pred cCC--CCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHH
Confidence 432 22345669999999999999999999999999999999999999999998766543
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=304.38 Aligned_cols=199 Identities=30% Similarity=0.521 Sum_probs=170.9
Q ss_pred cCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhH--hcCCCeeeEEeEEecCC----cce
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK--LQHRNLVKLLGCCTQRD----ERM 589 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~--l~H~nIv~l~g~~~~~~----~~~ 589 (738)
.+..+..+.||+|+||.||||++ +++.||||++... ..+.|.+|-+|... ++|+||+++++.-.... +++
T Consensus 209 l~pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~---~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eyw 284 (534)
T KOG3653|consen 209 LDPLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQ---EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYW 284 (534)
T ss_pred CCchhhHHHhhcCccceeehhhc-cCceeEEEecCHH---HHHHHHhHHHHHhccCccchhHHHhhchhccCCcccccee
Confidence 45566778999999999999999 4599999999654 45678888887765 58999999999976665 799
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEeCCCCCCcEEEcCCCceEEEee
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS------RLRIIHRDLKASNVLLDNTMNPKISDF 663 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~------~~~ivH~DLkp~NILl~~~~~vkL~DF 663 (738)
||+||.++|+|.++|. ...++|.+..+|+..+++||+|||+.- +++|+|||||.+||||.+|++..|+||
T Consensus 285 LVt~fh~kGsL~dyL~----~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDF 360 (534)
T KOG3653|consen 285 LVTEFHPKGSLCDYLK----ANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADF 360 (534)
T ss_pred EEeeeccCCcHHHHHH----hccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeecc
Confidence 9999999999999994 356899999999999999999999753 468999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCccchhcccCCC-CC-----chhHHHHHHHHHHHHHcCCCCCC
Q 004674 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FS-----VKSDVFSFGVLVLEIICGKKNRG 722 (738)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~t-----~ksDVwS~Gvil~elltG~~p~~ 722 (738)
|+|.++.......++...+||.+|||||++.+.. +. .+.||||+|.|||||++.=...+
T Consensus 361 GLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 361 GLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred ceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 9999988777666777789999999999998743 22 35899999999999998766554
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=310.88 Aligned_cols=197 Identities=29% Similarity=0.426 Sum_probs=175.9
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
.-|+..+.||+|+-|.|-.|++.. |+.+|||++.+.. ......+.+||.+|+.+.|||++++++++++..++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 347778899999999999999754 9999999987652 223456889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++|.|.+++ .+.+++++.++.+++.||+.|+.|+|..+ |+||||||+|+|||...++||+|||||....
T Consensus 92 Eyv~gGELFdyl---v~kG~l~e~eaa~ff~QIi~gv~yCH~~~---icHRDLKpENlLLd~~~nIKIADFGMAsLe~-- 163 (786)
T KOG0588|consen 92 EYVPGGELFDYL---VRKGPLPEREAAHFFRQILDGVSYCHAFN---ICHRDLKPENLLLDVKNNIKIADFGMASLEV-- 163 (786)
T ss_pred EecCCchhHHHH---HhhCCCCCHHHHHHHHHHHHHHHHHhhhc---ceeccCCchhhhhhcccCEeeeccceeeccc--
Confidence 999999999998 45678999999999999999999999987 9999999999999999999999999998743
Q ss_pred cccccccccccccCccchhcccCCCCC-chhHHHHHHHHHHHHHcCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIICGKKNRG 722 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~Gvil~elltG~~p~~ 722 (738)
........||++.|.|||++.+.+|. .++||||.|||||.|++|+.||+
T Consensus 164 -~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFd 213 (786)
T KOG0588|consen 164 -PGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFD 213 (786)
T ss_pred -CCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCC
Confidence 23334558999999999999999874 78999999999999999999998
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-34 Score=310.89 Aligned_cols=203 Identities=25% Similarity=0.369 Sum_probs=174.7
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|+..+.||+|+||.||++.... ++.||+|++++.. ......+++|+.++.+++|+||+++++.+.+....++||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 478889999999999999998754 7899999986532 223456888999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~g---ivHrDlKp~NILi~~~~~vkL~DFGla~~~~~~ 154 (363)
T cd05628 81 EFLPGGDMMTLLMK---KDTLTEEETQFYIAETVLAIDSIHQLG---FIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKA 154 (363)
T ss_pred cCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCCEEEeeccCccccccc
Confidence 99999999999853 356899999999999999999999988 999999999999999999999999998754321
Q ss_pred ccc---------------------------------ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCC
Q 004674 673 QTE---------------------------------ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719 (738)
Q Consensus 673 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~ 719 (738)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~ 234 (363)
T cd05628 155 HRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (363)
T ss_pred ccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCC
Confidence 100 00123579999999999999999999999999999999999999
Q ss_pred CCCCCC
Q 004674 720 NRGFNH 725 (738)
Q Consensus 720 p~~~~~ 725 (738)
||....
T Consensus 235 Pf~~~~ 240 (363)
T cd05628 235 PFCSET 240 (363)
T ss_pred CCCCCC
Confidence 997544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-35 Score=305.99 Aligned_cols=186 Identities=32% Similarity=0.481 Sum_probs=165.7
Q ss_pred ccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCCh
Q 004674 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 521 ~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (738)
.++-||.|+.|.||+|++ .++.||||+++... ..+|+-|++|+|+||+.+.|+|.....++||||||..|-|
T Consensus 128 ELeWlGSGaQGAVF~Grl-~netVAVKKV~elk-------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL 199 (904)
T KOG4721|consen 128 ELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK-------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQL 199 (904)
T ss_pred hhhhhccCcccceeeeec-cCceehhHHHhhhh-------hhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccH
Confidence 356799999999999999 56899999875322 3578899999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccc
Q 004674 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (738)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 680 (738)
..+|. .+.++.-.....+.++||.||.|||.+. |||||||.-||||..+..|||+|||-++..... . ....
T Consensus 200 ~~VLk---a~~~itp~llv~Wsk~IA~GM~YLH~hK---IIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~--S-TkMS 270 (904)
T KOG4721|consen 200 YEVLK---AGRPITPSLLVDWSKGIAGGMNYLHLHK---IIHRDLKSPNILISYDDVVKISDFGTSKELSDK--S-TKMS 270 (904)
T ss_pred HHHHh---ccCccCHHHHHHHHHHhhhhhHHHHHhh---HhhhccCCCceEeeccceEEeccccchHhhhhh--h-hhhh
Confidence 99994 3456778888899999999999999987 999999999999999999999999999876433 2 2334
Q ss_pred cccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
++||..|||||++.+.+.++|+||||||||||||+||..||.-
T Consensus 271 FaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkd 313 (904)
T KOG4721|consen 271 FAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKD 313 (904)
T ss_pred hhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccc
Confidence 8999999999999999999999999999999999999999964
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-34 Score=284.62 Aligned_cols=203 Identities=27% Similarity=0.393 Sum_probs=170.9
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCCeeeEEeEEecC--CcceE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERML 590 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~l 590 (738)
.+.|+.++.|++|.||.||+|+.+. +..||+|+++.... ...-.-.+||.+|.+++|||||.+-.+.... +..||
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmekek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~ 154 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEKEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYI 154 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccccccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeee
Confidence 3568888999999999999999765 77899999864422 1223457899999999999999998887543 56999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
|||||++ +|...+... .+++...+...++.|+++|++|||... |+||||||+|+|+.+.|.+||+|||+|+.++
T Consensus 155 VMe~~Eh-DLksl~d~m--~q~F~~~evK~L~~QlL~glk~lH~~w---ilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 155 VMEYVEH-DLKSLMETM--KQPFLPGEVKTLMLQLLRGLKHLHDNW---ILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eHHHHHh-hHHHHHHhc--cCCCchHHHHHHHHHHHHHHHHHhhce---eEecccchhheeeccCCcEEecccchhhhhc
Confidence 9999975 677777543 357899999999999999999999998 9999999999999999999999999999987
Q ss_pred CCcccccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
.+.. .....+-|..|+|||.+.+. .|+.++|+||+|||+.||+++++.|.....
T Consensus 229 sp~k--~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE 283 (419)
T KOG0663|consen 229 SPLK--PYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSE 283 (419)
T ss_pred CCcc--cCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCch
Confidence 6532 23336779999999999874 699999999999999999999999976543
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=289.78 Aligned_cols=207 Identities=24% Similarity=0.376 Sum_probs=178.2
Q ss_pred hcCCCCccceecccccEeEEEeeec-cccEEEEEEccCC-CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
..+.|+..+.||.|..++||+|+.. .+..||||++... .....+.+++|+..|+.++||||++.+..|..++..++||
T Consensus 24 n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVm 103 (516)
T KOG0582|consen 24 NAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNNDLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVM 103 (516)
T ss_pred CccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhhhHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEee
Confidence 3467888999999999999999854 4789999998644 3334688999999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
.||.+|++.+++...-. ..+++..+..|.+++++||.|||++| .||||||+.||||+.+|.|||+|||.+..+...
T Consensus 104 pfMa~GS~ldIik~~~~-~Gl~E~~Ia~iLre~LkaL~YLH~~G---~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 104 PFMAGGSLLDIIKTYYP-DGLEEASIATILREVLKALDYLHQNG---HIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred hhhcCCcHHHHHHHHcc-ccccHHHHHHHHHHHHHHHHHHHhcC---ceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 99999999999976544 34999999999999999999999998 999999999999999999999999987655332
Q ss_pred ccc--ccccccccccCccchhcccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QTE--ANTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~--~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
..+ ......+||+.|||||+++. ..|+.|+||||||+...||.+|+.||.-..
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~p 236 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYP 236 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCC
Confidence 211 11145789999999999654 459999999999999999999999997544
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=300.31 Aligned_cols=200 Identities=31% Similarity=0.457 Sum_probs=171.9
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHH--HHHHHHHhHhc-CCCeeeEEeEEecCC-cceE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEF--KNEVLLIAKLQ-HRNLVKLLGCCTQRD-ERML 590 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~--~~Ei~il~~l~-H~nIv~l~g~~~~~~-~~~l 590 (738)
.++|...++||.|.||.||+|+... +..||||++++.-.. .++. .+|++.|++++ |||||++.+++.+.+ ..++
T Consensus 9 m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s-~ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~f 87 (538)
T KOG0661|consen 9 MDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYS-WEECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYF 87 (538)
T ss_pred HHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhcc-HHHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEee
Confidence 4678888999999999999999654 888999999655322 3333 58999999998 999999999998888 8999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
|||||+ .+|.+++.+ ++.++++..+..|+.||++||+|+|++| +.||||||+|||+.....+||+|||+|+.+.
T Consensus 88 VfE~Md-~NLYqLmK~--R~r~fse~~irnim~QilqGL~hiHk~G---fFHRDlKPENiLi~~~~~iKiaDFGLARev~ 161 (538)
T KOG0661|consen 88 VFEFMD-CNLYQLMKD--RNRLFSESDIRNIMYQILQGLAHIHKHG---FFHRDLKPENILISGNDVIKIADFGLAREVR 161 (538)
T ss_pred eHHhhh-hhHHHHHhh--cCCcCCHHHHHHHHHHHHHHHHHHHhcC---cccccCChhheEecccceeEecccccccccc
Confidence 999996 467677644 3778999999999999999999999998 9999999999999988899999999999875
Q ss_pred CCcccccccccccccCccchhccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.. ......+.|..|+|||++. ...|+.++|+|++|||++||.+=+..|-...
T Consensus 162 Sk---pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~s 214 (538)
T KOG0661|consen 162 SK---PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGAS 214 (538)
T ss_pred cC---CCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCc
Confidence 43 2234478899999999876 5679999999999999999999999886543
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=310.15 Aligned_cols=203 Identities=24% Similarity=0.391 Sum_probs=173.0
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
.|+..+.||+|+||.||+++... ++.||+|++.... ....+.+.+|++++++++|+||+++++++.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 57788999999999999998754 7899999986532 2334678899999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~~LH~~g---ivHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~ 155 (381)
T cd05626 82 YIPGGDMMSLLIR---MEVFPEVLARFYIAELTLAIESVHKMG---FIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTH 155 (381)
T ss_pred cCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCcHHHEEECCCCCEEEeeCcCCccccccc
Confidence 9999999998853 345889999999999999999999987 9999999999999999999999999976432100
Q ss_pred c---------------------------------------------cccccccccccCccchhcccCCCCCchhHHHHHH
Q 004674 674 T---------------------------------------------EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFG 708 (738)
Q Consensus 674 ~---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~G 708 (738)
. .......+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (381)
T cd05626 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVG 235 (381)
T ss_pred ccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehh
Confidence 0 0001235799999999999998999999999999
Q ss_pred HHHHHHHcCCCCCCCCCC
Q 004674 709 VLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 709 vil~elltG~~p~~~~~~ 726 (738)
|++|||++|+.||....+
T Consensus 236 ~il~elltG~~Pf~~~~~ 253 (381)
T cd05626 236 VILFEMLVGQPPFLAPTP 253 (381)
T ss_pred hHHHHHHhCCCCCcCCCH
Confidence 999999999999976543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=276.69 Aligned_cols=205 Identities=30% Similarity=0.424 Sum_probs=181.8
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
.++|++.+.||+|.||.||.++.+. +..||+|++.+. ..+...++++|+++-..|+||||+++++++.+....||+
T Consensus 21 l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLi 100 (281)
T KOG0580|consen 21 LDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLI 100 (281)
T ss_pred hhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEE
Confidence 4788999999999999999999765 668999998654 234567899999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
+||.++|+|...|.+. +...+++.....++.|+|.|+.|+|... ++||||||+|+|++..+..||+|||-+..-.
T Consensus 101 lEya~~gel~k~L~~~-~~~~f~e~~~a~Yi~q~A~Al~y~h~k~---VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p- 175 (281)
T KOG0580|consen 101 LEYAPRGELYKDLQEG-RMKRFDEQRAATYIKQLANALLYCHLKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAP- 175 (281)
T ss_pred EEecCCchHHHHHHhc-ccccccccchhHHHHHHHHHHHHhccCC---cccCCCCHHHhccCCCCCeeccCCCceeecC-
Confidence 9999999999998643 4556899999999999999999999987 9999999999999999999999999987532
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~~ 728 (738)
.......|||..|.+||...+..++.++|+|++|++.||++.|.+||+....++
T Consensus 176 ---~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~e 229 (281)
T KOG0580|consen 176 ---SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSE 229 (281)
T ss_pred ---CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHH
Confidence 223344899999999999999999999999999999999999999998776443
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=297.88 Aligned_cols=198 Identities=24% Similarity=0.336 Sum_probs=173.8
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|+..+.||+|+||.||++... .++.||+|++.... ....+.+.+|+.++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLM 80 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEE
Confidence 46888899999999999999976 47899999986432 223456889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 e~~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~ 154 (291)
T cd05612 81 EYVPGGELFSYLRN---SGRFSNSTGLFYASEIVCALEYLHSKE---IVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR 154 (291)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEEecCcchhccCC
Confidence 99999999998853 346889999999999999999999988 999999999999999999999999999765321
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....|++.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 155 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~ 202 (291)
T cd05612 155 -----TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN 202 (291)
T ss_pred -----cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 223578999999999999899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-33 Score=301.31 Aligned_cols=206 Identities=31% Similarity=0.459 Sum_probs=170.1
Q ss_pred cCCCCccceecccccEeEEEeee------ccccEEEEEEccCCCC-cchHHHHHHHHHHhHh-cCCCeeeEEeEEecCC-
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGML------IEGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD- 586 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~------~~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~- 586 (738)
.++|++.+.||+|+||.||++.. ..++.||+|++..... ...+.+.+|+.++.++ +||||+++++++...+
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~ 85 (338)
T cd05102 6 RDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEHKALMSELKILIHIGNHLNVVNLLGACTKPNG 85 (338)
T ss_pred hhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccchHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCC
Confidence 46788899999999999999974 2246799999865432 2345788999999999 8999999999887654
Q ss_pred cceEEEeeCCCCChhHHHhhcCC---------------------------------------------------------
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTR--------------------------------------------------------- 609 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~--------------------------------------------------------- 609 (738)
..++||||+++|+|.+++.....
T Consensus 86 ~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (338)
T cd05102 86 PLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDD 165 (338)
T ss_pred ceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccc
Confidence 57899999999999998864211
Q ss_pred --CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccccccccCc
Q 004674 610 --SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687 (738)
Q Consensus 610 --~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y 687 (738)
..++++.++..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++...............++..|
T Consensus 166 ~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 166 LWKSPLTMEDLICYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 134788899999999999999999987 999999999999999999999999999865432222222224456789
Q ss_pred cchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 688 ~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
+|||++.+..++.++||||||++||||++ |+.||...
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~ 280 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGV 280 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999999997 99998754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=309.19 Aligned_cols=203 Identities=25% Similarity=0.350 Sum_probs=172.6
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|.+.+.||+|+||.||++... +++.||+|++.+. .....+.+++|++++++++||||+++++++.+....++||
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~ 80 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIM 80 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEE
Confidence 46888899999999999999865 4789999988543 2233467889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...
T Consensus 81 E~~~gg~L~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~g---ivHrDlkp~NIll~~~~~~kl~DfGla~~~~~~ 154 (377)
T cd05629 81 EFLPGGDLMTMLIK---YDTFSEDVTRFYMAECVLAIEAVHKLG---FIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQ 154 (377)
T ss_pred eCCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEEeecccccccccc
Confidence 99999999998853 346889999999999999999999988 999999999999999999999999998643210
Q ss_pred ccc---------------------------------------------ccccccccccCccchhcccCCCCCchhHHHHH
Q 004674 673 QTE---------------------------------------------ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSF 707 (738)
Q Consensus 673 ~~~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~ 707 (738)
... ......+||+.|+|||++.+..++.++|||||
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 234 (377)
T cd05629 155 HDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSL 234 (377)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEec
Confidence 000 00012469999999999999999999999999
Q ss_pred HHHHHHHHcCCCCCCCCC
Q 004674 708 GVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 708 Gvil~elltG~~p~~~~~ 725 (738)
||++|||++|+.||....
T Consensus 235 Gvil~elltG~~Pf~~~~ 252 (377)
T cd05629 235 GAIMFECLIGWPPFCSEN 252 (377)
T ss_pred chhhhhhhcCCCCCCCCC
Confidence 999999999999997544
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-33 Score=307.77 Aligned_cols=203 Identities=26% Similarity=0.393 Sum_probs=174.2
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|+..+.||+|+||.||+++... ++.||||++.... ....+.+.+|++++..++|+||+++++.+.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 80 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIM 80 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEE
Confidence 468889999999999999999754 7899999986431 233456788999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~~g~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~ 154 (364)
T cd05599 81 EYLPGGDMMTLLMK---KDTFTEEETRFYIAETILAIDSIHKLG---YIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKS 154 (364)
T ss_pred CCCCCcHHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEeecccceecccc
Confidence 99999999998853 346899999999999999999999988 999999999999999999999999998754321
Q ss_pred cccc------------------------------------cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc
Q 004674 673 QTEA------------------------------------NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC 716 (738)
Q Consensus 673 ~~~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt 716 (738)
.... .....+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~ 234 (364)
T cd05599 155 HRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLV 234 (364)
T ss_pred ccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhc
Confidence 1000 0112469999999999999999999999999999999999
Q ss_pred CCCCCCCCC
Q 004674 717 GKKNRGFNH 725 (738)
Q Consensus 717 G~~p~~~~~ 725 (738)
|+.||....
T Consensus 235 G~~Pf~~~~ 243 (364)
T cd05599 235 GYPPFCSDN 243 (364)
T ss_pred CCCCCCCCC
Confidence 999997543
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=303.40 Aligned_cols=198 Identities=26% Similarity=0.423 Sum_probs=174.8
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|++.+.||+|+||.||++.... ++.||+|++.... ....+.+.+|++++..++||||+++++++...+..++||
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~ 80 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAM 80 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEE
Confidence 368889999999999999999764 7899999986432 223457889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~- 153 (333)
T cd05600 81 EYVPGGDFRTLLNN---LGVLSEDHARFYMAEMFEAVDALHELG---YIHRDLKPENFLIDASGHIKLTDFGLSKGIVT- 153 (333)
T ss_pred eCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEEEeCcCCccccc-
Confidence 99999999999843 346889999999999999999999988 99999999999999999999999999976532
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 154 ----~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 202 (333)
T cd05600 154 ----YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGST 202 (333)
T ss_pred ----ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCC
Confidence 2233678999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-34 Score=288.45 Aligned_cols=199 Identities=26% Similarity=0.454 Sum_probs=177.9
Q ss_pred CCCCccceecccccEeEEEeee-ccccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~-~~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
..|++.+.||+|.||.|-++.. ..|+.||||.+++.. .+..-.+++||+||..++||||+.++.+|+..+...|||
T Consensus 53 HRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivM 132 (668)
T KOG0611|consen 53 HRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVM 132 (668)
T ss_pred hHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEE
Confidence 3577778999999999999986 569999999997653 344557899999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||..+|.|.+++. +.+.+++.+..+++.||..|+.|+|++. ++|||||.+|||||.++++||+|||++..+...
T Consensus 133 EYaS~GeLYDYiS---er~~LsErEaRhfFRQIvSAVhYCHknr---VvHRDLKLENILLD~N~NiKIADFGLSNly~~~ 206 (668)
T KOG0611|consen 133 EYASGGELYDYIS---ERGSLSEREARHFFRQIVSAVHYCHKNR---VVHRDLKLENILLDQNNNIKIADFGLSNLYADK 206 (668)
T ss_pred EecCCccHHHHHH---HhccccHHHHHHHHHHHHHHHHHHhhcc---ceecccchhheeecCCCCeeeeccchhhhhccc
Confidence 9999999999994 4567999999999999999999999987 999999999999999999999999999876432
Q ss_pred cccccccccccccCccchhcccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.....+||++-|.+||++.+.+|. +.+|-|||||+||-|+.|..||+..
T Consensus 207 ---kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~ 256 (668)
T KOG0611|consen 207 ---KFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGR 256 (668)
T ss_pred ---cHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCc
Confidence 234558999999999999998874 7899999999999999999999763
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=283.09 Aligned_cols=203 Identities=27% Similarity=0.438 Sum_probs=171.1
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCC-eeeEEeEEecCC------
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRN-LVKLLGCCTQRD------ 586 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~n-Iv~l~g~~~~~~------ 586 (738)
..|..+++||+|+||+||+|+.. .|+.||+|+++.... .......+|+.++++++|+| ||++.+++...+
T Consensus 11 ~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~ 90 (323)
T KOG0594|consen 11 FDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEEEGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIG 90 (323)
T ss_pred HHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccccCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccc
Confidence 45666778999999999999965 488999999865533 24456789999999999999 999999998877
Q ss_pred cceEEEeeCCCCChhHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecC
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl 665 (738)
..+|||||++ -+|..++...... ..++...+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+
T Consensus 91 ~l~lvfe~~d-~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~---IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 91 KLYLVFEFLD-RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHG---ILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred eEEEEEEeec-ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCcceEEECCCCcEeeeccch
Confidence 7889999996 4777777543321 45777889999999999999999998 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
|+....+... ....++|..|+|||++.+. .|+..+||||+|||+.||++++..|....
T Consensus 167 Ara~~ip~~~--yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 167 ARAFSIPMRT--YTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred HHHhcCCccc--ccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 9976544332 3346789999999999886 79999999999999999999998886543
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-32 Score=290.79 Aligned_cols=200 Identities=29% Similarity=0.440 Sum_probs=172.5
Q ss_pred CCccceecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.++.+++|+||+++++++.+.+..++||||
T Consensus 2 f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05631 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEe
Confidence 667789999999999999864 58899999886432 22334678899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++|+|...+... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 82 ~~~g~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 82 MNGGDLKFHIYNM-GNPGFDEQRAIFYAAELCCGLEDLQRER---IVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred cCCCcHHHHHHhh-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 9999998887543 2346899999999999999999999988 9999999999999999999999999998653221
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......||..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 1223568999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-33 Score=291.41 Aligned_cols=203 Identities=28% Similarity=0.452 Sum_probs=169.2
Q ss_pred hcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCC--------------cchHHHHHHHHHHhHhcCCCeeeEE
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--------------QGMEEFKNEVLLIAKLQHRNLVKLL 579 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--------------~~~~~~~~Ei~il~~l~H~nIv~l~ 579 (738)
..++|++.+.||+|.||.|-++... +++.||||++.+... ...+..++||.+|++++|||||+|+
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 3478999999999999999999865 488999999865321 1246789999999999999999999
Q ss_pred eEEecC--CcceEEEeeCCCCChhHHHhhcCCCCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC
Q 004674 580 GCCTQR--DERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (738)
Q Consensus 580 g~~~~~--~~~~lV~Ey~~~gsL~~~l~~~~~~~~-l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 656 (738)
.+..+. +..|||+|||..|.+... ....+ +++.++++++.++..||+|||.++ ||||||||+|+||++++
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~----p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg---iiHRDIKPsNLLl~~~g 247 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWC----PPDKPELSEQQARKYLRDVVLGLEYLHYQG---IIHRDIKPSNLLLSSDG 247 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccC----CCCcccccHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEEcCCC
Confidence 998765 468999999999988543 22334 899999999999999999999998 99999999999999999
Q ss_pred ceEEEeecCccccCCC---cccccccccccccCccchhcccCCC----CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 657 NPKISDFGLARSFGLD---QTEANTKRVVGTYGYMSPEYAIDGL----FSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 657 ~vkL~DFGla~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
++||+|||.+...... .........+||+.|+|||...++. .+.+.||||+||.||-|+.|+.||-.+
T Consensus 248 ~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~ 322 (576)
T KOG0585|consen 248 TVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDD 322 (576)
T ss_pred cEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccc
Confidence 9999999998765221 1122234478999999999987633 457889999999999999999999653
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.96 Aligned_cols=202 Identities=24% Similarity=0.393 Sum_probs=172.0
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
.|+..+.||+|+||.||+++... ++.+|+|++.+.. ....+.+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 57888999999999999998754 7889999986532 2234578899999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~al~~lH~~~---ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~ 155 (382)
T cd05625 82 YIPGGDMMSLLIR---MGIFPEDLARFYIAELTCAVESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (382)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEEeECCCCccccccc
Confidence 9999999998843 346888999999999999999999988 9999999999999999999999999975432100
Q ss_pred ---------------------------------------------ccccccccccccCccchhcccCCCCCchhHHHHHH
Q 004674 674 ---------------------------------------------TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFG 708 (738)
Q Consensus 674 ---------------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~G 708 (738)
........+||+.|+|||++.+..++.++||||||
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG 235 (382)
T cd05625 156 DSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVG 235 (382)
T ss_pred cccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEech
Confidence 00011235799999999999999999999999999
Q ss_pred HHHHHHHcCCCCCCCCC
Q 004674 709 VLVLEIICGKKNRGFNH 725 (738)
Q Consensus 709 vil~elltG~~p~~~~~ 725 (738)
|++|||++|+.||....
T Consensus 236 vil~elltG~~Pf~~~~ 252 (382)
T cd05625 236 VILYEMLVGQPPFLAQT 252 (382)
T ss_pred HHHHHHHhCCCCCCCCC
Confidence 99999999999997543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=302.62 Aligned_cols=200 Identities=25% Similarity=0.350 Sum_probs=174.6
Q ss_pred cCCCCccceecccccEeEEEeeecc--ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~--g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
.++|+..+.||+|+||.||++.... +..||+|++... .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 3578889999999999999998644 368999988543 22345678899999999999999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....
T Consensus 109 v~Ey~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~ 182 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRR---NKRFPNDVGCFYAAQIVLIFEYLQSLN---IVYRDLKPENLLLDKDGFIKMTDFGFAKVVD 182 (340)
T ss_pred EEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEecCCCCeecC
Confidence 9999999999999853 346899999999999999999999988 9999999999999999999999999998653
Q ss_pred CCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
.. .....||+.|+|||++.+..++.++|||||||++|||++|+.||....+
T Consensus 183 ~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 183 TR-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred CC-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 21 2236789999999999998899999999999999999999999976543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=308.31 Aligned_cols=203 Identities=24% Similarity=0.394 Sum_probs=173.2
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
+|++.+.||+|+||.||+++... ++.||+|++.+.. ....+.+.+|++++++++|+||+++++.+.+++..++|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 68889999999999999998754 7899999986432 2334678899999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+....
T Consensus 82 ~~~~g~L~~~i~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~ 155 (376)
T cd05598 82 YIPGGDMMSLLIR---LGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTH 155 (376)
T ss_pred CCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHEEECCCCCEEEEeCCCCccccccc
Confidence 9999999999843 346888999999999999999999988 9999999999999999999999999975331100
Q ss_pred -----------------------------------------ccccccccccccCccchhcccCCCCCchhHHHHHHHHHH
Q 004674 674 -----------------------------------------TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVL 712 (738)
Q Consensus 674 -----------------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ 712 (738)
........+||+.|+|||++.+..++.++|||||||++|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvily 235 (376)
T cd05598 156 DSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILY 235 (376)
T ss_pred cccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceee
Confidence 000111257999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCC
Q 004674 713 EIICGKKNRGFNHA 726 (738)
Q Consensus 713 elltG~~p~~~~~~ 726 (738)
||++|+.||....+
T Consensus 236 ell~G~~Pf~~~~~ 249 (376)
T cd05598 236 EMLVGQPPFLADTP 249 (376)
T ss_pred ehhhCCCCCCCCCH
Confidence 99999999976543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-33 Score=301.56 Aligned_cols=198 Identities=26% Similarity=0.352 Sum_probs=174.4
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|++.+.||+|+||.||++.... ++.||+|++.... ....+.+.+|+.++++++||||+++++++.+++..++||
T Consensus 18 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~ 97 (329)
T PTZ00263 18 SDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLL 97 (329)
T ss_pred hheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEE
Confidence 578888999999999999999764 7899999986432 233567889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 98 e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 98 EFVVGGELFTHLRK---AGRFPNDVAKFYHAELVLAFEYLHSKD---IIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred cCCCCChHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999988854 345788999999999999999999988 999999999999999999999999999865322
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 172 -----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~ 219 (329)
T PTZ00263 172 -----TFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219 (329)
T ss_pred -----cceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCC
Confidence 223578999999999999999999999999999999999999996543
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-33 Score=297.64 Aligned_cols=195 Identities=27% Similarity=0.371 Sum_probs=168.2
Q ss_pred ceecccccEeEEEeeec-cccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCC
Q 004674 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (738)
+.||+|+||.||++... +++.||+|++... .......+.+|+++++.++||||+++++.+...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 36999999999999865 4889999998643 2233456778999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccc
Q 004674 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678 (738)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 678 (738)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~ 152 (323)
T cd05595 81 ELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Ccc
Confidence 99888743 346899999999999999999999988 9999999999999999999999999987532221 122
Q ss_pred cccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 679 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 199 (323)
T cd05595 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred ccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCC
Confidence 33578999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=298.71 Aligned_cols=194 Identities=27% Similarity=0.363 Sum_probs=168.1
Q ss_pred ceecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCC
Q 004674 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (738)
+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++||||+++.+++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999875 48899999986432 223456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccc
Q 004674 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678 (738)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 678 (738)
+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~ 152 (323)
T cd05571 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALGYLHSCD---VVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATM 152 (323)
T ss_pred cHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Ccc
Confidence 99888853 346899999999999999999999988 9999999999999999999999999987532211 122
Q ss_pred cccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 679 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
...+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~ 198 (323)
T cd05571 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQ 198 (323)
T ss_pred cceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCC
Confidence 3367999999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=304.35 Aligned_cols=204 Identities=24% Similarity=0.303 Sum_probs=173.9
Q ss_pred HhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcce
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 589 (738)
...++|+..+.||+|+||.||++.... ++.+|+|.+.+. .....+.+.+|+.+++.++||||+++++++..++..+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLY 119 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEE
Confidence 345789999999999999999999765 788999998542 2223456789999999999999999999999999999
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcccc
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 669 (738)
+||||+++|+|.+++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...
T Consensus 120 lv~Ey~~gg~L~~~l~~----~~~~~~~~~~~~~qil~aL~~LH~~~---IvHrDLKp~NILl~~~~~~kL~DFG~a~~~ 192 (370)
T cd05621 120 MVMEYMPGGDLVNLMSN----YDVPEKWAKFYTAEVVLALDAIHSMG---LIHRDVKPDNMLLDKHGHLKLADFGTCMKM 192 (370)
T ss_pred EEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEEecccceec
Confidence 99999999999998843 24788999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccchhcccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 670 GLDQTEANTKRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
..... .......||+.|+|||++.+. .++.++||||+||++|||++|+.||....
T Consensus 193 ~~~~~-~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~ 251 (370)
T cd05621 193 DETGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADS 251 (370)
T ss_pred ccCCc-eecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCC
Confidence 43221 112346799999999998754 37889999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-33 Score=295.06 Aligned_cols=192 Identities=24% Similarity=0.324 Sum_probs=167.4
Q ss_pred ecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCCh
Q 004674 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 525 LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (738)
||+|+||.||++.... ++.||+|++.+. .......+.+|+.++++++||||+++++++...+..++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 7999999999999764 788999998643 233456778899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccc
Q 004674 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (738)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 680 (738)
.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... .....
T Consensus 81 ~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~ 152 (312)
T cd05585 81 FHHLQR---EGRFDLSRARFYTAELLCALENLHKFN---VIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD--DKTNT 152 (312)
T ss_pred HHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHeEECCCCcEEEEECcccccCccCC--Ccccc
Confidence 988853 346899999999999999999999988 9999999999999999999999999987543221 12233
Q ss_pred cccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~ 196 (312)
T cd05585 153 FCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDE 196 (312)
T ss_pred ccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCC
Confidence 67999999999999999999999999999999999999999643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-33 Score=303.32 Aligned_cols=204 Identities=25% Similarity=0.375 Sum_probs=174.9
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|+..+.||+|+||.||++.... ++.||+|++... .....+.+++|+.++..++|+||+++++.+.+++..++||
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~ 80 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIM 80 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 468888999999999999998764 789999998643 2334567888999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 E~~~gg~L~~~l~~---~~~l~~~~~~~~~~qi~~~L~~lH~~g---ivHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~ 154 (360)
T cd05627 81 EFLPGGDMMTLLMK---KDTLSEEATQFYIAETVLAIDAIHQLG---FIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKA 154 (360)
T ss_pred eCCCCccHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEccCCCHHHEEECCCCCEEEeeccCCcccccc
Confidence 99999999998843 346899999999999999999999988 999999999999999999999999998754321
Q ss_pred ccc---------------------------------ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCC
Q 004674 673 QTE---------------------------------ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719 (738)
Q Consensus 673 ~~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~ 719 (738)
... ......+||+.|+|||++.+..++.++|||||||++|||++|+.
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~ 234 (360)
T cd05627 155 HRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYP 234 (360)
T ss_pred cccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCC
Confidence 100 00113579999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 004674 720 NRGFNHA 726 (738)
Q Consensus 720 p~~~~~~ 726 (738)
||....+
T Consensus 235 Pf~~~~~ 241 (360)
T cd05627 235 PFCSETP 241 (360)
T ss_pred CCCCCCH
Confidence 9976543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=296.19 Aligned_cols=195 Identities=28% Similarity=0.386 Sum_probs=168.7
Q ss_pred ceecccccEeEEEeeec-cccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCC
Q 004674 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (738)
+.||+|+||.||++... .++.||+|++.+. .......+.+|+++++.++||||+++.+++...+..++||||++++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999865 4889999998653 2234467788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccc
Q 004674 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678 (738)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 678 (738)
+|...+.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ...
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~ 152 (328)
T cd05593 81 ELFFHLSR---ERVFSEDRTRFYGAEIVSALDYLHSGK---IVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATM 152 (328)
T ss_pred CHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecccCHHHeEECCCCcEEEecCcCCccCCCcc--ccc
Confidence 99888743 346899999999999999999999988 9999999999999999999999999987532211 122
Q ss_pred cccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 679 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~ 199 (328)
T cd05593 153 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (328)
T ss_pred ccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCC
Confidence 33679999999999999899999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-33 Score=302.50 Aligned_cols=202 Identities=34% Similarity=0.458 Sum_probs=170.7
Q ss_pred CCCCccceecccccEeEEEeeeccc----cE-EEEEEccC---CCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEG----QE-IAVKRLSK---GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g----~~-vavK~l~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 588 (738)
++....++||+|+||.||+|.+... .. ||+|.... ......++|.+|.++|+.++|||||+++|++..+.+.
T Consensus 157 ~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl 236 (474)
T KOG0194|consen 157 SDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPL 236 (474)
T ss_pred cCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCcc
Confidence 4445568999999999999997542 23 89998864 2345677899999999999999999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
++|||+|+||+|+++|.... +.++..++++++.+.|.||+|||+.+ ++||||.++|+|++.+..+||+|||+++.
T Consensus 237 ~ivmEl~~gGsL~~~L~k~~--~~v~~~ek~~~~~~AA~Gl~YLh~k~---~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 237 MLVMELCNGGSLDDYLKKNK--KSLPTLEKLRFCYDAARGLEYLHSKN---CIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred EEEEEecCCCcHHHHHHhCC--CCCCHHHHHHHHHHHHhHHHHHHHCC---CcchhHhHHHheecCCCeEEeCccccccC
Confidence 99999999999999996543 25899999999999999999999998 99999999999999999999999999876
Q ss_pred cCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
... .........-+.+|+|||.+....|+.++|||||||++||+++ |..||....
T Consensus 312 ~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~ 367 (474)
T KOG0194|consen 312 GSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMK 367 (474)
T ss_pred Ccc--eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCC
Confidence 431 1111101124679999999999999999999999999999999 788886543
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=295.52 Aligned_cols=207 Identities=30% Similarity=0.484 Sum_probs=179.5
Q ss_pred CCCCccceecccccEeEEEeeeccccEEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
+...++++||+|.||.|..+....+..||||.++..... ...+|..|+++|.+++||||++++|+|...+++++|+|||
T Consensus 538 s~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYm 617 (807)
T KOG1094|consen 538 SRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYM 617 (807)
T ss_pred hheehhhhhcCcccceeEEEEecCceEEEEeecCcccchhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHH
Confidence 345667899999999999999977899999999876544 3589999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++|+|..++....... ++-....+|+.||+.||+||.+.. +|||||.++|+|++.++++||+|||+++.+......
T Consensus 618 EnGDLnqFl~aheapt-~~t~~~vsi~tqiasgmaYLes~n---fVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy 693 (807)
T KOG1094|consen 618 ENGDLNQFLSAHELPT-AETAPGVSICTQIASGMAYLESLN---FVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYY 693 (807)
T ss_pred hcCcHHHHHHhccCcc-cccchhHHHHHHHHHHHHHHHhhc---hhhccccccceeecCcccEEecCcccccccccCCce
Confidence 9999999997653322 455667789999999999999887 999999999999999999999999999977655444
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHH--HcCCCCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI--ICGKKNRGFNHAD 727 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~el--ltG~~p~~~~~~~ 727 (738)
....+.+-+.+|||||.+..+.++.++|||+||+.+||+ ++.++||+...++
T Consensus 694 ~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 694 RVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred eeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 444445667899999999999999999999999999995 5788999876554
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-32 Score=294.07 Aligned_cols=201 Identities=26% Similarity=0.363 Sum_probs=174.8
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
.++|+..+.||+|+||.||+++... +..+|+|.+.... ....+++.+|++++++++|+||+++++++...+..++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEee
Confidence 4688999999999999999999764 7789999886542 2334678999999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++++|.+++.. ...+++..+..++.|++.||+|||+.+ .|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~--~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~- 157 (331)
T cd06649 84 HMDGGSLDQVLKE---AKRIPEEILGKVSIAVLRGLAYLREKH--QIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (331)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHhhcC--CEEcCCCChhhEEEcCCCcEEEccCccccccccc-
Confidence 9999999999854 345889999999999999999999853 3999999999999999999999999998765322
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 158 ---~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 206 (331)
T cd06649 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPD 206 (331)
T ss_pred ---ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223568999999999999999999999999999999999999996543
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-32 Score=287.77 Aligned_cols=201 Identities=25% Similarity=0.385 Sum_probs=172.7
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
++|++.+.||+|+||.||+++... ++.+|+|++.... ....+.+.+|+++++.++|+||+++++++...+..++|||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEENEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccccccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 468889999999999999999864 7789999986542 2345678899999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|++++.+..+.. ....+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 154 (287)
T cd07848 81 YVEKNMLELLEE---MPNGVPPEKVRSYIYQLIKAIHWCHKND---IVHRDIKPENLLISHNDVLKLCDFGFARNLSEGS 154 (287)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccCcccccccc
Confidence 999988765542 2346899999999999999999999987 9999999999999999999999999998764322
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
. .......|++.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 155 ~-~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~ 204 (287)
T cd07848 155 N-ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGE 204 (287)
T ss_pred c-ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCC
Confidence 1 1222356899999999999988999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=301.21 Aligned_cols=206 Identities=23% Similarity=0.301 Sum_probs=174.6
Q ss_pred HHHhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCc
Q 004674 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (738)
Q Consensus 512 l~~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 587 (738)
+....++|+..+.||+|+||.||++.... ++.+|+|++.+. .....+.+.+|+.+++.++||||+++++.+.++..
T Consensus 38 ~~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 38 LRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred cCcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCE
Confidence 34455889999999999999999999765 788999998542 22234567889999999999999999999999999
Q ss_pred ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcc
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 667 (738)
.++||||+++|+|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++.
T Consensus 118 ~~lv~Ey~~gg~L~~~~~~----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NIll~~~~~ikL~DfG~a~ 190 (371)
T cd05622 118 LYMVMEYMPGGDLVNLMSN----YDVPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCM 190 (371)
T ss_pred EEEEEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHEEECCCCCEEEEeCCcee
Confidence 9999999999999998843 24788889999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccchhcccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
....... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 191 ~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~ 251 (371)
T cd05622 191 KMNKEGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (371)
T ss_pred EcCcCCc-ccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCC
Confidence 7643221 112336799999999998754 37899999999999999999999997543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=292.69 Aligned_cols=200 Identities=29% Similarity=0.395 Sum_probs=170.3
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCC-CeeeEEeEEecCCcceEEE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHR-NLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~-nIv~l~g~~~~~~~~~lV~ 592 (738)
+|+..+.||+|+||.||++.... ++.||+|++.+. .....+.+..|++++..++|+ +|+++.+++...+..++||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 47788999999999999998765 678999998643 223456678899999998765 5888999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05587 81 EYVNGGDLMYHIQQ---VGKFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDAEGHIKIADFGMCKENIFG 154 (324)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEEcCCCCEEEeecCcceecCCC
Confidence 99999999988843 345889999999999999999999987 999999999999999999999999998753221
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
. .......||+.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (324)
T cd05587 155 G--KTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205 (324)
T ss_pred C--CceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 1 12234679999999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-32 Score=293.83 Aligned_cols=200 Identities=30% Similarity=0.398 Sum_probs=170.1
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEEE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
+|+..+.||+|+||.||++.... ++.||+|++.+.. ....+.+..|..++..+ +|++|+++++++...+..++||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 47778899999999999998764 6789999986542 22334566777888777 5899999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++|+|.+.+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 E~~~~g~L~~~~~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~ 154 (323)
T cd05616 81 EYVNGGDLMYQIQQ---VGRFKEPHAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENMWD 154 (323)
T ss_pred cCCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEecCCCHHHeEECCCCcEEEccCCCceecCCC
Confidence 99999999888843 345889999999999999999999987 999999999999999999999999998754322
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~ 205 (323)
T cd05616 155 G--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGED 205 (323)
T ss_pred C--CccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCC
Confidence 1 12233678999999999999999999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=283.73 Aligned_cols=198 Identities=27% Similarity=0.427 Sum_probs=161.3
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCc-----ceEE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE-----RMLI 591 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~-----~~lV 591 (738)
.|...+.+|.|+||.||+|++.+ ++.||||+.-...+ --.+|+++|++++|||||+++-++..... ..+|
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r----~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlV 100 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKR----YKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLV 100 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCC----cCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHH
Confidence 35567899999999999999765 68999998743322 23478999999999999999988864332 4589
Q ss_pred EeeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-CceEEEeecCcccc
Q 004674 592 YEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLARSF 669 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~vkL~DFGla~~~ 669 (738)
||||+. +|...+.+. ..+..++...+.-+..||.+||+|||+.+ |+||||||+|+|+|.+ +.+||+|||.|+.+
T Consensus 101 leymP~-tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~---IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L 176 (364)
T KOG0658|consen 101 LEYMPE-TLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHSHG---ICHRDIKPQNLLVDPDTGVLKICDFGSAKVL 176 (364)
T ss_pred HHhchH-HHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHhcC---cccCCCChheEEEcCCCCeEEeccCCcceee
Confidence 999986 666666542 22445777888889999999999999987 9999999999999965 99999999999988
Q ss_pred CCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 670 GLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
...... .. ..-|..|+|||.+.+ ..|+.+.||||.|||+.||+-|+..|...+.
T Consensus 177 ~~~epn--iS-YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~ 231 (364)
T KOG0658|consen 177 VKGEPN--IS-YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSS 231 (364)
T ss_pred ccCCCc--ee-EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCH
Confidence 654433 22 345889999999887 5699999999999999999999999976543
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-32 Score=293.39 Aligned_cols=195 Identities=28% Similarity=0.407 Sum_probs=167.2
Q ss_pred ceecccccEeEEEeeec----cccEEEEEEccCC----CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 523 NKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~----~g~~vavK~l~~~----~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+.||+|+||.||++... .++.||+|++... .......+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 57999999999999853 4778999998643 122345678899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++.. ...+.+..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~ 155 (323)
T cd05584 82 LSGGELFMHLER---EGIFMEDTACFYLSEISLALEHLHQQG---IIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT 155 (323)
T ss_pred CCCchHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC
Confidence 999999988843 346788889999999999999999988 99999999999999999999999999875432211
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 156 --VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred --cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 2233578999999999999889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-32 Score=301.38 Aligned_cols=203 Identities=25% Similarity=0.317 Sum_probs=172.6
Q ss_pred hcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
..++|+..+.||+|+||.||++.... ++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+++..++
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 34678899999999999999998754 789999998642 22334557889999999999999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
||||+++|+|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....
T Consensus 121 v~Ey~~gg~L~~~l~~----~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~ 193 (370)
T cd05596 121 VMEYMPGGDLVNLMSN----YDIPEKWARFYTAEVVLALDAIHSMG---FIHRDVKPDNMLLDKSGHLKLADFGTCMKMD 193 (370)
T ss_pred EEcCCCCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEcCCCCEEEEeccceeecc
Confidence 9999999999998843 24788889999999999999999987 9999999999999999999999999998654
Q ss_pred CCcccccccccccccCccchhcccCC----CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~----~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 194 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 251 (370)
T cd05596 194 ANGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADS 251 (370)
T ss_pred CCCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCC
Confidence 3221 112235799999999998653 47899999999999999999999997644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-32 Score=288.55 Aligned_cols=204 Identities=31% Similarity=0.490 Sum_probs=169.0
Q ss_pred CCCCccceecccccEeEEEeeecc-----------------ccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-----------------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKL 578 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-----------------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l 578 (738)
++|...+.||+|+||.||++...+ +..||+|.+.... .....++.+|++++.+++||||+++
T Consensus 5 ~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~ 84 (304)
T cd05096 5 GHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDANKNARNDFLKEVKILSRLKDPNIIRL 84 (304)
T ss_pred hhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCCHHHHHHHHHHHHHHhhcCCCCeeEE
Confidence 467788999999999999997532 3369999986543 2234678999999999999999999
Q ss_pred EeEEecCCcceEEEeeCCCCChhHHHhhcC----------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEe
Q 004674 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTT----------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIH 642 (738)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~----------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH 642 (738)
++++.+.+..++||||+++++|.+++.... ....+++..+.+++.||+.||+|||+.+ |+|
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---ivH 161 (304)
T cd05096 85 LGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLN---FVH 161 (304)
T ss_pred EEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCC---ccc
Confidence 999999999999999999999999885421 1134788899999999999999999987 999
Q ss_pred CCCCCCcEEEcCCCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc--CCCC
Q 004674 643 RDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC--GKKN 720 (738)
Q Consensus 643 ~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt--G~~p 720 (738)
|||||+|||+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986543322222223456789999999988899999999999999999986 5566
Q ss_pred CCC
Q 004674 721 RGF 723 (738)
Q Consensus 721 ~~~ 723 (738)
|..
T Consensus 242 ~~~ 244 (304)
T cd05096 242 YGE 244 (304)
T ss_pred CCc
Confidence 653
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-32 Score=285.38 Aligned_cols=201 Identities=26% Similarity=0.426 Sum_probs=170.2
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++|+..+.||+|+||.||++... +++.||+|+++... ......+.+|+.++++++||||+++++++..++..++||||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~ 84 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEY 84 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeC
Confidence 56888999999999999999875 47899999986443 23345778999999999999999999999999899999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++ +|.+++... ...+++..+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||+++.......
T Consensus 85 ~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~ 158 (288)
T cd07871 85 LDS-DLKQYLDNC--GNLMSMHNVKIFMFQLLRGLSYCHKRK---ILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK 158 (288)
T ss_pred CCc-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEECcCcceeeccCCCc
Confidence 985 888777432 345789999999999999999999988 99999999999999999999999999976532221
Q ss_pred cccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......+++.|+|||++.+ ..++.++||||+|+++|||++|+.||....
T Consensus 159 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~ 208 (288)
T cd07871 159 --TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGST 208 (288)
T ss_pred --cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223567899999998875 568999999999999999999999996543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-32 Score=305.39 Aligned_cols=204 Identities=20% Similarity=0.245 Sum_probs=175.6
Q ss_pred CCCccceecccccEeEEEeeecc--ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~--g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
.|...+.||+|++|.||++.... +..||+|.+..........+++|+.+++.++||||+++++++..++..+|||||+
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~ 147 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYG 147 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECC
Confidence 47888999999999999998543 5678888775544444567888999999999999999999999999999999999
Q ss_pred CCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 596 PNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 596 ~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
++|+|.+++... ....++++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 148 ~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~ 224 (478)
T PTZ00267 148 SGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRK---MMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS 224 (478)
T ss_pred CCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC---EEECCcCHHhEEECCCCcEEEEeCcCceecCCccc
Confidence 999999887543 23456899999999999999999999987 99999999999999999999999999987643322
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.......+||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 225 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~ 274 (478)
T PTZ00267 225 LDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGP 274 (478)
T ss_pred cccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCC
Confidence 22233467999999999999999999999999999999999999999654
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=293.58 Aligned_cols=202 Identities=26% Similarity=0.343 Sum_probs=172.1
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|++.+.||+|+||.||++.... ++.||+|++.+. .....+.+++|+.++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 468889999999999999999754 789999998642 2223456889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~g~~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 155 (331)
T cd05597 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVLAIDSVHQLG---YVHRDIKPDNVLLDKNGHIRLADFGSCLRLLAD 155 (331)
T ss_pred ecCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEECCCCHHHEEECCCCCEEEEECCceeecCCC
Confidence 999999999988532 345889999999999999999999988 999999999999999999999999998765432
Q ss_pred cccccccccccccCccchhcccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
... ......||+.|+|||++.. ..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 156 GTV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred CCc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 221 1222468999999999863 45788999999999999999999999653
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.8e-33 Score=289.06 Aligned_cols=209 Identities=26% Similarity=0.430 Sum_probs=183.1
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCC-CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
..|...+.||+|.||.||||.... ++.||+|++... .....+++.+|+.++..++++||.+.+|.+..+...+++|||
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey 92 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEY 92 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhhcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHH
Confidence 346667899999999999999755 788999998654 344568899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
|.+|++.+.+ .....+++..+.-++.+++.|+.|||.++ .+|||||+.|||+..++.+||+|||.+..+.....
T Consensus 93 ~~gGsv~~lL---~~~~~~~E~~i~~ilre~l~~l~ylH~~~---kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~ 166 (467)
T KOG0201|consen 93 CGGGSVLDLL---KSGNILDEFEIAVILREVLKGLDYLHSEK---KIHRDIKAANILLSESGDVKLADFGVAGQLTNTVK 166 (467)
T ss_pred hcCcchhhhh---ccCCCCccceeeeehHHHHHHhhhhhhcc---eecccccccceeEeccCcEEEEecceeeeeechhh
Confidence 9999999988 34455688888889999999999999998 99999999999999999999999999987755444
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCCccc
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~~~~~l~ 733 (738)
.. ..++||+.|||||++....|+.|+||||||++.+||.+|.+|+.-.++....-+|
T Consensus 167 rr--~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflI 223 (467)
T KOG0201|consen 167 RR--KTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLI 223 (467)
T ss_pred cc--ccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEec
Confidence 33 4589999999999999889999999999999999999999999887775544443
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=2.1e-32 Score=294.90 Aligned_cols=202 Identities=25% Similarity=0.320 Sum_probs=172.5
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|++.+.||+|+||.||+++... ++.||+|.+.+. .....+.+.+|+.++..++|+||+++++++.+++..++||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 478889999999999999999764 778999998642 2223455788999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++|+|..++... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 Ey~~gg~L~~~l~~~--~~~l~~~~~~~~~~qi~~~L~~lH~~~---iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~ 155 (331)
T cd05624 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYIAEMVLAIHSIHQLH---YVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQD 155 (331)
T ss_pred eCCCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCchHHEEEcCCCCEEEEeccceeeccCC
Confidence 999999999998542 346889999999999999999999988 999999999999999999999999999766433
Q ss_pred cccccccccccccCccchhcccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
... ......||+.|+|||++.+ ..++.++||||||++||||++|+.||...
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~ 211 (331)
T cd05624 156 GTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred Cce-eeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCC
Confidence 221 1223568999999999875 46788999999999999999999999653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.7e-32 Score=286.35 Aligned_cols=200 Identities=29% Similarity=0.420 Sum_probs=169.0
Q ss_pred cCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
.++|+..+.||+|+||.||++... +++.||+|++..... .....+.+|+.+++.++||||+++++++..+...++|||
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e 83 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFE 83 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEE
Confidence 467999999999999999999976 478999999865432 234567889999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|++ ++|.+++.. ....++...+..++.||+.||+|||+++ |+||||||+|||+++++.+||+|||++.......
T Consensus 84 ~~~-~~l~~~~~~--~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 157 (303)
T cd07869 84 YVH-TDLCQYMDK--HPGGLHPENVKLFLFQLLRGLSYIHQRY---ILHRDLKPQNLLISDTGELKLADFGLARAKSVPS 157 (303)
T ss_pred CCC-cCHHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECCCCcceeccCCC
Confidence 996 566666643 2345888999999999999999999988 9999999999999999999999999987543221
Q ss_pred ccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
. ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||..
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~ 206 (303)
T cd07869 158 H--TYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206 (303)
T ss_pred c--cCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 1 1223567899999998865 4588999999999999999999999965
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=298.26 Aligned_cols=203 Identities=26% Similarity=0.406 Sum_probs=176.6
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|++.+.||+|+||.||++... .++.||+|++.... ....+.+.+|++++..++|+||+++++++.+++..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVM 80 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEE
Confidence 46888999999999999999976 48899999986432 234567889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++++|.+++... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 e~~~~~~L~~~l~~~---~~l~~~~~~~i~~qi~~aL~~LH~~g---iiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~ 154 (350)
T cd05573 81 EYMPGGDLMNLLIRK---DVFPEETARFYIAELVLALDSVHKLG---FIHRDIKPDNILIDADGHIKLADFGLCKKMNKA 154 (350)
T ss_pred cCCCCCCHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEeecCCCCccCccc
Confidence 999999999998543 56899999999999999999999987 999999999999999999999999999866433
Q ss_pred c---------------------------ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 Q---------------------------TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~---------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
. .........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~ 234 (350)
T cd05573 155 KDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDT 234 (350)
T ss_pred CcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCC
Confidence 2 0011223568999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.1e-33 Score=280.33 Aligned_cols=204 Identities=26% Similarity=0.415 Sum_probs=172.4
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccC--CCCcchHHHHHHHHHHhHhcCCCeeeEEeEEec-----CCc
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-----RDE 587 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-----~~~ 587 (738)
...|...+.||+|+||.|.++.... |..||||++.. ......++..+|+++|+.++|+||+.+.+.+.. -+.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccce
Confidence 3455557889999999999998754 88999999873 344456778899999999999999999999865 245
Q ss_pred ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcc
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 667 (738)
.|+|+|+| ..+|..++. .++.++......++.||++||+|+|+.+ |+||||||+|+|++.+..+||+|||+|+
T Consensus 101 vYiV~elM-etDL~~iik---~~~~L~d~H~q~f~YQiLrgLKyiHSAn---ViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 101 VYLVFELM-ETDLHQIIK---SQQDLTDDHAQYFLYQILRGLKYIHSAN---VIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eEEehhHH-hhHHHHHHH---cCccccHHHHHHHHHHHHHhcchhhccc---ccccccchhheeeccCCCEEecccccee
Confidence 89999999 567777773 3445899999999999999999999998 9999999999999999999999999999
Q ss_pred ccCCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 668 SFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
..............+.|..|+|||++.. ..|+.++||||.|||+.||++|+..|-..+.
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~ 233 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDY 233 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCch
Confidence 8754433344455788999999998764 6799999999999999999999999976543
|
|
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=296.26 Aligned_cols=195 Identities=27% Similarity=0.370 Sum_probs=167.3
Q ss_pred ceecccccEeEEEeeec-cccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCC
Q 004674 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (738)
+.||+|+||.||++... .++.||+|++... .......+.+|++++..++||||+++.+++...+..++||||++++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 36999999999999864 4889999998653 2233456788999999999999999999999999999999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
+|..++.. ...+++..+..++.||+.||+|||+ .+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~L~~~l~~---~~~l~~~~~~~~~~qi~~aL~~lH~~~~---ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (325)
T cd05594 81 ELFFHLSR---ERVFSEDRARFYGAEIVSALDYLHSEKN---VVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--AT 152 (325)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---EEecCCCCCeEEECCCCCEEEecCCCCeecCCCC--cc
Confidence 99888743 3468999999999999999999997 56 9999999999999999999999999987532221 12
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~ 200 (325)
T cd05594 153 MKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 200 (325)
T ss_pred cccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCC
Confidence 233579999999999999999999999999999999999999996544
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.4e-32 Score=289.69 Aligned_cols=195 Identities=30% Similarity=0.425 Sum_probs=164.8
Q ss_pred ceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhH-hcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAK-LQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||++.... ++.||+|+++... ....+.+..|..++.. .+||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999754 7789999986431 2234455566666665 4899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~ 152 (316)
T cd05592 81 GDLMFHIQS---SGRFDEARARFYAAEIICGLQFLHKKG---IIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Cc
Confidence 999888843 345899999999999999999999987 9999999999999999999999999997643222 22
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~ 200 (316)
T cd05592 153 ASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGED 200 (316)
T ss_pred cccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCC
Confidence 234679999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.98 E-value=3e-32 Score=292.43 Aligned_cols=195 Identities=28% Similarity=0.437 Sum_probs=167.1
Q ss_pred ceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||+|+... ++.||+|++... .....+.+..|.+++..+ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 369999999999998765 789999998653 223345677888888876 799999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~aL~~LH~~~---ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (321)
T cd05591 81 GDLMFQIQR---SRKFDEPRSRFYAAEVTLALMFLHRHG---VIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG--VT 152 (321)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeecccceecccCC--cc
Confidence 999888843 345889999999999999999999988 9999999999999999999999999987543221 12
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~ 200 (321)
T cd05591 153 TTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADN 200 (321)
T ss_pred ccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCC
Confidence 233578999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=292.46 Aligned_cols=200 Identities=26% Similarity=0.378 Sum_probs=169.8
Q ss_pred CCCccceecccccEeEEEeeec----cccEEEEEEccCC----CCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcc
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~----~g~~vavK~l~~~----~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 588 (738)
+|++.+.||+|+||.||++... .++.||+|++.+. .....+.+..|+.++..+ +|+||+++++++...+..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 4778899999999999998753 4788999998642 122345678899999999 599999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
++||||+++|+|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.
T Consensus 81 ~lv~e~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nili~~~~~~kl~DfG~~~~ 154 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQ---RDNFSEDEVRFYSGEIILALEHLHKLG---IVYRDIKLENILLDSEGHVVLTDFGLSKE 154 (332)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHeEECCCCCEEEeeCcCCcc
Confidence 999999999999988853 345889999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCcccccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 669 FGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
...... .......||+.|+|||++.+. .++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 155 FLSEEK-ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccccCC-CccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 533221 122236799999999999865 4788999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-32 Score=291.01 Aligned_cols=198 Identities=29% Similarity=0.423 Sum_probs=167.7
Q ss_pred CCccceecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHHHH---hHhcCCCeeeEEeEEecCCcceEE
Q 004674 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLI---AKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il---~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
|++.+.||+|+||.||++... .++.||+|++.+.. ....+.+.+|++++ +.++||||+++++++...+..++|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 566789999999999999875 47899999986432 22345666776655 456799999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|||+++++|...+. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++....
T Consensus 81 ~E~~~~~~L~~~~~----~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~ 153 (324)
T cd05589 81 MEYAAGGDLMMHIH----TDVFSEPRAVFYAACVVLGLQYLHENK---IVYRDLKLDNLLLDTEGFVKIADFGLCKEGMG 153 (324)
T ss_pred EcCCCCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEecCCCHHHeEECCCCcEEeCcccCCccCCC
Confidence 99999999988773 246899999999999999999999988 99999999999999999999999999875322
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.. .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 154 ~~--~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~ 205 (324)
T cd05589 154 FG--DRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDD 205 (324)
T ss_pred CC--CcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCC
Confidence 11 12233678999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=4e-32 Score=292.82 Aligned_cols=203 Identities=23% Similarity=0.319 Sum_probs=172.0
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|++.+.||+|+||.||++.... ++.+|+|++.+. .....+.+.+|+.++..++|+||+++++.+.+.+..++||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 468889999999999999999765 678999998542 1223445888999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 81 ey~~~g~L~~~l~~~--~~~l~~~~~~~~~~qi~~al~~lH~~~---iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~ 155 (332)
T cd05623 81 DYYVGGDLLTLLSKF--EDRLPEDMARFYLAEMVIAIDSVHQLH---YVHRDIKPDNILMDMNGHIRLADFGSCLKLMED 155 (332)
T ss_pred eccCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHEEECCCCCEEEeecchheecccC
Confidence 999999999998542 345889999999999999999999988 999999999999999999999999998765322
Q ss_pred cccccccccccccCccchhccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.. .......||+.|+|||++. ...++.++|||||||++|||++|+.||....
T Consensus 156 ~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 156 GT-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred Cc-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 21 1122357999999999986 3468899999999999999999999997543
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.1e-32 Score=289.84 Aligned_cols=195 Identities=31% Similarity=0.486 Sum_probs=167.1
Q ss_pred ceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||++.... ++.||+|++.+. .....+.+..|..++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999764 789999998643 223455677888888876 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~l~~~~~~~~~~ql~~~L~~lH~~~---ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~ 152 (320)
T cd05590 81 GDLMFHIQK---SRRFDEARARFYAAEITSALMFLHDKG---IIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KT 152 (320)
T ss_pred chHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Cc
Confidence 999988743 345899999999999999999999988 9999999999999999999999999987542221 12
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 200 (320)
T cd05590 153 TSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAEN 200 (320)
T ss_pred ccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCC
Confidence 233578999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.2e-32 Score=290.67 Aligned_cols=195 Identities=25% Similarity=0.367 Sum_probs=167.5
Q ss_pred ceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||++.... ++.+|+|++++.. ....+.+.+|+.++.++ +|+||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999754 7889999987542 23345678899999888 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (327)
T cd05617 81 GDLMFHMQR---QRKLPEEHARFYAAEICIALNFLHERG---IIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DT 152 (327)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cc
Confidence 999888743 346899999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
....+||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~ 200 (327)
T cd05617 153 TSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200 (327)
T ss_pred eecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccC
Confidence 233679999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.2e-31 Score=282.04 Aligned_cols=195 Identities=33% Similarity=0.462 Sum_probs=168.0
Q ss_pred ecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCCh
Q 004674 525 LGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 525 LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (738)
||+|+||.||++... +++.+|+|.+.... ....+.+..|++++++++|+||+++.+++..+...++||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 799999999999865 47899999986432 12335678899999999999999999999999999999999999999
Q ss_pred hHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccccc
Q 004674 601 DYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679 (738)
Q Consensus 601 ~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 679 (738)
.+.+.... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..+..... ...
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~ 155 (280)
T cd05608 81 RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRR---IIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTK 155 (280)
T ss_pred HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccc
Confidence 88875432 3456899999999999999999999987 99999999999999999999999999976543222 122
Q ss_pred ccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 680 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
...||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 200 (280)
T cd05608 156 GYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200 (280)
T ss_pred ccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 357899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.6e-32 Score=290.68 Aligned_cols=193 Identities=25% Similarity=0.392 Sum_probs=166.0
Q ss_pred ceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||++.... ++.+|+|++.+. .....+.+.+|+.++.++ +||||+++++++..++..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 369999999999999754 788999998654 223345677888888776 899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~i~~qi~~~l~~lH~~~---ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~--~~ 152 (329)
T cd05618 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNYLHERG---IIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCCEEEeeCCccccccCCC--Cc
Confidence 999888743 346899999999999999999999988 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 2336789999999999999999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.7e-32 Score=295.56 Aligned_cols=206 Identities=33% Similarity=0.475 Sum_probs=170.8
Q ss_pred CCCCccceecccccEeEEEeeec------cccEEEEEEccCCC-CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 588 (738)
++|+..+.||+|+||.||+++.. .+..||+|++.... ....+.+.+|+.+++.+ +|+||+++++++......
T Consensus 38 ~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~ 117 (374)
T cd05106 38 DNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHTDEREALMSELKILSHLGQHKNIVNLLGACTHGGPV 117 (374)
T ss_pred HHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCHHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCe
Confidence 46888899999999999998742 23579999986543 22345688999999999 899999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcC------------------------------------------------------------
Q 004674 589 MLIYEYLPNKSLDYFIFDTT------------------------------------------------------------ 608 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~------------------------------------------------------------ 608 (738)
++||||+++|+|.+++....
T Consensus 118 ~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 197 (374)
T cd05106 118 LVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDS 197 (374)
T ss_pred EEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccccccc
Confidence 99999999999999885421
Q ss_pred -------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccccccc
Q 004674 609 -------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681 (738)
Q Consensus 609 -------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 681 (738)
....+++.++.+++.||++||+|||+.+ |+||||||+|||+++++.+||+|||+++..............
T Consensus 198 ~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g---iiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~ 274 (374)
T cd05106 198 KDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKN---CIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNA 274 (374)
T ss_pred cchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---EEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCC
Confidence 1134788999999999999999999987 999999999999999999999999999765432221111123
Q ss_pred ccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 682 ~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
.++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 275 ~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~ 319 (374)
T cd05106 275 RLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGIL 319 (374)
T ss_pred CCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCcccc
Confidence 35678999999999999999999999999999997 999986543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.8e-32 Score=289.89 Aligned_cols=200 Identities=29% Similarity=0.412 Sum_probs=169.5
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCC---CCcchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcceEEE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~lV~ 592 (738)
+|+..+.||+|+||.||++... +++.||+|++.+. .....+.+..|..++..+. |++|+++.+++...+..++||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 3667789999999999999865 4789999998643 2233456778888888885 577888999999989999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++|+|.+++.. ...+++.++..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.....
T Consensus 81 Ey~~~g~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~ 154 (323)
T cd05615 81 EYVNGGDLMYHIQQ---VGKFKEPQAVFYAAEISVGLFFLHRRG---IIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVD 154 (323)
T ss_pred cCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEeccccccccCCC
Confidence 99999999988843 345899999999999999999999988 999999999999999999999999998754322
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
. .......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 155 ~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~ 205 (323)
T cd05615 155 G--VTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGED 205 (323)
T ss_pred C--ccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCC
Confidence 1 12233568999999999999999999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=282.86 Aligned_cols=191 Identities=21% Similarity=0.307 Sum_probs=165.3
Q ss_pred ceecccccEeEEEeeeccccEEEEEEccCCCCcc---hHHHHHHHHHHhHhcCCCeeeEEeEEec----CCcceEEEeeC
Q 004674 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG---MEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERMLIYEYL 595 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~---~~~~~~Ei~il~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~ 595 (738)
..|++|++|.||+|.. +++.||+|+++...... .+.+.+|+.++++++||||+++++++.+ ....++||||+
T Consensus 26 ~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~ 104 (283)
T PHA02988 26 VLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYC 104 (283)
T ss_pred eEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeC
Confidence 5799999999999998 78899999987654333 4678899999999999999999999876 34678999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
++|+|.+++.. ...+++....+++.+++.||+|||+. + ++||||||+|||+++++.+||+|||+++......
T Consensus 105 ~~g~L~~~l~~---~~~~~~~~~~~i~~~i~~~l~~lH~~~~---~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 105 TRGYLREVLDK---EKDLSFKTKLDMAIDCCKGLYNLYKYTN---KPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCcHHHHHhh---CCCCChhHHHHHHHHHHHHHHHHHhcCC---CCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999854 34688999999999999999999984 5 7899999999999999999999999998653221
Q ss_pred cccccccccccCccchhcccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 12467899999999976 679999999999999999999999997544
|
|
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.7e-32 Score=290.19 Aligned_cols=193 Identities=24% Similarity=0.377 Sum_probs=166.8
Q ss_pred ceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||++.... ++.||+|++++.. ....+.+..|..++..+ +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 369999999999998754 7899999986532 23345678899999888 799999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~ 152 (329)
T cd05588 81 GDLMFHMQR---QRKLPEEHARFYSAEISLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DT 152 (329)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEECcCccccccccCC--Cc
Confidence 999888743 346899999999999999999999988 9999999999999999999999999987532111 12
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||+.
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 153 TSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred cccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 2336799999999999999999999999999999999999999964
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=289.73 Aligned_cols=201 Identities=25% Similarity=0.363 Sum_probs=173.8
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
.++|+..++||+|+||.||++.... +..+|+|.+.... ....+.+.+|++++++++|+||+++++++.+.+..++|||
T Consensus 4 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 83 (333)
T cd06650 4 DDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICME 83 (333)
T ss_pred hhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccCHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEe
Confidence 4688999999999999999999764 7788999876542 2334678999999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++++|.+++.. ...+++..+..++.+++.||+|||+.. +|+||||||+|||+++++.+||+|||++......
T Consensus 84 ~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~--~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~- 157 (333)
T cd06650 84 HMDGGSLDQVLKK---AGRIPEQILGKVSIAVIKGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS- 157 (333)
T ss_pred cCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcC--CEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh-
Confidence 9999999999853 345889999999999999999999753 3999999999999999999999999998755321
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......|+..|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 158 ---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 158 ---MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred ---ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 1223568999999999999899999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.1e-32 Score=313.72 Aligned_cols=204 Identities=35% Similarity=0.563 Sum_probs=172.2
Q ss_pred CCCCccceecccccEeEEEeeecc--cc----EEEEEEccCC-CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcce
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE--GQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~--g~----~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 589 (738)
++.+..+.||+|+||.||+|...+ +. .||+|.+++. +.+...+|.+|..+|++++|||||+++|+|.+....+
T Consensus 692 ~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~ 771 (1025)
T KOG1095|consen 692 KNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPL 771 (1025)
T ss_pred hheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcE
Confidence 344567789999999999999754 33 3899999765 4456779999999999999999999999999999999
Q ss_pred EEEeeCCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecC
Q 004674 590 LIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl 665 (738)
|++|||++|+|..+|.+.+. ...+...+.+.++.+||+|+.|||++. .|||||..+|+||++...+||+||||
T Consensus 772 i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~---fvHRDLAaRNCLL~~~r~VKIaDFGl 848 (1025)
T KOG1095|consen 772 ILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKH---FVHRDLAARNCLLDERRVVKIADFGL 848 (1025)
T ss_pred EEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCC---CcCcchhhhheeecccCcEEEcccch
Confidence 99999999999999987532 345889999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
|+.+.....-.......-...|||||.++++.++.|+|||||||+||||+| |..||..
T Consensus 849 ArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~ 907 (1025)
T KOG1095|consen 849 ARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPS 907 (1025)
T ss_pred hHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCC
Confidence 995543322221211223568999999999999999999999999999998 4566654
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=286.44 Aligned_cols=195 Identities=30% Similarity=0.459 Sum_probs=165.6
Q ss_pred ceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhH-hcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAK-LQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~-l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||++.... ++.||+|+++... ....+.+..|..++.. ++||||+++++++.+.+..++||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 369999999999999765 7889999986531 2234556677777776 4899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
|+|..++.. ...+++.++..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05619 81 GDLMFHIQS---CHKFDLPRATFYAAEIICGLQFLHSKG---IVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AK 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--Cc
Confidence 999988843 345889999999999999999999987 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (316)
T cd05619 153 TCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHD 200 (316)
T ss_pred eeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCC
Confidence 233578999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=276.48 Aligned_cols=207 Identities=25% Similarity=0.332 Sum_probs=176.9
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
+.|+.++.||+|.-|+||++.+.+ +..+|+|++.+.. .....+...|-+||+.++||.+..|+..++..+..+|+|
T Consensus 77 ~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~m 156 (459)
T KOG0610|consen 77 RHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVM 156 (459)
T ss_pred HHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEE
Confidence 456677899999999999999876 5889999997653 333456778999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC-
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL- 671 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~- 671 (738)
|||+||+|....+. +..+.+++..++-++.+|+-||+|||-.| ||.|||||+||||.++|++-|+||.++..+..
T Consensus 157 eyCpGGdL~~Lrqk-Qp~~~fse~~aRFYaAEvl~ALEYLHmlG---ivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 157 EYCPGGDLHSLRQK-QPGKRFSESAARFYAAEVLLALEYLHMLG---IVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred ecCCCccHHHHHhh-CCCCccchhhHHHHHHHHHHHHHHHHhhc---eeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 99999999777644 45678999999999999999999999998 99999999999999999999999998754311
Q ss_pred --------------------------------Ccc---------------------cccccccccccCccchhcccCCCC
Q 004674 672 --------------------------------DQT---------------------EANTKRVVGTYGYMSPEYAIDGLF 698 (738)
Q Consensus 672 --------------------------------~~~---------------------~~~~~~~~gt~~y~aPE~~~~~~~ 698 (738)
... .......+||-.|+|||++.+..+
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 000 011223689999999999999999
Q ss_pred CchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 004674 699 SVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (738)
Q Consensus 699 t~ksDVwS~Gvil~elltG~~p~~~~~~~ 727 (738)
+.++|.|+|||+||||+.|+.||.....+
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~ 341 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK 341 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCch
Confidence 99999999999999999999999876544
|
|
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=294.65 Aligned_cols=202 Identities=27% Similarity=0.389 Sum_probs=173.6
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|+..+.||+|+||.||++... .++.||+|+++... ....+.+.+|+.+++.++|+||+++++++.+.+..++||
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVM 80 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEE
Confidence 46888999999999999999875 48899999986532 234567889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++++|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++..+...
T Consensus 81 e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~qi~~aL~~lH~~~---i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~ 155 (330)
T cd05601 81 EYQPGGDLLSLLNRY--EDQFDEDMAQFYLAELVLAIHSVHQMG---YVHRDIKPENVLIDRTGHIKLADFGSAARLTAN 155 (330)
T ss_pred CCCCCCCHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEcccCchHheEECCCCCEEeccCCCCeECCCC
Confidence 999999999998543 246899999999999999999999988 999999999999999999999999999876433
Q ss_pred cccccccccccccCccchhccc------CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAI------DGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~------~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
... ......||+.|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 156 ~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~ 212 (330)
T cd05601 156 KMV-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEG 212 (330)
T ss_pred Cce-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCC
Confidence 221 222356899999999986 456789999999999999999999999654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.6e-32 Score=289.56 Aligned_cols=194 Identities=26% Similarity=0.357 Sum_probs=163.8
Q ss_pred ceecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHH-HHhHhcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVL-LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~-il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||++... +++.||+|++.+.. ....+++.+|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 36999999999999975 48899999986432 222334445544 56778999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++...... ...
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~g---ivH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~--~~~ 152 (323)
T cd05575 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGIEH--SKT 152 (323)
T ss_pred CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeCCCCHHHeEECCCCcEEEeccCCCcccccC--CCc
Confidence 999888843 346889999999999999999999988 999999999999999999999999998753221 112
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~ 199 (323)
T cd05575 153 TSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (323)
T ss_pred cccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCC
Confidence 23367899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=288.28 Aligned_cols=204 Identities=28% Similarity=0.390 Sum_probs=181.7
Q ss_pred HhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCc---chHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcc
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ---GMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDER 588 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~---~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~ 588 (738)
...+.|+..+.||+|.||.||+++... |+.+|+|.+.+.... ..+.+.+|+.+|+++. |||||.+.+.+++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 345678888999999999999999876 899999999766433 3468999999999998 99999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC----CCceEEEeec
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----TMNPKISDFG 664 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~----~~~vkL~DFG 664 (738)
++|||++.+|.|.+.+... .+++.++..++.||+.+++|||+.+ |+||||||+|+|+.. ++.+|++|||
T Consensus 112 ~lvmEL~~GGeLfd~i~~~----~~sE~da~~~~~~il~av~~lH~~g---vvHrDlKpEN~L~~~~~~~~~~ik~~DFG 184 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK----HYSERDAAGIIRQILEAVKYLHSLG---VVHRDLKPENLLLASKDEGSGRIKLIDFG 184 (382)
T ss_pred EEEEEecCCchHHHHHHHc----cCCHHHHHHHHHHHHHHHHHHHhCC---ceeccCCHHHeeeccccCCCCcEEEeeCC
Confidence 9999999999999998654 2899999999999999999999988 999999999999953 3579999999
Q ss_pred CccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 004674 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (738)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~ 727 (738)
++..... .......+||+.|+|||++....|+.++||||+|+++|.|++|..||......
T Consensus 185 la~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~ 244 (382)
T KOG0032|consen 185 LAKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEF 244 (382)
T ss_pred CceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChh
Confidence 9998754 33455689999999999999999999999999999999999999999876643
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-31 Score=292.53 Aligned_cols=204 Identities=30% Similarity=0.432 Sum_probs=169.8
Q ss_pred CCCCccceecccccEeEEEeee------ccccEEEEEEccCCC-CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGML------IEGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~------~~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 588 (738)
++|+..+.||+|+||.||++.. ..+..||+|+++... ....+.+.+|+.++..+ +||||+++++++..++..
T Consensus 35 ~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~ 114 (375)
T cd05104 35 NRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHINIVNLLGACTVGGPT 114 (375)
T ss_pred HHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCcHHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcc
Confidence 4678889999999999999863 235689999986443 23346788999999999 899999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcCC-----------------------------------------------------------
Q 004674 589 MLIYEYLPNKSLDYFIFDTTR----------------------------------------------------------- 609 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------- 609 (738)
++||||+++|+|.+++.....
T Consensus 115 ~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 194 (375)
T cd05104 115 LVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSY 194 (375)
T ss_pred eeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCccccccccccccccccccee
Confidence 999999999999988854211
Q ss_pred -------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 610 -------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 610 -------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.........
T Consensus 195 ~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~---ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~ 271 (375)
T cd05104 195 IDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN---CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYV 271 (375)
T ss_pred cccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCchhhEEEECCCcEEEecCccceeccCccccc
Confidence 124788999999999999999999987 9999999999999999999999999998664332211
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
......++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 272 ~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~ 319 (375)
T cd05104 272 VKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319 (375)
T ss_pred ccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCC
Confidence 1122335678999999999999999999999999999998 8888854
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-31 Score=286.83 Aligned_cols=195 Identities=30% Similarity=0.433 Sum_probs=165.7
Q ss_pred ceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||++.... ++.||+|.++... ....+.+..|..++... +||||+++++++.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 369999999999999764 7899999986531 22345567777777754 899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 g~L~~~i~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (316)
T cd05620 81 GDLMFHIQD---KGRFDLYRATFYAAEIVCGLQFLHSKG---IIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NR 152 (316)
T ss_pred CcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cc
Confidence 999888743 345889999999999999999999988 9999999999999999999999999987432111 12
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~ 200 (316)
T cd05620 153 ASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDD 200 (316)
T ss_pred eeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCC
Confidence 234678999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=302.50 Aligned_cols=208 Identities=22% Similarity=0.320 Sum_probs=175.9
Q ss_pred HhcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC----
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD---- 586 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~---- 586 (738)
...++|.+.+.||+|+||.||++... +++.||+|++.... ......+.+|+.++..++|+|++++...+....
T Consensus 29 ~~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~ 108 (496)
T PTZ00283 29 EQAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMSEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNP 108 (496)
T ss_pred ccCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCCHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCc
Confidence 34578999999999999999999864 58899999986542 233456788999999999999999988765432
Q ss_pred ----cceEEEeeCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEE
Q 004674 587 ----ERMLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (738)
Q Consensus 587 ----~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~ 661 (738)
..++||||+++|+|.+++.... ....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+
T Consensus 109 ~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~---IiHrDLKP~NILl~~~~~vkL~ 185 (496)
T PTZ00283 109 ENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKH---MIHRDIKSANILLCSNGLVKLG 185 (496)
T ss_pred ccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEeCCCCEEEE
Confidence 2679999999999999886432 2356899999999999999999999987 9999999999999999999999
Q ss_pred eecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 662 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
|||+++.+.............||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 186 DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~ 248 (496)
T PTZ00283 186 DFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGE 248 (496)
T ss_pred ecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 999998765433333334467999999999999999999999999999999999999999754
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=288.12 Aligned_cols=200 Identities=24% Similarity=0.375 Sum_probs=166.2
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC-----cce
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----ERM 589 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-----~~~ 589 (738)
+|++.+.||+|+||.||+++.. +++.||+|++... ......++.+|++++++++||||+++++++.... ..+
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~ 80 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEHVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIY 80 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhccchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEE
Confidence 4777889999999999999965 4889999998643 2223456889999999999999999999885433 479
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcccc
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 669 (738)
+||||+. ++|.+++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++..
T Consensus 81 lv~e~~~-~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 81 VVFELME-SDLHQVIKA---NDDLTPEHHQFFLYQLLRALKYIHTAN---VFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEecCC-CCHHHHHHh---cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 9999996 678877743 345899999999999999999999988 999999999999999999999999999764
Q ss_pred CCCcc-cccccccccccCccchhcccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 670 GLDQT-EANTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 670 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~ 211 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGK 211 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCC
Confidence 32211 111233578999999999876 67899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.1e-32 Score=288.68 Aligned_cols=195 Identities=25% Similarity=0.353 Sum_probs=163.6
Q ss_pred ceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHH-HHHhHhcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEV-LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei-~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||+++... ++.||+|++.+.. .....++.+|. .+++.++||||+++++.+.+.+..++||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999999754 7889999986432 12233455554 467889999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~~L~~lH~~~---ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (321)
T cd05603 81 GELFFHLQR---ERCFLEPRARFYAAEVASAIGYLHSLN---IIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ET 152 (321)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Cc
Confidence 999887743 345888899999999999999999987 9999999999999999999999999987532221 12
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....||+.|+|||.+.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 153 TSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred cccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 234678999999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=289.80 Aligned_cols=204 Identities=25% Similarity=0.381 Sum_probs=180.8
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCc-ceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE-RMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~-~~lV~ 592 (738)
++|..++++|+|+||.++..+.+. ++.+++|.+.-. .....+...+|+.++++++|||||.+.+.+.+++. .+|||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm 83 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVM 83 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEE
Confidence 678889999999999999888754 678999987543 33344577899999999999999999999999888 99999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
+|++||+|.+.+.... ...+++..+..++.|++.|+.|||+.. |+|||||+.||+++.+..|||+|||+|+.+..+
T Consensus 84 ~Y~eGg~l~~~i~~~k-~~~f~E~~i~~~~~Q~~~av~ylH~~~---iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 84 EYCEGGDLAQLIKEQK-GVLFPEERILKWFVQILLAVNYLHENR---VLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred eecCCCCHHHHHHHHh-hccccHHHHHHHHHHHHHHHHHHHhhh---hhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999986543 567999999999999999999999776 999999999999999999999999999988654
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
. ......+||+.||.||++.+.+|..|+|||||||++|||++=+++|...+.
T Consensus 160 ~--~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m 211 (426)
T KOG0589|consen 160 D--SLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNM 211 (426)
T ss_pred h--hhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccch
Confidence 3 234458999999999999999999999999999999999999999987654
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=292.41 Aligned_cols=194 Identities=20% Similarity=0.258 Sum_probs=166.6
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
..+|++.+.||+|+||.||++.... ++.||+|... .+.+.+|++++++++||||+++++++......++|+|+
T Consensus 91 ~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~------~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~ 164 (391)
T PHA03212 91 KAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQ------RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPR 164 (391)
T ss_pred cCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechh------hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEec
Confidence 3579999999999999999998754 7889999753 23568899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+. ++|..++.. ...+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 165 ~~-~~L~~~l~~---~~~l~~~~~~~i~~qi~~aL~ylH~~~---IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~- 236 (391)
T PHA03212 165 YK-TDLYCYLAA---KRNIAICDILAIERSVLRAIQYLHENR---IIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN- 236 (391)
T ss_pred CC-CCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHhEEEcCCCCEEEEeCCccccccccc-
Confidence 96 677777633 345889999999999999999999987 9999999999999999999999999997532211
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
........||+.|+|||++.+..++.++|||||||++|||++|+.|+..
T Consensus 237 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~ 285 (391)
T PHA03212 237 ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFE 285 (391)
T ss_pred ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCC
Confidence 1122336799999999999999999999999999999999999988754
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-32 Score=289.59 Aligned_cols=195 Identities=25% Similarity=0.351 Sum_probs=164.2
Q ss_pred ceecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHH-HHhHhcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVL-LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~-il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||++... +++.+|+|++.+.. ....+++..|.. +++.++||||+++++.+...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 36999999999999865 48899999986431 223344555554 46778999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|...+.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..... ...
T Consensus 81 ~~L~~~l~~---~~~~~~~~~~~~~~qi~~al~~lH~~g---ivH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~--~~~ 152 (325)
T cd05604 81 GELFFHLQR---ERSFPEPRARFYAAEIASALGYLHSIN---IVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQ--SDT 152 (325)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEEeecCCcccCCCC--CCC
Confidence 999888743 346899999999999999999999988 999999999999999999999999998753221 112
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....||+.|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~ 200 (325)
T cd05604 153 TTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRD 200 (325)
T ss_pred cccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCC
Confidence 234679999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=295.58 Aligned_cols=201 Identities=29% Similarity=0.419 Sum_probs=174.3
Q ss_pred CCccceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC------cceE
Q 004674 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ERML 590 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------~~~l 590 (738)
|...+.||+|+||.||+|+.+ .|+.||||.+.... ....+....|+++|++++|+|||+++++-++.. ...+
T Consensus 15 W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vl 94 (732)
T KOG4250|consen 15 WEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVL 94 (732)
T ss_pred eeehhhhcCCccceeeeecccccccchhHHhhhhhcccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceE
Confidence 445678999999999999965 49999999987643 345677889999999999999999999865544 4789
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc--CCC--ceEEEeecCc
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NTM--NPKISDFGLA 666 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~--~vkL~DFGla 666 (738)
|||||.+|+|...+........|++.+.+.+..++..||.|||+++ |+||||||.||++- +++ -.||+|||.|
T Consensus 95 vmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~---IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~A 171 (732)
T KOG4250|consen 95 VMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENG---IVHRDLKPGNIVLQIGEDGQSIYKLTDFGAA 171 (732)
T ss_pred EEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcC---ceeccCCCCcEEEeecCCCceEEeeeccccc
Confidence 9999999999999988877888999999999999999999999988 99999999999993 333 4799999999
Q ss_pred cccCCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 667 RSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
+.+..+. .....+||..|++||...+ +.|+.-+|.|||||++||.+||..||....
T Consensus 172 rel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 172 RELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred ccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 9875443 3455899999999999985 889999999999999999999999997543
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-33 Score=305.35 Aligned_cols=198 Identities=31% Similarity=0.530 Sum_probs=171.2
Q ss_pred CCccceecccccEeEEEeeecc-c---cEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~-g---~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
..+.+.||.|.||.|++|+++- | ..||||.++.... ....+|..|..||.+++||||++|.|+.......+||.|
T Consensus 631 i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~GytekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTE 710 (996)
T KOG0196|consen 631 VKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITE 710 (996)
T ss_pred eEEEEEEecccccceecccccCCCCcceeEEEeeeccCccHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhh
Confidence 3567889999999999999864 3 4699999976643 346789999999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
||+||+|+.+|... .+.+.+.+..-++.+||.||+||.+.+ +|||||.++|||++.+...|++|||+++.+..+.
T Consensus 711 yMENGsLDsFLR~~--DGqftviQLVgMLrGIAsGMkYLsdm~---YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~ 785 (996)
T KOG0196|consen 711 YMENGSLDSFLRQN--DGQFTVIQLVGMLRGIASGMKYLSDMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDP 785 (996)
T ss_pred hhhCCcHHHHHhhc--CCceEeehHHHHHHHHHHHhHHHhhcC---chhhhhhhhheeeccceEEEeccccceeecccCC
Confidence 99999999999754 356999999999999999999999887 9999999999999999999999999999875443
Q ss_pred cccccccccc--ccCccchhcccCCCCCchhHHHHHHHHHHHHH-cCCCCCC
Q 004674 674 TEANTKRVVG--TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII-CGKKNRG 722 (738)
Q Consensus 674 ~~~~~~~~~g--t~~y~aPE~~~~~~~t~ksDVwS~Gvil~ell-tG~~p~~ 722 (738)
........| +.+|.|||.+....+|.++||||||+|+||.+ .|.+||-
T Consensus 786 -~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYW 836 (996)
T KOG0196|consen 786 -EAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYW 836 (996)
T ss_pred -CccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCccc
Confidence 222221222 56999999999999999999999999999965 5889883
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-31 Score=287.84 Aligned_cols=194 Identities=26% Similarity=0.351 Sum_probs=162.5
Q ss_pred ceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHH-HHHhHhcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEV-LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei-~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||+++... ++.+|+|++.+.. .....++..|. .+++.++|+||+++++++...+..++||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 369999999999999764 6789999986432 12223444444 456778999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|.+++.. ...+.+..+..++.||++||+|||+.+ |+||||||+|||++.++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~~~~~~~~~~~~qi~~~L~~lH~~g---iiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~--~~ 152 (325)
T cd05602 81 GELFYHLQR---ERCFLEPRARFYAAEIASALGYLHSLN---IVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--GT 152 (325)
T ss_pred CcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEecCCCHHHeEECCCCCEEEccCCCCcccccCC--CC
Confidence 999988853 345788888899999999999999988 9999999999999999999999999987542211 12
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.....||+.|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 199 (325)
T cd05602 153 TSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSR 199 (325)
T ss_pred cccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCC
Confidence 33467999999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-33 Score=267.72 Aligned_cols=203 Identities=29% Similarity=0.430 Sum_probs=174.1
Q ss_pred hcCCCCccceecccccEeEEEeeec-cccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
.++.|++.+.||+|.|+.|++.... .|+.+|+|++... .....+++.+|++|.+.++|||||++...+.+....+||
T Consensus 9 f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylv 88 (355)
T KOG0033|consen 9 FSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLV 88 (355)
T ss_pred cchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEE
Confidence 4577888899999999999998764 4888888876432 233678899999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc---CCCceEEEeecCccc
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARS 668 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~vkL~DFGla~~ 668 (738)
+|+|+++.|..-+.. +...++..+-+.+.||+++|.|+|..+ |||||+||+|+||- ..--+||+|||+|..
T Consensus 89 Fe~m~G~dl~~eIV~---R~~ySEa~aSH~~rQiLeal~yCH~n~---IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~ 162 (355)
T KOG0033|consen 89 FDLVTGGELFEDIVA---REFYSEADASHCIQQILEALAYCHSNG---IVHRDLKPENLLLASKAKGAAVKLADFGLAIE 162 (355)
T ss_pred EecccchHHHHHHHH---HHHHHHHHHHHHHHHHHHHHHHHHhcC---ceeccCChhheeeeeccCCCceeecccceEEE
Confidence 999999999766633 245788888899999999999999998 99999999999994 344589999999998
Q ss_pred cCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
+.. ....-..+||++|||||+++..+|+..+|||+-|||||-|+.|..||..++.
T Consensus 163 l~~---g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~ 217 (355)
T KOG0033|consen 163 VND---GEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 217 (355)
T ss_pred eCC---ccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH
Confidence 762 2223347899999999999999999999999999999999999999976443
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=307.10 Aligned_cols=206 Identities=22% Similarity=0.345 Sum_probs=173.9
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC---cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|++.++||+|+||.||+|.... ++.||+|++..... ...+++.+|++++++++||||+++++++.+.+..++||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 578889999999999999998754 88999999865422 23457899999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeec
Q 004674 593 EYLPNKSLDYFIFDTTR--------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFG 664 (738)
||+++++|.+++..... ...+++..+.+++.||++||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~G---IIHRDLKPeNILLd~dg~vKLiDFG 158 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKG---VLHRDLKPDNILLGLFGEVVILDWG 158 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchheEEEcCCCCEEEEecC
Confidence 99999999998854211 234567788899999999999999987 9999999999999999999999999
Q ss_pred CccccCCCcc----------------cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 665 LARSFGLDQT----------------EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 665 la~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
+++....... .......+||+.|+|||++.+..++.++|||||||+++||++|+.||....
T Consensus 159 LAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 159 AAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred cceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 9986521110 001122569999999999999999999999999999999999999996543
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=279.18 Aligned_cols=201 Identities=31% Similarity=0.457 Sum_probs=172.7
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
+|+..+.||+|+||.||++... +++.||+|++.... ......+.+|+.++++++|+||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 4677889999999999999865 47899999986432 2223457789999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 156 (285)
T cd05605 81 LMNGGDLKFHIYNM-GNPGFDEERAVFYAAEITCGLEDLHRER---IVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE 156 (285)
T ss_pred ccCCCcHHHHHHhc-CcCCCCHHHHHHHHHHHHHHHHHHHHCC---cEecCCCHHHEEECCCCCEEEeeCCCceecCCCC
Confidence 99999999887543 2346899999999999999999999988 9999999999999999999999999997653222
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
. .....|+..|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~ 205 (285)
T cd05605 157 T---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRK 205 (285)
T ss_pred c---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCc
Confidence 1 123578999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=278.62 Aligned_cols=201 Identities=26% Similarity=0.435 Sum_probs=165.9
Q ss_pred CCCCccceecccccEeEEEeeec--cccEEEEEEccCCC--CcchHHHHHHHHHHhHh---cCCCeeeEEeEEec-----
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI--EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQ----- 584 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~--~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l---~H~nIv~l~g~~~~----- 584 (738)
++|+..+.||+|+||.||++... +++.||+|+++... ......+.+|+.+++.+ +||||+++++++..
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCCCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 46888899999999999999863 36789999886432 22234566777777766 69999999999852
Q ss_pred CCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeec
Q 004674 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (738)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFG 664 (738)
....++||||++ ++|..++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~-~~~~~~~~~~~~i~~qi~~aL~~lH~~~---iiH~dlkp~Nil~~~~~~~kl~Dfg 155 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKV-PEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLADFG 155 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEEcCCCCEEEcccc
Confidence 345899999997 5888887543 2345899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
+++..... .......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 156 ~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 213 (290)
T cd07862 156 LARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 213 (290)
T ss_pred ceEeccCC---cccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCC
Confidence 99765432 12233568999999999998899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=285.05 Aligned_cols=195 Identities=31% Similarity=0.438 Sum_probs=167.1
Q ss_pred ceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||++.... ++.||+|++.+. .....+.+..|.+++..+ +||||+++++++...+..++||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 369999999999998765 778999998653 223345677888888887 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...... ..
T Consensus 81 ~~L~~~~~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~--~~ 152 (318)
T cd05570 81 GDLMFHIQR---SGRFDEPRARFYAAEIVLGLQFLHERG---IIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG--VT 152 (318)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eEccCCCHHHeEECCCCcEEecccCCCeecCcCC--Cc
Confidence 999888743 346899999999999999999999987 9999999999999999999999999987532211 12
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
....+|++.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~ 200 (318)
T cd05570 153 TSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDD 200 (318)
T ss_pred ccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCC
Confidence 233578999999999999999999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-31 Score=276.84 Aligned_cols=202 Identities=27% Similarity=0.412 Sum_probs=169.8
Q ss_pred CCCCccceecccccEeEEEeeec----cccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~----~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
++|++.+.||+|+||.||+|.+. .+..||+|.++.... ...+.+.+|+.++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 84 (266)
T cd05064 5 KSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSDKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIV 84 (266)
T ss_pred HHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEE
Confidence 46788899999999999999753 356899999875532 2345788999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|||+++++|++++... ...+++..++.++.||+.||+|||+.+ ++||||||+|||++.++.+|++|||.+.....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~i~~al~~lH~~~---iiH~dikp~nili~~~~~~~l~dfg~~~~~~~ 159 (266)
T cd05064 85 TEYMSNGALDSFLRKH--EGQLVAGQLMGMLPGLASGMKYLSEMG---YVHKGLAAHKVLVNSDLVCKISGFRRLQEDKS 159 (266)
T ss_pred EEeCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeeccccHhhEEEcCCCcEEECCCcccccccc
Confidence 9999999999998542 346899999999999999999999987 99999999999999999999999998765322
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
... .......++..|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus 160 ~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~ 212 (266)
T cd05064 160 EAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDM 212 (266)
T ss_pred cch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 111 11112335678999999999999999999999999999775 99998643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.7e-32 Score=289.30 Aligned_cols=195 Identities=29% Similarity=0.349 Sum_probs=168.1
Q ss_pred ceecccccEeEEEeee----ccccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 523 NKLGEGGFGPVYKGML----IEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~----~~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
+.||+|+||.||++.. ..++.+|+|++.... ......+.+|++++++++||||+++++++..+...++||||++
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~ 81 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLR 81 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCC
Confidence 5799999999999875 247899999986532 1234567789999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+++|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++....... .
T Consensus 82 ~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~--~ 153 (318)
T cd05582 82 GGDLFTRLSK---EVMFTEEDVKFYLAELALALDHLHSLG---IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE--K 153 (318)
T ss_pred CCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHeEECCCCcEEEeeccCCcccCCCC--C
Confidence 9999988843 346899999999999999999999988 9999999999999999999999999987653321 1
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......|++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~ 202 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCC
Confidence 2233678999999999998889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-31 Score=290.32 Aligned_cols=206 Identities=31% Similarity=0.438 Sum_probs=171.8
Q ss_pred cCCCCccceecccccEeEEEeeecc------ccEEEEEEccCCCC-cchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCc
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDE 587 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~ 587 (738)
.+.|.+.+.||+|+||.||+|.... +..||+|++..... ...+.+.+|++++++++ ||||+++++++.+...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~ 115 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARSSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGP 115 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCc
Confidence 4678888999999999999998532 34699999965432 23467899999999996 9999999999999999
Q ss_pred ceEEEeeCCCCChhHHHhhcCC----------------------------------------------------------
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTR---------------------------------------------------------- 609 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 609 (738)
.+|||||+++|+|.+++.....
T Consensus 116 ~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 195 (400)
T cd05105 116 IYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIK 195 (400)
T ss_pred eEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhhhh
Confidence 9999999999999988864210
Q ss_pred -----------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC
Q 004674 610 -----------------------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654 (738)
Q Consensus 610 -----------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~ 654 (738)
...+++.++..++.||++||+|||+.+ |+||||||+|||+++
T Consensus 196 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dikp~Nill~~ 272 (400)
T cd05105 196 EASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKN---CVHRDLAARNVLLAQ 272 (400)
T ss_pred hhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHhEEEeC
Confidence 124788889999999999999999987 999999999999999
Q ss_pred CCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 655 TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 655 ~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 273 ~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~ 343 (400)
T cd05105 273 GKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGM 343 (400)
T ss_pred CCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCccc
Confidence 99999999999986543322222223456788999999999899999999999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=283.45 Aligned_cols=202 Identities=30% Similarity=0.515 Sum_probs=169.5
Q ss_pred CCCCccceecccccEeEEEeeecc-cc----EEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~----~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
.+|+..+.||+|+||.||+|+... +. .||+|.+.... ....+++.+|+.+++.++|+||+++++++... ..++
T Consensus 7 ~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~ 85 (316)
T cd05108 7 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 85 (316)
T ss_pred hhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-Ccee
Confidence 568889999999999999998643 33 48999986443 23456889999999999999999999999764 5789
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
++||+++|+|.+++... ...+++..+++++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.
T Consensus 86 v~e~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~ 160 (316)
T cd05108 86 ITQLMPFGCLLDYVREH--KDNIGSQYLLNWCVQIAKGMNYLEERR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 160 (316)
T ss_pred eeecCCCCCHHHHHHhc--cccCCHHHHHHHHHHHHHHHHHHHhcC---eeccccchhheEecCCCcEEEcccccccccc
Confidence 99999999999988643 235889999999999999999999987 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||+..
T Consensus 161 ~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~ 215 (316)
T cd05108 161 ADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGI 215 (316)
T ss_pred CCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 4332222222334678999999999999999999999999999997 99998653
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=288.76 Aligned_cols=195 Identities=29% Similarity=0.447 Sum_probs=164.0
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++|+..+.||+|+||.||++... +++.||+|++..... ...+.+.+|+++++.++|+||+++++++...+..++||||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 153 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEF 153 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCcHHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEec
Confidence 34566788999999999999875 488999999865432 2346789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|... ...++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.....
T Consensus 154 ~~~~~L~~~-------~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~ 223 (353)
T PLN00034 154 MDGGSLEGT-------HIADEQFLADVARQILSGIAYLHRRH---IVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD 223 (353)
T ss_pred CCCCccccc-------ccCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEcccccceecccccc
Confidence 999998543 23567788899999999999999988 99999999999999999999999999987643221
Q ss_pred cccccccccccCccchhcccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
......||..|+|||.+.. ...+.++|||||||++|||++|+.||..
T Consensus 224 --~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 224 --PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred --cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1223578999999998743 2345689999999999999999999974
|
|
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=279.35 Aligned_cols=204 Identities=25% Similarity=0.398 Sum_probs=177.0
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
-|...+.||+|.|++|-++++. .|..||||++.+.. ......+.+|++.|+.++|||||+++.+...+...|||+|.
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLEL 98 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILEL 98 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEecccccchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEe
Confidence 3556678999999999988865 48999999997663 33456788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE-cCCCceEEEeecCccccCCCc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl-~~~~~vkL~DFGla~~~~~~~ 673 (738)
-.+|+|.++|.+.. ..+.+....+++.||+.|+.|+|+.. +|||||||+|+.+ ..-|-|||.|||++..+...+
T Consensus 99 GD~GDl~DyImKHe--~Gl~E~La~kYF~QI~~AI~YCHqLH---VVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~ 173 (864)
T KOG4717|consen 99 GDGGDLFDYIMKHE--EGLNEDLAKKYFAQIVHAISYCHQLH---VVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK 173 (864)
T ss_pred cCCchHHHHHHhhh--ccccHHHHHHHHHHHHHHHHHHhhhh---hhcccCCcceeEEeeecCceEeeeccccccCCCcc
Confidence 99999999997654 45899999999999999999999987 9999999999987 467899999999998775433
Q ss_pred ccccccccccccCccchhcccCCCCC-chhHHHHHHHHHHHHHcCCCCCCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIICGKKNRGFNHADHD 729 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~Gvil~elltG~~p~~~~~~~~~ 729 (738)
.....||++.|-|||++.+..|+ +++||||||||||.|+||+.||....+-+.
T Consensus 174 ---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSET 227 (864)
T KOG4717|consen 174 ---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSET 227 (864)
T ss_pred ---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhh
Confidence 34458999999999999999987 568999999999999999999976555443
|
|
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=275.16 Aligned_cols=200 Identities=39% Similarity=0.593 Sum_probs=166.0
Q ss_pred ccceecccccEeEEEeeec-----cccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 521 EKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 521 ~~~~LG~G~fG~Vykg~~~-----~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
..+.||.|.||.||+|.+. .+..|+||.+..... ...+++.+|++.+++++||||++++|++...+..++||||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~ 82 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEY 82 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE-
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccccccceeeeecccccccccccccccccccccccccccccccc
Confidence 3568999999999999986 256799999955332 2367899999999999999999999999988889999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++|+|.+++... ....+++..+..++.||++||+|||+.+ ++|+||+++|||+++++.+||+|||++........
T Consensus 83 ~~~g~L~~~L~~~-~~~~~~~~~~~~i~~~i~~~l~~Lh~~~---iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~ 158 (259)
T PF07714_consen 83 CPGGSLDDYLKSK-NKEPLSEQQRLSIAIQIAEALSYLHSNN---IIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK 158 (259)
T ss_dssp -TTEBHHHHHHHT-CTTTSBHHHHHHHHHHHHHHHHHHHHTT---EEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS
T ss_pred ccccccccccccc-cccccccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc
Confidence 9999999999764 2356899999999999999999999987 99999999999999999999999999987632222
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
............|+|||.+.+..++.++||||||+++|||++ |+.|+...
T Consensus 159 ~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~ 209 (259)
T PF07714_consen 159 YKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDY 209 (259)
T ss_dssp EEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTS
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 222233456789999999999989999999999999999999 67887543
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=277.47 Aligned_cols=205 Identities=32% Similarity=0.516 Sum_probs=173.7
Q ss_pred CCCCccceecccccEeEEEeeecc------ccEEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcce
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 589 (738)
++|.+.+.||+|+||.||+|...+ ++.||+|.+...... ..+.+.+|++++++++|+||+++++++......+
T Consensus 5 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~ 84 (280)
T cd05049 5 DTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPI 84 (280)
T ss_pred HHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCHHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeE
Confidence 457778899999999999998643 468999998765443 4578999999999999999999999999999999
Q ss_pred EEEeeCCCCChhHHHhhcC-----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCce
Q 004674 590 LIYEYLPNKSLDYFIFDTT-----------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~-----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~v 658 (738)
+||||+++++|.+++.... ....+++..+..++.|++.|++|||+.+ ++||||||+||+++.++.+
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 85 MVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQH---FVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred EEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC---eeccccccceEEEcCCCeE
Confidence 9999999999999986432 1245789999999999999999999987 9999999999999999999
Q ss_pred EEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 659 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
||+|||+++...............+++.|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~ 228 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGL 228 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCC
Confidence 9999999976533222111222345788999999999999999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-31 Score=271.89 Aligned_cols=202 Identities=31% Similarity=0.449 Sum_probs=172.4
Q ss_pred CCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
++|+..+.||+|+||.||++...++..+|+|.+... ....+++.+|+.++++++||||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~ 82 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEG-AMSEEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFME 82 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccC-CccHHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCC
Confidence 457778899999999999999887888999987543 3345788999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||.++.........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05114 83 NGCLLNYLRQR--QGKLSKDMLLSMCQDVCEGMEYLERNS---FIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcceEEEcCCCeEEECCCCCccccCCCceec
Confidence 99999988542 235889999999999999999999987 9999999999999999999999999987653222111
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
.....++..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 158 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~ 206 (256)
T cd05114 158 -SSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKS 206 (256)
T ss_pred -cCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 112335668999999988889999999999999999999 899986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.5e-31 Score=278.52 Aligned_cols=206 Identities=35% Similarity=0.553 Sum_probs=172.9
Q ss_pred CCCCccceecccccEeEEEeeecc------ccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcce
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 589 (738)
++|+..+.||+|+||.||+|.... ...|++|.+..... ...+++.+|+.++.+++||||+++++++......+
T Consensus 5 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~ 84 (283)
T cd05048 5 SAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTC 84 (283)
T ss_pred HHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCCHHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceE
Confidence 467788999999999999998643 25799998864432 33467899999999999999999999999988999
Q ss_pred EEEeeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC
Q 004674 590 LIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 656 (738)
++|||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++
T Consensus 85 ~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 85 MLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHH---FVHRDLAARNCLVGEGL 161 (283)
T ss_pred EEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccccceEEEcCCC
Confidence 99999999999999864321 145889999999999999999999987 99999999999999999
Q ss_pred ceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 657 NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 657 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
.+||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFS 231 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999999986543322222223456788999999998899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.8e-31 Score=272.89 Aligned_cols=203 Identities=34% Similarity=0.504 Sum_probs=174.8
Q ss_pred cCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
.++|+..++||+|++|.||+|...++..||+|.+.... ...+.+.+|+.++++++|+||+++++.+...+..+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGT-MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYM 83 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCc-hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecC
Confidence 36788899999999999999998788899999875432 34678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~l~~~-~~~~~~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05072 84 AKGSLLDFLKSD-EGGKVLLPKLIDFSAQIAEGMAYIERKN---YIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT 159 (261)
T ss_pred CCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEecCCCcEEECCCccceecCCCcee
Confidence 999999988543 2346889999999999999999999987 999999999999999999999999999876432221
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
. .....++..|+|||++....++.++||||||+++|||++ |+.||...
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 208 (261)
T cd05072 160 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGM 208 (261)
T ss_pred c-cCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCC
Confidence 1 112345678999999998889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=278.18 Aligned_cols=205 Identities=34% Similarity=0.493 Sum_probs=171.5
Q ss_pred CCCCccceecccccEeEEEeee-----ccccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
++|+..+.||+|+||.||+|.. ..+..+++|.+.... .+...++.+|+.++++++|+||+++++++..+...++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~l 84 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINNPQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCM 84 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCCHHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEE
Confidence 4577788999999999999984 235789999986433 2334678899999999999999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCC--------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC
Q 004674 591 IYEYLPNKSLDYFIFDTTR--------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~--------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 656 (738)
||||+++++|.+++..... ...+++.+...++.|++.||+|||+.+ ++||||||+|||+++++
T Consensus 85 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~nili~~~~ 161 (283)
T cd05090 85 LFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQL 161 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcC---eehhccccceEEEcCCC
Confidence 9999999999998853211 234788999999999999999999987 99999999999999999
Q ss_pred ceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 657 NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 657 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
.+||+|||+++...............++..|+|||++.+..++.++||||||++++||++ |..||...
T Consensus 162 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05090 162 HVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGF 230 (283)
T ss_pred cEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 999999999987643322222233445778999999998889999999999999999998 88888543
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-31 Score=276.30 Aligned_cols=206 Identities=32% Similarity=0.508 Sum_probs=174.0
Q ss_pred CCCCccceecccccEeEEEeeec------cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
++|.+.+.||+|+||.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++++...+..++
T Consensus 5 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (288)
T cd05093 5 HNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIM 84 (288)
T ss_pred HHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEE
Confidence 56788899999999999999742 245689999876655556789999999999999999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcC----------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEE
Q 004674 591 IYEYLPNKSLDYFIFDTT----------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~----------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL 660 (738)
||||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~---i~H~dlkp~Nili~~~~~~kl 161 (288)
T cd05093 85 VFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQH---FVHRDLATRNCLVGENLLVKI 161 (288)
T ss_pred EEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCcEEe
Confidence 999999999999986432 1235899999999999999999999988 999999999999999999999
Q ss_pred EeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 661 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
+|||++................++..|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus 162 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~ 227 (288)
T cd05093 162 GDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLS 227 (288)
T ss_pred ccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999986543322222222445778999999998899999999999999999998 889886543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=273.17 Aligned_cols=193 Identities=30% Similarity=0.446 Sum_probs=165.4
Q ss_pred ecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCCh
Q 004674 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 525 LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (738)
||+|+||.||++.... ++.+|+|++.... ......+..|++++++++||||+++.+.+..+...++||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 7999999999998754 8899999986432 12234556799999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccc
Q 004674 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (738)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 680 (738)
.+++... ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.++|+|||++....... ....
T Consensus 81 ~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~ 153 (277)
T cd05607 81 KYHIYNV-GERGLEMERVIHYSAQITCGILHLHSMD---IVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQ 153 (277)
T ss_pred HHHHHhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---EEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeec
Confidence 8887543 2345889999999999999999999987 9999999999999999999999999987654321 1223
Q ss_pred cccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
..|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 154 RAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred cCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 56899999999999988999999999999999999999999643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.2e-31 Score=287.66 Aligned_cols=200 Identities=25% Similarity=0.381 Sum_probs=167.8
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC-----cce
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----ERM 589 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-----~~~ 589 (738)
+|+..+.||+|+||.||++... +++.||+|++.... ....+++.+|+++++.++|+||+++++++...+ ..+
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~ 80 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIY 80 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccchHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEE
Confidence 4678899999999999999864 58899999986532 223467889999999999999999999998776 789
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcccc
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 669 (738)
+||||+. ++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++..
T Consensus 81 lv~e~~~-~~l~~~~~---~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 81 VVTELMQ-SDLHKIIV---SPQPLSSDHVKVFLYQILRGLKYLHSAG---ILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEeeccc-cCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCChHHEEECCCCCEEeccccceeec
Confidence 9999997 46766663 3356899999999999999999999988 999999999999999999999999999865
Q ss_pred CCCcccccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 670 GLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
...... ......+++.|+|||++.+. .++.++|||||||+++||++|+.||....
T Consensus 154 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 209 (372)
T cd07853 154 EPDESK-HMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQS 209 (372)
T ss_pred ccCccc-cCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCC
Confidence 432221 12224678899999998874 57999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-31 Score=274.78 Aligned_cols=207 Identities=28% Similarity=0.463 Sum_probs=171.5
Q ss_pred hcCCCCccceecccccEeEEEeeec------cccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCc
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 587 (738)
..++|+..+.||+|+||.||++... .+..||+|++..... ....++.+|+.+++.++|+||+++++++.++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~ 83 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQP 83 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 4567899999999999999998753 246799998864322 234568899999999999999999999999999
Q ss_pred ceEEEeeCCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEE
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTR-------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL 660 (738)
.++||||+++++|.+++..... ...+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---~vH~dlkp~Nil~~~~~~~~l 160 (277)
T cd05062 84 TLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKI 160 (277)
T ss_pred eEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCcchheEEEcCCCCEEE
Confidence 9999999999999999864321 234678889999999999999999987 999999999999999999999
Q ss_pred EeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 661 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~ 225 (277)
T cd05062 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGM 225 (277)
T ss_pred CCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999876543222111112345778999999999899999999999999999999 68888643
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-31 Score=259.28 Aligned_cols=201 Identities=27% Similarity=0.437 Sum_probs=172.3
Q ss_pred HHhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC----Cc----chHHHHHHHHHHhHh-cCCCeeeEEeEE
Q 004674 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS----GQ----GMEEFKNEVLLIAKL-QHRNLVKLLGCC 582 (738)
Q Consensus 513 ~~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~----~~----~~~~~~~Ei~il~~l-~H~nIv~l~g~~ 582 (738)
...-.+|...+.||.|..++|-++..+. |+++|+|++.... .+ ..++-.+|+.+|+++ -||+|+++.+++
T Consensus 13 ~~fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~y 92 (411)
T KOG0599|consen 13 KGFYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVY 92 (411)
T ss_pred hhHHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeec
Confidence 3445678888999999999999888755 7899999875331 11 134456799999998 599999999999
Q ss_pred ecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEe
Q 004674 583 TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (738)
Q Consensus 583 ~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~D 662 (738)
+...-.++|+|.|+.|.|.+++.. .-.+++.+..+|+.|+.+|+.|||... ||||||||+|||++++.++||+|
T Consensus 93 es~sF~FlVFdl~prGELFDyLts---~VtlSEK~tR~iMrqlfegVeylHa~~---IVHRDLKpENILlddn~~i~isD 166 (411)
T KOG0599|consen 93 ESDAFVFLVFDLMPRGELFDYLTS---KVTLSEKETRRIMRQLFEGVEYLHARN---IVHRDLKPENILLDDNMNIKISD 166 (411)
T ss_pred cCcchhhhhhhhcccchHHHHhhh---heeecHHHHHHHHHHHHHHHHHHHHhh---hhhcccChhheeeccccceEEec
Confidence 999999999999999999999944 345899999999999999999999988 99999999999999999999999
Q ss_pred ecCccccCCCcccccccccccccCccchhcccC------CCCCchhHHHHHHHHHHHHHcCCCCCC
Q 004674 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAID------GLFSVKSDVFSFGVLVLEIICGKKNRG 722 (738)
Q Consensus 663 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~ksDVwS~Gvil~elltG~~p~~ 722 (738)
||+|..+... ......|||++|+|||.++. ..|+..+|+|+.|||+|.|+.|-.||-
T Consensus 167 FGFa~~l~~G---ekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFw 229 (411)
T KOG0599|consen 167 FGFACQLEPG---EKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFW 229 (411)
T ss_pred cceeeccCCc---hhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchh
Confidence 9999887533 33455899999999998854 348889999999999999999999984
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=271.61 Aligned_cols=201 Identities=25% Similarity=0.415 Sum_probs=172.8
Q ss_pred cCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
.++|++.+.||+|+||.||+|... +++.||+|++..........+++|+.++++++|+||+++++.+..++..++||||
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~ 87 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEY 87 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccchHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeC
Confidence 357888999999999999999964 5788999998755545556788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++.. ...+++..+..++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||++..+.....
T Consensus 88 ~~~~~L~~~~~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~ 161 (267)
T cd06646 88 CGGGSLQDIYHV---TGPLSELQIAYVCRETLQGLAYLHSKG---KMHRDIKGANILLTDNGDVKLADFGVAAKITATIA 161 (267)
T ss_pred CCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCCEEECcCccceeeccccc
Confidence 999999998843 346899999999999999999999987 99999999999999999999999999987643221
Q ss_pred cccccccccccCccchhccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
......|+..|+|||.+. ...++.++||||||++++||++|+.|+...
T Consensus 162 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~ 212 (267)
T cd06646 162 --KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDL 212 (267)
T ss_pred --ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 112356888999999874 345788999999999999999999998543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-31 Score=288.33 Aligned_cols=197 Identities=24% Similarity=0.362 Sum_probs=168.4
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhc-C-----CCeeeEEeEEecCCcceE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-H-----RNLVKLLGCCTQRDERML 590 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H-----~nIv~l~g~~~~~~~~~l 590 (738)
+|++.+.||+|.||.|.|+.... ++.||||+++.. .....+...|+.+|..++ | -|+|++++++..+++.+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~-k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~Hlci 265 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK-KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCI 265 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC-hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceee
Confidence 67889999999999999999655 889999999654 344566788999999997 4 499999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC--CCceEEEeecCccc
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--TMNPKISDFGLARS 668 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~vkL~DFGla~~ 668 (738)
|+|.+. .+|.+++... +...++...++.++.||+.||.+||+.+ |||+||||+||||.+ ...+||+|||.|..
T Consensus 266 VfELL~-~NLYellK~n-~f~Glsl~~ir~~~~Qil~~L~~L~~l~---IIHcDLKPENILL~~~~r~~vKVIDFGSSc~ 340 (586)
T KOG0667|consen 266 VFELLS-TNLYELLKNN-KFRGLSLPLVRKFAQQILTALLFLHELG---IIHCDLKPENILLKDPKRSRIKVIDFGSSCF 340 (586)
T ss_pred eehhhh-hhHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCChhheeeccCCcCceeEEecccccc
Confidence 999985 5788888553 3456999999999999999999999988 999999999999964 34799999999986
Q ss_pred cCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
...... ....+..|+|||++.+.+|+.+.||||||||+.||++|...|-.+.
T Consensus 341 ~~q~vy-----tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~n 392 (586)
T KOG0667|consen 341 ESQRVY-----TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDN 392 (586)
T ss_pred cCCcce-----eeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCC
Confidence 543221 3556889999999999999999999999999999999988775543
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=270.17 Aligned_cols=204 Identities=32% Similarity=0.493 Sum_probs=174.5
Q ss_pred cCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
.++|+..+.||+|++|.||++....++.||+|.++... ...+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 83 (261)
T cd05068 5 RTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGT-MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELM 83 (261)
T ss_pred hhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCc-ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecc
Confidence 35688889999999999999998778889999986543 34678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++.... ...+++..+..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 84 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~ 159 (261)
T cd05068 84 KYGSLLEYLQGGA-GRALKLPQLIDMAAQVASGMAYLEAQN---YIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE 159 (261)
T ss_pred cCCcHHHHHhccC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeccCCcceEEEcCCCCEEECCcceEEEccCCccc
Confidence 9999999985432 346899999999999999999999987 999999999999999999999999999876532211
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
. ......+..|+|||++.+..++.++||||||++++||++ |+.||....
T Consensus 160 ~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 209 (261)
T cd05068 160 A-REGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMT 209 (261)
T ss_pred c-cCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 1 111223457999999999899999999999999999999 999886533
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-31 Score=297.58 Aligned_cols=206 Identities=28% Similarity=0.352 Sum_probs=172.6
Q ss_pred CCCCccceecccccEeEEEeeeccc-cEEEEEEccCCCCcchHHHHHHHHHHhHhc-CCCeeeEEeEE-ec------CCc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEG-QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCC-TQ------RDE 587 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g-~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~-~~------~~~ 587 (738)
-+.++.+.|.+|||+.||.+....+ .++|+|++-..++...+.+++||++|++|+ |+|||.+++.. .. .-+
T Consensus 37 ~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~E 116 (738)
T KOG1989|consen 37 HRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWE 116 (738)
T ss_pred EEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeE
Confidence 4456778999999999999998876 999999987777788899999999999997 99999999932 21 125
Q ss_pred ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcc
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 667 (738)
++|.||||.+|.|-+++...... .|++.++++|+.++++|+++||... ++|||||||-+||||+.+++.||+|||.|.
T Consensus 117 vllLmEyC~gg~Lvd~mn~Rlq~-~lte~eVLkIf~dv~~AVa~mH~~~-pPiIHRDLKiENvLls~~g~~KLCDFGSat 194 (738)
T KOG1989|consen 117 VLLLMEYCKGGSLVDFMNTRLQT-RLTEDEVLKIFYDVCEAVAAMHYLK-PPIIHRDLKIENVLLSADGNYKLCDFGSAT 194 (738)
T ss_pred EEeehhhccCCcHHHHHHHHHhc-cCChHHHHHHHHHHHHHHHHHhcCC-CccchhhhhhhheEEcCCCCEEeCcccccc
Confidence 78999999999999998754444 4999999999999999999999986 789999999999999999999999999986
Q ss_pred ccCCCccccc-------ccccccccCccchhcc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 668 SFGLDQTEAN-------TKRVVGTYGYMSPEYA---IDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 668 ~~~~~~~~~~-------~~~~~gt~~y~aPE~~---~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
-.-....... .....-|+.|+|||.+ .+.++++|+|||+|||+||-|+....||+..
T Consensus 195 t~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s 261 (738)
T KOG1989|consen 195 TKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES 261 (738)
T ss_pred cccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC
Confidence 4322221100 0012348999999976 5788999999999999999999999999754
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-30 Score=269.61 Aligned_cols=201 Identities=32% Similarity=0.477 Sum_probs=172.0
Q ss_pred CCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
++|...+.||+|+||.||++...++..+|+|.+.... ...+++.+|+.++.+++||||+++++++.+....++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05113 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMS 82 (256)
T ss_pred HHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCc-ccHHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCC
Confidence 4577788999999999999988777789999886433 345789999999999999999999999999889999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+++|.+++.... ..+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||.++.........
T Consensus 83 ~~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~~ 157 (256)
T cd05113 83 NGCLLNYLREHG--KRFQPSQLLEMCKDVCEGMAYLESKQ---FIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEYTS 157 (256)
T ss_pred CCcHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCCEEECCCccceecCCCceee
Confidence 999999885432 36899999999999999999999987 9999999999999999999999999987654322111
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 -~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 205 (256)
T cd05113 158 -SVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERF 205 (256)
T ss_pred -cCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcC
Confidence 111235678999999998889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-30 Score=278.02 Aligned_cols=201 Identities=26% Similarity=0.439 Sum_probs=169.2
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++|...+.||+|+||.||++... .++.||+|+++... ......+.+|+.++++++|+||+++++++..++..++||||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 85 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEY 85 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeC
Confidence 56888899999999999999875 47789999986543 22345678899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++ +|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........
T Consensus 86 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 159 (309)
T cd07872 86 LDK-DLKQYMDDC--GNIMSMHNVKIFLYQILRGLAYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSVPTK 159 (309)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECccccceecCCCcc
Confidence 985 677766432 345889999999999999999999988 99999999999999999999999999976533221
Q ss_pred cccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 160 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~ 209 (309)
T cd07872 160 --TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGST 209 (309)
T ss_pred --ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1222467899999998865 568999999999999999999999997544
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=275.33 Aligned_cols=206 Identities=31% Similarity=0.492 Sum_probs=173.7
Q ss_pred CCCCccceecccccEeEEEeeec------cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
.+|...+.||+|+||.||++... ....+++|.+........+.+.+|++++++++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (291)
T cd05094 5 RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIM 84 (291)
T ss_pred HHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccHHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEE
Confidence 35677789999999999999742 345689999866555555789999999999999999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc
Q 004674 591 IYEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 657 (738)
||||+++++|.+++.... ....+++..++.++.||+.|++|||+.+ |+||||||+||++++++.
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil~~~~~~ 161 (291)
T cd05094 85 VFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQH---FVHRDLATRNCLVGANLL 161 (291)
T ss_pred EEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccCcceEEEccCCc
Confidence 999999999999986432 1235899999999999999999999988 999999999999999999
Q ss_pred eEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 658 PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 658 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
+||+|||++................++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 162 ~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 230 (291)
T cd05094 162 VKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLS 230 (291)
T ss_pred EEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999976543322122223456788999999999999999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=268.65 Aligned_cols=201 Identities=30% Similarity=0.480 Sum_probs=172.4
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCCC-----cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-----QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-----~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
++|+..+.||+|++|.||++... .++++++|.+..... ...+.+.+|++++++++||||+++++++.+++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 57888999999999999999865 488999998764321 123568899999999999999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
|+||+++++|.+.+.. ...+++..+.+++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||+++...
T Consensus 82 v~e~~~~~~l~~~~~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~ 155 (263)
T cd06625 82 FMEYMPGGSVKDQLKA---YGALTETVTRKYTRQILEGVEYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKRLQ 155 (263)
T ss_pred EEEECCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeecccceecc
Confidence 9999999999988853 345889999999999999999999987 9999999999999999999999999997654
Q ss_pred CCccccc-ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 671 LDQTEAN-TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 671 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
....... .....++..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 209 (263)
T cd06625 156 TICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAE 209 (263)
T ss_pred ccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccc
Confidence 3221111 1234578899999999998899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=287.93 Aligned_cols=194 Identities=29% Similarity=0.492 Sum_probs=172.1
Q ss_pred ceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCChh
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 601 (738)
-.||+|.||+||-|+..+ ...+|||.+.....+..+.+++||.+.+.++|.|||+.+|.+.++...-|.||.++||+|.
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLS 660 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLS 660 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHH
Confidence 369999999999999766 4579999998888888889999999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc-CCCceEEEeecCccccCCCcccccc
Q 004674 602 YFIFDTTRSKLL--DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANT 678 (738)
Q Consensus 602 ~~l~~~~~~~~l--~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~vkL~DFGla~~~~~~~~~~~~ 678 (738)
..+.. ..+++ ++..+-.+.+||++||.|||++. |||||||-+|+|++ -.|.+||+|||-++++.. ...-+
T Consensus 661 sLLrs--kWGPlKDNEstm~fYtkQILeGLkYLHen~---IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAg--inP~T 733 (1226)
T KOG4279|consen 661 SLLRS--KWGPLKDNESTMNFYTKQILEGLKYLHENK---IVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAG--INPCT 733 (1226)
T ss_pred HHHHh--ccCCCccchhHHHHHHHHHHHHhhhhhhcc---eeeccccCCcEEEeeccceEEecccccchhhcc--CCccc
Confidence 99953 45667 78888889999999999999987 99999999999996 578999999999987642 23334
Q ss_pred cccccccCccchhcccCCC--CCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 679 KRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 679 ~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
..+.||..|||||++..++ |..++|||||||.+.||.|||+||-.
T Consensus 734 ETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~E 780 (1226)
T KOG4279|consen 734 ETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVE 780 (1226)
T ss_pred cccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeee
Confidence 5578999999999998654 89999999999999999999999953
|
|
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=274.37 Aligned_cols=203 Identities=30% Similarity=0.459 Sum_probs=168.1
Q ss_pred CCCCccceecccccEeEEEeeecc-cc----EEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~----~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
++|+..+.||+|+||.||+|.... ++ .+++|.+..... ....++..|+.++++++||||+++++++. ....++
T Consensus 7 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~~~~ 85 (279)
T cd05111 7 TELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRSGRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GASLQL 85 (279)
T ss_pred hhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccccchHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCccEE
Confidence 467778899999999999998643 43 478888754322 23457788888999999999999999875 455789
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+|||+++++.+||+|||+++...
T Consensus 86 i~e~~~~gsL~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~ 160 (279)
T cd05111 86 VTQLSPLGSLLDHVRQH--RDSLDPQRLLNWCVQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLY 160 (279)
T ss_pred EEEeCCCCcHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEEcCCccceecc
Confidence 99999999999998542 346899999999999999999999987 9999999999999999999999999998654
Q ss_pred CCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
............++..|+|||.+.+..++.++||||||+++||+++ |+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 216 (279)
T cd05111 161 PDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMR 216 (279)
T ss_pred CCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 3322222233456789999999998899999999999999999998 999986544
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=275.34 Aligned_cols=201 Identities=27% Similarity=0.480 Sum_probs=175.5
Q ss_pred cCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
..+|+..+.||+|++|.||++... .++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||
T Consensus 19 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~ 98 (296)
T cd06654 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (296)
T ss_pred ccceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecc
Confidence 357888899999999999999864 5789999998766555567889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||++........
T Consensus 99 ~~~~~L~~~~~~----~~~~~~~~~~i~~ql~~aL~~LH~~g---i~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~ 171 (296)
T cd06654 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (296)
T ss_pred cCCCCHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEcCCCCEEECccccchhcccccc
Confidence 999999998842 34789999999999999999999988 99999999999999999999999999876532221
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
. .....+++.|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 172 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~ 220 (296)
T cd06654 172 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (296)
T ss_pred c--cCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 122468889999999998889999999999999999999999996544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=290.83 Aligned_cols=199 Identities=24% Similarity=0.411 Sum_probs=162.0
Q ss_pred hcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecC--------
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-------- 585 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-------- 585 (738)
..++|+..+.||+|+||.||+|... .++.||||++.... ....+|+.+++.++|+||+++.+++...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~----~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~ 139 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDP----QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKN 139 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCc----chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCc
Confidence 3467999999999999999999975 47899999885432 2345799999999999999998876432
Q ss_pred CcceEEEeeCCCCChhHHHhh-cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-ceEEEee
Q 004674 586 DERMLIYEYLPNKSLDYFIFD-TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDF 663 (738)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~-~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~vkL~DF 663 (738)
...++||||+++ +|.+++.. ......+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 140 ~~l~lvmE~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~---IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 140 IFLNVVMEFIPQ-TVHKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHSKF---ICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred eEEEEEEecCCc-cHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCcCHHHEEEcCCCCceeeecc
Confidence 135689999986 56555533 233457899999999999999999999988 99999999999998654 7999999
Q ss_pred cCccccCCCcccccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
|+++.+..... .....||+.|+|||++.+. .++.++|||||||++|||++|+.||...
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~ 274 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQ 274 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99986543221 2235689999999998764 6899999999999999999999999654
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=271.49 Aligned_cols=204 Identities=31% Similarity=0.511 Sum_probs=178.1
Q ss_pred cCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
..+|+..+.||+|+||.||++...+++.+++|.+.........++.+|+.+++.++|+||+++++++...+..++||||+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~ 84 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELM 84 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchhhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeec
Confidence 45678889999999999999998888999999997766556778999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++... ....+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~ 160 (261)
T cd05148 85 EKGSLLAFLRSP-EGQVLPVASLIDMACQVAEGMAYLEEQN---SIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYL 160 (261)
T ss_pred ccCCHHHHHhcC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccCcceEEEcCCceEEEccccchhhcCCcccc
Confidence 999999998653 3456899999999999999999999988 999999999999999999999999999776432221
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
. ....++..|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus 161 ~--~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~ 209 (261)
T cd05148 161 S--SDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMN 209 (261)
T ss_pred c--cCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCC
Confidence 1 12345678999999988899999999999999999998 899986543
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=286.91 Aligned_cols=198 Identities=22% Similarity=0.319 Sum_probs=169.7
Q ss_pred cCCCCccceecccccEeEEEeeec---cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI---EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
..+|++.+.||+|+||.||++... .+..|++|.+... +...+|++++++++|+||+++++++......++||
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~-----~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~ 165 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGG-----KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVM 165 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEecccc-----ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEe
Confidence 357889999999999999998753 2567999987543 34568999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
|++. ++|..++. ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||++......
T Consensus 166 e~~~-~~l~~~l~---~~~~l~~~~~~~i~~ql~~aL~~LH~~g---ivHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~ 238 (392)
T PHA03207 166 PKYK-CDLFTYVD---RSGPLPLEQAITIQRRLLEALAYLHGRG---IIHRDVKTENIFLDEPENAVLGDFGAACKLDAH 238 (392)
T ss_pred hhcC-CCHHHHHH---hcCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEccCccccccCcc
Confidence 9996 56767762 3456899999999999999999999988 999999999999999999999999999876543
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
..........||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 239 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 291 (392)
T PHA03207 239 PDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQ 291 (392)
T ss_pred cccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 33333334679999999999999999999999999999999999999996543
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=267.02 Aligned_cols=202 Identities=30% Similarity=0.441 Sum_probs=175.1
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|+..+.||+|++|.||++... +++.|++|.+... .....+++.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEY 80 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEe
Confidence 4677789999999999999875 4789999987643 233456788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~l~~~-~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 81 AENGDLHKLLKMQ-RGRPLPEDQVWRFFIQILLGLAHLHSKK---ILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred CCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999998653 2356899999999999999999999987 99999999999999999999999999887643322
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
. .....|++.|+|||+..+..++.++||||||++++||++|+.||....
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 205 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANN 205 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1 223568889999999999899999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=271.07 Aligned_cols=193 Identities=25% Similarity=0.396 Sum_probs=168.5
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++|+..+.||+|+||.||++... .++.||+|.+.... ....+++.+|++++++++||||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 80 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEF 80 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEec
Confidence 35777889999999999999864 57889999986542 23346788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|..+. .+++..+..++.|++.||+|||+.+ |+|+||||+|||++.++.+||+|||++......
T Consensus 81 ~~~~~l~~~~-------~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~-- 148 (279)
T cd06619 81 MDGGSLDVYR-------KIPEHVLGRIAVAVVKGLTYLWSLK---ILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS-- 148 (279)
T ss_pred CCCCChHHhh-------cCCHHHHHHHHHHHHHHHHHHHHCC---EeeCCCCHHHEEECCCCCEEEeeCCcceecccc--
Confidence 9999996542 3678888999999999999999988 999999999999999999999999999765322
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
......|+..|+|||++.+..++.++||||||+++|||++|+.||..
T Consensus 149 --~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~ 195 (279)
T cd06619 149 --IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQ 195 (279)
T ss_pred --cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchh
Confidence 12235789999999999998999999999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=267.74 Aligned_cols=201 Identities=31% Similarity=0.452 Sum_probs=170.5
Q ss_pred CCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
.+|+..+.||+|+||.||++....+..+|+|.+.+.. ....++.+|++++++++|+||+++++++...+..++||||++
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~ 82 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGA-MSEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMA 82 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCC-CCHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCC
Confidence 3467788999999999999988777789999986433 235678899999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.........
T Consensus 83 ~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~~ 157 (256)
T cd05059 83 NGCLLNYLRER--KGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTS 157 (256)
T ss_pred CCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHhhEEECCCCcEEECCcccceecccccccc
Confidence 99999988543 236899999999999999999999988 9999999999999999999999999987654221111
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 205 (256)
T cd05059 158 -SQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERF 205 (256)
T ss_pred -cCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCC
Confidence 111223457999999999899999999999999999999 78888654
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=276.22 Aligned_cols=200 Identities=26% Similarity=0.362 Sum_probs=171.7
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++|++.+.||+|+||.||++.... +..+|+|.+.... ....+++.+|++++.+++||||+++++++..++..++||||
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey 80 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEH 80 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeec
Confidence 468889999999999999998754 7788999876442 22345688999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++... ..+++..+..++.|+++||+|||+.. +++|+||||+|||+++++.+||+|||++......
T Consensus 81 ~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~-- 153 (308)
T cd06615 81 MDGGSLDQVLKKA---GRIPENILGKISIAVLRGLTYLREKH--KIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS-- 153 (308)
T ss_pred cCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhhC--CEEECCCChHHEEEecCCcEEEccCCCccccccc--
Confidence 9999999998542 56889999999999999999999742 3999999999999999999999999998754322
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......|+..|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus 154 --~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 154 --MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred --ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 1223568899999999988889999999999999999999999986443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=282.44 Aligned_cols=198 Identities=27% Similarity=0.381 Sum_probs=166.5
Q ss_pred hcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC-----
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----- 586 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~----- 586 (738)
..++|+..+.||+|+||.||++.... ++.||+|++... .....+++.+|+.+++.++||||+++++++....
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 98 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEF 98 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccccchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCcccc
Confidence 34789999999999999999998754 889999998643 2233567789999999999999999999986543
Q ss_pred -cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecC
Q 004674 587 -ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (738)
Q Consensus 587 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl 665 (738)
..++||||++++ |...+. ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 99 ~~~~lv~e~~~~~-l~~~~~-----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 99 QDVYLVMELMDAN-LCQVIH-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred ceeEEEEeCCCcC-HHHHHh-----ccCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEecCCC
Confidence 469999999764 544442 23788889999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
++...... ......||+.|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~ 225 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGT 225 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCC
Confidence 97643221 122356899999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-30 Score=280.49 Aligned_cols=204 Identities=31% Similarity=0.479 Sum_probs=168.8
Q ss_pred CCCCccceecccccEeEEEeeec------cccEEEEEEccCCCC-cchHHHHHHHHHHhHh-cCCCeeeEEeEEecC-Cc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR-DE 587 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~-~~ 587 (738)
++|++.+.||+|+||.||++... .++.||+|++..... ...+.+..|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~ 86 (337)
T cd05054 7 DRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGATASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGP 86 (337)
T ss_pred HHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCCHHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCC
Confidence 56888999999999999999642 246899999864432 2235677899999999 899999999988654 56
Q ss_pred ceEEEeeCCCCChhHHHhhcCC----------------------------------------------------------
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTR---------------------------------------------------------- 609 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 609 (738)
.+++|||+++++|.+++.....
T Consensus 87 ~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (337)
T cd05054 87 LMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELY 166 (337)
T ss_pred EEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhhHHh
Confidence 7899999999999998853221
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccccccccCccc
Q 004674 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689 (738)
Q Consensus 610 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 689 (738)
...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++.+.............++..|+|
T Consensus 167 ~~~l~~~~~~~~~~qi~~aL~~lH~~~---ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 167 KEPLTLEDLISYSFQVARGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred hcCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 136899999999999999999999987 99999999999999999999999999987643322222223456778999
Q ss_pred hhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 690 PEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 690 PE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
||++.+..++.++|||||||+++||++ |+.||..
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~ 278 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999999999999999997 9999864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=271.81 Aligned_cols=199 Identities=31% Similarity=0.453 Sum_probs=170.9
Q ss_pred CCccceecccccEeEEEeeec-cccEEEEEEccCCCC---cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
|+..+.||+|+||.||++... .++.+|+|.+..... ...+.+.+|+.++++++|++++++++.+.+.+..++||||
T Consensus 2 f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05630 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTL 81 (285)
T ss_pred ceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEe
Confidence 566788999999999999875 478999998865422 2234577899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.++|+|||++.......
T Consensus 82 ~~g~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 82 MNGGDLKFHIYHM-GEAGFEEGRAVFYAAEICCGLEDLHQER---IVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred cCCCcHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 9999999888543 2345899999999999999999999987 9999999999999999999999999987643221
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
......|+..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 112346899999999999999999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=271.49 Aligned_cols=199 Identities=29% Similarity=0.438 Sum_probs=171.0
Q ss_pred CCccceecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
|+..+.||+|+||.||++... +++.+|+|.+.... ....+.+.+|++++++++|+|++++.+.+..++..++||||
T Consensus 2 ~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~ 81 (285)
T cd05632 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTI 81 (285)
T ss_pred ceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEe
Confidence 566788999999999999875 47899999986432 12234578899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++... ....+++..+..++.|++.||.|||+.+ |+||||||+||++++++.+||+|||++.......
T Consensus 82 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~~---iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 82 MNGGDLKFHIYNM-GNPGFEEERALFYAAEILCGLEDLHREN---TVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred ccCccHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 9999999887543 2346899999999999999999999987 9999999999999999999999999987643221
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
......|+..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~ 204 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGR 204 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 122356899999999999889999999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=271.62 Aligned_cols=204 Identities=30% Similarity=0.493 Sum_probs=171.8
Q ss_pred CCCCccceecccccEeEEEeeec------cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~------~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
++|...++||+|+||.||++... .+..+++|.+........+.+.+|+++++.++|+||+++++++......++
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 84 (280)
T cd05092 5 RDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLM 84 (280)
T ss_pred HhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEE
Confidence 45677889999999999998632 355789998876655566789999999999999999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCC------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCce
Q 004674 591 IYEYLPNKSLDYFIFDTTR------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~v 658 (738)
+|||+++++|.+++..... ...+++..+..++.||+.|++|||+.+ ++||||||+|||+++++.+
T Consensus 85 v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~---i~H~dlkp~nil~~~~~~~ 161 (280)
T cd05092 85 VFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLH---FVHRDLATRNCLVGQGLVV 161 (280)
T ss_pred EEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCC---eecccccHhhEEEcCCCCE
Confidence 9999999999999864321 135889999999999999999999987 9999999999999999999
Q ss_pred EEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 659 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
||+|||++................+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 162 kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 162 KIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred EECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 9999999876533221111222345678999999999999999999999999999998 8898854
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=267.63 Aligned_cols=198 Identities=29% Similarity=0.473 Sum_probs=176.9
Q ss_pred CCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
|.++++||+|+||.|||+.+++ |+.+|||.+... ...+++..|+.+|++.+.+++|+.+|.+......++|||||.-
T Consensus 35 FDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~--sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGA 112 (502)
T KOG0574|consen 35 FDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD--TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGA 112 (502)
T ss_pred HHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc--chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCC
Confidence 5567899999999999999876 899999987543 4578899999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
|+..+++. .+++++.+.++..++...++||+|||... -+|||||+.||||+.+|..||+|||.|..+......
T Consensus 113 GSiSDI~R--~R~K~L~E~EIs~iL~~TLKGL~YLH~~~---KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMAK-- 185 (502)
T KOG0574|consen 113 GSISDIMR--ARRKPLSEQEISAVLRDTLKGLQYLHDLK---KIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMAK-- 185 (502)
T ss_pred CcHHHHHH--HhcCCccHHHHHHHHHHHHhHHHHHHHHH---HHHhhcccccEEEcccchhhhhhccccchhhhhHHh--
Confidence 99999995 35678999999999999999999999876 899999999999999999999999999876433332
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
...+.||+-|||||++..-.|..++||||||+...||..||+||.--+
T Consensus 186 RNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIH 233 (502)
T KOG0574|consen 186 RNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIH 233 (502)
T ss_pred hCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCccccc
Confidence 334789999999999999999999999999999999999999996543
|
|
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=268.90 Aligned_cols=202 Identities=31% Similarity=0.466 Sum_probs=171.9
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
.+|+..+.||+|++|.||++...+ ++.|++|.+... ....+++.+|++++++++|+||+++++++...+..+++|||+
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (263)
T cd05052 6 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFM 84 (263)
T ss_pred HHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC-chHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeC
Confidence 346778899999999999999764 788999998644 334567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++... ....+++..++.++.|+++||+|||+.+ ++||||||+||++++++.+||+|||++.........
T Consensus 85 ~~~~L~~~~~~~-~~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~ 160 (263)
T cd05052 85 TYGNLLDYLREC-NRQEVNAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT 160 (263)
T ss_pred CCCcHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCcEEeCCCccccccccceee
Confidence 999999988543 2346899999999999999999999987 999999999999999999999999999876432211
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
......++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 161 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~ 209 (263)
T cd05052 161 -AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGI 209 (263)
T ss_pred -ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 1111234568999999999999999999999999999998 89998653
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=284.55 Aligned_cols=193 Identities=27% Similarity=0.396 Sum_probs=160.8
Q ss_pred ecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHh---cCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 525 LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l---~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
||+|+||.||+++... ++.||+|++.+.. ......+..|..++... +||||+++++.+.+.+..++||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 7999999999998754 8899999986432 11223445566666655 699999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|..++.. ...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++....... ..
T Consensus 81 g~L~~~l~~---~~~~~~~~~~~~~~qil~al~~LH~~~---ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~--~~ 152 (330)
T cd05586 81 GELFWHLQK---EGRFSEDRAKFYIAELVLALEHLHKYD---IVYRDLKPENILLDATGHIALCDFGLSKANLTDN--KT 152 (330)
T ss_pred ChHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC--CC
Confidence 999888743 346899999999999999999999988 9999999999999999999999999987543221 12
Q ss_pred ccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
....+||+.|+|||++.+. .++.++|||||||++|||++|+.||....
T Consensus 153 ~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 153 TNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred ccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 2346799999999998764 48999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-30 Score=287.52 Aligned_cols=196 Identities=21% Similarity=0.269 Sum_probs=167.3
Q ss_pred hcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
....|.+.+.||+|+||.||++.... ++.||+|... ...+.+|++++++++|+|||++++++..+...++|||
T Consensus 167 ~~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e 240 (461)
T PHA03211 167 AGLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGW------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLP 240 (461)
T ss_pred ccCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccc------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEE
Confidence 34578999999999999999999865 7789999632 2346789999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
++. ++|..++.. ....+++.+++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++......
T Consensus 241 ~~~-~~L~~~l~~--~~~~l~~~~~~~i~~qi~~aL~yLH~~g---IvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~ 314 (461)
T PHA03211 241 KYR-SDLYTYLGA--RLRPLGLAQVTAVARQLLSAIDYIHGEG---IIHRDIKTENVLVNGPEDICLGDFGAACFARGSW 314 (461)
T ss_pred ccC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECcCCHHHEEECCCCCEEEcccCCceeccccc
Confidence 995 677777643 2346899999999999999999999988 9999999999999999999999999998654322
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRG 722 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~ 722 (738)
.........||..|+|||++.+..++.++|||||||+||||++|..++.
T Consensus 315 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf 363 (461)
T PHA03211 315 STPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLF 363 (461)
T ss_pred ccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcc
Confidence 2222233579999999999999999999999999999999999887653
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.3e-32 Score=266.66 Aligned_cols=205 Identities=27% Similarity=0.372 Sum_probs=177.5
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC---cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
.++|..++.||+|.||.|.+++-+. ++.+|+|++++... .....-..|-++|+..+||.+..+--.+...+..++|
T Consensus 167 m~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFV 246 (516)
T KOG0690|consen 167 MEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFV 246 (516)
T ss_pred cchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEE
Confidence 3678888999999999999998654 88999999976532 2334456788899999999999888888899999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|||..+|.|..++ .+...+++....-+-..|+.||.|||+++ ||.||||.+|+|||.+|++||+|||+++.--.
T Consensus 247 MeyanGGeLf~HL---srer~FsE~RtRFYGaEIvsAL~YLHs~~---ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 247 MEYANGGELFFHL---SRERVFSEDRTRFYGAEIVSALGYLHSRN---IVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEccCceEeeeh---hhhhcccchhhhhhhHHHHHHhhhhhhCC---eeeeechhhhheeccCCceEeeecccchhccc
Confidence 9999999998877 34567899888889999999999999987 99999999999999999999999999975321
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~~ 728 (738)
....++.+|||+.|+|||++....|..++|.|.+||++|||+|||.||...+.+.
T Consensus 321 --~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k 375 (516)
T KOG0690|consen 321 --YGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK 375 (516)
T ss_pred --ccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH
Confidence 2334566999999999999999999999999999999999999999998765543
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=272.63 Aligned_cols=202 Identities=27% Similarity=0.474 Sum_probs=176.6
Q ss_pred cCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
.++|+..+.||+|++|.||++... +++.||+|.+........+.+.+|+.+++.++|+||+++++++...+..++||||
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 97 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 97 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecc
Confidence 467888999999999999999964 5889999998766555567789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++.. ..+++.++..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~~~~~~~~~~~~~l~~~L~~LH~~~---i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~ 170 (297)
T cd06656 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALDFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (297)
T ss_pred cCCCCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEECcCccceEccCCcc
Confidence 999999998843 35788999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
. .....+++.|+|||.+.+..++.++||||||+++|++++|+.||....+
T Consensus 171 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 171 K--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred C--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 1 1224678899999999998899999999999999999999999966443
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=268.21 Aligned_cols=202 Identities=30% Similarity=0.494 Sum_probs=171.7
Q ss_pred CCCCccceecccccEeEEEeeecc----ccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
++|+..+.||+|+||.||+|.... ...||+|.++... .....++.+|+.++++++|+||+++++.+...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv 83 (266)
T cd05033 4 SYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSSDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMII 83 (266)
T ss_pred HHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEE
Confidence 568888999999999999998743 3579999886543 23346788999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|||+++++|.+++... ...+++..+..++.|++.|++|||+.+ |+|+||||+||++++++.+||+|||++.....
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 158 (266)
T cd05033 84 TEYMENGSLDKFLREN--DGKFTVGQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLED 158 (266)
T ss_pred EEcCCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCcceEEEcCCCCEEECccchhhcccc
Confidence 9999999999998542 236899999999999999999999987 99999999999999999999999999987652
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
...........++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~ 211 (266)
T cd05033 159 SEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWD 211 (266)
T ss_pred cccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCC
Confidence 222212222345678999999998899999999999999999998 9999853
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=269.88 Aligned_cols=199 Identities=25% Similarity=0.440 Sum_probs=172.0
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
++|+..+.||+|+||.||++... +++.+|+|.++.........+.+|+.+++.++||||+++++.+...+..++||||+
T Consensus 9 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~ 88 (267)
T cd06645 9 EDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFC 88 (267)
T ss_pred HHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchhHHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEecc
Confidence 46777889999999999999875 47889999987655445567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++.. .+.+++.++..++.|++.|++|||+.+ ++|+||||+||+++.++.+||+|||++........
T Consensus 89 ~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~- 161 (267)
T cd06645 89 GGGSLQDIYHV---TGPLSESQIAYVSRETLQGLYYLHSKG---KMHRDIKGANILLTDNGHVKLADFGVSAQITATIA- 161 (267)
T ss_pred CCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEECcceeeeEccCccc-
Confidence 99999998843 346899999999999999999999988 99999999999999999999999999876543221
Q ss_pred ccccccccccCccchhccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
......|+..|+|||++. ...++.++|||||||++|||++|+.||..
T Consensus 162 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~ 211 (267)
T cd06645 162 -KRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFD 211 (267)
T ss_pred -ccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCccc
Confidence 123356899999999874 45688999999999999999999999854
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-30 Score=269.19 Aligned_cols=201 Identities=31% Similarity=0.476 Sum_probs=170.1
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|+..+.||+|++|.||+|... .++.||+|++.... ....+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEF 80 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEec
Confidence 4777889999999999999975 48899999886432 22346788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
++ ++|.+++........+++..+..++.||++||+|||+.+ ++|+||||+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 81 LS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR---VLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred CC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 97 678777754444467899999999999999999999987 99999999999999999999999999976543321
Q ss_pred cccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
......+++.|+|||++.+. .++.++||||||++++||++|+.||...
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~ 205 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGD 205 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 11224568899999988654 5789999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-31 Score=278.43 Aligned_cols=206 Identities=28% Similarity=0.433 Sum_probs=176.4
Q ss_pred ceecccccEeEEEeeecc-ccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (738)
+.||+|.||+||-|+.+. |+.||||++.+. .......+++|+.||++++||.||.+.-.|+..+..++|||-+.+.-
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDM 649 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDM 649 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchH
Confidence 689999999999999764 999999998764 33445789999999999999999999999999999999999997766
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---CCceEEEeecCccccCCCcccc
Q 004674 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~vkL~DFGla~~~~~~~~~~ 676 (738)
|.-++.. ..+.+++....-++.||+.||+|||.++ |+|+||||+||||.. --++||+|||+|+.++...
T Consensus 650 LEMILSs--EkgRL~er~TkFlvtQIL~ALr~LH~kn---IvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks--- 721 (888)
T KOG4236|consen 650 LEMILSS--EKGRLPERITKFLVTQILVALRYLHFKN---IVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS--- 721 (888)
T ss_pred HHHHHHh--hcccchHHHHHHHHHHHHHHHHHhhhcc---eeeccCCchheeeccCCCCCceeeccccceeecchhh---
Confidence 6555532 3456888888889999999999999998 999999999999954 3579999999999986432
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCCcccccccC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHVSL 738 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~~~~~l~~~~~~ 738 (738)
..+.++||+.|+|||++.++.|...-|+||.|||+|--++|.-||.. +|++.+-|.+|+|
T Consensus 722 FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNE--dEdIndQIQNAaF 781 (888)
T KOG4236|consen 722 FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNE--DEDINDQIQNAAF 781 (888)
T ss_pred hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCC--ccchhHHhhcccc
Confidence 23458999999999999999999999999999999999999999853 4556666777664
|
|
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=272.00 Aligned_cols=206 Identities=26% Similarity=0.449 Sum_probs=170.2
Q ss_pred hcCCCCccceecccccEeEEEeeecc------ccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCc
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 587 (738)
..++|++.+.||+|+||.||+|...+ +..||+|.+..... ....++.+|+.+++.++|+||+++++++.+...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~ 83 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRERIEFLNEASVMKGFTCHHVVRLLGVVSKGQP 83 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCC
Confidence 45788999999999999999987532 45799998764432 233467889999999999999999999999999
Q ss_pred ceEEEeeCCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEE
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTR-------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL 660 (738)
.++||||+++|+|.+++..... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||
T Consensus 84 ~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dikp~nili~~~~~~~L 160 (288)
T cd05061 84 TLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKK---FVHRDLAARNCMVAHDFTVKI 160 (288)
T ss_pred cEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---CcCCCCChheEEEcCCCcEEE
Confidence 9999999999999999864221 234577888999999999999999987 999999999999999999999
Q ss_pred EeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 661 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 161 ~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~ 224 (288)
T cd05061 161 GDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQG 224 (288)
T ss_pred CcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCC
Confidence 99999986543222111222345678999999999999999999999999999998 7788854
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-31 Score=272.80 Aligned_cols=202 Identities=30% Similarity=0.449 Sum_probs=177.3
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
.+.|..-+.||+|+||.|+-++... |+.+|.|++.+. .........+|-.+|.+++.+.||.+--.++..+..+||
T Consensus 184 ~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClV 263 (591)
T KOG0986|consen 184 KNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLV 263 (591)
T ss_pred ccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEE
Confidence 4567888899999999999888654 889999988543 233445677899999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
+..|.+|+|..+|.+.. ...++++.++-++.+|+-||++||.+. ||.|||||+|||||+.|+++|+|+|+|..+..
T Consensus 264 LtlMNGGDLkfHiyn~g-~~gF~e~ra~FYAAEi~cGLehlH~~~---iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 264 LTLMNGGDLKFHIYNHG-NPGFDEQRARFYAAEIICGLEHLHRRR---IVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEeecCCceeEEeeccC-CCCCchHHHHHHHHHHHhhHHHHHhcc---eeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999987643 357999999999999999999999987 99999999999999999999999999988754
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.+.. ...+||.+|||||++.+..|+...|.||+||+||||+.|+.||...
T Consensus 340 g~~~---~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~ 389 (591)
T KOG0986|consen 340 GKPI---RGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQR 389 (591)
T ss_pred CCcc---ccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhh
Confidence 3332 2248999999999999999999999999999999999999999753
|
|
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.2e-30 Score=267.81 Aligned_cols=203 Identities=26% Similarity=0.408 Sum_probs=173.7
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|++.+.||+|+||.||++... +++.||+|.+... .......+.+|+++++.++||||+++++++...+..++|+
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 57888999999999999999965 5889999987542 2233456889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
||+++++|.+++.... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~ 158 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCC---eeCCCCCHHHEEEcCCCCEEECccccceeccc
Confidence 9999999998875432 2345889999999999999999999987 99999999999999999999999999887643
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
... ......++..|+|||.+.+..++.++|+||||+++|||++|+.||...
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~ 209 (267)
T cd08228 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred hhH--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccc
Confidence 221 122346788999999999888999999999999999999999998543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.3e-30 Score=274.35 Aligned_cols=198 Identities=25% Similarity=0.391 Sum_probs=160.2
Q ss_pred cceecccccEeEEEeeec---cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEec--CCcceEEEeeCC
Q 004674 522 KNKLGEGGFGPVYKGMLI---EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERMLIYEYLP 596 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~---~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~ 596 (738)
.++||+|+||.||++... .++.+|+|.+.... ....+.+|+.++++++||||+++++++.. ....+++|||+.
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~ 83 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTG--ISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE 83 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCC--CcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC
Confidence 358999999999999864 35789999986432 23567889999999999999999998854 345789999987
Q ss_pred CCChhHHHhhcC------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE----cCCCceEEEeecCc
Q 004674 597 NKSLDYFIFDTT------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLA 666 (738)
Q Consensus 597 ~gsL~~~l~~~~------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~vkL~DFGla 666 (738)
+ +|.+++.... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+ +.++.+||+|||++
T Consensus 84 ~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 84 H-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred C-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 5 6766654221 1235889999999999999999999988 9999999999999 45678999999999
Q ss_pred cccCCCcc-cccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 667 RSFGLDQT-EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 667 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
+....... ........||+.|+|||++.+ ..++.++||||+||+++||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 87643322 122234678999999999877 458999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=271.27 Aligned_cols=201 Identities=29% Similarity=0.439 Sum_probs=173.1
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
++|++.+.||+|+||.||++.... ++.+++|.+........+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 91 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFC 91 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecC
Confidence 568888999999999999999765 7899999987666556678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|..++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........
T Consensus 92 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~- 165 (292)
T cd06644 92 PGGAVDAIMLEL--DRGLTEPQIQVICRQMLEALQYLHSMK---IIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQ- 165 (292)
T ss_pred CCCcHHHHHHhh--cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeecCCCcceEEEcCCCCEEEccCccceecccccc-
Confidence 999998877432 345899999999999999999999987 99999999999999999999999999875432211
Q ss_pred ccccccccccCccchhccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
......++..|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 166 -~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 218 (292)
T cd06644 166 -RRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHEL 218 (292)
T ss_pred -ccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccc
Confidence 122346788999999884 345788999999999999999999998654
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=270.14 Aligned_cols=207 Identities=32% Similarity=0.514 Sum_probs=170.8
Q ss_pred cCCCCccceecccccEeEEEeeecc------ccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcc
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 588 (738)
.++|...+.||+|++|.||++.... +..|++|.+.... ......+.+|+.++++++|+||+++++++.+....
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPR 84 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCc
Confidence 4678888999999999999998754 4678999876443 22345689999999999999999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcCC----CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC---ceEEE
Q 004674 589 MLIYEYLPNKSLDYFIFDTTR----SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKIS 661 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~----~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~vkL~ 661 (738)
++||||+++++|.+++..... ...+++..+.+++.||+.||+|||+.+ ++||||||+||+++.++ .+||+
T Consensus 85 ~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~nil~~~~~~~~~~kl~ 161 (277)
T cd05036 85 FILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENH---FIHRDIAARNCLLTCKGPGRVAKIA 161 (277)
T ss_pred EEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchheEEEeccCCCcceEec
Confidence 999999999999999864321 135899999999999999999999987 99999999999998654 69999
Q ss_pred eecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 662 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
|||+++................+..|+|||++.+..++.++|||||||++|||++ |+.||....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~ 226 (277)
T cd05036 162 DFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRT 226 (277)
T ss_pred cCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999987632221111112233568999999999999999999999999999997 999986543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=269.76 Aligned_cols=192 Identities=27% Similarity=0.456 Sum_probs=160.6
Q ss_pred CCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhH--hcCCCeeeEEeEEecCC----cceE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK--LQHRNLVKLLGCCTQRD----ERML 590 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~--l~H~nIv~l~g~~~~~~----~~~l 590 (738)
++....+.||+|.||.||+|.+ .|..||||++...+ .+.+.+|.++.+. |+|+||+.+++.-.... +++|
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srd---E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwL 286 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRD---ERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWL 286 (513)
T ss_pred heeEEEEEecCccccceeeccc-cCCceEEEEecccc---hhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEE
Confidence 4566788999999999999999 68899999997554 4567888888775 59999999998754433 4899
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-----CCCCCeEeCCCCCCcEEEcCCCceEEEeecC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-----DSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-----~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl 665 (738)
|.+|.++|||.++|. ...++....++++..+|.||+|||- ++++.|.|||||+.|||+..+++..|+|+|+
T Consensus 287 vTdYHe~GSL~DyL~----r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGL 362 (513)
T KOG2052|consen 287 VTDYHEHGSLYDYLN----RNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 362 (513)
T ss_pred eeecccCCcHHHHHh----hccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeecee
Confidence 999999999999993 3568999999999999999999994 4778999999999999999999999999999
Q ss_pred ccccCCC--cccccccccccccCccchhcccCCC----C--CchhHHHHHHHHHHHHHc
Q 004674 666 ARSFGLD--QTEANTKRVVGTYGYMSPEYAIDGL----F--SVKSDVFSFGVLVLEIIC 716 (738)
Q Consensus 666 a~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~----~--t~ksDVwS~Gvil~ellt 716 (738)
|...... .........+||.+|||||++.... + -..+||||||.|+||+..
T Consensus 363 Av~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiar 421 (513)
T KOG2052|consen 363 AVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIAR 421 (513)
T ss_pred eEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHH
Confidence 9876543 2334455579999999999986532 1 135899999999999764
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-30 Score=267.11 Aligned_cols=198 Identities=28% Similarity=0.424 Sum_probs=165.2
Q ss_pred ceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCCh
Q 004674 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (738)
+.||+|+||.||++... +++.+|+|.+.... ......+.+|++++++++|+||+++++++......++||||+++++|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 80 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcH
Confidence 36999999999999875 58889999876443 23456789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccc
Q 004674 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (738)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 680 (738)
.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++..............
T Consensus 81 ~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 155 (252)
T cd05084 81 LTFLRTE--GPRLKVKELIQMVENAAAGMEYLESKH---CIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGM 155 (252)
T ss_pred HHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEEcCCCcEEECccccCcccccccccccCCC
Confidence 9988532 345889999999999999999999987 99999999999999999999999999876432211111111
Q ss_pred cccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
...+..|+|||.+.+..++.++||||||+++|||++ |..||....
T Consensus 156 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~ 201 (252)
T cd05084 156 KQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLS 201 (252)
T ss_pred CCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 123457999999999899999999999999999998 888886433
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.6e-30 Score=272.22 Aligned_cols=200 Identities=28% Similarity=0.496 Sum_probs=175.6
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
++|+..+.||.|++|.||++... +++.|++|.+........+.+.+|+.+++.++|+|++++++.+...+..++|+||+
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 98 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYL 98 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEec
Confidence 46888899999999999999864 58899999987655555678899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|..++.. ..+++.++..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++.........
T Consensus 99 ~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~~---i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~ 171 (296)
T cd06655 99 AGGSLTDVVTE----TCMDEAQIAAVCRECLQALEFLHANQ---VIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK 171 (296)
T ss_pred CCCcHHHHHHh----cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccchhccccccc
Confidence 99999998742 35899999999999999999999988 999999999999999999999999998765432221
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....++..|+|||.+.+..++.++|||||||++|||++|+.||....
T Consensus 172 --~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~ 219 (296)
T cd06655 172 --RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (296)
T ss_pred --CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 222468889999999998889999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.1e-30 Score=267.69 Aligned_cols=198 Identities=25% Similarity=0.359 Sum_probs=160.0
Q ss_pred eecccccEeEEEeeecc---ccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCC
Q 004674 524 KLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (738)
Q Consensus 524 ~LG~G~fG~Vykg~~~~---g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (738)
.||+|+||.||+|.... ...+++|.+..... .....+.+|+.+++.++|+||+++++.+......++||||+++|+
T Consensus 2 ~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05042 2 EIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGD 81 (269)
T ss_pred cCCccCCceEEEEEEecCCCCeEEEEeecCccCChHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCc
Confidence 59999999999997543 34688888754432 234568899999999999999999999999999999999999999
Q ss_pred hhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 600 LDYFIFDTTR--SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 600 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
|.+++..... ....++.....++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 82 LKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQAD---FIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred HHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcC---EecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 9999865432 234567888899999999999999987 99999999999999999999999999875432211111
Q ss_pred ccccccccCccchhccc-------CCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAI-------DGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~-------~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
.....++..|+|||++. ...++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~ 213 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDL 213 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcC
Confidence 12234567899999864 2457889999999999999999 77787543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=270.55 Aligned_cols=207 Identities=26% Similarity=0.446 Sum_probs=173.4
Q ss_pred cCCCCccceecccccEeEEEeeecc------ccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcc
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 588 (738)
.++|.+.+.||+|+||.||++.... +..||+|.+..... ....++.+|+.+++.++|+||+++++++......
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~ 84 (277)
T cd05032 5 REKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASMRERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPT 84 (277)
T ss_pred hHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCHHHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCc
Confidence 3578888999999999999998643 36799999865432 3345788999999999999999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcCC-------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEE
Q 004674 589 MLIYEYLPNKSLDYFIFDTTR-------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~-------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~ 661 (738)
++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+
T Consensus 85 ~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 85 LVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKK---FVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred EEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccChheEEEcCCCCEEEC
Confidence 999999999999999864321 234788999999999999999999987 9999999999999999999999
Q ss_pred eecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 662 DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
|||+++...............++..|+|||.+.+..++.++||||||+++||+++ |+.||....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 226 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLS 226 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCC
Confidence 9999986543322122223456789999999988889999999999999999998 889886433
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-30 Score=267.43 Aligned_cols=198 Identities=27% Similarity=0.398 Sum_probs=162.7
Q ss_pred eecccccEeEEEeeecc---ccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCC
Q 004674 524 KLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (738)
Q Consensus 524 ~LG~G~fG~Vykg~~~~---g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (738)
.||+|+||.||+|...+ +..+++|.++.... .....+.+|+.++++++||||+++++++.+....++||||+++++
T Consensus 2 ~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~ 81 (269)
T cd05087 2 EIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGD 81 (269)
T ss_pred cccccCCceEEEEEEcCCCCceEEEEEecCCCCChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCc
Confidence 69999999999998643 35799998865432 234578899999999999999999999999999999999999999
Q ss_pred hhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 600 LDYFIFDTTR--SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 600 L~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++++||+|||++...........
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 82 LKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNN---FIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred HHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---EeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 9999865322 234677888899999999999999987 99999999999999999999999999875433222222
Q ss_pred ccccccccCccchhcccCC-------CCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDG-------LFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~-------~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||...
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 213 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHL 213 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCC
Confidence 2234577889999988642 35789999999999999996 99999654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=272.30 Aligned_cols=205 Identities=31% Similarity=0.474 Sum_probs=170.0
Q ss_pred CCCccceecccccEeEEEeeecc------ccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~------g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
+|++.+.||+|+||.||+|.... ...+++|.+..... ...+++.+|+.+++.++||||+++++.+...+..++
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSSELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLL 80 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCHHHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEE
Confidence 46778899999999999998532 35688888865432 234678899999999999999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCc
Q 004674 591 IYEYLPNKSLDYFIFDTT---------------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 649 (738)
++||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 81 v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---ivH~dikp~n 157 (290)
T cd05045 81 IVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMK---LVHRDLAARN 157 (290)
T ss_pred EEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCC---eehhhhhhhe
Confidence 999999999999875421 1235889999999999999999999987 9999999999
Q ss_pred EEEcCCCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 650 VLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 650 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
||+++++.+||+|||+++...............++..|+|||.+.+..++.++||||||++++||++ |+.||....
T Consensus 158 ill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 234 (290)
T cd05045 158 VLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIA 234 (290)
T ss_pred EEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCC
Confidence 9999999999999999976533222111222345678999999988889999999999999999998 998886543
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-30 Score=274.10 Aligned_cols=204 Identities=33% Similarity=0.497 Sum_probs=169.7
Q ss_pred CCCccceecccccEeEEEeeecc------ccEEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
+|...+.||+|+||.||+|.... ++.||+|+++..... ..+.+.+|+.++..++||||+++++++...+..++
T Consensus 6 ~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~ 85 (283)
T cd05091 6 TVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSM 85 (283)
T ss_pred HHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEE
Confidence 45667889999999999998632 467999998754332 34668899999999999999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc
Q 004674 591 IYEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 657 (738)
++||+++++|.+++.... ....+++..+..++.|++.||+|||+.+ |+||||||+||++++++.
T Consensus 86 ~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 86 IFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHH---VVHKDLATRNVLVFDKLN 162 (283)
T ss_pred EEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhheEecCCCc
Confidence 999999999999985321 1235888999999999999999999987 999999999999999999
Q ss_pred eEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 658 PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 658 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 230 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGY 230 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCC
Confidence 99999999886543322222222445778999999988889999999999999999998 88887643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.9e-31 Score=259.50 Aligned_cols=198 Identities=27% Similarity=0.416 Sum_probs=168.7
Q ss_pred ceecccccEeEEEee-eccccEEEEEEccCCCCcchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcceEEEeeCCCCCh
Q 004674 523 NKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (738)
+.||+|+++.|-.++ +..+.++|||++.+...-...+..+|++++...+ |+||++++++++++..+|||||-|.+|+|
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGpl 163 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPL 163 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchH
Confidence 579999999998877 4579999999998887777888999999999985 99999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC---ceEEEeecCccccCCC-----
Q 004674 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKISDFGLARSFGLD----- 672 (738)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~vkL~DFGla~~~~~~----- 672 (738)
...|.+ ...+++.++.++.++|+.||.+||.++ |.||||||+|||-.+.. -+||+||.++.-+...
T Consensus 164 LshI~~---~~~F~E~EAs~vvkdia~aLdFlH~kg---IAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~sp 237 (463)
T KOG0607|consen 164 LSHIQK---RKHFNEREASRVVKDIASALDFLHTKG---IAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSP 237 (463)
T ss_pred HHHHHH---hhhccHHHHHHHHHHHHHHHHHHhhcC---cccccCCccceeecCCCCcCceeeeccccccccccCCCCCC
Confidence 988854 456899999999999999999999998 99999999999996544 3799999987654321
Q ss_pred cccccccccccccCccchhccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
.........+|+..|||||+.. ...|+.++|.||||||||-|++|..||-....
T Consensus 238 astP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg 296 (463)
T KOG0607|consen 238 ASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCG 296 (463)
T ss_pred CCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccC
Confidence 1222233467889999999763 24588999999999999999999999976554
|
|
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=270.30 Aligned_cols=207 Identities=27% Similarity=0.441 Sum_probs=173.6
Q ss_pred hcCCCCccceecccccEeEEEeeecc-----ccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEec-CCc
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDE 587 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-----g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-~~~ 587 (738)
..++|+..+.||+|+||.||+|...+ +..|++|++.... ....+.+.+|+.++++++|+||+++++++.. +..
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~ 83 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEP 83 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCC
Confidence 34678888999999999999999765 6789999886543 2335678899999999999999999998776 467
Q ss_pred ceEEEeeCCCCChhHHHhhcCCC-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEe
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRS-----KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~-----~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~D 662 (738)
.++++||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|
T Consensus 84 ~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kl~d 160 (280)
T cd05043 84 PFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRG---VIHKDIAARNCVIDEELQVKITD 160 (280)
T ss_pred CEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccCHhhEEEcCCCcEEECC
Confidence 89999999999999998654322 46899999999999999999999987 99999999999999999999999
Q ss_pred ecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 663 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
||+++.+.............++..|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus 161 ~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 223 (280)
T cd05043 161 NALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEI 223 (280)
T ss_pred CCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcC
Confidence 999986543222211222345778999999998889999999999999999999 99999654
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-30 Score=269.65 Aligned_cols=199 Identities=28% Similarity=0.434 Sum_probs=170.9
Q ss_pred CCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
|++.+.||+|+||.||++.... +..+++|.+........+.+.+|+++++.++|+||+++++++..++..++||||+++
T Consensus 7 ~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~ 86 (282)
T cd06643 7 WEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAG 86 (282)
T ss_pred HHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCHHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCC
Confidence 5667889999999999999765 678899998766555567889999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|..++.. ....+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++........ .
T Consensus 87 ~~l~~~~~~--~~~~l~~~~~~~~~~qi~~~L~~LH~~~---i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~ 159 (282)
T cd06643 87 GAVDAVMLE--LERPLTEPQIRVVCKQTLEALNYLHENK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--R 159 (282)
T ss_pred CcHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCcccEEEccCCCEEEcccccccccccccc--c
Confidence 999888753 2346899999999999999999999987 99999999999999999999999999876532211 1
Q ss_pred ccccccccCccchhccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.....++..|+|||++. +..++.++|||||||++|||++|+.||...
T Consensus 160 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 211 (282)
T cd06643 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHEL 211 (282)
T ss_pred cccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCcccc
Confidence 22356889999999874 455788999999999999999999998643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=266.62 Aligned_cols=201 Identities=28% Similarity=0.439 Sum_probs=169.2
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC-----CcchHHHHHHHHHHhHhcCCCeeeEEeEEecC--Ccc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~-----~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~ 588 (738)
++|+..+.||+|+||.||++...+ ++.|++|.+.... ....+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 578888999999999999998754 7899999875321 12245788899999999999999999988764 457
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
+++|||+++++|.+++.. ...+++..+.+++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 82 ~~v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~Dfg~~~~ 155 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKS---YGALTENVTRKYTRQILEGVSYLHSNM---IVHRDIKGANILRDSVGNVKLGDFGASKR 155 (265)
T ss_pred EEEEEecCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEecCCCCEEECcCccccc
Confidence 899999999999998853 235788899999999999999999988 99999999999999999999999999876
Q ss_pred cCCCcc-cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 669 FGLDQT-EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 669 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~ 211 (265)
T cd06652 156 LQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211 (265)
T ss_pred cccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCc
Confidence 532211 1122335688999999999888899999999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=264.40 Aligned_cols=201 Identities=32% Similarity=0.519 Sum_probs=170.5
Q ss_pred CCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
++|++.+.||+|+||.||++...++..+|+|.+..... ..+.+.+|+.++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~-~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (260)
T cd05070 6 ESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTM-SPESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIVTEYMS 83 (260)
T ss_pred HHhhhhheeccccCceEEEEEecCCceeEEEEecCCCC-CHHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEEEEecC
Confidence 56788899999999999999988888899999865433 4567999999999999999999999875 456899999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+++|.+++... ....+++..+..++.+++.||+|||+.+ ++||||||+||++++++.+||+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05070 84 KGSLLDFLKDG-EGRALKLPNLVDMAAQVAAGMAYIERMN---YIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCccceEEEeCCceEEeCCceeeeeccCccccc
Confidence 99999988543 2345899999999999999999999987 9999999999999999999999999998654322111
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
.....++..|+|||.+.+..++.++||||||++++||++ |+.||...
T Consensus 160 -~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~ 207 (260)
T cd05070 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred -ccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 111235668999999988889999999999999999999 88888643
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-30 Score=266.13 Aligned_cols=205 Identities=28% Similarity=0.418 Sum_probs=171.7
Q ss_pred HhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
.+++++.....||+|+||.||+|...+ +..|++|.+........+.+.+|+.++++++|+||+++++++..++..++|+
T Consensus 5 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 84 (268)
T cd06624 5 YEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFM 84 (268)
T ss_pred cccccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEE
Confidence 355666666789999999999998654 6789999987665556678999999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCceEEEeecCccccCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFGL 671 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla~~~~~ 671 (738)
||+++++|.+++.........++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+|||++.....
T Consensus 85 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~ 161 (268)
T cd06624 85 EQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQ---IVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAG 161 (268)
T ss_pred ecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCeEEEecchhheeccc
Confidence 99999999999865322112278888899999999999999987 999999999999976 67999999999876532
Q ss_pred CcccccccccccccCccchhcccCCC--CCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
... ......|+..|+|||++.+.. ++.++||||||+++|||++|+.||..
T Consensus 162 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~ 213 (268)
T cd06624 162 INP--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIE 213 (268)
T ss_pred CCC--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCcc
Confidence 211 122245789999999986643 78899999999999999999999864
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-30 Score=280.37 Aligned_cols=198 Identities=27% Similarity=0.363 Sum_probs=166.7
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecC------C
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------D 586 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~------~ 586 (738)
.++|+..+.||+|+||.||++.... ++.||||++.... ....+.+.+|+.+++.++|+||+++++++... .
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~ 102 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQ 102 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccccCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccC
Confidence 4789999999999999999998654 7889999986532 23346778899999999999999999987543 3
Q ss_pred cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCc
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla 666 (738)
..++||||+++ +|...+. ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~lv~e~~~~-~l~~~~~-----~~~~~~~~~~~~~qi~~aL~~LH~~~---ivH~Dlkp~NIll~~~~~~kL~DfG~a 173 (364)
T cd07875 103 DVYIVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 173 (364)
T ss_pred eEEEEEeCCCC-CHHHHHH-----hcCCHHHHHHHHHHHHHHHHHHhhCC---eecCCCCHHHEEECCCCcEEEEeCCCc
Confidence 47999999976 5655552 23788899999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
+...... ......||..|+|||++.+..++.++|||||||++|||++|+.||...+
T Consensus 174 ~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 174 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred cccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 8653321 1223568999999999999999999999999999999999999996543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-30 Score=270.54 Aligned_cols=198 Identities=30% Similarity=0.401 Sum_probs=173.9
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|+..+.||+|++|.||++.... ++.+|+|.+.... ....+.+.+|++++++++||||+++++++.++...++||
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 80 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVM 80 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEE
Confidence 467888999999999999999764 7899999886432 233567889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 e~~~~~~L~~~~~~---~~~l~~~~~~~~~~qil~~l~~lH~~~---i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 154 (290)
T cd05580 81 EYVPGGELFSHLRK---SGRFPEPVARFYAAQVVLALEYLHSLD---IVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR 154 (290)
T ss_pred ecCCCCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEECCCCCEEEeeCCCccccCCC
Confidence 99999999998854 356899999999999999999999987 999999999999999999999999999875432
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....+++.|+|||.+.+...+.++||||||++++||++|+.||....
T Consensus 155 -----~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 155 -----TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred -----CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 223568899999999988888999999999999999999999997544
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=264.93 Aligned_cols=202 Identities=31% Similarity=0.494 Sum_probs=170.3
Q ss_pred CCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
++|++.++||+|+||.||++...+...||+|+++... ...+++.+|++++++++|+||+++++.+. ....++||||++
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~-~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~e~~~ 83 (262)
T cd05071 6 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVTEYMS 83 (262)
T ss_pred HHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCc-cCHHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEEEcCC
Confidence 4588889999999999999988777789999986432 34568899999999999999999999874 456899999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+++|.+++... ....+++..+..++.|+++||+|||+.+ ++||||||+||++++++.+||+|||.++........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~- 158 (262)
T cd05071 84 KGSLLDFLKGE-MGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 158 (262)
T ss_pred CCcHHHHHhhc-cccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccCcccEEEcCCCcEEeccCCceeeccccccc-
Confidence 99999998543 2345789999999999999999999987 999999999999999999999999999766432211
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
......++..|+|||+..+..++.++||||||+++|||++ |+.||....
T Consensus 159 ~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~ 208 (262)
T cd05071 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMV 208 (262)
T ss_pred cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 1112345678999999988899999999999999999999 788886543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-30 Score=292.82 Aligned_cols=200 Identities=23% Similarity=0.315 Sum_probs=163.6
Q ss_pred HHhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCC------CeeeEEeEEecC
Q 004674 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR------NLVKLLGCCTQR 585 (738)
Q Consensus 513 ~~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~------nIv~l~g~~~~~ 585 (738)
....++|++.+.||+|+||.||++.... ++.||||+++... ....++..|+.++.+++|. +++++++++..+
T Consensus 125 ~~~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~-~~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 125 DVSTQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVP-KYTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred ccCCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecch-hhHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 3456789999999999999999998754 7789999986432 2345567788888887654 588888888765
Q ss_pred -CcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEcCCC-------
Q 004674 586 -DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTM------- 656 (738)
Q Consensus 586 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~------- 656 (738)
...++|||++ +++|.+++.. ...+++..+..++.||+.||+|||++ + |+||||||+|||++.++
T Consensus 204 ~~~~~iv~~~~-g~~l~~~l~~---~~~l~~~~~~~i~~qi~~aL~yLH~~~g---IiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 204 TGHMCIVMPKY-GPCLLDWIMK---HGPFSHRHLAQIIFQTGVALDYFHTELH---LMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CceEEEEEecc-CCCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhcCC---eecCCCCHHHEEEecCCccccccc
Confidence 4688999988 6677777743 34689999999999999999999974 6 99999999999998665
Q ss_pred ---------ceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 657 ---------NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 657 ---------~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.+||+|||.+..... .....+||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~ 349 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHD 349 (467)
T ss_pred ccccCCCCceEEECCCCccccCcc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 499999998754221 1223679999999999999999999999999999999999999997644
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.1e-30 Score=265.04 Aligned_cols=202 Identities=27% Similarity=0.436 Sum_probs=176.0
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
++|+..+.||+|+||.||++.... ++.+++|.+........+.+.+|++++++++||||+++++++..+...+++|||+
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~ 82 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYC 82 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchhhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCC
Confidence 678888999999999999998754 6789999987665556788999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 83 ~~~~l~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~- 156 (262)
T cd06613 83 GGGSLQDIYQVT--RGPLSELQIAYVCRETLKGLAYLHETG---KIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA- 156 (262)
T ss_pred CCCcHHHHHHhh--ccCCCHHHHHHHHHHHHHHHHHHHhCC---ceecCCChhhEEECCCCCEEECccccchhhhhhhh-
Confidence 999999987542 246899999999999999999999987 99999999999999999999999999876543221
Q ss_pred ccccccccccCccchhcccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDG---LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......++..|+|||.+.+. .++.++||||||++++||++|+.||....
T Consensus 157 -~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 157 -KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred -ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 11224678899999998776 88999999999999999999999986543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.4e-30 Score=263.57 Aligned_cols=200 Identities=29% Similarity=0.464 Sum_probs=175.9
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
++|+..+.||+|+||.||++.... ++.+++|.+..... .+++.+|++++++++|+||+++++.+......++++||+
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~ 80 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED--LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYC 80 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH--HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecC
Confidence 678888999999999999999865 78999999865432 678999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++.. ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~--~~~~l~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~- 154 (256)
T cd06612 81 GAGSVSDIMKI--TNKTLTEEEIAAILYQTLKGLEYLHSNK---KIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA- 154 (256)
T ss_pred CCCcHHHHHHh--CccCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcceEEECCCCcEEEcccccchhcccCcc-
Confidence 99999999853 2356899999999999999999999987 99999999999999999999999999987643321
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......++..|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 155 -~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~ 203 (256)
T cd06612 155 -KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIH 203 (256)
T ss_pred -ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 1223457889999999999899999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5e-30 Score=268.00 Aligned_cols=202 Identities=31% Similarity=0.478 Sum_probs=170.1
Q ss_pred hcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecC------C
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR------D 586 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~------~ 586 (738)
++..|+..+.||+|+||.||+|.... ++.+|+|++.... ....++.+|+.++.++ +|+||+++++++... .
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~ 82 (272)
T cd06637 4 PAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG-DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDD 82 (272)
T ss_pred hhhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC-ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCc
Confidence 45678888899999999999998754 7889999986543 3456788999999998 799999999998753 3
Q ss_pred cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCc
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla 666 (738)
..++||||+++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.+||+|||++
T Consensus 83 ~~~iv~e~~~~~~L~~~l~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~---ivh~dl~~~nili~~~~~~~l~Dfg~~ 158 (272)
T cd06637 83 QLWLVMEFCGAGSVTDLIKNT-KGNTLKEEWIAYICREILRGLSHLHQHK---VIHRDIKGQNVLLTENAEVKLVDFGVS 158 (272)
T ss_pred EEEEEEEcCCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---CccCCCCHHHEEECCCCCEEEccCCCc
Confidence 578999999999999988542 3346889999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccchhccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 667 RSFGLDQTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
........ ......|+..|+|||++. +..++.++|||||||++|||++|+.||..
T Consensus 159 ~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~ 218 (272)
T cd06637 159 AQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCD 218 (272)
T ss_pred eecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 86533221 223356889999999986 34588899999999999999999999964
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=280.45 Aligned_cols=204 Identities=30% Similarity=0.452 Sum_probs=169.7
Q ss_pred CCCCccceecccccEeEEEeeec------cccEEEEEEccCCCCc-chHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDER 588 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~ 588 (738)
++|.+.+.||+|+||.||++... .++.||+|++...... ..+.+.+|++++.++. ||||+++++++..+...
T Consensus 37 ~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~ 116 (401)
T cd05107 37 DNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARSSEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPI 116 (401)
T ss_pred HHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCChhHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCc
Confidence 45677889999999999999853 2467999999754322 2457889999999997 99999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcCC-----------------------------------------------------------
Q 004674 589 MLIYEYLPNKSLDYFIFDTTR----------------------------------------------------------- 609 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~----------------------------------------------------------- 609 (738)
++||||+++|+|.+++.....
T Consensus 117 ~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 196 (401)
T cd05107 117 YIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMK 196 (401)
T ss_pred EEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccchhcch
Confidence 999999999999999864211
Q ss_pred ------------------------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc
Q 004674 610 ------------------------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (738)
Q Consensus 610 ------------------------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (738)
...+++..++.++.||+.||+|||+.+ ++||||||+|||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~---ivHrdlkp~NiLl~ 273 (401)
T cd05107 197 GTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKN---CVHRDLAARNVLIC 273 (401)
T ss_pred hhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCC---cCcccCCcceEEEe
Confidence 124678888999999999999999887 99999999999999
Q ss_pred CCCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 654 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 274 ~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~ 344 (401)
T cd05107 274 EGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPE 344 (401)
T ss_pred CCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCC
Confidence 999999999999986533222111222456788999999998889999999999999999998 8888854
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-30 Score=270.25 Aligned_cols=202 Identities=30% Similarity=0.498 Sum_probs=168.0
Q ss_pred CCCCccceecccccEeEEEeeec-ccc----EEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQ----EIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~----~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
++|+..+.||+|+||.||+|... +++ .||+|.+.... ....+++.+|+.++..++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~l 85 (279)
T cd05109 7 TELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKANKEILDEAYVMAGVGSPYVCRLLGICLT-STVQL 85 (279)
T ss_pred hheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCHHHHHHHHHHHHHHHhcCCCCCceEEEEEcC-CCcEE
Confidence 56788899999999999999853 343 48999886543 2335678899999999999999999999875 45789
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
++||+++|+|.+++... ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 ~~~~~~~g~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~ 160 (279)
T cd05109 86 VTQLMPYGCLLDYVREN--KDRIGSQDLLNWCVQIAKGMSYLEEVR---LVHRDLAARNVLVKSPNHVKITDFGLARLLD 160 (279)
T ss_pred EEEcCCCCCHHHHHhhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEcCCCcEEECCCCceeecc
Confidence 99999999999988542 345899999999999999999999987 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 215 (279)
T cd05109 161 IDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGI 215 (279)
T ss_pred cccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 3322211222234678999999999899999999999999999998 89998653
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.3e-30 Score=265.88 Aligned_cols=202 Identities=28% Similarity=0.450 Sum_probs=166.9
Q ss_pred CCccceecccccEeEEEeeecc----ccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCc-----
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE----- 587 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~----g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~----- 587 (738)
|.+.+.||+|+||.||+|.... +..||+|+++... ....+++.+|++.++.++|+||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 80 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIP 80 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcCCHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCc
Confidence 4567889999999999998643 3679999986432 2234678999999999999999999999876554
Q ss_pred -ceEEEeeCCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEee
Q 004674 588 -RMLIYEYLPNKSLDYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (738)
Q Consensus 588 -~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DF 663 (738)
.+++|||+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+||
T Consensus 81 ~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~df 157 (273)
T cd05035 81 KPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRN---FIHRDLAARNCMLREDMTVCVADF 157 (273)
T ss_pred ccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCC---eeccccchheEEECCCCeEEECCc
Confidence 799999999999998885432 2246899999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
|+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~ 218 (273)
T cd05035 158 GLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218 (273)
T ss_pred cceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 99986643322211222334678999999988899999999999999999999 8888854
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=263.87 Aligned_cols=202 Identities=35% Similarity=0.513 Sum_probs=172.3
Q ss_pred cCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
.++|++.++||+|+||.||++...+++.+|+|.+.... ...+++.+|+.++++++|+||+++++++. .+..+++|||+
T Consensus 5 ~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~ 82 (260)
T cd05067 5 RETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGS-MSPEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYM 82 (260)
T ss_pred hHHceeeeeeccCccceEEeeecCCCceEEEEEecCCC-CcHHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcC
Confidence 35788889999999999999998888999999986543 34578999999999999999999999864 46789999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.++|+|||++.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~i~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~ 158 (260)
T cd05067 83 ENGSLVDFLKTP-EGIKLTINKLIDMAAQIAEGMAFIERKN---YIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT 158 (260)
T ss_pred CCCCHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHhcCC---eecccccHHhEEEcCCCCEEEccCcceeecCCCCcc
Confidence 999999988543 2346899999999999999999999987 999999999999999999999999999765422211
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
. .....++..|+|||.+....++.++||||||++++||++ |+.||...
T Consensus 159 ~-~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 207 (260)
T cd05067 159 A-REGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGM 207 (260)
T ss_pred c-ccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 1 112345678999999998889999999999999999999 99999643
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-31 Score=252.59 Aligned_cols=211 Identities=24% Similarity=0.295 Sum_probs=176.4
Q ss_pred hcCCCCccceecccccEeEEEee-eccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCc-----c
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE-----R 588 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~-----~ 588 (738)
..++|.+.+.||+|||.-||.++ +.+++.+|+|++.-...+..+..++|++..++++|||+++++++...+.. .
T Consensus 19 n~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~ 98 (302)
T KOG2345|consen 19 NNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEA 98 (302)
T ss_pred cCceEEEeeeecCCCceeeeeecccCcccchhhheeeccchHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeE
Confidence 34678889999999999999998 45678899999877766778889999999999999999999998754433 8
Q ss_pred eEEEeeCCCCChhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 667 (738)
||+++|...|+|.+.+..... +..+++.++++|+.+|++||++||+.. +++.||||||.|||+.+.+.++|.|||.+.
T Consensus 99 yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS~~ 177 (302)
T KOG2345|consen 99 YLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGSAT 177 (302)
T ss_pred EEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccCcc
Confidence 999999999999998865443 347999999999999999999999986 579999999999999999999999999987
Q ss_pred ccCCCcccc-------cccccccccCccchhccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 668 SFGLDQTEA-------NTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 668 ~~~~~~~~~-------~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
......... ......-|..|+|||.+. +..+++++|||||||+||+|+.|..||+...+
T Consensus 178 ~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~ 246 (302)
T KOG2345|consen 178 QAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQ 246 (302)
T ss_pred ccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhh
Confidence 653221110 011134588999999875 45688999999999999999999999986544
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-29 Score=265.42 Aligned_cols=201 Identities=29% Similarity=0.486 Sum_probs=164.1
Q ss_pred CccceecccccEeEEEeeecccc---EEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecC------Ccc
Q 004674 520 SEKNKLGEGGFGPVYKGMLIEGQ---EIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------DER 588 (738)
Q Consensus 520 ~~~~~LG~G~fG~Vykg~~~~g~---~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~------~~~ 588 (738)
.+.+.||+|+||.||+|...... .+|+|.++... ....+.+.+|+++++.++|+||+++++++... ...
T Consensus 2 ~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~ 81 (272)
T cd05075 2 ALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSP 81 (272)
T ss_pred ccccccCcccCceEEEeEEccCCCeeeEEEEecccCcCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCc
Confidence 45678999999999999976532 58999876542 33456788999999999999999999987532 246
Q ss_pred eEEEeeCCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecC
Q 004674 589 MLIYEYLPNKSLDYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl 665 (738)
+++|||+++++|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+
T Consensus 82 ~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~Dfg~ 158 (272)
T cd05075 82 VVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKS---FIHRDLAARNCMLNENMNVCVADFGL 158 (272)
T ss_pred EEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhheEEcCCCCEEECCCCc
Confidence 89999999999998874322 2345899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||..
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 217 (272)
T cd05075 159 SKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217 (272)
T ss_pred ccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCC
Confidence 987643222111122345678999999999999999999999999999999 7888854
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.6e-30 Score=266.77 Aligned_cols=198 Identities=33% Similarity=0.532 Sum_probs=171.2
Q ss_pred CCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchH--HHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGME--EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~--~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
|+..+.||+|+||.||++.... ++.+|+|++......... ...+|+.++++++|+||+++++++.+....++||||+
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~ 80 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEEREENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYC 80 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHHHHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccccchhhhhhhcccccccccccccccccccccccccccccc
Confidence 4567899999999999999866 568999999766433222 3456999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++. ....+++..+..++.||++||++||+.+ |+|+||||+||++++++.++|+|||.+..... ..
T Consensus 81 ~~~~L~~~l~---~~~~~~~~~~~~~~~qi~~~L~~Lh~~~---i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 81 PGGSLQDYLQ---KNKPLSEEEILKIAYQILEALAYLHSKG---IVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp TTEBHHHHHH---HHSSBBHHHHHHHHHHHHHHHHHHHHTT---EEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccc---cccccccccccccccccccccccccccc---cccccccccccccccccccccccccccccccc--cc
Confidence 9999999986 3456899999999999999999999987 99999999999999999999999999976411 12
Q ss_pred ccccccccccCccchhccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.......++..|+|||++. +..++.++||||+|+++++|++|+.||...
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 2233467899999999998 888999999999999999999999999864
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=271.12 Aligned_cols=203 Identities=31% Similarity=0.492 Sum_probs=167.9
Q ss_pred CCCCccceecccccEeEEEeeecc-c--cEEEEEEccCC-CCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-G--QEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g--~~vavK~l~~~-~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV 591 (738)
++|++.+.||+|+||.||++...+ + ..+++|.++.. .....+.+.+|+.++.++ +||||+++++++......++|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv 81 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIA 81 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEE
Confidence 568888999999999999998754 3 24788887643 233456789999999999 799999999999999999999
Q ss_pred EeeCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCce
Q 004674 592 YEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~v 658 (738)
|||+++++|.+++.... ....+++..++.++.|++.||+|||+.+ |+||||||+|||+++++.+
T Consensus 82 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dlkp~Nill~~~~~~ 158 (297)
T cd05089 82 IEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQ---FIHRDLAARNVLVGENLAS 158 (297)
T ss_pred EEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCcCCcceEEECCCCeE
Confidence 99999999999986432 1135889999999999999999999987 9999999999999999999
Q ss_pred EEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 659 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
||+|||++....... .......+..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 159 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~ 223 (297)
T cd05089 159 KIADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMT 223 (297)
T ss_pred EECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999999986432111 1111223557999999998899999999999999999997 999986543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=263.57 Aligned_cols=202 Identities=28% Similarity=0.435 Sum_probs=174.8
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|+..+.||+|++|.||++... +++.+|+|.++.. .....+.+.+|++++++++|+|++++++.+...+..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 57888999999999999999986 6889999987532 2233567899999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
||+++++|..++.... ....+++.++..++.++++||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~ 158 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKR---IMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred ecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecCCcChhhEEECCCCcEEEeccceeeeccC
Confidence 9999999999886432 2356899999999999999999999987 99999999999999999999999999876543
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.... .....++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 208 (267)
T cd08224 159 KTTA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCcc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCccc
Confidence 2211 1224678899999999988899999999999999999999999854
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=264.18 Aligned_cols=200 Identities=31% Similarity=0.485 Sum_probs=171.5
Q ss_pred CCCccceecccccEeEEEeeeccccEEEEEEccCCCC------cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~------~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
+|...+.||+|+||.||+|...+++.+|+|.+..... ...+.+.+|++++++++|+||+++++++.+....++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4677889999999999999887889999998764321 1235688999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~ 154 (265)
T cd06631 81 MEFVPGGSISSILNR---FGPLPEPVFCKYTKQILDGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAW 154 (265)
T ss_pred EecCCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHhEEECCCCeEEeccchhhHhhhh
Confidence 999999999999843 245789999999999999999999987 99999999999999999999999999876532
Q ss_pred Cc----ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 672 DQ----TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 672 ~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.. .........|+..|+|||++.+..++.++||||||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~ 210 (265)
T cd06631 155 VGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLAS 210 (265)
T ss_pred ccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCcccc
Confidence 11 11112235688999999999998899999999999999999999999964
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=264.13 Aligned_cols=201 Identities=31% Similarity=0.530 Sum_probs=170.8
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCCCc---------chHHHHHHHHHHhHhcCCCeeeEEeEEecCCc
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ---------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~---------~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 587 (738)
+|.....||+|++|.||+|... .++.+|+|.+...... ..+.+.+|+.++++++||||+++++++.+...
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 3667789999999999999875 4788999988654322 12568899999999999999999999999999
Q ss_pred ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcc
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 667 (738)
.++||||+++++|..++.. ...+++..+..++.|++.||+|||+.+ ++||||+|+||++++++.+||+|||+++
T Consensus 81 ~~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~~l~~~l~~lH~~~---ivH~di~p~nil~~~~~~~~l~dfg~~~ 154 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNN---YGAFEETLVRNFVRQILKGLNYLHNRG---IIHRDIKGANILVDNKGGIKISDFGISK 154 (267)
T ss_pred cEEEEEecCCCCHHHHHHh---ccCccHHHHHHHHHHHHHHHHHHHhcC---cccccCCHHHEEEcCCCCEEecccCCCc
Confidence 9999999999999999843 345889999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCccc----ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 668 SFGLDQTE----ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 668 ~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
........ .......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 155 KLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred ccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 76422111 1112245788999999999888999999999999999999999999653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.8e-30 Score=279.30 Aligned_cols=198 Identities=27% Similarity=0.360 Sum_probs=166.4
Q ss_pred hcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC-----
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----- 586 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~----- 586 (738)
..++|+..+.||+|+||.||++... .++.||+|++.... ....+.+.+|+.+++.++|+||+++++++....
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 94 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEF 94 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccChHHHHHHHHHHHHHHHhCCCchhceeeeeecccccccc
Confidence 4578999999999999999999865 47889999986542 223457788999999999999999999886433
Q ss_pred -cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecC
Q 004674 587 -ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (738)
Q Consensus 587 -~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl 665 (738)
..++||||+++ +|...+. ..+++..+..++.|+++||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 95 ~~~~lv~e~~~~-~l~~~~~-----~~l~~~~~~~~~~qi~~aL~~LH~~g---ivHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 95 QDVYLVMELMDA-NLCQVIQ-----MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred ceeEEEhhhhcc-cHHHHHh-----hcCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEECCCCCEEEeeCcc
Confidence 46899999976 4555542 24788899999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
++...... ......||..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 221 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGR 221 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 98653321 122356899999999999999999999999999999999999999653
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8e-30 Score=271.79 Aligned_cols=205 Identities=32% Similarity=0.466 Sum_probs=169.8
Q ss_pred CCCCccceecccccEeEEEeeecc--------ccEEEEEEccCCC-CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~--------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~ 586 (738)
++|.+.+.||+|+||.||++.... ...+|+|.+.... .....++.+|+.++.++ +|+||+++++++...+
T Consensus 18 ~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~ 97 (307)
T cd05098 18 DRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDG 97 (307)
T ss_pred HHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCC
Confidence 578889999999999999987522 3469999987542 23345788899999999 7999999999999999
Q ss_pred cceEEEeeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (738)
..++||||+++++|.+++..... ...+++.++++++.|++.||+|||+.+ ++||||||+||+++
T Consensus 98 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 174 (307)
T cd05098 98 PLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLVT 174 (307)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---cccccccHHheEEc
Confidence 99999999999999999865321 235889999999999999999999987 99999999999999
Q ss_pred CCCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 654 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 175 ~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~ 246 (307)
T cd05098 175 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGV 246 (307)
T ss_pred CCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 999999999999876542211111111234568999999998889999999999999999998 88888643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.1e-30 Score=271.04 Aligned_cols=204 Identities=29% Similarity=0.436 Sum_probs=168.1
Q ss_pred CCCCccceecccccEeEEEeeecc---------------ccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEe
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE---------------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLG 580 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~---------------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g 580 (738)
++|++.+.||+|+||.||++...+ ...||+|.++... ....+.+.+|++++++++|+|++++++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~ 84 (295)
T cd05097 5 QQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMSRLKNPNIIRLLG 84 (295)
T ss_pred HhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCCHHHHHHHHHHHHHHHhCCCCCcCeEEE
Confidence 568888999999999999987532 1248999986542 233457899999999999999999999
Q ss_pred EEecCCcceEEEeeCCCCChhHHHhhcCC---------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEE
Q 004674 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTR---------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (738)
Q Consensus 581 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~---------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 651 (738)
++...+..++||||+++++|.+++..... ...+++..+..++.|++.||+|||+.+ ++||||||+||+
T Consensus 85 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~---i~H~dlkp~Nil 161 (295)
T cd05097 85 VCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLN---FVHRDLATRNCL 161 (295)
T ss_pred EEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcC---eeccccChhhEE
Confidence 99999999999999999999998854211 124688999999999999999999987 999999999999
Q ss_pred EcCCCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc--CCCCCCC
Q 004674 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC--GKKNRGF 723 (738)
Q Consensus 652 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt--G~~p~~~ 723 (738)
+++++.+||+|||++................++..|+|||++.+..++.++||||||++++||++ |..||..
T Consensus 162 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~ 235 (295)
T cd05097 162 VGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSL 235 (295)
T ss_pred EcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999976543222111222345678999999998889999999999999999988 5567654
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.4e-30 Score=269.77 Aligned_cols=202 Identities=26% Similarity=0.410 Sum_probs=174.2
Q ss_pred cCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
.++|++.+.||+|++|.||++... ++..+|+|.+........+.+.+|++++++++|+||+++++.+..+...++||||
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 83 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEF 83 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeec
Confidence 356888899999999999999975 4788999998766555567889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|..++... ...+++..+..++.|++.||+|||+.+ |+|+||||+||+++.++.++|+|||++........
T Consensus 84 ~~~~~L~~~~~~~--~~~l~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~ 158 (280)
T cd06611 84 CDGGALDSIMLEL--ERGLTEPQIRYVCRQMLEALNFLHSHK---VIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQ 158 (280)
T ss_pred cCCCcHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEECCCCCEEEccCccchhhccccc
Confidence 9999999988542 346899999999999999999999988 99999999999999999999999999876533221
Q ss_pred cccccccccccCccchhccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
......++..|+|||.+. ...++.++||||||+++|||++|+.||...
T Consensus 159 --~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~ 211 (280)
T cd06611 159 --KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHEL 211 (280)
T ss_pred --ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccC
Confidence 122356889999999874 345788999999999999999999999654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.7e-30 Score=271.07 Aligned_cols=207 Identities=31% Similarity=0.472 Sum_probs=172.0
Q ss_pred hcCCCCccceecccccEeEEEeeec--------cccEEEEEEccCCC-CcchHHHHHHHHHHhHh-cCCCeeeEEeEEec
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ 584 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~ 584 (738)
..++|.+.+.||+|+||.||++... ++..||+|.+.... ....+++.+|+.+++.+ +|+||+++++++..
T Consensus 13 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 92 (304)
T cd05101 13 SRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQ 92 (304)
T ss_pred cHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccchHHHHHHHHHHHHHHhhccCCCchheeEEEec
Confidence 3467888899999999999999741 23479999886442 23456789999999999 89999999999999
Q ss_pred CCcceEEEeeCCCCChhHHHhhcCC-------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEE
Q 004674 585 RDERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651 (738)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NIL 651 (738)
....++||||+++++|.+++..... ...+++.++..++.||++||+|||+.+ ++||||||+||+
T Consensus 93 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nil 169 (304)
T cd05101 93 DGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQK---CIHRDLAARNVL 169 (304)
T ss_pred CCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCC---eeecccccceEE
Confidence 9999999999999999999865321 235788999999999999999999987 999999999999
Q ss_pred EcCCCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 652 l~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
+++++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 243 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGI 243 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccC
Confidence 99999999999999987643322222222345678999999998889999999999999999998 77887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=266.61 Aligned_cols=201 Identities=24% Similarity=0.384 Sum_probs=171.2
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
++|+..+.||+|++|.||+++... ++.||+|++.... ....+.+.+|+.++++++|+|++++++++......++|||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e 80 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDDPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFE 80 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccCccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEe
Confidence 468888999999999999999764 8899999885432 2234568899999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++++|+.++. ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~ql~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 81 YCDHTVLNELEK---NPRGVPEHLIKKIIWQTLQAVNFCHKHN---CIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred ccCccHHHHHHh---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 999999887763 2345899999999999999999999987 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
. ......++..|+|||.+.+ ..++.++||||||++++||++|+.||....
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~ 205 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKS 205 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 1 1222457889999999876 568899999999999999999999996543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=260.42 Aligned_cols=196 Identities=31% Similarity=0.435 Sum_probs=166.4
Q ss_pred ceecccccEeEEEeeeccccEEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCChh
Q 004674 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 601 (738)
+.||+|+||.||+|...+++.+|+|.+...... ....+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 80 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFL 80 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCHHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHH
Confidence 369999999999999888889999998655332 3456889999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccccccc
Q 004674 602 YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681 (738)
Q Consensus 602 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 681 (738)
+++... ...+++..+..++.|++.||.|||+.+ ++||||||+||++++++.+||+|||++.......... ....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~ 154 (250)
T cd05085 81 SFLRKK--KDELKTKQLVKFALDAAAGMAYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLK 154 (250)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeecccChheEEEcCCCeEEECCCccceecccccccc-CCCC
Confidence 988532 345789999999999999999999987 9999999999999999999999999987543221111 1112
Q ss_pred ccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 682 ~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
.++..|+|||++.+..++.++||||||+++||+++ |+.||...
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~ 198 (250)
T cd05085 155 QIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGM 198 (250)
T ss_pred CCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 34567999999998889999999999999999998 89898543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-29 Score=262.97 Aligned_cols=203 Identities=34% Similarity=0.530 Sum_probs=174.6
Q ss_pred cCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
.++|.+.+.||+|+||.||++...+++.+++|.+.... ...+++.+|+.++++++|+||+++++++......++||||+
T Consensus 5 ~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~ 83 (261)
T cd05034 5 RESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGT-MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYM 83 (261)
T ss_pred hhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCc-cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEecc
Confidence 46788899999999999999998778889999986543 34678999999999999999999999999888999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++... ....+++..+..++.+++.|++|||+.+ ++|+||||+||++++++.+||+|||++..+......
T Consensus 84 ~~~~L~~~i~~~-~~~~~~~~~~~~~~~~i~~al~~lh~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~ 159 (261)
T cd05034 84 SKGSLLDFLKSG-EGKKLRLPQLVDMAAQIAEGMAYLESRN---YIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT 159 (261)
T ss_pred CCCCHHHHHhcc-ccCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcchheEEEcCCCCEEECccccceeccchhhh
Confidence 999999998543 2346899999999999999999999987 999999999999999999999999999876432111
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
. .....++..|+|||.+.+..++.++||||||++++|+++ |+.||...
T Consensus 160 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~ 208 (261)
T cd05034 160 A-REGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGM 208 (261)
T ss_pred h-hhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1 111234568999999998889999999999999999998 99998543
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=269.74 Aligned_cols=201 Identities=27% Similarity=0.433 Sum_probs=169.2
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++|+..+.||+|+||.||++... .++.||+|.+.... ......+.+|+.++++++|+||+++++++..+...++||||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~ 85 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEY 85 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEec
Confidence 56888999999999999999875 47889999986443 23345678899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
++ ++|..++... ...+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||++........
T Consensus 86 ~~-~~l~~~l~~~--~~~~~~~~~~~~~~qi~~aL~~lH~~~---i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~ 159 (301)
T cd07873 86 LD-KDLKQYLDDC--GNSINMHNVKLFLFQLLRGLNYCHRRK---VLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159 (301)
T ss_pred cc-cCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC
Confidence 97 5887777442 345889999999999999999999987 99999999999999999999999999976433221
Q ss_pred cccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......+++.|+|||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 160 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~ 209 (301)
T cd07873 160 --TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGST 209 (301)
T ss_pred --cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1122456889999998865 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-29 Score=267.61 Aligned_cols=199 Identities=27% Similarity=0.432 Sum_probs=163.7
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC--cchHHHHHHHHHHhHh---cCCCeeeEEeEEecC-----C
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQR-----D 586 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l---~H~nIv~l~g~~~~~-----~ 586 (738)
+|+..+.||+|+||.||++.... ++.||+|.+..... .....+.+|+.+++.+ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~ 80 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNEDGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRET 80 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCCCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCc
Confidence 47788899999999999998764 78999998865322 2234566777777665 699999999987642 3
Q ss_pred cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCc
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla 666 (738)
..++||||+++ +|..++... ....+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||++
T Consensus 81 ~~~lv~e~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 81 KVTLVFEHVDQ-DLRTYLDKV-PPPGLPAETIKDLMRQFLRGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred eEEEEEccccc-CHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccCcc
Confidence 47899999985 787777442 2345899999999999999999999988 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
....... ......|+..|+|||++.+..++.++||||+||++|||++|+.||...
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~ 210 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGN 210 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCC
Confidence 8654221 122356789999999999989999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-29 Score=270.33 Aligned_cols=204 Identities=31% Similarity=0.446 Sum_probs=171.2
Q ss_pred CCCCccceecccccEeEEEeeec------cccEEEEEEccCCCC-cchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~------~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 588 (738)
++|...+.||+|+||.||++... .+..+|+|.++.... ...+.+.+|+.+++++ +|+||+++++++...+..
T Consensus 35 ~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~ 114 (302)
T cd05055 35 NNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPI 114 (302)
T ss_pred HHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCChHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCce
Confidence 56888899999999999998742 245799998865432 3346789999999999 799999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
++||||+++++|.+++.... ...+++.++..++.|++.||+|||+.+ |+|+||||+|||+++++.+||+|||+++.
T Consensus 115 ~lv~e~~~~~~L~~~i~~~~-~~~l~~~~~~~i~~~i~~~l~~lH~~~---ivH~dlkp~Nil~~~~~~~~l~dfg~~~~ 190 (302)
T cd05055 115 LVITEYCCYGDLLNFLRRKR-ESFLTLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNVLLTHGKIVKICDFGLARD 190 (302)
T ss_pred EEEEEcCCCCcHHHHHHhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eehhhhccceEEEcCCCeEEECCCccccc
Confidence 99999999999999985422 234899999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
..............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 191 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 191 IMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred ccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 543322111222345778999999999999999999999999999998 99998543
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.5e-30 Score=312.88 Aligned_cols=193 Identities=27% Similarity=0.499 Sum_probs=163.9
Q ss_pred hcCCCCccceecccccEeEEEeee-ccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
..+.+...+.||+|+||.||+|+. .++..||+|++...... ..+|++++++++|||||+++++|.+++..++|||
T Consensus 688 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~----~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~E 763 (968)
T PLN00113 688 ILSSLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI----PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHE 763 (968)
T ss_pred HHhhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCccc----cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEe
Confidence 345677788999999999999997 46889999998644322 2356889999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++|+|.+++. .++|.++.+++.||++||+|||+....+|+||||||+||+++.++.+++. |+.+......
T Consensus 764 y~~~g~L~~~l~------~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~- 835 (968)
T PLN00113 764 YIEGKNLSEVLR------NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD- 835 (968)
T ss_pred CCCCCcHHHHHh------cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC-
Confidence 999999999983 27899999999999999999997655669999999999999999888876 6665433211
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
....++..|+|||++.+..++.|+|||||||++|||++|+.||+..
T Consensus 836 -----~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 836 -----TKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred -----CCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 1236789999999999999999999999999999999999998643
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=263.86 Aligned_cols=190 Identities=23% Similarity=0.375 Sum_probs=159.5
Q ss_pred ceecccccEeEEEeeecc-------------ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcce
Q 004674 523 NKLGEGGFGPVYKGMLIE-------------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-------------g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 589 (738)
+.||+|+||.||+|.... ...|++|.+..........+.+|+.+++.++||||+++++++......+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~ 80 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHRDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENI 80 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhhhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCE
Confidence 369999999999998532 2258899876655455567889999999999999999999999999999
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc-------eEEEe
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN-------PKISD 662 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~-------vkL~D 662 (738)
+||||+++++|+.++.. ....+++..+..++.||++||+|||+.+ |+||||||+|||++.++. +|++|
T Consensus 81 lv~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~~l~~lH~~~---ivH~dlkp~Nill~~~~~~~~~~~~~~l~d 155 (262)
T cd05077 81 MVEEFVEFGPLDLFMHR--KSDVLTTPWKFKVAKQLASALSYLEDKD---LVHGNVCTKNILLAREGIDGECGPFIKLSD 155 (262)
T ss_pred EEEecccCCCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHhhhCC---eECCCCCcccEEEecCCccCCCCceeEeCC
Confidence 99999999999888743 2346899999999999999999999987 999999999999986654 89999
Q ss_pred ecCccccCCCcccccccccccccCccchhccc-CCCCCchhHHHHHHHHHHHHH-cCCCCCCC
Q 004674 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEII-CGKKNRGF 723 (738)
Q Consensus 663 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~Gvil~ell-tG~~p~~~ 723 (738)
||++...... ....++..|+|||.+. +..++.++||||||+++|||+ .|+.|+..
T Consensus 156 ~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 212 (262)
T cd05077 156 PGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKD 212 (262)
T ss_pred CCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9998754321 1245788899999887 467899999999999999997 57787754
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=272.65 Aligned_cols=207 Identities=31% Similarity=0.468 Sum_probs=172.2
Q ss_pred hcCCCCccceecccccEeEEEeeecc------ccEEEEEEccCCC-CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCC
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~ 586 (738)
..++|+..+.||+|+||.||++.... ...+|+|.+.... .....++.+|++++.++ +|+||+++++++....
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~ 89 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEG 89 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCCHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCC
Confidence 34568888999999999999998642 3579999886542 22345688999999999 8999999999999999
Q ss_pred cceEEEeeCCCCChhHHHhhc-------------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc
Q 004674 587 ERMLIYEYLPNKSLDYFIFDT-------------TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (738)
..+++|||+++++|..++... .....+++..+..++.|++.||+|||+.+ |+||||||+||+++
T Consensus 90 ~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~---ivH~dlkp~Nil~~ 166 (293)
T cd05053 90 PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKK---CIHRDLAARNVLVT 166 (293)
T ss_pred CeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---ccccccceeeEEEc
Confidence 999999999999999998542 12356899999999999999999999987 99999999999999
Q ss_pred CCCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 654 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
+++.+||+|||+++.+.............++..|+|||.+.+..++.++||||||+++|||++ |..||...
T Consensus 167 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 238 (293)
T cd05053 167 EDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 238 (293)
T ss_pred CCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCC
Confidence 999999999999987643322222222335678999999998899999999999999999997 88888543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=265.37 Aligned_cols=199 Identities=26% Similarity=0.420 Sum_probs=174.1
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++|+..+.||.|++|.||++... +++.+++|.+.... ......+.+|+++++.++|+||+++.+++.++...++|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEAEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEY 80 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccccchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEe
Confidence 36778889999999999999976 47899999986543 33456788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++.. ..+++..+..++.|++.|++|||+.+ ++|+||+|+||++++++.++|+|||+++.......
T Consensus 81 ~~~~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 81 CGGGSCLDLLKP----GKLDETYIAFILREVLLGLEYLHEEG---KIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 999999998843 26899999999999999999999987 99999999999999999999999999987654321
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
......++..|+|||++.+..++.++||||||+++|||++|+.||...
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~ 201 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDL 201 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccC
Confidence 222356788999999999888999999999999999999999999654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.7e-30 Score=265.80 Aligned_cols=202 Identities=26% Similarity=0.413 Sum_probs=173.6
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|+..+.||+|++|.||++... +++.+++|.+.... ....+++.+|+.+++.++|+||+++++++.+++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 46778889999999999999964 68899999875432 223457889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 593 EYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
||+++++|.+++... .....+++..+..++.||++||+|||+.+ ++|+||||+||+++.++.++|+|||++.....
T Consensus 82 e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRR---VMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158 (267)
T ss_pred EecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCCEEECcchhhhcccc
Confidence 999999999988542 23456899999999999999999999988 99999999999999999999999999876543
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
... ......++..|+|||.+.+..++.++||||||+++|||++|+.||..
T Consensus 159 ~~~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 208 (267)
T cd08229 159 KTT--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG 208 (267)
T ss_pred CCc--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccc
Confidence 221 12234688899999999988899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-30 Score=276.93 Aligned_cols=198 Identities=28% Similarity=0.426 Sum_probs=167.0
Q ss_pred HhcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecC-----
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR----- 585 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~----- 585 (738)
...++|...+.||+|+||.||++... .++.||+|++.... ....+.+.+|+.++++++|+||+++++++...
T Consensus 12 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 12 EVPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhhhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 45678999999999999999999865 47889999986532 22345677899999999999999999887543
Q ss_pred -CcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeec
Q 004674 586 -DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (738)
Q Consensus 586 -~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFG 664 (738)
...++++|++ +++|..++. ...+++..+..++.||+.||+|||+.+ |+||||||+|||+++++.+||+|||
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivHrdikp~Nil~~~~~~~kl~Dfg 163 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVK----CQKLSDEHVQFLIYQLLRGLKYIHSAG---IIHRDLKPSNVAVNEDCELRILDFG 163 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecccCChhhEEECCCCCEEEcCCc
Confidence 3468999987 778877763 345899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
+++..... .....||+.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 164 ~~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 164 LARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred cceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 99865322 223568999999999877 56899999999999999999999999653
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=263.59 Aligned_cols=202 Identities=30% Similarity=0.473 Sum_probs=169.8
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC-----cchHHHHHHHHHHhHhcCCCeeeEEeEEecC--Ccc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-----QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-----~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~ 588 (738)
.+|+..+.||+|+||.||++.... ++.|++|++..... ...+.+.+|+.++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTL 81 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEE
Confidence 468888999999999999998754 88999998754321 2245688999999999999999999988653 457
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
++++||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||+|+||++++++.+||+|||+++.
T Consensus 82 ~l~~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~~l~~LH~~~---i~H~~l~p~nil~~~~~~~~l~dfg~~~~ 155 (266)
T cd06651 82 TIFMEYMPGGSVKDQLKA---YGALTESVTRKYTRQILEGMSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (266)
T ss_pred EEEEeCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCCCccc
Confidence 899999999999998853 335889999999999999999999887 99999999999999999999999999976
Q ss_pred cCCCcc-cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 669 FGLDQT-EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 669 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
...... ........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~ 212 (266)
T cd06651 156 LQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEY 212 (266)
T ss_pred cccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCcccc
Confidence 543211 11122345788999999999988999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=261.88 Aligned_cols=199 Identities=37% Similarity=0.555 Sum_probs=171.9
Q ss_pred ceecccccEeEEEeeecc----ccEEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~----g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||++.... +..+++|.+...... ..+.+.+|+++++.++|+||+++++++......++||||+++
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEEERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEG 80 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchhHHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccC
Confidence 469999999999999764 778999998765433 367889999999999999999999999998999999999999
Q ss_pred CChhHHHhhcCC------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 598 KSLDYFIFDTTR------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 598 gsL~~~l~~~~~------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
++|.+++..... ...+++.++..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||.+.....
T Consensus 81 ~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~di~p~nili~~~~~~~l~dfg~~~~~~~ 157 (262)
T cd00192 81 GDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKK---FVHRDLAARNCLVGEDLVVKISDFGLSRDVYD 157 (262)
T ss_pred CcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCC---cccCccCcceEEECCCCcEEEccccccccccc
Confidence 999999865421 367899999999999999999999987 99999999999999999999999999987654
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
...........++..|+|||.+....++.++||||+|++++||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 211 (262)
T cd00192 158 DDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGL 211 (262)
T ss_pred ccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCC
Confidence 322122333567889999999988899999999999999999999 58998654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2e-29 Score=269.82 Aligned_cols=197 Identities=26% Similarity=0.402 Sum_probs=159.2
Q ss_pred ceecccccEeEEEeeecc---ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEec--CCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~---g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--~~~~~lV~Ey~~~ 597 (738)
.+||+|+||.||++...+ +..||+|.+.... ....+.+|+.++++++||||+++++++.. ....++||||+++
T Consensus 7 ~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~ 84 (317)
T cd07867 7 CKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTG--ISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH 84 (317)
T ss_pred eEeccCCCeeEEEEEecCCCccceEEEEEecCCC--CcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC
Confidence 579999999999998653 4689999886442 23567899999999999999999998854 4567899999886
Q ss_pred CChhHHHhhc------CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE----cCCCceEEEeecCcc
Q 004674 598 KSLDYFIFDT------TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLAR 667 (738)
Q Consensus 598 gsL~~~l~~~------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl----~~~~~vkL~DFGla~ 667 (738)
+|.+++... .....+++..+..++.||+.||+|||+.+ |+||||||+|||+ ++++.+||+|||+++
T Consensus 85 -~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~---ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~ 160 (317)
T cd07867 85 -DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANW---VLHRDLKPANILVMGEGPERGRVKIADMGFAR 160 (317)
T ss_pred -cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCC---EEcCCCCHHHEEEccCCCCCCcEEEeecccee
Confidence 555555321 11235889999999999999999999988 9999999999999 466789999999998
Q ss_pred ccCCCccc-ccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 668 SFGLDQTE-ANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 668 ~~~~~~~~-~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
........ .......||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 161 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 161 LFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred ccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 76433221 12233568999999999876 458999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-29 Score=261.72 Aligned_cols=195 Identities=29% Similarity=0.478 Sum_probs=161.7
Q ss_pred eecccccEeEEEeeec---cccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCC
Q 004674 524 KLGEGGFGPVYKGMLI---EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (738)
Q Consensus 524 ~LG~G~fG~Vykg~~~---~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (738)
.||+|+||.||+|... .+..||+|++..... ...+++.+|+.++++++|+||+++++++. .+..++||||+++++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~~~ 80 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASGGP 80 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccChHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCCCC
Confidence 4899999999999764 345699999865532 23467899999999999999999999885 457899999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc-c
Q 004674 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN-T 678 (738)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~-~ 678 (738)
|.+++.. ....+++..+.+++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++........... .
T Consensus 81 L~~~l~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 155 (257)
T cd05115 81 LNKFLSG--KKDEITVSNVVELMHQVSMGMKYLEGKN---FVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKAR 155 (257)
T ss_pred HHHHHHh--CCCCCCHHHHHHHHHHHHHHHHHHHhcC---eeecccchheEEEcCCCcEEeccCCccccccCCccceecc
Confidence 9998853 2346899999999999999999999987 99999999999999999999999999976543222111 1
Q ss_pred cccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 679 ~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
....++..|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus 156 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~ 202 (257)
T cd05115 156 SAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKM 202 (257)
T ss_pred CCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcC
Confidence 11223578999999988889999999999999999996 99998643
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.1e-31 Score=280.22 Aligned_cols=193 Identities=31% Similarity=0.490 Sum_probs=168.1
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcc---hHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG---MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~---~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
-|+.++.||.|+||.||-++... ...||||+++....+. ..++..|+..|++++|||++.+-|++..+...+||||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVME 106 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVME 106 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHH
Confidence 46777899999999999998654 6789999997654443 4578899999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
||- |+-.+++. ...+++.+.++..|..+.++||+|||+++ .||||||+.||||++.+.|||+|||.|.....
T Consensus 107 YCl-GSAsDlle--VhkKplqEvEIAAi~~gaL~gLaYLHS~~---~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P-- 178 (948)
T KOG0577|consen 107 YCL-GSASDLLE--VHKKPLQEVEIAAITHGALQGLAYLHSHN---RIHRDIKAGNILLSEPGLVKLADFGSASIMAP-- 178 (948)
T ss_pred HHh-ccHHHHHH--HHhccchHHHHHHHHHHHHHHHHHHHHhh---HHhhhccccceEecCCCeeeeccccchhhcCc--
Confidence 996 45566663 23467899999999999999999999998 99999999999999999999999999987543
Q ss_pred ccccccccccccCccchhccc---CCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRG 722 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvil~elltG~~p~~ 722 (738)
...++|||.|||||++. .+.|+-|+||||||+...||...++|..
T Consensus 179 ----AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlF 226 (948)
T KOG0577|consen 179 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF 226 (948)
T ss_pred ----hhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCcc
Confidence 33489999999999874 5789999999999999999999998874
|
|
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=262.34 Aligned_cols=202 Identities=26% Similarity=0.367 Sum_probs=173.6
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCC-CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
+|+..+.||+|+||.||++... .++.+|+|.++.. .....+.+.+|+.+++.++|+||+++++.+..+...++||||+
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSSSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYC 80 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcchHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeC
Confidence 4677889999999999999875 4788999988543 2334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++... ....+++..+..++.|++.||+|||+.+ |+|+||||+||++++++.++|+|||++........
T Consensus 81 ~~~~l~~~~~~~-~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~- 155 (255)
T cd08219 81 DGGDLMQKIKLQ-RGKLFPEDTILQWFVQMCLGVQHIHEKR---VLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA- 155 (255)
T ss_pred CCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEECCCCcEEEcccCcceeeccccc-
Confidence 999998887532 3456889999999999999999999988 99999999999999999999999999976543221
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......|+..|+|||++.+..++.++|+||||+++++|++|+.||....
T Consensus 156 -~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 156 -YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred -ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 1223568889999999999889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.2e-30 Score=268.62 Aligned_cols=202 Identities=26% Similarity=0.438 Sum_probs=170.8
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCC-CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++|+..+.||+|+||.||++... .++.+|+|.+... .....+.+.+|++++++++|+||+++++.+...+..++||||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELDESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEY 80 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccCHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEee
Confidence 46788899999999999999976 5889999988643 223346788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|..++........+++..+..++.+++.||.|||+.. +|+|+||||+||+++.++.+||+|||++.......
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~- 157 (286)
T cd06622 81 MDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEH--NIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL- 157 (286)
T ss_pred cCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcC--CEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc-
Confidence 999999988865433447899999999999999999999742 39999999999999999999999999987653221
Q ss_pred cccccccccccCccchhcccCC------CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDG------LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~------~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.....++..|+|||.+.+. .++.++|||||||++|||++|+.||...
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 210 (286)
T cd06622 158 ---AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPE 210 (286)
T ss_pred ---cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCc
Confidence 2224578899999988554 3588999999999999999999999643
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=268.76 Aligned_cols=205 Identities=29% Similarity=0.443 Sum_probs=169.3
Q ss_pred CCCCccceecccccEeEEEeeec-----------------cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-----------------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKL 578 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-----------------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l 578 (738)
++|++.+.||+|+||.||++... +...+|+|.+.... ....+++.+|+.++++++|+||+++
T Consensus 5 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~ 84 (296)
T cd05095 5 KRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFLKEIKIMSRLKDPNIIRL 84 (296)
T ss_pred hhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceE
Confidence 46888999999999999997532 23468999986543 2345678999999999999999999
Q ss_pred EeEEecCCcceEEEeeCCCCChhHHHhhcCC--------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcE
Q 004674 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTR--------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNV 650 (738)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NI 650 (738)
++++...+..++||||+++++|.+++..... ...+++.++..++.|++.||+|||+.+ ++||||||+||
T Consensus 85 ~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dlkp~Ni 161 (296)
T cd05095 85 LAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLN---FVHRDLATRNC 161 (296)
T ss_pred EEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCC---eecccCChheE
Confidence 9999999999999999999999999865321 134778899999999999999999988 99999999999
Q ss_pred EEcCCCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc--CCCCCCCC
Q 004674 651 LLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC--GKKNRGFN 724 (738)
Q Consensus 651 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt--G~~p~~~~ 724 (738)
|+++++.++|+|||+++.+.............++..|+|||...+..++.++||||||+++|||++ |..||...
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~ 237 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQL 237 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCcccc
Confidence 999999999999999986543222111222334678999999888889999999999999999998 66777543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.3e-29 Score=271.20 Aligned_cols=205 Identities=32% Similarity=0.466 Sum_probs=169.5
Q ss_pred CCCCccceecccccEeEEEeeec--------cccEEEEEEccCCC-CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~--------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~ 586 (738)
++|.+.+.||+|+||.||++... ....+|+|.+.... .....++.+|+.+++++ +||||+++++++....
T Consensus 12 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (314)
T cd05099 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNATDKDLADLISEMELMKLIGKHKNIINLLGVCTQEG 91 (314)
T ss_pred HHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCChHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCC
Confidence 56778899999999999998742 24568999886543 23356788999999999 6999999999999988
Q ss_pred cceEEEeeCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (738)
..++||||+++++|.+++.... ....+++.++..++.||+.||+|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~g---i~H~dlkp~Nill~ 168 (314)
T cd05099 92 PLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRR---CIHRDLAARNVLVT 168 (314)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCC---eeeccccceeEEEc
Confidence 9999999999999999986532 1245899999999999999999999987 99999999999999
Q ss_pred CCCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 654 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
+++.+||+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~ 240 (314)
T cd05099 169 EDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGI 240 (314)
T ss_pred CCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCC
Confidence 999999999999986643221111111234567999999998899999999999999999999 88888643
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=260.79 Aligned_cols=201 Identities=32% Similarity=0.506 Sum_probs=169.5
Q ss_pred CCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
++|+..+.||+|++|.||++....+..+|+|.+.... ...+.+.+|++++++++|+|++++++++. ....+++|||++
T Consensus 6 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~ 83 (260)
T cd05069 6 ESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGT-MMPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVTEFMG 83 (260)
T ss_pred HHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCC-ccHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEEEcCC
Confidence 4577888999999999999998777789999875433 34567899999999999999999999875 456889999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||++..........
T Consensus 84 ~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~~ 159 (260)
T cd05069 84 KGSLLDFLKEG-DGKYLKLPQLVDMAAQIADGMAYIERMN---YIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTA 159 (260)
T ss_pred CCCHHHHHhhC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccCcceEEEcCCCeEEECCCccceEccCCcccc
Confidence 99999988543 2345889999999999999999999987 9999999999999999999999999997654322111
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
.....++..|+|||...+..++.++||||||+++|||++ |+.||...
T Consensus 160 -~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 207 (260)
T cd05069 160 -RQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGM 207 (260)
T ss_pred -cCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112345678999999988889999999999999999999 88888653
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=267.46 Aligned_cols=205 Identities=31% Similarity=0.450 Sum_probs=171.6
Q ss_pred cCCCCccceecccccEeEEEeeecc-----------------ccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeee
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-----------------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVK 577 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-----------------g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~ 577 (738)
.++|++.+.||+|+||.||++.... +..||+|.+..... ...+++.+|++++++++|+||++
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~ 83 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEVKILSRLSDPNIAR 83 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCHHHHHHHHHHHHHHHhcCCCCEeE
Confidence 3578889999999999999987643 24589999865432 34567899999999999999999
Q ss_pred EEeEEecCCcceEEEeeCCCCChhHHHhhcC--------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCc
Q 004674 578 LLGCCTQRDERMLIYEYLPNKSLDYFIFDTT--------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649 (738)
Q Consensus 578 l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~--------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 649 (738)
+++++...+..+++|||+++++|..++.... ....+++..+..++.|++.||+|||+.+ |+||||||+|
T Consensus 84 ~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~---i~H~dlkp~N 160 (296)
T cd05051 84 LLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLN---FVHRDLATRN 160 (296)
T ss_pred EEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcC---ccccccchhc
Confidence 9999999999999999999999999986533 1126899999999999999999999987 9999999999
Q ss_pred EEEcCCCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc--CCCCCCC
Q 004674 650 VLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC--GKKNRGF 723 (738)
Q Consensus 650 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt--G~~p~~~ 723 (738)
|++++++.++|+|||+++...............++..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 161 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~ 236 (296)
T cd05051 161 CLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEH 236 (296)
T ss_pred eeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCC
Confidence 9999999999999999976543322222223456778999999988889999999999999999998 6677754
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=9e-30 Score=296.81 Aligned_cols=207 Identities=24% Similarity=0.382 Sum_probs=170.1
Q ss_pred HhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecC--Ccc
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~ 588 (738)
...++|.+.+.||+|+||.||++.... +..+|+|.+... .......+..|+.+++.++|||||++++++... ...
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~l 89 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKL 89 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEeccccCHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEE
Confidence 345789999999999999999999765 678899987643 223356788999999999999999999988543 458
Q ss_pred eEEEeeCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCC----CCeEeCCCCCCcEEEcCC--------
Q 004674 589 MLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSR----LRIIHRDLKASNVLLDNT-------- 655 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~----~~ivH~DLkp~NILl~~~-------- 655 (738)
+|||||+++++|..++.... ....+++..++.|+.||+.||+|||+.+. .+|+||||||+||||+.+
T Consensus 90 yIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~ 169 (1021)
T PTZ00266 90 YILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKIT 169 (1021)
T ss_pred EEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccccccc
Confidence 99999999999999886432 23569999999999999999999998541 249999999999999642
Q ss_pred ---------CceEEEeecCccccCCCcccccccccccccCccchhcccC--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 656 ---------MNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 656 ---------~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
..+||+|||++..+.... ......||+.|+|||++.+ ..++.++||||||||||||++|+.||..
T Consensus 170 ~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~ 245 (1021)
T PTZ00266 170 AQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHK 245 (1021)
T ss_pred ccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCc
Confidence 348999999998654322 1223578999999999864 4589999999999999999999999964
|
|
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=266.22 Aligned_cols=202 Identities=27% Similarity=0.417 Sum_probs=168.1
Q ss_pred hcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++++|...+.||+|+||.||+|... +++.|++|++..... .....+.+|+.+++.++|+||+++.+++..+...++||
T Consensus 3 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 3 AATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ccceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 3578889999999999999999865 488999999865432 23346788999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+. ++|...+... ...+++..+..++.||+.||+|||+.+ |+|+||||+||+++.++.+||+|||+++.....
T Consensus 83 e~~~-~~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~ 156 (291)
T cd07870 83 EYMH-TDLAQYMIQH--PGGLHPYNVRLFMFQLLRGLAYIHGQH---ILHRDLKPQNLLISYLGELKLADFGLARAKSIP 156 (291)
T ss_pred eccc-CCHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCChHHEEEcCCCcEEEeccccccccCCC
Confidence 9996 5666665332 245778888999999999999999987 999999999999999999999999999764332
Q ss_pred cccccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
... .....++..|+|||++.+. .++.++||||||++++||++|+.||...
T Consensus 157 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~ 207 (291)
T cd07870 157 SQT--YSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGV 207 (291)
T ss_pred CCC--CCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCc
Confidence 211 1224578899999998764 5788999999999999999999999643
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-29 Score=260.88 Aligned_cols=194 Identities=32% Similarity=0.488 Sum_probs=162.6
Q ss_pred eecccccEeEEEeeec---cccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCC
Q 004674 524 KLGEGGFGPVYKGMLI---EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNK 598 (738)
Q Consensus 524 ~LG~G~fG~Vykg~~~---~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (738)
.||+|+||.||+|... +++.+|+|+++.... ...+++.+|+.+++.++|+||+++++++. .+..++||||++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~~ 80 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAELG 80 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCCcHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCCC
Confidence 5999999999999753 467899999864432 23567899999999999999999999875 45678999999999
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc-c
Q 004674 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA-N 677 (738)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~-~ 677 (738)
+|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++.......... .
T Consensus 81 ~L~~~l~~---~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 81 PLNKFLQK---NKHVTEKNITELVHQVSMGMKYLEETN---FVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred cHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99998843 345899999999999999999999988 9999999999999999999999999998764332211 1
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
.....++..|+|||.+....++.++||||||+++|||++ |+.||...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 202 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGM 202 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 112234578999999988889999999999999999998 99999754
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-29 Score=261.49 Aligned_cols=196 Identities=31% Similarity=0.451 Sum_probs=167.7
Q ss_pred ceecccccEeEEEeeecc--c--cEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE--G--QEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~--g--~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|++|.||++.... + ..+|+|.+..... ...+++.+|+.++++++|+||+++++.+.. ...++||||+++
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~ 79 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPL 79 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccHHHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCC
Confidence 368999999999998643 2 3689999876655 456789999999999999999999999988 889999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc-c
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE-A 676 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~-~ 676 (738)
++|.+++..... ..+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.+||+|||++..+...... .
T Consensus 80 ~~L~~~l~~~~~-~~~~~~~~~~~~~qi~~~L~~lH~~~---i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 155 (257)
T cd05040 80 GSLLDRLRKDAL-GHFLISTLCDYAVQIANGMRYLESKR---FIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYV 155 (257)
T ss_pred CcHHHHHHhccc-ccCcHHHHHHHHHHHHHHHHHHHhCC---ccccccCcccEEEecCCEEEecccccccccccccccee
Confidence 999999865432 46899999999999999999999987 999999999999999999999999999876442211 1
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
......++..|+|||.+.+..++.++||||||++++||++ |+.||..
T Consensus 156 ~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~ 203 (257)
T cd05040 156 MEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAG 203 (257)
T ss_pred cccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 1112456789999999998899999999999999999998 9999854
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=268.96 Aligned_cols=202 Identities=23% Similarity=0.339 Sum_probs=171.0
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|+..+.||+|+||.||++.... ++.|++|.+.... ....+.+.+|+++++.++|+||+++++.+..++..++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVM 80 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEE
Confidence 468888999999999999999765 6889999886543 223457789999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.....
T Consensus 81 e~~~g~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~ 154 (305)
T cd05609 81 EYVEGGDCATLLKN---IGALPVDMARMYFAETVLALEYLHNYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMS 154 (305)
T ss_pred ecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCchHHEEECCCCCEEEeeCCCccccCcC
Confidence 99999999999844 346899999999999999999999987 999999999999999999999999998642111
Q ss_pred cc-------------cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 673 QT-------------EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 673 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.. ........++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~ 219 (305)
T cd05609 155 LTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGD 219 (305)
T ss_pred ccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 00 00111245788999999998888999999999999999999999998643
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-29 Score=265.01 Aligned_cols=201 Identities=30% Similarity=0.486 Sum_probs=167.8
Q ss_pred CCCCccceecccccEeEEEeeec-----cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecC--Ccce
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERM 589 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-----~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~ 589 (738)
++|++.+.||+|+||.||++... .+..||+|++........+.+.+|++++++++||||+++++++... ...+
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 83 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTAEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLR 83 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceE
Confidence 46788899999999999998742 4778999998766555567899999999999999999999987543 4588
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcccc
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 669 (738)
+||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++...
T Consensus 84 lv~e~~~~~~L~~~l~~~--~~~l~~~~~~~~~~~l~~aL~~LH~~~---i~H~dlkp~nili~~~~~~~l~dfg~~~~~ 158 (284)
T cd05081 84 LVMEYLPYGSLRDYLQKH--RERLDHRKLLLYASQICKGMEYLGSKR---YVHRDLATRNILVESENRVKIGDFGLTKVL 158 (284)
T ss_pred EEEEecCCCCHHHHHHhc--CcCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCCHhhEEECCCCeEEECCCcccccc
Confidence 999999999999998532 345899999999999999999999987 999999999999999999999999999876
Q ss_pred CCCcccc-cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 004674 670 GLDQTEA-NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRG 722 (738)
Q Consensus 670 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~ 722 (738)
....... ......++..|+|||.+.+..++.++||||||++++||++|..++.
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 159 PQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred cCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 4322111 0111223456999999998899999999999999999999887654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-29 Score=273.91 Aligned_cols=204 Identities=31% Similarity=0.474 Sum_probs=167.1
Q ss_pred CCCCccceecccccEeEEEeee------ccccEEEEEEccCCCC-cchHHHHHHHHHHhHh-cCCCeeeEEeEEecC-Cc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGML------IEGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR-DE 587 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~------~~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~-~~ 587 (738)
++|++.+.||+|+||.||+|.. ..++.||||+++.... .....+.+|+.++.++ +|+||+++++++... ..
T Consensus 7 ~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~ 86 (343)
T cd05103 7 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGP 86 (343)
T ss_pred hHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCChHHHHHHHHHHHHHHhccCCccHhhhcceeecCCCc
Confidence 5788899999999999999973 3467899999865432 2345688999999999 689999999988654 45
Q ss_pred ceEEEeeCCCCChhHHHhhcCC----------------------------------------------------------
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTR---------------------------------------------------------- 609 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~---------------------------------------------------------- 609 (738)
.++||||+++|+|.+++.....
T Consensus 87 ~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 166 (343)
T cd05103 87 LMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEA 166 (343)
T ss_pred eEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchhhhh
Confidence 7899999999999998854210
Q ss_pred ------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccccccccc
Q 004674 610 ------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683 (738)
Q Consensus 610 ------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~g 683 (738)
...+++..+..++.||++||+|||+.+ |+||||||+|||+++++.+||+|||++................+
T Consensus 167 ~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 167 EQEDLYKKVLTLEDLICYSFQVAKGMEFLASRK---CIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 124688888999999999999999987 99999999999999999999999999976533222111222345
Q ss_pred ccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 684 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 684 t~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
+..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~ 284 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence 678999999999899999999999999999997 8888854
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.2e-30 Score=270.04 Aligned_cols=195 Identities=28% Similarity=0.438 Sum_probs=169.9
Q ss_pred cceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCCh
Q 004674 522 KNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (738)
...||+|+||.||++... +++.||+|.+........+.+.+|+.+++.++||||+++++.+..++..++||||+++++|
T Consensus 26 ~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L 105 (297)
T cd06659 26 YIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGAL 105 (297)
T ss_pred hhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccchHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCH
Confidence 347999999999999875 4889999998665555567788999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccc
Q 004674 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (738)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 680 (738)
..++.. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++........ ....
T Consensus 106 ~~~~~~----~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~ 176 (297)
T cd06659 106 TDIVSQ----TRLNEEQIATVCESVLQALCYLHSQG---VIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKS 176 (297)
T ss_pred HHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccc
Confidence 887632 35889999999999999999999987 99999999999999999999999999876543221 1223
Q ss_pred cccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
..|+..|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 177 ~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 177 LVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred eecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 568899999999998899999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=268.72 Aligned_cols=205 Identities=25% Similarity=0.345 Sum_probs=174.6
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCc---chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ---GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~---~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|+..+.||+|++|.||++.... ++.+|+|.+...... ..+.+.+|+++++.++|+||+++++.+......++||
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 80 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVM 80 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEE
Confidence 467888999999999999999765 889999998754322 4457889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+.+++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||+++.++.++|+|||++......
T Consensus 81 e~~~~~~L~~~~~~~-~~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~ 156 (316)
T cd05574 81 DYCPGGELFRLLQRQ-PGKCLSEEVARFYAAEVLLALEYLHLLG---IVYRDLKPENILLHESGHIMLSDFDLSKQSDVE 156 (316)
T ss_pred EecCCCCHHHHHHhC-CCCccCHHHHHHHHHHHHHHHHHHHHCC---eeccCCChHHeEEcCCCCEEEeecchhhccccc
Confidence 999999999987532 3456899999999999999999999987 999999999999999999999999998754321
Q ss_pred cc---------------------------cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QT---------------------------EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~---------------------------~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.. ........|+..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 236 (316)
T cd05574 157 PPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSN 236 (316)
T ss_pred ccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCc
Confidence 10 011122467889999999999889999999999999999999999996443
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.7e-29 Score=265.27 Aligned_cols=204 Identities=31% Similarity=0.514 Sum_probs=170.2
Q ss_pred CCCCccceecccccEeEEEeeecc-cc----EEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~----~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
++|+..+.||+|+||.||+|.... +. .+|+|.+..... ...+++.+|+.++++++|+||+++++++.. ...++
T Consensus 7 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~ 85 (279)
T cd05057 7 TELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQL 85 (279)
T ss_pred HHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEE
Confidence 467778899999999999998643 32 589998865533 334678899999999999999999999987 78899
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
||||+++++|.+++... ...+++..+..++.||+.||+|||+.+ ++||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~LH~~~---i~H~di~p~nil~~~~~~~kL~dfg~~~~~~ 160 (279)
T cd05057 86 ITQLMPLGCLLDYVRNH--KDNIGSQYLLNWCVQIAKGMSYLEEKR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLD 160 (279)
T ss_pred EEecCCCCcHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEecccCcceEEEcCCCeEEECCCccccccc
Confidence 99999999999998543 335899999999999999999999987 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHA 726 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~~ 726 (738)
............++..|+|||.+....++.++||||||++++|+++ |+.||.....
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 217 (279)
T cd05057 161 VDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPA 217 (279)
T ss_pred CcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCH
Confidence 3322211111223568999999988889999999999999999998 9999976443
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-29 Score=259.97 Aligned_cols=202 Identities=24% Similarity=0.387 Sum_probs=174.2
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|+..+.||+|+||.||.+.... ++.+++|.+... .....+++.+|++++++++|+||+++++++.+.+..+++|||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~ 80 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEY 80 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEe
Confidence 47788999999999999888644 788999987543 234456788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++.... ...+++.++..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 81 ANGGTLYDKIVRQK-GQLFEEEMVLWYLFQIVSAVSYIHKAG---ILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred cCCCcHHHHHHhcc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---ccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 99999999885432 356899999999999999999999987 99999999999999999999999999987643332
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......+++.|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATN 205 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCC
Confidence 1223568899999999988888999999999999999999999987543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=276.44 Aligned_cols=201 Identities=26% Similarity=0.406 Sum_probs=176.7
Q ss_pred hcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCc--chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ--GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
....|.+...||+|.|+.|..+++.. +.+||||.+++..-. ..+.+.+|+++|..++|||||+++.+...+...|+|
T Consensus 54 ~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 54 SVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred cccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 34678888999999999999999754 889999999876433 345688999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|||+.+|.+.+++... +...+.....++.|+..|++|||+++ |||||||++||||+.+..+||+|||++..+..
T Consensus 134 ~eya~~ge~~~yl~~~---gr~~e~~ar~~F~q~vsaveYcH~k~---ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~ 207 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKH---GRMKEKEARAKFRQIVSAVEYCHSKN---IVHRDLKAENILLDENMNIKIADFGFSTFFDY 207 (596)
T ss_pred EEeccCchhHHHHHhc---ccchhhhhhhhhHHHHHHHHHHhhcc---eeccccchhhcccccccceeeeccccceeecc
Confidence 9999999999999654 34556888889999999999999998 99999999999999999999999999988753
Q ss_pred CcccccccccccccCccchhcccCCCC-CchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.......+|++.|.|||++.+..| ++++|+||+|++||-|++|..||+..
T Consensus 208 ---~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~ 258 (596)
T KOG0586|consen 208 ---GLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQ 258 (596)
T ss_pred ---cccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCc
Confidence 233445899999999999998775 57899999999999999999999854
|
|
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-29 Score=261.16 Aligned_cols=205 Identities=28% Similarity=0.448 Sum_probs=176.2
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++|++.+.||+|+||.||++... ++..+++|++.... ....+.+.+|+++++.++|+||+++++.+...+..++|||+
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~ 80 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQTSVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPY 80 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcchHHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEec
Confidence 47888999999999999999965 47889999986543 23457889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++........+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++..+.....
T Consensus 81 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~---i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~ 157 (267)
T cd06610 81 LSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNG---QIHRDIKAGNILLGEDGSVKIADFGVSASLADGGD 157 (267)
T ss_pred cCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccchHHHhccCcc
Confidence 999999999865433356899999999999999999999987 99999999999999999999999999877654322
Q ss_pred cc--cccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EA--NTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~--~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.. ......|+..|+|||.+... .++.++|+||||++++||++|+.||...
T Consensus 158 ~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~ 210 (267)
T cd06610 158 RTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKY 210 (267)
T ss_pred ccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCcccc
Confidence 21 22335688999999998876 7899999999999999999999999643
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.6e-30 Score=270.43 Aligned_cols=196 Identities=28% Similarity=0.436 Sum_probs=170.0
Q ss_pred ccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCC
Q 004674 521 EKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (738)
Q Consensus 521 ~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (738)
....||+|+||.||++... .+..||+|.+........+.+.+|+.+++.++|+||+++++.+..++..++||||+++++
T Consensus 26 ~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~ 105 (292)
T cd06658 26 SFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGA 105 (292)
T ss_pred hhhcccCCCCeEEEEEEECCCCCEEEEEEEecchHHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCc
Confidence 3457999999999999875 478999999866555556678999999999999999999999999999999999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccccc
Q 004674 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679 (738)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~ 679 (738)
|.+++.. ..+++.++..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++........ ...
T Consensus 106 L~~~~~~----~~l~~~~~~~~~~qi~~~l~~LH~~~---ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~ 176 (292)
T cd06658 106 LTDIVTH----TRMNEEQIATVCLSVLRALSYLHNQG---VIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRK 176 (292)
T ss_pred HHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCc
Confidence 9988732 34889999999999999999999987 99999999999999999999999999876533221 122
Q ss_pred ccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 680 ~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
...|+..|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus 177 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 177 SLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred eeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3568899999999988889999999999999999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=266.66 Aligned_cols=205 Identities=28% Similarity=0.472 Sum_probs=170.9
Q ss_pred cCCCCccceecccccEeEEEeeec------cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcc
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~------~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~ 588 (738)
.++|+..+.||+|+||.||++... .+..+|+|.+.... ....+++.+|+.++++++||||+++++++..+...
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~ 83 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPM 83 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcCHHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCcc
Confidence 357888899999999999999863 35789999986543 23346789999999999999999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcCC-------------------CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTR-------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~-------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~N 649 (738)
++||||+++++|.+++..... ...+++..++.++.|++.||+|||+.+ ++||||||+|
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~---i~H~dl~p~n 160 (288)
T cd05050 84 CLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERK---FVHRDLATRN 160 (288)
T ss_pred EEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCC---eecccccHhh
Confidence 999999999999999864211 124788899999999999999999987 9999999999
Q ss_pred EEEcCCCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 650 VLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 650 ILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
|++++++.+||+|||++..+..............+..|+|||.+.+..++.++||||||+++|||++ |..||..
T Consensus 161 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~ 235 (288)
T cd05050 161 CLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYG 235 (288)
T ss_pred eEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 9999999999999999876543221111112334668999999998899999999999999999997 8888753
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=263.90 Aligned_cols=202 Identities=28% Similarity=0.474 Sum_probs=168.4
Q ss_pred CCCccceecccccEeEEEeeecc-c---cEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g---~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
.|+..+.||+|+||.||+|.... + ..||+|.+.... ....++|..|+.+++.++||||+++++++.++...++||
T Consensus 5 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 84 (269)
T cd05065 5 CVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIIT 84 (269)
T ss_pred HeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEE
Confidence 46678899999999999998754 3 359999986542 334568999999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++......
T Consensus 85 e~~~~~~L~~~l~~~--~~~~~~~~~~~i~~~l~~al~~lH~~g---~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~ 159 (269)
T cd05065 85 EFMENGALDSFLRQN--DGQFTVIQLVGMLRGIAAGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 159 (269)
T ss_pred ecCCCCcHHHHHhhC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccChheEEEcCCCcEEECCCccccccccC
Confidence 999999999988543 345899999999999999999999987 999999999999999999999999998765432
Q ss_pred cccccccc-cc--cccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 673 QTEANTKR-VV--GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 673 ~~~~~~~~-~~--gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
........ .. .+..|+|||.+.+..++.++||||||+++||+++ |+.||...
T Consensus 160 ~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~ 215 (269)
T cd05065 160 TSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215 (269)
T ss_pred ccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCC
Confidence 22111111 11 2357999999999999999999999999999886 99998643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-29 Score=265.04 Aligned_cols=199 Identities=34% Similarity=0.492 Sum_probs=165.7
Q ss_pred CCccceecccccEeEEEeee-----ccccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecC--CcceE
Q 004674 519 FSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERML 590 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~-----~~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~l 590 (738)
|+..+.||+|+||.||++.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++... ...++
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQL 85 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccChHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEE
Confidence 37788999999999987653 3467899999865432 3456788999999999999999999988654 35789
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
||||+++++|.+++.. ..+++.++..++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++...
T Consensus 86 v~e~~~~~~l~~~~~~----~~l~~~~~~~i~~~l~~~l~~lH~~~---i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~ 158 (283)
T cd05080 86 IMEYVPLGSLRDYLPK----HKLNLAQLLLFAQQICEGMAYLHSQH---YIHRDLAARNVLLDNDRLVKIGDFGLAKAVP 158 (283)
T ss_pred EecCCCCCCHHHHHHH----cCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccChheEEEcCCCcEEEeecccccccC
Confidence 9999999999998843 34899999999999999999999987 9999999999999999999999999998664
Q ss_pred CCccccc-ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 671 LDQTEAN-TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 671 ~~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
....... .....++..|+|||.+.+..++.++||||||++++||++|+.|+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 213 (283)
T cd05080 159 EGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSP 213 (283)
T ss_pred CcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCC
Confidence 3222111 11234566799999999888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-30 Score=280.83 Aligned_cols=194 Identities=29% Similarity=0.463 Sum_probs=164.5
Q ss_pred ccceecccccEeEEEeeecc-ccEEEEEEcc--C--CCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCc--ceEEEe
Q 004674 521 EKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS--K--GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE--RMLIYE 593 (738)
Q Consensus 521 ~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~--~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~--~~lV~E 593 (738)
....||+|+|-+||||.... |-+||--.++ + ......++|..|+.+|+.|+|+||++++..+.+... .-+|.|
T Consensus 44 ~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTE 123 (632)
T KOG0584|consen 44 FDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITE 123 (632)
T ss_pred hhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeee
Confidence 34579999999999999754 6666633222 1 233445889999999999999999999999987665 678999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc-CCCceEEEeecCccccCCC
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~vkL~DFGla~~~~~~ 672 (738)
.|..|+|..++... +.++...+..|+.||++||.|||.+. ++|||||||-+||+|+ ..|.|||+|+|+|......
T Consensus 124 L~TSGtLr~Y~kk~---~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s 199 (632)
T KOG0584|consen 124 LFTSGTLREYRKKH---RRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS 199 (632)
T ss_pred cccCCcHHHHHHHh---ccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhcc
Confidence 99999999998554 45788899999999999999999986 7899999999999997 5789999999999986543
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
. ...+.|||.|||||... ..|.+.+|||||||+++||+|+..||..
T Consensus 200 ~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsE 245 (632)
T KOG0584|consen 200 H----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSE 245 (632)
T ss_pred c----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhh
Confidence 2 33478999999999876 7899999999999999999999999964
|
|
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=270.16 Aligned_cols=202 Identities=32% Similarity=0.510 Sum_probs=167.4
Q ss_pred CCCCccceecccccEeEEEeeecc-cc--EEEEEEccCCC-CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ--EIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~--~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV 591 (738)
++|++.+.||+|+||.||++.... +. .+++|.+.... ....+++.+|++++.++ +|+||+++++++...+..++|
T Consensus 7 ~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv 86 (303)
T cd05088 7 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 86 (303)
T ss_pred hhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEE
Confidence 567888999999999999998754 43 46787775432 23456788999999999 899999999999999999999
Q ss_pred EeeCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCce
Q 004674 592 YEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~v 658 (738)
|||+++++|.+++.... ....+++.+++.++.||+.||+|||+.+ ++||||||+|||+++++.+
T Consensus 87 ~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 87 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 163 (303)
T ss_pred EEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCC---ccccccchheEEecCCCcE
Confidence 99999999999986432 1235889999999999999999999987 9999999999999999999
Q ss_pred EEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 659 kL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
||+|||++...... .......++..|+|||++.+..++.++||||||++++||++ |+.||...
T Consensus 164 kl~dfg~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~ 227 (303)
T cd05088 164 KIADFGLSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGM 227 (303)
T ss_pred EeCccccCcccchh---hhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccC
Confidence 99999998643211 11111234567999999988889999999999999999998 99998643
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=260.93 Aligned_cols=198 Identities=30% Similarity=0.482 Sum_probs=171.6
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCC-----CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-----~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
+|+..+.||+|++|.||+|... +++.|++|.+.... .+..+.+.+|+.+++.++|+||+++++++......+++
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 3667789999999999999976 68899999886533 22456789999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
+||+++++|.+++.. ...+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~ 154 (258)
T cd06632 81 LELVPGGSLAKLLKK---YGSFPEPVIRLYTRQILLGLEYLHDRN---TVHRDIKGANILVDTNGVVKLADFGMAKQVVE 154 (258)
T ss_pred EEecCCCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEccCccceeccc
Confidence 999999999999853 345889999999999999999999987 99999999999999999999999999876543
Q ss_pred CcccccccccccccCccchhcccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.. ......|+..|+|||.+.... ++.++|+||||++++||++|+.||...
T Consensus 155 ~~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~ 205 (258)
T cd06632 155 FS---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQL 205 (258)
T ss_pred cc---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccC
Confidence 22 123356889999999987766 899999999999999999999998653
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=267.00 Aligned_cols=199 Identities=27% Similarity=0.431 Sum_probs=170.1
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
++|+..+.||+|+||.||++...+ ++.+|+|++..... ...+.+.+|+++++.++|+||+++++++..+...++|||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFE 80 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcchhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEe
Confidence 467888999999999999999864 78999998865432 234678899999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++++|+.+... ...+++.++..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 81 FVDHTVLDDLEKY---PNGLDESRVRKYLFQILRGIEFCHSHN---IIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred cCCccHHHHHHhc---cCCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999999877632 335899999999999999999999987 9999999999999999999999999988654332
Q ss_pred ccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
. ......++..|+|||++.+ ..++.++||||||++++||++|+.||..
T Consensus 155 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~ 203 (286)
T cd07846 155 E--VYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPG 203 (286)
T ss_pred c--ccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCC
Confidence 1 1223457889999998875 4578899999999999999999998864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=263.00 Aligned_cols=204 Identities=29% Similarity=0.516 Sum_probs=170.2
Q ss_pred CCCCccceecccccEeEEEeeecc-c---cEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g---~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
++|+..+.||+|+||.||++.... + ..+++|.+.... ....+++.+|++++++++|+|++++.+++...+..++|
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 84 (268)
T cd05063 5 SHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMII 84 (268)
T ss_pred HHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCHHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEE
Confidence 467778899999999999999753 3 368999886542 23356789999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|||+++++|..++... ...+++.++..++.|++.|++|||+.+ ++||||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~al~~lH~~~---i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~ 159 (268)
T cd05063 85 TEYMENGALDKYLRDH--DGEFSSYQLVGMLRGIAAGMKYLSDMN---YVHRDLAARNILVNSNLECKVSDFGLSRVLED 159 (268)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeccccchhhEEEcCCCcEEECCCccceeccc
Confidence 9999999999988542 346899999999999999999999987 99999999999999999999999999876543
Q ss_pred Cccccc-ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 672 DQTEAN-TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 672 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
...... ......+..|+|||++.+..++.++||||||+++|||++ |+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~ 215 (268)
T cd05063 160 DPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMS 215 (268)
T ss_pred ccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCC
Confidence 221111 111223457999999998889999999999999999997 999996543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-29 Score=264.41 Aligned_cols=208 Identities=26% Similarity=0.370 Sum_probs=172.4
Q ss_pred HHHHhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHh-cCCCeeeEEeEEe-----
Q 004674 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCT----- 583 (738)
Q Consensus 511 ~l~~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~----- 583 (738)
.+....++|++.+.||+|+||.||++.... ++.+|+|++.... ....++.+|+.+++++ +|+||+++++++.
T Consensus 12 ~~~~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~ 90 (286)
T cd06638 12 SFPDPSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH-DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVK 90 (286)
T ss_pred cCCCcccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc-chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccC
Confidence 345567899999999999999999998754 7889999875432 2346788999999999 6999999999874
Q ss_pred cCCcceEEEeeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEe
Q 004674 584 QRDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (738)
Q Consensus 584 ~~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~D 662 (738)
.++..++||||+++++|.+++... .....+++..+..++.|+++||.|||+.+ ++||||||+||++++++.+||+|
T Consensus 91 ~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nili~~~~~~kl~d 167 (286)
T cd06638 91 NGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNK---TIHRDVKGNNILLTTEGGVKLVD 167 (286)
T ss_pred CCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCC---ccccCCCHHhEEECCCCCEEEcc
Confidence 334689999999999999887542 23456889999999999999999999987 99999999999999999999999
Q ss_pred ecCccccCCCcccccccccccccCccchhcccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 663 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
||++........ ......|+..|+|||++.. ..++.++||||+|+++|||++|+.|+...
T Consensus 168 fg~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~ 232 (286)
T cd06638 168 FGVSAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232 (286)
T ss_pred CCceeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCC
Confidence 999876543221 1223468999999998753 45788999999999999999999998654
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=258.08 Aligned_cols=201 Identities=27% Similarity=0.375 Sum_probs=171.1
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC-cceEEEe
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-ERMLIYE 593 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-~~~lV~E 593 (738)
+|+..+.||+|++|.||++.... ++.+++|++.... ....+.+.+|++++++++|+|++++++.+...+ ..+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e 80 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMG 80 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhcCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEec
Confidence 47788999999999999998754 6789999986432 234567889999999999999999998876444 5789999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++++|.+++... ....+++.++..++.+++.|+++||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~l~~~l~~~-~~~~l~~~~~~~~~~~l~~~l~~lH~~~---i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 81 FCEGGDLYHKLKEQ-KGKLLPENQVVEWFVQIAMALQYLHEKH---ILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred ccCCCcHHHHHHHh-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 99999999888643 2346899999999999999999999988 9999999999999999999999999998664322
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
. ......+++.|+|||++.+..++.++||||||++++||++|+.||...
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 205 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAK 205 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCC
Confidence 1 223356889999999999999999999999999999999999999754
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=264.62 Aligned_cols=191 Identities=23% Similarity=0.328 Sum_probs=158.4
Q ss_pred eecccccEeEEEeeecc-------------------------ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeE
Q 004674 524 KLGEGGFGPVYKGMLIE-------------------------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKL 578 (738)
Q Consensus 524 ~LG~G~fG~Vykg~~~~-------------------------g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l 578 (738)
.||+|+||.||+|.+.. ...|++|.+........+++.+|+.+++.++||||+++
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~~~~~~~~~~~~~~~l~h~niv~~ 81 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHRDIALAFFETASLMSQVSHIHLAFV 81 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHHHHHHHHHHHHHHHhcCCCCCeeeE
Confidence 69999999999997421 13488998865544445678899999999999999999
Q ss_pred EeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC--
Q 004674 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-- 656 (738)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-- 656 (738)
++++.+....++||||+++++|+.++... ...+++..+..++.||++||+|||+.+ |+||||||+|||+++.+
T Consensus 82 ~~~~~~~~~~~lv~ey~~~g~L~~~l~~~--~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiH~dlkp~Nill~~~~~~ 156 (274)
T cd05076 82 HGVCVRGSENIMVEEFVEHGPLDVCLRKE--KGRVPVAWKITVAQQLASALSYLEDKN---LVHGNVCAKNILLARLGLA 156 (274)
T ss_pred EEEEEeCCceEEEEecCCCCcHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHcCC---ccCCCCCcccEEEeccCcc
Confidence 99999999999999999999999888532 346889999999999999999999987 99999999999997543
Q ss_pred -----ceEEEeecCccccCCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHH-HcCCCCCCCCC
Q 004674 657 -----NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEI-ICGKKNRGFNH 725 (738)
Q Consensus 657 -----~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~el-ltG~~p~~~~~ 725 (738)
.+|++|||++...... ....++..|+|||.+.+ ..++.++||||||+++||| ++|+.||....
T Consensus 157 ~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~ 226 (274)
T cd05076 157 EGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERT 226 (274)
T ss_pred cCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccC
Confidence 3799999988643211 11346788999998875 5689999999999999998 57999986543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-29 Score=266.53 Aligned_cols=198 Identities=28% Similarity=0.463 Sum_probs=170.2
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
.|+..+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|++++++++|+||+++++.+..+...++||||+
T Consensus 5 ~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06642 5 LFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred HHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccchHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEcc
Confidence 35566789999999999998654 7789999886443 234567899999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++. ...+++..+..++.|+++|++|||+.+ ++|+||+|+||++++++.++|+|||++..+.....
T Consensus 85 ~~~~L~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~---ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06642 85 GGGSALDLLK----PGPLEETYIATILREILKGLDYLHSER---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHhh----cCCCCHHHHHHHHHHHHHHHHHHhcCC---eeccCCChheEEEeCCCCEEEccccccccccCcch-
Confidence 9999998873 245889999999999999999999987 99999999999999999999999999976543221
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
......++..|+|||.+.+..++.++||||||++++||++|+.|+...
T Consensus 157 -~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~ 204 (277)
T cd06642 157 -KRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDL 204 (277)
T ss_pred -hhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCccc
Confidence 112245788999999999989999999999999999999999998643
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=272.97 Aligned_cols=192 Identities=22% Similarity=0.322 Sum_probs=163.4
Q ss_pred hcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
...+|++.+.||+|+||.||++.... ++.||+|..... ....|+.++++++|+||+++++++......++|||
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 137 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLP 137 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEE
Confidence 44679999999999999999999764 678999975332 23568999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
++. ++|..++.. ....+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.....
T Consensus 138 ~~~-~~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~- 210 (357)
T PHA03209 138 HYS-SDLYTYLTK--RSRPLPIDQALIIEKQILEGLRYLHAQR---IIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA- 210 (357)
T ss_pred ccC-CcHHHHHHh--ccCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEecCccccccccC-
Confidence 996 577777643 3356899999999999999999999987 999999999999999999999999998753221
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNR 721 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~ 721 (738)
.......||..|+|||++.+..++.++|||||||++|||+++..++
T Consensus 211 --~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 211 --PAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred --cccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 1222356899999999999999999999999999999999876655
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.8e-29 Score=258.24 Aligned_cols=198 Identities=31% Similarity=0.492 Sum_probs=172.1
Q ss_pred cCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
.++|+..+.||+|++|.||++.. .++.||+|.+..... ..+++.+|+.++++++|+||+++++++...+..++||||+
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 82 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST-AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYM 82 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh-HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEec
Confidence 35788889999999999999987 478999999865543 5678999999999999999999999999989999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+||+|||.++.......
T Consensus 83 ~~~~L~~~~~~~~-~~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~- 157 (256)
T cd05039 83 AKGSLVDYLRSRG-RAVITLAQQLGFALDVCEGMEYLEEKN---FVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD- 157 (256)
T ss_pred CCCcHHHHHHhcC-CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccchhcccceEEEeCCCCEEEcccccccccccccc-
Confidence 9999999985432 236899999999999999999999988 99999999999999999999999999987532211
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
....+..|+|||.+....++.++||||||++++|+++ |+.||...
T Consensus 158 ----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~ 203 (256)
T cd05039 158 ----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRI 203 (256)
T ss_pred ----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCC
Confidence 1334668999999988889999999999999999997 99988654
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=266.20 Aligned_cols=201 Identities=28% Similarity=0.426 Sum_probs=172.9
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++|++.+.||+|+||.||++... .++.+|+|++.... ....+.+.+|+++++.++|+||+++++++.....+++||||
T Consensus 5 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (284)
T cd06620 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEF 84 (284)
T ss_pred HHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCcchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEec
Confidence 56777889999999999999865 47889999876443 33457889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|..++.. .+.+++..+..++.+++.||.|||+.. +++||||+|+||++++++.++|+|||++......
T Consensus 85 ~~~~~L~~~~~~---~~~~~~~~~~~~~~~i~~~l~~LH~~~--~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~-- 157 (284)
T cd06620 85 MDCGSLDRIYKK---GGPIPVEILGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVSGELINS-- 157 (284)
T ss_pred CCCCCHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHHHhc--CeeccCCCHHHEEECCCCcEEEccCCcccchhhh--
Confidence 999999988743 346899999999999999999999742 3999999999999999999999999998654221
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
......|+..|+|||++.+..++.++||||||++++||++|+.||....+
T Consensus 158 --~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 158 --IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred --ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 12235789999999999888999999999999999999999999975443
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=261.55 Aligned_cols=200 Identities=28% Similarity=0.455 Sum_probs=168.7
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCCC---c-------chHHHHHHHHHHhHhcCCCeeeEEeEEecCC
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---Q-------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~---~-------~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~ 586 (738)
+|...+.||+|++|.||+|... +++.+|+|.++.... . ..+.+.+|+.+++.++|+|++++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 4667789999999999999865 488999998753211 0 1346788999999999999999999999999
Q ss_pred cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCc
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla 666 (738)
..++||||+++++|.+++... ..+++..+..++.||+.||.|||+.+ ++|+||+|+||++++++.++|+|||++
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~~~nil~~~~~~~~l~d~~~~ 155 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTY---GRFEEQLVRFFTEQVLEGLAYLHSKG---ILHRDLKADNLLVDADGICKISDFGIS 155 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhc---cCCCHHHHHHHHHHHHHHHHHHhhCC---eeecCCChhhEEEcCCCeEEEeecccc
Confidence 999999999999999988543 56899999999999999999999987 999999999999999999999999999
Q ss_pred cccCCCcccccccccccccCccchhcccCCC--CCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
................|+..|+|||.+.... ++.++|+||||++++|+++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 214 (272)
T cd06629 156 KKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSD 214 (272)
T ss_pred ccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcC
Confidence 7654322222223356788999999987654 78999999999999999999999853
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=269.37 Aligned_cols=202 Identities=32% Similarity=0.534 Sum_probs=166.9
Q ss_pred CCCCccceecccccEeEEEeeecc-cc----EEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~----~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
++|+..+.||+|+||.||++.... +. .+|+|.+..... ....++.+|+.+++.++|+||+++++++... ..++
T Consensus 7 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~ 85 (303)
T cd05110 7 TELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQL 85 (303)
T ss_pred hhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-Ccee
Confidence 567778899999999999998643 43 578898765432 2234788999999999999999999998754 5779
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
++||+++|+|.+++... ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||+++...
T Consensus 86 v~e~~~~g~l~~~~~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~ 160 (303)
T cd05110 86 VTQLMPHGCLLDYVHEH--KDNIGSQLLLNWCVQIAKGMMYLEERR---LVHRDLAARNVLVKSPNHVKITDFGLARLLE 160 (303)
T ss_pred eehhcCCCCHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHhhcC---eeccccccceeeecCCCceEEcccccccccc
Confidence 99999999999988542 335889999999999999999999987 9999999999999999999999999998764
Q ss_pred CCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
............++..|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 161 ~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~ 215 (303)
T cd05110 161 GDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGI 215 (303)
T ss_pred CcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 3322222222345678999999998999999999999999999997 89998643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=259.95 Aligned_cols=202 Identities=33% Similarity=0.488 Sum_probs=171.6
Q ss_pred cCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
.++|+..+.||+|+||.||++....+..+++|.+.... ...+.+.+|++++++++|+||+++.+.+.+ ...+++|||+
T Consensus 5 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~ 82 (260)
T cd05073 5 RESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGS-MSVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFM 82 (260)
T ss_pred ccceeEEeEecCccceEEEEEEecCCccEEEEecCCCh-hHHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeC
Confidence 46788899999999999999987777889999886432 345678999999999999999999999887 7789999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||.+.........
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~ 158 (260)
T cd05073 83 AKGSLLDFLKSD-EGSKQPLPKLIDFSAQIAEGMAFIEQRN---YIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT 158 (260)
T ss_pred CCCcHHHHHHhC-CccccCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCCcceeeccCCCcc
Confidence 999999998543 2346788999999999999999999987 999999999999999999999999999765432211
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
. .....++..|+|||++....++.++|+||||++++|+++ |+.||...
T Consensus 159 ~-~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~ 207 (260)
T cd05073 159 A-REGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGM 207 (260)
T ss_pred c-ccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCC
Confidence 1 112345678999999998889999999999999999998 88888653
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=265.42 Aligned_cols=201 Identities=27% Similarity=0.484 Sum_probs=174.8
Q ss_pred cCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
.++|...+.||+|+||.||++... +++.+++|.+........+.+.+|+.++++++||||+++++.+...+..++|+||
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~ 97 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEY 97 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEec
Confidence 367888899999999999999864 5788999998655545567789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++.. ..+++.++..++.|++.||+|||+.+ ++|+||+|+||+++.++.+||+|||++........
T Consensus 98 ~~~~~L~~~~~~----~~l~~~~~~~i~~~l~~al~~LH~~g---i~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~ 170 (293)
T cd06647 98 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 170 (293)
T ss_pred CCCCcHHHHHhh----cCCCHHHHHHHHHHHHHHHHHHHhCC---EeeccCCHHHEEEcCCCCEEEccCcceeccccccc
Confidence 999999998843 34789999999999999999999988 99999999999999999999999999876543222
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......+++.|+|||.+.+..++.++||||||+++||+++|+.||....
T Consensus 171 --~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~ 219 (293)
T cd06647 171 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNEN 219 (293)
T ss_pred --ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1222468889999999988889999999999999999999999997544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-29 Score=258.88 Aligned_cols=197 Identities=31% Similarity=0.449 Sum_probs=167.3
Q ss_pred ceecccccEeEEEeeeccccEEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCChh
Q 004674 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 601 (738)
++||+|++|.||++...+++.|++|++...... ..+.+.+|++++++++|+||+++++++......++||||+++++|.
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~ 80 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPPDLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLL 80 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHH
Confidence 369999999999999877899999988655433 4568899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccccccc
Q 004674 602 YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681 (738)
Q Consensus 602 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 681 (738)
+++... ...+++..+..++.+++.|++|||+.+ ++||||||+||+++.++.+||+|||++...............
T Consensus 81 ~~l~~~--~~~~~~~~~~~~~~~~~~~l~~lH~~~---i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~ 155 (251)
T cd05041 81 TFLRKK--KNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLK 155 (251)
T ss_pred HHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---EehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccC
Confidence 988542 235789999999999999999999987 999999999999999999999999999765422211111112
Q ss_pred ccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 682 ~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
..+..|+|||.+.+..++.++||||||++++||++ |+.||...
T Consensus 156 ~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~ 199 (251)
T cd05041 156 QIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGM 199 (251)
T ss_pred cceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccC
Confidence 34567999999998899999999999999999999 78888543
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-29 Score=269.25 Aligned_cols=199 Identities=19% Similarity=0.239 Sum_probs=164.0
Q ss_pred ccceeccc--ccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 521 EKNKLGEG--GFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 521 ~~~~LG~G--~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
..++||+| +|++||++... +++.||+|++.... ....+.+++|+++++.++||||+++++++..++..++||||+
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~ 81 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACTNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFM 81 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhccHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEecc
Confidence 35689999 78999999875 47899999986542 223456788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc-
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT- 674 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~- 674 (738)
++++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+++.||+..........
T Consensus 82 ~~~~l~~~~~~~~-~~~l~~~~~~~i~~qi~~~L~~LH~~~---iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 82 AYGSAKDLICTHF-MDGMSELAIAYILQGVLKALDYIHHMG---YVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred CCCcHHHHHHhhc-cCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999985432 235899999999999999999999988 99999999999999999999999986543321110
Q ss_pred ----cccccccccccCccchhcccC--CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 675 ----EANTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 675 ----~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
........++..|+|||++.+ ..++.++|||||||+++||++|+.||..
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 212 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 212 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 001122356778999999876 4689999999999999999999999964
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=262.67 Aligned_cols=199 Identities=28% Similarity=0.463 Sum_probs=171.8
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
.|+..+.||+|+||.||+|.... +..||+|.+.... ....+.+.+|+.++++++|+||+++++++.+....++||||+
T Consensus 5 ~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06640 5 LFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYL 84 (277)
T ss_pred hhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecC
Confidence 46677889999999999998754 7889999886543 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++.. ..+++.+...++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 85 ~~~~L~~~i~~----~~l~~~~~~~~~~~l~~~l~~lh~~~---ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06640 85 GGGSALDLLRA----GPFDEFQIATMLKEILKGLDYLHSEK---KIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhCC---ccCcCCChhhEEEcCCCCEEEcccccceeccCCcc-
Confidence 99999988742 35888999999999999999999987 99999999999999999999999999976543221
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......++..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 157 -~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06640 157 -KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMH 205 (277)
T ss_pred -ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcC
Confidence 1222457889999999998889999999999999999999999986543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=261.47 Aligned_cols=203 Identities=29% Similarity=0.469 Sum_probs=169.6
Q ss_pred CCCCccceecccccEeEEEeeecc----ccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
.+|++.+.||+|+||.||+|.... +..+|+|.+.... ....+.+.+|+.++.+++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 83 (267)
T cd05066 4 SCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIV 83 (267)
T ss_pred HHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCCHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEE
Confidence 467788999999999999998642 3369999886543 22346789999999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|||+++++|.+++... ...+++.++..++.|++.||+|||+.+ ++||||||+|||++.++.+||+|||++..+..
T Consensus 84 ~e~~~~~~L~~~~~~~--~~~~~~~~~~~i~~~i~~~l~~lH~~~---i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~ 158 (267)
T cd05066 84 TEYMENGSLDAFLRKH--DGQFTVIQLVGMLRGIASGMKYLSDMG---YVHRDLAARNILVNSNLVCKVSDFGLSRVLED 158 (267)
T ss_pred EEcCCCCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EeehhhchhcEEECCCCeEEeCCCCccccccc
Confidence 9999999999998543 245899999999999999999999987 99999999999999999999999999987643
Q ss_pred Ccccc-cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 672 DQTEA-NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 672 ~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
..... ......++..|+|||.+.+..++.++||||||++++|+++ |+.||...
T Consensus 159 ~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~ 213 (267)
T cd05066 159 DPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEM 213 (267)
T ss_pred ccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccC
Confidence 22111 1111223568999999998889999999999999999886 99998643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.1e-29 Score=264.06 Aligned_cols=211 Identities=29% Similarity=0.388 Sum_probs=174.4
Q ss_pred CHHHHHHhcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecC
Q 004674 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR 585 (738)
Q Consensus 508 ~~~~l~~~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~ 585 (738)
....+..+.++|+..+.||+|+||.||++... +++.+|+|.+.... ...+++.+|+.+++++ +|+|++++++++...
T Consensus 13 ~~~~~~~~~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~-~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~ 91 (291)
T cd06639 13 GLESLGDPTDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS-DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKA 91 (291)
T ss_pred hcccCCCCCCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc-cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEec
Confidence 34455567789999999999999999999875 47889999986432 2346778899999998 899999999998754
Q ss_pred C-----cceEEEeeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceE
Q 004674 586 D-----ERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659 (738)
Q Consensus 586 ~-----~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vk 659 (738)
+ ..++||||+++++|.+++... .....+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.+|
T Consensus 92 ~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---ivH~dlkp~nili~~~~~~k 168 (291)
T cd06639 92 DKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLGLQHLHNNR---IIHRDVKGNNILLTTEGGVK 168 (291)
T ss_pred cccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEE
Confidence 3 479999999999999887532 23456899999999999999999999987 99999999999999999999
Q ss_pred EEeecCccccCCCcccccccccccccCccchhcccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 660 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
|+|||++......... .....|+..|+|||.+... .++.++||||||+++|||++|+.||...
T Consensus 169 l~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~ 236 (291)
T cd06639 169 LVDFGVSAQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDM 236 (291)
T ss_pred Eeecccchhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCC
Confidence 9999998865432211 1224678899999987543 3688999999999999999999998654
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=257.60 Aligned_cols=201 Identities=30% Similarity=0.503 Sum_probs=171.2
Q ss_pred CCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
.+|+..+.||+|+||.||++...++..+|+|.+.... ....++.+|++++++++|||++++++++......++||||++
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~-~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~ 82 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGA-MSEEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFME 82 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCC-CCHHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCC
Confidence 4567788999999999999988778899999886443 345679999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+++|.+++... ...+++..+..++.+++.|++|||+.+ ++|+||||+||+++.++.+||+|||++..........
T Consensus 83 ~~~L~~~~~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~~ 157 (256)
T cd05112 83 HGCLSDYLRAQ--RGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYTS 157 (256)
T ss_pred CCcHHHHHHhC--ccCCCHHHHHHHHHHHHHHHHHHHHCC---ccccccccceEEEcCCCeEEECCCcceeecccCcccc
Confidence 99999888532 245789999999999999999999987 9999999999999999999999999987654322111
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
.....++.+|+|||.+.+..++.++||||||+++|||++ |+.||...
T Consensus 158 -~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 205 (256)
T cd05112 158 -STGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENR 205 (256)
T ss_pred -cCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcC
Confidence 111234678999999998889999999999999999998 89998643
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-29 Score=271.01 Aligned_cols=205 Identities=31% Similarity=0.455 Sum_probs=169.5
Q ss_pred CCCCccceecccccEeEEEeeecc--------ccEEEEEEccCCC-CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD 586 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~--------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~ 586 (738)
.+|++.+.||+|+||.||++.... ...||+|.+.... ....+++.+|+++++++ +|+||+++++++....
T Consensus 12 ~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~ 91 (334)
T cd05100 12 TRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDG 91 (334)
T ss_pred hHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccCHHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCC
Confidence 467888999999999999997421 2368999886432 23356789999999999 7999999999999999
Q ss_pred cceEEEeeCCCCChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (738)
..+++|||+++++|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+|||++
T Consensus 92 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~g---ivH~dlkp~Nill~ 168 (334)
T cd05100 92 PLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQK---CIHRDLAARNVLVT 168 (334)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCC---eeccccccceEEEc
Confidence 9999999999999999986422 2235888999999999999999999987 99999999999999
Q ss_pred CCCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 654 ~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
+++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 169 ~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~ 240 (334)
T cd05100 169 EDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGI 240 (334)
T ss_pred CCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCC
Confidence 999999999999986543222111222334567999999999999999999999999999998 88887543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=260.03 Aligned_cols=195 Identities=33% Similarity=0.527 Sum_probs=162.0
Q ss_pred ceecccccEeEEEeeecc-cc--EEEEEEccCCC-CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-GQ--EIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-g~--~vavK~l~~~~-~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||++...+ +. .+++|.+.... ....+.+.+|++++.++ +||||+++++++...+..++||||+++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPH 80 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCC
Confidence 369999999999999755 33 47888886432 33456788999999999 799999999999999999999999999
Q ss_pred CChhHHHhhcC-------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeec
Q 004674 598 KSLDYFIFDTT-------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (738)
Q Consensus 598 gsL~~~l~~~~-------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFG 664 (738)
++|.+++.... ....+++.++..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||
T Consensus 81 ~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nili~~~~~~kl~dfg 157 (270)
T cd05047 81 GNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVAKIADFG 157 (270)
T ss_pred CcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCC---EeecccccceEEEcCCCeEEECCCC
Confidence 99999986432 1235789999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
++...... ........+..|+|||++....++.++||||||++++||++ |+.||..
T Consensus 158 l~~~~~~~---~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~ 214 (270)
T cd05047 158 LSRGQEVY---VKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCG 214 (270)
T ss_pred Cccccchh---hhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccc
Confidence 98632211 11111233567999999988889999999999999999997 9999854
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-29 Score=259.16 Aligned_cols=189 Identities=26% Similarity=0.460 Sum_probs=160.1
Q ss_pred ceecccccEeEEEeeecccc-----------EEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 523 NKLGEGGFGPVYKGMLIEGQ-----------EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~g~-----------~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
+.||+|+||.||+|...+.. .+++|.+...... ...+.+|+.++++++|+||+++++++.. ...++|
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~-~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv 78 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD-SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMV 78 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh-HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEE
Confidence 36999999999999986533 4788877544333 6788999999999999999999999988 778999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-------ceEEEeec
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-------NPKISDFG 664 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-------~vkL~DFG 664 (738)
|||+++++|++++.... ..+++..+..++.||+.||+|||+.+ |+||||||+|||++.++ .+||+|||
T Consensus 79 ~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg 153 (259)
T cd05037 79 EEYVKFGPLDVFLHREK--NNVSLHWKLDVAKQLASALHYLEDKK---LVHGNVCGKNILVARYGLNEGYVPFIKLSDPG 153 (259)
T ss_pred EEcCCCCcHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHhhCC---eecccCccceEEEecCccccCCceeEEeCCCC
Confidence 99999999999986432 26899999999999999999999987 99999999999999887 79999999
Q ss_pred CccccCCCcccccccccccccCccchhcccCC--CCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
++..... .....++..|+|||++.+. .++.++||||||+++|||++ |..|+...
T Consensus 154 ~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~ 210 (259)
T cd05037 154 IPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210 (259)
T ss_pred ccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccC
Confidence 9976532 1124567789999998876 78999999999999999999 46766544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=264.08 Aligned_cols=200 Identities=31% Similarity=0.508 Sum_probs=167.8
Q ss_pred CCCCccceecccccEeEEEeee-----ccccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecC--Ccc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGML-----IEGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~-----~~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~ 588 (738)
+.|++.+.||+|+||.||++.. ..+..||+|.+.... ....+.+.+|+.+++.++|+||+++.+++... ...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGI 83 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCce
Confidence 3467888999999999999874 246789999986543 33456789999999999999999999998775 558
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
++||||+++++|.+++... ...+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++.
T Consensus 84 ~lv~e~~~g~~L~~~l~~~--~~~~~~~~~~~i~~~i~~aL~~lH~~g---i~H~dlkp~Nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05079 84 KLIMEFLPSGSLKEYLPRN--KNKINLKQQLKYAVQICKGMDYLGSRQ---YVHRDLAARNVLVESEHQVKIGDFGLTKA 158 (284)
T ss_pred EEEEEccCCCCHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecccchheEEEcCCCCEEECCCccccc
Confidence 8999999999999998532 235899999999999999999999988 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 004674 669 FGLDQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNR 721 (738)
Q Consensus 669 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~ 721 (738)
+...... .......++..|+|||.+.+..++.++||||||+++|||++++.|.
T Consensus 159 ~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 159 IETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred cccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 6433221 1112245677899999998888999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=266.65 Aligned_cols=206 Identities=26% Similarity=0.372 Sum_probs=169.3
Q ss_pred CCCccceecccccEeEEEeeecc---ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecC--Ccce
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERM 589 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~---g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~ 589 (738)
+|+..+.||+|++|.||+|.... ++.||+|.+.... ....+.+.+|+.++.+++||||+++++++... ...+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 36778899999999999999754 6899999987632 33456788899999999999999999999888 7799
Q ss_pred EEEeeCCCCChhHHHhhcC-C-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC----CCceEEEee
Q 004674 590 LIYEYLPNKSLDYFIFDTT-R-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN----TMNPKISDF 663 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~-~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~----~~~vkL~DF 663 (738)
+||||+++ +|...+.... . ...+++..+..++.||+.||+|||+.+ |+||||||+||+++. ++.+||+||
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~---i~h~dlkp~Nil~~~~~~~~~~~kl~Df 156 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNW---VLHRDLKPANILVMGEGPERGVVKIGDL 156 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCC---EeeCCCCHHHEEEcCCCCccceEEECCC
Confidence 99999986 4555543222 2 236889999999999999999999988 999999999999998 999999999
Q ss_pred cCccccCCCcc-cccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 004674 664 GLARSFGLDQT-EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (738)
Q Consensus 664 Gla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~ 727 (738)
|++........ ........++..|+|||.+.+ ..++.++||||||++++||++|+.||.....+
T Consensus 157 g~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 157 GLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred ccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 99987643322 112233567889999998876 45789999999999999999999999765443
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-29 Score=259.87 Aligned_cols=201 Identities=29% Similarity=0.449 Sum_probs=169.5
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCC-----CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecC--Ccc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DER 588 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~-----~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~ 588 (738)
.+|...+.||+|+||.||++.... ++.+++|.+... ..+..+.+++|++++++++|+||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 468888999999999999998754 889999987432 123345788999999999999999999998764 457
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
++|+||+++++|.+++.. ...+++.....++.|++.||.|||+.+ ++|+||||+||+++.++.++|+|||+++.
T Consensus 82 ~~v~e~~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~al~~LH~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~ 155 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKA---YGALTENVTRRYTRQILQGVSYLHSNM---IVHRDIKGANILRDSAGNVKLGDFGASKR 155 (264)
T ss_pred EEEEEeCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECccccccc
Confidence 899999999999988843 345789999999999999999999988 99999999999999999999999999986
Q ss_pred cCCCcc-cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 669 FGLDQT-EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 669 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
...... ........++..|+|||.+.+..++.++||||||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 211 (264)
T cd06653 156 IQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE 211 (264)
T ss_pred cccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCc
Confidence 543211 1112235688999999999988899999999999999999999999964
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-29 Score=262.83 Aligned_cols=200 Identities=28% Similarity=0.438 Sum_probs=168.1
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++|+..+.||+|++|.||++... +++.||+|.+..... .....+.+|++++++++|+||+++++++.+.+..++||||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 84 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEY 84 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEec
Confidence 67888899999999999999976 478999999865432 2234577899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++ +|.+++... ...+++.....++.|+++||+|||+.+ |+||||||+||++++++.+||+|||+++.......
T Consensus 85 ~~~-~L~~~~~~~--~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~ 158 (291)
T cd07844 85 LDT-DLKQYMDDC--GGGLSMHNVRLFLFQLLRGLAYCHQRR---VLHRDLKPQNLLISERGELKLADFGLARAKSVPSK 158 (291)
T ss_pred CCC-CHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccCCHHHEEEcCCCCEEECccccccccCCCCc
Confidence 985 888877543 236889999999999999999999987 99999999999999999999999999875432211
Q ss_pred cccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
. .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 159 ~--~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~ 207 (291)
T cd07844 159 T--YSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGS 207 (291)
T ss_pred c--ccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 1 112346788999998875 45889999999999999999999999543
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.3e-29 Score=261.06 Aligned_cols=201 Identities=27% Similarity=0.469 Sum_probs=170.9
Q ss_pred CCCccceecccccEeEEEeee-ccccEEEEEEccCCCC------cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 518 NFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSG------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~-~~g~~vavK~l~~~~~------~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
+|+..+.||+|++|.||++.. .+++.+|+|.+..... ...+.+++|++++++++|+||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477788999999999999986 4578999999864321 124678999999999999999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-ceEEEeecCcccc
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSF 669 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGla~~~ 669 (738)
||||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++ .+||+|||++...
T Consensus 81 v~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ql~~al~~LH~~~---i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~ 154 (268)
T cd06630 81 FVEWMAGGSVSHLLSK---YGAFKEAVIINYTEQLLRGLSYLHENQ---IIHRDVKGANLLIDSTGQRLRIADFGAAARL 154 (268)
T ss_pred EEeccCCCcHHHHHHH---hCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccccccccc
Confidence 9999999999998853 346889999999999999999999988 99999999999998765 6999999998776
Q ss_pred CCCcccc--cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 670 GLDQTEA--NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 670 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
....... ......++..|+|||.+.+..++.++||||+|++++||++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 211 (268)
T cd06630 155 AAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAE 211 (268)
T ss_pred ccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCC
Confidence 4332111 122346788999999998888999999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.8e-29 Score=260.69 Aligned_cols=202 Identities=28% Similarity=0.491 Sum_probs=170.8
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
+|+..+.||+|++|.||+|+.. +++.||+|++..... ...+.+.+|+.++++++|+||+++++++...+..++||||+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEEGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYM 80 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecC
Confidence 4778899999999999999986 478899999865532 23466788999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++ +|.+++........+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||++........
T Consensus 81 ~~-~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~---i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~- 155 (284)
T cd07836 81 DK-DLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR---VLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN- 155 (284)
T ss_pred Cc-cHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC---eeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc-
Confidence 85 78777755444456899999999999999999999987 99999999999999999999999999976543211
Q ss_pred ccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......++..|++||.+.+ ..++.++||||||+++|||++|+.||...+
T Consensus 156 -~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 205 (284)
T cd07836 156 -TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTN 205 (284)
T ss_pred -ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1122456889999998865 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-29 Score=260.77 Aligned_cols=203 Identities=30% Similarity=0.430 Sum_probs=171.1
Q ss_pred CCCCccceecccccEeEEEeeec------cccEEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcce
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~------~g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 589 (738)
++|+....||+|+||.||+++.. ..+.+++|.+...... ..+++.+|++++++++|+||+++++++.+.+..+
T Consensus 5 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 84 (275)
T cd05046 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHY 84 (275)
T ss_pred HhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccchHHHHHHHHHHHHHHhcCCcceeeeEEEECCCCcce
Confidence 56888899999999999999864 2457999988654433 4578999999999999999999999999989999
Q ss_pred EEEeeCCCCChhHHHhhcCCC------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEee
Q 004674 590 LIYEYLPNKSLDYFIFDTTRS------KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DF 663 (738)
+||||+++++|.+++...... ..+++..+..++.|++.||+|||+.+ |+||||||+||+++.++.++|+||
T Consensus 85 lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 85 MILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNAR---FVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred EEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcC---cccCcCccceEEEeCCCcEEEccc
Confidence 999999999999998644321 26899999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
|++....... ........++..|+|||.+.+...+.++||||||++++||++ |..||..
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~ 221 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccc
Confidence 9987543221 112222456778999999988888999999999999999998 7788853
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=256.96 Aligned_cols=195 Identities=29% Similarity=0.458 Sum_probs=166.3
Q ss_pred CCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEe-cCCcceEEEeeC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCT-QRDERMLIYEYL 595 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~-~~~~~~lV~Ey~ 595 (738)
++|+..+.||+|+||.||++.. .+..+++|.++.. ...+.+.+|+.++++++|+|++++++++. .++..++||||+
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~ 82 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYM 82 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCC--chHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECC
Confidence 4678889999999999999976 4788999988543 23567899999999999999999999764 455689999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|.+++... ....+++..+..++.|++.||+|||+.+ ++||||||+||++++++.+||+|||+++......
T Consensus 83 ~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-- 156 (256)
T cd05082 83 AKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEANN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-- 156 (256)
T ss_pred CCCcHHHHHHhc-CCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeccccchheEEEcCCCcEEecCCccceeccccC--
Confidence 999999988543 2345889999999999999999999987 9999999999999999999999999987643221
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
....++..|+|||++.+..++.++||||||+++|||++ |+.||..
T Consensus 157 ---~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~ 202 (256)
T cd05082 157 ---DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPR 202 (256)
T ss_pred ---CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCC
Confidence 12334568999999998889999999999999999997 9988864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=258.59 Aligned_cols=201 Identities=30% Similarity=0.519 Sum_probs=173.4
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCCCc--chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ--GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|+..+.||+|+||.||++... +++.+++|.+...... ..+.+.+|+.++++++|+||+++++.+...+..++|+||
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEY 80 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccchHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEec
Confidence 4677889999999999999865 5789999998765443 567889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++.. ...+++..+..++.++++||+|||+.+ |+|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~~~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 81 CSGGTLEELLEH---GRILDEHVIRVYTLQLLEGLAYLHSHG---IVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred CCCCcHHHHHhh---cCCCChHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999853 345789999999999999999999988 99999999999999999999999999987654322
Q ss_pred ccc--ccccccccCccchhcccCCC---CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EAN--TKRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~--~~~~~gt~~y~aPE~~~~~~---~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
... .....++..|+|||++.+.. ++.++||||||++++|+++|+.||...
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 211 12246788999999998766 889999999999999999999999643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=254.22 Aligned_cols=205 Identities=27% Similarity=0.377 Sum_probs=168.5
Q ss_pred cCCCCccceecccccEeEEEeeecc-----ccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCCeeeEEeEEec-CCc
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDE 587 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-----g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-~~~ 587 (738)
...|+....||+|.||.|||++-.+ .+.+|+|+++.... .......+|+.+++.++|+||+.+..++.+ ...
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~ 102 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKDGTGISMSACREIALLRELKHPNVISLVKVFLSHDKK 102 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCCCCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCce
Confidence 4568888999999999999996433 23689999864422 234567889999999999999999999877 677
Q ss_pred ceEEEeeCCCCChhHHHhhc--CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC----CceEEE
Q 004674 588 RMLIYEYLPNKSLDYFIFDT--TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT----MNPKIS 661 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~--~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~----~~vkL~ 661 (738)
.+|++||.+.. |..++... .....++-.....|+.||+.|+.|||+.. |+||||||.|||+..+ |.|||+
T Consensus 103 v~l~fdYAEhD-L~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NW---vlHRDLKPaNIlvmgdgperG~VKIa 178 (438)
T KOG0666|consen 103 VWLLFDYAEHD-LWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNW---VLHRDLKPANILVMGDGPERGRVKIA 178 (438)
T ss_pred EEEEehhhhhh-HHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhh---eeeccCCcceEEEeccCCccCeeEee
Confidence 89999999875 44554422 22356888999999999999999999988 9999999999999776 999999
Q ss_pred eecCccccCCCcc-cccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 662 DFGLARSFGLDQT-EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 662 DFGla~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
|+|+++.+..+-. -.....++-|..|+|||.+.+. .||.+.|||+.|||+.||++-++.|...
T Consensus 179 DlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~ 243 (438)
T KOG0666|consen 179 DLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGR 243 (438)
T ss_pred cccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccch
Confidence 9999999865432 2234457789999999999885 6899999999999999999999988653
|
|
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=257.44 Aligned_cols=201 Identities=28% Similarity=0.389 Sum_probs=176.8
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++|+..+.||+|++|.||+++... ++.+++|++..... ...+++.+|+..+.+++|+|++++++++......++||||
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEY 80 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcchHHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEe
Confidence 367888999999999999999875 88999999876543 3467899999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
+++++|.+++... ..+++..+..++.|+++|++|||+ .+ ++|+||+|+||+++.++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~---~~l~~~~~~~~~~~l~~~l~~lh~~~~---~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 81 MDGGSLADLLKKV---GKIPEPVLAYIARQILKGLDYLHTKRH---IIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred cCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHhccCC---CccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 9999999998543 568999999999999999999999 87 9999999999999999999999999998764332
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 155 ~~~--~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 155 DQC--NTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred Ccc--cceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 221 23467889999999999899999999999999999999999997653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=8e-29 Score=260.77 Aligned_cols=199 Identities=26% Similarity=0.404 Sum_probs=170.5
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|++.+.||+|++|.||++... +++.|++|++.... ....+.+.+|+.++++++|+||+++++++..+...++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 80 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLEGGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEY 80 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccccchhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEecc
Confidence 4777889999999999999975 58899999986543 33356789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+ +++|.+++.... ..+++.++..++.||++||+|||+.+ ++|+||||+||++++++.++|+|||++........
T Consensus 81 ~-~~~L~~~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 81 M-PSDLSEVLRDEE--RPLPEAQVKSYMRMLLKGVAYMHANG---IMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred c-CCCHHHHHHhcC--CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 9 999998885432 56899999999999999999999987 99999999999999999999999999987643321
Q ss_pred cccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.......++..|+|||.+.+. .++.++||||+|++++||++|+.+|..
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~ 203 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCC
Confidence 112235688999999988654 468999999999999999999877754
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.9e-29 Score=260.80 Aligned_cols=199 Identities=37% Similarity=0.560 Sum_probs=165.8
Q ss_pred ceecccccEeEEEeeecc-------ccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 523 NKLGEGGFGPVYKGMLIE-------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-------g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+.||+|+||.||+|...+ ++.+++|.+.... .....++.+|+.+++.++||||+++++++......++||||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMEL 80 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEec
Confidence 369999999999998643 2578999876543 23456789999999999999999999999998999999999
Q ss_pred CCCCChhHHHhhcC----CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-----ceEEEeecC
Q 004674 595 LPNKSLDYFIFDTT----RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-----NPKISDFGL 665 (738)
Q Consensus 595 ~~~gsL~~~l~~~~----~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-----~vkL~DFGl 665 (738)
+++++|.+++.... ....+++.++..++.|++.||+|||+.+ ++|+||||+||+++.+. .+||+|||+
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~ 157 (269)
T cd05044 81 MEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMH---FIHRDLAARNCLVSEKGYDADRVVKIGDFGL 157 (269)
T ss_pred cCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCC---cccCCCChheEEEecCCCCCCcceEECCccc
Confidence 99999999986432 2235789999999999999999999987 99999999999999877 899999999
Q ss_pred ccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
+................++..|+|||++.+..++.++||||||+++|||++ |+.||...
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~ 217 (269)
T cd05044 158 ARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPAL 217 (269)
T ss_pred ccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCccc
Confidence 976543322111222345678999999999999999999999999999998 99998643
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.9e-31 Score=278.10 Aligned_cols=202 Identities=26% Similarity=0.435 Sum_probs=176.2
Q ss_pred CCCCccceecccccEeEEEeeecccc-EEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQ-EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g~-~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
+.|+++..||.|+||.|||++.++.. ..|.|++........+++.-||+||...+||+||++++.|..++.++|..|||
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC 111 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFC 111 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeec
Confidence 55777888999999999999987643 45778887777778899999999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
.||..+.++..- ..+|.+.++..++.|++.||.|||++. |||||||+.|||++-+|.++|+|||.+...... .
T Consensus 112 ~GGAVDaimlEL--~r~LtE~QIqvvc~q~ldALn~LHs~~---iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t--~ 184 (1187)
T KOG0579|consen 112 GGGAVDAIMLEL--GRVLTEDQIQVVCYQVLDALNWLHSQN---IIHRDLKAGNILLTLDGDIRLADFGVSAKNKST--R 184 (1187)
T ss_pred CCchHhHHHHHh--ccccchHHHHHHHHHHHHHHHHHhhcc---hhhhhccccceEEEecCcEeeecccccccchhH--H
Confidence 999999988643 457999999999999999999999987 999999999999999999999999998654322 2
Q ss_pred ccccccccccCccchhccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....+.||+.|||||+.. ..+|+.++||||||+.|.||.-+.+|.....
T Consensus 185 qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHheln 239 (1187)
T KOG0579|consen 185 QKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELN 239 (1187)
T ss_pred hhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccc
Confidence 2233478999999999864 5689999999999999999999999975433
|
|
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.7e-29 Score=256.18 Aligned_cols=196 Identities=35% Similarity=0.535 Sum_probs=163.4
Q ss_pred ceecccccEeEEEeeecc----ccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~----g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|+||.||+|.... +..+|+|.+..... ...+++.+|+.+++.++|+||+++++++. .+..++||||+++
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~ 79 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIAAGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPL 79 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccchHHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCC
Confidence 469999999999997533 26899999875543 24567899999999999999999999875 5568999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|.+++... ..+++..+..++.|++.||+|||..+ ++|+||||+|||++.++.+||+|||+++..........
T Consensus 80 ~~L~~~l~~~---~~~~~~~~~~~~~qi~~~l~~lh~~~---i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~ 153 (257)
T cd05060 80 GPLLKYLKKR---REIPVSDLKELAHQVAMGMAYLESKH---FVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYR 153 (257)
T ss_pred CcHHHHHHhC---CCCCHHHHHHHHHHHHHHHHHHhhcC---eeccCcccceEEEcCCCcEEeccccccceeecCCcccc
Confidence 9999998543 36899999999999999999999987 99999999999999999999999999987643322111
Q ss_pred -ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 678 -TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 678 -~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
.....++..|+|||.+.+..++.++||||||+++|||++ |+.||....
T Consensus 154 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~ 203 (257)
T cd05060 154 ATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMK 203 (257)
T ss_pred cccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCC
Confidence 111223567999999998899999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=261.37 Aligned_cols=200 Identities=29% Similarity=0.397 Sum_probs=175.0
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
+|+..+.||.|+||.||++.... ++.+|+|.+.+.. ....+.+.+|++++++++||||+++++.+.++...++|+|
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 47788999999999999999764 8899999986542 2345788999999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++++|.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~~L~~~l~~~---~~l~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 154 (258)
T cd05578 81 LLLGGDLRYHLSQK---VKFSEEQVKFWICEIVLALEYLHSKG---IIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT 154 (258)
T ss_pred CCCCCCHHHHHHhc---CCcCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEEcCCCCEEEeecccccccCCCc
Confidence 99999999988432 46899999999999999999999987 9999999999999999999999999988754332
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
......|+..|+|||.+.+..++.++|+||||+++|+|++|+.||.....
T Consensus 155 ---~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 155 ---LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred ---cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 12235678899999999988899999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=4e-29 Score=263.03 Aligned_cols=197 Identities=26% Similarity=0.437 Sum_probs=165.5
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|+..+.||+|+||.||++... .|+.+|+|++.... ......+.+|++++++++|+||+++++++.+....++|+||
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 80 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEY 80 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEec
Confidence 4677889999999999999975 48899999886432 22345678899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++ +|..++... ...+++..+..++.||++||+|||+.+ |+||||||+||+++.++.+||+|||+++.......
T Consensus 81 ~~~-~l~~~~~~~--~~~~~~~~~~~~~~qi~~al~~LH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 81 CDQ-DLKKYFDSC--NGDIDPEIVKSFMFQLLKGLAFCHSHN---VLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred CCC-CHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 975 676665432 346899999999999999999999987 99999999999999999999999999986543221
Q ss_pred cccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRG 722 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~ 722 (738)
. .....++..|+|||.+.+. .++.++||||||+++|||++|+.|+.
T Consensus 155 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~ 201 (284)
T cd07839 155 C--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 201 (284)
T ss_pred C--cCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCc
Confidence 1 1224568899999988764 47899999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.7e-29 Score=259.81 Aligned_cols=197 Identities=21% Similarity=0.343 Sum_probs=157.7
Q ss_pred eecccccEeEEEeeeccc---cEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCC
Q 004674 524 KLGEGGFGPVYKGMLIEG---QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (738)
Q Consensus 524 ~LG~G~fG~Vykg~~~~g---~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (738)
.||+|+||.||++...++ ..+++|.+.... ....+.+.+|+.+++.++||||+++++.+......++||||+++++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~ 81 (268)
T cd05086 2 EIGNGWFGKVLLSEIYTDTGVARVVVKELKANASSKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGD 81 (268)
T ss_pred cCCCCcCceEEEEEEEcCCCcceEEEEEecCCCChHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCc
Confidence 699999999999975443 346677765433 2345688999999999999999999999999999999999999999
Q ss_pred hhHHHhhcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccc
Q 004674 600 LDYFIFDTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678 (738)
Q Consensus 600 L~~~l~~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~ 678 (738)
|.+++..... ....++..+..++.||+.||+|||+.+ ++||||||+|||++.++.+||+|||++............
T Consensus 82 L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~---i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~ 158 (268)
T cd05086 82 LKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHN---FLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETE 158 (268)
T ss_pred HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCC---eeccCCccceEEEcCCccEEecccccccccCcchhhhcc
Confidence 9999865322 234677778899999999999999987 999999999999999999999999998643221111122
Q ss_pred cccccccCccchhcccC-------CCCCchhHHHHHHHHHHHHHcC-CCCCCC
Q 004674 679 KRVVGTYGYMSPEYAID-------GLFSVKSDVFSFGVLVLEIICG-KKNRGF 723 (738)
Q Consensus 679 ~~~~gt~~y~aPE~~~~-------~~~t~ksDVwS~Gvil~elltG-~~p~~~ 723 (738)
....++..|+|||++.. ..++.++||||||+++|||+++ +.||..
T Consensus 159 ~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~ 211 (268)
T cd05086 159 DDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSH 211 (268)
T ss_pred cCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCC
Confidence 23567889999998753 2457899999999999999975 567743
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=256.52 Aligned_cols=201 Identities=24% Similarity=0.395 Sum_probs=172.6
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|+..+.||+|+||.+|++... +++.+++|++... .....+++.+|+.++++++|+||+++++++...+..++||||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMSPKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDY 80 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCChHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEec
Confidence 4778899999999999999865 4789999988643 223446789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~l~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 81 CEGGDLYKKINAQ-RGVLFPEDQILDWFVQICLALKHVHDRK---ILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 9999998887542 2335789999999999999999999987 99999999999999999999999999986543221
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
......|++.|+|||++.+..++.++||||||++++||++|+.||...
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~ 204 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAG 204 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCC
Confidence 122345788999999999888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-31 Score=300.15 Aligned_cols=207 Identities=29% Similarity=0.439 Sum_probs=175.0
Q ss_pred HHhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcce
Q 004674 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (738)
Q Consensus 513 ~~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~ 589 (738)
.+.+-+|.....||.|.||.||-+...+ |.-.|+|.+.... ......+.+|+.++..++|||+|+.+|+-.+.+..+
T Consensus 1231 snV~~rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~ 1310 (1509)
T KOG4645|consen 1231 SNVTFRWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSDHKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVY 1310 (1509)
T ss_pred ccceeeeccccccCCcceeeeEEeecCCccchhhhhhhhcCccccccCcchHHHHHHHHhccCccccccCceeecHHHHH
Confidence 3445567778899999999999998654 7788999775443 344567899999999999999999999999999999
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcccc
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 669 (738)
|.||||++|+|.+.+.. ....++.....+..|++.|++|||++| ||||||||.||+|+.+|.+|++|||.|..+
T Consensus 1311 IFMEyC~~GsLa~ll~~---gri~dE~vt~vyt~qll~gla~LH~~g---IVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki 1384 (1509)
T KOG4645|consen 1311 IFMEYCEGGSLASLLEH---GRIEDEMVTRVYTKQLLEGLAYLHEHG---IVHRDIKPANILLDFNGLIKYGDFGSAVKI 1384 (1509)
T ss_pred HHHHHhccCcHHHHHHh---cchhhhhHHHHHHHHHHHHHHHHHhcC---ceecCCCccceeeecCCcEEeecccceeEe
Confidence 99999999999999843 344677777788899999999999998 999999999999999999999999999887
Q ss_pred CCCcc--cccccccccccCccchhcccCC---CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 670 GLDQT--EANTKRVVGTYGYMSPEYAIDG---LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 670 ~~~~~--~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
..+.. ........||+.|||||++.+. ....++||||+|||++||+||++||...+
T Consensus 1385 ~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~d 1445 (1509)
T KOG4645|consen 1385 KNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELD 1445 (1509)
T ss_pred cCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhcc
Confidence 65421 1223346899999999999764 35678999999999999999999997554
|
|
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7e-29 Score=261.51 Aligned_cols=200 Identities=24% Similarity=0.386 Sum_probs=171.5
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
++|+..+.||+|++|.||++...+ ++.|++|++... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESEDDEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcccccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 368888999999999999999764 788999988643 23345788999999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|++++.+..+.. ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~ 154 (288)
T cd07833 81 YVERTLLELLEA---SPGGLPPDAVRSYIWQLLQAIAYCHSHN---IIHRDIKPENILVSESGVLKLCDFGFARALRARP 154 (288)
T ss_pred cCCCCHHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEEeeecccccCCCc
Confidence 999887766553 2345899999999999999999999987 9999999999999999999999999998765433
Q ss_pred ccccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.. ......++..|+|||++.+. .++.++||||||+++|||++|+.||..
T Consensus 155 ~~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~ 204 (288)
T cd07833 155 AS-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPG 204 (288)
T ss_pred cc-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 21 12235678899999999887 889999999999999999999999864
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-29 Score=262.73 Aligned_cols=204 Identities=28% Similarity=0.465 Sum_probs=177.5
Q ss_pred HhcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
...+.|+..+.||+|++|.||++... .++.+++|++..... ..+.+.+|+++++.++|+|++++++.+......++|+
T Consensus 16 ~~~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~ 94 (286)
T cd06614 16 DPRELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ-NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVM 94 (286)
T ss_pred CccccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch-hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEE
Confidence 45677888899999999999999986 478999999876544 5678899999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++......
T Consensus 95 e~~~~~~L~~~l~~~~--~~l~~~~~~~i~~~i~~~L~~lH~~g---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 95 EYMDGGSLTDIITQNF--VRMNEPQIAYVCREVLQGLEYLHSQN---VIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred eccCCCcHHHHHHHhc--cCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 9999999999986532 36899999999999999999999987 999999999999999999999999998765432
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.. ......++..|+|||.+.+..++.++||||||+++|||++|+.||....
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~ 220 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREP 220 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1122457889999999988889999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.3e-29 Score=259.21 Aligned_cols=199 Identities=27% Similarity=0.476 Sum_probs=170.9
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCC-CCcchHHHHHHHHHHhHhc---CCCeeeEEeEEecCCcceEEE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~---H~nIv~l~g~~~~~~~~~lV~ 592 (738)
.|+..+.||+|+||.||+|... +++.+++|.+... .....+++.+|+.++++++ |+|++++++++..+...++||
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~ 81 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIM 81 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEE
Confidence 4677789999999999999964 5889999998654 2334567889999999997 999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++++|.+++.. ..+++..+..++.|++.||+|||+.+ |+|+||+|+||++++++.++|+|||++......
T Consensus 82 e~~~~~~L~~~~~~----~~l~~~~~~~i~~~i~~~l~~lh~~~---i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06917 82 EYAEGGSVRTLMKA----GPIAEKYISVIIREVLVALKYIHKVG---VIHRDIKAANILVTNTGNVKLCDFGVAALLNQN 154 (277)
T ss_pred ecCCCCcHHHHHHc----cCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCcCHHHEEEcCCCCEEEccCCceeecCCC
Confidence 99999999988743 36889999999999999999999988 999999999999999999999999999876543
Q ss_pred cccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
... .....|+..|+|||.+.+ ..++.++||||||+++|||++|+.||....
T Consensus 155 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~ 206 (277)
T cd06917 155 SSK--RSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVD 206 (277)
T ss_pred ccc--cccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 321 223468889999998875 457899999999999999999999996543
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.7e-29 Score=258.90 Aligned_cols=202 Identities=27% Similarity=0.400 Sum_probs=167.8
Q ss_pred CCCCccceecccccEeEEEeeeccc----cEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEG----QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g----~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
++|...+.||+|+||.||+|...+. ..|++|...... ....+.+.+|+.++++++|+||+++++++.. +..++|
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv 84 (270)
T cd05056 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIV 84 (270)
T ss_pred hhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCCHHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEE
Confidence 4577888999999999999986432 468999886554 3445689999999999999999999998875 567899
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|||+++++|.+++... ...+++..+..++.+++.||+|||+.+ ++|+||||+||+++.++.+||+|||+++....
T Consensus 85 ~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~~l~~~l~~lH~~~---~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 159 (270)
T cd05056 85 MELAPLGELRSYLQVN--KYSLDLASLILYSYQLSTALAYLESKR---FVHRDIAARNVLVSSPDCVKLGDFGLSRYLED 159 (270)
T ss_pred EEcCCCCcHHHHHHhC--CCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccChheEEEecCCCeEEccCceeeeccc
Confidence 9999999999998542 235899999999999999999999987 99999999999999999999999999876543
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~ 725 (738)
..... .....++..|+|||.+....++.++||||||++++|+++ |+.||....
T Consensus 160 ~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 213 (270)
T cd05056 160 ESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVK 213 (270)
T ss_pred cccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 32111 112234568999999988889999999999999999986 999986543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-30 Score=291.74 Aligned_cols=207 Identities=26% Similarity=0.320 Sum_probs=179.9
Q ss_pred HHHHHhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccC---CCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecC
Q 004674 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR 585 (738)
Q Consensus 510 ~~l~~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~---~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~ 585 (738)
+.+.-..++|.+++.||+|+||.|..++.+. ++.+|+|++.+ -......-|.+|-.+|..-+.+-|+++.-.|.++
T Consensus 68 ~~lrl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~ 147 (1317)
T KOG0612|consen 68 KELRLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE 147 (1317)
T ss_pred HHHhCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc
Confidence 3444456889999999999999999999865 77899999876 2344556799999999999999999999999999
Q ss_pred CcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecC
Q 004674 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (738)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl 665 (738)
...|||||||+||+|-.++... ..+++..+.-++..|.-||.-||+.| +|||||||+|||||..|++||+|||.
T Consensus 148 ~~LYlVMdY~pGGDlltLlSk~---~~~pE~~ArFY~aEiVlAldslH~mg---yVHRDiKPDNvLld~~GHikLADFGs 221 (1317)
T KOG0612|consen 148 RYLYLVMDYMPGGDLLTLLSKF---DRLPEDWARFYTAEIVLALDSLHSMG---YVHRDIKPDNVLLDKSGHIKLADFGS 221 (1317)
T ss_pred cceEEEEecccCchHHHHHhhc---CCChHHHHHHHHHHHHHHHHHHHhcc---ceeccCCcceeEecccCcEeeccchh
Confidence 9999999999999999988543 36899999999999999999999988 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccchhccc----C-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAI----D-GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~-~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
+-.+..+.. ......+|||.|++||++. + +.|++.+|.||+||++|||+.|..||..
T Consensus 222 Clkm~~dG~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYa 283 (1317)
T KOG0612|consen 222 CLKMDADGT-VRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYA 283 (1317)
T ss_pred HHhcCCCCc-EEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchH
Confidence 887764432 2233478999999999985 2 5689999999999999999999999964
|
|
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.9e-29 Score=260.55 Aligned_cols=210 Identities=29% Similarity=0.462 Sum_probs=172.7
Q ss_pred CHHHHHHhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHh-cCCCeeeEEeEEec-
Q 004674 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ- 584 (738)
Q Consensus 508 ~~~~l~~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~- 584 (738)
++..+......|+..+.||+|+||.||++.... ++.+|+|++.... ....++..|+.++.++ +|+||+++++++..
T Consensus 7 ~~~~~~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~-~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~ 85 (282)
T cd06636 7 DLSALRDPAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTE-DEEEEIKLEINMLKKYSHHRNIATYYGAFIKK 85 (282)
T ss_pred hhhhhcChhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecCh-HHHHHHHHHHHHHHHhcCCCcEEEEeeehhcc
Confidence 344444566788999999999999999999754 7889999885543 3346788899999998 69999999999853
Q ss_pred -----CCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceE
Q 004674 585 -----RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659 (738)
Q Consensus 585 -----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vk 659 (738)
....+++|||+++++|.+++... ....+++..+..++.||+.||+|||+.+ |+|+||+|+||++++++.++
T Consensus 86 ~~~~~~~~~~iv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~~qi~~al~~LH~~~---ivH~dl~~~nili~~~~~~~ 161 (282)
T cd06636 86 SPPGHDDQLWLVMEFCGAGSVTDLVKNT-KGNALKEDWIAYICREILRGLAHLHAHK---VIHRDIKGQNVLLTENAEVK 161 (282)
T ss_pred cccCCCCEEEEEEEeCCCCcHHHHHHHc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEE
Confidence 35689999999999999988543 2345788889999999999999999987 99999999999999999999
Q ss_pred EEeecCccccCCCcccccccccccccCccchhccc-----CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 660 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
|+|||++........ ......|+..|+|||.+. +..++.++||||||+++|||++|+.||...
T Consensus 162 l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~ 229 (282)
T cd06636 162 LVDFGVSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDM 229 (282)
T ss_pred EeeCcchhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCcccc
Confidence 999999876532211 122356889999999875 346788999999999999999999999643
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-29 Score=262.22 Aligned_cols=199 Identities=30% Similarity=0.454 Sum_probs=167.7
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCCCc-----chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ-----GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~-----~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
+|+..+.||+|++|.||+|... +++.|++|++...... ....+..|++++++++|+||+++++++.+++..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 3677789999999999999975 4889999998654322 234577899999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|||+ +++|..++.... ..+++..+..++.||++||+|||+.+ ++|+||+|+||+++.++.+||+|||++.....
T Consensus 81 ~e~~-~~~L~~~i~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~ 154 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS--IVLTPADIKSYMLMTLRGLEYLHSNW---ILHRDLKPNNLLIASDGVLKLADFGLARSFGS 154 (298)
T ss_pred Eccc-CCCHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeecCCChhhEEEcCCCCEEEccceeeeeccC
Confidence 9999 899999885422 36899999999999999999999988 99999999999999999999999999987643
Q ss_pred CcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
... ......++..|+|||.+.+ ..++.++||||||++++||++|..+|...
T Consensus 155 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~ 206 (298)
T cd07841 155 PNR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGD 206 (298)
T ss_pred CCc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCC
Confidence 321 1122346788999998865 46789999999999999999997777543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=259.90 Aligned_cols=197 Identities=26% Similarity=0.433 Sum_probs=170.6
Q ss_pred CCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
|...+.||+|++|.||++... +++.+++|++........+.+.+|+.+++.++|+||+++++++...+..++++||+++
T Consensus 21 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~ 100 (285)
T cd06648 21 LDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEG 100 (285)
T ss_pred hhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCC
Confidence 444568999999999999864 5788999988655545566788999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|.+++.. ..+++..+..++.|++.||+|||+.+ ++||||+|+||+++.++.++|+|||++........ .
T Consensus 101 ~~L~~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~ 171 (285)
T cd06648 101 GALTDIVTH----TRMNEEQIATVCLAVLKALSFLHAQG---VIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--R 171 (285)
T ss_pred CCHHHHHHh----CCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCChhhEEEcCCCcEEEcccccchhhccCCc--c
Confidence 999998843 45889999999999999999999988 99999999999999999999999998875533221 1
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.....|+..|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~ 218 (285)
T cd06648 172 RKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNE 218 (285)
T ss_pred cccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCC
Confidence 12246889999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-29 Score=260.02 Aligned_cols=200 Identities=27% Similarity=0.394 Sum_probs=164.2
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHH-HhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLL-IAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~i-l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
++|++.+.||+|+||.||+++.. +++.||+|++.... .....++..|+.+ ++.++|+||+++++++......+++||
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e 80 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICME 80 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhh
Confidence 46888899999999999999976 48899999986542 2233455556665 556789999999999999999999999
Q ss_pred eCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 594 YLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 594 y~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|++ ++|..++... .....+++..+..++.||+.||+|||++ + ++||||||+||++++++.+||+|||++.....
T Consensus 81 ~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~---i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~ 156 (283)
T cd06617 81 VMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLS---VIHRDVKPSNVLINRNGQVKLCDFGISGYLVD 156 (283)
T ss_pred hhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCC---eecCCCCHHHEEECCCCCEEEeeccccccccc
Confidence 997 6787776542 2335689999999999999999999986 5 99999999999999999999999999876532
Q ss_pred CcccccccccccccCccchhcccC----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAID----GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.. ......++..|+|||.+.+ ..++.++|+||||+++|||++|+.||..
T Consensus 157 ~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 157 SV---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred cc---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 21 1122457889999998865 4568899999999999999999999863
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.6e-29 Score=260.09 Aligned_cols=200 Identities=28% Similarity=0.464 Sum_probs=168.4
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|+..+.||+|++|.||+++.. +++.||+|++.... ....+.+.+|++++++++||||+++++++.+.+..++||||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~ 80 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEF 80 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEccccccccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeec
Confidence 4778889999999999999875 48899999886432 22345788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+. ++|..++... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++........
T Consensus 81 ~~-~~l~~~~~~~-~~~~l~~~~~~~~~~~i~~~l~~lh~~~---i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 81 LH-QDLKKFMDAS-PLSGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred cc-cCHHHHHHhC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 96 5788877543 2356899999999999999999999987 99999999999999999999999999876543221
Q ss_pred cccccccccccCccchhcccCCC-CCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~-~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
. .....++..|+|||.+.+.. ++.++||||||+++|||++|+.||...
T Consensus 156 ~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~ 204 (284)
T cd07860 156 T--YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 204 (284)
T ss_pred c--cccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCC
Confidence 1 12235688999999887644 688999999999999999999999654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.4e-29 Score=259.70 Aligned_cols=199 Identities=28% Similarity=0.416 Sum_probs=173.4
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++|+..+.||+|++|.||++... +++.+++|++.... ....+++.+|++++++++||||+++++.+......++++||
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINEAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEY 80 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccChHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEe
Confidence 35777889999999999999986 47889999986653 23456788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
+++++|.+++.... ..+++..+.+++.|+++||+|||+ .+ ++|+||||+||++++++.+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~~--~~~~~~~~~~~~~~l~~~l~~lH~~~~---i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 81 MDGGSLDKILKEVQ--GRIPERILGKIAVAVLKGLTYLHEKHK---IIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred cCCCcHHHHHHHcc--CCCCHHHHHHHHHHHHHHHHHHcCCCC---eecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 99999999985432 568899999999999999999999 76 9999999999999999999999999987653221
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
. ....++..|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 1 1156788999999999999999999999999999999999999654
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.9e-31 Score=285.78 Aligned_cols=209 Identities=33% Similarity=0.473 Sum_probs=178.5
Q ss_pred CccceecccccEeEEEeeec-cc----cEEEEEEccCC-CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 520 SEKNKLGEGGFGPVYKGMLI-EG----QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 520 ~~~~~LG~G~fG~Vykg~~~-~g----~~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
...++||+|+||+||||.+- ++ -+||+|++... ..+..+++.+|+.+|.+++|||+++|+|+|.... ..||.+
T Consensus 699 kk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq 777 (1177)
T KOG1025|consen 699 KKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQ 777 (1177)
T ss_pred hhhceeccccceeEEeeeEecCCceecceeEEEEeeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHH
Confidence 34578999999999999853 33 36899988654 4445689999999999999999999999998765 889999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
||+.|+|.++++.. +..+.-...+.+..|||+||.|||++. ++||||.++|||+..-..+||.|||+++.+..+.
T Consensus 778 ~mP~G~LlDyvr~h--r~~igsq~lLnw~~QIAkgM~YLe~qr---lVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~ 852 (1177)
T KOG1025|consen 778 LMPLGCLLDYVREH--RDNIGSQDLLNWCYQIAKGMKYLEEQR---LVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDE 852 (1177)
T ss_pred hcccchHHHHHHHh--hccccHHHHHHHHHHHHHHHHHHHhcc---hhhhhhhhhheeecCCCeEEEEecchhhccCccc
Confidence 99999999999764 345778889999999999999999987 9999999999999999999999999999987666
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCCCCcccc
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADHDHNLLG 734 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~~~~~~~l~~ 734 (738)
.+.......-.+.|||-|.+....|+.++|||||||.+||++| |.+|++.-..+++.+++.
T Consensus 853 ~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~dlle 914 (1177)
T KOG1025|consen 853 KEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPDLLE 914 (1177)
T ss_pred ccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhHHHh
Confidence 5555554555778999999999999999999999999999876 789998766666665543
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=258.21 Aligned_cols=192 Identities=28% Similarity=0.411 Sum_probs=158.0
Q ss_pred eecccccEeEEEeeecc-ccEEEEEEccCCCC---cchHHHHHHHHHHhH---hcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAK---LQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 524 ~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~il~~---l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
.||+|+||.||++.... ++.+|+|.+..... .....+.+|..+++. .+|+||+.+.+.+..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 48999999999998754 78999998865321 112334445444433 479999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||++.......
T Consensus 81 ~~~L~~~i~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~--- 151 (279)
T cd05633 81 GGDLHYHLSQ---HGVFSEKEMRFYATEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (279)
T ss_pred CCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---cCCCCCCHHHEEECCCCCEEEccCCcceeccccC---
Confidence 9999988843 346899999999999999999999988 9999999999999999999999999987553221
Q ss_pred cccccccccCccchhccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....|+..|+|||.+. +..++.++||||+|++++||++|+.||....
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 152 -PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred -ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 12246899999999886 4568999999999999999999999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-30 Score=262.10 Aligned_cols=204 Identities=30% Similarity=0.401 Sum_probs=173.2
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV 591 (738)
.+|..+..||+|+||.|.++..+. ...+|||++++.. ....+--+.|-++|... +-|.++++..++..-+.+|+|
T Consensus 349 tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFV 428 (683)
T KOG0696|consen 349 TDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFV 428 (683)
T ss_pred cccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeE
Confidence 468888999999999999998765 4569999997652 12233345676777665 578889999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|||+.+|+|-..+.. -+.+.+..+.-++.+||.||-+||+++ |+.||||.+||||+.+|++||+|||+++.--.
T Consensus 429 MEyvnGGDLMyhiQQ---~GkFKEp~AvFYAaEiaigLFFLh~kg---IiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~ 502 (683)
T KOG0696|consen 429 MEYVNGGDLMYHIQQ---VGKFKEPVAVFYAAEIAIGLFFLHSKG---IIYRDLKLDNVMLDSEGHIKIADFGMCKENIF 502 (683)
T ss_pred EEEecCchhhhHHHH---hcccCCchhhhhhHHHHHHhhhhhcCC---eeeeeccccceEeccCCceEeeeccccccccc
Confidence 999999999888843 345778888999999999999999998 99999999999999999999999999975332
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~~ 728 (738)
....++..+||+.|+|||++...+|+..+|.|||||+||||+.|+.||+.+++++
T Consensus 503 --~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e 557 (683)
T KOG0696|consen 503 --DGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 557 (683)
T ss_pred --CCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 2334566999999999999999999999999999999999999999999877554
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=259.40 Aligned_cols=201 Identities=28% Similarity=0.378 Sum_probs=171.1
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCCCeeeEEeEEecCC--cceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD--ERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~--~~~lV~ 592 (738)
++|+..+.||.|++|.||++.... ++.+|+|.+..... ....++.+|++++++++|+||+++++++.... ..++||
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~ 80 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNPDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAM 80 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCchHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEE
Confidence 467788899999999999999854 78899998865432 34567899999999999999999999986543 589999
Q ss_pred eeCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
||+++++|.+++.... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++++.++|+|||++.....
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~---i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 157 (287)
T cd06621 81 EYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRK---IIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157 (287)
T ss_pred EecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEEecCCeEEEeeccccccccc
Confidence 9999999988865322 3456889999999999999999999988 99999999999999999999999999876532
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
... ....++..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 158 ~~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 158 SLA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred ccc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 211 1245788999999999999999999999999999999999999765
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-28 Score=257.34 Aligned_cols=198 Identities=29% Similarity=0.465 Sum_probs=170.4
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
-|+..+.||+|+||.||+|... ++..+|+|.+.... ....+.+.+|+.++.+++|+||+++++++..+...++||||+
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~ 84 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYL 84 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccchHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeC
Confidence 3667789999999999999864 57899999876443 233467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++++|..++. ...+++..+..++.|++.|++|||+.+ ++|+||+|+||+++.++.++|+|||++..+.....
T Consensus 85 ~~~~l~~~i~----~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~- 156 (277)
T cd06641 85 GGGSALDLLE----PGPLDETQIATILREILKGLDYLHSEK---KIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI- 156 (277)
T ss_pred CCCcHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHccCC---eecCCCCHHhEEECCCCCEEEeecccceecccchh-
Confidence 9999998873 235889999999999999999999987 99999999999999999999999999876543221
Q ss_pred ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
......++..|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 157 -~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 204 (277)
T cd06641 157 -KRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSEL 204 (277)
T ss_pred -hhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 122246788999999998888999999999999999999999998643
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=260.52 Aligned_cols=199 Identities=28% Similarity=0.386 Sum_probs=168.3
Q ss_pred CCCccceecccccEeEEEeeec----cccEEEEEEccCCC----CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcc
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 588 (738)
+|++.+.||+|+||.||++... +|+.||+|++.... ....+++.+|++++.++ +|+||+++++.+..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4677889999999999998863 57889999986432 22346788999999999 599999999999988899
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
++||||+++++|.+++.. ...+++..+..++.|+++||+|||+.+ ++||||+|+|||+++++.+||+|||++..
T Consensus 81 ~lv~e~~~~~~L~~~l~~---~~~l~~~~~~~~~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~ 154 (290)
T cd05613 81 HLILDYINGGELFTHLSQ---RERFKEQEVQIYSGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLSKE 154 (290)
T ss_pred EEEEecCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeEECCCCCEEEeeCcccee
Confidence 999999999999998853 346888999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCcccccccccccccCccchhcccCC--CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 669 FGLDQTEANTKRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
....... ......|+..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 155 ~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 155 FHEDEVE-RAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred ccccccc-ccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 5432211 12235688999999998753 467899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=255.55 Aligned_cols=195 Identities=30% Similarity=0.475 Sum_probs=158.2
Q ss_pred ceecccccEeEEEeeecc----ccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEec-CCcceEEEeeCC
Q 004674 523 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDERMLIYEYLP 596 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~----g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-~~~~~lV~Ey~~ 596 (738)
+.||+|+||.||+|...+ ...+|+|++.... ....+.+.+|+.+++.++||||+++++++.. +...++||||++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~ 80 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITDLEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMK 80 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCCHHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCC
Confidence 368999999999998642 3579999885432 2345678899999999999999999998764 456889999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc--
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT-- 674 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~-- 674 (738)
+++|.+++... ...+++..+..++.||++||+|||+.+ ++||||||+|||+++++.+||+|||+++.......
T Consensus 81 ~~~L~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~---i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~ 155 (262)
T cd05058 81 HGDLRNFIRSE--THNPTVKDLIGFGLQVAKGMEYLASKK---FVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYS 155 (262)
T ss_pred CCCHHHHHHhc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---ccccccCcceEEEcCCCcEEECCccccccccCCccee
Confidence 99999998543 234677888899999999999999987 99999999999999999999999999976532211
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCC-CCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK-NRG 722 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~-p~~ 722 (738)
........++..|+|||.+.+..++.++||||||+++|||++|+. ||.
T Consensus 156 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~ 204 (262)
T cd05058 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 204 (262)
T ss_pred ecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCC
Confidence 111112345678999999988899999999999999999999654 443
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=258.20 Aligned_cols=194 Identities=32% Similarity=0.457 Sum_probs=166.0
Q ss_pred ecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCCh
Q 004674 525 LGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 525 LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (738)
||+|+||.||++... +++.+++|.+.... ....+.+.+|++++++++||||+++++.+...+..++||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 689999999999865 48899999886432 22345567899999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccc
Q 004674 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (738)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 680 (738)
.+++.... ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++...... .....
T Consensus 81 ~~~l~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~---~~~~~ 153 (277)
T cd05577 81 KYHIYNVG-EPGFPEARAIFYAAQIICGLEHLHQRR---IVYRDLKPENVLLDDHGNVRISDLGLAVELKGG---KKIKG 153 (277)
T ss_pred HHHHHHcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEECCCCCEEEccCcchhhhccC---Ccccc
Confidence 99886533 246899999999999999999999988 999999999999999999999999998765321 11223
Q ss_pred cccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
..++..|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus 154 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 154 RAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred ccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 457889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.8e-29 Score=259.59 Aligned_cols=190 Identities=27% Similarity=0.434 Sum_probs=159.1
Q ss_pred ceecccccEeEEEeeecc--------ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 523 NKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~--------g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+.||+|+||.||+|.... ..++++|.+........+++.+|+.+++.++||||+++++++..+...++||||
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~ 80 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEY 80 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchhHHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEec
Confidence 369999999999998643 234888887655444557889999999999999999999999998999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc--------eEEEeecCc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--------PKISDFGLA 666 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--------vkL~DFGla 666 (738)
+++|+|..++... ...+++..+..++.||+.||+|||+.+ |+||||||+||+++.++. ++++|||++
T Consensus 81 ~~~g~L~~~l~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~ 155 (258)
T cd05078 81 VKFGSLDTYLKKN--KNLINISWKLEVAKQLAWALHFLEDKG---LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGIS 155 (258)
T ss_pred CCCCcHHHHHhcC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCccceEEEecccccccCCCceEEecccccc
Confidence 9999999998543 235889999999999999999999987 999999999999987665 699999988
Q ss_pred cccCCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCC-CCCCC
Q 004674 667 RSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGK-KNRGF 723 (738)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~-~p~~~ 723 (738)
..... .....++..|+|||++.+ ..++.++||||||+++|||++|. .|+..
T Consensus 156 ~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~ 208 (258)
T cd05078 156 ITVLP------KEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSA 208 (258)
T ss_pred cccCC------chhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhh
Confidence 65432 122457889999999986 45899999999999999999995 55443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=253.81 Aligned_cols=200 Identities=27% Similarity=0.415 Sum_probs=171.4
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|+..+.||+|++|.||++... .++.+|+|.+.... ....+.+.+|++++++++|+|++++++.+..++..++||||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~ 80 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEY 80 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEec
Confidence 4778889999999999999875 47889999886442 23456789999999999999999999999988999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-CceEEEeecCccccCCCc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~vkL~DFGla~~~~~~~ 673 (738)
+++++|.+++... ....+++..+.+++.++++||+|||+.+ ++|+||+|+||+++++ ..+||+|||++.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~---i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 81 APGGTLAEYIQKR-CNSLLDEDTILHFFVQILLALHHVHTKL---ILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred CCCCCHHHHHHHh-cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 9999999998543 2345899999999999999999999987 9999999999999854 468999999998764322
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
. .....++..|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 204 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccC
Confidence 1 22256788999999999888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-28 Score=254.43 Aligned_cols=196 Identities=26% Similarity=0.328 Sum_probs=162.1
Q ss_pred HHhcCCCCcccee--cccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcc
Q 004674 513 ANATDNFSEKNKL--GEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 513 ~~~~~~~~~~~~L--G~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 588 (738)
....++|++.+.+ |+|+||.||++... .+..+|+|.+........ |+.....+ +|+||+++++.+...+..
T Consensus 10 ~~~~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~ 84 (267)
T PHA03390 10 VQFLKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNAI-----EPMVHQLMKDNPNFIKLYYSVTTLKGH 84 (267)
T ss_pred HHHHHhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcchh-----hHHHHHHhhcCCCEEEEEEEEecCCee
Confidence 3345667776666 99999999999865 478899998864322111 22222222 699999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-ceEEEeecCcc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLAR 667 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGla~ 667 (738)
++||||+++++|.+++... ..+++.++..++.||++||+|||+.+ ++||||||+||+++.++ .++|+|||++.
T Consensus 85 ~iv~e~~~~~~L~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~~~l~dfg~~~ 158 (267)
T PHA03390 85 VLIMDYIKDGDLFDLLKKE---GKLSEAEVKKIIRQLVEALNDLHKHN---IIHNDIKLENVLYDRAKDRIYLCDYGLCK 158 (267)
T ss_pred EEEEEcCCCCcHHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEEeCCCCeEEEecCccce
Confidence 9999999999999998432 37899999999999999999999988 99999999999999888 99999999987
Q ss_pred ccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
...... ...++..|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 159 ~~~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 159 IIGTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred ecCCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 653221 2457899999999999899999999999999999999999997443
|
|
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=252.82 Aligned_cols=199 Identities=40% Similarity=0.589 Sum_probs=169.3
Q ss_pred CccceecccccEeEEEeeecc-----ccEEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 520 SEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 520 ~~~~~LG~G~fG~Vykg~~~~-----g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
++.+.||.|+||.||++.... +..||+|.+...... ..+.+.+|++++..++|+||+++++++.+.+..+++||
T Consensus 2 ~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e 81 (258)
T smart00219 2 TLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADEQQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVME 81 (258)
T ss_pred cccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCChHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEe
Confidence 456789999999999999754 378999998655433 56789999999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++++|.+++..... ..+++..+..++.|++.||+|||+.+ ++|+||||+||++++++.++|+|||++.......
T Consensus 82 ~~~~~~l~~~~~~~~~-~~~~~~~~~~~~~ql~~~l~~lh~~~---~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (258)
T smart00219 82 YMEGGDLLDYLRKNRP-KELSLSDLLSFALQIARGMEYLESKN---FIHRDLAARNCLVGENLVVKISDFGLSRDLYDDD 157 (258)
T ss_pred ccCCCCHHHHHHhhhh-ccCCHHHHHHHHHHHHHHHHHHhcCC---eeecccccceEEEccCCeEEEcccCCceeccccc
Confidence 9999999999854322 22899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
..... ...++..|+|||.+.+..++.++||||+|++++||++ |+.||..
T Consensus 158 ~~~~~-~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~ 207 (258)
T smart00219 158 YYKKK-GGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPG 207 (258)
T ss_pred ccccc-cCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 21111 1236789999999988889999999999999999998 7788764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=255.50 Aligned_cols=202 Identities=25% Similarity=0.419 Sum_probs=169.0
Q ss_pred CCCccceecccccEeEEEeeecc--ccEEEEEEccCCC----------CcchHHHHHHHHHHhH-hcCCCeeeEEeEEec
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGS----------GQGMEEFKNEVLLIAK-LQHRNLVKLLGCCTQ 584 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~--g~~vavK~l~~~~----------~~~~~~~~~Ei~il~~-l~H~nIv~l~g~~~~ 584 (738)
+|++.+.||+|+||.||++.... ++.+|+|.+.... .....++.+|+.++.+ ++|+||+++++++.+
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 46778899999999999999765 6789999875321 1223456778887765 799999999999999
Q ss_pred CCcceEEEeeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEee
Q 004674 585 RDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (738)
Q Consensus 585 ~~~~~lV~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DF 663 (738)
.+..+++|||+++++|.+++... .....+++..++.++.|++.||.|||+.. +++|+||+|+||+++.++.+||+||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~--~i~H~dl~~~nil~~~~~~~~l~df 158 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEK--RIVHRDLTPNNIMLGEDDKVTITDF 158 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCC--ceeecCCCHHHEEECCCCcEEEecc
Confidence 99999999999999998887542 23456899999999999999999999632 3999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
|++....... ......|+..|+|||.+.+..++.++||||||+++|||++|+.||...
T Consensus 159 g~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~ 216 (269)
T cd08528 159 GLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYST 216 (269)
T ss_pred cceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCccccc
Confidence 9998754332 223356889999999999888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=250.29 Aligned_cols=199 Identities=33% Similarity=0.521 Sum_probs=175.6
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
+|+..+.||+|++|.||++... +++.+++|++........+.+.+|++++++++|+|++++++.+......++++||++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~ 80 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCS 80 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccchhHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCC
Confidence 3667789999999999999986 578899999876655566789999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+++|.+++.... ..+++..+..++.|++.||++||+.+ ++|+||+|+||++++++.++|+|||.+........
T Consensus 81 ~~~L~~~~~~~~--~~~~~~~~~~i~~~i~~~l~~lh~~~---i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-- 153 (253)
T cd05122 81 GGSLKDLLKSTN--QTLTESQIAYVCKELLKGLEYLHSNG---IIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-- 153 (253)
T ss_pred CCcHHHHHhhcC--CCCCHHHHHHHHHHHHHHHHHhhcCC---EecCCCCHHHEEEccCCeEEEeecccccccccccc--
Confidence 999999885432 46899999999999999999999987 99999999999999999999999999987643321
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.....++..|+|||.+.+..++.++||||||++++||++|+.||...
T Consensus 154 -~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 154 -RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred -ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 23356888999999998888999999999999999999999998754
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=257.57 Aligned_cols=204 Identities=28% Similarity=0.441 Sum_probs=171.7
Q ss_pred HhcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCC-----
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRD----- 586 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~----- 586 (738)
..+++|+..+.||+|++|.||++... .++.+++|++..... ..+++.+|+.+++++ +|+||+++++++....
T Consensus 3 ~~~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (275)
T cd06608 3 DPTGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED-EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGND 81 (275)
T ss_pred CchhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch-hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcc
Confidence 35688999999999999999999975 477899999865433 456789999999999 6999999999997654
Q ss_pred -cceEEEeeCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeec
Q 004674 587 -ERMLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (738)
Q Consensus 587 -~~~lV~Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFG 664 (738)
..++||||+++++|.+++.... ....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~---i~H~~l~p~ni~~~~~~~~~l~d~~ 158 (275)
T cd06608 82 DQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENK---VIHRDIKGQNILLTKNAEVKLVDFG 158 (275)
T ss_pred eEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCC---cccCCCCHHHEEEccCCeEEECCCc
Confidence 3899999999999999885432 2456899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCcccccccccccccCccchhcccC-----CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAID-----GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
++........ ......|+..|+|||++.. ..++.++||||||++++||++|+.||..
T Consensus 159 ~~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~ 220 (275)
T cd06608 159 VSAQLDSTLG--RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCD 220 (275)
T ss_pred cceecccchh--hhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccc
Confidence 9876543221 1223568889999998753 3477899999999999999999999964
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-28 Score=254.40 Aligned_cols=192 Identities=29% Similarity=0.416 Sum_probs=167.9
Q ss_pred ecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCCh
Q 004674 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 525 LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (738)
||.|++|.||++.... ++.+++|++.... ....+.+.+|+.+++.++|+||+++++.+.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 6999999999999864 7899999986542 23446789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccc
Q 004674 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (738)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 680 (738)
.+++.. ...+++..+..++.||+.||+|||+.+ ++|+||+|+||+++.++.+||+|||++....... ....
T Consensus 81 ~~~l~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~ 151 (262)
T cd05572 81 WTILRD---RGLFDEYTARFYIACVVLAFEYLHNRG---IIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWT 151 (262)
T ss_pred HHHHhh---cCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---cccc
Confidence 999843 345889999999999999999999987 9999999999999999999999999998764322 1223
Q ss_pred cccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
..++..|+|||.+.+..++.++|+||||+++|||++|+.||....
T Consensus 152 ~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 152 FCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred ccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 567889999999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3e-28 Score=257.86 Aligned_cols=202 Identities=26% Similarity=0.389 Sum_probs=166.4
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCc-----
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDE----- 587 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~----- 587 (738)
++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|+.+++.++ |+||+++++++...+.
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMDEEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhccccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 46888899999999999999975 48899999876442 223467888999999995 6999999999877665
Q ss_pred ceEEEeeCCCCChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCceEEEeec
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTR--SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFG 664 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~vkL~DFG 664 (738)
.++||||+++ +|..++..... ...+++..+..++.||++||+|||+.+ |+||||+|+||+++. ++.+||+|||
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~~~nil~~~~~~~~kl~dfg 156 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHG---VMHRDLKPQNLLVDKQKGLLKIADLG 156 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEecCCCeEEEeecc
Confidence 7999999986 78777754322 346899999999999999999999987 999999999999998 8899999999
Q ss_pred CccccCCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
++..+...... .....+++.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~--~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 215 (295)
T cd07837 157 LGRAFSIPVKS--YTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGD 215 (295)
T ss_pred cceecCCCccc--cCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCC
Confidence 99865432211 112356788999998865 45799999999999999999999998643
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=268.83 Aligned_cols=198 Identities=32% Similarity=0.481 Sum_probs=169.7
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
+....++||-|.||.||.|+++. .-.||||.+++. ....++|..|..+|+.++|||+|+|+|+|..+..+|||.|||.
T Consensus 268 dItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED-tMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~ 346 (1157)
T KOG4278|consen 268 DITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMC 346 (1157)
T ss_pred heeeeeccCCCcccceeeeeeeccceeeehhhhhhc-chhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEeccc
Confidence 44567899999999999999876 668999999544 4567899999999999999999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+|+|.++|....+ ..++-...++++.||..||+||.... .|||||..+|+|+.++..||++|||+++.+..+....
T Consensus 347 yGNLLdYLRecnr-~ev~avvLlyMAtQIsSaMeYLEkkn---FIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTA 422 (1157)
T KOG4278|consen 347 YGNLLDYLRECNR-SEVPAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTA 422 (1157)
T ss_pred CccHHHHHHHhch-hhcchhHHHHHHHHHHHHHHHHHHhh---hhhhhhhhhhccccccceEEeeccchhhhhcCCceec
Confidence 9999999976433 34667778899999999999999887 9999999999999999999999999999875443222
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCC-CCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK-KNR 721 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~-~p~ 721 (738)
.. ...-.+.|.|||-+.-..++.|+|||+|||+||||.|-. .||
T Consensus 423 HA-GAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPY 467 (1157)
T KOG4278|consen 423 HA-GAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPY 467 (1157)
T ss_pred cc-CccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCC
Confidence 11 122357899999999999999999999999999998744 444
|
|
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=258.59 Aligned_cols=200 Identities=29% Similarity=0.415 Sum_probs=168.0
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecC--CcceEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERMLI 591 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~lV 591 (738)
++|+..+.||+|++|.||+|.... ++.+++|.+.... ......+.+|+.++++++||||+++++++... ...++|
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv 84 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEKEGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMV 84 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeeccccccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEE
Confidence 568888999999999999999764 7889999886432 22234567899999999999999999998877 789999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|||+++ +|.+++... ...+++..+..++.||+.||+|||+.+ ++|+||||+||++++++.+||+|||++.....
T Consensus 85 ~e~~~~-~L~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 85 MEYVEH-DLKSLMETM--KQPFLQSEVKCLMLQLLSGVAHLHDNW---ILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred ehhcCc-CHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 999984 888877432 236899999999999999999999988 99999999999999999999999999987654
Q ss_pred CcccccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
... ......++..|+|||.+.+. .++.++|+||||++++||++|+.||...
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~ 210 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGK 210 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 321 12224578899999988764 4689999999999999999999999754
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-28 Score=255.57 Aligned_cols=202 Identities=28% Similarity=0.439 Sum_probs=164.3
Q ss_pred CCccceecccccEeEEEeeec----cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC------
Q 004674 519 FSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~----~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------ 586 (738)
|.+.+.||+|+||.||+|... .++.+|+|++.... ....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 80 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLP 80 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccCChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCccc
Confidence 456778999999999999854 25789999886542 234567889999999999999999999886543
Q ss_pred cceEEEeeCCCCChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEee
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DF 663 (738)
..++++||+++++|..++.... ....+++.....++.||+.||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 81 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dikp~nili~~~~~~kl~df 157 (273)
T cd05074 81 IPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKN---FIHRDLAARNCMLNENMTVCVADF 157 (273)
T ss_pred ceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCC---EeecccchhhEEEcCCCCEEECcc
Confidence 2478899999999988875322 1235788999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCC
Q 004674 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGF 723 (738)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~ 723 (738)
|+++...............++..|++||.+....++.++||||||+++|||++ |+.||..
T Consensus 158 g~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~ 218 (273)
T cd05074 158 GLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218 (273)
T ss_pred cccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCC
Confidence 99987643322111222345678999999998889999999999999999999 8888754
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-29 Score=265.36 Aligned_cols=207 Identities=29% Similarity=0.486 Sum_probs=172.4
Q ss_pred CccceecccccEeEEEeeecc---cc--EEEEEEccCC-CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 520 SEKNKLGEGGFGPVYKGMLIE---GQ--EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 520 ~~~~~LG~G~fG~Vykg~~~~---g~--~vavK~l~~~-~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
...++||.|-||.||+|+..+ |. .||||..+.. .....+.|.+|..+|++++||||++++|+|.+ .+.+||||
T Consensus 392 tl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e-~P~WivmE 470 (974)
T KOG4257|consen 392 TLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVE-QPMWIVME 470 (974)
T ss_pred cHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeec-cceeEEEe
Confidence 446789999999999999643 33 4899988664 34457889999999999999999999999975 57899999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
.++-|.|..++.. +...++......++.||..||+|||+.. .|||||..+|||+.....|||+|||+++.+..+.
T Consensus 471 L~~~GELr~yLq~--nk~sL~l~tL~ly~~Qi~talaYLeSkr---fVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~ 545 (974)
T KOG4257|consen 471 LAPLGELREYLQQ--NKDSLPLRTLTLYCYQICTALAYLESKR---FVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA 545 (974)
T ss_pred cccchhHHHHHHh--ccccchHHHHHHHHHHHHHHHHHHHhhc---hhhhhhhhhheeecCcceeeecccchhhhccccc
Confidence 9999999999954 3456889999999999999999999987 9999999999999999999999999999876543
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHH-cCCCCCCCCCCCCCCcccccc
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII-CGKKNRGFNHADHDHNLLGHV 736 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ell-tG~~p~~~~~~~~~~~l~~~~ 736 (738)
.-... ...-+..|||||.+.-..++.++|||-|||++|||+ .|.+||..-. ..+.|.|+
T Consensus 546 yYkaS-~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvk---NsDVI~~i 605 (974)
T KOG4257|consen 546 YYKAS-RGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVK---NSDVIGHI 605 (974)
T ss_pred hhhcc-ccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCcccccc---ccceEEEe
Confidence 32222 234467899999999999999999999999999976 5889996532 24445543
|
|
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=256.58 Aligned_cols=191 Identities=29% Similarity=0.433 Sum_probs=158.2
Q ss_pred eecccccEeEEEeeecc-ccEEEEEEccCCCC---cchHHHHHHHHH---HhHhcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLL---IAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 524 ~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~i---l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
.||+|+||.||++.... ++.||+|.+.+... .....+.+|..+ ++...|++|+++.+++...+..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 38999999999998754 78999998865422 112233444443 344579999999999999999999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||||+||++++++.+||+|||++..+....
T Consensus 81 g~~L~~~l~~---~~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~--- 151 (278)
T cd05606 81 GGDLHYHLSQ---HGVFSEAEMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACDFSKKK--- 151 (278)
T ss_pred CCcHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHHCC---EEcCCCCHHHEEECCCCCEEEccCcCccccCccC---
Confidence 9999988743 356899999999999999999999987 9999999999999999999999999987653221
Q ss_pred cccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.....|+..|+|||.+.+. .++.++||||+|++++||++|+.||...
T Consensus 152 -~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 152 -PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred -CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 2235689999999998754 6899999999999999999999999754
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-28 Score=253.56 Aligned_cols=206 Identities=28% Similarity=0.416 Sum_probs=171.0
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEec--CCcceEEE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDERMLIY 592 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--~~~~~lV~ 592 (738)
+|+..+.||+|+||.||++... .++.+++|.+.... ....+++.+|++++++++|+||+++++++.. +...+++|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVM 80 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccCCHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEe
Confidence 4777889999999999999865 47889999886432 2334578889999999999999999998764 34578999
Q ss_pred eeCCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeCCCCCCcEEEcCCCceEEEeecCcccc
Q 004674 593 EYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 669 (738)
||+++++|.+++.... ....+++..+..++.||++||+|||..+ ..+++|+||+|+||++++++.+||+|||++...
T Consensus 81 e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~ 160 (265)
T cd08217 81 EYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKIL 160 (265)
T ss_pred hhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccc
Confidence 9999999999986432 2457899999999999999999999332 234999999999999999999999999999876
Q ss_pred CCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
...... .....++..|+|||.+.+..++.++||||||+++++|++|+.||...+
T Consensus 161 ~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 161 GHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred cCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 433221 222468899999999998889999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=258.10 Aligned_cols=203 Identities=31% Similarity=0.446 Sum_probs=170.3
Q ss_pred CCCCccceecccccEeEEEeeec-----cccEEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEEec--CCcc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQ--RDER 588 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-----~g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~--~~~~ 588 (738)
+.|+..+.||+|+||.||++... .+..+|+|.+...... ..+++.+|+++++.++|+||+++++++.. +...
T Consensus 4 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~ 83 (284)
T cd05038 4 RHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEEQHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSL 83 (284)
T ss_pred hhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccchHHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCce
Confidence 45677789999999999999864 2578999998755433 46789999999999999999999999877 5578
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
++||||+++++|.+++.... ..+++..+..++.|++.||+|||+.+ ++|+||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~~~l~~~l~~~~--~~~~~~~~~~~~~~l~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~ 158 (284)
T cd05038 84 RLIMEYLPSGSLRDYLQRHR--DQINLKRLLLFSSQICKGMDYLGSQR---YIHRDLAARNILVESEDLVKISDFGLAKV 158 (284)
T ss_pred EEEEecCCCCCHHHHHHhCc--cccCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHhEEEcCCCCEEEcccccccc
Confidence 99999999999999985432 35899999999999999999999987 99999999999999999999999999987
Q ss_pred cCCCccc-ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 669 FGLDQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 669 ~~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
....... .......++..|+|||.+.+..++.++||||||++++||++|+.|+...
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 159 LPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 6532211 1111123456799999998888999999999999999999999998643
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-28 Score=253.47 Aligned_cols=195 Identities=31% Similarity=0.488 Sum_probs=166.0
Q ss_pred CCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
++|++.+.||+|+||.||++.. .++.+|+|.++... ..+.+.+|+.++++++|+|++++++++.. +..++||||++
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~~~~~v~e~~~ 81 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDV--TAQAFLEETAVMTKLHHKNLVRLLGVILH-NGLYIVMELMS 81 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcc--hHHHHHHHHHHHHhCCCCCcCeEEEEEcC-CCcEEEEECCC
Confidence 4578889999999999999875 67889999885432 34678999999999999999999999865 45799999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~L~~~l~~~~-~~~~~~~~~~~~~~qi~~al~~lH~~~---~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~--- 154 (254)
T cd05083 82 KGNLVNFLRTRG-RALVSVIQLLQFSLDVAEGMEYLESKK---LVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV--- 154 (254)
T ss_pred CCCHHHHHHhcC-cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccccCcceEEEcCCCcEEECCCccceeccccC---
Confidence 999999986432 345889999999999999999999987 9999999999999999999999999987643211
Q ss_pred cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFN 724 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~ 724 (738)
.....+..|+|||.+.+..++.++||||||++++||++ |+.||...
T Consensus 155 --~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~ 201 (254)
T cd05083 155 --DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKM 201 (254)
T ss_pred --CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccC
Confidence 11234568999999998899999999999999999997 99998654
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.7e-28 Score=250.83 Aligned_cols=202 Identities=29% Similarity=0.463 Sum_probs=175.3
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCCeeeEEeEEecC--CcceEEE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERMLIY 592 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~lV~ 592 (738)
+|...+.||+|++|.||+|... +++.|++|++..... ...+.+.+|+.++++++|+||+++++.+... ...++|+
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 80 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFL 80 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccchHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEE
Confidence 3667789999999999999986 588999999865542 4467889999999999999999999999988 7899999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++++|.+++... ..+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.++|+|||.+......
T Consensus 81 e~~~~~~L~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~---~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 81 EYVSGGSLSSLLKKF---GKLPEPVIRKYTRQILEGLAYLHSNG---IVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EecCCCcHHHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 999999999998543 27899999999999999999999987 999999999999999999999999999876543
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
..........++..|+|||.+.+...+.++||||||++++||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 32111233567889999999988889999999999999999999999997644
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=281.63 Aligned_cols=201 Identities=22% Similarity=0.359 Sum_probs=157.5
Q ss_pred hcCCCCccceecccccEeEEEeeecc--ccEEEEE------------------EccCCCCcchHHHHHHHHHHhHhcCCC
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVK------------------RLSKGSGQGMEEFKNEVLLIAKLQHRN 574 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~--g~~vavK------------------~l~~~~~~~~~~~~~Ei~il~~l~H~n 574 (738)
..++|++.+.||+|+||.||++.... +...+.| .+. ........+.+|+.++++++|+|
T Consensus 146 ~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~-~~~~~~~~~~~Ei~il~~l~Hpn 224 (501)
T PHA03210 146 FLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVK-AGSRAAIQLENEILALGRLNHEN 224 (501)
T ss_pred hhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhh-cchHHHHHHHHHHHHHHhCCCCC
Confidence 45789999999999999999987532 1111111 111 11223456889999999999999
Q ss_pred eeeEEeEEecCCcceEEEeeCCCCChhHHHhhcCC--CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE
Q 004674 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR--SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (738)
Q Consensus 575 Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~--~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 652 (738)
|+++++++...+..++|+|++.. +|..++..... ........+..++.||+.||+|||+.+ |+||||||+|||+
T Consensus 225 Iv~l~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~g---IiHrDLKP~NILl 300 (501)
T PHA03210 225 ILKIEEILRSEANTYMITQKYDF-DLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKK---LIHRDIKLENIFL 300 (501)
T ss_pred cCcEeEEEEECCeeEEEEecccc-CHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEE
Confidence 99999999999999999999865 55555533211 122345667789999999999999988 9999999999999
Q ss_pred cCCCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 004674 653 DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNR 721 (738)
Q Consensus 653 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~ 721 (738)
+.++.+||+|||+++.+...... ......||..|+|||++.+..++.++|||||||++|||++|+.++
T Consensus 301 ~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 301 NCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred CCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 99999999999999876433221 122357999999999999999999999999999999999998543
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.8e-28 Score=259.89 Aligned_cols=195 Identities=30% Similarity=0.466 Sum_probs=165.4
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCCC---cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
+.|+..+.||+|+||.||++... +++.||+|.+..... ...+++.+|+++++.++||||+++.+++...+..++||
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~ 94 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVM 94 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEH
Confidence 55888899999999999999875 488999998864432 23356889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||++ |+|.+++.. ....+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 95 e~~~-g~l~~~~~~--~~~~l~~~~~~~~~~ql~~~L~~LH~~~---i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 95 EYCL-GSASDILEV--HKKPLQEVEIAAICHGALQGLAYLHSHE---RIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HhhC-CCHHHHHHH--cccCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 9997 566565532 2346899999999999999999999987 999999999999999999999999998754321
Q ss_pred cccccccccccccCccchhccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
....++..|+|||++. ...++.++||||||+++|||++|+.||..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~ 216 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCC
Confidence 1245788999999874 45688999999999999999999999864
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-28 Score=255.95 Aligned_cols=200 Identities=28% Similarity=0.457 Sum_probs=167.8
Q ss_pred CCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
|+..+.||.|++|.||++... +++.|++|++.... ....+.+.+|++++++++|+|++++++++.+++..+++|||+
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~ 80 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETEDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFL 80 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEecc
Confidence 566789999999999999865 58899999986443 223467889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
+ ++|.+++.... ...+++..+..++.|+++||+|||+.+ ++||||+|+||++++++.++|+|||++.........
T Consensus 81 ~-~~l~~~~~~~~-~~~~~~~~~~~~~~~i~~~L~~lH~~~---~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~~ 155 (283)
T cd07835 81 D-LDLKKYMDSSP-LTGLDPPLIKSYLYQLLQGIAYCHSHR---VLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRT 155 (283)
T ss_pred C-cCHHHHHhhCC-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeCCCCCHHHEEEcCCCcEEEeecccccccCCCccc
Confidence 5 68888875432 246899999999999999999999987 999999999999999999999999999765432211
Q ss_pred ccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....++..|+|||++.+. .++.++||||||+++|||++|+.||....
T Consensus 156 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 204 (283)
T cd07835 156 --YTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204 (283)
T ss_pred --cCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 1223568899999988664 57899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-28 Score=259.08 Aligned_cols=193 Identities=27% Similarity=0.432 Sum_probs=168.2
Q ss_pred ceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCChh
Q 004674 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 601 (738)
..||+|+||.||++... +++.||+|++........+.+.+|+.+++.++|+||+++++.+...+..++||||+++++|.
T Consensus 26 ~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 105 (292)
T cd06657 26 IKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALT 105 (292)
T ss_pred HHcCCCCCeEEEEEEEcCCCeEEEEEEecccchhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHH
Confidence 47999999999999875 58899999986555455667899999999999999999999999999999999999999999
Q ss_pred HHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccccccc
Q 004674 602 YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681 (738)
Q Consensus 602 ~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~ 681 (738)
+++.. ..+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.++|+|||++........ .....
T Consensus 106 ~~~~~----~~~~~~~~~~~~~ql~~~l~~lH~~g---ivH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 176 (292)
T cd06657 106 DIVTH----TRMNEEQIAAVCLAVLKALSVLHAQG---VIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSL 176 (292)
T ss_pred HHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEECCCCCEEEcccccceecccccc--ccccc
Confidence 87732 35789999999999999999999987 99999999999999999999999999876543221 12235
Q ss_pred ccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 682 ~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.|+..|+|||.+.+..++.++||||+|++++||++|+.||...
T Consensus 177 ~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~ 219 (292)
T cd06657 177 VGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNE 219 (292)
T ss_pred ccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 6789999999998888999999999999999999999998654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=255.97 Aligned_cols=195 Identities=29% Similarity=0.434 Sum_probs=168.1
Q ss_pred ecccccEeEEEeeecc-ccEEEEEEccCCCC---cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCCh
Q 004674 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 525 LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (738)
||+|+||.||++.... ++.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...+++|||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 6899999999999865 88999999865432 3456788999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc------
Q 004674 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT------ 674 (738)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~------ 674 (738)
.+++... ..+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 ~~~l~~~---~~~~~~~~~~i~~qi~~~L~~lH~~~---i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~ 154 (265)
T cd05579 81 ASLLENV---GSLDEDVARIYIAEIVLALEYLHSNG---IIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDD 154 (265)
T ss_pred HHHHHHc---CCCCHHHHHHHHHHHHHHHHHHHHcC---eecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccc
Confidence 9988542 36899999999999999999999987 99999999999999999999999999876533211
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
........++..|+|||...+...+.++||||||++++||++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 205 (265)
T cd05579 155 EKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGET 205 (265)
T ss_pred cccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 112223567889999999988889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.2e-29 Score=263.00 Aligned_cols=203 Identities=28% Similarity=0.415 Sum_probs=172.8
Q ss_pred HhcCCCCccceecccccEeEEEeeeccccEEEEEEcc--CCCCcchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcceE
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLS--KGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~--~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~l 590 (738)
.....|+++++||+||...|||+...+.+.+|+|++. ..+.+...-|++|+..|.+++ |.+||+|++|-..++..||
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYm 437 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYM 437 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEE
Confidence 3456788999999999999999998888888888764 345566788999999999995 9999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
||||- ..+|..+|..... ....| .+..+..|++.++.++|+++ |||.||||.|+|+-. |.+||+|||+|..+.
T Consensus 438 vmE~G-d~DL~kiL~k~~~-~~~~~-~lk~ywkqML~aV~~IH~~g---IVHSDLKPANFLlVk-G~LKLIDFGIA~aI~ 510 (677)
T KOG0596|consen 438 VMECG-DIDLNKILKKKKS-IDPDW-FLKFYWKQMLLAVKTIHQHG---IVHSDLKPANFLLVK-GRLKLIDFGIANAIQ 510 (677)
T ss_pred Eeecc-cccHHHHHHhccC-CCchH-HHHHHHHHHHHHHHHHHHhc---eeecCCCcccEEEEe-eeEEeeeechhcccC
Confidence 99986 4688888854332 23334 67788899999999999998 999999999999965 599999999999988
Q ss_pred CCcccccccccccccCccchhcccCCC-----------CCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDGL-----------FSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~-----------~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.+.+.......+||+.||+||.+.... .++++||||+|||||+|+-|+.||+.
T Consensus 511 ~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~ 574 (677)
T KOG0596|consen 511 PDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQ 574 (677)
T ss_pred ccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHH
Confidence 777777777789999999999885432 56789999999999999999999963
|
|
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.5e-28 Score=255.81 Aligned_cols=201 Identities=29% Similarity=0.438 Sum_probs=165.8
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
++|+..+.||+|++|.||+|... +++.||+|++.... ....+.+.+|++++++++|+||+++++++......++|||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 81 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQEDEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFE 81 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccccccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEe
Confidence 56888899999999999999975 47899999886442 2234678899999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCceEEEeecCccccCCC
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFGLD 672 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla~~~~~~ 672 (738)
|+++ +|...+... ....+++..+..++.||+.||+|||+.+ ++|+||+|+||++++ ++.+||+|||++......
T Consensus 82 ~~~~-~l~~~~~~~-~~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 82 YLDL-DLKKHMDSS-PDFAKNPRLIKTYLYQILRGIAYCHSHR---VLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred cccc-cHHHHHHhC-CCCCcCHHHHHHHHHHHHHHHHHHHhCC---eeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9964 676666332 2234678888899999999999999987 999999999999985 567999999999765432
Q ss_pred cccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.. ......+++.|+|||++.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~ 207 (294)
T PLN00009 157 VR--TFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGD 207 (294)
T ss_pred cc--ccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 11 1122456889999998866 45789999999999999999999999654
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.4e-29 Score=269.52 Aligned_cols=200 Identities=31% Similarity=0.443 Sum_probs=171.4
Q ss_pred CCccceecccccEeEEEeeecc--cc--EEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIE--GQ--EIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~--g~--~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
....++||+|.||.|++|.+.. |+ .||||.+...... ...+|.+|+.+|.+|+|+|+++|+|++.+ ...+||||
T Consensus 112 i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~E 190 (1039)
T KOG0199|consen 112 IKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNAIMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFE 190 (1039)
T ss_pred HHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccchhHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhh
Confidence 3445789999999999999764 44 5899999766443 67899999999999999999999999987 78899999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
.++.|+|.+.|.+ .....|.......++.|||.||.||..+. +|||||..+|+||-....|||+|||+.+.++...
T Consensus 191 LaplGSLldrLrk-a~~~~llv~~Lcdya~QiA~aM~YLeskr---lvHRDLAARNlllasprtVKI~DFGLmRaLg~ne 266 (1039)
T KOG0199|consen 191 LAPLGSLLDRLRK-AKKAILLVSRLCDYAMQIAKAMQYLESKR---LVHRDLAARNLLLASPRTVKICDFGLMRALGENE 266 (1039)
T ss_pred hcccchHHHHHhh-ccccceeHHHHHHHHHHHHHHHHHHhhhh---hhhhhhhhhhheecccceeeeecccceeccCCCC
Confidence 9999999999987 45678889999999999999999999987 9999999999999999999999999999886543
Q ss_pred cccc-ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcC-CCCCCC
Q 004674 674 TEAN-TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG-KKNRGF 723 (738)
Q Consensus 674 ~~~~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG-~~p~~~ 723 (738)
.... .....-...|.|||.+....++.++|||+|||.||||+++ +.||-.
T Consensus 267 d~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G 318 (1039)
T KOG0199|consen 267 DMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVG 318 (1039)
T ss_pred cceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCC
Confidence 2221 1222335689999999999999999999999999999985 477754
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.7e-28 Score=263.51 Aligned_cols=200 Identities=25% Similarity=0.402 Sum_probs=165.7
Q ss_pred cCCCCccceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC-----cc
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----ER 588 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-----~~ 588 (738)
+++|++.+.||+|+||.||+|... +++.||+|++.... ......+.+|+.++++++|+||+++++++.... ..
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 83 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDV 83 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceE
Confidence 578999999999999999999864 48899999986432 234466888999999999999999999876543 47
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
++|+||+++ +|...+. ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||++..
T Consensus 84 ~lv~e~~~~-~l~~~~~----~~~l~~~~~~~i~~ql~~aL~~LH~~~---ivH~dlkp~Nill~~~~~~kl~dfg~~~~ 155 (336)
T cd07849 84 YIVQELMET-DLYKLIK----TQHLSNDHIQYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTNCDLKICDFGLARI 155 (336)
T ss_pred EEEehhccc-CHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEECCCCCEEECcccceee
Confidence 999999975 6666652 346899999999999999999999988 99999999999999999999999999976
Q ss_pred cCCCcccc-cccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 669 FGLDQTEA-NTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 669 ~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
........ ......|+..|+|||.+.+ ..++.++||||||++++||++|+.||..
T Consensus 156 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~ 212 (336)
T cd07849 156 ADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPG 212 (336)
T ss_pred ccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCC
Confidence 54322111 1223568899999998754 5689999999999999999999999954
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.4e-28 Score=254.34 Aligned_cols=200 Identities=28% Similarity=0.447 Sum_probs=168.2
Q ss_pred CCccceecccccEeEEEeeecc-ccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecC--CcceEEEe
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERMLIYE 593 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~lV~E 593 (738)
|++.+.||+|++|.||++...+ ++.+|+|++.... ....+.+.+|++++++++|+|++++++++... ...++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e 80 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMENEKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFE 80 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEecccccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEec
Confidence 5667899999999999999764 7899999987653 33456788999999999999999999999887 78999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++ +|..++... ...+++..+..++.||++||+|||+.+ ++|+||+|+||++++++.+||+|||++.......
T Consensus 81 ~~~~-~l~~~~~~~--~~~~~~~~~~~i~~~i~~al~~LH~~~---~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 81 YMDH-DLTGLLDSP--EVKFTESQIKCYMKQLLEGLQYLHSNG---ILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred cccc-cHHHHHhcc--CCCCCHHHHHHHHHHHHHHHHHHHHCC---ceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 9985 787777432 246899999999999999999999987 9999999999999999999999999998765432
Q ss_pred ccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.. ......++..|+|||.+.+ ..++.++||||||++++||++|+.||....
T Consensus 155 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~ 206 (287)
T cd07840 155 SA-DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGST 206 (287)
T ss_pred cc-cccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 21 1222456788999998765 467899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-28 Score=251.53 Aligned_cols=201 Identities=27% Similarity=0.424 Sum_probs=171.1
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|+..+.||+|+||.||++.... +..+|+|.+.... ....+.+.+|+++++.++|+||+++++.+......++|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~ 80 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEY 80 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEec
Confidence 46778899999999999999764 7889999985432 23446788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-ceEEEeecCccccCCCc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGLDQ 673 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGla~~~~~~~ 673 (738)
+++++|.+++... ....+++..+..++.|+++||+|||+.+ ++|+||||+||++++++ .+||+|||.+.......
T Consensus 81 ~~~~~L~~~~~~~-~~~~~~~~~~~~~~~~l~~~l~~lh~~~---i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 81 CDGGDLMKRINRQ-RGVLFSEDQILSWFVQISLGLKHIHDRK---ILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred CCCCcHHHHHHhc-cCCCCCHHHHHHHHHHHHHHHHHHHHCC---cccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 9999999988543 2335799999999999999999999987 99999999999998875 46999999997764322
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
. ......|++.|+|||+..+..++.++||||||++++||++|+.||...
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 205 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGN 205 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 1 112245788999999998888999999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.3e-28 Score=257.59 Aligned_cols=204 Identities=25% Similarity=0.424 Sum_probs=165.9
Q ss_pred cCCCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCc-----
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE----- 587 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~----- 587 (738)
.++|+..+.||+|+||.||++... +++.||+|.+.... ......+.+|++++++++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 11 VSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCcCCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 357889999999999999999975 48899999885432 2223456789999999999999999999876543
Q ss_pred ---ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeec
Q 004674 588 ---RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (738)
Q Consensus 588 ---~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFG 664 (738)
.++||||+.+ +|...+.. ....+++.++..++.||+.||+|||+.+ ++|+||||+||+++.++.+||+|||
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~al~~lH~~~---i~H~dl~p~nil~~~~~~~kl~dfg 164 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSN--KNVKFTLSEIKKVMKMLLNGLYYIHRNK---ILHRDMKAANILITKDGILKLADFG 164 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHh--cccCCCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHEEECCCCcEEECcCC
Confidence 4999999975 67666632 2235899999999999999999999987 9999999999999999999999999
Q ss_pred CccccCCCccc--ccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 665 LARSFGLDQTE--ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 665 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
++......... .......++..|+|||.+.+. .++.++||||||++++||++|+.||....
T Consensus 165 ~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~ 228 (310)
T cd07865 165 LARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNT 228 (310)
T ss_pred CcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 99866432221 111224567899999988764 47889999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.6e-28 Score=251.47 Aligned_cols=191 Identities=29% Similarity=0.369 Sum_probs=160.1
Q ss_pred ceecccccEeEEEeeec-cccEEEEEEccCCCCc---chHHHHHHHHHH-hHhcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ---GMEEFKNEVLLI-AKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~---~~~~~~~Ei~il-~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.||+|++|.||++... .++.||+|.+.+.... ....+..|..++ ...+|+|++++++++...+..++|+||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 46999999999999875 4789999998654321 122344454443 445899999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
++|..++.. ...+++..+..++.|++.||.|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 82 ~~L~~~l~~---~~~~~~~~~~~i~~qi~~aL~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------ 149 (260)
T cd05611 82 GDCASLIKT---LGGLPEDWAKQYIAEVVLGVEDLHQRG---IIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------ 149 (260)
T ss_pred CCHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCcEEEeecccceeccc------
Confidence 999998843 346889999999999999999999987 99999999999999999999999999875432
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.....++..|+|||.+.+..++.++||||||++++||++|+.||....
T Consensus 150 ~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 197 (260)
T cd05611 150 NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAET 197 (260)
T ss_pred cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCC
Confidence 122457889999999988889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.96 E-value=5e-28 Score=258.13 Aligned_cols=201 Identities=30% Similarity=0.470 Sum_probs=166.6
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCCeeeEEeEEecC--CcceE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERML 590 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--~~~~l 590 (738)
.++|+..+.||+|+||.||++.... ++.||+|+++.... .....+.+|+.++++++|+||+++++++... +..++
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~l 85 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFL 85 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEE
Confidence 4678899999999999999999754 88999999864322 2234567899999999999999999998755 45899
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
||||+++ +|.+++... ...+++.++..++.||++||+|||+.+ ++||||||+||++++++.+||+|||++....
T Consensus 86 v~e~~~~-~l~~~l~~~--~~~l~~~~~~~~~~qi~~~l~~lH~~~---i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 86 VMEYCEQ-DLASLLDNM--PTPFSESQVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEecCCC-CHHHHHHhc--ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 9999975 777777432 256899999999999999999999988 9999999999999999999999999998765
Q ss_pred CCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
..... .....++..|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 160 ~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~ 212 (309)
T cd07845 160 LPAKP--MTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGK 212 (309)
T ss_pred CccCC--CCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCC
Confidence 33211 112345788999999865 56889999999999999999999999644
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-28 Score=263.45 Aligned_cols=198 Identities=28% Similarity=0.388 Sum_probs=166.8
Q ss_pred hcCCCCccceecccccEeEEEeeec-cccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecC------
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------ 585 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~------ 585 (738)
..++|+..+.||+|+||.||++... .++.||+|++... .....+++.+|+.++++++|+||+++++++...
T Consensus 14 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 93 (353)
T cd07850 14 VLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQNVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEF 93 (353)
T ss_pred hhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccccChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcccc
Confidence 3477999999999999999999865 5889999998643 223345677899999999999999999988644
Q ss_pred CcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecC
Q 004674 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (738)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl 665 (738)
...++||||+.+ +|.+.+.. .++...+..++.|++.||+|||+.+ |+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~lv~e~~~~-~l~~~~~~-----~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nil~~~~~~~kL~Dfg~ 164 (353)
T cd07850 94 QDVYLVMELMDA-NLCQVIQM-----DLDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGL 164 (353)
T ss_pred CcEEEEEeccCC-CHHHHHhh-----cCCHHHHHHHHHHHHHHHHHHHhCC---eeeCCCCHHHEEECCCCCEEEccCcc
Confidence 246999999964 77666632 2788999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
++....... .....++..|+|||.+.+..++.++||||||+++++|++|+.||...
T Consensus 165 ~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~ 220 (353)
T cd07850 165 ARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGT 220 (353)
T ss_pred ceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCC
Confidence 987543221 22245788999999999999999999999999999999999999654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.6e-28 Score=248.31 Aligned_cols=198 Identities=32% Similarity=0.477 Sum_probs=173.0
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|+..+.||+|++|.||++... .++.+++|.+..... ...+.+.+|++++++++|+|++++++++...+..+++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEY 80 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccCHHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEec
Confidence 4677889999999999999875 478899999866543 3456889999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+++++|.+++.. ...+++..+..++.|++.||+|||+.+ |+||||+|+||+++.++.++|+|||++........
T Consensus 81 ~~~~~L~~~~~~---~~~l~~~~~~~~~~~i~~~l~~lH~~~---i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 81 AENGSLRQIIKK---FGPFPESLVAVYVYQVLQGLAYLHEQG---VIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred CCCCcHHHHHHh---ccCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999998843 256899999999999999999999987 99999999999999999999999999987653322
Q ss_pred cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
. .....++..|+|||...+..++.++||||+|++++||++|+.||..
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~ 201 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYD 201 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 1 2235678899999999888889999999999999999999999864
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=258.39 Aligned_cols=206 Identities=32% Similarity=0.452 Sum_probs=170.4
Q ss_pred CCCCccceecccccEeEEEeee-ccccEEEEEEccCCCC-------cchHHHHHHHHHHhHhcCCCeeeEEeEEe-cCCc
Q 004674 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSG-------QGMEEFKNEVLLIAKLQHRNLVKLLGCCT-QRDE 587 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~-~~g~~vavK~l~~~~~-------~~~~~~~~Ei~il~~l~H~nIv~l~g~~~-~~~~ 587 (738)
+.|-.+++||+|+|+.|||+.. .+.+.||+|+-..... ...+...+|.+|.+.|+||.||++++++. +.+.
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtds 542 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDS 542 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeecccc
Confidence 3455678899999999999985 4577899997543211 12345678999999999999999999985 5567
Q ss_pred ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc---CCCceEEEeec
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFG 664 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~vkL~DFG 664 (738)
++-|+||+++.+|+.+|. ....+++.++..|+.||+.||.||.+.. ++|||-||||.||||- .-|.+||.|||
T Consensus 543 FCTVLEYceGNDLDFYLK---QhklmSEKEARSIiMQiVnAL~YLNEik-pPIIHYDLKPgNILLv~GtacGeIKITDFG 618 (775)
T KOG1151|consen 543 FCTVLEYCEGNDLDFYLK---QHKLMSEKEARSIIMQIVNALKYLNEIK-PPIIHYDLKPGNILLVNGTACGEIKITDFG 618 (775)
T ss_pred ceeeeeecCCCchhHHHH---hhhhhhHHHHHHHHHHHHHHHHHHhccC-CCeeeeccCCccEEEecCcccceeEeeecc
Confidence 899999999999999994 4567899999999999999999998876 7899999999999995 45789999999
Q ss_pred CccccCCCccc-----ccccccccccCccchhcccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 665 LARSFGLDQTE-----ANTKRVVGTYGYMSPEYAID----GLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 665 la~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~----~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
+++.+..+... ..+....||..|++||.+.- ..++.|+||||+|||+|+.+-|++||+.+..
T Consensus 619 LSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqs 689 (775)
T KOG1151|consen 619 LSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQS 689 (775)
T ss_pred hhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchh
Confidence 99988654433 22444679999999997743 3588999999999999999999999987654
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.8e-28 Score=255.97 Aligned_cols=204 Identities=27% Similarity=0.424 Sum_probs=167.6
Q ss_pred HhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC----
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD---- 586 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~---- 586 (738)
...++|++.+.||+|+||.||+|.... ++.||+|+++... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~ 83 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEKEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALD 83 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhh
Confidence 345788999999999999999999864 7899999986542 223456788999999999999999999987655
Q ss_pred ------cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEE
Q 004674 587 ------ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (738)
Q Consensus 587 ------~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL 660 (738)
..++|+||+++ ++...+.. ....+++..+..++.||+.||+|||+.+ |+|+||||+||++++++.+||
T Consensus 84 ~~~~~~~~~lv~e~~~~-~l~~~l~~--~~~~~~~~~~~~i~~qi~~aL~~LH~~~---i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 84 FKKDKGAFYLVFEYMDH-DLMGLLES--GLVHFSEDHIKSFMKQLLEGLNYCHKKN---FLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred ccccCCcEEEEEcccCc-cHHHHHhc--CCCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCcEEe
Confidence 68999999987 55555532 2346899999999999999999999987 999999999999999999999
Q ss_pred EeecCccccCCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 661 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
+|||++......... ......++..|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 158 ~dfg~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~ 221 (302)
T cd07864 158 ADFGLARLYNSEESR-PYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221 (302)
T ss_pred CcccccccccCCccc-ccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCC
Confidence 999999876433221 1122345778999998765 45789999999999999999999999653
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=261.42 Aligned_cols=202 Identities=28% Similarity=0.463 Sum_probs=167.1
Q ss_pred hcCCCCccceecccccEeEEEeeec-cccEEEEEEccCC--CCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecC--Ccc
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR--DER 588 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~--~~~ 588 (738)
..++|+..+.||+|+||.||+|... .++.+|+|++... .......+..|+.+++++ +|+||+++++++... ...
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 84 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDI 84 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceE
Confidence 3467888899999999999999976 4788999988543 223345677899999999 999999999998654 358
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
++||||++ ++|..++.. ..+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 85 ~lv~e~~~-~~L~~~~~~----~~~~~~~~~~i~~qi~~~L~~LH~~~---i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 85 YLVFEYME-TDLHAVIRA----NILEDVHKRYIMYQLLKALKYIHSGN---VIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEecccc-cCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 99999997 588777732 26889999999999999999999987 99999999999999999999999999986
Q ss_pred cCCCccc---ccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 669 FGLDQTE---ANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 669 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
....... .......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~ 216 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGT 216 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCC
Confidence 6433221 12233568899999998765 56788999999999999999999998643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.2e-30 Score=266.14 Aligned_cols=208 Identities=25% Similarity=0.331 Sum_probs=183.0
Q ss_pred CCCCccceecccccEeEEEeeecccc-EEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQ-EIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g~-~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
.+++.+..||-|+||.|=++...... .+|+|++++. +....+.+..|-.+|...+.|.||+++..+.+....||.|
T Consensus 420 ~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLm 499 (732)
T KOG0614|consen 420 SDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLM 499 (732)
T ss_pred hhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhH
Confidence 45666778999999999988875543 3788877654 3445667889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
|-|-+|.|-.++. .++.++.....-++..+++|++|||.++ ||.|||||+|++|+.+|-+||.|||+|+.++..
T Consensus 500 EaClGGElWTiLr---dRg~Fdd~tarF~~acv~EAfeYLH~k~---iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 500 EACLGGELWTILR---DRGSFDDYTARFYVACVLEAFEYLHRKG---IIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HhhcCchhhhhhh---hcCCcccchhhhhHHHHHHHHHHHHhcC---ceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 9999999999984 4567889999999999999999999998 999999999999999999999999999988644
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCCccc
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~~~~~l~ 733 (738)
. .+-.+|||+.|.|||++.++.++.++|.||||++++||++|++||...++...+|+|
T Consensus 574 ~---KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~I 631 (732)
T KOG0614|consen 574 R---KTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLI 631 (732)
T ss_pred C---ceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHH
Confidence 3 355589999999999999999999999999999999999999999998887776664
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=256.33 Aligned_cols=195 Identities=29% Similarity=0.473 Sum_probs=164.6
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCCC---cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
.|+..+.||+|+||.||+++.. ++..+|+|++..... ...+++.+|++++++++|+|++++++++.+.+..++|||
T Consensus 26 ~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 105 (317)
T cd06635 26 LFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVME 105 (317)
T ss_pred hhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEe
Confidence 3667789999999999999965 478999999864422 234568889999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++ +|.+.+.. ....+++.++..++.+++.||.|||+.+ ++||||+|+||+++.++.+||+|||++.....
T Consensus 106 ~~~g-~l~~~~~~--~~~~l~~~~~~~i~~~i~~~l~~lH~~~---i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~-- 177 (317)
T cd06635 106 YCLG-SASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASIASP-- 177 (317)
T ss_pred CCCC-CHHHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCcccEEECCCCCEEEecCCCccccCC--
Confidence 9975 66666543 2345899999999999999999999987 99999999999999999999999999875432
Q ss_pred ccccccccccccCccchhccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.....|+..|+|||++. ...++.++||||||++++||++|+.||...
T Consensus 178 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~ 227 (317)
T cd06635 178 ----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 227 (317)
T ss_pred ----cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 12246788999999874 456889999999999999999999998543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.7e-28 Score=254.90 Aligned_cols=203 Identities=20% Similarity=0.236 Sum_probs=152.2
Q ss_pred hcCCCCccceecccccEeEEEeeeccc----cEEEEEEccCCCCcchH-----------HHHHHHHHHhHhcCCCeeeEE
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIEG----QEIAVKRLSKGSGQGME-----------EFKNEVLLIAKLQHRNLVKLL 579 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~g----~~vavK~l~~~~~~~~~-----------~~~~Ei~il~~l~H~nIv~l~ 579 (738)
..+.|++.+.||+|+||.||+|...++ ..+++|........... ....+...+..++|+|+++++
T Consensus 10 ~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~~~~ 89 (294)
T PHA02882 10 TGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIPKYY 89 (294)
T ss_pred CCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCCcEE
Confidence 346789999999999999999997543 45666654322211111 112233345566899999999
Q ss_pred eEEecCCc----ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC
Q 004674 580 GCCTQRDE----RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT 655 (738)
Q Consensus 580 g~~~~~~~----~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~ 655 (738)
+++..... .++++|++.. ++.+.+.. ....++..+..++.|++.||+|||+.+ |+||||||+|||++.+
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~---~~~~~~~~~~~i~~qi~~~l~~lH~~~---iiHrDiKp~Nill~~~ 162 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLVE-NTKEIFKR---IKCKNKKLIKNIMKDMLTTLEYIHEHG---ISHGDIKPENIMVDGN 162 (294)
T ss_pred EeeeEecCCceEEEEEEehhcc-CHHHHHHh---hccCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCC
Confidence 98765442 3677777643 45454422 223578888999999999999999987 9999999999999999
Q ss_pred CceEEEeecCccccCCCcc-----cccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 656 MNPKISDFGLARSFGLDQT-----EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 656 ~~vkL~DFGla~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
+.++|+|||+++.+..... ........||+.|+|||++.+..++.++||||||++++||++|+.||...
T Consensus 163 ~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~ 236 (294)
T PHA02882 163 NRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGF 236 (294)
T ss_pred CcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCcc
Confidence 9999999999987642211 11122346999999999999999999999999999999999999999755
|
|
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.8e-30 Score=226.99 Aligned_cols=110 Identities=48% Similarity=0.780 Sum_probs=80.9
Q ss_pred CCcEEEeecCCCCCccC--CccEEEeecCCceEEEECCCCCeEEEe-cCCCCC-CcceEEEecCCcEEEecCCCCCCCce
Q 004674 91 EGTVTWVANRDAPLSDR--SGVLRINGERNGILVLLNSTNDTVWSS-NSSISA-QKPVAALMESGNLVVKDGKDNNPDNI 166 (738)
Q Consensus 91 ~~t~VW~Anr~~p~~~~--~~~l~~~~~~~g~l~l~~~~~~~~ws~-~~~~~~-~~~~a~l~d~GNlvl~~~~~~~~~~~ 166 (738)
++||||+|||+.|+... .++|.|+ .||+|+|+|..++++|++ ++.+.. ....|+|+|+|||||++.. +++
T Consensus 1 ~~tvvW~an~~~p~~~~s~~~~L~l~--~dGnLvl~~~~~~~iWss~~t~~~~~~~~~~~L~~~GNlvl~d~~----~~~ 74 (114)
T PF01453_consen 1 PRTVVWVANRNSPLTSSSGNYTLILQ--SDGNLVLYDSNGSVIWSSNNTSGRGNSGCYLVLQDDGNLVLYDSS----GNV 74 (114)
T ss_dssp ---------TTEEEEECETTEEEEEE--TTSEEEEEETTTEEEEE--S-TTSS-SSEEEEEETTSEEEEEETT----SEE
T ss_pred CcccccccccccccccccccccceEC--CCCeEEEEcCCCCEEEEecccCCccccCeEEEEeCCCCEEEEeec----ceE
Confidence 37999999999999653 3778887 999999999999999999 555433 5788999999999999863 899
Q ss_pred eeeeccCCCCCcCCCCeeeeeecCCCceEEEEeccCCCCC
Q 004674 167 LWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPA 206 (738)
Q Consensus 167 ~WqSFd~PTDtlLpgq~l~~~~~tg~~~~l~Sw~s~~dps 206 (738)
+||||||||||+||+|+|+.+..++.+..++||++.+|||
T Consensus 75 lW~Sf~~ptdt~L~~q~l~~~~~~~~~~~~~sw~s~~dps 114 (114)
T PF01453_consen 75 LWQSFDYPTDTLLPGQKLGDGNVTGKNDSLTSWSSNTDPS 114 (114)
T ss_dssp EEESTTSSS-EEEEEET--TSEEEEESTSSEEEESS----
T ss_pred EEeecCCCccEEEeccCcccCCCccccceEEeECCCCCCC
Confidence 9999999999999999999988887777899999999997
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=253.94 Aligned_cols=200 Identities=27% Similarity=0.401 Sum_probs=163.4
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCC-CcchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|+..+.||+|+||.||++.... ++.+|+|.+.... ......+.+|+.++.++. |+||+++++++..+...+++|||
T Consensus 5 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~ 84 (288)
T cd06616 5 DLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDEKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMEL 84 (288)
T ss_pred HhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccChHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEec
Confidence 45566789999999999998754 7899999986543 234557889999999996 99999999999998899999999
Q ss_pred CCCCChhHHHhh--cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 595 LPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 595 ~~~gsL~~~l~~--~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
++. ++.++... ......+++..+..++.++++||+|||+.. +++||||||+||+++.++.+||+|||++......
T Consensus 85 ~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~--~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~ 161 (288)
T cd06616 85 MDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDS 161 (288)
T ss_pred ccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcC--CeeccCCCHHHEEEccCCcEEEeecchhHHhccC
Confidence 874 44443211 112356899999999999999999999752 2999999999999999999999999999765432
Q ss_pred cccccccccccccCccchhcccCC---CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDG---LFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~---~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.. .....|+..|+|||.+.+. .++.++||||||+++|||++|+.||..
T Consensus 162 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 212 (288)
T cd06616 162 IA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPK 212 (288)
T ss_pred Cc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchh
Confidence 21 1224578899999998776 689999999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=261.13 Aligned_cols=201 Identities=22% Similarity=0.395 Sum_probs=167.4
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEec----CCcc
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDER 588 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~----~~~~ 588 (738)
.++|+..+.||+|++|.||++.... ++.||+|++.... ....+.+.+|+.++++++|+||+++.+++.. ....
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 83 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFDVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDV 83 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceE
Confidence 3688889999999999999998754 8899999986542 2345677889999999999999999988753 3457
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
++||||+. ++|.+++. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||++..
T Consensus 84 ~lv~e~~~-~~l~~~~~---~~~~~~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 84 YVVMDLME-SDLHHIIH---SDQPLTEEHIRYFLYQLLRGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEehhh-hhHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHEEEcCCCcEEeccccccee
Confidence 99999996 58888773 3345899999999999999999999987 99999999999999999999999999976
Q ss_pred cCCCcccc--cccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 669 FGLDQTEA--NTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 669 ~~~~~~~~--~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
........ ......|+..|+|||.+.+ ..++.++||||||+++|||++|+.||..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~ 214 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPG 214 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCC
Confidence 54322111 1123468899999998865 4688999999999999999999999954
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.6e-28 Score=253.28 Aligned_cols=203 Identities=31% Similarity=0.439 Sum_probs=174.3
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCC---CcchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcceEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~lV 591 (738)
++|...+.||+|++|.||++... +++.+++|++.... ....+.+.+|++++++++ |+||+++++++...+..++|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv 80 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFV 80 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEE
Confidence 46888899999999999999976 58899999986532 233467889999999998 99999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|||+++++|.+++.. ...+++..+..++.|++.||+|||+.+ ++|+||+|+||+++.++.++|+|||++.....
T Consensus 81 ~e~~~~~~L~~~l~~---~~~l~~~~~~~i~~ql~~~l~~Lh~~~---~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~ 154 (280)
T cd05581 81 LEYAPNGELLQYIRK---YGSLDEKCTRFYAAEILLALEYLHSKG---IIHRDLKPENILLDKDMHIKITDFGTAKVLDP 154 (280)
T ss_pred EcCCCCCcHHHHHHH---cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCCHHHeEECCCCCEEecCCccccccCC
Confidence 999999999998854 336999999999999999999999987 99999999999999999999999999886643
Q ss_pred Cccc------------------ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 672 DQTE------------------ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 672 ~~~~------------------~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.... .......++..|+|||.+.+..++.++||||||++++|+++|+.||....
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 155 NSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 2211 11223457889999999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=258.92 Aligned_cols=203 Identities=28% Similarity=0.420 Sum_probs=168.8
Q ss_pred HHHHHHhcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecC
Q 004674 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR 585 (738)
Q Consensus 509 ~~~l~~~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~ 585 (738)
..++....++|+..+.||+|+||.||++... +++.||+|++.... ....+.+.+|+.++++++|+||+++.+++...
T Consensus 9 ~~~~~~~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~ 88 (345)
T cd07877 9 NKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPA 88 (345)
T ss_pred HHHHhhccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchhhHHHHHHHHHHHHHHHcCCCcccceeeeeeec
Confidence 3455667899999999999999999999864 58899999986532 22345678899999999999999999987643
Q ss_pred ------CcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceE
Q 004674 586 ------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659 (738)
Q Consensus 586 ------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vk 659 (738)
...++++|++ +++|.+++. ...+++..+..++.|+++||+|||+.+ |+||||||+||++++++.+|
T Consensus 89 ~~~~~~~~~~lv~~~~-~~~L~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~---ivH~dlkp~NIll~~~~~~k 160 (345)
T cd07877 89 RSLEEFNDVYLVTHLM-GADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELK 160 (345)
T ss_pred ccccccccEEEEehhc-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHHCC---eeecCCChHHEEEcCCCCEE
Confidence 2367888876 778877763 235899999999999999999999988 99999999999999999999
Q ss_pred EEeecCccccCCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 660 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
|+|||++..... ......++..|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 161 l~dfg~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~ 221 (345)
T cd07877 161 ILDFGLARHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGT 221 (345)
T ss_pred Eecccccccccc-----cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 999999876432 1223567889999998876 56889999999999999999999998643
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=250.10 Aligned_cols=196 Identities=24% Similarity=0.352 Sum_probs=161.1
Q ss_pred CCccceecccccEeEEEeeec-cccEEEEEEccCCCC-cchHHHHHHHHHHhHhc-CCCeeeEEeEEecC--CcceEEEe
Q 004674 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQR--DERMLIYE 593 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~--~~~~lV~E 593 (738)
|+..+.||+|+||.||++... +++.+|+|+++.... .......+|+.++.++. |+|++++++++.+. +..++|||
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e 80 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFE 80 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEe
Confidence 556788999999999999865 478999999865422 22234457888888885 99999999999887 78999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++ +|.+.+... ...+++.++..++.|++.||+|||+.+ ++||||+|+||+++. +.+||+|||+++......
T Consensus 81 ~~~~-~l~~~l~~~--~~~~~~~~~~~~~~qi~~~L~~LH~~~---i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~ 153 (282)
T cd07831 81 LMDM-NLYELIKGR--KRPLPEKRVKSYMYQLLKSLDHMHRNG---IFHRDIKPENILIKD-DILKLADFGSCRGIYSKP 153 (282)
T ss_pred cCCc-cHHHHHHhc--cCCCCHHHHHHHHHHHHHHHHHHHHCC---ceecccCHHHEEEcC-CCeEEEecccccccccCC
Confidence 9974 676666432 246899999999999999999999987 999999999999999 999999999998764322
Q ss_pred ccccccccccccCccchhccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
. .....++..|+|||.+. +..++.++|||||||++|||++|+.||...
T Consensus 154 ~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~ 202 (282)
T cd07831 154 P---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGT 202 (282)
T ss_pred C---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCC
Confidence 1 12245788999999764 456788999999999999999999999654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=245.60 Aligned_cols=202 Identities=26% Similarity=0.405 Sum_probs=175.5
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|+..+.||+|++|.||++... +++.+++|++..... ...+++.+|+++++.++|+|++++.+.+......++|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~ 80 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMSEKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEY 80 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCChHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEe
Confidence 4677889999999999999976 478999999865432 4566789999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 595 LPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 595 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
+++++|.+++.... ....+++..+..++.+++.||+|||+.+ ++|+||+|+||++++++.++|+|||++.......
T Consensus 81 ~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~---~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~ 157 (258)
T cd08215 81 ADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRK---ILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157 (258)
T ss_pred cCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCC---EecccCChHHeEEcCCCcEEECCccceeecccCc
Confidence 99999999886532 1367899999999999999999999987 9999999999999999999999999998764432
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
. ......|++.|+|||...+..++.++||||+|+++++|++|+.||...
T Consensus 158 ~--~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~ 206 (258)
T cd08215 158 D--LAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGE 206 (258)
T ss_pred c--eecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCC
Confidence 1 222356888999999998888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=247.49 Aligned_cols=201 Identities=30% Similarity=0.447 Sum_probs=173.1
Q ss_pred CCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|++.+.||+|++|.||++... +++.+++|.+.... .....++.+|+++++.++|+||+++.+++.+....++||||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 80 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEY 80 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhccHHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehh
Confidence 4677889999999999999865 47889999986532 23345778899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcC-CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 595 LPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 595 ~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
+++++|..++.... ....+++..+..++.|++.||+|||+.+ ++|+||+|+||++++++.+||+|||++......
T Consensus 81 ~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~---i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~- 156 (256)
T cd08530 81 APFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQK---ILHRDLKSANILLVANDLVKIGDLGISKVLKKN- 156 (256)
T ss_pred cCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCC---cccCCCCcceEEEecCCcEEEeeccchhhhccC-
Confidence 99999999885522 2356899999999999999999999987 999999999999999999999999999876443
Q ss_pred ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......++..|+|||.+.+..++.++|+||||++++||++|+.||...+
T Consensus 157 ---~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 205 (256)
T cd08530 157 ---MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARS 205 (256)
T ss_pred ---CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 1222457889999999999999999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=252.91 Aligned_cols=199 Identities=29% Similarity=0.400 Sum_probs=167.4
Q ss_pred CCCccceecccccEeEEEeeec----cccEEEEEEccCCC----CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcc
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~----~g~~vavK~l~~~~----~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~ 588 (738)
+|+..+.||+|++|.||++... ++..+|+|.+.+.. ....+.+.+|+.++.++ +|+||+++++.+..+...
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 3667789999999999998743 46789999886432 22345688999999999 599999999999999999
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
++||||+++++|..++.. ...+++..+..++.|+++||+|||+.+ ++||||+|+||+++.++.++|+|||+++.
T Consensus 81 ~lv~e~~~~~~L~~~~~~---~~~~~~~~~~~~~~ql~~~l~~lH~~~---~~H~dl~p~nil~~~~~~~~l~dfg~~~~ 154 (288)
T cd05583 81 HLILDYVNGGELFTHLYQ---REHFTESEVRVYIAEIVLALDHLHQLG---IIYRDIKLENILLDSEGHVVLTDFGLSKE 154 (288)
T ss_pred EEEEecCCCCcHHHHHhh---cCCcCHHHHHHHHHHHHHHHHHHHHCC---eeccCCCHHHeEECCCCCEEEEECccccc
Confidence 999999999999988843 345889999999999999999999987 99999999999999999999999999876
Q ss_pred cCCCcccccccccccccCccchhcccCCC--CCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGL--FSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
........ .....|+..|+|||.+.+.. .+.++||||||++++||++|+.||..
T Consensus 155 ~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 155 FLAEEEER-AYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred cccccccc-cccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 54332211 12246789999999987655 78899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=258.19 Aligned_cols=196 Identities=27% Similarity=0.439 Sum_probs=163.9
Q ss_pred cCCCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC------
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------ 586 (738)
.++|...+.||+|+||.||+|+.. .++.||+|++.... ......+.+|+.++++++|+||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~ 93 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQ 93 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCc
Confidence 478988999999999999999965 58899999986532 223456889999999999999999999986543
Q ss_pred cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCc
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla 666 (738)
.+++|+||+.. +|..+. ...+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.+||+|||++
T Consensus 94 ~~~lv~e~~~~-~l~~~~-----~~~~~~~~~~~~~~qi~~aL~~LH~~~---i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 94 DFYLVMPYMQT-DLQKIM-----GHPLSEDKVQYLVYQMLCGLKYIHSAG---IIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred eEEEEeccccc-CHHHHH-----cCCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 36899999974 665544 235889999999999999999999987 999999999999999999999999998
Q ss_pred cccCCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 667 RSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
+..... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||....
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 764321 122467889999999876 468899999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2e-27 Score=256.57 Aligned_cols=202 Identities=25% Similarity=0.368 Sum_probs=165.0
Q ss_pred CCCCc-cceecccccEeEEEeeec-cccEEEEEEccCCCCcc--------------hHHHHHHHHHHhHhcCCCeeeEEe
Q 004674 517 DNFSE-KNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQG--------------MEEFKNEVLLIAKLQHRNLVKLLG 580 (738)
Q Consensus 517 ~~~~~-~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~--------------~~~~~~Ei~il~~l~H~nIv~l~g 580 (738)
++|.. .+.||+|+||.||++... .++.||+|++....... ...+.+|+++++.++|+||+++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~ 87 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVD 87 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeE
Confidence 45543 467999999999999965 48899999886432211 124778999999999999999999
Q ss_pred EEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEE
Q 004674 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (738)
Q Consensus 581 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL 660 (738)
++..++..++||||++ ++|.+++.. ...+++.....++.|++.||+|||+.+ ++|+||+|+||+++.++.+||
T Consensus 88 ~~~~~~~~~lv~e~~~-~~l~~~l~~---~~~~~~~~~~~~~~ql~~aL~~LH~~~---i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 88 VYVEGDFINLVMDIMA-SDLKKVVDR---KIRLTESQVKCILLQILNGLNVLHKWY---FMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEecCCcEEEEEeccc-cCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecccccHHHeEECCCCCEEE
Confidence 9999999999999997 588887743 345889999999999999999999987 999999999999999999999
Q ss_pred EeecCccccCCCc------------ccccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 661 SDFGLARSFGLDQ------------TEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 661 ~DFGla~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
+|||++....... .........++..|+|||.+.+. .++.++||||||++++||++|+.||....
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~ 238 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGEN 238 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999997654111 01111223467889999998764 47899999999999999999999997543
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3e-28 Score=259.41 Aligned_cols=207 Identities=23% Similarity=0.391 Sum_probs=176.3
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCC---CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS---GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~---~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
.-|..++.||-|+||.|.+++..+ ...+|+|.+++.+ .......+.|-+||...+.+-||+|+-.|.+.+.+|+||
T Consensus 629 SmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVM 708 (1034)
T KOG0608|consen 629 SMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVM 708 (1034)
T ss_pred cceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEE
Confidence 347778899999999999988655 5678999997653 334567889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
||+++|++-.+|. +.+.+++..+..++.++.-|+++.|.-| .|||||||+|||||.+|++||.|||++.-+.-.
T Consensus 709 dYIPGGDmMSLLI---rmgIFeE~LARFYIAEltcAiesVHkmG---FIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 709 DYIPGGDMMSLLI---RMGIFEEDLARFYIAELTCAIESVHKMG---FIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred eccCCccHHHHHH---HhccCHHHHHHHHHHHHHHHHHHHHhcc---ceecccCccceEEccCCceeeeeccccccceec
Confidence 9999999988874 4567899999999999999999999988 999999999999999999999999997544100
Q ss_pred ---------c-------------------------------ccccccccccccCccchhcccCCCCCchhHHHHHHHHHH
Q 004674 673 ---------Q-------------------------------TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVL 712 (738)
Q Consensus 673 ---------~-------------------------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ 712 (738)
. ........+||+.|+|||++....++..+|.||.|||||
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 001112257999999999999999999999999999999
Q ss_pred HHHcCCCCCCCCCCCCC
Q 004674 713 EIICGKKNRGFNHADHD 729 (738)
Q Consensus 713 elltG~~p~~~~~~~~~ 729 (738)
||+.|+.||-...+.+.
T Consensus 863 em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHhhCCCCccCCCCCcc
Confidence 99999999987777654
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=256.63 Aligned_cols=199 Identities=25% Similarity=0.417 Sum_probs=167.2
Q ss_pred HHhcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC---
Q 004674 513 ANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD--- 586 (738)
Q Consensus 513 ~~~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~--- 586 (738)
....++|+..+.||+|+||.||++... ++..||+|++.... ....+.+.+|++++++++|+||+++++++....
T Consensus 11 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 90 (343)
T cd07880 11 WEVPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLD 90 (343)
T ss_pred hccccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccccchHHHHHHHHHHHHHHhcCCCCccceeeeecCCcccc
Confidence 345678999999999999999999864 58899999985432 223456889999999999999999999987554
Q ss_pred ---cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEee
Q 004674 587 ---ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (738)
Q Consensus 587 ---~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DF 663 (738)
..++||||+ +++|..++. ...+++..+..++.||++||+|||+.+ |+||||||+||++++++.+||+||
T Consensus 91 ~~~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~i~~qi~~al~~LH~~g---i~H~dlkp~Nill~~~~~~kl~df 162 (343)
T cd07880 91 RFHDFYLVMPFM-GTDLGKLMK----HEKLSEDRIQFLVYQMLKGLKYIHAAG---IIHRDLKPGNLAVNEDCELKILDF 162 (343)
T ss_pred ccceEEEEEecC-CCCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeec
Confidence 358999998 678887763 245899999999999999999999987 999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
|++...... .....+++.|+|||.+.+ ..++.++|+||||++++++++|+.||...
T Consensus 163 g~~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~ 219 (343)
T cd07880 163 GLARQTDSE-----MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219 (343)
T ss_pred ccccccccC-----ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999765321 122457889999999876 45889999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=222.54 Aligned_cols=197 Identities=27% Similarity=0.451 Sum_probs=164.5
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+|...++||+|.||+|||++..+ +..||+|+.+.. ++.......+|+-+++.++|.|||+++++........+|+||
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrlddddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~ 82 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEF 82 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccCCCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHH
Confidence 45556789999999999999766 678999987543 344456788999999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+.. .|..+. + .-++.++.+....++.|+++||.++|++. +.||||||+|+|++.+|+.|++|||+++.++.+..
T Consensus 83 cdq-dlkkyf-d-slng~~d~~~~rsfmlqllrgl~fchshn---vlhrdlkpqnllin~ngelkladfglarafgipvr 156 (292)
T KOG0662|consen 83 CDQ-DLKKYF-D-SLNGDLDPEIVRSFMLQLLRGLGFCHSHN---VLHRDLKPQNLLINRNGELKLADFGLARAFGIPVR 156 (292)
T ss_pred hhH-HHHHHH-H-hcCCcCCHHHHHHHHHHHHhhhhhhhhhh---hhhccCCcceEEeccCCcEEecccchhhhcCCceE
Confidence 964 455443 2 23456889999999999999999999998 99999999999999999999999999998876542
Q ss_pred cccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRG 722 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~ 722 (738)
-. ...+-|..|++|+++.+. .|+...|+||-|||+.|+....+|..
T Consensus 157 cy--saevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplf 203 (292)
T KOG0662|consen 157 CY--SAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLF 203 (292)
T ss_pred ee--eceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCC
Confidence 22 224568999999999875 58899999999999999986655543
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=249.16 Aligned_cols=199 Identities=29% Similarity=0.440 Sum_probs=168.7
Q ss_pred CCccceecccccEeEEEeeec-cccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++..+...++||||+
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFESEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFM 80 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccccchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEecc
Confidence 456788999999999999875 578899999865432 24567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
++ +|..++... ...+++..+..++.||++||+|||+.+ |+|+||||+||++++++.+||+|||.+........
T Consensus 81 ~~-~l~~~l~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~- 153 (283)
T cd05118 81 DT-DLYKLIKDR--QRGLPESLIKSYLYQLLQGLAFCHSHG---ILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR- 153 (283)
T ss_pred CC-CHHHHHHhh--cccCCHHHHHHHHHHHHHHHHHHHHCC---eeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc-
Confidence 86 777776442 246899999999999999999999988 99999999999999999999999999987654331
Q ss_pred ccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
......++..|+|||.+.+. .++.++||||||+++++|++|+.||....
T Consensus 154 -~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 203 (283)
T cd05118 154 -PYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKS 203 (283)
T ss_pred -cccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 11224577889999998776 78999999999999999999999986543
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=251.33 Aligned_cols=194 Identities=30% Similarity=0.469 Sum_probs=163.1
Q ss_pred CCccceecccccEeEEEeeec-cccEEEEEEccCCCC---cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 519 FSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
|...+.||+|+||.||+|+.. .++.|++|++..... ...+.+.+|+++++.++|+|++++++++.+.+..++||||
T Consensus 23 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~ 102 (313)
T cd06633 23 FVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEY 102 (313)
T ss_pred hhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEec
Confidence 555678999999999999875 478899999864322 2335678899999999999999999999999999999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
+. ++|.+++.. ....+++.++..++.||+.|++|||+.+ ++|+||+|+||++++++.+||+|||++.....
T Consensus 103 ~~-~~l~~~l~~--~~~~l~~~~~~~~~~qi~~al~~LH~~g---i~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 103 CL-GSASDLLEV--HKKPLQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred CC-CCHHHHHHh--cCCCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 96 466666532 2346899999999999999999999987 99999999999999999999999999864321
Q ss_pred cccccccccccCccchhccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.....|+..|+|||++. ...++.++||||||+++|||++|+.||...
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~ 223 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNM 223 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 12356888999999874 456889999999999999999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=253.59 Aligned_cols=202 Identities=28% Similarity=0.435 Sum_probs=163.9
Q ss_pred cCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCC--cchHHHHHHHHHHhHhcCCCeeeEEeEEecCC------
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------ 586 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------ 586 (738)
.++|+..+.||+|++|.||++... +++.+++|++..... .....+.+|++++++++|+||+++++++.+..
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 86 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRK 86 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCCCcchhHHHHHHHHHhcCCCCccchhhheeccccccccc
Confidence 478999999999999999999975 478999998854322 22346788999999999999999999875443
Q ss_pred --cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeec
Q 004674 587 --ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (738)
Q Consensus 587 --~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFG 664 (738)
..++||||+.. +|...+.. ....+++..+..++.|+++||+|||+.+ |+|+||||+||++++++.+||+|||
T Consensus 87 ~~~~~lv~~~~~~-~l~~~~~~--~~~~~~~~~~~~i~~~l~~al~~lH~~~---i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 87 RGSVYMVTPYMDH-DLSGLLEN--PSVKLTESQIKCYMLQLLEGINYLHENH---ILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred CceEEEEEecCCc-CHHHHHhc--cccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEECCCCCEEECcCc
Confidence 35999999975 55555532 2346899999999999999999999988 9999999999999999999999999
Q ss_pred CccccCCCcccc---------cccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 665 LARSFGLDQTEA---------NTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 665 la~~~~~~~~~~---------~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
+++......... ......+++.|+|||.+.+ ..++.++||||||++++||++|+.||..
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~ 229 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCC
Confidence 997654322111 1122456788999998765 4588999999999999999999999864
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-27 Score=247.83 Aligned_cols=199 Identities=27% Similarity=0.454 Sum_probs=165.3
Q ss_pred CCccceecccccEeEEEeeecc-ccEEEEEEccCCCC--cchHHHHHHHHHHhHh---cCCCeeeEEeEEecCCc-----
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQRDE----- 587 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--~~~~~~~~Ei~il~~l---~H~nIv~l~g~~~~~~~----- 587 (738)
|++.+.||+|+||.||++.... ++.+|+|++..... .....+.+|+.++.++ +|+|++++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~ 80 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSEEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELK 80 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccccchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCce
Confidence 5667899999999999999865 88999999864322 2234566788877766 59999999999988776
Q ss_pred ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcc
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 667 (738)
.+++|||+++ +|.+++.... ...+++..+..++.|+++||+|||+.+ ++|+||+|+||++++++.+||+|||++.
T Consensus 81 ~~l~~e~~~~-~l~~~l~~~~-~~~l~~~~~~~~~~~i~~al~~LH~~~---i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 81 LTLVFEHVDQ-DLATYLSKCP-KPGLPPETIKDLMRQLLRGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eEEEehhccc-CHHHHHHHcc-CCCCCHHHHHHHHHHHHHHHHHHHHCC---eeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 7877775422 235899999999999999999999987 9999999999999999999999999997
Q ss_pred ccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
....... .....++..|+|||++.+..++.++||||||++++||++|+.||....
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~ 210 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTS 210 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCC
Confidence 7643321 122457889999999999899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=257.20 Aligned_cols=200 Identities=25% Similarity=0.407 Sum_probs=166.5
Q ss_pred cCCCCccceecccccEeEEEeeec-cccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC-----c
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----E 587 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-----~ 587 (738)
.++|...+.||+|+||.||++... .++.||+|.+... .......+.+|+.+++.++|+||+++++++.... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~ 83 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDNRIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFND 83 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccccchhHHHHHHHHHHHhcCCCCccchHHheecccccccCc
Confidence 357888999999999999999865 4789999998653 2233456788999999999999999999876543 4
Q ss_pred ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcc
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 667 (738)
.++||||+. ++|.+++. ....+++..+..++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||++.
T Consensus 84 ~~lv~e~~~-~~L~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~---i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 84 VYIVYELMD-TDLHQIIR---SSQTLSDDHCQYFLYQLLRGLKYIHSAN---VLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred EEEEEeCCC-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---EecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 799999996 67877773 2356899999999999999999999987 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 668 SFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
...... .......++..|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 654321 11223467889999998865 46889999999999999999999999643
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=251.26 Aligned_cols=199 Identities=24% Similarity=0.416 Sum_probs=164.3
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC-cchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcceEEE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~lV~ 592 (738)
.++|+..+.||+|++|.||++.... ++.||+|.+..... ....++..|+.++.+.. |+||+++++++.+....+++|
T Consensus 14 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~ 93 (296)
T cd06618 14 LNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICM 93 (296)
T ss_pred cchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChHHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEe
Confidence 3677888999999999999999865 88999999865432 23455667777777775 999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC-CCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
||+++ +|..++... ...+++..+..++.||+.||+|||+. + |+||||+|+||++++++.+||+|||++..+..
T Consensus 94 e~~~~-~l~~l~~~~--~~~l~~~~~~~i~~~i~~~l~~lH~~~~---i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 94 ELMST-CLDKLLKRI--QGPIPEDILGKMTVAIVKALHYLKEKHG---VIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eccCc-CHHHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhhCC---EecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 99864 666665432 24689999999999999999999974 5 99999999999999999999999999876543
Q ss_pred CcccccccccccccCccchhcccCCC----CCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGL----FSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.... ....++..|+|||.+.+.. ++.++||||||+++|||++|+.||..
T Consensus 168 ~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 168 SKAK---TRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred CCcc---cCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 2221 2235778999999987553 78899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=236.88 Aligned_cols=199 Identities=23% Similarity=0.381 Sum_probs=161.9
Q ss_pred CccceecccccEeEEEeeecc-ccEEEEEEccCCC-CcchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcceEEEeeCC
Q 004674 520 SEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 520 ~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
+.+..||.|..|+|++++... |..+|||.+.+.. .+..+++...++++.+-+ +|.||+.+|+|.......+-||.|.
T Consensus 95 ~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelMs 174 (391)
T KOG0983|consen 95 ENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELMS 174 (391)
T ss_pred hhHHhhcCCCccceEEEEEcccceEEEEEeecccCCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHHH
Confidence 345679999999999999765 7889999987653 334556777777776664 8999999999999999999999884
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
..++.++. +..+++++.-+-++...+.+||.||-++. .|+|||+||+|||+|+.|++||+|||++.++-....
T Consensus 175 -~C~ekLlk--rik~piPE~ilGk~tva~v~AL~YLKeKH--~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-- 247 (391)
T KOG0983|consen 175 -TCAEKLLK--RIKGPIPERILGKMTVAIVKALYYLKEKH--GVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-- 247 (391)
T ss_pred -HHHHHHHH--HhcCCchHHhhhhhHHHHHHHHHHHHHhc--ceeecccCccceEEccCCCEEeecccccceeecccc--
Confidence 34444442 23456888888899999999999998765 599999999999999999999999999987643322
Q ss_pred cccccccccCccchhcccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
..+..|-+.|||||.+.- ..|+.++||||||+.|+||.||+.||....-
T Consensus 248 -htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~t 299 (391)
T KOG0983|consen 248 -HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKT 299 (391)
T ss_pred -cccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCc
Confidence 223578899999998864 4689999999999999999999999987543
|
|
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=252.74 Aligned_cols=198 Identities=20% Similarity=0.226 Sum_probs=162.4
Q ss_pred cceecccccEeEEEeeeccccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCC
Q 004674 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (738)
.+.+|.|+++.|+++.. .++.||+|++... .....+.+.+|+++++.++|+||+++++++.+.+..+++|||+++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~ 85 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSCSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGS 85 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEeccccchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCC
Confidence 34456666666666655 6889999998654 33455789999999999999999999999999999999999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc-----
Q 004674 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT----- 674 (738)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~----- 674 (738)
|.+++.... ...+++..+..++.|+++||+|||+.+ |+||||||+||+++.++.+||+|||.+........
T Consensus 86 l~~~l~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~---ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 86 CEDLLKTHF-PEGLPELAIAFILKDVLNALDYIHSKG---FIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred HHHHHHHhc-ccCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999986432 345889999999999999999999987 99999999999999999999999998865432111
Q ss_pred cccccccccccCccchhcccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 675 EANTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
........++..|+|||++.. ..++.++||||||++++||++|+.||...
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~ 213 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDM 213 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCC
Confidence 111122456778999999876 35889999999999999999999999743
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >PF00954 S_locus_glycop: S-locus glycoprotein family; InterPro: IPR000858 In Brassicaceae, self-incompatible plants have a self/non-self recognition system, which involves the inability of flowering plants to achieve self-fertilisation | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.4e-28 Score=214.86 Aligned_cols=110 Identities=47% Similarity=1.057 Sum_probs=105.5
Q ss_pred EEeCCCCCcccccccccccCCeeEEEEeeCCceeEEEeecCCCCccceEEEcccCcEEEEEEecCCceeEEEEeecCCCc
Q 004674 232 FRAGSWNGLHWTGVPQLQLNPVYTFEYVSNEKEAFYTYNLSNSSVPSRMVINPAGTVQRYTWMERTKTWTLFSRFSGVTL 311 (738)
Q Consensus 232 ~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~r~~l~~~G~l~~y~w~~~~~~W~~~~~~~~~~~ 311 (738)
||+|+|||..|+|+|++..+..+.+.|+.+++|.+++|.+.+.++++|++||++|++++|.|++..+.|..+|.. |.
T Consensus 1 wrsG~WnG~~f~g~p~~~~~~~~~~~fv~~~~e~~~t~~~~~~s~~~r~~ld~~G~l~~~~w~~~~~~W~~~~~~---p~ 77 (110)
T PF00954_consen 1 WRSGPWNGQRFSGIPEMSSNSLYNYSFVSNNEEVYYTYSLSNSSVLSRLVLDSDGQLQRYIWNESTQSWSVFWSA---PK 77 (110)
T ss_pred CCccccCCeEECCcccccccceeEEEEEECCCeEEEEEecCCCceEEEEEEeeeeEEEEEEEecCCCcEEEEEEe---cc
Confidence 899999999999999999889999999999999999999999999999999999999999999999999999998 99
Q ss_pred ccCcccCCCCCCccccCCCCCCcccccCCCCcCC
Q 004674 312 DQCDSYALCGAYASCNINSNSPECECLQGFVPNS 345 (738)
Q Consensus 312 ~~C~~~g~CG~~g~C~~~~~~~~C~Cl~GF~~~~ 345 (738)
|+||+|+.||+||+|+. ++.+.|+||+||+|++
T Consensus 78 d~Cd~y~~CG~~g~C~~-~~~~~C~Cl~GF~P~n 110 (110)
T PF00954_consen 78 DQCDVYGFCGPNGICNS-NNSPKCSCLPGFEPKN 110 (110)
T ss_pred cCCCCccccCCccEeCC-CCCCceECCCCcCCCc
Confidence 99999999999999985 5678999999999975
|
This is sporophytically controlled by multiple alleles at a single locus (S). There are a total of 50 different S alleles in Brassica oleracea. S-locus glycoproteins, as well as S-receptor kinases, are in linkage with the S-alleles []. Most of the proteins within this family contain apple-like domain (IPR003609 from INTERPRO), which is predicted to possess protein- and/or carbohydrate-binding functions.; GO: 0048544 recognition of pollen |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.4e-27 Score=252.37 Aligned_cols=198 Identities=28% Similarity=0.429 Sum_probs=166.6
Q ss_pred HhcCCCCccceecccccEeEEEeeec-cccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEec-CCcce
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-RDERM 589 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~-~~~~~ 589 (738)
..+++|+..+.||.|+||.||++... +++.||+|++.+. .....+.+.+|+++++.++||||+++.+++.. ....+
T Consensus 7 ~~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 7 EITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFSTPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 35688999999999999999999865 5889999987543 22345678899999999999999999999865 45788
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcccc
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 669 (738)
+++||+ +++|..++. ...+++.....++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||++...
T Consensus 87 lv~e~~-~~~L~~~~~----~~~~~~~~~~~~~~ql~~aL~~LH~~~---iiH~dl~p~Nili~~~~~~~l~dfg~~~~~ 158 (328)
T cd07856 87 FVTELL-GTDLHRLLT----SRPLEKQFIQYFLYQILRGLKYVHSAG---VVHRDLKPSNILINENCDLKICDFGLARIQ 158 (328)
T ss_pred EEeehh-ccCHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEeECCCCCEEeCcccccccc
Confidence 999998 467877763 235788888899999999999999987 999999999999999999999999998754
Q ss_pred CCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 670 GLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
... .....++..|+|||.+.+ ..++.++||||||++++||++|+.||...
T Consensus 159 ~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~ 209 (328)
T cd07856 159 DPQ-----MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGK 209 (328)
T ss_pred CCC-----cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 221 122456889999998766 56899999999999999999999999654
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=255.49 Aligned_cols=201 Identities=27% Similarity=0.416 Sum_probs=170.3
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC-----cce
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----ERM 589 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-----~~~ 589 (738)
+|.+.+.||+|++|.||+++... ++.+++|++.... ....+.+.+|+.+++.++|+||+++++++.... ..+
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~ 80 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVY 80 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccccchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceE
Confidence 47778899999999999999765 8899999986543 334567899999999999999999999988775 789
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcccc
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 669 (738)
+||||+++ +|..++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.++|+|||++...
T Consensus 81 lv~e~~~~-~l~~~l~~---~~~l~~~~~~~i~~~l~~~l~~LH~~g---i~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 81 IVTELMET-DLHKVIKS---PQPLTDDHIQYFLYQILRGLKYLHSAN---VIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEecchhh-hHHHHHhC---CCCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 99999984 78777732 347899999999999999999999988 999999999999999999999999999876
Q ss_pred CCCcc-cccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 670 GLDQT-EANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 670 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
..... ........++..|+|||.+.+. .++.++||||||+++++|++|+.||....
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~ 211 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRD 211 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCC
Confidence 54321 0112234678899999999887 78999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-27 Score=242.24 Aligned_cols=193 Identities=30% Similarity=0.415 Sum_probs=167.6
Q ss_pred ecccccEeEEEeeecc-ccEEEEEEccCCCC---cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCCh
Q 004674 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 525 LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL 600 (738)
||+|+||.||++.... ++.+++|.+..... ...+.+.+|++++++++|+||+++++.+..+...++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 6899999999999764 88999999865432 2456789999999999999999999999999999999999999999
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccc
Q 004674 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680 (738)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~ 680 (738)
.+++... ..+++..+..++.|+++|+.|||+.+ ++|+||+|+||++++++.++|+|||++....... .....
T Consensus 81 ~~~l~~~---~~l~~~~~~~~~~qi~~~l~~lh~~~---~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~ 152 (250)
T cd05123 81 FSHLSKE---GRFSEERARFYAAEIVLALEYLHSLG---IIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNT 152 (250)
T ss_pred HHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHHCC---ceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccC
Confidence 9988432 35899999999999999999999987 9999999999999999999999999997754321 11233
Q ss_pred cccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 681 ~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
..++..|+|||...+...+.++|+||||++++|+++|+.||....
T Consensus 153 ~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 153 FCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred CcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 567889999999988889999999999999999999999996544
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.4e-28 Score=227.62 Aligned_cols=203 Identities=26% Similarity=0.362 Sum_probs=165.5
Q ss_pred cCCCCccceecccccEeEEEeeec-cccEEEEEEccCC-CCcchHHHHHHHHHHhH-hcCCCeeeEEeEEecCCcceEEE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAK-LQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~-~~~~~~~~~~Ei~il~~-l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
.+.......||+|++|.|-+.++. +|+..|+|++... ..+..++..+|+.+..+ ..+|.+|.++|....+...++.|
T Consensus 45 ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcM 124 (282)
T KOG0984|consen 45 ADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICM 124 (282)
T ss_pred hhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeH
Confidence 344555678999999999988875 5889999998654 33445667788887655 47999999999999999999999
Q ss_pred eeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 593 EYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
|.|. .||+.+-.+. .+...+++..+-+|+..+.+||.|||++- .++|||+||+|||++.+|++||+|||++..+..
T Consensus 125 E~M~-tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL--~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~d 201 (282)
T KOG0984|consen 125 ELMD-TSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKL--SVIHRDVKPSNILINYDGQVKICDFGISGYLVD 201 (282)
T ss_pred HHhh-hhHHHHHHHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHh--hhhhccCCcceEEEccCCcEEEcccccceeehh
Confidence 9995 5777664432 34567899999999999999999999864 699999999999999999999999999987643
Q ss_pred CcccccccccccccCccchhcccC----CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAID----GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~----~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
... .....|...|||||.+.. ..|+.|+||||||+.+.||.+++.||+..
T Consensus 202 SiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 202 SIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred hhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 221 112457789999998753 36899999999999999999999999753
|
|
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-27 Score=256.74 Aligned_cols=201 Identities=24% Similarity=0.390 Sum_probs=165.3
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecC---------
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--------- 585 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~--------- 585 (738)
..+|...+.||.|+||.||+|.... ++.||+|++........+.+.+|++++++++||||+++++++...
T Consensus 4 ~~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~ 83 (342)
T cd07854 4 GSRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDPQSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVG 83 (342)
T ss_pred CcceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCCchHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccc
Confidence 3678889999999999999998754 789999998766555667889999999999999999999776543
Q ss_pred -----CcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc-CCCceE
Q 004674 586 -----DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPK 659 (738)
Q Consensus 586 -----~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~vk 659 (738)
...++||||++ ++|..++. ...+++..+..++.||+.||.|||+.+ |+||||||+||+++ ++..+|
T Consensus 84 ~~~~~~~~~lv~e~~~-~~L~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~g---ivH~dikp~Nili~~~~~~~k 155 (342)
T cd07854 84 SLTELNSVYIVQEYME-TDLANVLE----QGPLSEEHARLFMYQLLRGLKYIHSAN---VLHRDLKPANVFINTEDLVLK 155 (342)
T ss_pred cccccceEEEEeeccc-ccHHHHHH----cCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEcCCCceEE
Confidence 34789999997 57877763 235889999999999999999999988 99999999999997 456789
Q ss_pred EEeecCccccCCCcccc-cccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 660 ISDFGLARSFGLDQTEA-NTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 660 L~DFGla~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
|+|||++.......... ......++..|+|||.+.+ ..++.++||||||+++|||++|+.||...
T Consensus 156 l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~ 222 (342)
T cd07854 156 IGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGA 222 (342)
T ss_pred ECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999997654321111 1122457889999998754 56888999999999999999999999643
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-27 Score=247.34 Aligned_cols=198 Identities=31% Similarity=0.482 Sum_probs=168.9
Q ss_pred CCccceecccccEeEEEeeecc-ccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
|+..+.||+|++|.||+++... ++.+++|.+.... ....+.+..|+.++++++|+|++++++++.+.+..++||||+
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~ 80 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDNEEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYC 80 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEeccccccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCc
Confidence 4556789999999999999865 8899999987653 334567889999999999999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
+ ++|.+++.... ..+++..+..++.+++.||+|||+.+ |+||||+|+||++++++.+||+|||.+........
T Consensus 81 ~-~~l~~~i~~~~--~~~~~~~~~~~~~~i~~~l~~LH~~~---i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 81 D-MDLKKYLDKRP--GPLSPNLIKSIMYQLLRGLAYCHSHR---ILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred C-cCHHHHHHhhc--cCCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 8 58988885432 46899999999999999999999987 99999999999999999999999999987643222
Q ss_pred ccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
......++..|+|||.+.+. .++.++||||||++++||++|+.||...
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~ 202 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGD 202 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCc
Confidence 11223457789999998776 7899999999999999999999998654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.2e-27 Score=252.46 Aligned_cols=200 Identities=26% Similarity=0.361 Sum_probs=162.8
Q ss_pred CCCccceecccccEeEEEeeecc---ccEEEEEEccCCC--CcchHHHHHHHHHHhHh-cCCCeeeEEeEEecC----Cc
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR----DE 587 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~---g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~----~~ 587 (738)
+|+..+.||+|+||.||++.... +..+|+|++.... ....+.+.+|+.+++++ +|+||+++++.+... ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~ 80 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE 80 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEeccccccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCc
Confidence 46777899999999999999653 6789999886432 22346778899999999 599999999875432 34
Q ss_pred ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcc
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 667 (738)
.++++||+. ++|...+. ....+++..+..++.||+.||+|||+.+ |+||||||+||++++++.+||+|||+++
T Consensus 81 ~~~~~e~~~-~~L~~~l~---~~~~~~~~~~~~~~~qi~~aL~~LH~~g---ivH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 81 LYLYEELME-ADLHQIIR---SGQPLTDAHFQSFIYQILCGLKYIHSAN---VLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred EEEEEeccc-CCHHHHHh---cCCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 688889886 57887773 3456899999999999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcc--cccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 668 SFGLDQT--EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 668 ~~~~~~~--~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.+..... ........|+..|+|||++.+ ..++.++||||+|+++++|++|+.||...
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~ 213 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGK 213 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCC
Confidence 6543221 111233578999999998765 56899999999999999999999998653
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=243.99 Aligned_cols=202 Identities=27% Similarity=0.381 Sum_probs=162.8
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC-cchHHHHHHHHHHhH-hcCCCeeeEEeEEecCCcceEEEe
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAK-LQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~il~~-l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
++.+.+..||.|+||+|+|..++. |+.+|||+++.... ...+++..|.+...+ -+.||||+++|.+..+...++-||
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCME 143 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNIEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICME 143 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccchHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHH
Confidence 344556789999999999998765 89999999976543 456678888876655 479999999999999999999999
Q ss_pred eCCCCChhHHHh--hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 594 YLPNKSLDYFIF--DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 594 y~~~gsL~~~l~--~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
.|. .||+.+-. ...+...+++.-.-+|..-..+||.||-+.- .|||||+||+||||+..|.+||+|||++..+..
T Consensus 144 LMd-~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~l--kiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 144 LMD-ISLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEEL--KIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHh-hhHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHh--hhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 995 46654421 1123345788888888889999999997754 699999999999999999999999999876532
Q ss_pred CcccccccccccccCccchhcccC--CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAID--GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
. .......|...|||||.+.. ..|+.++||||||+.|+|+.||+-|+...
T Consensus 221 S---iAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w 272 (361)
T KOG1006|consen 221 S---IAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKW 272 (361)
T ss_pred H---HHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchH
Confidence 2 22223568889999999864 35899999999999999999999999654
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-27 Score=252.15 Aligned_cols=198 Identities=23% Similarity=0.309 Sum_probs=161.2
Q ss_pred ceeccc--ccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEG--GFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G--~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
..||+| +||+||++... .++.||+|++.... ....+.+++|+.+++.++||||+++++++..++..++||||+.+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~ 83 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAY 83 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCHHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccC
Confidence 357776 89999999875 58999999986432 22346788999999999999999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc-
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA- 676 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~- 676 (738)
++|.+++.... ...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+|++||+.+..........
T Consensus 84 ~~l~~~l~~~~-~~~~~~~~~~~~~~qi~~aL~~lH~~~---ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 84 GSANSLLKTYF-PEGMSEALIGNILFGALRGLNYLHQNG---YIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99998885432 235889999999999999999999987 9999999999999999999999998654332111100
Q ss_pred ----cccccccccCccchhcccCC--CCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 677 ----NTKRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 677 ----~~~~~~gt~~y~aPE~~~~~--~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
......++..|+|||++.+. .++.++||||||++++||++|+.||...
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~ 213 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDM 213 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 01112345679999998764 4789999999999999999999999654
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=239.00 Aligned_cols=199 Identities=26% Similarity=0.338 Sum_probs=166.4
Q ss_pred cCCCCc-cceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHh-cCCCeeeEEeEEec----CCcc
Q 004674 516 TDNFSE-KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ----RDER 588 (738)
Q Consensus 516 ~~~~~~-~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~----~~~~ 588 (738)
+++|++ .+.||-|-.|.|..+..+. ++.+|+|++... ...++|+++.-.. .|+|||.++++++. ....
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds-----~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcL 134 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS-----PKARREVELHWMASGHPHIVSIIDVYENSYQGRKCL 134 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC-----HHHHhHhhhhhhhcCCCceEEeehhhhhhccCceee
Confidence 455654 3579999999999888754 788999998543 4567888876665 69999999999754 3457
Q ss_pred eEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc---CCCceEEEeecC
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGL 665 (738)
Q Consensus 589 ~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~vkL~DFGl 665 (738)
.+|||.|+||.|...+.+ .....+++.++-.|+.||..|++|||+.+ |.||||||+|+|.. .+-.+||+|||+
T Consensus 135 LiVmE~meGGeLfsriq~-~g~~afTErea~eI~~qI~~Av~~lH~~n---IAHRDlKpENLLyt~t~~na~lKLtDfGF 210 (400)
T KOG0604|consen 135 LIVMECMEGGELFSRIQD-RGDQAFTEREASEIMKQIGLAVRYLHSMN---IAHRDLKPENLLYTTTSPNAPLKLTDFGF 210 (400)
T ss_pred EeeeecccchHHHHHHHH-cccccchHHHHHHHHHHHHHHHHHHHhcc---hhhccCChhheeeecCCCCcceEeccccc
Confidence 899999999999988855 34567999999999999999999999987 99999999999995 456799999999
Q ss_pred ccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
|+.-. .......-+-|+.|.|||++....|+..+|+||+||++|-|+||..||..++.
T Consensus 211 AK~t~---~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg 268 (400)
T KOG0604|consen 211 AKETQ---EPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_pred ccccC---CCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCC
Confidence 98632 23444557889999999999999999999999999999999999999986654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.3e-27 Score=246.05 Aligned_cols=198 Identities=30% Similarity=0.406 Sum_probs=165.4
Q ss_pred CCccceecccccEeEEEeeecc-ccEEEEEEccCCCC-cchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcceEEEeeC
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
|++.+.||+|++|.||+|+..+ ++.|++|++..... .......+|+..+++++ |+|++++++++..++..++||||+
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~ 80 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM 80 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccchhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC
Confidence 5567899999999999999864 78899999865432 22234457899999999 999999999999999999999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~ 675 (738)
+++|.+.+.... ...+++..+..++.|++.+|.|||+.+ ++|+||+|+||++++++.++|+|||++........
T Consensus 81 -~~~l~~~~~~~~-~~~~~~~~~~~~~~~l~~~l~~Lh~~~---i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~- 154 (283)
T cd07830 81 -EGNLYQLMKDRK-GKPFSESVIRSIIYQILQGLAHIHKHG---FFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP- 154 (283)
T ss_pred -CCCHHHHHHhcc-cccCCHHHHHHHHHHHHHHHHHHHHCC---cccCCCChhhEEEcCCCCEEEeecccceeccCCCC-
Confidence 788888775432 346899999999999999999999987 99999999999999999999999999976543211
Q ss_pred ccccccccccCccchhccc-CCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 676 ANTKRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~-~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
.....++..|+|||++. ...++.++|+||||++++||++|+.||...
T Consensus 155 --~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~ 202 (283)
T cd07830 155 --YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGS 202 (283)
T ss_pred --cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCC
Confidence 12245788999999875 455789999999999999999999998543
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-27 Score=249.92 Aligned_cols=194 Identities=31% Similarity=0.483 Sum_probs=163.2
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
.|+..+.||+|++|.||+|+... +..+++|.+... .....+++.+|+++++.++|+|++++.+++......++|||
T Consensus 16 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 95 (308)
T cd06634 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVME 95 (308)
T ss_pred HHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEE
Confidence 36667789999999999999754 778999988643 22234567889999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+. ++|.+.+... ...+++.++..++.|++.||.|||+.+ ++||||+|+||+++.++.+||+|||++......
T Consensus 96 ~~~-~~l~~~~~~~--~~~l~~~~~~~~~~~l~~~l~~LH~~~---i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~- 168 (308)
T cd06634 96 YCL-GSASDLLEVH--KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA- 168 (308)
T ss_pred ccC-CCHHHHHHHc--CCCCCHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHhEEECCCCcEEECCcccceeecCc-
Confidence 997 5776666432 345889999999999999999999987 999999999999999999999999998764321
Q ss_pred ccccccccccccCccchhccc---CCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYAI---DGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~---~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
....++..|+|||.+. ...++.++||||||++++||++|+.||..
T Consensus 169 -----~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 216 (308)
T cd06634 169 -----NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFN 216 (308)
T ss_pred -----ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcc
Confidence 2246788999999874 35678899999999999999999999854
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-27 Score=243.11 Aligned_cols=200 Identities=30% Similarity=0.403 Sum_probs=164.3
Q ss_pred CCCccceecccccEeEEEeeecc-ccEEEEEEccCC-----CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG-----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~-----~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
+|.+.+.||+|+||.||++.... +..+++|.++.. ......++..|+.++++++||||+++++++.+....++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 46778899999999999998654 344555554321 122334567889999999999999999999999999999
Q ss_pred EeeCCCCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 592 YEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
|||+++++|.+++... .....+++..+..++.|+++||+|||+.+ ++|+||+|+||++++ +.+||+|||++....
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~---i~h~~l~~~nili~~-~~~~l~d~g~~~~~~ 156 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRR---ILHRDLKAKNIFLKN-NLLKIGDFGVSRLLM 156 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcC---ccccCCChhheEeec-CCEeecccCceeecC
Confidence 9999999999888642 23457899999999999999999999987 999999999999975 569999999987654
Q ss_pred CCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.... ......|+..|+|||.+.+..++.++|+||||+++++|++|+.||..
T Consensus 157 ~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~ 207 (260)
T cd08222 157 GSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEG 207 (260)
T ss_pred CCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 3221 12224578899999999888899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-27 Score=273.47 Aligned_cols=198 Identities=30% Similarity=0.493 Sum_probs=157.7
Q ss_pred HhcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCC-CcchHHHHHHHHHHhHhcCCCeeeEEeEEec-------
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ------- 584 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~-~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~------- 584 (738)
+-..+|++++.||+||||.|||++.+ +|+.+|||++.... ......+.+|+.++++|+|||||+++..+.+
T Consensus 476 RY~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~~ 555 (1351)
T KOG1035|consen 476 RYLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKASDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELTV 555 (1351)
T ss_pred hHhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCchHHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCcccc
Confidence 34567889999999999999999965 69999999987653 3344578899999999999999998741100
Q ss_pred --------------------------------------------------------------------------------
Q 004674 585 -------------------------------------------------------------------------------- 584 (738)
Q Consensus 585 -------------------------------------------------------------------------------- 584 (738)
T Consensus 556 ~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS~ 635 (1351)
T KOG1035|consen 556 LEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTSD 635 (1351)
T ss_pred ccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCcccccccccccccccccc
Confidence
Q ss_pred ------------------------C--------CcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Q 004674 585 ------------------------R--------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632 (738)
Q Consensus 585 ------------------------~--------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL 632 (738)
+ ...||=||||+..+|++++....... .-...++++.+|++||+|+
T Consensus 636 ~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~--~~d~~wrLFreIlEGLaYI 713 (1351)
T KOG1035|consen 636 SEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS--QRDEAWRLFREILEGLAYI 713 (1351)
T ss_pred cCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch--hhHHHHHHHHHHHHHHHHH
Confidence 0 11367799999988888884332111 4677889999999999999
Q ss_pred HhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC----------------CCcccccccccccccCccchhcccCC
Q 004674 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG----------------LDQTEANTKRVVGTYGYMSPEYAIDG 696 (738)
Q Consensus 633 H~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~ 696 (738)
|+.+ ||||||||.||+|+++..|||+|||+|.... ...........+||.-|+|||++.+.
T Consensus 714 H~~g---iIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 714 HDQG---IIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HhCc---eeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 9998 9999999999999999999999999998721 00111133447899999999999764
Q ss_pred ---CCCchhHHHHHHHHHHHHHc
Q 004674 697 ---LFSVKSDVFSFGVLVLEIIC 716 (738)
Q Consensus 697 ---~~t~ksDVwS~Gvil~ellt 716 (738)
.|+.|+|+||+||||+||+-
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y 813 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY 813 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc
Confidence 49999999999999999975
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=269.84 Aligned_cols=145 Identities=28% Similarity=0.398 Sum_probs=129.4
Q ss_pred CCCCccceecccccEeEEEeeec-cccEEEEEEccCCCC---cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~---~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|.+.++||+|+||.||++... .++.||+|++..... ...+.+.+|+.++..++|+||+++++.+......+|||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 67888999999999999999976 488999999865422 23467889999999999999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcc
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 667 (738)
||+++++|..++.. ...+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~---~~~l~~~~~~~i~~qil~aL~yLH~~g---IiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHI---YGYFDEEMAVKYISEVALALDYLHRHG---IIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHHhCC---EEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 99999999998853 345888999999999999999999987 9999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=253.37 Aligned_cols=197 Identities=28% Similarity=0.451 Sum_probs=166.5
Q ss_pred hcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCc----
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE---- 587 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~---- 587 (738)
..++|+..+.||+|++|.||++.... ++.||+|++... .....+.+.+|+.++++++|+|++++.+++...+.
T Consensus 13 ~~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 13 VPDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred ccCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccchhhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 46789999999999999999999764 788999988643 22234567789999999999999999988766554
Q ss_pred --ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecC
Q 004674 588 --RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (738)
Q Consensus 588 --~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl 665 (738)
.++|+||+ +++|.+++.. ..+++..+..++.|+++||+|||+.+ |+||||+|+||++++++.+||+|||+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~----~~l~~~~~~~~~~ql~~aL~~LH~~g---i~H~dlkp~Nill~~~~~~kL~dfg~ 164 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKC----QKLSDDHIQFLVYQILRGLKYIHSAG---IIHRDLKPSNIAVNEDCELKILDFGL 164 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCCHHHeEECCCCCEEEccccc
Confidence 89999998 5688887742 46899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
+...... .....++..|+|||.+.+ ..++.++||||||++++|+++|+.||...
T Consensus 165 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~ 219 (343)
T cd07851 165 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGS 219 (343)
T ss_pred ccccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 9865322 223467889999998865 46789999999999999999999999643
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=257.65 Aligned_cols=212 Identities=28% Similarity=0.446 Sum_probs=180.8
Q ss_pred CHHHHHHhcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHh-cCCCeeeEEeEEec-
Q 004674 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ- 584 (738)
Q Consensus 508 ~~~~l~~~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~- 584 (738)
.+..+...++.|++.+.||+|.+|.||+++.. +++..|+|++... ....+++..|.++++.. .|||++.++|++..
T Consensus 10 ~~~~lpdp~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~-~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~ 88 (953)
T KOG0587|consen 10 DLSSLPDPADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPT-EDEEEEIELEYNMLKKYSHHPNVATFYGAFIKK 88 (953)
T ss_pred chhhCCCCCCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCC-ccccHHHHHHHHHHHhccCCCCcceEEEEEEEe
Confidence 44555667788999999999999999999965 4788899988544 34567888999999887 69999999999864
Q ss_pred ----CCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEE
Q 004674 585 ----RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (738)
Q Consensus 585 ----~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL 660 (738)
+++++||||||.+|+..+++.... ...+.|..+..|+..++.|+.+||... ++|||||-.||||+.++.|||
T Consensus 89 ~~~~~DqLWLVMEfC~gGSVTDLVKn~~-g~rl~E~~IaYI~re~lrgl~HLH~nk---viHRDikG~NiLLT~e~~VKL 164 (953)
T KOG0587|consen 89 DPGNGDQLWLVMEFCGGGSVTDLVKNTK-GNRLKEEWIAYILREILRGLAHLHNNK---VIHRDIKGQNVLLTENAEVKL 164 (953)
T ss_pred cCCCCCeEEEEeeccCCccHHHHHhhhc-ccchhhHHHHHHHHHHHHHHHHHhhcc---eeeecccCceEEEeccCcEEE
Confidence 456999999999999999987655 678999999999999999999999987 999999999999999999999
Q ss_pred EeecCccccCCCcccccccccccccCccchhcccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 661 ~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
.|||++..+... ........||+.|||||++... .|+.++|+||||++..||--|..|+-..++
T Consensus 165 vDFGvSaQldsT--~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHP 233 (953)
T KOG0587|consen 165 VDFGVSAQLDST--VGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHP 233 (953)
T ss_pred eeeeeeeeeecc--cccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcch
Confidence 999999876543 3334447899999999998643 478899999999999999999999865444
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=236.31 Aligned_cols=180 Identities=23% Similarity=0.193 Sum_probs=152.8
Q ss_pred cccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCChhHHHhh
Q 004674 528 GGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606 (738)
Q Consensus 528 G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 606 (738)
|.+|.||++... +++.+|+|++.... .+.+|...+....||||+++++++.+.+..++||||+++++|.+++..
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~-----~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 78 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS-----EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISK 78 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh-----hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHH
Confidence 889999999975 47899999986542 234455555566799999999999999999999999999999988854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccccccccC
Q 004674 607 TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686 (738)
Q Consensus 607 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 686 (738)
. ..+++..+..++.|++.||+|||+.+ ++||||||+||+++.++.++++|||.+....... ....++..
T Consensus 79 ~---~~l~~~~~~~~~~ql~~~l~~lH~~~---i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~ 147 (237)
T cd05576 79 F---LNIPEECVKRWAAEMVVALDALHREG---IVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENM 147 (237)
T ss_pred h---cCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCcc
Confidence 2 35899999999999999999999987 9999999999999999999999999886553221 12345678
Q ss_pred ccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 687 y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
|+|||.+.+..++.++||||+|++++||++|+.|+..
T Consensus 148 y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~ 184 (237)
T cd05576 148 YCAPEVGGISEETEACDWWSLGAILFELLTGKTLVEC 184 (237)
T ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhc
Confidence 9999999888899999999999999999999987754
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=255.79 Aligned_cols=204 Identities=22% Similarity=0.318 Sum_probs=153.1
Q ss_pred hcCCCCccceecccccEeEEEeee-----------------ccccEEEEEEccCCCCcchH--------------HHHHH
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGML-----------------IEGQEIAVKRLSKGSGQGME--------------EFKNE 563 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~-----------------~~g~~vavK~l~~~~~~~~~--------------~~~~E 563 (738)
..++|++.++||+|+||.||+|.. ..++.||||++........+ ....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 357899999999999999999964 23467999998644322222 23447
Q ss_pred HHHHhHhcCCCe-----eeEEeEEec--------CCcceEEEeeCCCCChhHHHhhcC---------------------C
Q 004674 564 VLLIAKLQHRNL-----VKLLGCCTQ--------RDERMLIYEYLPNKSLDYFIFDTT---------------------R 609 (738)
Q Consensus 564 i~il~~l~H~nI-----v~l~g~~~~--------~~~~~lV~Ey~~~gsL~~~l~~~~---------------------~ 609 (738)
+.++.+++|.++ ++++++|.. +...+|||||+++++|.+++.... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777788877655 667777653 346899999999999999886421 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccccccccCccc
Q 004674 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689 (738)
Q Consensus 610 ~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~a 689 (738)
...+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||++........ .......+++.|+|
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~---ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~g~~tp~Y~a 378 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIG---IVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN-FNPLYGMLDPRYSP 378 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCC---eecCCCchHhEEECCCCcEEEEeCcCccccccCCc-cCccccCCCcceeC
Confidence 123567888899999999999999987 99999999999999999999999999976533211 11111234789999
Q ss_pred hhcccCCCC----------------------CchhHHHHHHHHHHHHHcCCC-CCC
Q 004674 690 PEYAIDGLF----------------------SVKSDVFSFGVLVLEIICGKK-NRG 722 (738)
Q Consensus 690 PE~~~~~~~----------------------t~ksDVwS~Gvil~elltG~~-p~~ 722 (738)
||.+..... ..+.||||+||+++||++|.. |+.
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCcc
Confidence 998754321 124799999999999999985 553
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=253.99 Aligned_cols=197 Identities=27% Similarity=0.358 Sum_probs=164.6
Q ss_pred hcCCCCccceecccccEeEEEeeec-cccEEEEEEccCCCCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEEE
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
.++.|+....+|.|+|+.|-++... .++..++|++.+... +..+|+.++... +|+||+++.+.+.++.+.++||
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~----~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~ 395 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD----DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVM 395 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc----ccccccchhhhhcCCCcceeecceecCCceeeeee
Confidence 4577888888999999999888865 478899999976622 334566565555 7999999999999999999999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE-cCCCceEEEeecCccccCC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL-DNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl-~~~~~vkL~DFGla~~~~~ 671 (738)
|.+.++-+.+.+.... ... .++.+|+.+|+.|+.|||+++ +|||||||+|||+ ++.++++|+|||.++....
T Consensus 396 e~l~g~ell~ri~~~~---~~~-~e~~~w~~~lv~Av~~LH~~g---vvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~ 468 (612)
T KOG0603|consen 396 ELLDGGELLRRIRSKP---EFC-SEASQWAAELVSAVDYLHEQG---VVHRDLKPGNILLDGSAGHLRLTYFGFWSELER 468 (612)
T ss_pred hhccccHHHHHHHhcc---hhH-HHHHHHHHHHHHHHHHHHhcC---eeecCCChhheeecCCCCcEEEEEechhhhCch
Confidence 9999998877774322 223 677789999999999999988 9999999999999 6899999999999987643
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~ 727 (738)
. ...-+-|..|.|||++....|++++|+||||++||||++|+.||.....+
T Consensus 469 ~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 469 S-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred h-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 3 22245688999999999999999999999999999999999999754433
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=7e-27 Score=232.42 Aligned_cols=202 Identities=25% Similarity=0.375 Sum_probs=171.3
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~l 590 (738)
.++|..+..||+|+|+.|..+.+.. .+.+|+|++++. ..+...=.+.|-.+.... +||.+|.+..++..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 3678888999999999999999865 678999988654 222333345566666554 79999999999999999999
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
|.||+++|+|-..+ .+...++++.+.-+...|.-||.|||+.+ ||.||||.+|+|+|..+++||.|+|+.+.--
T Consensus 329 vieyv~ggdlmfhm---qrqrklpeeharfys~ei~lal~flh~rg---iiyrdlkldnvlldaeghikltdygmcke~l 402 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHM---QRQRKLPEEHARFYSAEICLALNFLHERG---IIYRDLKLDNVLLDAEGHIKLTDYGMCKEGL 402 (593)
T ss_pred EEEEecCcceeeeh---hhhhcCcHHHhhhhhHHHHHHHHHHhhcC---eeeeeccccceEEccCCceeecccchhhcCC
Confidence 99999999986555 44556899999999999999999999998 9999999999999999999999999997532
Q ss_pred CCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
.+ ...+..++||+.|+|||++.+..|...+|.|++||+++||+.|+.||+.-.
T Consensus 403 ~~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 403 GP--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred CC--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 22 234556999999999999999999999999999999999999999997543
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.5e-26 Score=205.34 Aligned_cols=115 Identities=44% Similarity=0.724 Sum_probs=101.6
Q ss_pred CccCCCCeEeeCCCeEEEEeecCCCCCceeEEEeeeecCCCcEEEeecCCCCCccCCccEEEeecCCceEEEECCCCCeE
Q 004674 52 QSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTV 131 (738)
Q Consensus 52 ~~l~~~~~l~s~~g~f~lgF~~~~~~~~~yl~iw~~~~~~~t~VW~Anr~~p~~~~~~~l~~~~~~~g~l~l~~~~~~~~ 131 (738)
++|.+|++|+|+++.|++|||++......+.+|||.+++ +++||.|||+.| ....+.|.|+ .||+|+|+|.+|.++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q~~dgnlv~~~~~~-~~~vW~snt~~~-~~~~~~l~l~--~dGnLvl~~~~g~~v 77 (116)
T cd00028 2 NPLSSGQTLVSSGSLFELGFFKLIMQSRDYNLILYKGSS-RTVVWVANRDNP-SGSSCTLTLQ--SDGNLVIYDGSGTVV 77 (116)
T ss_pred cCcCCCCEEEeCCCcEEEecccCCCCCCeEEEEEEeCCC-CeEEEECCCCCC-CCCCEEEEEe--cCCCeEEEcCCCcEE
Confidence 578899999999999999999997654589999999887 899999999998 3446788888 899999999999999
Q ss_pred EEecCCCCCCcceEEEecCCcEEEecCCCCCCCceeeeeccCC
Q 004674 132 WSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYP 174 (738)
Q Consensus 132 ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~WqSFd~P 174 (738)
|+|++.......+|+|+|+|||||++.. ++++|||||||
T Consensus 78 W~S~~~~~~~~~~~~L~ddGnlvl~~~~----~~~~W~Sf~~P 116 (116)
T cd00028 78 WSSNTTRVNGNYVLVLLDDGNLVLYDSD----GNFLWQSFDYP 116 (116)
T ss_pred EEecccCCCCceEEEEeCCCCEEEECCC----CCEEEcCCCCC
Confidence 9999765356678899999999999874 78999999999
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.9e-26 Score=227.72 Aligned_cols=199 Identities=34% Similarity=0.460 Sum_probs=171.7
Q ss_pred CCccceecccccEeEEEeeecc-ccEEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
|...+.||+|++|.||++...+ ++.+++|.+...... ..+.+.+|++.+++++|+|++++++++......++++||++
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTEKQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCE 80 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccchHHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccC
Confidence 4556789999999999999876 789999998765544 56789999999999999999999999999899999999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccc
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~ 676 (738)
+++|.+++..... .+++..+..++.+++.++.+||+.+ ++|+||+|+||+++.++.++|+|||.+.........
T Consensus 81 ~~~L~~~~~~~~~--~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~- 154 (225)
T smart00221 81 GGDLFDYLRKKGG--KLSEEEARFYLRQILEALEYLHSLG---IVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA- 154 (225)
T ss_pred CCCHHHHHHhccc--CCCHHHHHHHHHHHHHHHHHHHhCC---eecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-
Confidence 9999998854321 1789999999999999999999987 999999999999999999999999999876543211
Q ss_pred cccccccccCccchhcc-cCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 677 NTKRVVGTYGYMSPEYA-IDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~-~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
......++..|++||.+ ....++.++|||+||++++||++|+.||..
T Consensus 155 ~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12235678899999998 667788899999999999999999999955
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=260.32 Aligned_cols=203 Identities=33% Similarity=0.464 Sum_probs=167.3
Q ss_pred cCCCCccceecccccEeEEEeeecc--------ccEEEEEEccCCCC-cchHHHHHHHHHHhHh-cCCCeeeEEeEEecC
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR 585 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~--------g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~ 585 (738)
.++..+.+.||+|.||.|++|.... ...||||.++.... ...+.+..|+++|+.+ +|+||+.++|+|...
T Consensus 295 ~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~ 374 (609)
T KOG0200|consen 295 RENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASSSEKKDLMSELNVLKELGKHPNIVNLLGACTQD 374 (609)
T ss_pred hhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCcHHHHHHHHHHHHHHHhcCCcchhhheeeeccC
Confidence 3444555699999999999998531 34699999875533 3567899999999998 699999999999999
Q ss_pred CcceEEEeeCCCCChhHHHhhcC------C-----C--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE
Q 004674 586 DERMLIYEYLPNKSLDYFIFDTT------R-----S--KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (738)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~------~-----~--~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 652 (738)
...++|+||+..|+|..++...+ . . ..+...+.+.++.|||.||+||++.. ++||||..+|||+
T Consensus 375 ~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~---~vHRDLAaRNVLi 451 (609)
T KOG0200|consen 375 GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVP---CVHRDLAARNVLI 451 (609)
T ss_pred CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCC---ccchhhhhhhEEe
Confidence 99999999999999999997655 0 0 24889999999999999999999987 9999999999999
Q ss_pred cCCCceEEEeecCccccCCCcccccccccc--cccCccchhcccCCCCCchhHHHHHHHHHHHHHcCC-CCCC
Q 004674 653 DNTMNPKISDFGLARSFGLDQTEANTKRVV--GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK-KNRG 722 (738)
Q Consensus 653 ~~~~~vkL~DFGla~~~~~~~~~~~~~~~~--gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~-~p~~ 722 (738)
.++..+||+|||+|+.......-... ... -...|||||.+....|+.|+|||||||+||||++-. .|+.
T Consensus 452 ~~~~~~kIaDFGlar~~~~~~~y~~~-~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp 523 (609)
T KOG0200|consen 452 TKNKVIKIADFGLARDHYNKDYYRTK-SSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYP 523 (609)
T ss_pred cCCCEEEEccccceeccCCCCceEec-CCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCC
Confidence 99999999999999965433221111 111 245699999999999999999999999999999865 5553
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=244.65 Aligned_cols=196 Identities=27% Similarity=0.378 Sum_probs=165.2
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCC--------cchHHHHHHHHHHhHhc---CCCeeeEEeEEec
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--------QGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQ 584 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~--------~~~~~~~~Ei~il~~l~---H~nIv~l~g~~~~ 584 (738)
.+|...+.+|.|+||.|+.+.++. ..+|+||.+.+..- ...-..-.||.||..++ |+||++++++|++
T Consensus 561 s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEd 640 (772)
T KOG1152|consen 561 SDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFED 640 (772)
T ss_pred ccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeec
Confidence 357888999999999999999875 56789998765321 11223557999999997 9999999999999
Q ss_pred CCcceEEEeeCC-CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEee
Q 004674 585 RDERMLIYEYLP-NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663 (738)
Q Consensus 585 ~~~~~lV~Ey~~-~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DF 663 (738)
.+.+||+||-.. +-+|.+++ .....+++.+...|+.||+.|+++||+++ |||||||-+|+.++.+|.+||+||
T Consensus 641 dd~yyl~te~hg~gIDLFd~I---E~kp~m~E~eAk~IFkQV~agi~hlh~~~---ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 641 DDYYYLETEVHGEGIDLFDFI---EFKPRMDEPEAKLIFKQVVAGIKHLHDQG---IVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred CCeeEEEecCCCCCcchhhhh---hccCccchHHHHHHHHHHHhccccccccC---ceecccccccEEEecCCeEEEeec
Confidence 999999999864 45666777 33456899999999999999999999998 999999999999999999999999
Q ss_pred cCccccCCCcccccccccccccCccchhcccCCCCC-chhHHHHHHHHHHHHHcCCCCCC
Q 004674 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS-VKSDVFSFGVLVLEIICGKKNRG 722 (738)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t-~ksDVwS~Gvil~elltG~~p~~ 722 (738)
|.|...... ....++||.+|.|||++.+..|- ..-|||++|++||.++....||.
T Consensus 715 gsaa~~ksg----pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSG----PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCC----CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 999875432 34458999999999999988764 45799999999999999988874
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-28 Score=231.18 Aligned_cols=204 Identities=25% Similarity=0.453 Sum_probs=163.6
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccC--CCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecC--------
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-------- 585 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~--~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~-------- 585 (738)
..|+...+||+|.||.||+++..+ ++.||+|+.-- ..........+|+++|..++|+|++.++..|...
T Consensus 17 ~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r 96 (376)
T KOG0669|consen 17 SKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDR 96 (376)
T ss_pred hHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccccc
Confidence 345667789999999999999765 77788886522 1222345567899999999999999999988542
Q ss_pred CcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecC
Q 004674 586 DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (738)
Q Consensus 586 ~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGl 665 (738)
...+|||.+++. +|.-++.+ ....++..++.+++.++..||.|+|... |+|||+||.|+||+.++.+||+|||+
T Consensus 97 ~t~ylVf~~ceh-DLaGlLsn--~~vr~sls~Ikk~Mk~Lm~GL~~iHr~k---ilHRDmKaaNvLIt~dgilklADFGl 170 (376)
T KOG0669|consen 97 ATFYLVFDFCEH-DLAGLLSN--RKVRFSLSEIKKVMKGLMNGLYYIHRNK---ILHRDMKAANVLITKDGILKLADFGL 170 (376)
T ss_pred ceeeeeHHHhhh-hHHHHhcC--ccccccHHHHHHHHHHHHHHHHHHHHhh---HHhhcccHhhEEEcCCceEEeecccc
Confidence 237999999975 45555533 2245889999999999999999999876 99999999999999999999999999
Q ss_pred ccccCCCccc--ccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 666 ARSFGLDQTE--ANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 666 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
++.+...... ......+-|..|++||.+.+ ..|+++.|||.-|||+.||+++.+.+..+..
T Consensus 171 ar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnte 234 (376)
T KOG0669|consen 171 ARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTE 234 (376)
T ss_pred ccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChH
Confidence 9877543222 22233456999999999887 5699999999999999999999998876654
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.7e-27 Score=238.55 Aligned_cols=200 Identities=23% Similarity=0.296 Sum_probs=166.5
Q ss_pred hcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhc-CC-----CeeeEEeEEecCCc
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HR-----NLVKLLGCCTQRDE 587 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~-----nIv~l~g~~~~~~~ 587 (738)
.+.+|.+..++|+|.||.|-++.... +..||+|+++.. ....+..+-|+++++++. +. -+|++.+++...++
T Consensus 87 l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V-~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrgh 165 (415)
T KOG0671|consen 87 LTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV-DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGH 165 (415)
T ss_pred cccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH-HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCc
Confidence 36788999999999999999988655 678999998533 334566788999999994 22 36788888999999
Q ss_pred ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-------------
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN------------- 654 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~------------- 654 (738)
.+||+|.+ +-|+.+++... .-.+++...++.|+.|+++++++||+.+ ++|.||||+|||+.+
T Consensus 166 iCivfell-G~S~~dFlk~N-~y~~fpi~~ir~m~~QL~~sv~fLh~~k---l~HTDLKPENILfvss~~~~~~~~k~~~ 240 (415)
T KOG0671|consen 166 ICIVFELL-GLSTFDFLKEN-NYIPFPIDHIRHMGYQLLESVAFLHDLK---LTHTDLKPENILFVSSEYFKTYNPKKKV 240 (415)
T ss_pred eEEEEecc-ChhHHHHhccC-CccccchHHHHHHHHHHHHHHHHHHhcc---eeecCCChheEEEeccceEEEeccCCcc
Confidence 99999998 45788888442 2357899999999999999999999987 999999999999932
Q ss_pred -------CCceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 655 -------TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 655 -------~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
+..+||+|||.|...... ...++.|..|+|||++.+-.++.++||||+||||.|+.+|...|...+
T Consensus 241 ~~~r~~ks~~I~vIDFGsAtf~~e~-----hs~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHe 313 (415)
T KOG0671|consen 241 CFIRPLKSTAIKVIDFGSATFDHEH-----HSTIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHE 313 (415)
T ss_pred ceeccCCCcceEEEecCCcceeccC-----cceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCC
Confidence 234899999999864322 244788999999999999999999999999999999999999997654
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.2e-28 Score=232.87 Aligned_cols=206 Identities=25% Similarity=0.377 Sum_probs=166.5
Q ss_pred CccceecccccEeEEEeeec-cccEEEEEEccCCC--CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC-----cceEE
Q 004674 520 SEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD-----ERMLI 591 (738)
Q Consensus 520 ~~~~~LG~G~fG~Vykg~~~-~g~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~-----~~~lV 591 (738)
+..+.||.|+||.||.+... +|+.||+|++...- -...+.+-+|+++++-.+|.|++..++...... +.|++
T Consensus 56 ~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~ 135 (449)
T KOG0664|consen 56 QPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQNLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVL 135 (449)
T ss_pred CCCCcccccceeEEEeccCCCCccchhHhhcchHHHHHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHH
Confidence 34568999999999998864 58999999885432 224567889999999999999999888765443 46788
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
.|.|. .+|..++ ...+.++-..+..+..||++||+|||+.+ |.||||||.|+|++.+-.+||+|||+++....
T Consensus 136 TELmQ-SDLHKII---VSPQ~Ls~DHvKVFlYQILRGLKYLHsA~---ILHRDIKPGNLLVNSNCvLKICDFGLARvee~ 208 (449)
T KOG0664|consen 136 TELMQ-SDLHKII---VSPQALTPDHVKVFVYQILRGLKYLHTAN---ILHRDIKPGNLLVNSNCILKICDFGLARTWDQ 208 (449)
T ss_pred HHHHH-hhhhhee---ccCCCCCcchhhhhHHHHHhhhHHHhhcc---hhhccCCCccEEeccCceEEecccccccccch
Confidence 88885 4566665 34456888888889999999999999988 99999999999999999999999999997655
Q ss_pred CcccccccccccccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCCCCccc
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~~~~~~~~l~ 733 (738)
++....+ ..+-|..|+|||++++. .|+.++||||.|||+.||+-.|..|....+-+-.++|
T Consensus 209 d~~~hMT-qEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lI 270 (449)
T KOG0664|consen 209 RDRLNMT-HEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMI 270 (449)
T ss_pred hhhhhhH-HHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHH
Confidence 4443333 35668899999999985 5899999999999999999999999877664444443
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=7.7e-25 Score=223.38 Aligned_cols=186 Identities=32% Similarity=0.466 Sum_probs=164.3
Q ss_pred ccEeEEEeeecc-ccEEEEEEccCCCCcc-hHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCChhHHHhh
Q 004674 529 GFGPVYKGMLIE-GQEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606 (738)
Q Consensus 529 ~fG~Vykg~~~~-g~~vavK~l~~~~~~~-~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~ 606 (738)
+||.||++.... ++.+++|++....... .+.+.+|++.+++++|+|++++++.+......++++||+++++|..++..
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~ 80 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKKRERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKK 80 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccHHHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHh
Confidence 589999999875 8899999987665444 68899999999999999999999999999999999999999999998854
Q ss_pred cCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccccccccC
Q 004674 607 TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686 (738)
Q Consensus 607 ~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~ 686 (738)
.. .+++..+..++.+++.++++||+.+ ++|+||+|+||++++++.++|+|||.+....... ......++..
T Consensus 81 ~~---~~~~~~~~~~~~~l~~~l~~lh~~~---i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~ 151 (244)
T smart00220 81 RG---RLSEDEARFYARQILSALEYLHSNG---IIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPE 151 (244)
T ss_pred cc---CCCHHHHHHHHHHHHHHHHHHHHcC---eecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcC
Confidence 32 2889999999999999999999987 9999999999999999999999999998764332 2233567889
Q ss_pred ccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 687 y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
|++||.+.+..++.++||||||++++||++|+.||..
T Consensus 152 ~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 152 YMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred CCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999988899999999999999999999999865
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.6e-25 Score=252.65 Aligned_cols=200 Identities=24% Similarity=0.328 Sum_probs=140.3
Q ss_pred hcCCCCccceecccccEeEEEeeecc-----ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeE------Ee
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC------CT 583 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-----g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~------~~ 583 (738)
..++|+..+.||+|+||.||+|++.+ +..||+|++..... .+....| .+....+.++..++.. ..
T Consensus 130 ~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~--~e~~~~e--~l~~~~~~~~~~~~~~~~~~~~~~ 205 (566)
T PLN03225 130 KKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGA--VEIWMNE--RVRRACPNSCADFVYGFLEPVSSK 205 (566)
T ss_pred ccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccch--hHHHHHH--HHHhhchhhHHHHHHhhhcccccc
Confidence 45789999999999999999999754 57899998754321 1111111 1112222222222111 24
Q ss_pred cCCcceEEEeeCCCCChhHHHhhcCCC-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 004674 584 QRDERMLIYEYLPNKSLDYFIFDTTRS-----------------KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (738)
Q Consensus 584 ~~~~~~lV~Ey~~~gsL~~~l~~~~~~-----------------~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 646 (738)
.+...++||||+++++|.+++...... .......+..++.||+.||+|||+++ |+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~g---IiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTG---IVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCC---EEeCcCC
Confidence 566799999999999999888542110 01123345678999999999999987 9999999
Q ss_pred CCcEEEcC-CCceEEEeecCccccCCCcccccccccccccCccchhcccCC----------------------CCCchhH
Q 004674 647 ASNVLLDN-TMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG----------------------LFSVKSD 703 (738)
Q Consensus 647 p~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~t~ksD 703 (738)
|+|||+++ ++.+||+|||+|+.+...... ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 579999999999865432221 22346789999999965322 2345679
Q ss_pred HHHHHHHHHHHHcCCCCCC
Q 004674 704 VFSFGVLVLEIICGKKNRG 722 (738)
Q Consensus 704 VwS~Gvil~elltG~~p~~ 722 (738)
||||||+||||+++..+++
T Consensus 362 VwSlGviL~el~~~~~~~~ 380 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSD 380 (566)
T ss_pred cHHHHHHHHHHHhCcCCCc
Confidence 9999999999999776543
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.4e-25 Score=213.02 Aligned_cols=198 Identities=24% Similarity=0.420 Sum_probs=166.0
Q ss_pred hcCCCCccceecccccEeEEEeee-ccccEEEEEEccCCCCcchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCc--ceE
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDE--RML 590 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~--~~l 590 (738)
..++|++.+++|+|.++.||.|.. .+...++||+++.. ..+.+++|+++|..++ ||||+++++...++.. ..|
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV---kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaL 112 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV---KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSL 112 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH---HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchh
Confidence 457899999999999999999985 45778999998643 3578899999999997 9999999999987654 689
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCceEEEeecCcccc
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSF 669 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla~~~ 669 (738)
|+||+.+.+...+- +.++..++..++.++++||.|+|+.| |+|||+||+|+++|. .-.++|+|+|+|..+
T Consensus 113 iFE~v~n~Dfk~ly------~tl~d~dIryY~~elLkALdyCHS~G---ImHRDVKPhNvmIdh~~rkLrlIDWGLAEFY 183 (338)
T KOG0668|consen 113 IFEYVNNTDFKQLY------PTLTDYDIRYYIYELLKALDYCHSMG---IMHRDVKPHNVMIDHELRKLRLIDWGLAEFY 183 (338)
T ss_pred HhhhhccccHHHHh------hhhchhhHHHHHHHHHHHHhHHHhcC---cccccCCcceeeechhhceeeeeecchHhhc
Confidence 99999998775543 24777888999999999999999998 999999999999985 567999999999876
Q ss_pred CCCcccccccccccccCccchhcccC-CCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 004674 670 GLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (738)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~ 727 (738)
..... ....+.+..|--||.+.. ..|+..-|+|||||+|.+|+..+.||....+.
T Consensus 184 Hp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN 239 (338)
T KOG0668|consen 184 HPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDN 239 (338)
T ss_pred CCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCC
Confidence 54332 222456778889998876 45888899999999999999999999876654
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-24 Score=194.52 Aligned_cols=113 Identities=45% Similarity=0.747 Sum_probs=99.6
Q ss_pred CccCCCCeEeeCCCeEEEEeecCCCCCceeEEEeeeecCCCcEEEeecCCCCCccCCccEEEeecCCceEEEECCCCCeE
Q 004674 52 QSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTV 131 (738)
Q Consensus 52 ~~l~~~~~l~s~~g~f~lgF~~~~~~~~~yl~iw~~~~~~~t~VW~Anr~~p~~~~~~~l~~~~~~~g~l~l~~~~~~~~ 131 (738)
+.|..+++|+|+++.|++|||.+... ..+.+|||++.+ +++||+|||+.|+.++ +.|.++ .||+|+|+|.+|.++
T Consensus 2 ~~l~~~~~l~s~~~~f~~G~~~~~~q-~dgnlV~~~~~~-~~~vW~snt~~~~~~~-~~l~l~--~dGnLvl~~~~g~~v 76 (114)
T smart00108 2 NTLSSGQTLVSGNSLFELGFFTLIMQ-NDYNLILYKSSS-RTVVWVANRDNPVSDS-CTLTLQ--SDGNLVLYDGDGRVV 76 (114)
T ss_pred cccCCCCEEecCCCcEeeeccccCCC-CCEEEEEEECCC-CcEEEECCCCCCCCCC-EEEEEe--CCCCEEEEeCCCCEE
Confidence 56888999999999999999998654 678999999887 8999999999998763 788887 899999999999999
Q ss_pred EEecCCCCCCcceEEEecCCcEEEecCCCCCCCceeeeeccC
Q 004674 132 WSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDY 173 (738)
Q Consensus 132 ws~~~~~~~~~~~a~l~d~GNlvl~~~~~~~~~~~~WqSFd~ 173 (738)
|+|++.......+|+|+|+|||||++.. ++++||||||
T Consensus 77 W~S~t~~~~~~~~~~L~ddGnlvl~~~~----~~~~W~Sf~~ 114 (114)
T smart00108 77 WSSNTTGANGNYVLVLLDDGNLVIYDSD----GNFLWQSFDY 114 (114)
T ss_pred EEecccCCCCceEEEEeCCCCEEEECCC----CCEEeCCCCC
Confidence 9999763456678899999999999874 7899999997
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-25 Score=223.69 Aligned_cols=216 Identities=24% Similarity=0.344 Sum_probs=174.5
Q ss_pred HHHHHhcCCCCccceecccccEeEEEeeecc------ccEEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEE
Q 004674 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (738)
Q Consensus 510 ~~l~~~~~~~~~~~~LG~G~fG~Vykg~~~~------g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~ 582 (738)
+++....+++.....+-+|.||.||+|.+.+ .+.|-+|.++....+ ....+..|.-.+..+.|||+..+.+++
T Consensus 277 ~~l~v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~iQv~~~L~es~lly~~sH~nll~V~~V~ 356 (563)
T KOG1024|consen 277 QELTVQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQIQVNLLLQESMLLYGASHPNLLSVLGVS 356 (563)
T ss_pred HhhhhhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccHHHHHHHHHHHHHHhcCcCCCccceeEEE
Confidence 3444445667777789999999999997543 345677777554332 345678888889999999999999998
Q ss_pred ecC-CcceEEEeeCCCCChhHHHh-----hcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC
Q 004674 583 TQR-DERMLIYEYLPNKSLDYFIF-----DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (738)
Q Consensus 583 ~~~-~~~~lV~Ey~~~gsL~~~l~-----~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 656 (738)
.+. ...+.+|.++.-|+|..++. +....+.+...+...++.|++.||+|||.++ +||.||..+|.+|++..
T Consensus 357 ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~---ViHkDiAaRNCvIdd~L 433 (563)
T KOG1024|consen 357 IEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHG---VIHKDIAARNCVIDDQL 433 (563)
T ss_pred eeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcC---cccchhhhhcceehhhe
Confidence 654 55788999999999999997 3333456778888899999999999999998 99999999999999999
Q ss_pred ceEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc-CCCCCCCCCCCC
Q 004674 657 NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADH 728 (738)
Q Consensus 657 ~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt-G~~p~~~~~~~~ 728 (738)
++||+|=.+++.+-.............+..||+||.+.+..|+.++|||||||+||||+| |+.|+..-+|.+
T Consensus 434 qVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 434 QVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred eEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHH
Confidence 999999999998755554443333445789999999999999999999999999999876 778876555544
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.8e-25 Score=245.32 Aligned_cols=199 Identities=30% Similarity=0.436 Sum_probs=159.7
Q ss_pred CCccceecccccEe-EEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHh-cCCCeeeEEeEEecCCcceEEEeeCC
Q 004674 519 FSEKNKLGEGGFGP-VYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 519 ~~~~~~LG~G~fG~-Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
|...+.+|.|+.|+ ||+|.. ++++||||++-.. ...-..+|+..|+.- +|||||++++.-.+++..||..|.|.
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e---~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~ 586 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEE---FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELCA 586 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhH---hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHhh
Confidence 34456789998876 589998 7899999998532 234567899999887 59999999999888899999999995
Q ss_pred CCChhHHHhhc-CCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-----CCceEEEeecCccccC
Q 004674 597 NKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----TMNPKISDFGLARSFG 670 (738)
Q Consensus 597 ~gsL~~~l~~~-~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-----~~~vkL~DFGla~~~~ 670 (738)
.+|++++... ...........+.+..|+++||++||+.+ ||||||||+||||+. ...++|+|||+++.+.
T Consensus 587 -~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHsl~---iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~ 662 (903)
T KOG1027|consen 587 -CSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHSLK---IVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLA 662 (903)
T ss_pred -hhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHhcc---cccccCCCceEEEEccCCCcceeEEecccccccccC
Confidence 6899988653 11111121445678899999999999977 999999999999965 2578999999999987
Q ss_pred CCcccc-cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcC-CCCCCCCC
Q 004674 671 LDQTEA-NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG-KKNRGFNH 725 (738)
Q Consensus 671 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG-~~p~~~~~ 725 (738)
..+... ......||.+|+|||++....-+.++||+|+|||+|+.++| .+||+-.-
T Consensus 663 ~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~ 719 (903)
T KOG1027|consen 663 GGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL 719 (903)
T ss_pred CCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH
Confidence 654432 23446799999999999988888899999999999999988 89997543
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.6e-24 Score=210.36 Aligned_cols=195 Identities=29% Similarity=0.386 Sum_probs=159.5
Q ss_pred CCCCccceecccccEeEEEeee-ccccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC------c
Q 004674 517 DNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD------E 587 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~-~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~------~ 587 (738)
..|..+..+|.|.- .|-.+.. ..+++||+|++... .....++..+|..++..++|+||++++.++.-.. .
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e 95 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQNQTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQE 95 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCccccCccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHh
Confidence 45666778888887 4444432 24789999987543 3345567789999999999999999999986443 4
Q ss_pred ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcc
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 667 (738)
.|+|||+|. .+|...+. -.++-.++..|..|++.|++|||+.+ |+||||||+||++..+..+||.|||+|+
T Consensus 96 ~y~v~e~m~-~nl~~vi~-----~elDH~tis~i~yq~~~~ik~lhs~~---IihRdLkPsnivv~~~~~lKi~dfg~ar 166 (369)
T KOG0665|consen 96 VYLVMELMD-ANLCQVIL-----MELDHETISYILYQMLCGIKHLHSAG---IIHRDLKPSNIVVNSDCTLKILDFGLAR 166 (369)
T ss_pred HHHHHHhhh-hHHHHHHH-----HhcchHHHHHHHHHHHHHHHHHHhcc---eeecccCcccceecchhheeeccchhhc
Confidence 799999995 57777764 23677888899999999999999988 9999999999999999999999999998
Q ss_pred ccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
..... -.....+.|..|+|||++.+..+.+.+||||+||++.||++|+-.|...
T Consensus 167 ~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~ 220 (369)
T KOG0665|consen 167 TEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGK 220 (369)
T ss_pred ccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCc
Confidence 75433 2233367789999999999988999999999999999999999888643
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.1e-24 Score=226.04 Aligned_cols=209 Identities=20% Similarity=0.244 Sum_probs=173.4
Q ss_pred CHHHHHHhcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhc------CCCeeeEEe
Q 004674 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ------HRNLVKLLG 580 (738)
Q Consensus 508 ~~~~l~~~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~------H~nIv~l~g 580 (738)
.+..-+.....|.+....|+|-|++|.+|.... |+.||||++..+. ...+.=..|+++|++|+ .-|.++++-
T Consensus 423 rv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE-~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r 501 (752)
T KOG0670|consen 423 RVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNE-VMHKTGLKELEILKKLNDADPEDKFHCLRLFR 501 (752)
T ss_pred EEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecch-HHhhhhhHHHHHHHHhhccCchhhhHHHHHHH
Confidence 334444455778888889999999999998755 8899999996542 22344467999999995 358899999
Q ss_pred EEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-CceE
Q 004674 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPK 659 (738)
Q Consensus 581 ~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~vk 659 (738)
.|...+++|||||-+ ..+|.++|......-.|....+..++.|+.-||..|-..+ |+|.||||.|||+++. ..+|
T Consensus 502 ~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~---vlHaDIKPDNiLVNE~k~iLK 577 (752)
T KOG0670|consen 502 HFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCG---VLHADIKPDNILVNESKNILK 577 (752)
T ss_pred HhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcC---eeecccCccceEeccCcceee
Confidence 999999999999987 4689999987777777888999999999999999998877 9999999999999865 5689
Q ss_pred EEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 660 L~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
|+|||.|........ +. ..-+.-|.|||++.+.+|+...|+||.||.||||.||+..|....
T Consensus 578 LCDfGSA~~~~enei---tP-YLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~T 639 (752)
T KOG0670|consen 578 LCDFGSASFASENEI---TP-YLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRT 639 (752)
T ss_pred eccCccccccccccc---cH-HHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCC
Confidence 999999987643322 22 334668999999999999999999999999999999999986543
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.6e-22 Score=198.36 Aligned_cols=183 Identities=38% Similarity=0.628 Sum_probs=157.6
Q ss_pred ecccccEeEEEeeecc-ccEEEEEEccCCCCc-chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCChhH
Q 004674 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ-GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDY 602 (738)
Q Consensus 525 LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~-~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~ 602 (738)
||+|.+|.||++.... ++.+++|++...... ..+.+.+|++.++.++|++++++++++......++++|++++++|..
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~ 80 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKD 80 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchhHHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHH
Confidence 6899999999999865 889999998655332 35689999999999999999999999999899999999999999999
Q ss_pred HHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCceEEEeecCccccCCCccccccccc
Q 004674 603 FIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARSFGLDQTEANTKRV 681 (738)
Q Consensus 603 ~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla~~~~~~~~~~~~~~~ 681 (738)
++.... ..+++..+..++.++++++++||+.+ ++|+||+|.||+++. ++.++|+|||.+........ .....
T Consensus 81 ~~~~~~--~~~~~~~~~~~~~~l~~~l~~lh~~~---~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~ 153 (215)
T cd00180 81 LLKENE--GKLSEDEILRILLQILEGLEYLHSNG---IIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTI 153 (215)
T ss_pred HHHhcc--CCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcc
Confidence 885421 35889999999999999999999987 999999999999999 89999999999986543321 12224
Q ss_pred ccccCccchhcccCC-CCCchhHHHHHHHHHHHH
Q 004674 682 VGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEI 714 (738)
Q Consensus 682 ~gt~~y~aPE~~~~~-~~t~ksDVwS~Gvil~el 714 (738)
.+...|++||..... ..+.+.|+|++|+++++|
T Consensus 154 ~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 154 VGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred cCCCCccChhHhcccCCCCchhhhHHHHHHHHHH
Confidence 567899999998877 888999999999999998
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-23 Score=214.12 Aligned_cols=205 Identities=27% Similarity=0.446 Sum_probs=169.1
Q ss_pred HHHhcCCCCccceecccccEeEEEeeecc----ccEEEEEEccCCCCcchHHHHHHHHHHhHhc-CCCeeeEEeEEecCC
Q 004674 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRD 586 (738)
Q Consensus 512 l~~~~~~~~~~~~LG~G~fG~Vykg~~~~----g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~ 586 (738)
.....+.|..+++||.|.|++||++.+.. .+.||+|.+...+ ....+.+|+++|..+. +.||+++.+++..++
T Consensus 31 ~p~~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts--~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 31 IPFISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS--SPSRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc--CchHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 44556778899999999999999998654 5679999986543 3467899999999985 999999999999999
Q ss_pred cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-CCceEEEeecC
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFGL 665 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGl 665 (738)
+..+|+||+++....++... ++..++..++..+++||+++|..| ||||||||+|+|.+. .+.-.|.|||+
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~------l~~~~i~~Yl~~ll~Al~~~h~~G---IvHRDiKpsNFL~n~~t~rg~LvDFgL 179 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS------LSLAEIRWYLRNLLKALAHLHKNG---IVHRDIKPSNFLYNRRTQRGVLVDFGL 179 (418)
T ss_pred eeEEEecccCccCHHHHHhc------CCHHHHHHHHHHHHHHhhhhhccC---ccccCCCccccccccccCCceEEechh
Confidence 99999999999999888743 678899999999999999999998 999999999999975 56789999999
Q ss_pred ccccCCCc-------------c-----------------------------cccccccccccCccchhcccC-CCCCchh
Q 004674 666 ARSFGLDQ-------------T-----------------------------EANTKRVVGTYGYMSPEYAID-GLFSVKS 702 (738)
Q Consensus 666 a~~~~~~~-------------~-----------------------------~~~~~~~~gt~~y~aPE~~~~-~~~t~ks 702 (738)
|......+ . ....-...||+||+|||++.. ...+.++
T Consensus 180 A~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~Qttai 259 (418)
T KOG1167|consen 180 AQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAI 259 (418)
T ss_pred HHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCcc
Confidence 87221000 0 000011469999999999865 5678999
Q ss_pred HHHHHHHHHHHHHcCCCCCCCCCCC
Q 004674 703 DVFSFGVLVLEIICGKKNRGFNHAD 727 (738)
Q Consensus 703 DVwS~Gvil~elltG~~p~~~~~~~ 727 (738)
||||.|||++-+++++.||....++
T Consensus 260 Diws~GVI~Lslls~~~PFf~a~dd 284 (418)
T KOG1167|consen 260 DIWSAGVILLSLLSRRYPFFKAKDD 284 (418)
T ss_pred ceeeccceeehhhccccccccCccc
Confidence 9999999999999999999765544
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.4e-23 Score=204.15 Aligned_cols=195 Identities=22% Similarity=0.381 Sum_probs=155.5
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHh-cCCCeeeEEeE-EecCCcceEEE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGC-CTQRDERMLIY 592 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~-~~~~~~~~lV~ 592 (738)
.+.|.+.+.||+|.||.+.++.++. ...+++|-+... ....++|.+|..---.| .|.||+.-+++ ++..+.+.+++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p-~tt~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~q 101 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRP-QTTQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQ 101 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcc-hhhHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEee
Confidence 3678888999999999999999876 567899987544 33567888887754444 58999887765 55566788999
Q ss_pred eeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc--CCCceEEEeecCccccC
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NTMNPKISDFGLARSFG 670 (738)
Q Consensus 593 Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~~vkL~DFGla~~~~ 670 (738)
||++.|+|..-+. ...+-+....+++.|++.|+.|||++. +||||||.+||||- +...+||+|||+.+..+
T Consensus 102 E~aP~gdL~snv~----~~GigE~~~K~v~~ql~SAi~fMHskn---lVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g 174 (378)
T KOG1345|consen 102 EFAPRGDLRSNVE----AAGIGEANTKKVFAQLLSAIEFMHSKN---LVHRDLKAENILIFDADFYRVKLCDFGLTRKVG 174 (378)
T ss_pred ccCccchhhhhcC----cccccHHHHHHHHHHHHHHHHHhhccc---hhhcccccceEEEecCCccEEEeeecccccccC
Confidence 9999999976652 245778888999999999999999998 99999999999993 45589999999998755
Q ss_pred CCcccccccccccccCccchhcccCC-----CCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDG-----LFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.... ...-+..|.+||..... ...+.+|||.||+|++.+++|+.|+..
T Consensus 175 ~tV~-----~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQk 227 (378)
T KOG1345|consen 175 TTVK-----YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQK 227 (378)
T ss_pred ceeh-----hhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchh
Confidence 3322 12335679999976543 245678999999999999999999974
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=5.5e-22 Score=207.35 Aligned_cols=132 Identities=27% Similarity=0.381 Sum_probs=106.4
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhc--------CCCeeeEEeEEec---
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ--------HRNLVKLLGCCTQ--- 584 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~--------H~nIv~l~g~~~~--- 584 (738)
..|.+.++||=|.|++||++.... .+.||+|+.+.. ..-.+....||++|++++ ..+||+|++.|..
T Consensus 78 gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSA-qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp 156 (590)
T KOG1290|consen 78 GRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSA-QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP 156 (590)
T ss_pred ceEEEEEeccccccceeEEEeeccCCeEEEEEEEehh-hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC
Confidence 567788999999999999998654 678999987432 334566788999999984 2479999999864
Q ss_pred -CCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc
Q 004674 585 -RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (738)
Q Consensus 585 -~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (738)
+.+.+||+|++....| .+|... .-+.++...+.+|+.||+.||.|||.++ +|||.||||+|||+.
T Consensus 157 NG~HVCMVfEvLGdnLL-klI~~s-~YrGlpl~~VK~I~~qvL~GLdYLH~ec--gIIHTDlKPENvLl~ 222 (590)
T KOG1290|consen 157 NGQHVCMVFEVLGDNLL-KLIKYS-NYRGLPLSCVKEICRQVLTGLDYLHREC--GIIHTDLKPENVLLC 222 (590)
T ss_pred CCcEEEEEehhhhhHHH-HHHHHh-CCCCCcHHHHHHHHHHHHHHHHHHHHhc--CccccCCCcceeeee
Confidence 4579999999955444 444332 2345899999999999999999999988 699999999999994
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=9.9e-22 Score=210.21 Aligned_cols=166 Identities=19% Similarity=0.203 Sum_probs=128.6
Q ss_pred HhcCCCCccceecccccEeEEEeeec--cccEEEEEEccCCC-----CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCC
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLI--EGQEIAVKRLSKGS-----GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD 586 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~~~--~g~~vavK~l~~~~-----~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~ 586 (738)
...++|...+.||+|+||.||++... +++.+|||++.... ....+.+.+|++++++++|+|+++.+.. ..
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~---~~ 91 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLA---TG 91 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEE---cC
Confidence 34578999999999999999999865 46778999865331 1234568999999999999999853322 24
Q ss_pred cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCcEEEcCCCceEEEeecC
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNTMNPKISDFGL 665 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL-kp~NILl~~~~~vkL~DFGl 665 (738)
..+|||||+++++|.... .. . ...++.+++++|+|||+.+ |+|||| ||+|||++.++.+||+|||+
T Consensus 92 ~~~LVmE~~~G~~L~~~~----~~---~---~~~~~~~i~~aL~~lH~~g---IiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 92 KDGLVRGWTEGVPLHLAR----PH---G---DPAWFRSAHRALRDLHRAG---ITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CcEEEEEccCCCCHHHhC----cc---c---hHHHHHHHHHHHHHHHHCC---CeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 579999999999996321 11 1 1467889999999999988 999999 99999999999999999999
Q ss_pred ccccCCCccccc------ccccccccCccchhcccC
Q 004674 666 ARSFGLDQTEAN------TKRVVGTYGYMSPEYAID 695 (738)
Q Consensus 666 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~ 695 (738)
|+.+........ .....+++.|+|||.+..
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 997754322111 124568889999998854
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-23 Score=224.03 Aligned_cols=203 Identities=27% Similarity=0.411 Sum_probs=174.8
Q ss_pred hcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
-.++|+....+|.|.+|.|||++... ++..|+|.++........-.++|+-+++..+|+|||.++|.+...+..++.||
T Consensus 13 P~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicME 92 (829)
T KOG0576|consen 13 PQDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICME 92 (829)
T ss_pred CccchhheeeecCCcccchhhhcccccCchhhheeeeccCCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEE
Confidence 34678888999999999999999754 78899999887776777788899999999999999999999999999999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+.+|+|.++-+ -.+++++.++...+...++|++|||+.+ -+|||||-.|||+++.+.+|++|||.+..+...-
T Consensus 93 ycgggslQdiy~---~TgplselqiayvcRetl~gl~ylhs~g---k~hRdiKGanilltd~gDvklaDfgvsaqitati 166 (829)
T KOG0576|consen 93 YCGGGSLQDIYH---VTGPLSELQIAYVCRETLQGLKYLHSQG---KIHRDIKGANILLTDEGDVKLADFGVSAQITATI 166 (829)
T ss_pred ecCCCcccceee---ecccchhHHHHHHHhhhhccchhhhcCC---cccccccccceeecccCceeecccCchhhhhhhh
Confidence 999999988753 2467999999999999999999999998 7999999999999999999999999987664322
Q ss_pred ccccccccccccCccchhcc---cCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 674 TEANTKRVVGTYGYMSPEYA---IDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~---~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
...+...||+.|||||+. +.+.|..++|||+.|+...|+-.-+.|....+
T Consensus 167 --~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlh 219 (829)
T KOG0576|consen 167 --AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLH 219 (829)
T ss_pred --hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccc
Confidence 233447899999999976 35678999999999999999877676654333
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.7e-20 Score=196.94 Aligned_cols=203 Identities=25% Similarity=0.289 Sum_probs=165.2
Q ss_pred CCCccceecccccEeEEEeeeccc--cEEEEEEccCCCCcchHHHHHHHHHHhHhcC----CCeeeEEeEE-ecCCcceE
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIEG--QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH----RNLVKLLGCC-TQRDERML 590 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~g--~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H----~nIv~l~g~~-~~~~~~~l 590 (738)
+|.+.++||+|+||.||++..... ..+|+|............++.|+.++..+.+ +++..+++.. ..+...++
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~i 98 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPSVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFI 98 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEE
Confidence 789999999999999999997653 4788888765433333378889999998873 5888888888 46777899
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-----CceEEEeecC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-----MNPKISDFGL 665 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-----~~vkL~DFGl 665 (738)
||+.+ +.+|.++..... .+.++..+..+++.|++.+|++||+.| ++||||||.|+++... ..+.|.|||+
T Consensus 99 VM~l~-G~sL~dl~~~~~-~~~fs~~T~l~ia~q~l~~l~~lH~~G---~iHRDiKp~N~~~g~~~~~~~~~~~llDfGl 173 (322)
T KOG1164|consen 99 VMSLL-GPSLEDLRKRNP-PGRFSRKTVLRIAIQNLNALEDLHSKG---FIHRDIKPENFVVGQSSRSEVRTLYLLDFGL 173 (322)
T ss_pred EEecc-CccHHHHHHhCC-CCCcCHhHHHHHHHHHHHHHHHHHhcC---cccCCcCHHHeeecCCCCcccceEEEEecCC
Confidence 99876 778888764433 567999999999999999999999998 9999999999999754 4699999999
Q ss_pred cc--ccCCCcc----cc-c-ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 666 AR--SFGLDQT----EA-N-TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 666 a~--~~~~~~~----~~-~-~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
++ .+..... .. . .....||..|.+++...+...+++.|+||++.++.|++.|..|+....
T Consensus 174 ar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~ 241 (322)
T KOG1164|consen 174 ARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALE 241 (322)
T ss_pred CccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCcccc
Confidence 98 3321111 11 1 223569999999999999999999999999999999999999996544
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.82 E-value=5.8e-19 Score=187.41 Aligned_cols=202 Identities=34% Similarity=0.488 Sum_probs=169.0
Q ss_pred CCccceecccccEeEEEeeeccccEEEEEEccCCCCc---chHHHHHHHHHHhHhcCC-CeeeEEeEEecCCcceEEEee
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ---GMEEFKNEVLLIAKLQHR-NLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~---~~~~~~~Ei~il~~l~H~-nIv~l~g~~~~~~~~~lV~Ey 594 (738)
|...+.||.|+||.||++... ..+++|.+...... ....+.+|+.+++.+.|+ +++++.+.+......++++|+
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 556778999999999999886 78899988665433 367899999999999988 799999999777778999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC-ceEEEeecCccccCCCc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGLDQ 673 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGla~~~~~~~ 673 (738)
+.++++..++........+.......++.|++.++.|+|+.+ ++|||+||+||+++... .+++.|||+++......
T Consensus 80 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~---~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~ 156 (384)
T COG0515 80 VDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHSKG---IIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPG 156 (384)
T ss_pred CCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCC---eeccCCCHHHeeecCCCCeEEEeccCcceecCCCC
Confidence 999999966643221126888999999999999999999998 99999999999999988 79999999998654333
Q ss_pred ccc----cccccccccCccchhcccC---CCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 674 TEA----NTKRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 674 ~~~----~~~~~~gt~~y~aPE~~~~---~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
... ......|+..|+|||.+.+ .......|+||+|++++++++|+.|+....
T Consensus 157 ~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 157 STSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEK 215 (384)
T ss_pred ccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 221 2345789999999999987 578889999999999999999999976544
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.82 E-value=1.2e-20 Score=226.01 Aligned_cols=148 Identities=21% Similarity=0.282 Sum_probs=112.4
Q ss_pred HhcC-CCeeeEEeEE-------ecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 004674 569 KLQH-RNLVKLLGCC-------TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640 (738)
Q Consensus 569 ~l~H-~nIv~l~g~~-------~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~i 640 (738)
.++| +||+++++.+ .+....++++||+ +++|.+++... ...+++.+++.++.||++||+|||+++ |
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~--~~~~~~~~~~~i~~qi~~al~~lH~~g---I 101 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNP--DRSVDAFECFHVFRQIVEIVNAAHSQG---I 101 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcc--cccccHHHHHHHHHHHHHHHHHHHhCC---e
Confidence 3445 5777777776 2234567888987 55999998532 346899999999999999999999988 9
Q ss_pred EeCCCCCCcEEEcC-------------------CCceEEEeecCccccCCCcc--------------cccccccccccCc
Q 004674 641 IHRDLKASNVLLDN-------------------TMNPKISDFGLARSFGLDQT--------------EANTKRVVGTYGY 687 (738)
Q Consensus 641 vH~DLkp~NILl~~-------------------~~~vkL~DFGla~~~~~~~~--------------~~~~~~~~gt~~y 687 (738)
+||||||+||||+. ++.+||+|||+++....... ........||+.|
T Consensus 102 vHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y 181 (793)
T PLN00181 102 VVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWY 181 (793)
T ss_pred eeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcce
Confidence 99999999999954 44556666666654211000 0001113578899
Q ss_pred cchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCC
Q 004674 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRG 722 (738)
Q Consensus 688 ~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~ 722 (738)
||||++.+..++.++|||||||+||||++|..|+.
T Consensus 182 ~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~ 216 (793)
T PLN00181 182 TSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSRE 216 (793)
T ss_pred EChhhhccCCCCchhhhhhHHHHHHHHhhCCCchh
Confidence 99999999999999999999999999999998875
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.81 E-value=2e-19 Score=176.97 Aligned_cols=140 Identities=16% Similarity=0.145 Sum_probs=108.3
Q ss_pred cceecccccEeEEEeeeccccEEEEEEccCCCCc--c-------hHH-----------------HHHHHHHHhHhcCCCe
Q 004674 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ--G-------MEE-----------------FKNEVLLIAKLQHRNL 575 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~--~-------~~~-----------------~~~Ei~il~~l~H~nI 575 (738)
.+.||+|++|.||+|...+|+.||+|+++..... . ... ...|++++.++.|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3579999999999999888999999998644211 1 112 2349999999988776
Q ss_pred eeEEeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeCCCCCCcEEEcC
Q 004674 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL-HQDSRLRIIHRDLKASNVLLDN 654 (738)
Q Consensus 576 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~DLkp~NILl~~ 654 (738)
.....+.. ...+|||||++++++..... ....++..+..+++.|++.+|.+| |+.+ |+||||||+|||++
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~---~~~~~~~~~~~~i~~qi~~~L~~l~H~~g---iiHrDlkP~NIli~- 152 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRL---KDAPLSESKARELYLQVIQIMRILYQDCR---LVHADLSEYNLLYH- 152 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhh---hcCCCCHHHHHHHHHHHHHHHHHHHHhCC---cccCCCCHHHEEEE-
Confidence 44332222 23489999999987765432 234688999999999999999999 6777 99999999999998
Q ss_pred CCceEEEeecCccccC
Q 004674 655 TMNPKISDFGLARSFG 670 (738)
Q Consensus 655 ~~~vkL~DFGla~~~~ 670 (738)
++.++|+|||+|....
T Consensus 153 ~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 153 DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCcEEEEEccccccCC
Confidence 4789999999997543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.79 E-value=1.4e-18 Score=171.52 Aligned_cols=140 Identities=17% Similarity=0.194 Sum_probs=110.6
Q ss_pred cceecccccEeEEEeeeccccEEEEEEccCCCCcc--------------------------hHHHHHHHHHHhHhcCCCe
Q 004674 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG--------------------------MEEFKNEVLLIAKLQHRNL 575 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~--------------------------~~~~~~Ei~il~~l~H~nI 575 (738)
...||+|++|.||+|...+|+.||||+++...... ...++.|.+.+.+++|+++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999998789999999986542110 1123578999999999987
Q ss_pred eeEEeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcC
Q 004674 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN 654 (738)
Q Consensus 576 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~ 654 (738)
.....+... ..+|||||++++++..... ....++..+..+++.|++.++.+||+ .+ |+||||||+|||++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l---~~~~~~~~~~~~i~~~l~~~l~~lH~~~g---ivHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRL---KDVPLEEEEAEELYEQVVEQMRRLYQEAG---LVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhh---hhccCCHHHHHHHHHHHHHHHHHHHHhCC---EecCCCChhhEEEE-
Confidence 544443332 3589999999886544322 12357788899999999999999999 77 99999999999999
Q ss_pred CCceEEEeecCccccC
Q 004674 655 TMNPKISDFGLARSFG 670 (738)
Q Consensus 655 ~~~vkL~DFGla~~~~ 670 (738)
++.++|+|||++....
T Consensus 153 ~~~~~liDFG~a~~~~ 168 (190)
T cd05145 153 DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCEEEEEcccceecC
Confidence 7899999999998654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.3e-19 Score=178.74 Aligned_cols=171 Identities=13% Similarity=0.146 Sum_probs=131.9
Q ss_pred hcCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHH---------HHHHHHHHhHhcCCCeeeEEeEEecC
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEE---------FKNEVLLIAKLQHRNLVKLLGCCTQR 585 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~---------~~~Ei~il~~l~H~nIv~l~g~~~~~ 585 (738)
...+|...+.+|.|+||.||.... ++..+|+|.+........+. +.+|+..+.+++|++|..+..++...
T Consensus 29 l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~~~~~ 107 (232)
T PRK10359 29 LSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDFYLLA 107 (232)
T ss_pred hhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEeeeec
Confidence 457899999999999999999655 57789999997553332222 67899999999999999998885533
Q ss_pred --------CcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc
Q 004674 586 --------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN 657 (738)
Q Consensus 586 --------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~ 657 (738)
...+|||||+++.+|.++.. ++. ....+++.+++.||+.+ ++|||+||+||++++++
T Consensus 108 ~~~~~~~~~~~~lvmEyi~G~tL~~~~~-------~~~----~~~~~i~~~l~~lH~~g---i~H~Dikp~Nili~~~g- 172 (232)
T PRK10359 108 ERKTLRYAHTYIMLIEYIEGVELNDMPE-------ISE----DVKAKIKASIESLHQHG---MVSGDPHKGNFIVSKNG- 172 (232)
T ss_pred ccccccccCCeEEEEEEECCccHHHhhh-------ccH----HHHHHHHHHHHHHHHcC---CccCCCChHHEEEeCCC-
Confidence 34789999999999977631 222 24568999999999998 99999999999999988
Q ss_pred eEEEeecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHH
Q 004674 658 PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715 (738)
Q Consensus 658 vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ell 715 (738)
++|+|||.......... ...++....+..++|+|+||+.+..+.
T Consensus 173 i~liDfg~~~~~~e~~a--------------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 173 LRIIDLSGKRCTAQRKA--------------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred EEEEECCCcccccchhh--------------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999998765321110 011344455667899999999887653
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=7.9e-19 Score=168.57 Aligned_cols=200 Identities=23% Similarity=0.307 Sum_probs=162.9
Q ss_pred cCCCCccceecccccEeEEEeee-ccccEEEEEEccCCCCcchHHHHHHHHHHhHhcC-CCeeeEEeEEecCCcceEEEe
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH-RNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H-~nIv~l~g~~~~~~~~~lV~E 593 (738)
..+|..+++||.|+||.+|.|.. ..|.+||||.-+.... .-++..|.++.+.++| ..|..+..+..++..-.||||
T Consensus 14 ~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~--hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMd 91 (341)
T KOG1163|consen 14 GGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAK--HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMD 91 (341)
T ss_pred ccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCC--CcchhHHHHHHHHhccCCCCchhhhhccccccceeeee
Confidence 46788999999999999999985 4589999998654432 3456778888888875 677777788888888999999
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC---CCceEEEeecCccccC
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGLARSFG 670 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~vkL~DFGla~~~~ 670 (738)
.+ +-+|.+...-. ...++..+.+-++-|++.-++|+|.++ .+||||||+|+|..- ...+.|+|||+|+.+.
T Consensus 92 LL-GPsLEdLfnfC--~R~ftmkTvLMLaDQml~RiEyvH~r~---fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~ 165 (341)
T KOG1163|consen 92 LL-GPSLEDLFNFC--SRRFTMKTVLMLADQMLSRIEYVHLRN---FIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYR 165 (341)
T ss_pred cc-CccHHHHHHHH--hhhhhHHhHHHHHHHHHHHHHHHHhhc---cccccCCccceeeccccccceEEEEeccchhhhc
Confidence 87 66887765322 235888899999999999999999998 999999999999964 3568999999999875
Q ss_pred CCcccc-----cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 671 LDQTEA-----NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 671 ~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
...+.. ......||.+|.+-....+...+.+.|+-|+|.+|.++--|..||..
T Consensus 166 d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQg 223 (341)
T KOG1163|consen 166 DIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQG 223 (341)
T ss_pred cccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccc
Confidence 432211 12336799999998888888889999999999999999999999965
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=5.2e-18 Score=170.03 Aligned_cols=201 Identities=21% Similarity=0.309 Sum_probs=165.7
Q ss_pred CCCCccceecccccEeEEEee-eccccEEEEEEccCCCCcchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcceEEEee
Q 004674 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~-~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
-+|.+.++||+|.||.++.|+ +-+++.||||.-...+ ..-+++.|.+..+.|. .++|...+-+-.++.+-.||+|.
T Consensus 28 ~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS--~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidL 105 (449)
T KOG1165|consen 28 PHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS--EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDL 105 (449)
T ss_pred ccceeccccccCcceeeecccccccCceEEEEeccccC--CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhh
Confidence 468889999999999999998 4468999999754433 2346788888888884 68888888777788888999998
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-----CceEEEeecCcccc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-----MNPKISDFGLARSF 669 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-----~~vkL~DFGla~~~ 669 (738)
+ +-+|.++..- -...++..++..+|+|++.-++|+|++. +|.|||||+|+||... ..+-|+|||||+.+
T Consensus 106 L-GPSLEDLFD~--CgR~FSvKTV~miA~Qmi~rie~vH~k~---LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~Y 179 (449)
T KOG1165|consen 106 L-GPSLEDLFDL--CGRRFSVKTVAMIAKQMITRIEYVHEKD---LIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEY 179 (449)
T ss_pred h-CcCHHHHHHH--hcCcccHHhHHHHHHHHHHHHHHHHhcc---eeecccCccceeecCCCCCCCceEEEEeccchhhh
Confidence 7 6688776532 2346899999999999999999999998 9999999999999643 45899999999988
Q ss_pred CCCcccc-----cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCC
Q 004674 670 GLDQTEA-----NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 670 ~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~ 725 (738)
..+.+.. ..+...||.+||+=....+...+.+-|.-|+|-++.+.+-|..||....
T Consensus 180 rDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLK 240 (449)
T KOG1165|consen 180 RDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 240 (449)
T ss_pred cCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCcccccc
Confidence 6554432 2234679999999999999999999999999999999999999996543
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=2.8e-18 Score=167.03 Aligned_cols=107 Identities=21% Similarity=0.172 Sum_probs=93.0
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
|+|.+++.. +...+++.+++.++.||++||+|||+++ ||+|||++.++.+|+ ||++.......
T Consensus 1 GsL~~~l~~--~~~~l~~~~~~~i~~qi~~~L~~lH~~~---------kp~Nil~~~~~~~~~--fG~~~~~~~~~---- 63 (176)
T smart00750 1 VSLADILEV--RGRPLNEEEIWAVCLQCLRALRELHRQA---------KSGNILLTWDGLLKL--DGSVAFKTPEQ---- 63 (176)
T ss_pred CcHHHHHHH--hCCCCCHHHHHHHHHHHHHHHHHHHhcC---------CcccEeEcCccceee--ccceEeecccc----
Confidence 678888853 2456999999999999999999999864 999999999999999 99987653221
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~ 724 (738)
..||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 64 ---~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~ 107 (176)
T smart00750 64 ---SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEE 107 (176)
T ss_pred ---CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCcccc
Confidence 25789999999999999999999999999999999999999653
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.74 E-value=3.5e-17 Score=159.62 Aligned_cols=185 Identities=19% Similarity=0.112 Sum_probs=137.6
Q ss_pred ccceecccccEeEEEeeeccccEEEEEEccCCCCcc----hHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcceEEEeeC
Q 004674 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG----MEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 521 ~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~----~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
+...|++|+||+||.+.- .+.+++.+.+....... ...+++|+++|++++ |+++.+++++ +..+++|||+
T Consensus 6 ~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI 80 (218)
T PRK12274 6 VNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYL 80 (218)
T ss_pred cceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeee
Confidence 346899999999996655 67788888776543321 125789999999995 5889999886 3468999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC-CCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDL-KASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL-kp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
.+.+|...+. . ....++.|++++|+++|+++ |+|||| ||+|||++.++.++|+|||+|........
T Consensus 81 ~G~~L~~~~~----~------~~~~~~~qi~~~L~~lH~~G---IvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 81 AGAAMYQRPP----R------GDLAYFRAARRLLQQLHRCG---VAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred cCccHHhhhh----h------hhHHHHHHHHHHHHHHHHCc---CccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 9998864431 0 11357789999999999998 999999 79999999999999999999986543221
Q ss_pred c------cc-----ccccccccCccchhcccCC-CCC-chhHHHHHHHHHHHHHcCCCCCCC
Q 004674 675 E------AN-----TKRVVGTYGYMSPEYAIDG-LFS-VKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 675 ~------~~-----~~~~~gt~~y~aPE~~~~~-~~t-~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
. .+ ......++.|++|+...-. ..+ ...+.++-|.-+|.++|++.++-.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccc
Confidence 0 00 0112357788888754322 223 567999999999999999988643
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.73 E-value=4.6e-17 Score=161.79 Aligned_cols=136 Identities=21% Similarity=0.270 Sum_probs=105.5
Q ss_pred CccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHh-----cCCCeeeEEeEEecCC---c-ceE
Q 004674 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-----QHRNLVKLLGCCTQRD---E-RML 590 (738)
Q Consensus 520 ~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-----~H~nIv~l~g~~~~~~---~-~~l 590 (738)
+..+.||+|+||.||. +.+....+||++........+.+.+|+.+++.+ +||||++++|++.+.. . ..+
T Consensus 5 ~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~ 82 (210)
T PRK10345 5 SEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDGGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDV 82 (210)
T ss_pred CCcceecCCCceEEEE--CCCCcCeEEEEEeccccchHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEE
Confidence 3456899999999996 433333479988665444567899999999999 5799999999998864 2 337
Q ss_pred EEee--CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEeCCCCCCcEEEcC----CCceEEEee
Q 004674 591 IYEY--LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL-LYLHQDSRLRIIHRDLKASNVLLDN----TMNPKISDF 663 (738)
Q Consensus 591 V~Ey--~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL-~yLH~~~~~~ivH~DLkp~NILl~~----~~~vkL~DF 663 (738)
|+|| +++++|.+++.. ..+++. ..++.+++.++ +|||+++ |+||||||+|||++. +..++|+||
T Consensus 83 I~e~~G~~~~tL~~~l~~----~~~~e~--~~~~~~~L~~l~~yLh~~~---IvhrDlKp~NILl~~~~~~~~~~~LiDg 153 (210)
T PRK10345 83 IADFDGKPSITLTEFAEQ----CRYEED--VAQLRQLLKKLKRYLLDNR---IVTMELKPQNILCQRISESEVIPVVCDN 153 (210)
T ss_pred EecCCCCcchhHHHHHHc----ccccHh--HHHHHHHHHHHHHHHHHCC---EeecCCCHHHEEEeccCCCCCcEEEEEC
Confidence 8999 568999999943 225554 35677888777 8999998 999999999999974 347999994
Q ss_pred cCc
Q 004674 664 GLA 666 (738)
Q Consensus 664 Gla 666 (738)
+.+
T Consensus 154 ~G~ 156 (210)
T PRK10345 154 IGE 156 (210)
T ss_pred CCC
Confidence 444
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.7e-18 Score=167.31 Aligned_cols=193 Identities=24% Similarity=0.352 Sum_probs=153.6
Q ss_pred cceecccccEeEEEeeeccccEEEEEEccCC--CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCC
Q 004674 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gs 599 (738)
..+|.+...|..|+|+++ |..+++|++... .....++|.+|.-.|+...||||+.++|.|.......++..||+.|+
T Consensus 195 ~tkl~e~hsgelwrgrwq-gndivakil~vr~~t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gs 273 (448)
T KOG0195|consen 195 ITKLAESHSGELWRGRWQ-GNDIVAKILNVREVTARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGS 273 (448)
T ss_pred hhhhccCCCccccccccc-CcchhhhhhhhhhcchhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchH
Confidence 446888889999999994 455666776433 23345789999999999999999999999999999999999999999
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEE--eecCccccCCCccccc
Q 004674 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS--DFGLARSFGLDQTEAN 677 (738)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~--DFGla~~~~~~~~~~~ 677 (738)
|...+++. ..-..+..++.+++.+|++|++|||+..+ -|.---|+.+.+++|++.+.+|+ |--++..
T Consensus 274 lynvlhe~-t~vvvd~sqav~faldiargmaflhslep-~ipr~~lns~hvmidedltarismad~kfsfq--------- 342 (448)
T KOG0195|consen 274 LYNVLHEQ-TSVVVDHSQAVRFALDIARGMAFLHSLEP-MIPRFYLNSKHVMIDEDLTARISMADTKFSFQ--------- 342 (448)
T ss_pred HHHHHhcC-ccEEEecchHHHHHHHHHhhHHHHhhcch-hhhhhhcccceEEecchhhhheecccceeeee---------
Confidence 99999654 34467888999999999999999999873 24455789999999999998875 2211111
Q ss_pred ccccccccCccchhcccCCCCC---chhHHHHHHHHHHHHHcCCCCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFS---VKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t---~ksDVwS~Gvil~elltG~~p~~~~~~ 726 (738)
.......+.||+||.+...+-+ +++|+|||+++||||.|.+.||....+
T Consensus 343 e~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlsp 394 (448)
T KOG0195|consen 343 EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSP 394 (448)
T ss_pred ccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCc
Confidence 1112346899999999876543 578999999999999999999976554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.70 E-value=3.9e-18 Score=194.40 Aligned_cols=201 Identities=23% Similarity=0.347 Sum_probs=157.9
Q ss_pred ccceecccccEeEEEeeecc-ccEEEEEEccCC--CCcc----hHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEe
Q 004674 521 EKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQG----MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 521 ~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~--~~~~----~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
..+.+|.|++|.|+...... .+..+.|..... .... ...+..|+.+-..++|+|++..+..+.+.....-+||
T Consensus 322 ~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE 401 (601)
T KOG0590|consen 322 PGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSME 401 (601)
T ss_pred ccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhhh
Confidence 45689999999777665332 333333332210 1111 1225567777778899999888888777777666699
Q ss_pred eCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 y~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~ 673 (738)
|+++ +|..++.. ...+...++..+++|++.|++|||+.+ |.|||||++|+++..++.+||+|||.+..+..+.
T Consensus 402 ~~~~-Dlf~~~~~---~~~~~~~e~~c~fKqL~~Gv~y~h~~G---iahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 402 YCPY-DLFSLVMS---NGKLTPLEADCFFKQLLRGVKYLHSMG---LAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred cccH-HHHHHHhc---ccccchhhhhHHHHHHHHHHHHHHhcC---ceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 9999 88887732 346888899999999999999999998 9999999999999999999999999998876665
Q ss_pred cc--ccccccccccCccchhcccCCCCCch-hHHHHHHHHHHHHHcCCCCCCCCCCCC
Q 004674 674 TE--ANTKRVVGTYGYMSPEYAIDGLFSVK-SDVFSFGVLVLEIICGKKNRGFNHADH 728 (738)
Q Consensus 674 ~~--~~~~~~~gt~~y~aPE~~~~~~~t~k-sDVwS~Gvil~elltG~~p~~~~~~~~ 728 (738)
.. ......+|+..|+|||++.+..|.+. .||||.|+++..|++|+.||.....++
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~ 532 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSD 532 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccc
Confidence 54 45556889999999999999998875 799999999999999999997765543
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.69 E-value=5.6e-17 Score=188.29 Aligned_cols=200 Identities=22% Similarity=0.275 Sum_probs=159.6
Q ss_pred HHhcCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhc---CCCeeeEEeEEecCCcce
Q 004674 513 ANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDERM 589 (738)
Q Consensus 513 ~~~~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~---H~nIv~l~g~~~~~~~~~ 589 (738)
+...+.|.+.+.||+|+||.||+|...+|+.||+|+-+...... |---.+++.+|+ -+.|..+...+.-.+.-+
T Consensus 694 ~~~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE---fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 694 EVGGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE---FYICLQVMERLKPQMLPSIMHISSAHVFQNASV 770 (974)
T ss_pred eecceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee---eeehHHHHHhhchhhhcchHHHHHHHccCCcce
Confidence 34557888999999999999999999889999999876554331 111122333333 233444444555667789
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc-------CCCceEEEe
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-------NTMNPKISD 662 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-------~~~~vkL~D 662 (738)
||+||.+.|+|.+++. ..+.++|.....++.|+++.+++||..+ |||+||||+|.||. +...++|+|
T Consensus 771 lv~ey~~~Gtlld~~N---~~~~m~e~lv~~~~~qml~ive~lH~~~---IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 771 LVSEYSPYGTLLDLIN---TNKVMDEYLVMFFSCQMLRIVEHLHAMG---IIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeccccccHHHhhc---cCCCCCchhhhHHHHHHHHHHHHHHhcc---eecccCCcceeEeecccCCCCcccceEEEe
Confidence 9999999999999985 5567999999999999999999999988 99999999999993 234589999
Q ss_pred ecCccccCCCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 004674 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNR 721 (738)
Q Consensus 663 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~ 721 (738)
||-+..+..-.........++|-.+-.+|...+.+++..+|.|.++-+++-|+.|+..-
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~q 903 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYME 903 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHHH
Confidence 99997765433334556678899999999999999999999999999999999999754
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.68 E-value=4.4e-16 Score=158.55 Aligned_cols=147 Identities=17% Similarity=0.160 Sum_probs=112.6
Q ss_pred HhcCCCCccceecccccEeEEEee--eccccEEEEEEccCCCCc------------------------chHHHHHHHHHH
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGM--LIEGQEIAVKRLSKGSGQ------------------------GMEEFKNEVLLI 567 (738)
Q Consensus 514 ~~~~~~~~~~~LG~G~fG~Vykg~--~~~g~~vavK~l~~~~~~------------------------~~~~~~~Ei~il 567 (738)
.....|.+.+.||+|++|.||+|. ..+|+.||+|+++..... ....+..|+.++
T Consensus 25 ~~~~~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L 104 (237)
T smart00090 25 NRGILSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNL 104 (237)
T ss_pred hcCchHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHH
Confidence 334457788999999999999998 567999999988643210 012356899999
Q ss_pred hHhcCCC--eeeEEeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC
Q 004674 568 AKLQHRN--LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDL 645 (738)
Q Consensus 568 ~~l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL 645 (738)
.++.+.. +.++++. ...++||||+++.+|..... ....+...+...++.||+.++++||+.+ .++||||
T Consensus 105 ~~L~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~---~~~~~~~~~~~~i~~qi~~~l~~LH~~g--~iiH~Di 175 (237)
T smart00090 105 QRLYEAGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRL---KDVEPEEEEEFELYDDILEEMRKLYKEG--ELVHGDL 175 (237)
T ss_pred HHHHhcCCCCCeeeEe----cCceEEEEEecCCccccccc---ccCCcchHHHHHHHHHHHHHHHHHHhcC--CEEeCCC
Confidence 9997633 3344432 23589999999988866542 2234566667889999999999999876 4999999
Q ss_pred CCCcEEEcCCCceEEEeecCccccC
Q 004674 646 KASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 646 kp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
||+||+++ ++.++|+|||.+....
T Consensus 176 kp~NIli~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 176 SEYNILVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred ChhhEEEE-CCCEEEEEChhhhccC
Confidence 99999999 8899999999987654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.68 E-value=5.9e-16 Score=155.48 Aligned_cols=134 Identities=21% Similarity=0.278 Sum_probs=112.5
Q ss_pred ceecccccEeEEEeeeccccEEEEEEccCCCCc--------chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ--------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~--------~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
+.||+|++|.||+|.. .+..+++|+....... ....+.+|+.++..++|+++.....++......+++|||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 6778999976432211 123577899999999999998877777777889999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
+++++|.+.+... .. .+..++.+++.+|++||+.+ ++|+|++|+|||++ ++.++|+|||.+..
T Consensus 81 ~~G~~L~~~~~~~------~~-~~~~i~~~i~~~l~~lH~~~---i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSN------GM-EELELSREIGRLVGKLHSAG---IIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhc------cH-HHHHHHHHHHHHHHHHHhCC---cccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 9999999887432 12 77889999999999999988 99999999999999 78999999999875
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.8e-17 Score=180.25 Aligned_cols=185 Identities=30% Similarity=0.354 Sum_probs=153.0
Q ss_pred ecccccEeEEEeee----ccccEEEEEEccCCCCc--chHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcceEEEeeCCC
Q 004674 525 LGEGGFGPVYKGML----IEGQEIAVKRLSKGSGQ--GMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 525 LG~G~fG~Vykg~~----~~g~~vavK~l~~~~~~--~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+|+|.||.|+.+.. +.+.-+|+|.+.+.... .....+.|..++..++ ||.+|++.-.+..+...+++++|..+
T Consensus 2 lg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rg 81 (612)
T KOG0603|consen 2 LGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRTHTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRG 81 (612)
T ss_pred CCcCCCcchHHHHHhccccccchhhhhcccccccccccccccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhccc
Confidence 78999999997653 33667888887654211 1125567888888887 99999999999999999999999999
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCccccc
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~ 677 (738)
|.|...+. ....+++.....+...++-+++++|+.+ |+|||+|++||+++.+|.+++.|||+++..-...
T Consensus 82 g~lft~l~---~~~~f~~~~~~~~~aelaLald~lh~l~---iiyrd~k~enilld~~Ghi~~tdfglske~v~~~---- 151 (612)
T KOG0603|consen 82 GDLFTRLS---KEVMFDELDVAFYLAELALALDHLHKLG---IAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK---- 151 (612)
T ss_pred chhhhccc---cCCchHHHHHHHHHHHHHHHHhhcchhH---HHHhcccccceeecccCccccCCchhhhHhHhhh----
Confidence 99877663 3445677777778888999999999988 9999999999999999999999999998653221
Q ss_pred ccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 678 ~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
..|||..|||||++. ....++|.||||++++||++|-.||..
T Consensus 152 --~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 152 --IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred --hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 138999999999998 457789999999999999999999976
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.66 E-value=2.9e-16 Score=161.28 Aligned_cols=201 Identities=22% Similarity=0.348 Sum_probs=132.6
Q ss_pred CCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhc----------CCCeeeEEeEEe-
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQ----------HRNLVKLLGCCT- 583 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~----------H~nIv~l~g~~~- 583 (738)
+...+.||.|+++.||.++..+ ++++|+|++... .....+++++|...+..+. |..++..++...
T Consensus 14 l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i 93 (288)
T PF14531_consen 14 LVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRI 93 (288)
T ss_dssp EEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEE
T ss_pred EEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEE
Confidence 3456789999999999999876 889999987433 2334567777776555532 333433333221
Q ss_pred --------cCC--------cceEEEeeCCCCChhHHHh---hcCC-CCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeC
Q 004674 584 --------QRD--------ERMLIYEYLPNKSLDYFIF---DTTR-SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643 (738)
Q Consensus 584 --------~~~--------~~~lV~Ey~~~gsL~~~l~---~~~~-~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~ 643 (738)
... ..+++|+-+ .++|.+++. ...+ ...+....++.+..|+++.+++||..+ ++|+
T Consensus 94 ~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~G---lVHg 169 (288)
T PF14531_consen 94 PGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYG---LVHG 169 (288)
T ss_dssp TTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTT---EEES
T ss_pred cCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcc---eEec
Confidence 111 135677777 567777643 2211 123445666777899999999999998 9999
Q ss_pred CCCCCcEEEcCCCceEEEeecCccccCCCcccccccccccccCccchhcccC--------CCCCchhHHHHHHHHHHHHH
Q 004674 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID--------GLFSVKSDVFSFGVLVLEII 715 (738)
Q Consensus 644 DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~t~ksDVwS~Gvil~ell 715 (738)
||+|+|++++.+|.+.|+||+.....+..... ...+..|.+||.... ..++.+.|.|++|+++|.|.
T Consensus 170 di~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lW 244 (288)
T PF14531_consen 170 DIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLW 244 (288)
T ss_dssp T-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHH
T ss_pred ccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHH
Confidence 99999999999999999999988765432221 223577999997643 24789999999999999999
Q ss_pred cCCCCCCCCCCCC
Q 004674 716 CGKKNRGFNHADH 728 (738)
Q Consensus 716 tG~~p~~~~~~~~ 728 (738)
||+.||+...++.
T Consensus 245 C~~lPf~~~~~~~ 257 (288)
T PF14531_consen 245 CGRLPFGLSSPEA 257 (288)
T ss_dssp HSS-STCCCGGGS
T ss_pred HccCCCCCCCccc
Confidence 9999998765543
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.66 E-value=1e-15 Score=152.23 Aligned_cols=143 Identities=20% Similarity=0.227 Sum_probs=110.8
Q ss_pred HHHhcCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCc----------------------chHHHHHHHHHHhH
Q 004674 512 IANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ----------------------GMEEFKNEVLLIAK 569 (738)
Q Consensus 512 l~~~~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~----------------------~~~~~~~Ei~il~~ 569 (738)
+......|...+.||+|+||.||++...+|+.||||++...... ....+..|+.++..
T Consensus 10 ~~~~~~~~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~ 89 (198)
T cd05144 10 LVKRGVVESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA 89 (198)
T ss_pred HHHcCchhhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH
Confidence 33344457778899999999999999888999999986543210 11235678899999
Q ss_pred hcCCC--eeeEEeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCC
Q 004674 570 LQHRN--LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKA 647 (738)
Q Consensus 570 l~H~n--Iv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp 647 (738)
+.|++ +.+.++ ....++||||+++++|..... ......++.+++.++.++|+.+ ++||||||
T Consensus 90 l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~---------~~~~~~~~~~i~~~l~~lh~~g---i~H~Dl~p 153 (198)
T cd05144 90 LYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRV---------LEDPEEVLDEILEEIVKAYKHG---IIHGDLSE 153 (198)
T ss_pred HHHcCCCCCceee----cCCceEEEEEeCCcchhhccc---------cccHHHHHHHHHHHHHHHHHCC---CCcCCCCc
Confidence 98874 444443 234589999999999876531 0234578899999999999987 99999999
Q ss_pred CcEEEcCCCceEEEeecCccccC
Q 004674 648 SNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 648 ~NILl~~~~~vkL~DFGla~~~~ 670 (738)
+||++++++.++|+|||++....
T Consensus 154 ~Nill~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 154 FNILVDDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred ccEEEcCCCcEEEEECCccccCC
Confidence 99999999999999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.65 E-value=1.2e-15 Score=151.70 Aligned_cols=131 Identities=23% Similarity=0.344 Sum_probs=106.4
Q ss_pred eecccccEeEEEeeeccccEEEEEEccCCCCc--------chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeC
Q 004674 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQ--------GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 524 ~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~--------~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~ 595 (738)
.||+|++|.||+|.. .+..+++|........ ..+++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 389999999999985 6788999986432211 1256778999999999887765555566667789999999
Q ss_pred CCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcccc
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 669 (738)
++++|.+.+.... ..++.+++.+|++||+.+ ++|+|++|+||+++ ++.+++.|||++...
T Consensus 80 ~g~~l~~~~~~~~----------~~~~~~i~~~l~~lH~~g---i~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------DELLREIGRLVGKLHKAG---IVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----------HHHHHHHHHHHHHHHHCC---eecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999988773211 078899999999999988 99999999999999 789999999998763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.64 E-value=1.1e-15 Score=175.00 Aligned_cols=138 Identities=20% Similarity=0.315 Sum_probs=111.9
Q ss_pred cCCCCccceecccccEeEEEeeeccccEEEEEE-ccCCCC-------cchHHHHHHHHHHhHhcCCCeeeEEeEEecCCc
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKR-LSKGSG-------QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~-l~~~~~-------~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~ 587 (738)
...|...+.||+|+||.||++...... +++|+ ..+... ...+++.+|++++..++|++++....++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 345566789999999999999875543 33333 222111 123568899999999999999988888877778
Q ss_pred ceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCcc
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 588 ~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 667 (738)
.++||||+++++|.+++. ....++.+++++|++||+.+ ++||||||+|||+ +++.++|+|||+++
T Consensus 411 ~~lv~E~~~g~~L~~~l~-----------~~~~~~~~i~~~L~~lH~~g---iiHrDlkp~NILl-~~~~~~liDFGla~ 475 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-----------GNPELVRKVGEIVAKLHKAG---IVHGDLTTSNFIV-RDDRLYLIDFGLGK 475 (535)
T ss_pred CEEEEEecCCCcHHHHHH-----------HHHHHHHHHHHHHHHHHhCC---CccCCCChHHEEE-ECCcEEEEeCcccc
Confidence 899999999999988873 34678999999999999988 9999999999999 67799999999997
Q ss_pred cc
Q 004674 668 SF 669 (738)
Q Consensus 668 ~~ 669 (738)
..
T Consensus 476 ~~ 477 (535)
T PRK09605 476 YS 477 (535)
T ss_pred cC
Confidence 64
|
|
| >PF08276 PAN_2: PAN-like domain; InterPro: IPR013227 PAN domains have significant functional versatility fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions [] | Back alignment and domain information |
|---|
Probab=99.62 E-value=2.8e-16 Score=125.52 Aligned_cols=66 Identities=50% Similarity=1.052 Sum_probs=58.8
Q ss_pred cCCCCceEEeeeecCCCCcccccccccCHHHHHHHHhccCceeeeecccccCCCccceecccccccc
Q 004674 366 CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDI 432 (738)
Q Consensus 366 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~~~l~~~ 432 (738)
|+.+|+|+++++|++|+++...++.+.++++|++.||+||||+||+|.++. ++++|.+|+++|+++
T Consensus 1 C~~~d~F~~l~~~~~p~~~~~~~~~~~s~~~C~~~Cl~nCsC~Ayay~~~~-~~~~C~lW~~~L~d~ 66 (66)
T PF08276_consen 1 CGSGDGFLKLPNMKLPDFDNAIVDSSVSLEECEKACLSNCSCTAYAYSNLS-GGGGCLLWYGDLVDL 66 (66)
T ss_pred CcCCCEEEEECCeeCCCCcceeeecCCCHHHHHhhcCCCCCEeeEEeeccC-CCCEEEEEcCEeecC
Confidence 555699999999999999887777789999999999999999999997655 668999999999874
|
These domains contain a hair-pin loop like structure, similar to knottins, but the pattern of disulphide bonds differs |
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.60 E-value=4.8e-16 Score=176.85 Aligned_cols=197 Identities=18% Similarity=0.228 Sum_probs=150.3
Q ss_pred CCCccceecccccEeEEEeeeccccEEEEEEccCCC-CcchHHHHHHHHHHh--HhcCCCeeeEEeEEecCCcceEEEee
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS-GQGMEEFKNEVLLIA--KLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~-~~~~~~~~~Ei~il~--~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
++...+.||++.|=+|.+++.++|. |+||++-+.. .-..+.|+++++-++ .++|||.+++.-.-......|||-+|
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~l~~~pn~lPfqk~~~t~kAAylvRqy 102 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIKFALMKAPNCLPFQKVLVTDKAAYLVRQY 102 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHHHHhhcCCcccchHHHHHhhHHHHHHHHH
Confidence 4566788999999999999998887 8999986654 334566665555444 45899999998887777778888888
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~ 674 (738)
..+ +|.+.+ ..+..+...+..-|+.|++.|+.-+|..+ |+|||||.+||||+.-.-+.|+||..-+....+..
T Consensus 103 vkh-nLyDRl---STRPFL~~iEKkWiaFQLL~al~qcH~~g---VcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 103 VKH-NLYDRL---STRPFLVLIEKKWIAFQLLKALSQCHKLG---VCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred Hhh-hhhhhh---ccchHHHHHHHHHHHHHHHHHHHHHHHcC---ccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 854 566666 34556778888899999999999999998 99999999999999999999999987765433222
Q ss_pred cc-cccc----cccccCccchhcccCC----------C-CCchhHHHHHHHHHHHHHcC-CCCCC
Q 004674 675 EA-NTKR----VVGTYGYMSPEYAIDG----------L-FSVKSDVFSFGVLVLEIICG-KKNRG 722 (738)
Q Consensus 675 ~~-~~~~----~~gt~~y~aPE~~~~~----------~-~t~ksDVwS~Gvil~elltG-~~p~~ 722 (738)
+. +... ...-..|+|||.+... . .+++.||||+||++.||++- +++|+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~ 240 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFT 240 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCccc
Confidence 11 1111 1122479999976431 2 67899999999999998765 77774
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.57 E-value=3.1e-14 Score=133.99 Aligned_cols=135 Identities=22% Similarity=0.219 Sum_probs=114.3
Q ss_pred ccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcC--CCeeeEEeEEecCCcceEEEeeCCCC
Q 004674 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRDERMLIYEYLPNK 598 (738)
Q Consensus 521 ~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~g 598 (738)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.++..++| .++.+++.+...++..+++|||++++
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~--~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~ 78 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK--GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGE 78 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc--hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCe
Confidence 35689999999999999854 7899998865433 5678999999999987 58899999888888899999999988
Q ss_pred ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 599 sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
.+..+ +......++.++++++++||......++|+|++|+||++++.+.+++.|||.+..
T Consensus 79 ~~~~~----------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~ 138 (155)
T cd05120 79 TLDEV----------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY 138 (155)
T ss_pred ecccC----------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence 77432 4566678899999999999986545699999999999999989999999999864
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.56 E-value=2.3e-14 Score=141.05 Aligned_cols=137 Identities=20% Similarity=0.249 Sum_probs=98.5
Q ss_pred cceecccccEeEEEeeeccccEEEEEEccCCCCcc--hHH----------------------HHHHHHHHhHhcCCC--e
Q 004674 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG--MEE----------------------FKNEVLLIAKLQHRN--L 575 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~--~~~----------------------~~~Ei~il~~l~H~n--I 575 (738)
.+.||+|+||.||++...+++.||||++....... ... ...|...+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 35799999999999998889999999876432111 111 135666666665443 3
Q ss_pred eeEEeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHh-CCCCCeEeCCCCCCcEEEcC
Q 004674 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDN 654 (738)
Q Consensus 576 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~ 654 (738)
.+.+++ ...++||||++++.+......... .. .+...++.+++.++.++|. .+ |+|+||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~---~~-~~~~~~~~~~~~~l~~lh~~~~---ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR---LL-EDPEELYDQILELMRKLYREAG---LVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh---hc-ccHHHHHHHHHHHHHHHhhccC---cCcCCCChhhEEEE-
Confidence 444443 246899999999554322111100 11 5677899999999999999 76 99999999999999
Q ss_pred CCceEEEeecCccccC
Q 004674 655 TMNPKISDFGLARSFG 670 (738)
Q Consensus 655 ~~~vkL~DFGla~~~~ 670 (738)
++.++|+|||.+....
T Consensus 150 ~~~~~liDfg~a~~~~ 165 (187)
T cd05119 150 DGKVYIIDVPQAVEID 165 (187)
T ss_pred CCcEEEEECccccccc
Confidence 8899999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.8e-14 Score=155.67 Aligned_cols=155 Identities=27% Similarity=0.427 Sum_probs=126.4
Q ss_pred HhHhcCCCeeeEEeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC
Q 004674 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK 646 (738)
Q Consensus 567 l~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk 646 (738)
|+.+.|.|+.+++|.+.++...+.|.+|+..|+|.+.+.. ....+++.....++.+|++||+|||... --.|+.|+
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~--~~~~~d~~F~~s~~rdi~~Gl~ylh~s~--i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSN--EDIKLDYFFILSFIRDISKGLAYLHNSP--IGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhc--cccCccHHHHHHHHHHHHHHHHHHhcCc--ceeeeeec
Confidence 3568899999999999999999999999999999999965 3345889999999999999999999864 23999999
Q ss_pred CCcEEEcCCCceEEEeecCccccCCCcccccccccccccCccchhcccCC-------CCCchhHHHHHHHHHHHHHcCCC
Q 004674 647 ASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG-------LFSVKSDVFSFGVLVLEIICGKK 719 (738)
Q Consensus 647 p~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~t~ksDVwS~Gvil~elltG~~ 719 (738)
+.|.+++....+||+|||+.................-..-|.|||.+... ..+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 99999999999999999998765321111111112234579999988763 14677999999999999999999
Q ss_pred CCCCCC
Q 004674 720 NRGFNH 725 (738)
Q Consensus 720 p~~~~~ 725 (738)
||....
T Consensus 157 ~~~~~~ 162 (484)
T KOG1023|consen 157 PFDLRN 162 (484)
T ss_pred cccccc
Confidence 997643
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.50 E-value=2.4e-13 Score=138.83 Aligned_cols=135 Identities=20% Similarity=0.249 Sum_probs=103.9
Q ss_pred ceec-ccccEeEEEeeeccccEEEEEEccCCC-------------CcchHHHHHHHHHHhHhcCCCe--eeEEeEEecCC
Q 004674 523 NKLG-EGGFGPVYKGMLIEGQEIAVKRLSKGS-------------GQGMEEFKNEVLLIAKLQHRNL--VKLLGCCTQRD 586 (738)
Q Consensus 523 ~~LG-~G~fG~Vykg~~~~g~~vavK~l~~~~-------------~~~~~~~~~Ei~il~~l~H~nI--v~l~g~~~~~~ 586 (738)
..|| .|+.|+||++.. .+..+++|++.... ......+.+|++++.+++|++| ++.+++...+.
T Consensus 37 ~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~ 115 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRH 115 (239)
T ss_pred ceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeeec
Confidence 4687 889999999877 46788888774321 1223567889999999998875 66777654332
Q ss_pred c----ceEEEeeCCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEE
Q 004674 587 E----RMLIYEYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (738)
Q Consensus 587 ~----~~lV~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~ 661 (738)
. .++|||++++ .+|.+++.. ..++.. .+.+|+.++++||+.+ |+||||||+|||++.++.++|+
T Consensus 116 ~~~~~~~lV~e~l~G~~~L~~~l~~----~~l~~~----~~~~i~~~l~~lH~~G---I~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 116 GLFYRADILIERIEGARDLVALLQE----APLSEE----QWQAIGQLIARFHDAG---VYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred CcceeeeEEEEecCCCCCHHHHHhc----CCCCHH----HHHHHHHHHHHHHHCC---CCCCCCCchhEEEcCCCCEEEE
Confidence 2 2599999997 688888732 234443 3568999999999998 9999999999999998899999
Q ss_pred eecCcccc
Q 004674 662 DFGLARSF 669 (738)
Q Consensus 662 DFGla~~~ 669 (738)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99998753
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.50 E-value=5.8e-15 Score=157.92 Aligned_cols=124 Identities=29% Similarity=0.438 Sum_probs=107.9
Q ss_pred cceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCc
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (738)
Q Consensus 587 ~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla 666 (738)
..++.|+++...+|.+++.........++...+.++.|++.|+.| ++ .+|+|+||.||+...+.++||+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~---~ihrdlkp~nif~~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KG---LIHRDLKPSNIFFSDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---cc---chhhhccccccccccchhhhhhhhhhe
Confidence 478999999999999999766666678889999999999999999 55 899999999999999999999999998
Q ss_pred cccCCCc----ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHc
Q 004674 667 RSFGLDQ----TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC 716 (738)
Q Consensus 667 ~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~ellt 716 (738)
....... .........||..||+||.+.+..|+.|+||||||+||+|++.
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 7654333 1122334689999999999999999999999999999999988
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.49 E-value=1.5e-14 Score=164.92 Aligned_cols=169 Identities=24% Similarity=0.365 Sum_probs=120.5
Q ss_pred cCCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
.++|+.++.|..|++|.||..+++. .+.+|+|+ .++.- -.++ ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~ki-Nkq~l----ilRn---ilt~a~npfvv------------------ 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKI-NKQNL----ILRN---ILTFAGNPFVV------------------ 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhcc-cccch----hhhc---cccccCCccee------------------
Confidence 4678889999999999999998865 45677743 22110 0111 22222233332
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCc-
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ- 673 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~- 673 (738)
|+=...+ ...++++.. ++.+++|||+.+ |+|||+||+|.+|+.-|++|+.|||+++......
T Consensus 136 ---gDc~tll---k~~g~lPvd--------mvla~Eylh~yg---ivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~a 198 (1205)
T KOG0606|consen 136 ---GDCATLL---KNIGPLPVD--------MVLAVEYLHSYG---IVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLA 198 (1205)
T ss_pred ---chhhhhc---ccCCCCcch--------hhHHhHhhccCC---eecCCCCCCcceeeecccccccchhhhhhhhhhcc
Confidence 1111122 112233332 277899999988 9999999999999999999999999987542111
Q ss_pred ------------ccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCC
Q 004674 674 ------------TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (738)
Q Consensus 674 ------------~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~~~~~ 727 (738)
..-..+.++||+.|+|||++....|...+|.|++|+|+||.+.|..||....+|
T Consensus 199 tnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpe 264 (1205)
T KOG0606|consen 199 TNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPE 264 (1205)
T ss_pred chhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHH
Confidence 111234479999999999999999999999999999999999999999887554
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.43 E-value=4e-13 Score=138.07 Aligned_cols=145 Identities=23% Similarity=0.328 Sum_probs=106.1
Q ss_pred cCCCeeeEEeEEec---------------------------CCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHH
Q 004674 571 QHRNLVKLLGCCTQ---------------------------RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIA 623 (738)
Q Consensus 571 ~H~nIv~l~g~~~~---------------------------~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~ 623 (738)
+|||||++.+.|.+ +...|+||...+ .+|..++.. ...+.....-++.
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-~tLr~yl~~----~~~s~r~~~~~la 348 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-QTLREYLWT----RHRSYRTGRVILA 348 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-hhHHHHHhc----CCCchHHHHHHHH
Confidence 58888888776532 234678888775 477777743 3356677778899
Q ss_pred HHHHHHHHHHhCCCCCeEeCCCCCCcEEE--cCCC--ceEEEeecCccccCCC----cccccccccccccCccchhcccC
Q 004674 624 GIARGLLYLHQDSRLRIIHRDLKASNVLL--DNTM--NPKISDFGLARSFGLD----QTEANTKRVVGTYGYMSPEYAID 695 (738)
Q Consensus 624 ~ia~gL~yLH~~~~~~ivH~DLkp~NILl--~~~~--~vkL~DFGla~~~~~~----~~~~~~~~~~gt~~y~aPE~~~~ 695 (738)
|+++|+.|||+++ |.|||||.+|||+ ++|. .+.|+|||.+---... ..........|.-.-||||+...
T Consensus 349 QlLEav~hL~~hg---vAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta 425 (598)
T KOG4158|consen 349 QLLEAVTHLHKHG---VAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATA 425 (598)
T ss_pred HHHHHHHHHHHcc---chhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhc
Confidence 9999999999998 9999999999999 3443 4689999976432110 01111222456778899998764
Q ss_pred CC------CCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 696 GL------FSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 696 ~~------~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
.+ --.|+|.|+.|-+.||++....||..
T Consensus 426 ~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~ 459 (598)
T KOG4158|consen 426 VPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYK 459 (598)
T ss_pred CCCCceeeccchhhhhhhhhhHHHHhccCCcccc
Confidence 32 23589999999999999999999965
|
|
| >cd00129 PAN_APPLE PAN/APPLE-like domain; present in N-terminal (N) domains of plasminogen/ hepatocyte growth factor proteins, plasma prekallikrein/coagulation factor XI and microneme antigen proteins, plant receptor-like protein kinases, and various nematode and leech anti-platelet proteins | Back alignment and domain information |
|---|
Probab=99.40 E-value=3.1e-13 Score=111.44 Aligned_cols=71 Identities=28% Similarity=0.433 Sum_probs=61.5
Q ss_pred cCCCCceEEeeeecCCCCcccccccccCHHHHHHHHhc---cCceeeeecccccCCCccceeccccc-ccccccCCCCcc
Q 004674 366 CKHGDGFLEHKAVKLPDTRFSWVDKNITLWECKELCSK---NCSCTAYANADVRGRGSGCLLWFHDL-IDIKELPESGQD 441 (738)
Q Consensus 366 C~~~~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~---~CsC~a~~~~~~~~~~~~C~~w~~~l-~~~~~~~~~~~~ 441 (738)
|...++|+++.++++|++.. .+++||+++|++ ||||+||+|.+. +.||.+|++++ ++++..++.+.+
T Consensus 5 ~~~~g~fl~~~~~klpd~~~------~s~~eC~~~Cl~~~~nCsC~Aya~~~~---~~gC~~W~~~l~~d~~~~~~~g~~ 75 (80)
T cd00129 5 CKSAGTTLIKIALKIKTTKA------NTADECANRCEKNGLPFSCKAFVFAKA---RKQCLWFPFNSMSGVRKEFSHGFD 75 (80)
T ss_pred eecCCeEEEeecccCCcccc------cCHHHHHHHHhcCCCCCCceeeeccCC---CCCeEEecCcchhhHHhccCCCce
Confidence 44457899999999999764 689999999999 999999999652 35899999999 999888888899
Q ss_pred eeee
Q 004674 442 LFIR 445 (738)
Q Consensus 442 lyir 445 (738)
+|+|
T Consensus 76 Ly~r 79 (80)
T cd00129 76 LYEN 79 (80)
T ss_pred eEeE
Confidence 9997
|
Common structural features include two disulfide bonds that link the alpha-helix to the central region of the protein. PAN domains have significant functional versatility, fulfilling diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.39 E-value=4.4e-14 Score=161.39 Aligned_cols=208 Identities=26% Similarity=0.350 Sum_probs=165.4
Q ss_pred CCCCccceecccccEeEEEeeeccc--cEEEEEEccCCC--CcchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcceEE
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEG--QEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~g--~~vavK~l~~~~--~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~lV 591 (738)
..|...+.||+|+|+.|-....... ..+|+|.+.... ....+....|..+-..+. |+|++++++...+.+..+++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~ 99 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPPKSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLS 99 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCCCccchhhhcCccccccccccccccccccCCccCCCcccccc
Confidence 4567777899999999987766443 446666665442 233445556777777776 99999999999999999999
Q ss_pred EeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEeCCCCCCcEEEcCCC-ceEEEeecCcccc
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH-QDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSF 669 (738)
Q Consensus 592 ~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH-~~~~~~ivH~DLkp~NILl~~~~-~vkL~DFGla~~~ 669 (738)
.||..++++...+.. ......+......+..|+..++.|+| ..+ +.|+||||+|.+++..+ ..+++|||+|..+
T Consensus 100 ~~~s~g~~~f~~i~~-~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~---~~h~~ikP~n~~l~~s~~~l~~~df~~At~~ 175 (601)
T KOG0590|consen 100 LSYSDGGSLFSKISH-PDSTGTSSSSASRYLPQLNSGLSYLHPENG---VTHRDIKPSNSLLDESGSALKIADFGLATAY 175 (601)
T ss_pred cCccccccccccccc-CCccCCCCcchhhhhhhhccCccccCcccc---cccCCCCCccchhccCCCcccCCCchhhccc
Confidence 999999999777731 11114556667788999999999999 766 99999999999999999 9999999999887
Q ss_pred CC-Cccccccccccc-ccCccchhcccCC-CCCchhHHHHHHHHHHHHHcCCCCCCCCCCCC
Q 004674 670 GL-DQTEANTKRVVG-TYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728 (738)
Q Consensus 670 ~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~t~ksDVwS~Gvil~elltG~~p~~~~~~~~ 728 (738)
.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..|++......
T Consensus 176 ~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~ 237 (601)
T KOG0590|consen 176 RNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKD 237 (601)
T ss_pred cccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCcccccccc
Confidence 66 445555556788 9999999999884 44667899999999999999999998765543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.8e-12 Score=143.79 Aligned_cols=141 Identities=22% Similarity=0.287 Sum_probs=100.6
Q ss_pred cceecccccEeEEEeeeccccEEEEEEccCCCCcc----------------------------------------hHHHH
Q 004674 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG----------------------------------------MEEFK 561 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~----------------------------------------~~~~~ 561 (738)
.+.||.|++|.||+|++.+|+.||||+.+...... .-+|.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 36899999999999999999999999975432110 01244
Q ss_pred HHHHHHhHhc----CCCeeeEEeEEe-cCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHH-HHHHHHhC
Q 004674 562 NEVLLIAKLQ----HRNLVKLLGCCT-QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR-GLLYLHQD 635 (738)
Q Consensus 562 ~Ei~il~~l~----H~nIv~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL~yLH~~ 635 (738)
+|...+.+++ |.+-+.+-.++. .....+|||||+++++|.+....... .. .+.+++..+++ .+..+|..
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~--~~---~~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA--GL---DRKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhc--CC---CHHHHHHHHHHHHHHHHHhC
Confidence 5555555553 333333333332 24457999999999999887643211 12 23456666666 46788988
Q ss_pred CCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 636 ~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
+ ++|+|+||.||++++++.+++.|||++..+.
T Consensus 277 g---~~H~D~hPgNilv~~~g~i~liDfG~~~~l~ 308 (437)
T TIGR01982 277 G---FFHADLHPGNIFVLKDGKIIALDFGIVGRLS 308 (437)
T ss_pred C---ceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence 7 9999999999999999999999999998764
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd01098 PAN_AP_plant Plant PAN/APPLE-like domain; present in plant S-receptor protein kinases and secreted glycoproteins | Back alignment and domain information |
|---|
Probab=99.27 E-value=6.4e-12 Score=106.31 Aligned_cols=80 Identities=46% Similarity=0.897 Sum_probs=64.2
Q ss_pred CcccCCC---CceEEeeeecCCCCcccccccccCHHHHHHHHhccCceeeeecccccCCCccceecccccccccccCCCC
Q 004674 363 PLDCKHG---DGFLEHKAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHDLIDIKELPESG 439 (738)
Q Consensus 363 ~l~C~~~---~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~~~l~~~~~~~~~~ 439 (738)
+++|..+ ++|.++.++++|+..+.. .+.++++|++.|++||+|.||+|.+ ++++|.+|...+.+.+.....+
T Consensus 2 ~~~C~~~~~~~~f~~~~~~~~~~~~~~~--~~~s~~~C~~~Cl~nCsC~a~~~~~---~~~~C~~~~~~~~~~~~~~~~~ 76 (84)
T cd01098 2 PLNCGGDGSTDGFLKLPDVKLPDNASAI--TAISLEECREACLSNCSCTAYAYNN---GSGGCLLWNGLLNNLRSLSSGG 76 (84)
T ss_pred CcccCCCCCCCEEEEeCCeeCCCchhhh--ccCCHHHHHHHHhcCCCcceeeecC---CCCeEEEEeceecceEeecCCC
Confidence 4567554 689999999999886653 6789999999999999999999963 3578999999998876544445
Q ss_pred cceeeeec
Q 004674 440 QDLFIRMA 447 (738)
Q Consensus 440 ~~lyir~a 447 (738)
..+|+|++
T Consensus 77 ~~~yiKv~ 84 (84)
T cd01098 77 GTLYLRLA 84 (84)
T ss_pred cEEEEEeC
Confidence 77888763
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. S-receptor protein kinases and S-locus glycoproteins are involved in sporophytic self-incompatibility response in Brassica, one of probably many molecular mechanisms, by which hermaphrodite flowering plants avoid self-fertilization. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.24 E-value=4.7e-11 Score=115.27 Aligned_cols=131 Identities=21% Similarity=0.148 Sum_probs=97.8
Q ss_pred cceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCee-eEEeEEecCCcceEEEeeCCCCCh
Q 004674 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gsL 600 (738)
.+.|+.|.++.||++... ++.+++|....... ....+..|+.++..+.+.+++ +++... ....++||||+++.++
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~-~~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l 78 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTE-LLINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSEL 78 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCcc-cccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCcc
Confidence 357899999999998874 77899998754432 234568899999998766654 344432 3346899999999887
Q ss_pred hHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS--RLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
.... .....++.+++++|+.||+.+ ...++|+|++|.||+++ ++.++++||+.+..
T Consensus 79 ~~~~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 79 LTED-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred cccc-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 5320 011245678999999999876 23469999999999999 66899999999864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.18 E-value=1.1e-10 Score=131.10 Aligned_cols=145 Identities=16% Similarity=0.183 Sum_probs=94.1
Q ss_pred CCCCccceecccccEeEEEeeecc-ccEEEEEEccCCCCc----------------------------------chH---
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ----------------------------------GME--- 558 (738)
Q Consensus 517 ~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~~~~----------------------------------~~~--- 558 (738)
..|+. +.||+|++|+||++++.+ |+.||||+.+..... ..+
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35665 789999999999999987 999999998654210 011
Q ss_pred ---HHHHHHHHHhHhc----CCCeeeEEeEEec-CCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHH-HH
Q 004674 559 ---EFKNEVLLIAKLQ----HRNLVKLLGCCTQ-RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR-GL 629 (738)
Q Consensus 559 ---~~~~Ei~il~~l~----H~nIv~l~g~~~~-~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~-gL 629 (738)
++.+|...+.+++ +.+.+.+-.++.+ ....+|||||++|+.+.++..-.. ...+.. .++...++ -+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~--~g~d~~---~la~~~v~~~~ 273 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRA--AGTDMK---LLAERGVEVFF 273 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHh--cCCCHH---HHHHHHHHHHH
Confidence 2344554454443 4444444444433 456889999999999987532111 111211 22222111 12
Q ss_pred HHHHhCCCCCeEeCCCCCCcEEEcCCC----ceEEEeecCccccC
Q 004674 630 LYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDFGLARSFG 670 (738)
Q Consensus 630 ~yLH~~~~~~ivH~DLkp~NILl~~~~----~vkL~DFGla~~~~ 670 (738)
.-++..+ ++|+|+||.||+++.++ .+++.|||++..+.
T Consensus 274 ~Qif~~G---ffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~ 315 (537)
T PRK04750 274 TQVFRDG---FFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLN 315 (537)
T ss_pred HHHHhCC---eeeCCCChHHeEEecCCCCCCeEEEEecceEEECC
Confidence 2234455 99999999999999888 99999999998764
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.7e-09 Score=105.84 Aligned_cols=136 Identities=12% Similarity=0.097 Sum_probs=97.5
Q ss_pred ceecccccEeEEEeeecc-------ccEEEEEEccCC-------------C---------CcchHHHH----HHHHHHhH
Q 004674 523 NKLGEGGFGPVYKGMLIE-------GQEIAVKRLSKG-------------S---------GQGMEEFK----NEVLLIAK 569 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-------g~~vavK~l~~~-------------~---------~~~~~~~~----~Ei~il~~ 569 (738)
..||.|--+.||.|...+ +..+|||+.+.. + ....+.++ +|.+.|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 479999999999998653 478999975421 0 01122333 79999999
Q ss_pred hcC--CCeeeEEeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEeCCCC
Q 004674 570 LQH--RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL-HQDSRLRIIHRDLK 646 (738)
Q Consensus 570 l~H--~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~~~~ivH~DLk 646 (738)
+.. .++.+++++ ...+|||||+.+..+..... ....++..+...+..+++.+|..| |+.+ |+|+||+
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~L---kd~~~~~~~~~~i~~~i~~~l~~l~H~~g---lVHGDLs 152 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKL---KDAKLNDEEMKNAYYQVLSMMKQLYKECN---LVHADLS 152 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhh---hccccCHHHHHHHHHHHHHHHHHHHHhCC---eecCCCC
Confidence 864 455566654 45789999998754422111 112345556677889999999999 7776 9999999
Q ss_pred CCcEEEcCCCceEEEeecCcccc
Q 004674 647 ASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 647 p~NILl~~~~~vkL~DFGla~~~ 669 (738)
+.|||+++ +.+.|+|||.+...
T Consensus 153 ~~NIL~~~-~~v~iIDF~qav~~ 174 (197)
T cd05146 153 EYNMLWHD-GKVWFIDVSQSVEP 174 (197)
T ss_pred HHHEEEEC-CcEEEEECCCceeC
Confidence 99999974 68999999988754
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.08 E-value=1.3e-09 Score=109.98 Aligned_cols=142 Identities=20% Similarity=0.269 Sum_probs=109.9
Q ss_pred ceecccccEeEEEeeeccccEEEEEEccCCCC-cchHHHHHHHHHHhHhcCC--CeeeEEeEEecCC---cceEEEeeCC
Q 004674 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHR--NLVKLLGCCTQRD---ERMLIYEYLP 596 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~H~--nIv~l~g~~~~~~---~~~lV~Ey~~ 596 (738)
+.|+.|..+.||++...+|+.+++|....... ....++..|.+++..+++. ++.+++.+..... ..++||||++
T Consensus 4 ~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~ 83 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALLPSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVD 83 (223)
T ss_pred eecCCCccceEEEEEecCCcceEEEeCCCcccCcccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeC
Confidence 57899999999999887778999998754432 2456789999999999764 4566777766543 5689999999
Q ss_pred CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------------
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS---------------------------------------- 636 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~---------------------------------------- 636 (738)
+.++...+.. ..++..++..++.+++++|+.||+..
T Consensus 84 G~~l~~~~~~----~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (223)
T cd05154 84 GRVLRDRLLR----PELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMER 159 (223)
T ss_pred CEecCCCCCC----CCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHH
Confidence 9988665421 34677778888888888888888531
Q ss_pred -------------CCCeEeCCCCCCcEEEcC--CCceEEEeecCccc
Q 004674 637 -------------RLRIIHRDLKASNVLLDN--TMNPKISDFGLARS 668 (738)
Q Consensus 637 -------------~~~ivH~DLkp~NILl~~--~~~vkL~DFGla~~ 668 (738)
...++|+|++|.||+++. ++.+.|+||+.+..
T Consensus 160 ~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 160 LLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 245799999999999998 66789999998753
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.07 E-value=1.1e-09 Score=121.07 Aligned_cols=166 Identities=18% Similarity=0.239 Sum_probs=125.6
Q ss_pred eccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHH
Q 004674 538 LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSK 617 (738)
Q Consensus 538 ~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~ 617 (738)
..++.+|.|...+.......+..++-++.|+.+|||||++++...+.....|||+|.+. .|..++.. +....
T Consensus 34 k~~~~~vsVF~~~~~~~~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~------l~~~~ 105 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNGEVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKE------LGKEE 105 (690)
T ss_pred eccCCceEEEEEeCCCchhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHH------hHHHH
Confidence 34578888888766555445667888999999999999999999999999999999984 56555532 22455
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcccccccccccccCccchhcccCCC
Q 004674 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL 697 (738)
Q Consensus 618 ~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 697 (738)
....+.||+.||.+||+.+ .++|++|.-..|++++.|+.||++|.++........ ..+...--..|..|+.+....
T Consensus 106 v~~Gl~qIl~AL~FL~~d~--~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~ 181 (690)
T KOG1243|consen 106 VCLGLFQILAALSFLNDDC--NLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE 181 (690)
T ss_pred HHHHHHHHHHHHHHHhccC--CeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc
Confidence 5667889999999999877 599999999999999999999999998765422111 111111223567777553332
Q ss_pred CCchhHHHHHHHHHHHHHcC
Q 004674 698 FSVKSDVFSFGVLVLEIICG 717 (738)
Q Consensus 698 ~t~ksDVwS~Gvil~elltG 717 (738)
-..|.|-||++++|++.|
T Consensus 182 --~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 182 --WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred --cchhhhhHHHHHHHHhCc
Confidence 346999999999999999
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.06 E-value=2.6e-09 Score=100.93 Aligned_cols=131 Identities=22% Similarity=0.343 Sum_probs=101.5
Q ss_pred ceecccccEeEEEeeeccccEEEEEE-ccCCC--Cc-----chHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEEee
Q 004674 523 NKLGEGGFGPVYKGMLIEGQEIAVKR-LSKGS--GQ-----GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~g~~vavK~-l~~~~--~~-----~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~Ey 594 (738)
..+.+|+-+.+|.+.+. |.++++|. +++.- ++ ..+...+|.+++.+++--.|....-+..+.....|+|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 35889999999998663 44455553 33321 11 234567899999999877776666667788889999999
Q ss_pred CCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
+++..|.+.+... ...++..+-.-+.-||..+ |+|+||.++||++..+. +.++|||++..
T Consensus 81 I~G~~lkd~l~~~----------~~~~~r~vG~~vg~lH~~g---ivHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA----------RPDLLREVGRLVGKLHKAG---IVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc----------chHHHHHHHHHHHHHHhcC---eecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888432 2457777888889999998 99999999999998775 99999999974
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.02 E-value=4.5e-09 Score=98.64 Aligned_cols=144 Identities=24% Similarity=0.299 Sum_probs=106.6
Q ss_pred ccceecccccEeEEEeeeccccEEEEE-EccCCC-------CcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceEEE
Q 004674 521 EKNKLGEGGFGPVYKGMLIEGQEIAVK-RLSKGS-------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 521 ~~~~LG~G~fG~Vykg~~~~g~~vavK-~l~~~~-------~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
....|-+|+-+.|+++.. .|+...|| ++.+.- .-..++.++|++++.+++--.|.-..-++.+...-.|+|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 456899999999999988 55665555 343331 113456789999999988666655555666777778999
Q ss_pred eeCCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC---ceEEEeecCccc
Q 004674 593 EYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKISDFGLARS 668 (738)
Q Consensus 593 Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~---~vkL~DFGla~~ 668 (738)
||+++ -++.+++....... ........++..|-+.+.-||... |+|+||..+||+|..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~-~~d~~~~~~~~~iG~~igklH~nd---iiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDE-SEDEGLAELARRIGELIGKLHDND---IIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCc-ccchhHHHHHHHHHHHHHHhhhCC---eecccccccceEEecCCCcCceEEEeecchhc
Confidence 99987 47788876544332 222333678889999999999987 99999999999996543 358999999875
Q ss_pred c
Q 004674 669 F 669 (738)
Q Consensus 669 ~ 669 (738)
-
T Consensus 166 s 166 (229)
T KOG3087|consen 166 S 166 (229)
T ss_pred c
Confidence 3
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.01 E-value=4e-10 Score=113.87 Aligned_cols=157 Identities=24% Similarity=0.293 Sum_probs=118.0
Q ss_pred HHHHHhHhcCCCeeeEEeEEecCC-----cceEEEeeCCCCChhHHHhhcCCC-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 004674 563 EVLLIAKLQHRNLVKLLGCCTQRD-----ERMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLYLHQDS 636 (738)
Q Consensus 563 Ei~il~~l~H~nIv~l~g~~~~~~-----~~~lV~Ey~~~gsL~~~l~~~~~~-~~l~~~~~~~i~~~ia~gL~yLH~~~ 636 (738)
-..-|-.+.|.|||++..|+.+.. ...++.|||..|++..+|...... ..+......+++-||+.||.|||+-
T Consensus 117 vFdnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~- 195 (458)
T KOG1266|consen 117 VFDNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSC- 195 (458)
T ss_pred HHHHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhcc-
Confidence 344455667999999999876543 467899999999999999765433 3577777889999999999999986
Q ss_pred CCCeEeCCCCCCcEEEcCCCceEEEeecCccccC--CCcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHH
Q 004674 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG--LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714 (738)
Q Consensus 637 ~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~--~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~el 714 (738)
.++|+|+++..+.|++..++-+||+----..... ............+-++|.|||.=.....+.++|||+||+..+||
T Consensus 196 ~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 196 DPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred CCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 4789999999999999999988885322111000 00001112224567899999987777778899999999999999
Q ss_pred HcCCCC
Q 004674 715 ICGKKN 720 (738)
Q Consensus 715 ltG~~p 720 (738)
..+..-
T Consensus 276 ailEiq 281 (458)
T KOG1266|consen 276 AILEIQ 281 (458)
T ss_pred HHheec
Confidence 888743
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.86 E-value=2.8e-09 Score=116.90 Aligned_cols=199 Identities=25% Similarity=0.312 Sum_probs=149.4
Q ss_pred CCCccceecc--cccEeEEEeee--c-cccEEEEEEccCC--CCcchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcce
Q 004674 518 NFSEKNKLGE--GGFGPVYKGML--I-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERM 589 (738)
Q Consensus 518 ~~~~~~~LG~--G~fG~Vykg~~--~-~g~~vavK~l~~~--~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~ 589 (738)
.|...+.+|. |.+|.||++.. . .+..+|+|+-+.. .......=.+|+....+++ |+|.++....+...+..+
T Consensus 115 ~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lf 194 (524)
T KOG0601|consen 115 RFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGSGILF 194 (524)
T ss_pred hcccccccccCCCCCceeecccCCcccCCcccccccccCCCCCccccccccchhhcccccCccccccccCcccccCCcce
Confidence 3455677999 99999999886 3 3678898874322 2222333345666666664 999999888888888899
Q ss_pred EEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEeCCCCCCcEEEcCC-CceEEEeec
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFG 664 (738)
Q Consensus 590 lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~----gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~vkL~DFG 664 (738)
+-.|.+. .+|..+.. .....++....+....+... |+.++|... ++|-|+||.||++..+ ...+++|||
T Consensus 195 iqtE~~~-~sl~~~~~--~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~---~~~~~~kp~~i~~~~~~~s~~~~df~ 268 (524)
T KOG0601|consen 195 IQTELCG-ESLQSYCH--TPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNN---IVHDDLKPANIFTTSDWTSCKLTDFG 268 (524)
T ss_pred eeecccc-chhHHhhh--cccccCCchhhhhHHhhhhhcccccccccCCCc---ccccccchhheecccccceeecCCcc
Confidence 9889886 56655543 23344677777788888888 999999987 9999999999999988 889999999
Q ss_pred CccccCCCcccc---cccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCCCC
Q 004674 665 LARSFGLDQTEA---NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 665 la~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~~~ 723 (738)
+...++...-.. ...+..|...|++||... +.++.+.|+|++|.+.+|..++...+..
T Consensus 269 ~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~ev~l~~~l~~~~~~~ 329 (524)
T KOG0601|consen 269 LVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGEVILEAILGSHLPSV 329 (524)
T ss_pred eeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhhhhHhhHhhcccccC
Confidence 988776443111 112235677899999664 4568899999999999999998876643
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.76 E-value=1.7e-07 Score=97.01 Aligned_cols=140 Identities=18% Similarity=0.116 Sum_probs=99.8
Q ss_pred eecccccEeEEEeeeccccEEEEEEccCCCC-----------cchHHHHHHHHHHhHhcCCCe--eeEEeEEec-----C
Q 004674 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG-----------QGMEEFKNEVLLIAKLQHRNL--VKLLGCCTQ-----R 585 (738)
Q Consensus 524 ~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~-----------~~~~~~~~Ei~il~~l~H~nI--v~l~g~~~~-----~ 585 (738)
.+-.-....|++..+ +|+.+.||+...... .....+.+|...+.++...+| .+++++... .
T Consensus 29 ~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~ 107 (268)
T PRK15123 29 VFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNPAT 107 (268)
T ss_pred EEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCcc
Confidence 344334445667655 677899997633221 112247899999998864444 444555543 2
Q ss_pred CcceEEEeeCCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcC-------CCc
Q 004674 586 DERMLIYEYLPNK-SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-------TMN 657 (738)
Q Consensus 586 ~~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-------~~~ 657 (738)
..-+||+|++++. +|.+++.... ....+...+..++.+++..++-||+.+ |+|+|++++|||++. +..
T Consensus 108 ~~s~LVte~l~~~~sL~~~~~~~~-~~~~~~~~~~~ll~~la~~i~~LH~~G---i~HgDL~~~NiLl~~~~~~~~~~~~ 183 (268)
T PRK15123 108 RTSFIITEDLAPTISLEDYCADWA-TNPPDPRLKRMLIKRVATMVRDMHAAG---INHRDCYICHFLLHLPFPGREEDLK 183 (268)
T ss_pred ceeEEEEeeCCCCccHHHHHHhhc-ccCCCHHHHHHHHHHHHHHHHHHHHCc---CccCCCChhhEEEeccccCCCCCce
Confidence 3467999999986 8888874321 234566777889999999999999998 999999999999975 468
Q ss_pred eEEEeecCccc
Q 004674 658 PKISDFGLARS 668 (738)
Q Consensus 658 vkL~DFGla~~ 668 (738)
+.|+||+.+..
T Consensus 184 ~~LIDl~r~~~ 194 (268)
T PRK15123 184 LSVIDLHRAQI 194 (268)
T ss_pred EEEEECCcccc
Confidence 99999998854
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.75 E-value=6.3e-08 Score=94.43 Aligned_cols=126 Identities=25% Similarity=0.340 Sum_probs=82.1
Q ss_pred eEEEeeeccccEEEEEEccCCC--------------C-------c-----chHHHHHHHHHHhHhcCC--CeeeEEeEEe
Q 004674 532 PVYKGMLIEGQEIAVKRLSKGS--------------G-------Q-----GMEEFKNEVLLIAKLQHR--NLVKLLGCCT 583 (738)
Q Consensus 532 ~Vykg~~~~g~~vavK~l~~~~--------------~-------~-----~~~~~~~Ei~il~~l~H~--nIv~l~g~~~ 583 (738)
.||.|...++..+|+|...... . . .....++|.+.|.++... ++.+++.+
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~-- 78 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDY-- 78 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEE--
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEE--
Confidence 4899998889999999754310 0 0 123457899999999766 45555544
Q ss_pred cCCcceEEEeeCC--CCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEeCCCCCCcEEEcCCCceEE
Q 004674 584 QRDERMLIYEYLP--NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY-LHQDSRLRIIHRDLKASNVLLDNTMNPKI 660 (738)
Q Consensus 584 ~~~~~~lV~Ey~~--~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y-LH~~~~~~ivH~DLkp~NILl~~~~~vkL 660 (738)
....|||||++ +..+..+.... ++......++.+++..+.. +|..+ |+|+||.+.|||++++ .+.|
T Consensus 79 --~~~~ivME~I~~~G~~~~~l~~~~-----~~~~~~~~~~~~il~~~~~~~~~~g---ivHGDLs~~NIlv~~~-~~~i 147 (188)
T PF01163_consen 79 --NRNVIVMEYIGEDGVPLPRLKDVD-----LSPEEPKELLEEILEEIIKMLHKAG---IVHGDLSEYNILVDDG-KVYI 147 (188)
T ss_dssp --ETTEEEEE--EETTEEGGCHHHCG-----GGGSTHHHHHHHHHHHHHHHHHCTT---EEESS-STTSEEEETT-CEEE
T ss_pred --eCCEEEEEecCCCccchhhHHhcc-----ccchhHHHHHHHHHHHHHHHHHhcC---ceecCCChhhEEeecc-eEEE
Confidence 24579999999 65665443211 1123345677778886666 46766 9999999999999988 9999
Q ss_pred EeecCccccC
Q 004674 661 SDFGLARSFG 670 (738)
Q Consensus 661 ~DFGla~~~~ 670 (738)
+|||.+....
T Consensus 148 IDf~qav~~~ 157 (188)
T PF01163_consen 148 IDFGQAVDSS 157 (188)
T ss_dssp --GTTEEETT
T ss_pred EecCcceecC
Confidence 9999887543
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.72 E-value=6.3e-09 Score=114.17 Aligned_cols=195 Identities=25% Similarity=0.270 Sum_probs=147.6
Q ss_pred cCCCCccceecccccEeEEEeeec--cccEEEEEEccCCCCcchHHH--HHHHHHHhHh-cCCCeeeEEeEEecCCcceE
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI--EGQEIAVKRLSKGSGQGMEEF--KNEVLLIAKL-QHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~--~g~~vavK~l~~~~~~~~~~~--~~Ei~il~~l-~H~nIv~l~g~~~~~~~~~l 590 (738)
..+|..+..||.|.|+.|++.... ++..+++|.+.+.......+. ..|+-+...+ .|.++++....+..-.+.++
T Consensus 264 ~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~i 343 (524)
T KOG0601|consen 264 LTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYI 343 (524)
T ss_pred cCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhhcchhhhhHhhHhhcccccCCCCCCccccccccC
Confidence 457888899999999999987754 467899998765543332222 3455555555 58889988888888888889
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC-CceEEEeecCcccc
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLARSF 669 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~vkL~DFGla~~~ 669 (738)
=-||++++++...+ .....++...++++..|++.++.++|+.. ++|+|++|+||++..+ +.-+++|||.+..+
T Consensus 344 p~e~~~~~s~~l~~---~~~~~~d~~~~~~~~~q~~~~l~~i~s~~---~~~~d~~psni~i~~~~~~~~~~~~~~~t~~ 417 (524)
T KOG0601|consen 344 PLEFCEGGSSSLRS---VTSQMLDEDPRLRLTAQILTALNVIHSKL---FVHLDVKPSNILISNDGFFSKLGDFGCWTRL 417 (524)
T ss_pred chhhhcCcchhhhh---HHHHhcCcchhhhhHHHHHhccccccchh---hhcccccccceeeccchhhhhcccccccccc
Confidence 99999999988776 23345788889999999999999999877 9999999999999876 88899999998653
Q ss_pred CCCcccccccccccccCcc--chhcccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 004674 670 GLDQTEANTKRVVGTYGYM--SPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNR 721 (738)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~--aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~ 721 (738)
..... . ....-+++ +|+......+-.+.|++|||.-+.|.+++....
T Consensus 418 ~~~~~--~---~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 418 AFSSG--V---FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred ceecc--c---ccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 21111 0 12233444 555666778888999999999999988887543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=98.71 E-value=3.9e-09 Score=121.44 Aligned_cols=208 Identities=20% Similarity=0.262 Sum_probs=143.9
Q ss_pred hcCCCCccceecccccEeEEEeeecc-ccEEEEEEccCC---CCcchHHHHHHHHHHhHhcCCCeeeEEeEEecCCcceE
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~-g~~vavK~l~~~---~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
..+.+.+.+.+-+|.++.++...-.. |...++|..... .....+....+-.++-.-+||-+++..--+......+|
T Consensus 802 S~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L 881 (1205)
T KOG0606|consen 802 SPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPL 881 (1205)
T ss_pred CCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcch
Confidence 45677777888899999998766432 323333332211 11122233333333323345666655544556778899
Q ss_pred EEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
+++|..+++|...++... ..+..-....+..+..+++|||... +.|+|++|.|+|...++..+++|||.....+
T Consensus 882 ~~~~~~~~~~~Skl~~~~---~~saepaRs~i~~~vqs~e~L~s~~---r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg 955 (1205)
T KOG0606|consen 882 VGHYLNGGDLPSKLHNSG---CLSAEPARSPILERVQSLESLHSSL---RKHRDLKPDSLLIAYDGHRPLTDFGTLSKVG 955 (1205)
T ss_pred hhHHhccCCchhhhhcCC---CcccccccchhHHHHhhhhccccch---hhcccccccchhhcccCCcccCccccccccc
Confidence 999999999988875432 3444444555667888999999875 8999999999999999999999998433221
Q ss_pred C-------------------------Cccc----ccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 004674 671 L-------------------------DQTE----ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNR 721 (738)
Q Consensus 671 ~-------------------------~~~~----~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~ 721 (738)
. ++.. .......||+.|.+||...+......+|.|++|++++|.++|..||
T Consensus 956 ~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~ 1035 (1205)
T KOG0606|consen 956 LIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPF 1035 (1205)
T ss_pred cccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCC
Confidence 0 0000 1122357899999999999999999999999999999999999999
Q ss_pred CCCCCCC
Q 004674 722 GFNHADH 728 (738)
Q Consensus 722 ~~~~~~~ 728 (738)
....+..
T Consensus 1036 na~tpq~ 1042 (1205)
T KOG0606|consen 1036 NAETPQQ 1042 (1205)
T ss_pred CCcchhh
Confidence 8766653
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.70 E-value=2.1e-07 Score=100.15 Aligned_cols=169 Identities=22% Similarity=0.305 Sum_probs=128.2
Q ss_pred cEeEEEeee-ccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeeeEEeEEec----CCcceEEEeeCCC-CChhHH
Q 004674 530 FGPVYKGML-IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERMLIYEYLPN-KSLDYF 603 (738)
Q Consensus 530 fG~Vykg~~-~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~l~g~~~~----~~~~~lV~Ey~~~-gsL~~~ 603 (738)
-.+.||+.. .+|..+++|+++....+.......-++.++++.|.|+|++..++.. ....++||+|.++ ++|-+.
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~ 368 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQSTNKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDL 368 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCcccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHH
Confidence 356788875 4689999999955444444344556788999999999999998763 3458899999985 466655
Q ss_pred HhhcC------------CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCC
Q 004674 604 IFDTT------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 604 l~~~~------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~ 671 (738)
-+... .....++..++.++.|+..||.++|+.| +.-+-|.|++||++.+.+++|+.-|+...+..
T Consensus 369 ~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssG---LAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 369 YFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSG---LACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcC---ceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 54322 2235788999999999999999999998 88899999999999999999998888766543
Q ss_pred CcccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCC
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKN 720 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p 720 (738)
+.. |-+.. -.+-|.=.||.+++.|.||...
T Consensus 446 d~~----------------~~le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 446 DPT----------------EPLES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred CCC----------------cchhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 321 11111 2357999999999999999654
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.48 E-value=6.6e-07 Score=100.11 Aligned_cols=143 Identities=17% Similarity=0.321 Sum_probs=94.8
Q ss_pred CCCccceecccccEeEEEeeeccccEEEEEEccCCCCcc------------------------------hH---------
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG------------------------------ME--------- 558 (738)
Q Consensus 518 ~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~------------------------------~~--------- 558 (738)
.|+. +.|+.++-|+||+|++.+|+.||||+.+..-... .+
T Consensus 127 eF~~-~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~E 205 (517)
T COG0661 127 EFEP-EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREE 205 (517)
T ss_pred HcCC-CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHH
Confidence 4443 6899999999999999999999999975432110 11
Q ss_pred -HHHHHHHHHhHhc-----CCCeeeEEeEE-ecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHH-
Q 004674 559 -EFKNEVLLIAKLQ-----HRNLVKLLGCC-TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL- 630 (738)
Q Consensus 559 -~~~~Ei~il~~l~-----H~nIv~l~g~~-~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~- 630 (738)
++..|...+.+++ .+++ ++-.++ .-.....|+|||++|-.+.+...... ...+. ..++..++++.-
T Consensus 206 lDy~~EA~n~~~~~~nf~~~~~v-~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~--~g~d~---k~ia~~~~~~f~~ 279 (517)
T COG0661 206 LDYRREAANAERFRENFKDDPDV-YVPKVYWEYTTRRVLTMEWIDGIKISDIAALKS--AGIDR---KELAELLVRAFLR 279 (517)
T ss_pred hCHHHHHHHHHHHHHHcCCCCCe-EeceeehhccCCcEEEEEeeCCEecccHHHHHh--cCCCH---HHHHHHHHHHHHH
Confidence 2334444444442 2333 333333 33567899999999999988853322 23443 233333333322
Q ss_pred HHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccC
Q 004674 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 631 yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~ 670 (738)
.+-..+ ++|.|.+|.||+++.++++.+.|||+...+.
T Consensus 280 q~~~dg---ffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~ 316 (517)
T COG0661 280 QLLRDG---FFHADPHPGNILVRSDGRIVLLDFGIVGRLD 316 (517)
T ss_pred HHHhcC---ccccCCCccceEEecCCcEEEEcCcceecCC
Confidence 222234 9999999999999999999999999987764
|
|
| >smart00108 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.46 E-value=8.5e-07 Score=79.55 Aligned_cols=91 Identities=22% Similarity=0.355 Sum_probs=63.5
Q ss_pred ccEEEeecCCceEEEECCC-CCeEEEecCCCC-CCcceEEEecCCcEEEecCCCCCCCceeeeeccCCCCCcCCCCeeee
Q 004674 109 GVLRINGERNGILVLLNST-NDTVWSSNSSIS-AQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGI 186 (738)
Q Consensus 109 ~~l~~~~~~~g~l~l~~~~-~~~~ws~~~~~~-~~~~~a~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgq~l~~ 186 (738)
+..++..+.||+||+++.. +.++|++++... .....+.|.++|||||++.. +.++|+|=. .
T Consensus 20 G~~~~~~q~dgnlV~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~S~t---~---------- 82 (114)
T smart00108 20 GFFTLIMQNDYNLILYKSSSRTVVWVANRDNPVSDSCTLTLQSDGNLVLYDGD----GRVVWSSNT---T---------- 82 (114)
T ss_pred eccccCCCCCEEEEEEECCCCcEEEECCCCCCCCCCEEEEEeCCCCEEEEeCC----CCEEEEecc---c----------
Confidence 3344445589999999765 589999997432 22367889999999999864 678898711 0
Q ss_pred eecCCCceEEEEeccCCCCCCCceEeecCCCCCceEEEeeCCeEEEEeC
Q 004674 187 NLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAG 235 (738)
Q Consensus 187 ~~~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g 235 (738)
...|.+.+.++.+|+..++-. .+.+.|.+.
T Consensus 83 ------------------~~~~~~~~~L~ddGnlvl~~~-~~~~~W~Sf 112 (114)
T smart00108 83 ------------------GANGNYVLVLLDDGNLVIYDS-DGNFLWQSF 112 (114)
T ss_pred ------------------CCCCceEEEEeCCCCEEEECC-CCCEEeCCC
Confidence 134568889999999765433 345777653
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.46 E-value=1.8e-06 Score=86.25 Aligned_cols=106 Identities=26% Similarity=0.314 Sum_probs=83.9
Q ss_pred hHHHHHHHHHHhHhcCCC--eeeEEeEEecCC----cceEEEeeCCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Q 004674 557 MEEFKNEVLLIAKLQHRN--LVKLLGCCTQRD----ERMLIYEYLPNK-SLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629 (738)
Q Consensus 557 ~~~~~~Ei~il~~l~H~n--Iv~l~g~~~~~~----~~~lV~Ey~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL 629 (738)
.....+|...+..++... ..+.+++..... ..+||+|++++. +|.+++..... ++......++.+++..+
T Consensus 55 ~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~---~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 55 RSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ---LDPSQRRELLRALARLI 131 (206)
T ss_pred chHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc---cchhhHHHHHHHHHHHH
Confidence 456788999888886443 456666665533 348999999984 78888854222 56667788999999999
Q ss_pred HHHHhCCCCCeEeCCCCCCcEEEcCCC---ceEEEeecCccc
Q 004674 630 LYLHQDSRLRIIHRDLKASNVLLDNTM---NPKISDFGLARS 668 (738)
Q Consensus 630 ~yLH~~~~~~ivH~DLkp~NILl~~~~---~vkL~DFGla~~ 668 (738)
+-||+.+ |+|+|+++.|||++.+. .+.++||+-++.
T Consensus 132 ~~lH~~g---i~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 132 AKLHDAG---IYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHHHCc---CCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999998 99999999999998887 899999998765
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.45 E-value=1.7e-06 Score=86.80 Aligned_cols=134 Identities=22% Similarity=0.257 Sum_probs=94.2
Q ss_pred CccceecccccEeEEEeeeccccEEEEEEccCC--------------------C--CcchHHHHHHHHHHhHhcCC--Ce
Q 004674 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--------------------S--GQGMEEFKNEVLLIAKLQHR--NL 575 (738)
Q Consensus 520 ~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~--------------------~--~~~~~~~~~Ei~il~~l~H~--nI 575 (738)
.+.++||-|--+.||.|....|.++|||.-+.. + .......++|.++|.++.-. .+
T Consensus 94 ~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~V 173 (304)
T COG0478 94 AIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVKV 173 (304)
T ss_pred hhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCCC
Confidence 345789999999999999999999999953211 0 01134567899999998644 45
Q ss_pred eeEEeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCC
Q 004674 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT 655 (738)
Q Consensus 576 v~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~ 655 (738)
.+.+++ +.-.+|||++++-.|...- ++....-.++..|+.-++.+-..| |||+|+++-||+++++
T Consensus 174 P~P~~~----nRHaVvMe~ieG~eL~~~r--------~~~en~~~il~~il~~~~~~~~~G---iVHGDlSefNIlV~~d 238 (304)
T COG0478 174 PKPIAW----NRHAVVMEYIEGVELYRLR--------LDVENPDEILDKILEEVRKAYRRG---IVHGDLSEFNILVTED 238 (304)
T ss_pred CCcccc----ccceeeeehcccceeeccc--------CcccCHHHHHHHHHHHHHHHHHcC---ccccCCchheEEEecC
Confidence 555443 4457999999987764321 122333344445555555554555 9999999999999999
Q ss_pred CceEEEeecCccc
Q 004674 656 MNPKISDFGLARS 668 (738)
Q Consensus 656 ~~vkL~DFGla~~ 668 (738)
+.+.++||--+..
T Consensus 239 g~~~vIDwPQ~v~ 251 (304)
T COG0478 239 GDIVVIDWPQAVP 251 (304)
T ss_pred CCEEEEeCccccc
Confidence 9999999976654
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.44 E-value=1.7e-06 Score=90.88 Aligned_cols=191 Identities=15% Similarity=0.163 Sum_probs=121.9
Q ss_pred ccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHh-cCCCeeeEEeE------EecCCc-ceEEE
Q 004674 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGC------CTQRDE-RMLIY 592 (738)
Q Consensus 521 ~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l-~H~nIv~l~g~------~~~~~~-~~lV~ 592 (738)
....||+|+-+.+|-.- +-...+.|+.+........+..+ .|.+. .||-+-.=+.+ -.++.. .-+.|
T Consensus 15 ~gr~LgqGgea~ly~l~--e~~d~VAKIYh~Pppa~~aqk~a---~la~~p~~p~~~~rvaWPqa~L~G~~~~~~iGflm 89 (637)
T COG4248 15 PGRPLGQGGEADLYTLG--EVRDQVAKIYHAPPPAAQAQKVA---ELAATPDAPLLNYRVAWPQATLHGGRRGKVIGFLM 89 (637)
T ss_pred CCccccCCccceeeecc--hhhchhheeecCCCchHHHHHHH---HhccCCCCcchhhhhcccHHHhhCCCccceeEEec
Confidence 45679999999998432 21223446665543332222222 22232 35433220110 011222 45667
Q ss_pred eeCCCC-ChhHHHhhcC---CCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 593 EYLPNK-SLDYFIFDTT---RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 593 Ey~~~g-sL~~~l~~~~---~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
..+++. ....+..... .-...+|...++.+..++.+++-||+.| .+-+|++++|+|+++++.+.|.|=..-..
T Consensus 90 P~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~G---h~vGDVn~~~~lVsd~~~V~LVdsDsfqi 166 (637)
T COG4248 90 PKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHG---HVVGDVNQNSFLVSDDSKVVLVDSDSFQI 166 (637)
T ss_pred ccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcC---CcccccCccceeeecCceEEEEcccceee
Confidence 766654 2222222111 2245889999999999999999999998 88999999999999999999998554333
Q ss_pred cCCCcccccccccccccCccchhccc-----CCCCCchhHHHHHHHHHHHHHcC-CCCCC
Q 004674 669 FGLDQTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICG-KKNRG 722 (738)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~t~ksDVwS~Gvil~elltG-~~p~~ 722 (738)
. .......-.+|...|.+||... +..-+...|-|.+|+++++++.| ++||.
T Consensus 167 ~---~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPys 223 (637)
T COG4248 167 N---ANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYS 223 (637)
T ss_pred c---cCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCC
Confidence 2 1222222346888999999654 33456779999999999998887 89985
|
|
| >cd00028 B_lectin Bulb-type mannose-specific lectin | Back alignment and domain information |
|---|
Probab=98.40 E-value=1.6e-06 Score=78.07 Aligned_cols=89 Identities=21% Similarity=0.326 Sum_probs=63.7
Q ss_pred EEeecC-CceEEEECCC-CCeEEEecCCC-CCCcceEEEecCCcEEEecCCCCCCCceeeeeccCCCCCcCCCCeeeeee
Q 004674 112 RINGER-NGILVLLNST-NDTVWSSNSSI-SAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (738)
Q Consensus 112 ~~~~~~-~g~l~l~~~~-~~~~ws~~~~~-~~~~~~a~l~d~GNlvl~~~~~~~~~~~~WqSFd~PTDtlLpgq~l~~~~ 188 (738)
++..+. ||+||+++.. +.++|++|+.. ......+.|.++|||||++.+ +.++|+|=-.
T Consensus 23 ~~~~q~~dgnlv~~~~~~~~~vW~snt~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~S~~~--------------- 83 (116)
T cd00028 23 KLIMQSRDYNLILYKGSSRTVVWVANRDNPSGSSCTLTLQSDGNLVIYDGS----GTVVWSSNTT--------------- 83 (116)
T ss_pred cCCCCCCeEEEEEEeCCCCeEEEECCCCCCCCCCEEEEEecCCCeEEEcCC----CcEEEEeccc---------------
Confidence 344446 9999999765 58999999753 235566889999999999864 6788886421
Q ss_pred cCCCceEEEEeccCCCCCCCceEeecCCCCCceEEEeeCCeEEEEeCC
Q 004674 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (738)
Q Consensus 189 ~tg~~~~l~Sw~s~~dps~G~f~~~~~~~g~~~~~~~~~~~~~~~~g~ 236 (738)
.+.+.+.+.|+.+|+..++-.+ +.+.|.+..
T Consensus 84 ----------------~~~~~~~~~L~ddGnlvl~~~~-~~~~W~Sf~ 114 (116)
T cd00028 84 ----------------RVNGNYVLVLLDDGNLVLYDSD-GNFLWQSFD 114 (116)
T ss_pred ----------------CCCCceEEEEeCCCCEEEECCC-CCEEEcCCC
Confidence 1246788999999987655433 566787653
|
The domain contains a three-fold internal repeat (beta-prism architecture). The consensus sequence motif QXDXNXVXY is involved in alpha-D-mannose recognition. Lectins are carbohydrate-binding proteins which specifically recognize diverse carbohydrates and mediate a wide variety of biological processes, such as cell-cell and host-pathogen interactions, serum glycoprotein turnover, and innate immune responses. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.32 E-value=1.1e-05 Score=81.71 Aligned_cols=140 Identities=18% Similarity=0.219 Sum_probs=85.8
Q ss_pred ceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCe--eeEEeEEecCCcceEEEeeCCCCC-
Q 004674 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL--VKLLGCCTQRDERMLIYEYLPNKS- 599 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nI--v~l~g~~~~~~~~~lV~Ey~~~gs- 599 (738)
.+||+|..+.||+. .+..+++|..+... ......+|.++++.+..-.+ .+.+++....+...+|||+++|..
T Consensus 7 ~~i~~G~t~~~y~~---~~~~~VlR~~~~~~--~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~~ 81 (226)
T TIGR02172 7 TQTGEGGNGESYTH---KTGKWMLKLYNPGF--DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKRS 81 (226)
T ss_pred eeecCCCCcceeEe---cCCCEEEEeCCCCC--CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCccc
Confidence 57999999999983 25567788875432 34567899999999875444 567777777777889999999963
Q ss_pred hhHHHh--------------------hcCCCCCCCHHHHHH-HHH----------HHHH-HHHHHHh-CCCCCeEeCCCC
Q 004674 600 LDYFIF--------------------DTTRSKLLDWSKRSH-IIA----------GIAR-GLLYLHQ-DSRLRIIHRDLK 646 (738)
Q Consensus 600 L~~~l~--------------------~~~~~~~l~~~~~~~-i~~----------~ia~-gL~yLH~-~~~~~ivH~DLk 646 (738)
+...+. +...-.......... +-. .+.+ ..++|.. .....++|+|+.
T Consensus 82 ~~~~~~~~~~~~~~l~~~la~~l~~lH~~~~~~~~l~~~~~~~~~~l~~~~~~~~~~~~~l~~~l~~~~~~~~~~HgD~~ 161 (226)
T TIGR02172 82 FSRIISDNPSRLEEIAKIFAEMAKKLHSTKCDTSTFQSYKEKIRKFIEEKDFVPKDYKEKARAFIKEVPDTSTCLHGDFQ 161 (226)
T ss_pred hhhhhcCCHHHHHHHHHHHHHHHHHHhCCCCCCCcHHHHHHHHHHHHHhccCCCHHHHHHHHHHHHhCCCCCceEecCCC
Confidence 211110 000000011111000 000 0011 1122221 122457999999
Q ss_pred CCcEEEcCCCceEEEeecCccc
Q 004674 647 ASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 647 p~NILl~~~~~vkL~DFGla~~ 668 (738)
|.||++++++ +.|+||+.+..
T Consensus 162 ~~Nii~~~~~-~~iIDwe~a~~ 182 (226)
T TIGR02172 162 IGNLITSGKG-TYWIDLGDFGY 182 (226)
T ss_pred CCcEEEcCCC-cEEEechhcCc
Confidence 9999999888 99999998753
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.29 E-value=1.4e-05 Score=78.68 Aligned_cols=138 Identities=15% Similarity=0.172 Sum_probs=101.1
Q ss_pred ecccccEeEEEeeeccccEEEEEEccCC------CCcchHHHHHHHHHHhHhcCCC--eeeEEeEEe-cCC----cceEE
Q 004674 525 LGEGGFGPVYKGMLIEGQEIAVKRLSKG------SGQGMEEFKNEVLLIAKLQHRN--LVKLLGCCT-QRD----ERMLI 591 (738)
Q Consensus 525 LG~G~fG~Vykg~~~~g~~vavK~l~~~------~~~~~~~~~~Ei~il~~l~H~n--Iv~l~g~~~-~~~----~~~lV 591 (738)
-|+||-+-|++-.+ +|+.+-+|+-... .+.....|.+|+..|.++...+ +.++. ++. ... .-+||
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 45688888888766 4446888875411 1345678999999999996433 34444 332 111 25799
Q ss_pred EeeCCC-CChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCc--eEEEeecCccc
Q 004674 592 YEYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--PKISDFGLARS 668 (738)
Q Consensus 592 ~Ey~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~--vkL~DFGla~~ 668 (738)
+|-+++ .+|.+++.+.. ..+.+...+..+..++++.++-||+.+ +.|+|+.+.||+++.++. ++++||.-++.
T Consensus 104 Te~L~g~~~L~~~l~~~~-~~~~~~~~k~~il~~va~~ia~LH~~G---v~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHA-VSPYSDEVRQAMLKAVALAFKKMHSVN---RQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCC-cCCcchHHHHHHHHHHHHHHHHHHHCC---CcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997764 58888874322 235677888899999999999999998 999999999999986666 99999987764
|
|
| >smart00473 PAN_AP divergent subfamily of APPLE domains | Back alignment and domain information |
|---|
Probab=98.25 E-value=1.8e-06 Score=71.46 Aligned_cols=72 Identities=33% Similarity=0.629 Sum_probs=53.7
Q ss_pred CceEEeeeecCCCCcccccccccCHHHHHHHHhc-cCceeeeecccccCCCccceecc-cccccccccCCCCcceeee
Q 004674 370 DGFLEHKAVKLPDTRFSWVDKNITLWECKELCSK-NCSCTAYANADVRGRGSGCLLWF-HDLIDIKELPESGQDLFIR 445 (738)
Q Consensus 370 ~~f~~~~~~~~p~~~~~~~~~~~s~~~C~~~Cl~-~CsC~a~~~~~~~~~~~~C~~w~-~~l~~~~~~~~~~~~lyir 445 (738)
..|.+++++.+++..... ....++++|++.|++ +|+|.||.|.. .+.+|.+|. +.+.+.+..+..+.++|.|
T Consensus 4 ~~f~~~~~~~l~~~~~~~-~~~~s~~~C~~~C~~~~~~C~s~~y~~---~~~~C~l~~~~~~~~~~~~~~~~~~~y~~ 77 (78)
T smart00473 4 DCFVRLPNTKLPGFSRIV-ISVASLEECASKCLNSNCSCRSFTYNN---GTKGCLLWSESSLGDARLFPSGGVDLYEK 77 (78)
T ss_pred ceeEEecCccCCCCccee-EcCCCHHHHHHHhCCCCCceEEEEEcC---CCCEEEEeeCCccccceecccCCceeEEe
Confidence 568899999998665432 346799999999999 99999999964 356899999 6666665444444455543
|
Apple-like domains present in Plasminogen, C. elegans hypothetical ORFs and the extracellular portion of plant receptor-like protein kinases. Predicted to possess protein- and/or carbohydrate-binding functions. |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.10 E-value=3.2e-05 Score=76.33 Aligned_cols=137 Identities=16% Similarity=0.178 Sum_probs=88.4
Q ss_pred cCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHH---------HHHHHHHhHhcCC---CeeeEEeEEe
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEF---------KNEVLLIAKLQHR---NLVKLLGCCT 583 (738)
Q Consensus 516 ~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~---------~~Ei~il~~l~H~---nIv~l~g~~~ 583 (738)
..+|+..+.+-......|.+-.. +++.+++|..+.......+.| .+++..+.+++.. ....++.+..
T Consensus 30 ~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl~~e 108 (229)
T PF06176_consen 30 DNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYLAAE 108 (229)
T ss_pred hCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccceeeee
Confidence 45677766776666666666555 578889998765433222222 2334444444322 2222222222
Q ss_pred -----cCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCce
Q 004674 584 -----QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (738)
Q Consensus 584 -----~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~v 658 (738)
.....+|+|||++|..|.+... ++. .++..+.+++.-||+.| +.|+|.+|.|++++++ .+
T Consensus 109 kk~~~~~~~~~ll~EYIeG~~l~d~~~-------i~e----~~~~ki~~~ikqlH~~G---~~HGD~hpgNFlv~~~-~i 173 (229)
T PF06176_consen 109 KKIFRYTSSYVLLMEYIEGVELNDIED-------IDE----DLAEKIVEAIKQLHKHG---FYHGDPHPGNFLVSNN-GI 173 (229)
T ss_pred eeeccceeEEEEEEEEecCeecccchh-------cCH----HHHHHHHHHHHHHHHcC---CccCCCCcCcEEEECC-cE
Confidence 2234568999999988865531 222 24456778899999998 9999999999999865 59
Q ss_pred EEEeecCccc
Q 004674 659 KISDFGLARS 668 (738)
Q Consensus 659 kL~DFGla~~ 668 (738)
++.||+..+.
T Consensus 174 ~iID~~~k~~ 183 (229)
T PF06176_consen 174 RIIDTQGKRM 183 (229)
T ss_pred EEEECccccc
Confidence 9999987653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.06 E-value=5.2e-05 Score=77.84 Aligned_cols=141 Identities=15% Similarity=0.131 Sum_probs=85.3
Q ss_pred eeccccc-EeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhc-CCCeeeEEeEEecCCcceEEEeeCCCCChh
Q 004674 524 KLGEGGF-GPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601 (738)
Q Consensus 524 ~LG~G~f-G~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~-H~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~ 601 (738)
.|-.|.. ..||+.... +..+.+|+..... ..+...|++++..+. +.-+.+++++....+..++|||++++.+|.
T Consensus 5 ~~~~g~~~~~v~~~~~~-~~~~~vk~~~~~~---~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~ 80 (244)
T cd05150 5 RVTEGQSGATVYRLDGK-NPGLYLKIAPSGP---TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAA 80 (244)
T ss_pred ecCCCCCcCeEEEEcCC-CCcEEEEecCCCc---ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHh
Confidence 3555555 788988764 4678888875432 345778999988884 444556777776666789999999998876
Q ss_pred HHHh------------------hcCC--CCCCCH--HHHHHHHH--------------------HHHHHHHHHHh----C
Q 004674 602 YFIF------------------DTTR--SKLLDW--SKRSHIIA--------------------GIARGLLYLHQ----D 635 (738)
Q Consensus 602 ~~l~------------------~~~~--~~~l~~--~~~~~i~~--------------------~ia~gL~yLH~----~ 635 (738)
.... +... ..++.. ........ .+...+..|-. .
T Consensus 81 ~~~~~~~~~~~~~~l~~~l~~lH~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 160 (244)
T cd05150 81 ALWEELEPERLVDALAEALRRLHALPVADCPFDRRLDRRLAEARARVENGLVDEDDFDDERRGWSAEELYAELEATRPAE 160 (244)
T ss_pred HhhcccCHHHHHHHHHHHHHHHhcCCcccCCcchhHHHHHHHHHHHHhcCCcChhhCcHhhcCCCHHHHHHHHHhhCCCc
Confidence 4321 0000 001110 00000000 01111222211 1
Q ss_pred CCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 636 ~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
..+.++|+|+.|.|||++++..+.|+||+.+..
T Consensus 161 ~~~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 161 EDLVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred CceEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 234599999999999999987789999998753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.01 E-value=6.5e-05 Score=74.95 Aligned_cols=138 Identities=16% Similarity=0.225 Sum_probs=92.4
Q ss_pred ceecccccEeEEEeeeccccEEEEEEccCCCC-------------------cchHH-----HHHHHHHHhHhc--CCCee
Q 004674 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG-------------------QGMEE-----FKNEVLLIAKLQ--HRNLV 576 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~-------------------~~~~~-----~~~Ei~il~~l~--H~nIv 576 (738)
..|.+|.-+.||+|...++..+|+|++..... ...++ .+.|...|.++. +-.+.
T Consensus 54 g~istGKEA~Vy~a~~~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrvP 133 (268)
T COG1718 54 GCISTGKEANVYLAETGDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRVP 133 (268)
T ss_pred eeecCCcceEEEeeccCCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCCC
Confidence 46778999999999988899999998743210 01111 234666676664 33444
Q ss_pred eEEeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCC
Q 004674 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656 (738)
Q Consensus 577 ~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~ 656 (738)
+.+.+. .-.|||||+.......=. ...-++...+...+..++++.+.-|-... .+||+||..=|||+. ++
T Consensus 134 ~Pi~~~----~nVLvMEfIg~~g~pAP~---LkDv~~e~~e~~~~~~~~v~~~~~l~~~a--~LVHgDLSEyNiL~~-~~ 203 (268)
T COG1718 134 EPIAFR----NNVLVMEFIGDDGLPAPR---LKDVPLELEEAEGLYEDVVEYMRRLYKEA--GLVHGDLSEYNILVH-DG 203 (268)
T ss_pred Cceeec----CCeEEEEeccCCCCCCCC---cccCCcCchhHHHHHHHHHHHHHHHHHhc--CcccccchhhheEEE-CC
Confidence 444443 246999999765211000 01112233356677788999999887733 399999999999999 88
Q ss_pred ceEEEeecCccccC
Q 004674 657 NPKISDFGLARSFG 670 (738)
Q Consensus 657 ~vkL~DFGla~~~~ 670 (738)
.+.|+|+|-|....
T Consensus 204 ~p~iID~~QaV~~~ 217 (268)
T COG1718 204 EPYIIDVSQAVTID 217 (268)
T ss_pred eEEEEECccccccC
Confidence 99999999887654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.01 E-value=3.9e-05 Score=85.77 Aligned_cols=140 Identities=16% Similarity=0.205 Sum_probs=90.0
Q ss_pred ceecccccEeEEEeeeccccEEEEEEccCCCCcc-------------------------------------hHHHHHHHH
Q 004674 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQG-------------------------------------MEEFKNEVL 565 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~-------------------------------------~~~~~~Ei~ 565 (738)
+.|+..+.|.||++++++|+.||||+-+..-+.. .-+|..|.+
T Consensus 167 ~piaaASlaQVhrA~L~~G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA~ 246 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKNGEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEAK 246 (538)
T ss_pred chhhhcchhheEEEEecCCCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHHH
Confidence 5899999999999999999999999865331110 112334444
Q ss_pred HHhHh----cCCCe---eeEEeEEe-cCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH-HhCC
Q 004674 566 LIAKL----QHRNL---VKLLGCCT-QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL-HQDS 636 (738)
Q Consensus 566 il~~l----~H~nI---v~l~g~~~-~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yL-H~~~ 636 (738)
...+. +|-++ |.+-.++. -...+.|+||||+|..+.+...-.. ..++...+ +..+.++...+ =..|
T Consensus 247 Nae~~~~~f~~~~~~~~V~VP~Vy~~~st~RVLtME~~~G~~i~Dl~~i~~--~gi~~~~i---~~~l~~~~~~qIf~~G 321 (538)
T KOG1235|consen 247 NAERFRENFKDFSLLTYVLVPKVYWDLSTKRVLTMEYVDGIKINDLDAIDK--RGISPHDI---LNKLVEAYLEQIFKTG 321 (538)
T ss_pred hHHHHHHHHHhcccccceeCCeehhhcCcceEEEEEecCCccCCCHHHHHH--cCCCHHHH---HHHHHHHHHHHHHhcC
Confidence 44333 35551 22333332 2346899999999998877643222 23444433 33333333222 1223
Q ss_pred CCCeEeCCCCCCcEEEcC----CCceEEEeecCccccC
Q 004674 637 RLRIIHRDLKASNVLLDN----TMNPKISDFGLARSFG 670 (738)
Q Consensus 637 ~~~ivH~DLkp~NILl~~----~~~vkL~DFGla~~~~ 670 (738)
.+|+|=+|.||++.. +.++.+-|||+...+.
T Consensus 322 ---ffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 322 ---FFHADPHPGNILVRPNPEGDEEIVLLDHGLYAVIS 356 (538)
T ss_pred ---CccCCCCCCcEEEecCCCCCccEEEEccccccccc
Confidence 999999999999983 6789999999987653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.01 E-value=5.9e-07 Score=98.91 Aligned_cols=189 Identities=18% Similarity=0.141 Sum_probs=133.6
Q ss_pred hcCCCCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCC-eeeEEeEEecCCcceEEEe
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN-LVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 515 ~~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n-Iv~l~g~~~~~~~~~lV~E 593 (738)
.++.+...+.+++++++.++|.+....+....+.+... ....-++++|.+++||| .+..++-+..++...++++
T Consensus 240 k~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~-----l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~ 314 (829)
T KOG0576|consen 240 KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT-----LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMR 314 (829)
T ss_pred CccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc-----hhhHHHHHHHHHccCCCCcccccccCCcccccchhhh
Confidence 34445556678999999999987654454445544322 55677899999999999 7777777777788899999
Q ss_pred eCCCC-ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCC
Q 004674 594 YLPNK-SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 594 y~~~g-sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~ 672 (738)
++..+ +-..-. ....-.+...+...+...-++++++||+.. -+|+| ||+..+ ...|..||+.+..+...
T Consensus 315 i~s~~rs~~~~~--~~se~~~~~~~~~~~~r~et~~l~~l~~~~---~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~ 384 (829)
T KOG0576|consen 315 ICSTGRSSALEM--TVSEIALEQYQFAYPLRKETRPLAELHSSY---KVHRD----NILGSE-EEVKLLDFAVPPQLTRT 384 (829)
T ss_pred hhcCCccccccC--ChhhHhhhhhhhhhhhhhhccccccccccc---ccCcc----cccccc-cccccccccCCcccCcc
Confidence 99877 221111 001111333334445556778899999864 48888 777766 68899999998776543
Q ss_pred cccccccccccccCccchhcccCCCCCchhHHHHHHHHHHHHHcCCCCC
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNR 721 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~ksDVwS~Gvil~elltG~~p~ 721 (738)
. ..+...+++.++|||+..+..+..+.|+|+.|+=..++.-|-.|-
T Consensus 385 ~---~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr 430 (829)
T KOG0576|consen 385 M---KPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPR 430 (829)
T ss_pred c---ccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCC
Confidence 3 233467899999999999999999999999998666666666554
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.99 E-value=4.4e-05 Score=77.30 Aligned_cols=144 Identities=20% Similarity=0.202 Sum_probs=84.8
Q ss_pred cceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCC--eeeEEeEEecC---CcceEEEeeCC
Q 004674 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLGCCTQR---DERMLIYEYLP 596 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n--Iv~l~g~~~~~---~~~~lV~Ey~~ 596 (738)
++.|+.|..+.||+....+ ..+++|..... .....+.+|..+++.+.... +.+++...... ...+++||+++
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~~~vlK~~~~~--~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~ 78 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-GRYVLKFYRPP--DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIP 78 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-SEEEEEEESSH--HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEES
T ss_pred CccCCCCCeeeEEEEEECC-cEEEEEEeCCC--CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEec
Confidence 3578999999999999876 68999986543 34567889999998886443 45666544322 23689999999
Q ss_pred CCChhH----------------HHh---hc-CCCCCCCHHHHH---------HH------------HHHHHH-HHHHHHh
Q 004674 597 NKSLDY----------------FIF---DT-TRSKLLDWSKRS---------HI------------IAGIAR-GLLYLHQ 634 (738)
Q Consensus 597 ~gsL~~----------------~l~---~~-~~~~~l~~~~~~---------~i------------~~~ia~-gL~yLH~ 634 (738)
+..+.. .+. .. .....+...... .. ...+.+ .++.+++
T Consensus 79 g~~~~~~~~~~~~~~~~~~~~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (239)
T PF01636_consen 79 GRPLDDELSPEQRPELLRQLGRALAQLHQVPPPFSPFADWPEWRLEFLRQLESWTARLRASELFDDLEELEERLLQELEA 158 (239)
T ss_dssp SEEHHHTSTHHHHHHHHHHHHHHHHHHHHSHTTCCCHTHHHHHHHHHHHHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHH
T ss_pred cccccccccccccccccccchhhhhhcccccccccccccccccccccccccccccccccchhhhhhhHHHHHHHHHHHHh
Confidence 998877 110 11 011111111100 00 111222 2333332
Q ss_pred ----CCCCCeEeCCCCCCcEEEc-CCCceEEEeecCccc
Q 004674 635 ----DSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARS 668 (738)
Q Consensus 635 ----~~~~~ivH~DLkp~NILl~-~~~~vkL~DFGla~~ 668 (738)
.....++|+|+.|+|||++ +++.+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 159 LLPKPLPPVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp HHHCCSCEEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred hhccCCCcEEEEeccccccceeeeccceeEEEecccceE
Confidence 2345699999999999999 666668999988753
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.94 E-value=3.8e-05 Score=75.25 Aligned_cols=105 Identities=24% Similarity=0.235 Sum_probs=82.9
Q ss_pred HHHHHHHhHhcC-CCeeeEEeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 004674 561 KNEVLLIAKLQH-RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639 (738)
Q Consensus 561 ~~Ei~il~~l~H-~nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ 639 (738)
.+|..+++.+++ +++.+++|.|- .++|.||...+++...-..-..-...+|..|.+||.++++.+.+|++.....
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 458888889876 69999999995 3789999987765321000011123689999999999999999998855445
Q ss_pred eEeCCCCCCcEEEcCCCceEEEeecCcccc
Q 004674 640 IIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 640 ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 669 (738)
+..+|++|+|+-+++++.+|+.|...+...
T Consensus 83 ~~lcDv~~~nfgv~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGVNDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEEeCCCcEEEEechhcchh
Confidence 899999999999999999999999877654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.82 E-value=3.5e-06 Score=94.19 Aligned_cols=99 Identities=22% Similarity=0.430 Sum_probs=75.7
Q ss_pred HHHHHHHHHHHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCccccCCCcc------cccc-cccccccCccchhcccC
Q 004674 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT------EANT-KRVVGTYGYMSPEYAID 695 (738)
Q Consensus 623 ~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~~~~~~------~~~~-~~~~gt~~y~aPE~~~~ 695 (738)
.+++.|+.|+|..- ++||++|.|++|.++..+..||+.|+.+.....+.. .... .-..-...|.|||++.+
T Consensus 106 ~~v~dgl~flh~sA--k~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~ 183 (700)
T KOG2137|consen 106 GNVADGLAFLHRSA--KVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLG 183 (700)
T ss_pred hcccchhhhhccCc--ceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcc
Confidence 44669999999864 699999999999999999999999998765432111 0000 00123458999999999
Q ss_pred CCCCchhHHHHHHHHHHHHH-cCCCCCCC
Q 004674 696 GLFSVKSDVFSFGVLVLEII-CGKKNRGF 723 (738)
Q Consensus 696 ~~~t~ksDVwS~Gvil~ell-tG~~p~~~ 723 (738)
...+.++|++|+|++++-+. .|+.-+..
T Consensus 184 ~~~~~~sd~fSlG~li~~i~~~gk~i~~a 212 (700)
T KOG2137|consen 184 TTNTPASDVFSLGVLIYTIYNGGKSIIAA 212 (700)
T ss_pred ccccccccceeeeeEEEEEecCCcchhhc
Confidence 88999999999999999999 55554444
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=97.80 E-value=0.00036 Score=68.73 Aligned_cols=133 Identities=16% Similarity=0.252 Sum_probs=91.8
Q ss_pred ccceecccccEeEEEeeeccccEEEEEEccCCC----------------CcchHHHHHHHHHHhHhc------CCCeeeE
Q 004674 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS----------------GQGMEEFKNEVLLIAKLQ------HRNLVKL 578 (738)
Q Consensus 521 ~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~----------------~~~~~~~~~Ei~il~~l~------H~nIv~l 578 (738)
....||+|+.-.||. +++....+||+..... ....++..+|+.-...+. +.+|.++
T Consensus 5 ~~~~i~~G~~R~cy~--HP~dp~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 5 ESDLIAQGGERDCYQ--HPDDPNLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CCcccccCCCceEEE--CCCCCCeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 345799999999995 5556677888875544 123456677777666665 8899999
Q ss_pred EeEEecCCcceEEEeeCCC--C----ChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEE
Q 004674 579 LGCCTQRDERMLIYEYLPN--K----SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (738)
Q Consensus 579 ~g~~~~~~~~~lV~Ey~~~--g----sL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 652 (738)
+|..++....-+|+|.+.+ | +|.+++. .+.++. ...+.+. +-..||-++. |+.+||+|+||++
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~----~~~~~~-~~~~~L~---~f~~~l~~~~---Iv~~dl~~~NIv~ 151 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNISPTLEDYLK----EGGLTE-ELRQALD---EFKRYLLDHH---IVIRDLNPHNIVV 151 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCcCccHHHHHH----cCCccH-HHHHHHH---HHHHHHHHcC---CeecCCCcccEEE
Confidence 9999999999999998753 2 5666662 233554 3333333 3445665555 9999999999999
Q ss_pred cCC---C-ceEEEe-ecCc
Q 004674 653 DNT---M-NPKISD-FGLA 666 (738)
Q Consensus 653 ~~~---~-~vkL~D-FGla 666 (738)
... . .+.|+| ||-.
T Consensus 152 ~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 152 QRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred EecCCCceEEEEEeCCCCc
Confidence 532 2 577888 4543
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF01453 B_lectin: D-mannose binding lectin; InterPro: IPR001480 A bulb lectin super-family (Amaryllidaceae, Orchidaceae and Aliaceae) contains a ~115-residue-long domain whose overall three dimensional fold is very similar to that of [, ]: Dictyostelium discoideum comitin, an actin binding protein Curculigo latifolia curculin, a sweet tasting and taste-modifying protein This domain generally binds mannose, but in at least one protein, curculin, it is apparently devoid of mannose-binding activity | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00037 Score=62.32 Aligned_cols=99 Identities=25% Similarity=0.434 Sum_probs=61.6
Q ss_pred eEeeCCCeEEEEeecCCCCCceeEEEeeeecCCCcEEEee-cCCCCCccCCccEEEeecCCceEEEECCCCCeEEEecCC
Q 004674 59 TLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVA-NRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSS 137 (738)
Q Consensus 59 ~l~s~~g~f~lgF~~~~~~~~~yl~iw~~~~~~~t~VW~A-nr~~p~~~~~~~l~~~~~~~g~l~l~~~~~~~~ws~~~~ 137 (738)
.+.+.+|.+.|-|-..|+ |.| |. ...++||.. +...... ....+.|. +||||||+|..+.++|++..
T Consensus 13 p~~~~s~~~~L~l~~dGn-----Lvl-~~--~~~~~iWss~~t~~~~~-~~~~~~L~--~~GNlvl~d~~~~~lW~Sf~- 80 (114)
T PF01453_consen 13 PLTSSSGNYTLILQSDGN-----LVL-YD--SNGSVIWSSNNTSGRGN-SGCYLVLQ--DDGNLVLYDSSGNVLWQSFD- 80 (114)
T ss_dssp EEEECETTEEEEEETTSE-----EEE-EE--TTTEEEEE--S-TTSS--SSEEEEEE--TTSEEEEEETTSEEEEESTT-
T ss_pred ccccccccccceECCCCe-----EEE-Ec--CCCCEEEEecccCCccc-cCeEEEEe--CCCCEEEEeecceEEEeecC-
Confidence 344444777777765433 233 22 335779999 4333322 35678887 99999999999999999952
Q ss_pred CCCCcceEEEec--CCcEEEecCCCCCCCceeeeeccCCC
Q 004674 138 ISAQKPVAALME--SGNLVVKDGKDNNPDNILWQSFDYPC 175 (738)
Q Consensus 138 ~~~~~~~a~l~d--~GNlvl~~~~~~~~~~~~WqSFd~PT 175 (738)
.........++ .||++ .... ..+.|.|=+.|.
T Consensus 81 -~ptdt~L~~q~l~~~~~~-~~~~----~~~sw~s~~dps 114 (114)
T PF01453_consen 81 -YPTDTLLPGQKLGDGNVT-GKND----SLTSWSSNTDPS 114 (114)
T ss_dssp -SSS-EEEEEET--TSEEE-EEST----SSEEEESS----
T ss_pred -CCccEEEeccCcccCCCc-cccc----eEEeECCCCCCC
Confidence 23455567777 89999 5432 578998877663
|
Each bulb-type lectin domain consists of three sequential beta-sheet subdomains (I, II, III) that are inter-related by pseudo three-fold symmetry. The three subdomains are flat four-stranded, antiparrallel beta-sheets. Together they form a 12-stranded beta-barrel in which the barrel axis coincides with the pseudo 3-fold axis.; GO: 0005529 sugar binding; PDB: 3M7H_A 3M7J_B 3MEZ_D 1DLP_A 1BWU_D 1KJ1_A 1B2P_A 1XD6_A 2DPF_C 2D04_B .... |
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00047 Score=83.32 Aligned_cols=79 Identities=20% Similarity=0.377 Sum_probs=57.8
Q ss_pred cceecccccEeEEEeeeccc---cEEEEEEccCCCC-cchHHHHHHHHHHhHhc-CCCe--eeEEeEEecC---CcceEE
Q 004674 522 KNKLGEGGFGPVYKGMLIEG---QEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQ-HRNL--VKLLGCCTQR---DERMLI 591 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g---~~vavK~l~~~~~-~~~~~~~~Ei~il~~l~-H~nI--v~l~g~~~~~---~~~~lV 591 (738)
.+.++.|.+..+|+.....+ ..+++|+...... .....+.+|.++++.+. |.++ .+++.+|.+. ...++|
T Consensus 43 v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flV 122 (822)
T PLN02876 43 VSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQSAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYI 122 (822)
T ss_pred EEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCccHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEE
Confidence 46789999999999876553 4677777643321 23457889999999995 6665 7778887664 357899
Q ss_pred EeeCCCCCh
Q 004674 592 YEYLPNKSL 600 (738)
Q Consensus 592 ~Ey~~~gsL 600 (738)
|||+++..+
T Consensus 123 ME~v~G~~~ 131 (822)
T PLN02876 123 MEYLEGRIF 131 (822)
T ss_pred EEecCCccc
Confidence 999998654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.72 E-value=0.00027 Score=72.16 Aligned_cols=73 Identities=15% Similarity=0.269 Sum_probs=45.8
Q ss_pred ceecccccEe-EEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCC---CeeeEEeEEecCC---cceEEEeeC
Q 004674 523 NKLGEGGFGP-VYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR---NLVKLLGCCTQRD---ERMLIYEYL 595 (738)
Q Consensus 523 ~~LG~G~fG~-Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~---nIv~l~g~~~~~~---~~~lV~Ey~ 595 (738)
+.|+.|+... ||+. +..+++|..+.. .....+.+|.+++..+... -+.+.++.....+ ..+++||++
T Consensus 3 ~~~~~gG~~n~vy~~----~~~~VlR~~~~~--~~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i 76 (235)
T cd05155 3 EPVDSGGTDNATFRL----GDDMSVRLPSAA--GYAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWL 76 (235)
T ss_pred eeccCCCcccceEEc----CCceEEEcCCcc--chHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEee
Confidence 4678777764 8874 235677765432 2345788999999888532 2334444333221 347899999
Q ss_pred CCCChh
Q 004674 596 PNKSLD 601 (738)
Q Consensus 596 ~~gsL~ 601 (738)
+|.++.
T Consensus 77 ~G~~l~ 82 (235)
T cd05155 77 EGETAT 82 (235)
T ss_pred cCCCCC
Confidence 997774
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.67 E-value=0.00061 Score=69.39 Aligned_cols=74 Identities=20% Similarity=0.293 Sum_probs=49.3
Q ss_pred ceecccccEeEEEeeecc--ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCee-eEEeEEecCCcceEEEeeCCCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGCCTQRDERMLIYEYLPNKS 599 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~--g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gs 599 (738)
+.|..|-...+|+....+ ++.+++|+...... ......+|+.++..+...+++ ++++... ..++|||+++.+
T Consensus 4 ~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~-~~~d~~~E~~~~~~l~~~gl~P~v~~~~~----~~~l~e~i~G~~ 78 (235)
T cd05157 4 KRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTE-LIIDRERELRIHKLLSKHGLAPKLYATFQ----NGLIYEFIPGRT 78 (235)
T ss_pred EEcCCcccceEEEEEcCCCCCCeEEEEEccCCcc-ceecHHHHHHHHHHHHhCCCCCeEEEEeC----CcEEEEeeCCCc
Confidence 467888889999987764 67888997754322 222345788888888654443 3443322 248999999877
Q ss_pred hh
Q 004674 600 LD 601 (738)
Q Consensus 600 L~ 601 (738)
+.
T Consensus 79 l~ 80 (235)
T cd05157 79 LE 80 (235)
T ss_pred CC
Confidence 63
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0005 Score=65.06 Aligned_cols=129 Identities=20% Similarity=0.239 Sum_probs=86.4
Q ss_pred ccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCeee-EEeEEecCCcceEEEeeCCCCC
Q 004674 521 EKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK-LLGCCTQRDERMLIYEYLPNKS 599 (738)
Q Consensus 521 ~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv~-l~g~~~~~~~~~lV~Ey~~~gs 599 (738)
..+.|++|.+|.||+|... +..+|+|+-+.. .....+..|.+++..++-.++-+ ++.+-. -.+.|||+.+-.
T Consensus 26 v~~~L~KG~~s~Vyl~~~~-~~~~a~Kvrr~d--s~r~~l~kEakiLeil~g~~~~p~vy~yg~----~~i~me~i~G~~ 98 (201)
T COG2112 26 VEKELAKGTTSVVYLGEWR-GGEVALKVRRRD--SPRRNLEKEAKILEILAGEGVTPEVYFYGE----DFIRMEYIDGRP 98 (201)
T ss_pred hhhhhhcccccEEEEeecc-CceEEEEEecCC--cchhhHHHHHHHHHHhhhcCCCceEEEech----hhhhhhhhcCcc
Confidence 3467999999999999884 458888875433 34578899999999998766643 333322 234599999988
Q ss_pred hhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCC-CCcEEEcCCCceEEEeecCcccc
Q 004674 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLK-ASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 600 L~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLk-p~NILl~~~~~vkL~DFGla~~~ 669 (738)
|...-... + + +-...+++.---|...+ |-|+.|. |..++|-.+..+.|+||..|..-
T Consensus 99 L~~~~~~~------~---r-k~l~~vlE~a~~LD~~G---I~H~El~~~~k~vlv~~~~~~iIDFd~At~k 156 (201)
T COG2112 99 LGKLEIGG------D---R-KHLLRVLEKAYKLDRLG---IEHGELSRPWKNVLVNDRDVYIIDFDSATFK 156 (201)
T ss_pred hhhhhhcc------c---H-HHHHHHHHHHHHHHHhc---cchhhhcCCceeEEecCCcEEEEEccchhhc
Confidence 86654211 1 1 22334555544455545 8888886 45455555559999999998743
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.0012 Score=69.79 Aligned_cols=79 Identities=14% Similarity=0.120 Sum_probs=57.3
Q ss_pred CCccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcC---CCeeeEEeEEecC---CcceEEE
Q 004674 519 FSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH---RNLVKLLGCCTQR---DERMLIY 592 (738)
Q Consensus 519 ~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H---~nIv~l~g~~~~~---~~~~lV~ 592 (738)
....+.||.|..+.||+....++ .+.+|..+. ......+..|.+.++.+.. ..+.++++.+..+ +..+|||
T Consensus 16 ~~~~~~i~~G~~~~vy~~~~~~~-~~~~k~~~~--~~~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVm 92 (297)
T PRK10593 16 LSRVECISEQPYAALWALYDSQG-NPMPLMARS--FSTPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLL 92 (297)
T ss_pred hheeeecCCccceeEEEEEcCCC-CEEEEEecc--cccchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEE
Confidence 34456899999999999876555 466666432 1133578999999998853 3577888877543 5589999
Q ss_pred eeCCCCCh
Q 004674 593 EYLPNKSL 600 (738)
Q Consensus 593 Ey~~~gsL 600 (738)
|++++.++
T Consensus 93 E~i~G~~~ 100 (297)
T PRK10593 93 ERLRGVSV 100 (297)
T ss_pred eccCCEec
Confidence 99998765
|
|
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0005 Score=71.15 Aligned_cols=139 Identities=17% Similarity=0.119 Sum_probs=80.0
Q ss_pred eecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCee-eEEeEEecCCcceEEEeeCCCCChhH
Q 004674 524 KLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGCCTQRDERMLIYEYLPNKSLDY 602 (738)
Q Consensus 524 ~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~gsL~~ 602 (738)
.+..|-...+|+... +++.+++|..............+|.++++.+....++ +++.... ..+||||+++..+..
T Consensus 3 ~~~~G~tn~~y~~~~-~~~~~vlR~~~~~~~~~~~~r~~E~~~l~~l~~~g~~P~~i~~~~----~~~v~e~i~G~~~~~ 77 (256)
T TIGR02721 3 TLSGGLTNRSWRIEH-PGISFVWRPQSPVCKALGVDRQREYQILQALSALGLAPKPILVNE----HWLLVEWLEGEVITL 77 (256)
T ss_pred cCCCcCcCCeEEEEe-CCccEEEeeCCcccccccCcHHHHHHHHHHHHhcCCCCceEEEeC----CEEEEEeccCccccc
Confidence 356677888998763 5677888876543322212457889999888654443 3343322 368999999877642
Q ss_pred H-----------------HhhcC-CCCCCCHHHH-HHHHHH---------HHHHHHHHHhC-----CCCCeEeCCCCCCc
Q 004674 603 F-----------------IFDTT-RSKLLDWSKR-SHIIAG---------IARGLLYLHQD-----SRLRIIHRDLKASN 649 (738)
Q Consensus 603 ~-----------------l~~~~-~~~~l~~~~~-~~i~~~---------ia~gL~yLH~~-----~~~~ivH~DLkp~N 649 (738)
. ++... ...+++.... .++..+ +...+..+... .+..++|+|+.|.|
T Consensus 78 ~~~~~~~~~~~la~~l~~lH~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~H~Dl~~~N 157 (256)
T TIGR02721 78 DQFVALDLLLELAALLHQLHSQPRFGYPLSLKARIAHYWLQIDPARRTPEWLRLYKQFRSAPEPAPLPLAPLHMDVHAYN 157 (256)
T ss_pred ccccCchhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHHhcccccCChHHHHHHHHHHhccCCCCCCCeeecCCCCcCc
Confidence 1 11111 1112222211 111111 11112222111 12358999999999
Q ss_pred EEEcCCCceEEEeecCccc
Q 004674 650 VLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 650 ILl~~~~~vkL~DFGla~~ 668 (738)
|++++++ +.|+||..+..
T Consensus 158 il~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 158 LVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred EEEeCCC-CEEEeccccCc
Confidence 9999876 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=97.55 E-value=0.00097 Score=65.22 Aligned_cols=125 Identities=26% Similarity=0.375 Sum_probs=90.1
Q ss_pred CCCCccceeccccc-EeEEEeeeccccEEEEEEccC---CCC------------------cchHHHHHHHHHHhHhc---
Q 004674 517 DNFSEKNKLGEGGF-GPVYKGMLIEGQEIAVKRLSK---GSG------------------QGMEEFKNEVLLIAKLQ--- 571 (738)
Q Consensus 517 ~~~~~~~~LG~G~f-G~Vykg~~~~g~~vavK~l~~---~~~------------------~~~~~~~~Ei~il~~l~--- 571 (738)
.+++.++.||.|.- |.|||+.. +|+.+|+|.+.. ... .....|..|.+...+++
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I-~g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~~ 115 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEI-DGRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEAG 115 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEE-CCeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhcc
Confidence 77888999999999 99999998 678999999321 100 11235788999888885
Q ss_pred CCCe--eeEEeEEecC------------------CcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHH
Q 004674 572 HRNL--VKLLGCCTQR------------------DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631 (738)
Q Consensus 572 H~nI--v~l~g~~~~~------------------~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~y 631 (738)
+.++ |+.+|+..-. ..+.||.||++... .+. ..-+.+|.+-|..
T Consensus 116 ~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------~~~----~~~~~~~~~dl~~ 179 (207)
T PF13095_consen 116 REGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------PLQ----IRDIPQMLRDLKI 179 (207)
T ss_pred ccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------ccc----hhHHHHHHHHHHH
Confidence 4455 8999987321 11467888876543 111 2234567788888
Q ss_pred HHhCCCCCeEeCCCCCCcEEEcCCCceEEEeecCc
Q 004674 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (738)
Q Consensus 632 LH~~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla 666 (738)
+|..+ |+-+|+++.|.. .-||+|||.+
T Consensus 180 ~~k~g---I~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 180 LHKLG---IVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred HHHCC---eeeccCcccccc-----CCEEEecccC
Confidence 99988 999999999985 4579999864
|
|
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.0025 Score=69.54 Aligned_cols=76 Identities=14% Similarity=0.198 Sum_probs=54.5
Q ss_pred cceecccccEeEEEeeeccc-cEEEEEEccCC-----C--CcchHHHHHHHHHHhHhc---CCCeeeEEeEEecCCcceE
Q 004674 522 KNKLGEGGFGPVYKGMLIEG-QEIAVKRLSKG-----S--GQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g-~~vavK~l~~~-----~--~~~~~~~~~Ei~il~~l~---H~nIv~l~g~~~~~~~~~l 590 (738)
.+.||.|.+..||++...+| +.++||.-... . ....+++..|.+.|..+. ..++.+++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 35799999999999998776 58999974311 1 224567788888888763 2456666666 4466889
Q ss_pred EEeeCCCCC
Q 004674 591 IYEYLPNKS 599 (738)
Q Consensus 591 V~Ey~~~gs 599 (738)
||||+++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998743
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.29 E-value=0.0016 Score=68.81 Aligned_cols=143 Identities=20% Similarity=0.188 Sum_probs=86.5
Q ss_pred cceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCC--eeeEEeE------EecCCcceEEEe
Q 004674 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLGC------CTQRDERMLIYE 593 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n--Iv~l~g~------~~~~~~~~lV~E 593 (738)
.+.|..|....+|+....+ ..+++|+... ...++...|++++..+++.+ +.+++.. ....+..++|+|
T Consensus 19 i~~i~~G~~n~~y~v~~~~-~~~vLr~~~~---~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~ 94 (296)
T cd05153 19 FEGISAGIENTNYFVTTDS-GRYVLTLFEK---VSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVE 94 (296)
T ss_pred eecccCccccceEEEEeCC-CcEEEEEcCC---CChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEE
Confidence 4567778888999887644 4688888754 23456778888888885433 3444432 122345689999
Q ss_pred eCCCCChhH----H----------HhhcCC--------CCCCCHHHHH----------HHHHHHHHHHHHHHh----CCC
Q 004674 594 YLPNKSLDY----F----------IFDTTR--------SKLLDWSKRS----------HIIAGIARGLLYLHQ----DSR 637 (738)
Q Consensus 594 y~~~gsL~~----~----------l~~~~~--------~~~l~~~~~~----------~i~~~ia~gL~yLH~----~~~ 637 (738)
|++|..+.. . ++.... .....|.... .....+..++.++.+ ..+
T Consensus 95 ~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~ 174 (296)
T cd05153 95 FLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLP 174 (296)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCC
Confidence 999877632 0 010000 0111222111 011123344555543 122
Q ss_pred CCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 638 ~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
..++|+|++|.||+++++..+.|.||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 3599999999999999987778999998753
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.27 E-value=0.0023 Score=67.87 Aligned_cols=141 Identities=25% Similarity=0.346 Sum_probs=83.9
Q ss_pred ceecccccEeEEEeeecc-------ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCee-eEEeEEecCCcceEEEee
Q 004674 523 NKLGEGGFGPVYKGMLIE-------GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-------g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv-~l~g~~~~~~~~~lV~Ey 594 (738)
+.+..|-...+|+....+ ++.+++|+..... ....+..+|.+++..+....+. ++++.+.. .+|+||
T Consensus 4 ~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~-~~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~v~e~ 78 (302)
T cd05156 4 SKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSV-ELLIDRERELVVFARLSERNLGPKLYGIFPN----GRIEEF 78 (302)
T ss_pred EEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCC-cceechHHHHHHHHHHHhCCCCCceEEEeCC----Cchhhe
Confidence 456667777899887654 4788899865443 2334567888888888644443 44544432 358999
Q ss_pred CCCCChhHHH-----------------hhcCCCC------CCC--HHHHHH--------------------------HHH
Q 004674 595 LPNKSLDYFI-----------------FDTTRSK------LLD--WSKRSH--------------------------IIA 623 (738)
Q Consensus 595 ~~~gsL~~~l-----------------~~~~~~~------~l~--~~~~~~--------------------------i~~ 623 (738)
++|..+.... +...... ..+ +....+ +..
T Consensus 79 i~G~~l~~~~~~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (302)
T cd05156 79 IPSRTLTTEELRDPDISAEIARRMAKLHSIVVPLSPEERDLTPAIWKLLKQWLDLAETVIEIVDSDSEKLLEVELSLFLE 158 (302)
T ss_pred eCCCcCCHhHcCCcHHHHHHHHHHHHhhCCCCCCCCCcCcccchHHHHHHHHHHHhhhhhhhcccchhhhhhhhHHHHHH
Confidence 9987764311 0100000 011 111111 111
Q ss_pred HHHHHHHHHHh------CCCCCeEeCCCCCCcEEEcCC----CceEEEeecCccc
Q 004674 624 GIARGLLYLHQ------DSRLRIIHRDLKASNVLLDNT----MNPKISDFGLARS 668 (738)
Q Consensus 624 ~ia~gL~yLH~------~~~~~ivH~DLkp~NILl~~~----~~vkL~DFGla~~ 668 (738)
.+...++.|.. ..+..++|+|+.|.|||++++ +.++++||..|..
T Consensus 159 ~~~~~~~~l~~~~~~~~~~~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 159 DEAKYLRFLLESTSEESGSPVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred HHHHHHHHHHhhccCCCCCCceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 22223334432 134569999999999999874 8899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.82 E-value=0.014 Score=63.18 Aligned_cols=141 Identities=17% Similarity=0.266 Sum_probs=82.8
Q ss_pred ceecccccEeEEEeeecc-----ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCee-eEEeEEecCCcceEEEeeCC
Q 004674 523 NKLGEGGFGPVYKGMLIE-----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~-----g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~ 596 (738)
..+-.|-.-.+|+....+ ++.+++|+......... .-.+|..++..+...++. ++++.+..+ .|.||++
T Consensus 42 ~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t~~~i-dR~~E~~~~~~l~~~gl~P~~~~~~~~g----~v~efi~ 116 (344)
T PLN02236 42 IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGVELFF-DRDDEIRTFECMSRHGQGPRLLGRFPNG----RVEEFIH 116 (344)
T ss_pred EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCCCeee-chHHHHHHHHHHHHcCCCCceEEEECCc----eEEEeeC
Confidence 456567778889876532 36788998765433322 337789998888655553 455555332 5899998
Q ss_pred CCChhHH-----------------HhhcC-CC--CCCCHHHHHHHHHH-----------------HHHHHHHH----Hh-
Q 004674 597 NKSLDYF-----------------IFDTT-RS--KLLDWSKRSHIIAG-----------------IARGLLYL----HQ- 634 (738)
Q Consensus 597 ~gsL~~~-----------------l~~~~-~~--~~l~~~~~~~i~~~-----------------ia~gL~yL----H~- 634 (738)
+.+|... ++... .. ....+.++.++..+ +...+..| ..
T Consensus 117 g~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~~~~~~~~l~~~~~~~~~~~~~l~~~~~~L~~~~~~~ 196 (344)
T PLN02236 117 ARTLSAADLRDPEISALIAAKLREFHSLDMPGPKNVLLWDRLRNWLKEAKNLCSPEEAKEFRLDSLEDEINLLEKELSGD 196 (344)
T ss_pred CCCCCHHHcCChHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHhhcCcchhhhcCHHHHHHHHHHHHHHhccc
Confidence 8776421 01100 00 01122333233211 11112222 21
Q ss_pred CCCCCeEeCCCCCCcEEEcC-CCceEEEeecCccc
Q 004674 635 DSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARS 668 (738)
Q Consensus 635 ~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla~~ 668 (738)
..+..++|+|+++.|||+++ ++.+.++||..+..
T Consensus 197 ~~~~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 197 DQEIGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred CCCceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 22346899999999999986 47899999998764
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.029 Score=59.99 Aligned_cols=143 Identities=20% Similarity=0.203 Sum_probs=78.1
Q ss_pred cceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCC--eeeEEeE------EecCCcceEEEe
Q 004674 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLGC------CTQRDERMLIYE 593 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n--Iv~l~g~------~~~~~~~~lV~E 593 (738)
.+.|..|....+|+....+| .+++|+.. . ...+....|+.++..+...+ +.+.+.. ....+..++++|
T Consensus 27 ~~~l~~G~~n~~y~v~t~~g-~~vLK~~~-~--~~~~~l~~~~~~l~~L~~~glpvP~~i~~~~G~~~~~~~g~~~~l~~ 102 (319)
T PRK05231 27 LKGIAEGIENSNFFLTTTQG-EYVLTLFE-R--LTAEDLPFFLGLMQHLAARGVPVPAPVARRDGAALGELAGKPAAIVT 102 (319)
T ss_pred cchhccccccceEEEEeCCC-cEEEEEec-c--CChHHhHHHHHHHHHHHHCCCCCCcceeCCCCCEeeeeCCEEEEEEE
Confidence 34567777788998876555 68888875 2 22344555666666664222 2233321 122445789999
Q ss_pred eCCCCChhH-----H---------HhhcCCC------C--CCCH-HHHHH------------HH-HHHHHHHHHHHhC--
Q 004674 594 YLPNKSLDY-----F---------IFDTTRS------K--LLDW-SKRSH------------II-AGIARGLLYLHQD-- 635 (738)
Q Consensus 594 y~~~gsL~~-----~---------l~~~~~~------~--~l~~-~~~~~------------i~-~~ia~gL~yLH~~-- 635 (738)
|+++..+.. . ++..... . .+.| ..... .. ..+...++.+.+.
T Consensus 103 ~l~G~~~~~~~~~~~~~~G~~LA~lH~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 182 (319)
T PRK05231 103 FLEGKWPRAPTAAHCAEVGEMLARMHLAGRDFPLERPNLRGLAWWRELAPRLLPFLADEQAALLEAELAAQLAFLASAAW 182 (319)
T ss_pred ecCCCCCCCCCHHHHHHHHHHHHHHHhhhhcCCccCCCCCChHHHHHHHHHHhhccChhHHHHHHHHHHHHHHhhhcccc
Confidence 999875421 1 0110000 0 1111 11111 11 1111222333211
Q ss_pred --CCCCeEeCCCCCCcEEEcCCCceEEEeecCccc
Q 004674 636 --SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 636 --~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~ 668 (738)
-+..+||+|++|.||+++.+...-|+||+.+..
T Consensus 183 ~~lp~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 183 PALPRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred ccCCcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 234599999999999999765568999998753
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=96.71 E-value=0.032 Score=59.36 Aligned_cols=143 Identities=24% Similarity=0.242 Sum_probs=82.3
Q ss_pred cceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCC--eeeEEeEE------ecCCcceEEEe
Q 004674 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN--LVKLLGCC------TQRDERMLIYE 593 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~n--Iv~l~g~~------~~~~~~~lV~E 593 (738)
.+.++.|....+|+....++ .+++|+.+... ..++...|++++..+.... +.+++... ...+..++++|
T Consensus 27 i~~~~~G~~n~~y~v~t~~~-~~vLK~~~~~~--~~~~i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~~~~g~~~~l~e 103 (307)
T TIGR00938 27 LKGIAEGVENSNYLLTTDVG-RYILTLYEKRV--KAEELPFFLALTTHLAARGLPVPKPVKSRDGRQLSTLAGKPACLVE 103 (307)
T ss_pred ccccCCccccceEEEEeCCC-cEEEEEecCCC--CHHHHHHHHHHHHHHHHCCCCCCccccCCCCCeehhcCCeEEEEEE
Confidence 45677777788998876444 57788764422 2345667777777775332 33443321 12345689999
Q ss_pred eCCCCChhH----H----------HhhcCCC------C---CCCHHHHH------------HHHHHHHHHHHHHHh----
Q 004674 594 YLPNKSLDY----F----------IFDTTRS------K---LLDWSKRS------------HIIAGIARGLLYLHQ---- 634 (738)
Q Consensus 594 y~~~gsL~~----~----------l~~~~~~------~---~l~~~~~~------------~i~~~ia~gL~yLH~---- 634 (738)
|++|..+.. . ++..... . .-.|.... .....+.+.++++..
T Consensus 104 ~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~~~~~l~~~~~~l~~~~~~ 183 (307)
T TIGR00938 104 FLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAHMGAELDKELDYLDKFWPR 183 (307)
T ss_pred eCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHHHHHHHHHHHHHHHhhhhh
Confidence 999865421 0 1110000 0 01111100 001123344555532
Q ss_pred CCCCCeEeCCCCCCcEEEcCCCceEEEeecCcc
Q 004674 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 635 ~~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~ 667 (738)
.-...++|+|+++.||++++++.+.|.||+.+.
T Consensus 184 ~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 184 DLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred cCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 123469999999999999988777899999874
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.021 Score=60.29 Aligned_cols=138 Identities=17% Similarity=0.230 Sum_probs=80.7
Q ss_pred ceecccccEeEEEeeeccccEEEEEEcc-CCCCcchHHHHHHHHHHhHhcC--CCeeeEEeEEecCC--cceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQH--RNLVKLLGCCTQRD--ERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~g~~vavK~l~-~~~~~~~~~~~~Ei~il~~l~H--~nIv~l~g~~~~~~--~~~lV~Ey~~~ 597 (738)
+.+-.|..-.+|..... ++++++++-. ...........+|..+|+.+.- .-+-+.++.|.++. ..+.||+|.++
T Consensus 31 ~~~~~G~sn~t~~~~~~-~~~~vlR~P~~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veG 109 (321)
T COG3173 31 EEISGGWSNDTFRLGDT-GQKYVLRKPPRGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEG 109 (321)
T ss_pred eeccCCcccceEEEecC-CceEEEecCCccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecc
Confidence 33433333334443332 6777777221 1223345566788888887743 23345577777666 57999999988
Q ss_pred CChhHHHhhcCCCCCCCHHHHHHHH-HHHHHHHHHHHh------------------------------------------
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHII-AGIARGLLYLHQ------------------------------------------ 634 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~-~~ia~gL~yLH~------------------------------------------ 634 (738)
..+...+.... .. .+++ ..+++.|+-||+
T Consensus 110 e~~~~~~~~~~----~~----~~~~~~~l~~~La~LH~ida~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~ 181 (321)
T COG3173 110 EVVWSALPPES----LG----RQFALDALADFLAELHSIDAAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLAD 181 (321)
T ss_pred eeccCcCCccc----ch----HHHHHHHHHHHHHHHhCCCCcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHH
Confidence 54322211000 00 1111 133344444442
Q ss_pred --------C-----CCCCeEeCCCCCCcEEEcCCCceEEEeecCcccc
Q 004674 635 --------D-----SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 635 --------~-----~~~~ivH~DLkp~NILl~~~~~vkL~DFGla~~~ 669 (738)
+ ++..++|+|+++.||+++++.-+-|.||+++..-
T Consensus 182 ~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 182 RLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred HHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 2 2246999999999999998888999999998753
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.023 Score=59.57 Aligned_cols=75 Identities=20% Similarity=0.272 Sum_probs=48.5
Q ss_pred CccceecccccEeEEEeeeccccEEEEEEccCCCCcchHHHHHHHHHHhHhc---CCCeeeEEeEEecCCcceEEEeeCC
Q 004674 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 520 ~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~---H~nIv~l~g~~~~~~~~~lV~Ey~~ 596 (738)
+..+.++.|....+|+.. .+++.+.||.-. ......|..|.+-|+.|. -..+.+.+++....+..+||+||++
T Consensus 20 ~~~~~v~GG~i~~a~~~~-~~~~~~FvK~~~---~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~ 95 (288)
T PF03881_consen 20 TSIEPVSGGDINEAYRLD-TDGGSYFVKVNS---ESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLE 95 (288)
T ss_dssp -EEEEE--SSSSEEEEEE-TTS-EEEEEEEE---GGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE---
T ss_pred eeeEecCCCChhheEEEE-CCCccEEEEecC---hhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeec
Confidence 445678989999999877 567889999865 233457888888888883 4456788888877777899999998
Q ss_pred CC
Q 004674 597 NK 598 (738)
Q Consensus 597 ~g 598 (738)
.+
T Consensus 96 ~~ 97 (288)
T PF03881_consen 96 MG 97 (288)
T ss_dssp --
T ss_pred CC
Confidence 77
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >cd01100 APPLE_Factor_XI_like Subfamily of PAN/APPLE-like domains; present in plasma prekallikrein/coagulation factor XI, microneme antigen proteins, and a few prokaryotic proteins | Back alignment and domain information |
|---|
Probab=96.32 E-value=0.0034 Score=51.19 Aligned_cols=49 Identities=18% Similarity=0.384 Sum_probs=34.7
Q ss_pred eeecCCCCcccccccccCHHHHHHHHhccCceeeeecccccCCCccceecccc
Q 004674 376 KAVKLPDTRFSWVDKNITLWECKELCSKNCSCTAYANADVRGRGSGCLLWFHD 428 (738)
Q Consensus 376 ~~~~~p~~~~~~~~~~~s~~~C~~~Cl~~CsC~a~~~~~~~~~~~~C~~w~~~ 428 (738)
+++.++..+.... ...+.++|++.|+.+|+|.||.|.. +...|+++...
T Consensus 10 ~~~~~~g~d~~~~-~~~s~~~Cq~~C~~~~~C~afT~~~---~~~~C~lk~~~ 58 (73)
T cd01100 10 SNVDFRGGDLSTV-FASSAEQCQAACTADPGCLAFTYNT---KSKKCFLKSSE 58 (73)
T ss_pred CCCccccCCccee-ecCCHHHHHHHcCCCCCceEEEEEC---CCCeEEcccCC
Confidence 4555555444332 2568899999999999999999963 23468877753
|
PAN/APPLE domains fulfill diverse biological functions by mediating protein-protein or protein-carbohydrate interactions. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.28 E-value=0.039 Score=57.69 Aligned_cols=31 Identities=23% Similarity=0.457 Sum_probs=26.0
Q ss_pred CCeEeCCCCCCcEEEcCCCc-eEEEeecCccc
Q 004674 638 LRIIHRDLKASNVLLDNTMN-PKISDFGLARS 668 (738)
Q Consensus 638 ~~ivH~DLkp~NILl~~~~~-vkL~DFGla~~ 668 (738)
..++|+|++|.|||+++++. .-|.||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999997555 46999998864
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.0054 Score=63.53 Aligned_cols=141 Identities=18% Similarity=0.195 Sum_probs=92.3
Q ss_pred HHHHHhcCCCCccceecccccEeEEEeeeccccEEEEEEccCC-----------------CCc-----chHHHHHHHHHH
Q 004674 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG-----------------SGQ-----GMEEFKNEVLLI 567 (738)
Q Consensus 510 ~~l~~~~~~~~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~-----------------~~~-----~~~~~~~Ei~il 567 (738)
+.+.....-++..++||-|.-+.||.+...+|++.++|.-+.. ... ..-....|...|
T Consensus 85 ktL~~R~~v~svGnqIGVGKESDIY~v~d~~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafm 164 (465)
T KOG2268|consen 85 KTLSNRGSVESVGNQIGVGKESDIYVVADEEGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFM 164 (465)
T ss_pred HHHHhcchhhhhccccccccccceEEEecCCCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHH
Confidence 3333333346778999999999999999988999988842110 000 122345677788
Q ss_pred hHhcCC--CeeeEEeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCC
Q 004674 568 AKLQHR--NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDL 645 (738)
Q Consensus 568 ~~l~H~--nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL 645 (738)
+.+... -+.+.+++ +..++|||++.+-.|...- ...+..++..-+. .-+--|..+| +||+|.
T Consensus 165 kaL~e~gfpVPkpiD~----~RH~Vvmelv~g~Pl~~v~------~v~d~~~ly~~lm---~~Iv~la~~G---lIHgDF 228 (465)
T KOG2268|consen 165 KALYERGFPVPKPIDH----NRHCVVMELVDGYPLRQVR------HVEDPPTLYDDLM---GLIVRLANHG---LIHGDF 228 (465)
T ss_pred HHHHHcCCCCCCcccc----cceeeHHHhhcccceeeee------ecCChHHHHHHHH---HHHHHHHHcC---ceeccc
Confidence 877532 12333333 3457899999988875442 1223333333333 3334455666 999999
Q ss_pred CCCcEEEcCCCceEEEeecCc
Q 004674 646 KASNVLLDNTMNPKISDFGLA 666 (738)
Q Consensus 646 kp~NILl~~~~~vkL~DFGla 666 (738)
+-=||+++++..++++||--.
T Consensus 229 NEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 229 NEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred chheeEEecCCCEEEeechHh
Confidence 999999999999999999744
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.051 Score=58.31 Aligned_cols=73 Identities=14% Similarity=0.205 Sum_probs=48.1
Q ss_pred eecccccEeEEEeeeccc-cEEEEEEcc----C---CCCcchHHHHHHHHHHhHhc--CCC-eeeEEeEEecCCcceEEE
Q 004674 524 KLGEGGFGPVYKGMLIEG-QEIAVKRLS----K---GSGQGMEEFKNEVLLIAKLQ--HRN-LVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 524 ~LG~G~fG~Vykg~~~~g-~~vavK~l~----~---~~~~~~~~~~~Ei~il~~l~--H~n-Iv~l~g~~~~~~~~~lV~ 592 (738)
.||.|...-||++...++ +.|+||.-. . .-+-..++..-|.+.|+... -|. +.+++.+ +++...+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 589999999999998654 689999632 1 11334556667777776653 343 3344433 556677999
Q ss_pred eeCCCC
Q 004674 593 EYLPNK 598 (738)
Q Consensus 593 Ey~~~g 598 (738)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999653
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=96.10 E-value=0.017 Score=69.04 Aligned_cols=154 Identities=19% Similarity=0.175 Sum_probs=109.8
Q ss_pred HHHHHHHHhHhcCCCeeeEEeEEecCCcce----EEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhC
Q 004674 560 FKNEVLLIAKLQHRNLVKLLGCCTQRDERM----LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635 (738)
Q Consensus 560 ~~~Ei~il~~l~H~nIv~l~g~~~~~~~~~----lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~ 635 (738)
..-|...+.++.|+|++.++++..+....- +.-|++..-++...+. .-...+....+.+..++.+|++|+|..
T Consensus 229 ~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q---~v~~i~~~~~r~~~~~~~~GL~~~h~~ 305 (1351)
T KOG1035|consen 229 TEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQ---SVGSIPLETLRILHQKLLEGLAYLHSL 305 (1351)
T ss_pred HHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHh---hccccCHHHHHHHHHHHhhhHHHHHHh
Confidence 345677788889999999999976654432 3457777777777663 334578888888999999999999987
Q ss_pred CCCCeEeCCCCCC---cEEEcCCCceEEE--eecCccccCCCcccccccccccccCccchhcccCCCCCch--hHHHHHH
Q 004674 636 SRLRIIHRDLKAS---NVLLDNTMNPKIS--DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVK--SDVFSFG 708 (738)
Q Consensus 636 ~~~~ivH~DLkp~---NILl~~~~~vkL~--DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~k--sDVwS~G 708 (738)
. +.|.-|..+ +--.+.++.+.++ ||+.++......... ...-+..+.+||......+..+ .|+|.+|
T Consensus 306 ~---l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~---~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lg 379 (1351)
T KOG1035|consen 306 S---LEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSF---SDLLAEIRNADEDLKENTAKKSRLTDLWCLG 379 (1351)
T ss_pred c---cceeEEecccccccccCccceeecchhhhcccccCCCcccch---hhcCccccccccccccccchhhhhhHHHHHH
Confidence 5 666655555 4444566677777 888887654322211 1223556788888777665544 7999999
Q ss_pred HHHHHHHcCCCCCC
Q 004674 709 VLVLEIICGKKNRG 722 (738)
Q Consensus 709 vil~elltG~~p~~ 722 (738)
..+..+..|..+-.
T Consensus 380 ll~~~~~~~~~i~~ 393 (1351)
T KOG1035|consen 380 LLLLQLSQGEDISE 393 (1351)
T ss_pred HHHhhhhhcCcccc
Confidence 99999999887654
|
|
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.97 E-value=0.039 Score=59.91 Aligned_cols=74 Identities=12% Similarity=0.106 Sum_probs=50.2
Q ss_pred cceecccccEeEEEeeecc-ccEEEEEEc----cC--CCCcchHHHHHHHHHHhHhc--CCC-eeeEEeEEecCCcceEE
Q 004674 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRL----SK--GSGQGMEEFKNEVLLIAKLQ--HRN-LVKLLGCCTQRDERMLI 591 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~-g~~vavK~l----~~--~~~~~~~~~~~Ei~il~~l~--H~n-Iv~l~g~~~~~~~~~lV 591 (738)
.+.||.|.-.-||++.... ++.|+||.- +. .-+-..++..-|.+.|+... -|. +.+++.+ +++...+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 4579999999999999743 568999963 21 12334567777888887663 343 4445443 55567789
Q ss_pred EeeCCC
Q 004674 592 YEYLPN 597 (738)
Q Consensus 592 ~Ey~~~ 597 (738)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999865
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.13 Score=56.24 Aligned_cols=73 Identities=12% Similarity=0.104 Sum_probs=49.7
Q ss_pred cceecccccEeEEEeeeccccEEEEEEccCC-----C--CcchHHHHHHHHHHhHhc---CCCeeeEEeEEecCCcceEE
Q 004674 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG-----S--GQGMEEFKNEVLLIAKLQ---HRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 522 ~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~-----~--~~~~~~~~~Ei~il~~l~---H~nIv~l~g~~~~~~~~~lV 591 (738)
.+.||.|....||+... .++.++||+-... . +-...+-..|.+.|+.+. ..++.+++.++. +..+++
T Consensus 37 ~~eiggGn~N~VyrV~~-~~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~vlv 113 (418)
T PLN02756 37 IKEVGDGNLNFVYIVVS-SSGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMALIG 113 (418)
T ss_pred EEEcCCCceeeEEEEEc-CCccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCEEE
Confidence 46799999999999876 4567889975411 1 013344455566666553 246777888876 457889
Q ss_pred EeeCCC
Q 004674 592 YEYLPN 597 (738)
Q Consensus 592 ~Ey~~~ 597 (738)
||++++
T Consensus 114 ME~L~~ 119 (418)
T PLN02756 114 MRYLEP 119 (418)
T ss_pred EeecCC
Confidence 999977
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.87 E-value=0.025 Score=56.59 Aligned_cols=123 Identities=20% Similarity=0.270 Sum_probs=60.6
Q ss_pred ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCe-eeEEeEEecCCcceEEEeeCCCCChhHH-------H--------
Q 004674 541 GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIYEYLPNKSLDYF-------I-------- 604 (738)
Q Consensus 541 g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nI-v~l~g~~~~~~~~~lV~Ey~~~gsL~~~-------l-------- 604 (738)
.+.|++|+.... ....-.-..|..+++.+...++ .++++.+.. .+|+||+++..|+.- +
T Consensus 2 ~~~~~~Ri~g~~-t~~~idr~~E~~~~~~l~~~g~~p~~~~~~~~----g~v~e~i~g~~l~~~~~~~~~~~~~iA~~l~ 76 (211)
T PF01633_consen 2 PEKYLVRIPGEG-TENFIDRENENEALKLLSEAGLGPKIIYFFEN----GRVEEFIEGRTLSPEDFRNPEILKRIAKLLA 76 (211)
T ss_dssp TSEEEEEEEESC-GCSHHHHHHHHHHHHHHHHTTSSS-EEEEETT----EEEEE--SSEE--CGGGGSHHHHHHHHHHHH
T ss_pred CCEEEEEeCCCC-cccccCHHHHHHHHHHHHHcCCCCeEEEEcCC----CcEEEEecccccChhhccChHHHHHHHHHHH
Confidence 456788877555 3344566788999988875555 445555433 267799977665321 0
Q ss_pred --hh--c--CCCCCCCHHHHHHH----------------------HHHHHHHHHHHHh-----CCCCCeEeCCCCCCcEE
Q 004674 605 --FD--T--TRSKLLDWSKRSHI----------------------IAGIARGLLYLHQ-----DSRLRIIHRDLKASNVL 651 (738)
Q Consensus 605 --~~--~--~~~~~l~~~~~~~i----------------------~~~ia~gL~yLH~-----~~~~~ivH~DLkp~NIL 651 (738)
+. . .....--+....++ ...+.+-+..+.+ ..+..++|+||.|.|||
T Consensus 77 ~lH~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~~~~~~~v~cHnDl~~~Nil 156 (211)
T PF01633_consen 77 KLHSIPISPNSKKPDLWDRIDKYMNKKSEFLFKRKKKKKSIDKEDLEDLQEELEELEKLLEKSNSPLVFCHNDLNPGNIL 156 (211)
T ss_dssp HHHTHHHTTSSSS-HHHHHHHHHHHHHHTCCCCHHTTTCHHHHHHHHHHHHHHHHHHHHHHTSCGGEEEE-S--SGGGEE
T ss_pred HHhhcccccccCcchHHHHhhhhccchhhhhhhhhhhccccccCCHHHHHHHHhhhhhhhhccCCCceEeeccCccccEE
Confidence 00 0 00001111111111 0111222222211 11235899999999999
Q ss_pred E-cCCCceEEEeecCccc
Q 004674 652 L-DNTMNPKISDFGLARS 668 (738)
Q Consensus 652 l-~~~~~vkL~DFGla~~ 668 (738)
+ +.++.++++||..|..
T Consensus 157 ~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 157 INNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp ETSSSSCEEE--GTT-EE
T ss_pred eccCCCeEEEecHHHHhh
Confidence 9 8899999999988753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=95.86 E-value=0.076 Score=57.10 Aligned_cols=141 Identities=17% Similarity=0.224 Sum_probs=80.7
Q ss_pred ceecccccEeEEEeeecc----ccEEEEEEccCCCCcchHHHHHHHHHHhHhcCCCee-eEEeEEecCCcceEEEeeCCC
Q 004674 523 NKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~LG~G~fG~Vykg~~~~----g~~vavK~l~~~~~~~~~~~~~Ei~il~~l~H~nIv-~l~g~~~~~~~~~lV~Ey~~~ 597 (738)
+.|..|=.-.+|+....+ +..+++|+....... .-.-.+|..+++.+...++- ++++++..+ +|.||+++
T Consensus 20 ~~l~gGlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t~~-~IdR~~E~~il~~l~~~gl~P~~l~~~~~G----~i~~fi~g 94 (330)
T PLN02421 20 ERISGGITNLLLKVSVKEENGNEVSVTVRLFGPNTDY-VIDRERELQAIKYLSAAGFGAKLLGVFGNG----MIQSFINA 94 (330)
T ss_pred EEeCCcccceEEEEEecCCCCCCceEEEEEecCCcCe-EechHHHHHHHHHHHhcCCCCceeEEeCCc----EeehhhcC
Confidence 456557777888876543 237888887654332 23346788899888766663 455555322 58999987
Q ss_pred CChhHH-------H----------hhcC-C-CC-CCCHHHHHHHHHHH----------------------HHHHHHHH--
Q 004674 598 KSLDYF-------I----------FDTT-R-SK-LLDWSKRSHIIAGI----------------------ARGLLYLH-- 633 (738)
Q Consensus 598 gsL~~~-------l----------~~~~-~-~~-~l~~~~~~~i~~~i----------------------a~gL~yLH-- 633 (738)
..|..- + +... . .. +--|..+.++..++ .+-+..+.
T Consensus 95 ~~l~~~~l~~~~~~~~ia~~L~~lH~~~~~~~~~~~~~~~i~~y~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~l~~~ 174 (330)
T PLN02421 95 RTLTPSDMRKPKVAAEIAKELRRLHQVEIPGSKEPQLWNDIFKFYEKASTVKFEDPEKQKKYETISFEELRDEIVELKEI 174 (330)
T ss_pred CCCChHHCCCHHHHHHHHHHHHHHhCCCCCCCCCCcHHHHHHHHHHHhhhcccCcHHHhhhhcccCHHHHHHHHHHHHHH
Confidence 766321 1 1100 0 01 11233322222211 11111111
Q ss_pred --h-CCCCCeEeCCCCCCcEEEcC-CCceEEEeecCccc
Q 004674 634 --Q-DSRLRIIHRDLKASNVLLDN-TMNPKISDFGLARS 668 (738)
Q Consensus 634 --~-~~~~~ivH~DLkp~NILl~~-~~~vkL~DFGla~~ 668 (738)
. ..+..++|.|+.+.|||+++ ++.++++||..|..
T Consensus 175 ~~~~~~~~v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 175 TDSLKAPVVFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred hccCCCCeEEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 1 12234899999999999975 57899999998754
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.82 E-value=0.028 Score=59.35 Aligned_cols=142 Identities=18% Similarity=0.194 Sum_probs=95.7
Q ss_pred CccceecccccEeEEEeeeccccEEEEEEccCC-------C---------------CcchHH----HHHHHHHHhHhcCC
Q 004674 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG-------S---------------GQGMEE----FKNEVLLIAKLQHR 573 (738)
Q Consensus 520 ~~~~~LG~G~fG~Vykg~~~~g~~vavK~l~~~-------~---------------~~~~~~----~~~Ei~il~~l~H~ 573 (738)
.+...|..|--+.||.+.-.+|..+|||+++.. . ....+. ...|++-|.+++..
T Consensus 147 ~inGCiSTGKEANVYHat~~dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~a 226 (520)
T KOG2270|consen 147 EINGCISTGKEANVYHATEEDGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNA 226 (520)
T ss_pred ecccccccCccceeEeeecCCCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhc
Confidence 345689999999999999999999999986421 0 001111 23477777777654
Q ss_pred CeeeEEeEEecCCcceEEEeeCCCCChhHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCCCCcEEEc
Q 004674 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653 (738)
Q Consensus 574 nIv~l~g~~~~~~~~~lV~Ey~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~ 653 (738)
.|.-. .-..- ..-.|||+|+...... ........++...+..+-.+++.-|.-|.+.+ ++||.||.-=|+|+-
T Consensus 227 GIP~P-ePIlL-k~hVLVM~FlGrdgw~---aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c--~LVHADLSEfN~Lyh 299 (520)
T KOG2270|consen 227 GIPCP-EPILL-KNHVLVMEFLGRDGWA---APKLKDASLSTSKARELYQQCVRIMRRLYQKC--RLVHADLSEFNLLYH 299 (520)
T ss_pred CCCCC-Cceee-ecceEeeeeccCCCCc---CcccccccCChHHHHHHHHHHHHHHHHHHHHh--ceeccchhhhhheEE
Confidence 43210 00000 1246899998643221 11122345677788888899999999999888 599999999999985
Q ss_pred CCCceEEEeecCcccc
Q 004674 654 NTMNPKISDFGLARSF 669 (738)
Q Consensus 654 ~~~~vkL~DFGla~~~ 669 (738)
+ |.+.|+|-+-+...
T Consensus 300 d-G~lyiIDVSQSVE~ 314 (520)
T KOG2270|consen 300 D-GKLYIIDVSQSVEH 314 (520)
T ss_pred C-CEEEEEEccccccC
Confidence 5 58899998766544
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 738 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 2e-44 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 3e-43 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 3e-40 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 8e-40 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-38 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-38 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 6e-38 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-36 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 1e-24 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 3e-24 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 5e-24 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-24 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 6e-23 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 7e-23 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 7e-23 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 8e-23 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 8e-23 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-23 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-23 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-23 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 9e-23 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-22 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-22 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-22 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-22 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 1e-21 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-21 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 2e-21 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 2e-21 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 3e-21 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 3e-21 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 5e-21 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 9e-21 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-20 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-20 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 3e-20 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 3e-20 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 3e-20 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 3e-20 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 3e-20 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-20 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 4e-20 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-20 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 5e-20 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-20 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 5e-20 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 7e-20 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 7e-20 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 7e-20 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 8e-20 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 8e-20 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 1e-19 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 1e-19 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 1e-19 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-19 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 1e-19 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 1e-19 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-19 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 1e-19 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 1e-19 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 1e-19 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 1e-19 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 1e-19 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 1e-19 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-19 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 2e-19 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 2e-19 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-19 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-19 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 3e-19 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 4e-19 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 5e-19 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 6e-19 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 8e-19 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 9e-19 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-19 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 1e-18 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-18 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 1e-18 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 2e-18 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-18 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 3e-18 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 3e-18 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 3e-18 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-18 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 3e-18 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 3e-18 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 3e-18 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-18 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 4e-18 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 4e-18 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-18 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 4e-18 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 4e-18 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 4e-18 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 5e-18 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 5e-18 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 5e-18 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-18 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 5e-18 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-18 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 6e-18 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 6e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-18 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 6e-18 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 6e-18 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 7e-18 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 7e-18 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 7e-18 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 7e-18 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 7e-18 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 7e-18 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 7e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 8e-18 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 9e-18 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 1e-17 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-17 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-17 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 1e-17 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 1e-17 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-17 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 1e-17 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 1e-17 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 1e-17 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 1e-17 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 1e-17 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 1e-17 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 1e-17 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 1e-17 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 1e-17 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-17 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-17 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-17 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 2e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 2e-17 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 2e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 2e-17 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 2e-17 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 2e-17 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 2e-17 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 2e-17 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 2e-17 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 2e-17 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-17 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 2e-17 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 2e-17 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 2e-17 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 2e-17 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-17 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 2e-17 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-17 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 2e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 2e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 2e-17 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 2e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 2e-17 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 2e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 2e-17 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-17 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-17 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 3e-17 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-17 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-17 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 5e-17 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 5e-17 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 5e-17 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 5e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-17 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 5e-17 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 5e-17 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 6e-17 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 6e-17 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 6e-17 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 7e-17 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 7e-17 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 7e-17 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 7e-17 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 7e-17 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 8e-17 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 8e-17 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 8e-17 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 8e-17 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 9e-17 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 9e-17 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 9e-17 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 9e-17 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 1e-16 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 1e-16 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 1e-16 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-16 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 1e-16 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 2e-16 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 2e-16 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-16 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 2e-16 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 2e-16 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 2e-16 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 2e-16 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 2e-16 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 3e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 3e-16 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 4e-16 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 4e-16 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 4e-16 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 4e-16 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 4e-16 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 4e-16 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-16 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 4e-16 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 4e-16 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 4e-16 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 5e-16 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 5e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-16 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 5e-16 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 5e-16 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 5e-16 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 5e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-16 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 7e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 8e-16 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 8e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 8e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 8e-16 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 8e-16 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 8e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 8e-16 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 9e-16 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 9e-16 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 9e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 9e-16 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-15 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-15 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-15 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-15 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-15 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-15 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 1e-15 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-15 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-15 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 1e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 1e-15 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 1e-15 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-15 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 2e-15 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 2e-15 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 2e-15 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 2e-15 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 2e-15 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 2e-15 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-15 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 2e-15 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 2e-15 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 2e-15 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 2e-15 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 2e-15 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 2e-15 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 2e-15 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 2e-15 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 2e-15 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-15 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 2e-15 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-15 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 2e-15 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-15 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 2e-15 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 2e-15 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 2e-15 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 2e-15 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-15 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-15 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 3e-15 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 3e-15 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-15 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 3e-15 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 3e-15 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 3e-15 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-15 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 3e-15 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 3e-15 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-15 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 3e-15 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 3e-15 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 3e-15 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 3e-15 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 3e-15 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 3e-15 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-15 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 3e-15 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 3e-15 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 3e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-15 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-15 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 4e-15 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-15 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-15 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-15 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 4e-15 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 4e-15 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 4e-15 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 4e-15 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 4e-15 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-15 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 4e-15 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-15 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 5e-15 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 5e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 5e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 5e-15 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-15 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 6e-15 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-15 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 6e-15 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 7e-15 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 7e-15 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 7e-15 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 7e-15 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 7e-15 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 8e-15 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 8e-15 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 9e-15 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 9e-15 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-14 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-14 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-14 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-14 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-14 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 1e-14 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-14 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-14 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 1e-14 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-14 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 1e-14 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-14 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 1e-14 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-14 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 1e-14 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-14 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-14 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-14 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 1e-14 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 1e-14 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-14 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-14 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 2e-14 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-14 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 2e-14 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 2e-14 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-14 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 2e-14 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 2e-14 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 2e-14 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 2e-14 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-14 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 2e-14 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-14 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 2e-14 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-14 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 2e-14 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 2e-14 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-14 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 3e-14 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 3e-14 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 3e-14 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-14 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-14 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-14 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-14 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 3e-14 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 3e-14 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 3e-14 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 4e-14 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 4e-14 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 4e-14 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 4e-14 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 4e-14 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 4e-14 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-14 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 5e-14 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 5e-14 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 5e-14 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 5e-14 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 5e-14 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 5e-14 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 5e-14 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 5e-14 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 6e-14 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 6e-14 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-14 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 7e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 7e-14 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-14 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 7e-14 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 7e-14 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 7e-14 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-14 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-14 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 7e-14 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 7e-14 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 8e-14 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 8e-14 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 8e-14 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 8e-14 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-14 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 8e-14 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 8e-14 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 8e-14 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 9e-14 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 9e-14 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 9e-14 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 9e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 9e-14 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 9e-14 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 9e-14 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-13 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 1e-13 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-13 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-13 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 1e-13 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 1e-13 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 1e-13 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-13 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 1e-13 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 1e-13 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-13 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-13 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 1e-13 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 1e-13 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 2e-13 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-13 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 2e-13 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 2e-13 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 2e-13 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 2e-13 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-13 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-13 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-13 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 3e-13 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 3e-13 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 3e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-13 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 3e-13 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-13 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 5e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 5e-13 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 6e-13 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-13 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-13 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 6e-13 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-13 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-12 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 1e-12 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 1e-12 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-12 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 1e-12 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 1e-12 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-12 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 2e-12 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 2e-12 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-12 | ||
| 2y4i_B | 319 | Ksr2-Mek1 Heterodimer Length = 319 | 2e-12 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 2e-12 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 2e-12 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 2e-12 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 2e-12 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 2e-12 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-12 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 2e-12 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 2e-12 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 2e-12 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 2e-12 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-12 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 2e-12 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-12 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-12 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 2e-12 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-12 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 2e-12 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-12 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-12 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-12 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-12 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 3e-12 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-12 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-12 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 3e-12 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 3e-12 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 3e-12 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-12 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 4e-12 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 5e-12 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 5e-12 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 6e-12 | ||
| 4bcf_A | 331 | Structure Of Cdk9 In Complex With Cyclin T And A 2- | 6e-12 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 6e-12 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 6e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 6e-12 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 6e-12 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 7e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 7e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 7e-12 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 7e-12 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-12 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 7e-12 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 8e-12 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 8e-12 | ||
| 4ec8_A | 373 | Structure Of Full Length Cdk9 In Complex With Cycli | 8e-12 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 8e-12 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 8e-12 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-12 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-12 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 8e-12 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 8e-12 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 9e-12 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 9e-12 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 9e-12 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 9e-12 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-12 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 9e-12 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-11 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 1e-11 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-11 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 1e-11 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-11 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 1e-11 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-11 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 1e-11 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-11 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 1e-11 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 1e-11 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 1e-11 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 1e-11 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 1e-11 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 1e-11 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 1e-11 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-11 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 1e-11 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 1e-11 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 2e-11 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-11 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 2e-11 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 2e-11 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 2e-11 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-11 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-11 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-11 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-11 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 2e-11 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-11 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-11 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 2e-11 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-11 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-11 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-11 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-11 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 2e-11 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-11 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-11 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 2e-11 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 2e-11 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 3e-11 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 3e-11 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 3e-11 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 3e-11 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 3e-11 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 3e-11 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 4e-11 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 4e-11 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 4e-11 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 4e-11 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 4e-11 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 4e-11 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 4e-11 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 4e-11 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 4e-11 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-11 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 4e-11 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 4e-11 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 4e-11 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 4e-11 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 4e-11 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 4e-11 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 4e-11 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 4e-11 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 4e-11 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 4e-11 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-11 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 4e-11 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 4e-11 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 4e-11 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 4e-11 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 4e-11 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 4e-11 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 4e-11 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 4e-11 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 4e-11 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 4e-11 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-11 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 5e-11 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 5e-11 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 5e-11 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 5e-11 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 5e-11 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 5e-11 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-11 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 5e-11 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 5e-11 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 5e-11 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 5e-11 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 5e-11 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 5e-11 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 5e-11 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 5e-11 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 5e-11 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 5e-11 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-11 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 5e-11 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 5e-11 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 5e-11 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 5e-11 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 5e-11 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 5e-11 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 5e-11 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 5e-11 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 6e-11 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-11 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 6e-11 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-11 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 6e-11 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 6e-11 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 6e-11 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 6e-11 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 6e-11 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 6e-11 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 6e-11 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 6e-11 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 6e-11 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 6e-11 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 6e-11 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 6e-11 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 6e-11 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 6e-11 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 6e-11 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 7e-11 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 7e-11 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 7e-11 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 7e-11 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 7e-11 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 7e-11 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 7e-11 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 7e-11 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 8e-11 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 8e-11 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 8e-11 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 8e-11 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 8e-11 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 8e-11 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 8e-11 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 8e-11 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 8e-11 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 9e-11 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-11 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 9e-11 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 9e-11 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-11 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 9e-11 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 1e-10 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 1e-10 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-10 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-10 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-10 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 1e-10 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 1e-10 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-10 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-10 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 1e-10 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 1e-10 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 1e-10 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-10 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-10 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 1e-10 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 2e-10 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 2e-10 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 2e-10 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-10 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-10 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-10 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-10 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-10 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 3e-10 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 3e-10 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 3e-10 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 3e-10 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 3e-10 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 3e-10 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 3e-10 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 3e-10 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 3e-10 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 3e-10 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 3e-10 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 3e-10 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 3e-10 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 3e-10 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 3e-10 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 3e-10 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-10 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 4e-10 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 4e-10 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 4e-10 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 4e-10 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 4e-10 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 4e-10 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 4e-10 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 4e-10 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 4e-10 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 4e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 5e-10 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 5e-10 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 5e-10 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 5e-10 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 5e-10 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-10 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 5e-10 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 6e-10 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 6e-10 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 6e-10 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 6e-10 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 7e-10 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 7e-10 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 7e-10 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 7e-10 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 7e-10 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 7e-10 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 7e-10 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 7e-10 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-10 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 8e-10 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 8e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 8e-10 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-10 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 8e-10 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 8e-10 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 8e-10 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 9e-10 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 9e-10 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 9e-10 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 9e-10 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 9e-10 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 9e-10 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 9e-10 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-09 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-09 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 1e-09 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-09 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-09 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-09 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-09 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 1e-09 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-09 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 1e-09 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 1e-09 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 1e-09 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 1e-09 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-09 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-09 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-09 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-09 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-09 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-09 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-09 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 2e-09 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 2e-09 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-09 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 2e-09 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-09 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 2e-09 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 2e-09 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 2e-09 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 2e-09 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 3e-09 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 3e-09 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-09 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 3e-09 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 3e-09 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-09 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 3e-09 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-09 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 3e-09 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 3e-09 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 4e-09 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 4e-09 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 4e-09 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 4e-09 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 4e-09 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 4e-09 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 4e-09 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 5e-09 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-09 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-09 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-09 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-09 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 5e-09 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-09 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 5e-09 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 5e-09 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-09 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 5e-09 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 5e-09 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 6e-09 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 6e-09 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 6e-09 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-09 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 6e-09 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 7e-09 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 7e-09 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 7e-09 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 7e-09 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 7e-09 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-09 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 7e-09 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 7e-09 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 7e-09 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 7e-09 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 7e-09 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 7e-09 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-09 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 7e-09 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 8e-09 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 8e-09 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 8e-09 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 8e-09 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 8e-09 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 9e-09 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 9e-09 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 9e-09 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 9e-09 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-08 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-08 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 1e-08 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 1e-08 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-08 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 1e-08 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-08 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-08 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 1e-08 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 1e-08 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 1e-08 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 1e-08 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 1e-08 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 1e-08 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-08 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 1e-08 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 1e-08 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 1e-08 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-08 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 2e-08 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-08 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 2e-08 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 2e-08 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 2e-08 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 2e-08 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-08 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 2e-08 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 2e-08 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-08 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-08 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 3e-08 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 3e-08 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-08 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 3e-08 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 3e-08 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 4e-08 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 5e-08 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-08 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-08 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 5e-08 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 5e-08 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 6e-08 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 6e-08 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 6e-08 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 6e-08 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 6e-08 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 7e-08 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 8e-08 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 8e-08 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 8e-08 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 8e-08 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 8e-08 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 8e-08 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 8e-08 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 9e-08 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 9e-08 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 1e-07 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 1e-07 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-07 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-07 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-07 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 1e-07 | ||
| 3enm_A | 316 | The Structure Of The Map2k Mek6 Reveals An Autoinhi | 1e-07 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 1e-07 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 2e-07 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-07 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 2e-07 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 3e-07 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 3e-07 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 3e-07 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 3e-07 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 3e-07 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 3e-07 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 4e-07 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-07 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 4e-07 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 4e-07 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-07 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 5e-07 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 7e-07 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 7e-07 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 7e-07 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 9e-07 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 9e-07 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 1e-06 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 1e-06 | ||
| 3ll6_A | 337 | Crystal Structure Of The Human Cyclin G Associated | 1e-06 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 2e-06 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 2e-06 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-06 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 2e-06 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 2e-06 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 2e-06 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 2e-06 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 3e-06 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 4e-06 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 6e-06 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 7e-06 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 9e-06 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 9e-06 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 1e-05 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 1e-05 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 1e-05 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 1e-05 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 1e-05 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 1e-05 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3ENM|A Chain A, The Structure Of The Map2k Mek6 Reveals An Autoinhibitory Dimer Length = 316 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 366 bits (941), Expect = e-122
Identities = 95/253 (37%), Positives = 137/253 (54%), Gaps = 17/253 (6%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEK------NKLGEGGFGPVYKGMLIEGQEIAVK 547
N+ E + F + N T+NF E+ NK+GEGGFG VYKG + +AVK
Sbjct: 2 NKSLEVSDTRFHSFSFYELKNVTNNFDERPISVGGNKMGEGGFGVVYKG-YVNNTTVAVK 60
Query: 548 RLSKG----SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF 603
+L+ + + ++F E+ ++AK QH NLV+LLG + D+ L+Y Y+PN SL
Sbjct: 61 KLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDR 120
Query: 604 IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
+ + L W R I G A G+ +LH++ IHRD+K++N+LLD KISDF
Sbjct: 121 LSCLDGTPPLSWHMRCKIAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDF 177
Query: 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723
GLAR+ T R+VGT YM+PE + G + KSD++SFGV++LEII G
Sbjct: 178 GLARASEKFAQTVMTSRIVGTTAYMAPEA-LRGEITPKSDIYSFGVVLLEIITGLPA--V 234
Query: 724 NHADHDHNLLGHV 736
+ LL
Sbjct: 235 DEHREPQLLLDIK 247
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 357 bits (918), Expect = e-118
Identities = 104/235 (44%), Positives = 139/235 (59%), Gaps = 5/235 (2%)
Query: 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGME-EFKNEV 564
F L+ + A+DNFS KN LG GGFG VYKG L +G +AVKRL + QG E +F+ EV
Sbjct: 19 RFSLRELQVASDNFSNKNILGRGGFGKVYKGRLADGTLVAVKRLKEERTQGGELQFQTEV 78
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIA 623
+I+ HRNL++L G C ER+L+Y Y+ N S+ + + S+ LDW KR I
Sbjct: 79 EMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIAL 138
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
G ARGL YLH +IIHRD+KA+N+LLD + DFGLA+ T T V G
Sbjct: 139 GSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVTT-AVRG 197
Query: 684 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA--DHDHNLLGHV 736
T G+++PEY G S K+DVF +GV++LE+I G++ D D LL V
Sbjct: 198 TIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWV 252
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 329 bits (845), Expect = e-107
Identities = 94/229 (41%), Positives = 141/229 (61%), Gaps = 6/229 (2%)
Query: 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL 566
L + AT+NF K +G G FG VYKG+L +G ++A+KR + S QG+EEF+ E+
Sbjct: 29 VPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKVALKRRTPESSQGIEEFETEIET 88
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-LDWSKRSHIIAGI 625
++ +H +LV L+G C +R+E +LIY+Y+ N +L ++ + + + W +R I G
Sbjct: 89 LSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGA 148
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF-GLDQTEANTKRVVGT 684
ARGL YLH + IIHRD+K+ N+LLD PKI+DFG+++ LDQT +T V GT
Sbjct: 149 ARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLST-VVKGT 204
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733
GY+ PEY I G + KSDV+SFGV++ E++C + + NL
Sbjct: 205 LGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLA 253
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 263 bits (673), Expect = 4e-82
Identities = 58/246 (23%), Positives = 108/246 (43%), Gaps = 22/246 (8%)
Query: 507 FDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLL 566
+ + + G FG V+K + + +AVK Q + + EV
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQ-LLNEYVAVKIFPIQDKQSWQ-NEYEVYS 71
Query: 567 IAKLQHRNLVKLLGCCTQRD----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
+ ++H N+++ +G + + LI + SL F+ ++ ++ W++ HI
Sbjct: 72 LPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL----KANVVSWNELCHIA 127
Query: 623 AGIARGLLYLHQD-------SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
+ARGL YLH+D + I HRD+K+ NVLL N + I+DFGLA F ++
Sbjct: 128 ETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSA 187
Query: 676 ANTKRVVGTYGYMSPEYAIDGL-----FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH 730
+T VGT YM+PE + ++ D+++ G+++ E+ ++
Sbjct: 188 GDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEYML 247
Query: 731 NLLGHV 736
+
Sbjct: 248 PFEEEI 253
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 2e-66
Identities = 65/256 (25%), Positives = 109/256 (42%), Gaps = 35/256 (13%)
Query: 502 MELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFK 561
ME + + DN +G G +G VYKG L + + +AVK S + Q K
Sbjct: 1 MEAAASEPSL---DLDNLKLLELIGRGRYGAVYKGSL-DERPVAVKVFSFANRQNFINEK 56
Query: 562 NEVLLIAKLQHRNLVKLLGCCT-----QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
+ + ++H N+ + + R E +L+ EY PN SL ++ T DW
Sbjct: 57 -NIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT----SDWV 111
Query: 617 KRSHIIAGIARGLLYLHQD------SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF- 669
+ + RGL YLH + + I HRDL + NVL+ N ISDFGL+
Sbjct: 112 SSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLT 171
Query: 670 -----GLDQTEANTKRVVGTYGYMSPEYAIDGLFSV--------KSDVFSFGVLVLEIIC 716
+ + VGT YM+PE ++G ++ + D+++ G++ EI
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEV-LEGAVNLRDXESALKQVDMYALGLIYWEIFM 230
Query: 717 GKKNRGFNHADHDHNL 732
+ + ++ +
Sbjct: 231 RCTDLFPGESVPEYQM 246
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-62
Identities = 72/239 (30%), Positives = 121/239 (50%), Gaps = 15/239 (6%)
Query: 491 KHSNQGNEKEEMELPIFDLKIIANATD------NFSE---KNKLGEGGFGPVYKGMLIEG 541
KH + + + ++P + A D + + K K+G G FG V++ G
Sbjct: 2 KHHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEW-HG 60
Query: 542 QEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599
++AVK L + + + EF EV ++ +L+H N+V +G TQ ++ EYL S
Sbjct: 61 SDVAVKILMEQDFHAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGS 120
Query: 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPK 659
L + + + LD +R + +A+G+ YLH I+HR+LK+ N+L+D K
Sbjct: 121 LYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVK 179
Query: 660 ISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
+ DFGL+R T ++K GT +M+PE D + KSDV+SFGV++ E+ +
Sbjct: 180 VCDFGLSRL--KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-59
Identities = 70/216 (32%), Positives = 107/216 (49%), Gaps = 24/216 (11%)
Query: 518 NFSE---KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKL 570
+F+E + +G GGFG VY+ G E+AVK Q +E + E L A L
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAML 63
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+H N++ L G C + L+ E+ L+ + K + + IARG+
Sbjct: 64 KHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVL----SGKRIPPDILVNWAVQIARGMN 119
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNP--------KISDFGLARSFGLDQTEANTKRVV 682
YLH ++ + IIHRDLK+SN+L+ + KI+DFGLAR +
Sbjct: 120 YLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR----EWHRTTKMSAA 175
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
G Y +M+PE +FS SDV+S+GVL+ E++ G+
Sbjct: 176 GAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGE 211
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 8e-59
Identities = 67/230 (29%), Positives = 98/230 (42%), Gaps = 28/230 (12%)
Query: 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFK 561
DL LG+G FG K E G+ + +K L + + F
Sbjct: 6 IFRPSDLIH----------GEVLGKGCFGQAIKVTHRETGEVMVMKELIRFDEETQRTFL 55
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
EV ++ L+H N++K +G + I EY+ +L I WS+R
Sbjct: 56 KEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKS--MDSQYPWSQRVSF 113
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR- 680
IA G+ YLH + IIHRDL + N L+ N ++DFGLAR ++T+ R
Sbjct: 114 AKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRS 170
Query: 681 -----------VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
VVG +M+PE + K DVFSFG+++ EII
Sbjct: 171 LKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVN 220
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 8e-58
Identities = 63/232 (27%), Positives = 123/232 (53%), Gaps = 27/232 (11%)
Query: 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG----- 556
E P L +A+ + + ++G+GGFG V+KG L++ +A+K L G +G
Sbjct: 7 EFPKSRLPTLAD--NEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMI 64
Query: 557 --MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLD 614
+EF+ EV +++ L H N+VKL G ++ E++P L + + D ++ +
Sbjct: 65 EKFQEFQREVFIMSNLNHPNIVKLYGLMHN--PPRMVMEFVPCGDLYHRLLD--KAHPIK 120
Query: 615 WSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----TMNPKISDFGLARSF 669
WS + ++ IA G+ Y+ I+HRDL++ N+ L + + K++DFGL++
Sbjct: 121 WSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQ-- 177
Query: 670 GLDQTEANTKRVVGTYGYMSPE--YAIDGLFSVKSDVFSFGVLVLEIICGKK 719
Q+ + ++G + +M+PE A + ++ K+D +SF +++ I+ G+
Sbjct: 178 ---QSVHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEG 226
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 1e-57
Identities = 56/204 (27%), Positives = 91/204 (44%), Gaps = 11/204 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+ +G G FG V K +++A+K++ S + F E+ ++++ H N+V
Sbjct: 8 KEIEVEEVVGRGAFGVVCKAKW-RAKDVAIKQIE--SESERKAFIVELRQLSRVNHPNIV 64
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
KL G C L+ EY SL + + ++G+ YLH
Sbjct: 65 KLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 637 RLRIIHRDLKASNVLLDNTMN-PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
+IHRDLK N+LL KI DFG A + + G+ +M+PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVLKICDFGTAC-----DIQTHMTNNKGSAAWMAPEVFEG 177
Query: 696 GLFSVKSDVFSFGVLVLEIICGKK 719
+S K DVFS+G+++ E+I +K
Sbjct: 178 SNYSEKCDVFSWGIILWEVITRRK 201
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-57
Identities = 52/212 (24%), Positives = 92/212 (43%), Gaps = 22/212 (10%)
Query: 518 NFSE---KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQH 572
+F + KL E G ++KG +G +I VK L S + +F E + H
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRDFNEECPRLRIFSH 66
Query: 573 RNLVKLLGCCTQRDER--MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
N++ +LG C LI ++P SL + + T + D S+ +ARG+
Sbjct: 67 PNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVV-DQSQAVKFALDMARGMA 125
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LH L I L + +V++D M +IS + SF + + +++P
Sbjct: 126 FLHTLEPL-IPRHALNSRSVMIDEDMTARISMADVKFSF-------QSPGRMYAPAWVAP 177
Query: 691 EYAIDG----LFSVKSDVFSFGVLVLEIICGK 718
E A+ +D++SF VL+ E++ +
Sbjct: 178 E-ALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 193 bits (493), Expect = 2e-56
Identities = 64/235 (27%), Positives = 112/235 (47%), Gaps = 23/235 (9%)
Query: 489 RKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKR 548
H + ++ E+P + + ++G G FG VYKG ++AVK
Sbjct: 6 HHHHHGSRDAADDWEIPDGQITV----------GQRIGSGSFGTVYKGKW--HGDVAVKM 53
Query: 549 LSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD 606
L+ + Q ++ FKNEV ++ K +H N++ +G T + ++ ++ SL + +
Sbjct: 54 LNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHA 112
Query: 607 TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
+ K I ARG+ YLH IIHRDLK++N+ L KI DFGLA
Sbjct: 113 --SETKFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLA 167
Query: 667 RSFGLDQTEANTKRVVGTYGYMSPE---YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+++ G+ +M+PE +S +SDV++FG+++ E++ G+
Sbjct: 168 TEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQ 222
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 189 bits (483), Expect = 1e-54
Identities = 63/245 (25%), Positives = 103/245 (42%), Gaps = 32/245 (13%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVK 547
+K S +E ++P L+I +G+G FG VY G E+A++
Sbjct: 14 FPRKASQTSIFLQEWDIPFEQLEI----------GELIGKGRFGQVYHGRW--HGEVAIR 61
Query: 548 RLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
+ + ++ FK EV+ + +H N+V +G C +I ++L +
Sbjct: 62 LIDIERDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVR 121
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
D +LD +K I I +G+ YLH I+H+DLK+ NV DN I+DFGL
Sbjct: 122 D--AKIVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYDN-GKVVITDFGL 175
Query: 666 ARSFGLDQTEANTKR---VVGTYGYMSPE---------YAIDGLFSVKSDVFSFGVLVLE 713
G+ Q + G +++PE FS SDVF+ G + E
Sbjct: 176 FSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYE 235
Query: 714 IICGK 718
+ +
Sbjct: 236 LHARE 240
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 172 bits (439), Expect = 9e-49
Identities = 55/219 (25%), Positives = 94/219 (42%), Gaps = 27/219 (12%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNE--VLLIAKLQHRNLVKLLG 580
+G+G +G V++G +G+ +AVK S + + + E + L+H N++ +
Sbjct: 14 ECVGKGRYGEVWRGSW-QGENVAVKIFSS---RDEKSWFRETELYNTVMLRHENILGFIA 69
Query: 581 CCT----QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ LI Y SL ++ + LD I+ IA GL +LH +
Sbjct: 70 SDMTSRHSSTQLWLITHYHEMGSLYDYL----QLTTLDTVSCLRIVLSIASGLAHLHIEI 125
Query: 637 RLR-----IIHRDLKASNVLLDNTMNPKISDFGLAR--SFGLDQTEANTKRVVGTYGYMS 689
I HRDLK+ N+L+ I+D GLA S +Q + VGT YM+
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMA 185
Query: 690 PE------YAIDGLFSVKSDVFSFGVLVLEIICGKKNRG 722
PE + D+++FG+++ E+ + G
Sbjct: 186 PEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 1e-48
Identities = 57/239 (23%), Positives = 100/239 (41%), Gaps = 32/239 (13%)
Query: 504 LPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNE 563
LP+ + IA ++G+G +G V+ G G+++AVK + E
Sbjct: 27 LPLLVQRTIA---KQIQMVKQIGKGRYGEVWMGKW-RGEKVAVKVFFT---TEEASWFRE 79
Query: 564 --VLLIAKLQHRNLVKLLGCCTQ----RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSK 617
+ ++H N++ + + + LI +Y N SL ++ +S LD
Sbjct: 80 TEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYL----KSTTLDAKS 135
Query: 618 RSHIIAGIARGLLYLHQDSRLR-----IIHRDLKASNVLLDNTMNPKISDFGLARSF--G 670
+ GL +LH + I HRDLK+ N+L+ I+D GLA F
Sbjct: 136 MLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISD 195
Query: 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSV-------KSDVFSFGVLVLEIICGKKNRG 722
++ + VGT YM PE +D + +D++SFG+++ E+ + G
Sbjct: 196 TNEVDIPPNTRVGTKRYMPPE-VLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 3e-47
Identities = 71/246 (28%), Positives = 112/246 (45%), Gaps = 39/246 (15%)
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-----E 540
+Y + + +++ + LK + +LG+G FG V
Sbjct: 20 LYFQGAMGSAFEDRDPTQFEERHLKFL----------QQLGKGNFGSVEMCRYDPLQDNT 69
Query: 541 GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER--MLIYEYLPNK 598
G+ +AVK+L + + + +F+ E+ ++ LQH N+VK G C R LI EYLP
Sbjct: 70 GEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYG 129
Query: 599 SLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654
SL ++ KLL ++ + I +G+ YL R IHRDL N+L++N
Sbjct: 130 SLRDYLQKHKERIDHIKLLQYT------SQICKGMEYL---GTKRYIHRDLATRNILVEN 180
Query: 655 TMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGV 709
KI DFGL + D+ V G + +PE + FSV SDV+SFGV
Sbjct: 181 ENRVKIGDFGLTKVLPQDKEYY----KVKEPGESPIFWYAPESLTESKFSVASDVWSFGV 236
Query: 710 LVLEII 715
++ E+
Sbjct: 237 VLYELF 242
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-46
Identities = 58/239 (24%), Positives = 101/239 (42%), Gaps = 32/239 (13%)
Query: 504 LPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNE 563
LP+ + IA + +G+G FG V++G G+E+AVK S + + E
Sbjct: 32 LPLLVQRTIA---RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSS---REERSWFRE 84
Query: 564 --VLLIAKLQHRNLVKLLGCCTQRD----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSK 617
+ L+H N++ + + + + L+ +Y + SL FD +
Sbjct: 85 AEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----FDYLNRYTVTVEG 140
Query: 618 RSHIIAGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF--G 670
+ A GL +LH + + I HRDLK+ N+L+ I+D GLA
Sbjct: 141 MIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSA 200
Query: 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSV-------KSDVFSFGVLVLEIICGKKNRG 722
D + VGT YM+PE +D ++ ++D+++ G++ EI G
Sbjct: 201 TDTIDIAPNHRVGTKRYMAPE-VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-46
Identities = 68/210 (32%), Positives = 101/210 (48%), Gaps = 29/210 (13%)
Query: 522 KNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+LG+G FG V G+ +AVK+L + + + +F+ E+ ++ LQH N+V
Sbjct: 15 LQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIV 74
Query: 577 KLLGCCTQRDER--MLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLL 630
K G C R LI EYLP SL ++ KLL ++ + I +G+
Sbjct: 75 KYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYT------SQICKGME 128
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG---- 686
YL R IHRDL N+L++N KI DFGL + D+ V G
Sbjct: 129 YL---GTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFF----KVKEPGESPI 181
Query: 687 -YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ +PE + FSV SDV+SFGV++ E+
Sbjct: 182 FWYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 2e-45
Identities = 69/240 (28%), Positives = 109/240 (45%), Gaps = 39/240 (16%)
Query: 492 HSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-----EGQEIAV 546
H+ ++ LK I ++LG+G FG V G +AV
Sbjct: 8 HAQLYACQDPTIFEERHLKYI----------SQLGKGNFGSVELCRYDPLGDNTGALVAV 57
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER--MLIYEYLPNKSLDYFI 604
K+L +F+ E+ ++ L +VK G + L+ EYLP+ L F+
Sbjct: 58 KQLQHSGPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFL 117
Query: 605 FD----TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
S+LL +S + I +G+ YL R +HRDL A N+L+++ + KI
Sbjct: 118 QRHRARLDASRLLLYS------SQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKI 168
Query: 661 SDFGLARSFGLDQTEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+DFGLA+ LD+ VV G + +PE D +FS +SDV+SFGV++ E+
Sbjct: 169 ADFGLAKLLPLDKDYY----VVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELF 224
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 165 bits (421), Expect = 2e-45
Identities = 61/235 (25%), Positives = 99/235 (42%), Gaps = 17/235 (7%)
Query: 483 GGLMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGML-IEG 541
L + ++ K++ L DL + ++G G FG V+ G L +
Sbjct: 90 QPLTKKSGVVLHRAVPKDKWVLNHEDLVLG----------EQIGRGNFGEVFSGRLRADN 139
Query: 542 QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600
+AVK + +F E ++ + H N+V+L+G CTQ+ ++ E +
Sbjct: 140 TLVAVKSCRETLPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDF 199
Query: 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
F+ T L ++ A G+ YL IHRDL A N L+ KI
Sbjct: 200 LTFL--RTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKI 254
Query: 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
SDFG++R A+ + +PE G +S +SDV+SFG+L+ E
Sbjct: 255 SDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETF 309
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 162 bits (413), Expect = 6e-45
Identities = 65/207 (31%), Positives = 92/207 (44%), Gaps = 24/207 (11%)
Query: 522 KNKLGEGGFGPVYKGMLI-----EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNL 575
LGEG FG V G+ +AVK L +G Q +K E+ ++ L H ++
Sbjct: 36 IRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKADAGPQHRSGWKQEIDILRTLYHEHI 95
Query: 576 VKLLGCCTQRDER--MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
+K GCC L+ EY+P SL ++ + ++ I G+ YLH
Sbjct: 96 IKYKGCCEDAGAASLQLVMEYVPLGSLRDYL----PRHSIGLAQLLLFAQQICEGMAYLH 151
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YM 688
IHRDL A NVLLDN KI DFGLA++ V G +
Sbjct: 152 A---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY----RVREDGDSPVFWY 204
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEII 715
+PE + F SDV+SFGV + E++
Sbjct: 205 APECLKEYKFYYASDVWSFGVTLYELL 231
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 161 bits (410), Expect = 1e-44
Identities = 69/250 (27%), Positives = 109/250 (43%), Gaps = 44/250 (17%)
Query: 483 GGLMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI--- 539
G ++ +K + E + LK I LGEG FG V
Sbjct: 1 GDIVSEKKPAT----EVDPTHFEKRFLKRI----------RDLGEGHFGKVELCRYDPEG 46
Query: 540 --EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER--MLIYEY 594
G+++AVK L SG + + K E+ ++ L H N+VK G CT+ LI E+
Sbjct: 47 DNTGEQVAVKSLKPESGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEF 106
Query: 595 LPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNV 650
LP+ SL ++ + L ++ I +G+ YL + +HRDL A NV
Sbjct: 107 LPSGSLKEYLPKNKNKINLKQQLKYA------VQICKGMDYL---GSRQYVHRDLAARNV 157
Query: 651 LLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVF 705
L+++ KI DFGL ++ D+ V + +PE + F + SDV+
Sbjct: 158 LVESEHQVKIGDFGLTKAIETDKEYY----TVKDDRDSPVFWYAPECLMQSKFYIASDVW 213
Query: 706 SFGVLVLEII 715
SFGV + E++
Sbjct: 214 SFGVTLHELL 223
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 1e-44
Identities = 62/208 (29%), Positives = 105/208 (50%), Gaps = 30/208 (14%)
Query: 523 NKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLV 576
LG G FG VYKG+ I E +A+K L + + +E +E ++A + + ++
Sbjct: 21 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 80
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLYL 632
+LLG C LI + +P L ++ + LL+W IA+G+ YL
Sbjct: 81 RLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIAKGMNYL 133
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----Y 687
R++HRDL A NVL+ + KI+DFGLA+ G ++ E + + G +
Sbjct: 134 ---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----GKVPIKW 185
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEII 715
M+ E + +++ +SDV+S+GV V E++
Sbjct: 186 MALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-43
Identities = 62/245 (25%), Positives = 109/245 (44%), Gaps = 41/245 (16%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVK 547
++ + D+ + +LGEG FG V+ + +AVK
Sbjct: 28 QYFSDACVHHIKRRDIVLK----------WELGEGAFGKVFLAECHNLLPEQDKMLVAVK 77
Query: 548 RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF---- 603
L + S ++F+ E L+ LQH+++V+ G CT+ ++++EY+ + L+ F
Sbjct: 78 ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137
Query: 604 --------IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT 655
+ L + + + +A G++YL + L +HRDL N L+
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYL---AGLHFVHRDLATRNCLVGQG 194
Query: 656 MNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVL 710
+ KI DFG++R D + R VG +M PE + F+ +SDV+SFGV+
Sbjct: 195 LVVKIGDFGMSR----DIYSTDYYR-VGGRTMLPIRWMPPESILYRKFTTESDVWSFGVV 249
Query: 711 VLEII 715
+ EI
Sbjct: 250 LWEIF 254
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 158 bits (402), Expect = 1e-43
Identities = 65/246 (26%), Positives = 106/246 (43%), Gaps = 42/246 (17%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVK 547
+ + D+ + +LGEG FG V+ + +AVK
Sbjct: 2 AMHSGIHVQHIKRRDIVLK----------RELGEGAFGKVFLAECYNLSPTKDKMLVAVK 51
Query: 548 RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF---- 603
L + ++F+ E L+ LQH ++VK G C D ++++EY+ + L+ F
Sbjct: 52 ALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111
Query: 604 ---------IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN 654
L S+ HI + IA G++YL + +HRDL N L+
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGA 168
Query: 655 TMNPKISDFGLARSFGLDQTEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGV 709
+ KI DFG++R D + R VG + +M PE + F+ +SDV+SFGV
Sbjct: 169 NLLVKIGDFGMSR----DVYSTDYYR-VGGHTMLPIRWMPPESIMYRKFTTESDVWSFGV 223
Query: 710 LVLEII 715
++ EI
Sbjct: 224 ILWEIF 229
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 3e-43
Identities = 62/209 (29%), Positives = 97/209 (46%), Gaps = 30/209 (14%)
Query: 522 KNKLGEGGFGPVYKGMLI---EGQEI--AVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNL 575
LG G FG V+KG+ I E +I +K + SG Q + + +L I L H ++
Sbjct: 18 LKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKSGRQSFQAVTDHMLAIGSLDHAHI 77
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIARGLLY 631
V+LLG C L+ +YLP SL + LL+W IA+G+ Y
Sbjct: 78 VRLLGLCPG-SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWG------VQIAKGMYY 130
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG----- 686
L ++HR+L A NVLL + +++DFG+A D +
Sbjct: 131 L---EEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSE-----AKTPIK 182
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+ E G ++ +SDV+S+GV V E++
Sbjct: 183 WMALESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 155 bits (395), Expect = 7e-43
Identities = 58/225 (25%), Positives = 97/225 (43%), Gaps = 35/225 (15%)
Query: 498 EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM 557
+ L + +LK++ +G+G FG V G G ++AVK + +
Sbjct: 12 YRSGWALNMKELKLL----------QTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA-- 58
Query: 558 EEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
+ F E ++ +L+H NLV+LLG + ++ EY+ SL ++ + +L
Sbjct: 59 QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYL-RSRGRSVLGGD 117
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676
+ + YL +HRDL A NVL+ K+SDFGL + + +
Sbjct: 118 CLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASST 170
Query: 677 NTKRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ +PE + FS KSDV+SFG+L+ EI
Sbjct: 171 -------QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIY 208
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 9e-43
Identities = 61/201 (30%), Positives = 96/201 (47%), Gaps = 21/201 (10%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
++G G FG V+ G + ++A+K + +G+ E+F E ++ KL H LV+L G
Sbjct: 13 VQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLVQLYGV 71
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIAGIARGLLYLHQDSR 637
C ++ L+ E++ + L ++ LL + G+ YL
Sbjct: 72 CLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMC------LDVCEGMAYL---EE 122
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEYAI 694
+IHRDL A N L+ K+SDFG+ R DQ ++T GT + SPE
Sbjct: 123 ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSST----GTKFPVKWASPEVFS 178
Query: 695 DGLFSVKSDVFSFGVLVLEII 715
+S KSDV+SFGVL+ E+
Sbjct: 179 FSRYSSKSDVWSFGVLMWEVF 199
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 1e-42
Identities = 71/219 (32%), Positives = 106/219 (48%), Gaps = 33/219 (15%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
+LGE FG VYKG L + Q +A+K L G EEF++E +L A+LQH N
Sbjct: 14 MEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPLREEFRHEAMLRARLQHPN 73
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYF-------------IFDTTRSKLLDWSKRSHI 621
+V LLG T+ +I+ Y + L F D T L+ H+
Sbjct: 74 VVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 133
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
+A IA G+ YL S ++H+DL NVL+ + +N KISD GL R + +
Sbjct: 134 VAQIAAGMEYL---SSHHVVHKDLATRNVLVYDKLNVKISDLGLFRE--VYAADYYKL-- 186
Query: 682 VGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+PE + G FS+ SD++S+GV++ E+
Sbjct: 187 -LGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 2e-42
Identities = 63/231 (27%), Positives = 103/231 (44%), Gaps = 23/231 (9%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVK 547
+ S G E+ DL + +LG G FG V G ++A+K
Sbjct: 5 SKNAPSTAGLGYGSWEIDPKDLTFL----------KELGTGQFGVVKYGKWRGQYDVAIK 54
Query: 548 RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT 607
+ +GS +EF E ++ L H LV+L G CT++ +I EY+ N L ++
Sbjct: 55 MIKEGSMS-EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYL--R 111
Query: 608 TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ + + + YL + +HRDL A N L+++ K+SDFGL+R
Sbjct: 112 EMRHRFQTQQLLEMCKDVCEAMEYL---ESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR 168
Query: 668 SFGLDQTEANTKRVVGT---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
D+ ++ G+ + PE + FS KSD+++FGVL+ EI
Sbjct: 169 YVLDDEYTSSV----GSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY 215
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 3e-42
Identities = 63/214 (29%), Positives = 107/214 (50%), Gaps = 30/214 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKGSGQG-MEEFKNEVLLIAKL 570
F + LG G FG VYKG+ I E +A+K L + + +E +E ++A +
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 74
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD----TTRSKLLDWSKRSHIIAGIA 626
+ ++ +LLG C LI + +P L ++ + LL+W IA
Sbjct: 75 DNPHVCRLLGICLT-STVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWC------VQIA 127
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
+G+ YL R++HRDL A NVL+ + KI+DFGLA+ G ++ E + + G
Sbjct: 128 KGMNYL---EDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEG-----G 179
Query: 687 -----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+ E + +++ +SDV+S+GV V E++
Sbjct: 180 KVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 3e-42
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 23/230 (10%)
Query: 487 YRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAV 546
+ + L + +LK++ +G+G FG V G G ++AV
Sbjct: 173 MEGTVAAQDEFYRSGWALNMKELKLL----------QTIGKGEFGDVMLGDY-RGNKVAV 221
Query: 547 KRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIF 605
K + + + F E ++ +L+H NLV+LLG + ++ EY+ SL ++
Sbjct: 222 KCIKNDATA--QAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLR 279
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
R +L + + YL +HRDL A NVL+ K+SDFGL
Sbjct: 280 SRGR-SVLGGDCLLKFSLDVCEAMEYL---EGNNFVHRDLAARNVLVSEDNVAKVSDFGL 335
Query: 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ T+ K V + +PE + FS KSDV+SFG+L+ EI
Sbjct: 336 TKE--ASSTQDTGKLPV---KWTAPEALREKKFSTKSDVWSFGILLWEIY 380
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 4e-42
Identities = 62/200 (31%), Positives = 103/200 (51%), Gaps = 17/200 (8%)
Query: 522 KNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
K+KLG G +G VY+G+ +AVK L + + + +EEF E ++ +++H NLV+LLG
Sbjct: 18 KHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNLVQLLG 76
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRI 640
CT+ +I E++ +L ++ + + ++ I+ + YL +
Sbjct: 77 VCTREPPFYIITEFMTYGNLLDYL-RECNRQEVSAVVLLYMATQISSAMEYL---EKKNF 132
Query: 641 IHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK-----RVVGTYGYMSPEYAID 695
IHRDL A N L+ K++DFGL+R D A+ + + +PE
Sbjct: 133 IHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIK------WTAPESLAY 186
Query: 696 GLFSVKSDVFSFGVLVLEII 715
FS+KSDV++FGVL+ EI
Sbjct: 187 NKFSIKSDVWAFGVLLWEIA 206
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 5e-42
Identities = 62/197 (31%), Positives = 98/197 (49%), Gaps = 13/197 (6%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+LG G FG V G ++AVK + +GS +EF E + KL H LVK G
Sbjct: 13 LKELGSGQFGVVKLGKWKGQYDVAVKMIKEGS-MSEDEFFQEAQTMMKLSHPKLVKFYGV 71
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRII 641
C++ ++ EY+ N L ++ + K L+ S+ + + G+ +L + I
Sbjct: 72 CSKEYPIYIVTEYISNGCLLNYL--RSHGKGLEPSQLLEMCYDVCEGMAFL---ESHQFI 126
Query: 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGLF 698
HRDL A N L+D + K+SDFG+ R DQ ++ GT + +PE +
Sbjct: 127 HRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYVSSV----GTKFPVKWSAPEVFHYFKY 182
Query: 699 SVKSDVFSFGVLVLEII 715
S KSDV++FG+L+ E+
Sbjct: 183 SSKSDVWAFGILMWEVF 199
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 6e-42
Identities = 68/215 (31%), Positives = 97/215 (45%), Gaps = 31/215 (14%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
LG G FG VY+G + ++AVK L + S Q +F E L+I+K H+N
Sbjct: 35 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 94
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLL 630
+V+ +G Q R ++ E + L F+ ++ L H+ IA G
Sbjct: 95 IVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 154
Query: 631 YLHQDSRLRIIHRDLKASNVLL-----DNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
YL IHRD+ A N LL KI DFG+AR D A+ R G
Sbjct: 155 YL---EENHFIHRDIAARNCLLTCPGPGRVA--KIGDFGMAR----DIYRASYYR-KGGC 204
Query: 686 GY-----MSPEYAIDGLFSVKSDVFSFGVLVLEII 715
M PE ++G+F+ K+D +SFGVL+ EI
Sbjct: 205 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 7e-42
Identities = 62/231 (26%), Positives = 105/231 (45%), Gaps = 29/231 (12%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE----IAVKRLSKG 552
E +++ +P + +G+G FG VY G I+ + A+K LS+
Sbjct: 9 AEVKDVLIPHERVVT--------HSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI 60
Query: 553 SGQG-MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIFDT--- 607
+ +E F E LL+ L H N++ L+G + ++ Y+ + L FI
Sbjct: 61 TEMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRN 120
Query: 608 -TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666
T L+ + +ARG+ YL + + +HRDL A N +LD + K++DFGLA
Sbjct: 121 PTVKDLISFG------LQVARGMEYL---AEQKFVHRDLAARNCMLDESFTVKVADFGLA 171
Query: 667 RSFGLDQTEANTKRVVGTY--GYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
R + + + + + E F+ KSDV+SFGVL+ E++
Sbjct: 172 RDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 8e-42
Identities = 66/238 (27%), Positives = 110/238 (46%), Gaps = 40/238 (16%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE-----IAVKR 548
NQ K E+ + +G G FG VYKGML +A+K
Sbjct: 31 NQAVLKFTTEIHPSCVTRQ----------KVIGAGEFGEVYKGMLKTSSGKKEVPVAIKT 80
Query: 549 LSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI--- 604
L G + + +F E ++ + H N+++L G ++ M+I EY+ N +LD F+
Sbjct: 81 LKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREK 140
Query: 605 -FDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
+ + +L+ GIA G+ YL + + +HRDL A N+L+++ + K+SDF
Sbjct: 141 DGEFSVLQLVGML------RGIAAGMKYL---ANMNYVHRDLAARNILVNSNLVCKVSDF 191
Query: 664 GLARSFGLDQTEANTKRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
GL+R D T G + +PE F+ SDV+SFG+++ E++
Sbjct: 192 GLSRVLEDDPEATYTTS-----GGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM 244
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 8e-42
Identities = 61/209 (29%), Positives = 100/209 (47%), Gaps = 29/209 (13%)
Query: 523 NKLGEGGFGPVYKGMLIEG----QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVK 577
+G G FG VY G L++ AVK L++ + +F E +++ H N++
Sbjct: 31 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 90
Query: 578 LLGCCTQRDE-RMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
LLG C + + +++ Y+ + L FI + T L+ + +A+G+ YL
Sbjct: 91 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG------LQVAKGMKYL 144
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG------ 686
+ + +HRDL A N +LD K++DFGLAR D + V G
Sbjct: 145 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEYYSVHNKTGAKLPVK 197
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+ E F+ KSDV+SFGVL+ E++
Sbjct: 198 WMALESLQTQKFTTKSDVWSFGVLLWELM 226
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 9e-42
Identities = 62/224 (27%), Positives = 108/224 (48%), Gaps = 17/224 (7%)
Query: 493 SNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSK 551
++ E+ D+ + +KLG G +G VY+G+ +AVK L +
Sbjct: 206 YGVSPNYDKWEMERTDITMK----------HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE 255
Query: 552 GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK 611
+ + +EEF E ++ +++H NLV+LLG CT+ +I E++ +L ++ +
Sbjct: 256 DTME-VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYL-RECNRQ 313
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
+ ++ I+ + YL + IHR+L A N L+ K++DFGL+R
Sbjct: 314 EVSAVVLLYMATQISSAMEYL---EKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG 370
Query: 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
D A+ + +PE FS+KSDV++FGVL+ EI
Sbjct: 371 DTYTAHAGAKF-PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA 413
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 1e-41
Identities = 63/213 (29%), Positives = 100/213 (46%), Gaps = 27/213 (12%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
+LG+G FG VY+G+ +A+K +++ S + EF NE ++ + +
Sbjct: 30 SRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHH 89
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYF-------IFDTTRSKLLDWSKRSHIIAGIAR 627
+V+LLG +Q ++I E + L + + + SK + IA
Sbjct: 90 VVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIAD 149
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
G+ YL + + +HRDL A N ++ KI DFG+ R D E + R G G
Sbjct: 150 GMAYL---NANKFVHRDLAARNCMVAEDFTVKIGDFGMTR----DIYETDYYR-KGGKGL 201
Query: 688 -----MSPEYAIDGLFSVKSDVFSFGVLVLEII 715
MSPE DG+F+ SDV+SFGV++ EI
Sbjct: 202 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 152 bits (386), Expect = 1e-41
Identities = 76/220 (34%), Positives = 118/220 (53%), Gaps = 21/220 (9%)
Query: 498 EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGM 557
++E E+P LK++ +LG G FG V+ G ++AVK L +GS
Sbjct: 4 WEDEWEVPRETLKLV----------ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS-P 52
Query: 558 EEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSK 617
+ F E L+ +LQH+ LV+L TQ + +I EY+ N SL F+ T L +K
Sbjct: 53 DAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFL-KTPSGIKLTINK 110
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
+ A IA G+ ++ IHRDL+A+N+L+ +T++ KI+DFGLAR ++
Sbjct: 111 LLDMAAQIAEGMAFI---EERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY--- 164
Query: 678 TKRVVGTYGY--MSPEYAIDGLFSVKSDVFSFGVLVLEII 715
T R + +PE G F++KSDV+SFG+L+ EI+
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 204
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 154 bits (391), Expect = 2e-41
Identities = 68/215 (31%), Positives = 96/215 (44%), Gaps = 31/215 (14%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
LG G FG VY+G + ++AVK L + S Q +F E L+I+K H+N
Sbjct: 76 IRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEVCSEQDELDFLMEALIISKFNHQN 135
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLL 630
+V+ +G Q R ++ E + L F+ ++ L H+ IA G
Sbjct: 136 IVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQ 195
Query: 631 YLHQDSRLRIIHRDLKASNVLL-----DNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
YL IHRD+ A N LL KI DFG+AR D A R G
Sbjct: 196 YL---EENHFIHRDIAARNCLLTCPGPGRVA--KIGDFGMAR----DIYRAGYYR-KGGC 245
Query: 686 GY-----MSPEYAIDGLFSVKSDVFSFGVLVLEII 715
M PE ++G+F+ K+D +SFGVL+ EI
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-41
Identities = 65/217 (29%), Positives = 102/217 (47%), Gaps = 34/217 (15%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQE---IAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLV 576
++ +GEG FG V K + + A+KR+ + S +F E+ ++ KL H N++
Sbjct: 30 QDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNII 89
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYF-------------IFDTTRSKLLDWSKRSHIIA 623
LLG C R L EY P+ +L F + + L + H A
Sbjct: 90 NLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAA 149
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK---- 679
+ARG+ YL S+ + IHRDL A N+L+ KI+DFGL+R + T
Sbjct: 150 DVARGMDYL---SQKQFIHRDLAARNILVGENYVAKIADFGLSRG--QEVYVKKTMGRLP 204
Query: 680 -RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
R +M+ E +++ SDV+S+GVL+ EI+
Sbjct: 205 VR------WMAIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 2e-41
Identities = 67/237 (28%), Positives = 105/237 (44%), Gaps = 39/237 (16%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRL 549
+ E+ + I + +G G G V G L +A+K L
Sbjct: 36 GRAGRSFTREIEASRIHI----------EKIIGSGDSGEVCYGRLRVPGQRDVPVAIKAL 85
Query: 550 SKGSGQGM-EEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT- 607
G + +F +E ++ + H N+++L G T+ M++ EY+ N SLD F+
Sbjct: 86 KAGYTERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHD 145
Query: 608 ---TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
T +L+ G+ G+ YL S L +HRDL A NVL+D+ + K+SDFG
Sbjct: 146 GQFTIMQLVGML------RGVGAGMRYL---SDLGYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 665 LARSFGLDQTEANTKRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
L+R D A T G + +PE FS SDV+SFGV++ E++
Sbjct: 197 LSRVLEDDPDAAYTTT-----GGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL 248
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 154 bits (390), Expect = 3e-41
Identities = 66/233 (28%), Positives = 108/233 (46%), Gaps = 25/233 (10%)
Query: 491 KHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE----IAV 546
+ Q + EL ++ I +G G FG V G L + +A+
Sbjct: 29 EDPTQTVHEFAKELDATNISID----------KVVGAGEFGEVCSGRLKLPSKKEISVAI 78
Query: 547 KRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
K L G + +F E ++ + H N+++L G T+ M++ EY+ N SLD F+
Sbjct: 79 KTLKVGYTEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFL- 137
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
+ ++ GIA G+ YL S + +HRDL A N+L+++ + K+SDFGL
Sbjct: 138 -RKHDAQFTVIQLVGMLRGIASGMKYL---SDMGYVHRDLAARNILINSNLVCKVSDFGL 193
Query: 666 ARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
R D A T R G + SPE F+ SDV+S+G+++ E++
Sbjct: 194 GRVLEDDPEAAYTTR--GGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVM 244
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 3e-41
Identities = 58/235 (24%), Positives = 102/235 (43%), Gaps = 40/235 (17%)
Query: 495 QGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI--EGQEI--AVKRLS 550
G+ + E+ +++ +GEG FG V++G+ + E + A+K
Sbjct: 3 MGSSTRDYEIQRERIELG----------RCIGEGQFGDVHQGIYMSPENPALAVAIKTCK 52
Query: 551 KG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----F 605
S E+F E L + + H ++VKL+G T+ + +I E L F+ +
Sbjct: 53 NCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKY 111
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
+ L+ ++ ++ L YL R +HRD+ A NVL+ + K+ DFGL
Sbjct: 112 SLDLASLILYA------YQLSTALAYL---ESKRFVHRDIAARNVLVSSNDCVKLGDFGL 162
Query: 666 ARSFGLDQTEANTK-----RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+R +K + +M+PE F+ SDV+ FGV + EI+
Sbjct: 163 SRYMEDSTYYKASKGKLPIK------WMAPESINFRRFTSASDVWMFGVCMWEIL 211
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 3e-41
Identities = 62/233 (26%), Positives = 94/233 (40%), Gaps = 36/233 (15%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGML--IEGQEI--AVKRLSKG 552
+ + DL+++ KLG+G FG V +G G+ + AVK L
Sbjct: 8 LQSLTCLIGEKDLRLL----------EKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPD 57
Query: 553 ---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----F 605
+ M++F EV + L HRNL++L G ++ E P SL +
Sbjct: 58 VLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQG 116
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
L ++ +A G+ YL R IHRDL A N+LL KI DFGL
Sbjct: 117 HFLLGTLSRYA------VQVAEGMGYL---ESKRFIHRDLAARNLLLATRDLVKIGDFGL 167
Query: 666 ARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
R+ + + + + +PE FS SD + FGV + E+
Sbjct: 168 MRALPQNDDHYVMQE--HRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-41
Identities = 74/234 (31%), Positives = 116/234 (49%), Gaps = 33/234 (14%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRL 549
+ EK+ E+P LK+ KLG G FG V+ + ++AVK +
Sbjct: 171 SSKPQKPWEKDAWEIPRESLKLE----------KKLGAGQFGEVWMATYNKHTKVAVKTM 220
Query: 550 SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--- 606
GS +E F E ++ LQH LVKL T+ + +I E++ SL F+
Sbjct: 221 KPGSMS-VEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEG 278
Query: 607 --TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664
KL+D+S A IA G+ ++ + IHRDL+A+N+L+ ++ KI+DFG
Sbjct: 279 SKQPLPKLIDFS------AQIAEGMAFI---EQRNYIHRDLRAANILVSASLVCKIADFG 329
Query: 665 LARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
LAR ++ A G + +PE G F++KSDV+SFG+L++EI+
Sbjct: 330 LARVIEDNEYTARE----GAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIV 379
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 151 bits (384), Expect = 5e-41
Identities = 58/214 (27%), Positives = 97/214 (45%), Gaps = 29/214 (13%)
Query: 522 KNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNL 575
LGEG FG V +G L ++AVK + S + +EEF +E + H N+
Sbjct: 39 GKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDNSSQREIEEFLSEAACMKDFSHPNV 98
Query: 576 VKLLGCCTQRD-----ERMLIYEYLPNKSLDYFI---FDTTRSKLLDWSKRSHIIAGIAR 627
++LLG C + + M+I ++ L ++ T K + + IA
Sbjct: 99 IRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIAL 158
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTK-----RV 681
G+ YL S +HRDL A N +L + M ++DFGL++ + D +
Sbjct: 159 GMEYL---SNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK- 214
Query: 682 VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+++ E D +++ KSDV++FGV + EI
Sbjct: 215 -----WIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 8e-41
Identities = 61/226 (26%), Positives = 106/226 (46%), Gaps = 30/226 (13%)
Query: 500 EEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE---IAVKRLSKGSG-Q 555
+++ L +L I +LG G FG V +G+ ++ +A+K L +G+
Sbjct: 2 KKLFLKRDNLLIA---------DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKA 52
Query: 556 GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDW 615
EE E ++ +L + +V+L+G C + ML+ E L F+ + + +
Sbjct: 53 DTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFL--VGKREEIPV 109
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
S + ++ ++ G+ YL +HRDL A NVLL N KISDFGL+++ G D +
Sbjct: 110 SNVAELLHQVSMGMKYL---EEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSY 166
Query: 676 ANTKRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ + +PE FS +SDV+S+GV + E +
Sbjct: 167 YTARS-----AGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 207
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 60/231 (25%), Positives = 96/231 (41%), Gaps = 38/231 (16%)
Query: 499 KEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGML-IEGQEI--AVKRLSKG--S 553
+E+ L L + E +LG G FG V KG ++ AVK L
Sbjct: 8 PKEVYLDRKLLTL---------EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEAND 58
Query: 554 GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD---TTRS 610
+E E ++ +L + +V+++G C + ML+ E L+ ++
Sbjct: 59 PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDK 117
Query: 611 KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
+++ ++ G+ YL +HRDL A NVLL KISDFGL+++
Sbjct: 118 NIIELV------HQVSMGMKYL---EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALR 168
Query: 671 LDQTEANTKRVVGTYG------YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
D+ + + +PE FS KSDV+SFGVL+ E
Sbjct: 169 ADENYYKAQT-----HGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 214
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 1e-40
Identities = 48/215 (22%), Positives = 92/215 (42%), Gaps = 36/215 (16%)
Query: 522 KNKLGEGGFGPVYKGML--------IEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR 573
LG+G F ++KG+ + E+ +K L K E F +++KL H+
Sbjct: 13 NESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHK 72
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT----TRSKLLDWSKRSHIIAGIARGL 629
+LV G C DE +L+ E++ SLD ++ L+ + +A +
Sbjct: 73 HLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVA------KQLAAAM 126
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNP--------KISDFGLARSFGLDQTEANTKRV 681
+L +IH ++ A N+LL + K+SD G++ + + + +R+
Sbjct: 127 HFL---EENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISIT--VLPKDILQERI 181
Query: 682 VGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEII 715
++ PE + ++ +D +SFG + EI
Sbjct: 182 ----PWVPPECIENPKNLNLATDKWSFGTTLWEIC 212
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 1e-40
Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 36/227 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKG-SGQGMEEFKNEVLLI 567
D + LGEG FG V + E +AVK L + + + + +E+ ++
Sbjct: 35 DKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 94
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DY------------FIFDTTRSKLL 613
+ +H+N++ LLG CTQ +I EY +L +Y + + + +
Sbjct: 95 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 154
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+ +ARG+ YL + + IHRDL A NVL+ KI+DFGLAR D
Sbjct: 155 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 207
Query: 674 TEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ + T G +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 208 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 152 bits (385), Expect = 1e-40
Identities = 61/209 (29%), Positives = 102/209 (48%), Gaps = 29/209 (13%)
Query: 523 NKLGEGGFGPVYKGMLIEG----QEIAVKRLSKGSGQG-MEEFKNEVLLIAKLQHRNLVK 577
+G G FG VY G L++ AVK L++ + G + +F E +++ H N++
Sbjct: 95 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLS 154
Query: 578 LLGCCTQRDE-RMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
LLG C + + +++ Y+ + L FI + T L+ + +A+G+ +L
Sbjct: 155 LLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG------LQVAKGMKFL 208
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG------ 686
+ + +HRDL A N +LD K++DFGLAR D + V G
Sbjct: 209 ---ASKKFVHRDLAARNCMLDEKFTVKVADFGLAR----DMYDKEFDSVHNKTGAKLPVK 261
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+ E F+ KSDV+SFGVL+ E++
Sbjct: 262 WMALESLQTQKFTTKSDVWSFGVLLWELM 290
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 2e-40
Identities = 65/232 (28%), Positives = 107/232 (46%), Gaps = 41/232 (17%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML--IEGQE----IAVKRLSKG-SGQGMEEFKNEVLLIAK 569
N LGEG FG V K ++G+ +AVK L + S + + +E ++ +
Sbjct: 23 KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSELRDLLSEFNVLKQ 82
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSL---------------------DYFIFDTT 608
+ H +++KL G C+Q +LI EY SL + D
Sbjct: 83 VNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP 142
Query: 609 RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
+ L I++G+ YL + ++++HRDL A N+L+ KISDFGL+R
Sbjct: 143 DERALTMGDLISFAWQISQGMQYL---AEMKLVHRDLAARNILVAEGRKMKISDFGLSR- 198
Query: 669 FGLDQTEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
D E ++ + G +M+ E D +++ +SDV+SFGVL+ EI+
Sbjct: 199 ---DVYEEDSYV-KRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 3e-40
Identities = 58/214 (27%), Positives = 92/214 (42%), Gaps = 28/214 (13%)
Query: 522 KNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNL 575
LG+G FG V + L ++AVK L + +EEF E + + H ++
Sbjct: 28 GRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADIIASSDIEEFLREAACMKEFDHPHV 87
Query: 576 VKLLGCCTQRDER------MLIYEYLPNKSLDYFIFD---TTRSKLLDWSKRSHIIAGIA 626
KL+G + + M+I ++ + L F+ L + IA
Sbjct: 88 AKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA 147
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
G+ YL S IHRDL A N +L M ++DFGL+R + R G
Sbjct: 148 CGMEYL---SSRNFIHRDLAARNCMLAEDMTVCVADFGLSR----KIYSGDYYR-QGCAS 199
Query: 687 -----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+++ E D L++V SDV++FGV + EI+
Sbjct: 200 KLPVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 3e-40
Identities = 59/227 (25%), Positives = 96/227 (42%), Gaps = 41/227 (18%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRN 574
+GEG FG V++ +AVK L + S +F+ E L+A+ + N
Sbjct: 52 VRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPN 111
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYF---------------------IFDTTRSKLL 613
+VKLLG C L++EY+ L+ F + L
Sbjct: 112 IVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPL 171
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+++ I +A G+ YL S + +HRDL N L+ M KI+DFGL+R +
Sbjct: 172 SCAEQLCIARQVAAGMAYL---SERKFVHRDLATRNCLVGENMVVKIADFGLSR----NI 224
Query: 674 TEANTKRVVGTYGY-----MSPEYAIDGLFSVKSDVFSFGVLVLEII 715
A+ + M PE ++ +SDV+++GV++ EI
Sbjct: 225 YSADYYK-ADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 152 bits (387), Expect = 3e-40
Identities = 69/222 (31%), Positives = 112/222 (50%), Gaps = 17/222 (7%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS 553
QG K+ E+P L++ KLG+G FG V+ G +A+K L G+
Sbjct: 171 TQGLAKDAWEIPRESLRLE----------VKLGQGCFGEVWMGTWNGTTRVAIKTLKPGT 220
Query: 554 GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLL 613
E F E ++ KL+H LV+L ++ + ++ EY+ SL F K L
Sbjct: 221 MS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF-LKGETGKYL 277
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+ + A IA G+ Y+ R+ +HRDL+A+N+L+ + K++DFGLAR ++
Sbjct: 278 RLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 334
Query: 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
A + +PE A+ G F++KSDV+SFG+L+ E+
Sbjct: 335 YTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 375
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 150 bits (382), Expect = 4e-40
Identities = 66/227 (29%), Positives = 106/227 (46%), Gaps = 36/227 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKG-SGQGMEEFKNEVLLI 567
D + LGEG FG V + E +AVK L + + + + +E+ ++
Sbjct: 81 DKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKDLSDLVSEMEMM 140
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DY------------FIFDTTRSKLL 613
+ +H+N++ LLG CTQ +I EY +L +Y + + + +
Sbjct: 141 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQM 200
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+ +ARG+ YL + + IHRDL A NVL+ KI+DFGLAR D
Sbjct: 201 TFKDLVSCTYQLARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLAR----DI 253
Query: 674 TEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ + T G +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 254 NNIDYYK-KTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 6e-40
Identities = 56/208 (26%), Positives = 96/208 (46%), Gaps = 30/208 (14%)
Query: 522 KNKLGEGGFGPVYKGMLI--EGQEI--AVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLV 576
LGEG FG VY+G+ +G++I AVK K + E+F +E +++ L H ++V
Sbjct: 17 NRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDNKEKFMSEAVIMKNLDHPHIV 76
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
KL+G + + +I E P L +++ L+ +S I + + YL
Sbjct: 77 KLIGIIEE-EPTWIIMELYPYGELGHYLERNKNSLKVLTLVLYS------LQICKAMAYL 129
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK-----RVVGTYGY 687
+ +HRD+ N+L+ + K+ DFGL+R + + + +
Sbjct: 130 ---ESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIK------W 180
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEII 715
MSPE F+ SDV+ F V + EI+
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEIL 208
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 148 bits (376), Expect = 6e-40
Identities = 61/221 (27%), Positives = 94/221 (42%), Gaps = 35/221 (15%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHR 573
LG G FG V + + +AVK L +G + +E+ ++ + H
Sbjct: 32 GKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHL 91
Query: 574 NLVKLLGCCTQRDE-RMLIYEYLPNKSL-DY------------FIFDTTRSKLLDWSKRS 619
N+V LLG CT+ M+I E+ +L Y + L
Sbjct: 92 NVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLI 151
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
+A+G+ +L + + IHRDL A N+LL KI DFGLAR D +
Sbjct: 152 CYSFQVAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLAR----DIYKDPDY 204
Query: 680 RVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+PE D +++++SDV+SFGVL+ EI
Sbjct: 205 V-RKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 8e-40
Identities = 70/227 (30%), Positives = 113/227 (49%), Gaps = 17/227 (7%)
Query: 489 RKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKR 548
K QG K+ E+P L++ KLG+G FG V+ G +A+K
Sbjct: 249 TSKPQTQGLAKDAWEIPRESLRLE----------VKLGQGCFGEVWMGTWNGTTRVAIKT 298
Query: 549 LSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTT 608
L G+ E F E ++ KL+H LV+L ++ + ++ EY+ SL F
Sbjct: 299 LKPGTMS-PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDF-LKGE 355
Query: 609 RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
K L + + A IA G+ Y+ R+ +HRDL+A+N+L+ + K++DFGLAR
Sbjct: 356 TGKYLRLPQLVDMAAQIASGMAYV---ERMNYVHRDLRAANILVGENLVCKVADFGLARL 412
Query: 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
++ A + +PE A+ G F++KSDV+SFG+L+ E+
Sbjct: 413 IEDNEYTARQGAKF-PIKWTAPEAALYGRFTIKSDVWSFGILLTELT 458
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 2e-39
Identities = 64/223 (28%), Positives = 98/223 (43%), Gaps = 32/223 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML--IEGQE----IAVKRLSKG-SGQGMEEFKNEVLLIAK 569
+N LG G FG V + + ++ +AVK L E +E+ +++
Sbjct: 46 NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTAHADEKEALMSELKIMSH 105
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-----------DYFIFDTTRSKLLDWSK 617
L QH N+V LLG CT ++I EY L + +
Sbjct: 106 LGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD 165
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
H + +A+G+ +L + IHRD+ A NVLL N KI DFGLAR D +
Sbjct: 166 LLHFSSQVAQGMAFL---ASKNCIHRDVAARNVLLTNGHVAKIGDFGLAR----DIMNDS 218
Query: 678 TKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
V +M+PE D +++V+SDV+S+G+L+ EI
Sbjct: 219 NYIV-KGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 3e-39
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 28/220 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+F E +G GGFG V+K I+G+ +KR+ + E+ + EV +AKL H N+
Sbjct: 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN----EKAEREVKALAKLDHVNI 66
Query: 576 VKLLGCCTQRDERM----------------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRS 619
V GC D + E+ +L+ +I + R + LD
Sbjct: 67 VHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWI-EKRRGEKLDKVLAL 125
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK 679
+ I +G+ Y+H ++I+RDLK SN+ L +T KI DFGL S + +
Sbjct: 126 ELFEQITKGVDYIHSK---KLINRDLKPSNIFLVDTKQVKIGDFGLVTSL---KNDGKRT 179
Query: 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
R GT YMSPE + + D+++ G+++ E++
Sbjct: 180 RSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 151 bits (383), Expect = 8e-39
Identities = 60/233 (25%), Positives = 108/233 (46%), Gaps = 17/233 (7%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE---IAV 546
+ + EL L + + + +LG G FG V +G+ ++ +A+
Sbjct: 311 DTSVFESPFSDPEELKDKKLFLKRD--NLLIADIELGCGNFGSVRQGVYRMRKKQIDVAI 368
Query: 547 KRLSKGSGQGM-EEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF 605
K L +G+ + EE E ++ +L + +V+L+G C + ML+ E L F+
Sbjct: 369 KVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQ-AEALMLVMEMAGGGPLHKFL- 426
Query: 606 DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665
+ + + S + ++ ++ G+ YL +HR+L A NVLL N KISDFGL
Sbjct: 427 -VGKREEIPVSNVAELLHQVSMGMKYL---EEKNFVHRNLAARNVLLVNRHYAKISDFGL 482
Query: 666 ARSFGLDQTEANTKRVVGT---YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+++ G D + + + +PE FS +SDV+S+GV + E +
Sbjct: 483 SKALGADDSYYTAR--SAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 145 bits (367), Expect = 9e-39
Identities = 58/227 (25%), Positives = 90/227 (39%), Gaps = 36/227 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAK 569
+ S LG G FG V + +AVK L E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF---------------IFDTTRSKLL 613
L H N+V LLG CT ++I EY L F L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
D +A+G+ +L + IHRDL A N+LL + KI DFGLAR +
Sbjct: 143 DLEDLLSFSYQVAKGMAFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARD--IKN 197
Query: 674 TEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+ +M+PE + +++ +SDV+S+G+ + E+
Sbjct: 198 DSNYVVK---GNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-38
Identities = 66/222 (29%), Positives = 102/222 (45%), Gaps = 36/222 (16%)
Query: 522 KNKLGEGGFGPVYKGMLI--------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-Q 571
LGEG FG V I ++AVK L + + + + +E+ ++ + +
Sbjct: 74 GKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGK 133
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSL-DY------------FIFDTTRSKLLDWSKR 618
H+N++ LLG CTQ +I EY +L +Y + + L
Sbjct: 134 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+ARG+ YL + + IHRDL A NVL+ KI+DFGLAR + +
Sbjct: 194 VSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLAR--DIHHIDYYK 248
Query: 679 KRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
K T G +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 249 KT---TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 3e-38
Identities = 55/203 (27%), Positives = 97/203 (47%), Gaps = 17/203 (8%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
++G G F VYKG+ E+A + K + + FK E ++ LQH N+V+
Sbjct: 33 EIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYD 92
Query: 581 CC--TQRDERML--IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
T + ++ + + E + + +L ++ R K++ I +GL +LH +
Sbjct: 93 SWESTVKGKKCIVLVTELMTSGTLKTYL---KRFKVMKIKVLRSWCRQILKGLQFLHTRT 149
Query: 637 RLRIIHRDLKASNVLLDNTM-NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
IIHRDLK N+ + + KI D GLA + + K V+GT +M+PE +
Sbjct: 150 P-PIIHRDLKCDNIFITGPTGSVKIGDLGLATL----KRASFAKAVIGTPEFMAPEM-YE 203
Query: 696 GLFSVKSDVFSFGVLVLEIICGK 718
+ DV++FG+ +LE+ +
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSE 226
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 4e-38
Identities = 57/224 (25%), Positives = 94/224 (41%), Gaps = 27/224 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQHRN 574
+F LG GGFG V++ ++ A+KR+ E+ EV +AKL+H
Sbjct: 5 TDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 64
Query: 575 LVKLLGC---------CTQRDERMLIY---EYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
+V+ ++ +Y + ++L ++ + + S HI
Sbjct: 65 IVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIF 124
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV- 681
IA + +LH ++HRDLK SN+ K+ DFGL + D+ E
Sbjct: 125 LQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPM 181
Query: 682 ---------VGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC 716
VGT YMSPE +S K D+FS G+++ E++
Sbjct: 182 PAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY 225
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-37
Identities = 62/227 (27%), Positives = 97/227 (42%), Gaps = 41/227 (18%)
Query: 522 KNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHR 573
LG G FG V ++AVK L + E +E+ ++ +L H
Sbjct: 50 GKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHE 109
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSL------------DYFIFDTTRSKLLDWSKRSHI 621
N+V LLG CT LI+EY L + I + +L + + +
Sbjct: 110 NIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVL 169
Query: 622 -------IAG-IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
A +A+G+ +L +HRDL A NVL+ + KI DFGLAR +
Sbjct: 170 TFEDLLCFAYQVAKGMEFL---EFKSCVHRDLAARNVLVTHGKVVKICDFGLARD--IMS 224
Query: 674 TEANTKRVVGTYG-----YMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
R +M+PE +G++++KSDV+S+G+L+ EI
Sbjct: 225 DSNYVVR---GNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 2e-37
Identities = 66/299 (22%), Positives = 124/299 (41%), Gaps = 35/299 (11%)
Query: 428 DLIDI--KELPESGQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAVIFIGGL 485
DLID + + + Q IR + + N ++ + ++S++ + +
Sbjct: 312 DLIDGYCRLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEII 371
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLI--EGQE 543
+ + + E+ +++ +GEG FG V++G+ + E
Sbjct: 372 DE---EDTYTMPSTRDYEIQRERIELG----------RCIGEGQFGDVHQGIYMSPENPA 418
Query: 544 I--AVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600
+ A+K S E+F E L + + H ++VKL+G T+ + +I E L
Sbjct: 419 MAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVITE-NPVWIIMELCTLGEL 477
Query: 601 DYFIFDT----TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM 656
F+ + L+ ++ ++ L YL R +HRD+ A NVL+ +
Sbjct: 478 RSFLQVRKFSLDLASLILYA------YQLSTALAYL---ESKRFVHRDIAARNVLVSSND 528
Query: 657 NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
K+ DFGL+R +K + +M+PE F+ SDV+ FGV + EI+
Sbjct: 529 CVKLGDFGLSRYMEDSTYYKASKGKL-PIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 141 bits (357), Expect = 5e-37
Identities = 49/205 (23%), Positives = 94/205 (45%), Gaps = 9/205 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+ + K+GEG FG +G++ +K ++ S + EE + EV ++A ++H
Sbjct: 24 EKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRMSSKEREESRREVAVLANMKHP 83
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V+ + ++ +Y L I + + L + I L ++H
Sbjct: 84 NIVQYRESFEENGSLYIVMDYCEGGDLFKRI-NAQKGVLFQEDQILDWFVQICLALKHVH 142
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
+I+HRD+K+ N+ L ++ DFG+AR A +GT Y+SPE
Sbjct: 143 DR---KILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARA--CIGTPYYLSPEIC 197
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGK 718
+ ++ KSD+++ G ++ E+ K
Sbjct: 198 ENKPYNNKSDIWALGCVLYELCTLK 222
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-37
Identities = 54/242 (22%), Positives = 101/242 (41%), Gaps = 23/242 (9%)
Query: 492 HSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSK 551
H + + ++ + ++ +S ++G GG V++ + + Q A+K ++
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNL 62
Query: 552 G--SGQGMEEFKNEVLLIAKLQHRNL--VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT 607
Q ++ ++NE+ + KLQ + ++L ++ E N L+ ++
Sbjct: 63 EEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWL--- 118
Query: 608 TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
+ K +D +R + + +HQ I+H DLK +N L+ + K+ DFG+A
Sbjct: 119 KKKKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIAN 174
Query: 668 SFGLDQTEANTKRVVGTYGYMSPE-----------YAIDGLFSVKSDVFSFGVLVLEIIC 716
D T VGT YM PE S KSDV+S G ++ +
Sbjct: 175 QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTY 234
Query: 717 GK 718
GK
Sbjct: 235 GK 236
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 2e-36
Identities = 61/245 (24%), Positives = 105/245 (42%), Gaps = 38/245 (15%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
+F E LG+G FG V K ++ + A+K++ + + +EV+L+A L H+
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHTEEK-LSTILSEVMLLASLNHQY 63
Query: 575 LVKLLGC----------CTQRDERMLIY---EYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
+V+ T ++ ++ EY N +L I + + + +
Sbjct: 64 VVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLI--HSENLNQQRDEYWRL 121
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF------------ 669
I L Y+H IIHRDLK N+ +D + N KI DFGLA++
Sbjct: 122 FRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQ 178
Query: 670 GLDQTEANTKRVVGTYGYMSPE-YAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728
L + N +GT Y++ E G ++ K D++S G++ E+I F+
Sbjct: 179 NLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY-----PFSTGME 233
Query: 729 DHNLL 733
N+L
Sbjct: 234 RVNIL 238
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 3e-36
Identities = 52/211 (24%), Positives = 91/211 (43%), Gaps = 23/211 (10%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNL--VKL 578
++G GG V++ + + Q A+K ++ Q ++ ++NE+ + KLQ + ++L
Sbjct: 15 KQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSDKIIRL 74
Query: 579 LGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
++ E N L+ ++ + K +D +R + + +HQ
Sbjct: 75 YDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIHQ---H 127
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE------- 691
I+H DLK +N L+ + K+ DFG+A D T VGT YM PE
Sbjct: 128 GIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSS 186
Query: 692 ----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
S KSDV+S G ++ + GK
Sbjct: 187 SRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 3e-36
Identities = 62/210 (29%), Positives = 96/210 (45%), Gaps = 10/210 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+++ +G G +G K +G+ + K L G + + +EV L+ +L+H
Sbjct: 6 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 65
Query: 574 NLVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLL 630
N+V+ R L + EY L I T+ + LD ++ + L
Sbjct: 66 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 125
Query: 631 YLHQ--DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
H+ D ++HRDLK +NV LD N K+ DFGLAR D + A T VGT YM
Sbjct: 126 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKT--FVGTPYYM 183
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
SPE ++ KSD++S G L+ E+
Sbjct: 184 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 213
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 5e-36
Identities = 56/207 (27%), Positives = 99/207 (47%), Gaps = 10/207 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
NF + K+G G F VY+ L++G +A+K++ + + E+ L+ +L H
Sbjct: 32 ANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNH 91
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGLLY 631
N++K + +E ++ E L I + +L+ + L +
Sbjct: 92 PNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
+H R++HRD+K +NV + T K+ D GL R F T A++ +VGT YMSPE
Sbjct: 152 MHSR---RVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHS--LVGTPYYMSPE 206
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+ ++ KSD++S G L+ E+ +
Sbjct: 207 RIHENGYNFKSDIWSLGCLLYEMAALQ 233
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 8e-36
Identities = 52/216 (24%), Positives = 92/216 (42%), Gaps = 23/216 (10%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNL 575
+S ++G GG V++ + + Q A+K ++ Q ++ ++NE+ + KLQ +
Sbjct: 57 IYSILKQIGSGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTLDSYRNEIAYLNKLQQHSD 116
Query: 576 --VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
++L ++ E N L+ ++ + K +D +R + + +H
Sbjct: 117 KIIRLYDYEITDQYIYMVMEC-GNIDLNSWL---KKKKSIDPWERKSYWKNMLEAVHTIH 172
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE-- 691
Q I+H DLK +N L+ + K+ DFG+A D T VG YM PE
Sbjct: 173 Q---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAI 228
Query: 692 ---------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
S KSDV+S G ++ + GK
Sbjct: 229 KDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-35
Identities = 60/233 (25%), Positives = 107/233 (45%), Gaps = 18/233 (7%)
Query: 491 KHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRL 549
+ + +G+ + ++ ++ D ++ LG+G +G VY G + IA+K +
Sbjct: 3 RSTEEGDCESDLLEYDYEY-------DENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEI 55
Query: 550 SKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR 609
+ + + E+ L L+H+N+V+ LG ++ + E +P SL +
Sbjct: 56 PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWG 115
Query: 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARS 668
+ I GL YLH + +I+HRD+K NVL++ KISDFG ++
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDN---QIVHRDIKGDNVLINTYSGVLKISDFGTSKR 172
Query: 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIICGK 718
L T+ GT YM+PE ID + +D++S G ++E+ GK
Sbjct: 173 --LAGINPCTETFTGTLQYMAPE-IIDKGPRGYGKAADIWSLGCTIIEMATGK 222
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 5e-35
Identities = 56/238 (23%), Positives = 95/238 (39%), Gaps = 17/238 (7%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANAT-DNFSEKNKLGEGGFGPVYKGM-LIEGQEIA 545
+ ++ S +G E ++ P +D + +F ++LG G +G V+K +G+ A
Sbjct: 27 QPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGEVFKVRSKEDGRLYA 86
Query: 546 VKRLSKG--SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIY-EYLPNKSLD 601
VKR + EV K+ QH V+L + + + E SL
Sbjct: 87 VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQA-WEEGGILYLQTELC-GPSLQ 144
Query: 602 YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661
L ++ + L +LH ++H D+K +N+ L K+
Sbjct: 145 QHC--EAWGASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLG 199
Query: 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
DFGL G G YM+PE + G + +DVFS G+ +LE+ C +
Sbjct: 200 DFGLLVELG-TAGAGEV--QEGDPRYMAPE-LLQGSYGTAADVFSLGLTILEVACNME 253
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 1e-34
Identities = 58/235 (24%), Positives = 108/235 (45%), Gaps = 17/235 (7%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATD---NFSEKNKLGEGGFGPVYKGMLIE-GQE 543
S ++ L+++ + D K+GEG G V G++
Sbjct: 17 NLYFQSGVVTHEQFKA----ALRMVVDQGDPRLLLDSYVKIGEGSTGIVCLAREKHSGRQ 72
Query: 544 IAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYF 603
+AVK + Q E NEV+++ QH N+V++ +E ++ E+L +L
Sbjct: 73 VAVKMMDLRKQQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALT-- 130
Query: 604 IFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDF 663
D L+ + + + + + L YLH +IHRD+K+ ++LL K+SDF
Sbjct: 131 --DIVSQVRLNEEQIATVCEAVLQALAYLHAQ---GVIHRDIKSDSILLTLDGRVKLSDF 185
Query: 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
G D + + +VGT +M+PE L++ + D++S G++V+E++ G+
Sbjct: 186 GFCAQISKDVPKRKS--LVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGE 238
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-34
Identities = 62/226 (27%), Positives = 118/226 (52%), Gaps = 17/226 (7%)
Query: 497 NEKEEMELPIFDLKIIANATD---NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG 552
+++E +E L+ I + D ++ K+G+G G VY M + GQE+A+++++
Sbjct: 1 SDEEILE----KLRSIVSVGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ 56
Query: 553 SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL 612
E NE+L++ + ++ N+V L DE ++ EYL SL D
Sbjct: 57 QQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLT----DVVTETC 112
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+D + + + + L +LH + ++IHRD+K+ N+LL + K++DFG +
Sbjct: 113 MDEGQIAAVCRECLQALEFLHSN---QVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169
Query: 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
Q++ +T +VGT +M+PE + K D++S G++ +E+I G+
Sbjct: 170 QSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 132 bits (333), Expect = 4e-34
Identities = 50/218 (22%), Positives = 88/218 (40%), Gaps = 21/218 (9%)
Query: 518 NFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
++ KLGEGGF V L +G A+KR+ Q EE + E + H N++
Sbjct: 30 HYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCHEQQDREEAQREADMHRLFNHPNIL 89
Query: 577 KLLGCCTQRDERM----LIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
+L+ C + L+ + +L + + L + ++ GI RGL
Sbjct: 90 RLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICRGLEA 149
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV-------GT 684
+H HRDLK +N+LL + P + D G + + + T
Sbjct: 150 IHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCT 206
Query: 685 YGYMSPEYAIDG----LFSVKSDVFSFGVLVLEIICGK 718
Y +PE + ++DV+S G ++ ++ G+
Sbjct: 207 ISYRAPE-LFSVQSHCVIDERTDVWSLGCVLYAMMFGE 243
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-33
Identities = 59/244 (24%), Positives = 102/244 (41%), Gaps = 21/244 (8%)
Query: 483 GGLMYRRKKHSNQGNEKEEMELPIFDLKI-IANATDNFSEKNKLGEGGFGPVYKGMLIE- 540
G +R + NE + + + + + ++G G FG V++ +
Sbjct: 23 GSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRMKDKQT 82
Query: 541 GQEIAVKRLSKGSGQGMEEFK-NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKS 599
G + AVK++ +E F+ E++ A L +V L G + + E L S
Sbjct: 83 GFQCAVKKVR------LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGS 136
Query: 600 LDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP- 658
L I + L + + + GL YLH RI+H D+KA NVLL + +
Sbjct: 137 LGQLI---KQMGCLPEDRALYYLGQALEGLEYLHTR---RILHGDVKADNVLLSSDGSRA 190
Query: 659 KISDFGLAR---SFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEI 714
+ DFG A GL ++ + GT +M+PE + G K D++S ++L +
Sbjct: 191 ALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPE-VVMGKPCDAKVDIWSSCCMMLHM 249
Query: 715 ICGK 718
+ G
Sbjct: 250 LNGC 253
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 4e-33
Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 19/210 (9%)
Query: 518 NFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEV-LLIAKLQHRNLV 576
+F K+ LG G G + + + +++AVKR+ + EV LL +H N++
Sbjct: 25 SFCPKDVLGHGAEGTIVYRGMFDNRDVAVKRILP---ECFSFADREVQLLRESDEHPNVI 81
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ R + + E +Y + + ++ GL +LH
Sbjct: 82 RYFCTEKDRQFQYIAIELCAATLQEYVE---QKDFAHLGLEPITLLQQTTSGLAHLHS-- 136
Query: 637 RLRIIHRDLKASNVLLDNT-----MNPKISDFGLARSFGLDQTE-ANTKRVVGTYGYMSP 690
L I+HRDLK N+L+ + ISDFGL + + + + V GT G+++P
Sbjct: 137 -LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAP 195
Query: 691 EY---AIDGLFSVKSDVFSFGVLVLEIICG 717
E + D+FS G + +I
Sbjct: 196 EMLSEDCKENPTYTVDIFSAGCVFYYVISE 225
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 5e-33
Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 22/221 (9%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQ 571
+ + + LG+G V++G + G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 572 HRNLVKLLGCCTQRDERM--LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H+N+VKL + R LI E+ P SL + + + + L S+ ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 630 LYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+L + I+HR++K N++ D K++DFG AR D + + + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179
Query: 686 GYMSPE--------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y+ P+ + D++S GV G
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-32
Identities = 61/208 (29%), Positives = 109/208 (52%), Gaps = 11/208 (5%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG-MEEFKNEVLLIAKL 570
A+ + F++ K+G+G FG V+KG+ + +A+K + + +E+ + E+ ++++
Sbjct: 18 ADPEELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 77
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
+ K G + + +I EYL S D LD ++ + I+ I +GL
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL----DLLEPGPLDETQIATILREILKGLD 133
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
YLH + + IHRD+KA+NVLL K++DFG+A Q + NT VGT +M+P
Sbjct: 134 YLHSE---KKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIKRNT--FVGTPFWMAP 188
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + K+D++S G+ +E+ G+
Sbjct: 189 EVIKQSAYDSKADIWSLGITAIELARGE 216
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 4e-32
Identities = 55/230 (23%), Positives = 90/230 (39%), Gaps = 38/230 (16%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKR--LSKGSGQGMEEFKNEVLLIAKL-Q 571
T F E K+G G FG V+K + ++G A+KR + EV A L Q
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNALREVYAHAVLGQ 69
Query: 572 HRNLVKLLGCCTQRDERMLIY-EYLPNKSLDYFIFDTTRS-KLLDWSKRSHIIAGIARGL 629
H ++V+ + D MLI EY SL I + R ++ ++ + RGL
Sbjct: 70 HSHVVRYFSAWAEDD-HMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGL 128
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNP-------------------KISDFGLARSFG 670
Y+H ++H D+K SN+ + T P KI D G
Sbjct: 129 RYIHSM---SLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS 185
Query: 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFS--VKSDVFSFGVLVLEIICGK 718
Q E G +++ E + ++ K+D+F+ + V+ +
Sbjct: 186 SPQVE------EGDSRFLANE-VLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 128 bits (323), Expect = 4e-32
Identities = 50/221 (22%), Positives = 92/221 (41%), Gaps = 22/221 (9%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQ 571
+ + + LG+G V++G + G A+K + S + E ++ KL
Sbjct: 6 TSNHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKLN 65
Query: 572 HRNLVKLLGCCTQRDERM--LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H+N+VKL + R LI E+ P SL + + + + L S+ ++ + G+
Sbjct: 66 HKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM 125
Query: 630 LYLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+L + I+HR++K N++ D K++DFG AR D + + + GT
Sbjct: 126 NHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELE-DDEQFVS--LYGTE 179
Query: 686 GYMSPE--------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y+ P+ + D++S GV G
Sbjct: 180 EYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 5e-32
Identities = 62/204 (30%), Positives = 107/204 (52%), Gaps = 10/204 (4%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
+ F KLGEG +G VYK + E GQ +A+K++ ++E E+ ++ + +
Sbjct: 28 EEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP--VESDLQEIIKEISIMQQCDSPH 85
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VK G + + ++ EY S+ I R+K L + + I+ +GL YLH
Sbjct: 86 VVKYYGSYFKNTDLWIVMEYCGAGSVSDII--RLRNKTLTEDEIATILQSTLKGLEYLHF 143
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
R IHRD+KA N+LL+ + K++DFG+A + NT V+GT +M+PE
Sbjct: 144 M---RKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAKRNT--VIGTPFWMAPEVIQ 198
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+ ++ +D++S G+ +E+ GK
Sbjct: 199 EIGYNCVADIWSLGITAIEMAEGK 222
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 5e-32
Identities = 55/200 (27%), Positives = 87/200 (43%), Gaps = 16/200 (8%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LG+GGF ++ + + A K + K E E+ + L H+++V G
Sbjct: 49 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
D ++ E +SL + R L + R + + I G YLH+
Sbjct: 109 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLHR---N 160
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
R+IHRDLK N+ L+ + KI DFGLA D + GT Y++PE
Sbjct: 161 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 218
Query: 699 SVKSDVFSFGVLVLEIICGK 718
S + DV+S G ++ ++ GK
Sbjct: 219 SFEVDVWSIGCIMYTLLVGK 238
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 126 bits (318), Expect = 7e-32
Identities = 35/222 (15%), Positives = 66/222 (29%), Gaps = 22/222 (9%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK 569
+ + LGEG F VY+ Q+ +K + + +
Sbjct: 64 SKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGTQLMERLKP 123
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI--FDTTRSKLLDWSKRSHIIAGIAR 627
+K ++ +L+ E +L I + T K++ +
Sbjct: 124 SMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAMRMLY 183
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-----------KISDFGLARSFGLDQTEA 676
+ +H IIH D+K N +L N + D G + L
Sbjct: 184 MIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGT 240
Query: 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
T G+ E + ++ + D F V ++ G
Sbjct: 241 IFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGT 282
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 8e-32
Identities = 55/209 (26%), Positives = 102/209 (48%), Gaps = 13/209 (6%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
+ + +LG+G FG VYK E G A K + S + +E++ E+ ++A H
Sbjct: 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKSEEELEDYIVEIEILATCDHPY 77
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VKLLG + ++ E+ P ++D + + L + + + L +LH
Sbjct: 78 IVKLLGAYYHDGKLWIMIEFCPGGAVDAIM--LELDRGLTEPQIQVVCRQMLEALNFLHS 135
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE--- 691
RIIHRDLKA NVL+ + +++DFG++ + ++ +GT +M+PE
Sbjct: 136 K---RIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQKRDS--FIGTPYWMAPEVVM 190
Query: 692 --YAIDGLFSVKSDVFSFGVLVLEIICGK 718
D + K+D++S G+ ++E+ +
Sbjct: 191 CETMKDTPYDYKADIWSLGITLIEMAQIE 219
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 1e-31
Identities = 56/200 (28%), Positives = 87/200 (43%), Gaps = 16/200 (8%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LG+GGF ++ + + A K + K E E+ + L H+++V G
Sbjct: 23 LGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
D ++ E +SL + R L + R + + I G YLH R
Sbjct: 83 FFEDNDFVFVVLELCRRRSL----LELHKRRKALTEPEAR-YYLRQIVLGCQYLH---RN 134
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
R+IHRDLK N+ L+ + KI DFGLA D + GT Y++PE
Sbjct: 135 RVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKV--LCGTPNYIAPEVLSKKGH 192
Query: 699 SVKSDVFSFGVLVLEIICGK 718
S + DV+S G ++ ++ GK
Sbjct: 193 SFEVDVWSIGCIMYTLLVGK 212
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 2e-31
Identities = 59/214 (27%), Positives = 92/214 (42%), Gaps = 17/214 (7%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHR 573
+ K +LG GGFG V + + + G+++A+K+ + E + E+ ++ KL H
Sbjct: 13 CGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRERWCLEIQIMKKLNHP 72
Query: 574 NLVKLL------GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
N+V D +L EY L ++ L +++ I+
Sbjct: 73 NVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISS 132
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
L YLH+ RIIHRDLK N++L + KI D G A+ VGT
Sbjct: 133 ALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELD-QGELCTE--FVGT 186
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y++PE ++V D +SFG L E I G
Sbjct: 187 LQYLAPELLEQKKYTVTVDYWSFGTLAFECITGF 220
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 8e-31
Identities = 55/204 (26%), Positives = 100/204 (49%), Gaps = 11/204 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQHRN 574
D+F + ++LG G G V+K G +A K + + + E+ ++ +
Sbjct: 33 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPY 92
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+V G E + E++ SLD + ++ + + + +GL YL
Sbjct: 93 IVGFYGAFYSDGEISICMEHMDGGSLDQVL---KKAGRIPEQILGKVSIAVIKGLTYLR- 148
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+ +I+HRD+K SN+L+++ K+ DFG+ S L + AN+ VGT YMSPE
Sbjct: 149 -EKHKIMHRDVKPSNILVNSRGEIKLCDFGV--SGQLIDSMANS--FVGTRSYMSPERLQ 203
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
+SV+SD++S G+ ++E+ G+
Sbjct: 204 GTHYSVQSDIWSMGLSLVEMAVGR 227
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 9e-31
Identities = 64/200 (32%), Positives = 100/200 (50%), Gaps = 15/200 (7%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEE-FKNEVLLIAKLQHRNLVKLLG 580
LG+G F VY+ I G E+A+K + K + GM + +NEV + +L+H ++++L
Sbjct: 19 LGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 581 CCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRL 638
+ L+ E N + R K ++ H + I G+LYLH
Sbjct: 79 YFEDSNYVYLVLEMCHNGEM----NRYLKNRVKPFSENEARHFMHQIITGMLYLH---SH 131
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF 698
I+HRDL SN+LL MN KI+DFGLA + + T + GT Y+SPE A
Sbjct: 132 GILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHEKHYT--LCGTPNYISPEIATRSAH 189
Query: 699 SVKSDVFSFGVLVLEIICGK 718
++SDV+S G + ++ G+
Sbjct: 190 GLESDVWSLGCMFYTLLIGR 209
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-30
Identities = 60/272 (22%), Positives = 89/272 (32%), Gaps = 72/272 (26%)
Query: 517 DNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQHRN 574
+F +G GGFG V++ ++ A+KR+ E+ EV +AKL+H
Sbjct: 6 TDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPNRELAREKVMREVKALAKLEHPG 65
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSK----------------------- 611
+V+ + E D S
Sbjct: 66 IVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVG 125
Query: 612 ----------------------LLDWSKRS------------HIIAGIARGLLYLHQDSR 637
L DW R HI IA + +LH
Sbjct: 126 QLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHS--- 182
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK----------RVVGTYGY 687
++HRDLK SN+ K+ DFGL + D+ E VGT Y
Sbjct: 183 KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLY 242
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
MSPE +S K D+FS G+++ E++
Sbjct: 243 MSPEQIHGNNYSHKVDIFSLGLILFELLYSFS 274
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 2e-30
Identities = 56/199 (28%), Positives = 100/199 (50%), Gaps = 11/199 (5%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
KLG GG VY I ++A+K + + + ++ F+ EV ++L H+N+V ++
Sbjct: 18 KLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMI 77
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
+ D L+ EY+ +L +I L + I G+ + H +R
Sbjct: 78 DVDEEDDCYYLVMEYIEGPTLSEYIESHGP---LSVDTAINFTNQILDGIKHAH---DMR 131
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
I+HRD+K N+L+D+ KI DFG+A++ + + T V+GT Y SPE A
Sbjct: 132 IVHRDIKPQNILIDSNKTLKIFDFGIAKALS-ETSLTQTNHVLGTVQYFSPEQAKGEATD 190
Query: 700 VKSDVFSFGVLVLEIICGK 718
+D++S G+++ E++ G+
Sbjct: 191 ECTDIYSIGIVLYEMLVGE 209
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 2e-30
Identities = 52/222 (23%), Positives = 84/222 (37%), Gaps = 33/222 (14%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGC 581
L EGGF VY+ + G+E A+KRL + EV + KL H N+V+
Sbjct: 35 VLAEGGFAFVYEAQDVGSGREYALKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSA 94
Query: 582 CTQRDERM-------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+ E L+ L L F+ L I R + ++H+
Sbjct: 95 ASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR 154
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR----------VVGT 684
+ IIHRDLK N+LL N K+ DFG A + + + + T
Sbjct: 155 -QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 685 YGYMSPEYAIDGLFSV--------KSDVFSFGVLVLEIICGK 718
Y +PE + + K D+++ G ++ + +
Sbjct: 214 PMYRTPE-----IIDLYSNFPIGEKQDIWALGCILYLLCFRQ 250
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 2e-30
Identities = 56/242 (23%), Positives = 89/242 (36%), Gaps = 38/242 (15%)
Query: 503 ELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN 562
+P F+ + + + LG G G V +G+ +AVKR+ +
Sbjct: 5 NIPNFEQSL----KNLVVSEKILGYGSSGTVVFQGSFQGRPVAVKRMLIDF---CDIALM 57
Query: 563 EV-LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----FDTTRSKLLDWSK 617
E+ LL H N+++ T + E N +L + KL
Sbjct: 58 EIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKNVSDENLKLQKEYN 116
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-------------KISDFG 664
++ IA G+ +LH L+IIHRDLK N+L+ + ISDFG
Sbjct: 117 PISLLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFG 173
Query: 665 LARSFGLDQT--EANTKRVVGTYGYMSPEYAIDGLFSV-------KSDVFSFGVLVLEII 715
L + Q+ N GT G+ +PE + D+FS G + I+
Sbjct: 174 LCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYIL 233
Query: 716 CG 717
Sbjct: 234 SK 235
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 4e-30
Identities = 69/236 (29%), Positives = 109/236 (46%), Gaps = 22/236 (9%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ 555
++ L DL + + F +G G +G VYKG ++ GQ A+K + +G
Sbjct: 4 SDSPARSLDEIDLSALRDPAGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVM-DVTGD 62
Query: 556 GMEEFKNEVLLIAKL-QHRNLVKLLGC------CTQRDERMLIYEYLPNKSL-DYFIFDT 607
EE K E+ ++ K HRN+ G D+ L+ E+ S+ D +
Sbjct: 63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTD--LIKN 120
Query: 608 TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667
T+ L ++I I RGL +LHQ ++IHRD+K NVLL K+ DFG++
Sbjct: 121 TKGNTLKEEWIAYICREILRGLSHLHQH---KVIHRDIKGQNVLLTENAEVKLVDFGVSA 177
Query: 668 SFGLDQTEANTKRVVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
LD+T +GT +M+PE D + KSD++S G+ +E+ G
Sbjct: 178 Q--LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGA 231
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 7e-30
Identities = 43/215 (20%), Positives = 82/215 (38%), Gaps = 26/215 (12%)
Query: 524 KLGEGGFGPVYKG--MLIEGQEIAVKRL-SKGSGQGMEEFKNEVLLIAKLQHRNLVKLL- 579
+ GG G +Y + G+ + +K L G + E +A++ H ++V++
Sbjct: 87 CIAHGGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQAMAMAERQFLAEVVHPSIVQIFN 146
Query: 580 -GCCTQRDERMLIY---EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
T R + Y EY+ +SL L ++ + I L YLH
Sbjct: 147 FVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQK-----LPVAEAIAYLLEILPALSYLH-- 199
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
+ +++ DLK N++L K+ D G ++ + GT G+ +PE
Sbjct: 200 -SIGLVYNDLKPENIMLTEE-QLKLIDLGAVSR--INSFGY----LYGTPGFQAPEIV-R 250
Query: 696 GLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH 730
+V +D+++ G + + N D
Sbjct: 251 TGPTVATDIYTVGRTLAALTLDL--PTRNGRYVDG 283
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-30
Identities = 64/220 (29%), Positives = 103/220 (46%), Gaps = 19/220 (8%)
Query: 506 IFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS---KGSGQGMEEFK 561
+ +L + FS+ ++G G FG VY + + +A+K++S K S + ++
Sbjct: 43 VAELFFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDII 102
Query: 562 NEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
EV + KL+H N ++ GC + L+ EY + D K L + + +
Sbjct: 103 KEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASD---LLEVHKKPLQEVEIAAV 159
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRV 681
G +GL YLH +IHRD+KA N+LL K+ DFG A AN+
Sbjct: 160 THGALQGLAYLHSH---NMIHRDVKAGNILLSEPGLVKLGDFGSASIM----APANS--F 210
Query: 682 VGTYGYMSPE---YAIDGLFSVKSDVFSFGVLVLEIICGK 718
VGT +M+PE +G + K DV+S G+ +E+ K
Sbjct: 211 VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 250
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-29
Identities = 66/248 (26%), Positives = 105/248 (42%), Gaps = 28/248 (11%)
Query: 485 LMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGMLIE 540
+ + S + N + +L I + + SE KLG G +G V
Sbjct: 1 MHHHHHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKV 60
Query: 541 -GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597
E A+K + K S + EV ++ L H N++KL + L+ E
Sbjct: 61 THVERAIKIIRKTSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKG 120
Query: 598 KSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653
L FD R K ++ + II + G+ YLH+ I+HRDLK N+LL+
Sbjct: 121 GEL----FDEIIHRMKF---NEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLE 170
Query: 654 NTM---NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
+ KI DFGL+ F + K +GT Y++PE + + K DV+S GV+
Sbjct: 171 SKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYIAPE-VLRKKYDEKCDVWSIGVI 226
Query: 711 VLEIICGK 718
+ ++ G
Sbjct: 227 LFILLAGY 234
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 3e-29
Identities = 61/207 (29%), Positives = 94/207 (45%), Gaps = 16/207 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEE-FKNEVLLIAKLQH 572
++F LG+G FG VY + +A+K L K G+E + EV + + L+H
Sbjct: 9 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 68
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLY 631
N+++L G LI EY P ++ + + D + + I +A L Y
Sbjct: 69 PNILRLYGYFHDATRVYLILEYAPLGTV----YRELQKLSKFDEQRTATYITELANALSY 124
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
H R+IHRD+K N+LL + KI+DFG S + + GT Y+ PE
Sbjct: 125 CH---SKRVIHRDIKPENLLLGSAGELKIADFGW--SVHAPSSRRTD--LCGTLDYLPPE 177
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+ K D++S GVL E + GK
Sbjct: 178 MIEGRMHDEKVDLWSLGVLCYEFLVGK 204
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 7e-29
Identities = 58/214 (27%), Positives = 100/214 (46%), Gaps = 21/214 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVL-----LIAKL 570
++ + ++G G +G V K + GQ +AVKR+ E+ + ++L ++
Sbjct: 22 EDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTVD---EKEQKQLLMDLDVVMRSS 78
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLD--YFIFDTTRSKLLDWSKRSHIIAGIARG 628
+V+ G + + + E + + S D Y + ++ I +
Sbjct: 79 DCPYIVQFYGALFREGDCWICMELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKA 137
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
L +L L+IIHRD+K SN+LLD + N K+ DFG+ S L + A T R G YM
Sbjct: 138 LNHLK--ENLKIIHRDIKPSNILLDRSGNIKLCDFGI--SGQLVDSIAKT-RDAGCRPYM 192
Query: 689 SPE----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+PE A + V+SDV+S G+ + E+ G+
Sbjct: 193 APERIDPSASRQGYDVRSDVWSLGITLYELATGR 226
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 8e-29
Identities = 57/213 (26%), Positives = 95/213 (44%), Gaps = 20/213 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-----EVLLIAKL 570
D+ +LG G +G V K + GQ +AVKR+ +E K ++ + +
Sbjct: 7 DDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATVNS--QEQKRLLMDLDISM-RTV 63
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGL 629
V G + + + E + + SLD F + + + I I + L
Sbjct: 64 DCPFTVTFYGALFREGDVWICMELM-DTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKAL 122
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
+LH S+L +IHRD+K SNVL++ K+ DFG++ L A G YM+
Sbjct: 123 EHLH--SKLSVIHRDVKPSNVLINALGQVKMCDFGISGY--LVDDVAKD-IDAGCKPYMA 177
Query: 690 PE----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
PE +SVKSD++S G+ ++E+ +
Sbjct: 178 PERINPELNQKGYSVKSDIWSLGITMIELAILR 210
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 117 bits (294), Expect = 1e-28
Identities = 25/229 (10%), Positives = 51/229 (22%), Gaps = 43/229 (18%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
L G V+ +E ++ A+K + S +E A+L + +
Sbjct: 70 LRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARD 129
Query: 581 CC--------------------------TQRDERMLIYEYLP---NKSLDYFIFDTTRSK 611
+L+ F
Sbjct: 130 RRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRG 189
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
+ A + R L ++H N+ + + D G
Sbjct: 190 DEGILALHILTAQLIRLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG- 245
Query: 672 DQTEANTKRVVGTYGYMSPEY--AIDGLFSVKSDVFSFGVLVLEIICGK 718
Y E+ A F+ + + G+ + + C
Sbjct: 246 ----TRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLF 290
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 114 bits (289), Expect = 2e-28
Identities = 54/186 (29%), Positives = 89/186 (47%), Gaps = 26/186 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+NF + K+GEG +G VYK G+ +A+K++ ++ E+ L+
Sbjct: 3 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIR------LDTETEGVPSTAIREISLL 56
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+L H N+VKLL ++ L++E+L K D + + + +
Sbjct: 57 KELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKF----MDASALTGIPLPLIKSYLFQL 112
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+GL + H R++HRDLK N+L++ K++DFGLAR+FG T VV T
Sbjct: 113 LQGLAFCHSH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVV-TL 167
Query: 686 GYMSPE 691
Y +PE
Sbjct: 168 WYRAPE 173
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 4e-28
Identities = 56/205 (27%), Positives = 92/205 (44%), Gaps = 17/205 (8%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
LG GG V+ L + +++AVK L F+ E A L H +V +
Sbjct: 19 ILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVY 78
Query: 580 --GCCTQRDERMLIY---EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
G + L Y EY+ +L + + + +IA + L + H
Sbjct: 79 DTGE-AETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQALNFSH- 133
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD-QTEANTKRVVGTYGYMSPEYA 693
+ IIHRD+K +N+++ T K+ DFG+AR+ + T V+GT Y+SPE A
Sbjct: 134 --QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQA 191
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGK 718
+SDV+S G ++ E++ G+
Sbjct: 192 RGDSVDARSDVYSLGCVLYEVLTGE 216
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 5e-28
Identities = 57/222 (25%), Positives = 100/222 (45%), Gaps = 26/222 (11%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLS-KGSGQGMEEFKNEVLLIAKLQ 571
D++ + +G G V +++A+KR++ + M+E E+ +++
Sbjct: 12 INRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKCQTSMDELLKEIQAMSQCH 71
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSL-----DYFIFDTTRSKLLDWSKRSHIIAGIA 626
H N+V +DE L+ + L S+ +S +LD S + I+ +
Sbjct: 72 HPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVL 131
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS-FGLDQTEANTKR--VVG 683
GL YLH++ IHRD+KA N+LL + +I+DFG++ N R VG
Sbjct: 132 EGLEYLHKN---GQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVG 188
Query: 684 TYGYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
T +M+PE Y K+D++SFG+ +E+ G
Sbjct: 189 TPCWMAPEVMEQVRGY------DFKADIWSFGITAIELATGA 224
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 8e-28
Identities = 57/211 (27%), Positives = 91/211 (43%), Gaps = 13/211 (6%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKL 570
D F K KLG G FG V+ G E +K ++K Q E + E+ ++ L
Sbjct: 18 GTIDDLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDRSQVPMEQIEAEIEVLKSL 77
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H N++K+ ++ E L + + R K L + ++ + L
Sbjct: 78 DHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNAL 137
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
Y H ++H+DLK N+L +T KI DFGLA F D+ + GT
Sbjct: 138 AYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGTAL 191
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
YM+PE + K D++S GV++ ++ G
Sbjct: 192 YMAPE-VFKRDVTFKCDIWSAGVVMYFLLTG 221
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 53/185 (28%), Positives = 93/185 (50%), Gaps = 26/185 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIA 568
+ + + K+GEG +G VYK +G+ +A+KR+ ++ E+ L+
Sbjct: 21 EKYQKLEKVGEGTYGVVYKAKDSQGRIVALKRIR------LDAEDEGIPSTAIREISLLK 74
Query: 569 KLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+L H N+V L+ L++E++ K + D ++ L D + + +
Sbjct: 75 ELHHPNIVSLIDVIHSERCLTLVFEFMEKDLKKV----LDENKTGLQDSQIKI-YLYQLL 129
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
RG+ + HQ RI+HRDLK N+L+++ K++DFGLAR+FG + T VV T
Sbjct: 130 RGVAHCHQH---RILHRDLKPQNLLINSDGALKLADFGLARAFG-IPVRSYTHEVV-TLW 184
Query: 687 YMSPE 691
Y +P+
Sbjct: 185 YRAPD 189
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 1e-27
Identities = 53/234 (22%), Positives = 98/234 (41%), Gaps = 17/234 (7%)
Query: 493 SNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRL-S 550
S+ + K+ L I + A D ++G G G V+K + G IAVK++
Sbjct: 2 SSGSSGKQTGYLTIGGQRYQAEIND-LENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRR 60
Query: 551 KGSGQGMEEFKNEV-LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTR 609
G+ + + ++ +++ +V+ G + + E + +
Sbjct: 61 SGNKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAE--KLKKRM 117
Query: 610 SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
+ + I + L YL + +IHRD+K SN+LLD K+ DFG+ S
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLK--EKHGVIHRDVKPSNILLDERGQIKLCDFGI--SG 173
Query: 670 GLDQTEANTKRVVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
L +A R G YM+PE + +++DV+S G+ ++E+ G+
Sbjct: 174 RLVDDKAKD-RSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQ 226
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-27
Identities = 54/228 (23%), Positives = 95/228 (41%), Gaps = 35/228 (15%)
Query: 517 DNFSEKNKLGEGGFGPVY---------------KGMLIEGQEIAVKRLSKGSGQGMEE-F 560
+++ L +G F + K +L + ++ K S + + F
Sbjct: 31 NDYRIIRTLNQGKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDF 90
Query: 561 KNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DY----FIFDTTRSKLLDW 615
KNE+ +I +++ + G T DE +IYEY+ N S+ + F+ D + +
Sbjct: 91 KNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPI 150
Query: 616 SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675
II + Y+H + I HRD+K SN+L+D K+SDFG + +
Sbjct: 151 QVIKCIIKSVLNSFSYIH--NEKNICHRDVKPSNILMDKNGRVKLSDFGESEYM----VD 204
Query: 676 ANTKRVVGTYGYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
K GTY +M PE + +G K D++S G+ + +
Sbjct: 205 KKIKGSRGTYEFMPPEFFSNESSYNGA---KVDIWSLGICLYVMFYNV 249
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 2e-27
Identities = 66/213 (30%), Positives = 103/213 (48%), Gaps = 25/213 (11%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQ 571
+D + + LG+G FG V GQE AVK +SK E EV L+ +L
Sbjct: 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLD 84
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIAR 627
H N++KL + L+ E L FD +R + S+ + II +
Sbjct: 85 HPNIMKLYEFFEDKGYFYLVGEVYTGGEL----FDEIISRKRF---SEVDAARIIRQVLS 137
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTM---NPKISDFGLARSFGLDQTEANTKRVVGT 684
G+ Y+H+ +I+HRDLK N+LL++ N +I DFGL+ F + K +GT
Sbjct: 138 GITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKK---MKDKIGT 191
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
Y++PE + G + K DV+S GV++ ++ G
Sbjct: 192 AYYIAPE-VLHGTYDEKCDVWSTGVILYILLSG 223
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 41/216 (18%), Positives = 80/216 (37%), Gaps = 18/216 (8%)
Query: 516 TDNFSEKNKLGEG--GFGPVYKGMLIE-GQEIAVKR--LSKGSGQGMEEFKNEVLLIAKL 570
+ +G+G V G+ + V+R L S + + + E+ +
Sbjct: 24 GGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEACSNEMVTFLQGELHVSKLF 83
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
H N+V +E ++ ++ S D + T ++ ++I+ G+ + L
Sbjct: 84 NHPNIVPYRATFIADNELWVVTSFMAYGSAKD--LICTHFMDGMNELAIAYILQGVLKAL 141
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT-----KRVVGT 684
Y+H +HR +KAS++L+ +S S K V
Sbjct: 142 DYIHHM---GYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198
Query: 685 YGYMSPE--YAIDGLFSVKSDVFSFGVLVLEIICGK 718
++SPE + KSD++S G+ E+ G
Sbjct: 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGH 234
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-27
Identities = 33/233 (14%), Positives = 66/233 (28%), Gaps = 43/233 (18%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH-------- 572
LG+ + G+ V +++ K EVL + L+
Sbjct: 86 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 145
Query: 573 --------RNLVKLLGCCT-----QRDERMLIYEY-----LPNKSL----DYFIFDTTRS 610
+LVK + M + +L + + ++
Sbjct: 146 VHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTH 205
Query: 611 KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
K L R + + R L LH ++H L+ +++LD ++ F G
Sbjct: 206 KSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG 262
Query: 671 LDQTEANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGK 718
+ R + L + D ++ G+ + I C
Sbjct: 263 -ASAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 4e-27
Identities = 64/220 (29%), Positives = 101/220 (45%), Gaps = 24/220 (10%)
Query: 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEV 564
+L + ++ LG+G FG V K QE AVK ++K + EV
Sbjct: 13 NLYFQGTFAERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREV 72
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SH 620
L+ KL H N++KL ++ E L FD R + S+ +
Sbjct: 73 ELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRF---SEHDAAR 125
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARSFGLDQTEAN 677
II + G+ Y+H+ I+HRDLK N+LL++ + KI DFGL+ F +
Sbjct: 126 IIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK--- 179
Query: 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
K +GT Y++PE + G + K DV+S GV++ ++ G
Sbjct: 180 MKDRIGTAYYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 4e-27
Identities = 35/241 (14%), Positives = 73/241 (30%), Gaps = 58/241 (24%)
Query: 525 LGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQ--------- 571
LG+ + E G+ V +++ K EVL + L+
Sbjct: 81 LGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAK 140
Query: 572 ----------------HRNLVKLLGCCTQRDERMLIY---EYLPNKSL----DYFIFDTT 608
+ ++++ +RD +L +L + + ++
Sbjct: 141 VHLRFIFPFDLVKDPQKKKMIRVRL--DERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 198
Query: 609 RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
K L R + + R L LH ++H L+ +++LD ++ F
Sbjct: 199 THKSLVHHARLQLTLQVIRLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 255
Query: 669 FGLDQTEANTKRVVGTYGYMSPEYAID-----------GLFSVKSDVFSFGVLVLEIICG 717
G + G+ PE L + D ++ G+++ I C
Sbjct: 256 DGARVV------SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCA 309
Query: 718 K 718
Sbjct: 310 D 310
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 4e-27
Identities = 42/202 (20%), Positives = 80/202 (39%), Gaps = 17/202 (8%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLS---KGSGQGMEEFKNEVLLIAKLQHRNLVKL- 578
+G GG G VY+ + + +A+K +S + E +LQ ++V +
Sbjct: 41 LVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIH 100
Query: 579 -LGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
G + D ++ + + L + L + I+ I L H
Sbjct: 101 DFG---EIDGQLYVDMRLINGVDLAAMLRRQGP---LAPPRAVAIVRQIGSALDAAHAA- 153
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
HRD+K N+L+ + DFG+A + D+ VGT YM+PE +
Sbjct: 154 --GATHRDVKPENILVSADDFAYLVDFGIASATT-DEKLTQLGNTVGTLYYMAPERFSES 210
Query: 697 LFSVKSDVFSFGVLVLEIICGK 718
+ ++D+++ ++ E + G
Sbjct: 211 HATYRADIYALTCVLYECLTGS 232
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 5e-27
Identities = 53/185 (28%), Positives = 89/185 (48%), Gaps = 26/185 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN--------EVLLIA 568
+ + K+GEG +G VYK G+ A+K++ +E+ E+ ++
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIR------LEKEDEGIPSTTIREISILK 55
Query: 569 KLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+L+H N+VKL + +L++E+L K L D L + +S + +
Sbjct: 56 ELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKL----LDVCEGGLESVTAKS-FLLQLL 110
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
G+ Y H R++HRDLK N+L++ KI+DFGLAR+FG T +V T
Sbjct: 111 NGIAYCHDR---RVLHRDLKPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIV-TLW 165
Query: 687 YMSPE 691
Y +P+
Sbjct: 166 YRAPD 170
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 6e-27
Identities = 48/186 (25%), Positives = 88/186 (47%), Gaps = 27/186 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + K+GEG +G V+K E + +A+KR+ +++ E+ L+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVR------LDDDDEGVPSSALREICLL 55
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+L+H+N+V+L + L++E+ K FD+ L +S + +
Sbjct: 56 KELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKY----FDSCNGDLDPEIVKS-FLFQL 110
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+GL + H ++HRDLK N+L++ K+++FGLAR+FG + VV T
Sbjct: 111 LKGLGFCHSR---NVLHRDLKPQNLLINRNGELKLANFGLARAFG-IPVRCYSAEVV-TL 165
Query: 686 GYMSPE 691
Y P+
Sbjct: 166 WYRPPD 171
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 8e-27
Identities = 50/237 (21%), Positives = 94/237 (39%), Gaps = 19/237 (8%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGMLIE-GQEI 544
N ++ E + + + + + +LG G FG V++ + G+
Sbjct: 20 GPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSGAFGVVHRCVEKATGRVF 79
Query: 545 AVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI 604
K ++ KNE+ ++ +L H L+ L + E +LI E+L L
Sbjct: 80 VAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGEL---- 135
Query: 605 FD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP--KI 660
FD + ++ + + GL ++H+ I+H D+K N++ + KI
Sbjct: 136 FDRIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKI 192
Query: 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
DFGLA D+ K T + +PE +D+++ GVL ++ G
Sbjct: 193 IDFGLATKLNPDE---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSG 246
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 9e-27
Identities = 51/214 (23%), Positives = 93/214 (43%), Gaps = 26/214 (12%)
Query: 516 TDNFSEK----NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ ++ N +G G +G V + A K++ K + ++ FK E+ ++ L
Sbjct: 4 KGDINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFVEDVDRFKQEIEIMKSL 63
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIA 626
H N+++L + L+ E L F+ + + + I+ +
Sbjct: 64 DHPNIIRLYETFEDNTDIYLVMELCTGGEL----FERVVHKRVF---RESDAARIMKDVL 116
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARSFGLDQTEANTKRVVG 683
+ Y H+ L + HRDLK N L K+ DFGLA F + + VG
Sbjct: 117 SAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVG 170
Query: 684 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
T Y+SP+ ++GL+ + D +S GV++ ++CG
Sbjct: 171 TPYYVSPQ-VLEGLYGPECDEWSAGVMMYVLLCG 203
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 63/212 (29%), Positives = 98/212 (46%), Gaps = 24/212 (11%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQH 572
+ ++ LG+G FG V K QE AVK ++K + EV L+ KL H
Sbjct: 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAKNKDTSTILREVELLKKLDH 80
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARG 628
N++KL ++ E L FD R + S+ + II + G
Sbjct: 81 PNIMKLFEILEDSSSFYIVGELYTGGEL----FDEIIKRKRF---SEHDAARIIKQVFSG 133
Query: 629 LLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+ Y+H+ I+HRDLK N+LL + + KI DFGL+ F + K +GT
Sbjct: 134 ITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTA 187
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
Y++PE + G + K DV+S GV++ ++ G
Sbjct: 188 YYIAPE-VLRGTYDEKCDVWSAGVILYILLSG 218
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 59/189 (31%), Positives = 90/189 (47%), Gaps = 30/189 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + + LGEG F VYK Q +A+K++ G E K+ E+ L+
Sbjct: 10 KRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGH---RSEAKDGINRTALREIKLL 66
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHI---I 622
+L H N++ LL + L+++++ + + L SHI +
Sbjct: 67 QELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVI----IKDNSLVLTP----SHIKAYM 118
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
+GL YLHQ I+HRDLK +N+LLD K++DFGLA+SFG A T +VV
Sbjct: 119 LMTLQGLEYLHQH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFG-SPNRAYTHQVV 174
Query: 683 GTYGYMSPE 691
T Y +PE
Sbjct: 175 -TRWYRAPE 182
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-26
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 21/233 (9%)
Query: 489 RKKHSNQGNEKEEMELPIFDLKIIANATDNFSE------KNKLGEGGFGPVYKGMLIE-G 541
+ K ++ FD +I+ + LG G FG V+K G
Sbjct: 55 KSKRTSALAVDIPAPPAPFDHRIVTAKQGAVNSFYTVSKTEILGGGRFGQVHKCEETATG 114
Query: 542 QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD 601
++A K + + EE KNE+ ++ +L H NL++L +++ +L+ EY+ L
Sbjct: 115 LKLAAKIIKTRGMKDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGEL- 173
Query: 602 YFIFD--TTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP- 658
FD S L + I G+ ++HQ + I+H DLK N+L N
Sbjct: 174 ---FDRIIDESYNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQ 227
Query: 659 -KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
KI DFGLAR + + K GT +++PE S +D++S GV+
Sbjct: 228 IKIIDFGLARRYKPRE---KLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVI 277
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 1e-26
Identities = 55/207 (26%), Positives = 90/207 (43%), Gaps = 16/207 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEE-FKNEVLLIAKLQH 572
D+F LG+G FG VY + +A+K L K +G+E + E+ + + L+H
Sbjct: 14 DDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRH 73
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAGIARGLLY 631
N++++ R L+ E+ P L + + D + + + +A L Y
Sbjct: 74 PNILRMYNYFHDRKRIYLMLEFAPRGEL----YKELQKHGRFDEQRSATFMEELADALHY 129
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
H ++IHRD+K N+L+ KI+DFG S T + GT Y+ PE
Sbjct: 130 CH---ERKVIHRDIKPENLLMGYKGELKIADFGW--SVHAPSLRRRT--MCGTLDYLPPE 182
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
K D++ GVL E + G
Sbjct: 183 MIEGKTHDEKVDLWCAGVLCYEFLVGM 209
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 3e-26
Identities = 65/249 (26%), Positives = 109/249 (43%), Gaps = 35/249 (14%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKR 548
N + + ++ K +++ + KLG G +G V E A+K
Sbjct: 9 SGRENLYFQGIAINPGMYVRKKEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKV 68
Query: 549 LSK-------------GSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595
+ K + EE NE+ L+ L H N++KL + L+ E+
Sbjct: 69 IKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFY 128
Query: 596 PNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
L F+ R K + ++I+ I G+ YLH+ I+HRD+K N+L
Sbjct: 129 EGGEL----FEQIINRHKF---DECDAANIMKQILSGICYLHK---HNIVHRDIKPENIL 178
Query: 652 LDNT---MNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFG 708
L+N +N KI DFGL+ F D + +GT Y++PE + ++ K DV+S G
Sbjct: 179 LENKNSLLNIKIVDFGLSSFFSKDYK---LRDRLGTAYYIAPE-VLKKKYNEKCDVWSCG 234
Query: 709 VLVLEIICG 717
V++ ++CG
Sbjct: 235 VIMYILLCG 243
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 113 bits (283), Expect = 3e-26
Identities = 51/239 (21%), Positives = 95/239 (39%), Gaps = 19/239 (7%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGMLIE-GQ 542
+ S+ + + + + D+ + +LG G FG V++ G
Sbjct: 124 GKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYDIHEELGTGAFGVVHRVTERATGN 183
Query: 543 EIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDY 602
A K + E + E+ ++ L+H LV L +E ++IYE++ L
Sbjct: 184 NFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGEL-- 241
Query: 603 FIFDTTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-- 658
F+ + S+ + + +GL ++H+ +H DLK N++ +
Sbjct: 242 --FEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNEL 296
Query: 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
K+ DFGL Q + K GT + +PE A +D++S GVL ++ G
Sbjct: 297 KLIDFGLTAHLDPKQ---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 4e-26
Identities = 51/186 (27%), Positives = 92/186 (49%), Gaps = 17/186 (9%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-----EVLLI 567
+++ F + KLG G + VYKG+ G +A+K + S +G E+ L+
Sbjct: 2 SSSSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDSEEGT----PSTAIREISLM 57
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+L+H N+V+L ++ L++E++ N K + L+ + + +
Sbjct: 58 KELKHENIVRLYDVIHTENKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL 117
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+GL + H++ +I+HRDLK N+L++ K+ DFGLAR+FG + VV T
Sbjct: 118 LQGLAFCHEN---KILHRDLKPQNLLINKRGQLKLGDFGLARAFG-IPVNTFSSEVV-TL 172
Query: 686 GYMSPE 691
Y +P+
Sbjct: 173 WYRAPD 178
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 8e-26
Identities = 55/212 (25%), Positives = 91/212 (42%), Gaps = 15/212 (7%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVK-----RLSKGSGQGMEEFKNEVLLIAK 569
D + +G+G F V + + E GQ+ AVK + + G E+ K E +
Sbjct: 23 EDVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHM 82
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSHIIAGIARG 628
L+H ++V+LL + +++E++ L + + + SH + I
Sbjct: 83 LKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEA 142
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKRVVGTY 685
L Y H IIHRD+K VLL + N K+ FG+A G A VGT
Sbjct: 143 LRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGG--RVGTP 197
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
+M+PE + DV+ GV++ ++ G
Sbjct: 198 HFMAPEVVKREPYGKPVDVWGCGVILFILLSG 229
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 1e-25
Identities = 53/274 (19%), Positives = 92/274 (33%), Gaps = 52/274 (18%)
Query: 494 NQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVK----- 547
+ + E F + + K +G+G +G V + + A+K
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQKKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKN 62
Query: 548 RLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT 607
++ + + + +E K EV L+ KL H N+ +L L+ E L +
Sbjct: 63 KIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVF 122
Query: 608 TRSKLLDWSKR-------------------------------------SHIIAGIARGLL 630
+ S+I+ I L
Sbjct: 123 IDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALH 182
Query: 631 YLHQDSRLRIIHRDLKASNVLL--DNTMNPKISDFGLARSFGLDQTEANT--KRVVGTYG 686
YLH I HRD+K N L + + K+ DFGL++ F GT
Sbjct: 183 YLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPY 239
Query: 687 YMSPE--YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+++PE + + K D +S GVL+ ++ G
Sbjct: 240 FVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGA 273
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 58/212 (27%), Positives = 97/212 (45%), Gaps = 23/212 (10%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKNEVLLIAKLQH 572
+DN+ K +LG+G F V + + G E A K ++ S + ++ + E + KLQH
Sbjct: 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLEREARICRKLQH 64
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARG 628
N+V+L + L+++ + L F+ R S+ SH I I
Sbjct: 65 PNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFY---SEADASHCIQQILES 117
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKRVVGTY 685
+ Y H I+HR+LK N+LL + K++DFGLA + GT
Sbjct: 118 IAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTP 171
Query: 686 GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
GY+SPE +S D+++ GV++ ++ G
Sbjct: 172 GYLSPEVLKKDPYSKPVDIWACGVILYILLVG 203
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 2e-25
Identities = 45/184 (24%), Positives = 77/184 (41%), Gaps = 23/184 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + + K+GEG +G V+K + GQ +A+K+ E E+ ++
Sbjct: 3 EKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKF------LESEDDPVIKKIALREIRML 56
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+L+H NLV LL ++ L++EY + L + + I +
Sbjct: 57 KQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELD---RYQRGVPEHLVKSITWQTLQ 113
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
+ + H+ IHRD+K N+L+ K+ DFG AR ++ V T Y
Sbjct: 114 AVNFCHKH---NCIHRDVKPENILITKHSVIKLCDFGFARLLT-GPSDYYDDEVA-TRWY 168
Query: 688 MSPE 691
SPE
Sbjct: 169 RSPE 172
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-25
Identities = 54/226 (23%), Positives = 99/226 (43%), Gaps = 48/226 (21%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN-EVLLIAKLQHRN 574
++ +G G FG V++ L+E E+A+K++ + + FKN E+ ++ ++H N
Sbjct: 39 EIAYTNCKVIGNGSFGVVFQAKLVESDEVAIKKVLQD-----KRFKNRELQIMRIVKHPN 93
Query: 575 LVKLLGCCTQRDERM------LIYEYLPNKSLDYFIFDTTRSKLLD-WSKRSHIIAG--- 624
+V L ++ L+ EY+P T + ++K +
Sbjct: 94 VVDLKAFFYSNGDKKDEVFLNLVLEYVP----------ETVYRASRHYAKLKQTMPMLLI 143
Query: 625 ------IARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEAN 677
+ R L Y+H + I HRD+K N+LLD + K+ DFG A+ E N
Sbjct: 144 KLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKIL--IAGEPN 198
Query: 678 TKRVVGTYGYMSPEYAIDGLF-----SVKSDVFSFGVLVLEIICGK 718
+ Y Y +PE +F + D++S G ++ E++ G+
Sbjct: 199 VSYICSRY-YRAPEL----IFGATNYTTNIDIWSTGCVMAELMQGQ 239
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 3e-25
Identities = 51/184 (27%), Positives = 83/184 (45%), Gaps = 24/184 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-----EVLLIAKL 570
+ + + +KLGEG + VYKG +A+K + +G EV L+ L
Sbjct: 2 ETYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHEEGA----PCTAIREVSLLKDL 57
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPN---KSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+H N+V L L++EYL + LD +++ + + R
Sbjct: 58 KHANIVTLHDIIHTEKSLTLVFEYLDKDLKQYLD------DCGNIINMHNVKLFLFQLLR 111
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
GL Y H+ +++HRDLK N+L++ K++DFGLAR+ T+ VV T Y
Sbjct: 112 GLAYCHRQ---KVLHRDLKPQNLLINERGELKLADFGLARAKS-IPTKTYDNEVV-TLWY 166
Query: 688 MSPE 691
P+
Sbjct: 167 RPPD 170
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 5e-25
Identities = 53/197 (26%), Positives = 91/197 (46%), Gaps = 37/197 (18%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + K+G+G FG V+K + + A+K++ ME K E+ ++
Sbjct: 17 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVL------MENEKEGFPITALREIKIL 70
Query: 568 AKLQHRNLVKLLGCCTQRDERM--------LIYEYLPN--KSLDYFIFDTTRSKLLDWSK 617
L+H N+V L+ C + L++++ + L K S+
Sbjct: 71 QLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGL----LSNVLVKFTL-SE 125
Query: 618 RSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN 677
++ + GL Y+H++ +I+HRD+KA+NVL+ K++DFGLAR+F L +
Sbjct: 126 IKRVMQMLLNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQP 182
Query: 678 ---TKRVVGTYGYMSPE 691
T RVV T Y PE
Sbjct: 183 NRYTNRVV-TLWYRPPE 198
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 6e-25
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 27/214 (12%)
Query: 510 KIIANATDNFSEK----NKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKN 562
+ + NA+ FS+ +LG+G F V + + G E A K ++ S + ++ +
Sbjct: 18 EFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSARDFQKLER 77
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR-- 618
E + KLQH N+V+L + L+++ + L F+ R S+
Sbjct: 78 EARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----FEDIVAREFY---SEADA 130
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTE 675
SH I I + Y H I+HR+LK N+LL + K++DFGLA +
Sbjct: 131 SHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA- 186
Query: 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGV 709
GT GY+SPE +S D+++ GV
Sbjct: 187 --WHGFAGTPGYLSPEVLKKDPYSKPVDIWACGV 218
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 23/184 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
+ + +GEG +G V K + G+ +A+K+ + E+ L+
Sbjct: 25 EKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFL------ESDDDKMVKKIAMREIKLL 78
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+L+H NLV LL C ++ L++E++ + LD LD+ + I
Sbjct: 79 KQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDL---ELFPNGLDYQVVQKYLFQIIN 135
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
G+ + H IIHRD+K N+L+ + K+ DFG AR+ E V T Y
Sbjct: 136 GIGFCHSH---NIIHRDIKPENILVSQSGVVKLCDFGFARTLA-APGEVYDDEVA-TRWY 190
Query: 688 MSPE 691
+PE
Sbjct: 191 RAPE 194
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 7e-25
Identities = 56/195 (28%), Positives = 84/195 (43%), Gaps = 41/195 (21%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN--------EVLLI 567
D + KLGEG +G VYK + + +A+KR+ +E + EV L+
Sbjct: 34 DRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIR------LEHEEEGVPGTAIREVSLL 87
Query: 568 AKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR---SHI--- 621
+LQHRN+++L LI+EY + K +D + I
Sbjct: 88 KELQHRNIIELKSVIHHNHRLHLIFEYA----------ENDLKKYMDKNPDVSMRVIKSF 137
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP-----KISDFGLARSFGLDQTEA 676
+ + G+ + H R +HRDLK N+LL + KI DFGLAR+FG
Sbjct: 138 LYQLINGVNFCHSR---RCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFG-IPIRQ 193
Query: 677 NTKRVVGTYGYMSPE 691
T ++ T Y PE
Sbjct: 194 FTHEII-TLWYRPPE 207
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 40/202 (19%), Positives = 81/202 (40%), Gaps = 16/202 (7%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
+ + LG G FG V++ + + K + G K E+ ++ +H
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARH 60
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR--SHIIAGIARGLL 630
RN++ L +E ++I+E++ + F+ + + ++R + + L
Sbjct: 61 RNILHLHESFESMEELVMIFEFISGLDI----FERINTSAFELNEREIVSYVHQVCEALQ 116
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGTYGYM 688
+LH I H D++ N++ + KI +FG AR + + Y
Sbjct: 117 FLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDN---FRLLFTAPEYY 170
Query: 689 SPEYAIDGLFSVKSDVFSFGVL 710
+PE + S +D++S G L
Sbjct: 171 APEVHQHDVVSTATDMWSLGTL 192
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 1e-24
Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 22/210 (10%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
F LG G F V+ G+ A+K + K +NE+ ++ K++H N
Sbjct: 8 RKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLENEIAVLKKIKHEN 67
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLL 630
+V L L+ + + L FD R +++ S +I + +
Sbjct: 68 IVTLEDIYESTTHYYLVMQLVSGGEL----FDRILERGVY---TEKDASLVIQQVLSAVK 120
Query: 631 YLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
YLH+ I+HRDLK N+L + I+DFGL++ GT GY
Sbjct: 121 YLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ----NGIMSTACGTPGY 173
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
++PE +S D +S GV+ ++CG
Sbjct: 174 VAPEVLAQKPYSKAVDCWSIGVITYILLCG 203
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 1e-24
Identities = 55/213 (25%), Positives = 94/213 (44%), Gaps = 28/213 (13%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------GSGQGMEEFKNEVL 565
+ D++ +LG G F V K G+E A K + K G EE + EV
Sbjct: 1 SMVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVN 60
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHI 621
++ +++H N++ L + + +LI E + L FD + L ++ +
Sbjct: 61 ILREIRHPNIITLHDIFENKTDVVLILELVSGGEL----FDFLAEKESL---TEDEATQF 113
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEAN 677
+ I G+ YLH RI H DLK N++L + P K+ DFG+A
Sbjct: 114 LKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE--- 167
Query: 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
K + GT +++PE +++D++S GV+
Sbjct: 168 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 200
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 2e-24
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNLVKLLGCC 582
LGEG +G V + + + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 583 TQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDSRL 638
+ + + L EY L D + + + ++AG+ YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV----YLH---GI 124
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE------Y 692
I HRD+K N+LLD N KISDFGLA F + E ++ GT Y++PE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICG 717
DV+S G+++ ++ G
Sbjct: 185 --HAE---PVDVWSCGIVLTAMLAG 204
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 2e-24
Identities = 58/213 (27%), Positives = 90/213 (42%), Gaps = 28/213 (13%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------GSGQGMEEFKNEVL 565
D + +LG G F V K G E A K + K G EE + EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVS 67
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHI 621
++ ++ H N++ L R + +LI E + L FD + L S+ +
Sbjct: 68 ILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESL---SEEEATSF 120
Query: 622 IAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEAN 677
I I G+ YLH +I H DLK N++L + P K+ DFGLA
Sbjct: 121 IKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE--- 174
Query: 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
K + GT +++PE +++D++S GV+
Sbjct: 175 FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 103 bits (259), Expect = 2e-24
Identities = 57/210 (27%), Positives = 90/210 (42%), Gaps = 22/210 (10%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------GSGQGMEEFKNEVL 565
D + +LG G F V K G E A K + K G EE + EV
Sbjct: 8 QKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVS 67
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT-TRSKLLDWSKRSHIIAG 624
++ ++ H N++ L R + +LI E + L FD + + L + + I
Sbjct: 68 ILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL----FDFLAQKESLSEEEATSFIKQ 123
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEANTKR 680
I G+ YLH +I H DLK N++L + P K+ DFGLA K
Sbjct: 124 ILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKN 177
Query: 681 VVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
+ GT +++PE +++D++S GV+
Sbjct: 178 IFGTPEFVAPEIVNYEPLGLEADMWSIGVI 207
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-24
Identities = 59/229 (25%), Positives = 105/229 (45%), Gaps = 53/229 (23%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-EVLLIAKLQHR 573
++++ +G G FG VY+ L + G+ +A+K++ + + FKN E+ ++ KL H
Sbjct: 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQD-----KRFKNRELQIMRKLDHC 107
Query: 574 NLVKLLGCCTQRDERM------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRS-------H 620
N+V+L E+ L+ +Y+P T ++ R+ +
Sbjct: 108 NIVRLRYFFYSSGEKKDEVYLNLVLDYVP----------ETVYRVARHYSRAKQTLPVIY 157
Query: 621 I---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEA 676
+ + + R L Y+H I HRD+K N+LLD +T K+ DFG A+ L + E
Sbjct: 158 VKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQ--LVRGEP 212
Query: 677 NTKRVVGTYGYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
N + Y Y +PE Y + DV+S G ++ E++ G+
Sbjct: 213 NVSYICSRY-YRAPELIFGATDY------TSSIDVWSAGCVLAELLLGQ 254
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 104 bits (260), Expect = 4e-24
Identities = 51/242 (21%), Positives = 98/242 (40%), Gaps = 33/242 (13%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAV 546
+ K N + E + D + K+ +G G V + + G E AV
Sbjct: 65 QPKGTENLYFQSMGPEDELPDWAAAKEFYQKYDPKDVIGRGVSSVVRRCVHRATGHEFAV 124
Query: 547 KRLSKGSGQG--------MEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPN 597
K + + + E + E ++ ++ H +++ L+ L+++ +
Sbjct: 125 KIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRK 184
Query: 598 KSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653
L FD T + L S++ I+ + + +LH I+HRDLK N+LLD
Sbjct: 185 GEL----FDYLTEKVAL---SEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLD 234
Query: 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE------YAIDGLFSVKSDVFSF 707
+ M ++SDFG + + + + GT GY++PE + + D+++
Sbjct: 235 DNMQIRLSDFGFSCHLEPGEK---LRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWAC 291
Query: 708 GV 709
GV
Sbjct: 292 GV 293
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 5e-24
Identities = 50/193 (25%), Positives = 91/193 (47%), Gaps = 32/193 (16%)
Query: 517 DNFSEKNKLGEGGFGPVYKG--MLIEGQEIAVKRLSKGSGQGMEEFKN--------EVLL 566
+ ++GEG +G V+K + G+ +A+KR+ ++ + EV +
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR------VQTGEEGMPLSTIREVAV 64
Query: 567 IAKLQ---HRNLVKLLGCCTQRDER-----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKR 618
+ L+ H N+V+L CT L++E++ ++ L ++ D +
Sbjct: 65 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-DQDLTTYL-DKVPEPGVPTETI 122
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
++ + RGL +LH R++HRDLK N+L+ ++ K++DFGLAR + T
Sbjct: 123 KDMMFQLLRGLDFLHSH---RVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMAL--T 177
Query: 679 KRVVGTYGYMSPE 691
VV T Y +PE
Sbjct: 178 SVVV-TLWYRAPE 189
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 7e-24
Identities = 58/205 (28%), Positives = 91/205 (44%), Gaps = 27/205 (13%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNLVKLLGCC 582
LGEG +G V + + + +AVK + E K E+ + L H N+VK G
Sbjct: 15 LGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHR 74
Query: 583 TQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDSRL 638
+ + + L EY L D + + + ++AG+ YLH +
Sbjct: 75 REGNIQYLFLEYCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVV----YLH---GI 124
Query: 639 RIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE------Y 692
I HRD+K N+LLD N KISDFGLA F + E ++ GT Y++PE +
Sbjct: 125 GITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREF 184
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICG 717
DV+S G+++ ++ G
Sbjct: 185 --HAE---PVDVWSCGIVLTAMLAG 204
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 8e-24
Identities = 57/229 (24%), Positives = 98/229 (42%), Gaps = 38/229 (16%)
Query: 514 NATDNFSEK----NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM---------EE 559
++T F E LG G V + + +E AVK + G E
Sbjct: 10 HSTHGFYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREA 69
Query: 560 FKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWS 616
EV ++ K+ H N+++L L+++ + L FD T + L S
Sbjct: 70 TLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----FDYLTEKVTL---S 122
Query: 617 KR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
++ I+ + + LH+ L I+HRDLK N+LLD+ MN K++DFG + +
Sbjct: 123 EKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK 179
Query: 675 EANTKRVVGTYGYMSPE------YAIDGLFSVKSDVFSFGVLVLEIICG 717
+ V GT Y++PE + + D++S GV++ ++ G
Sbjct: 180 ---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 225
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 9e-24
Identities = 54/191 (28%), Positives = 88/191 (46%), Gaps = 22/191 (11%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQ-GMEEFKN----EVLLIA 568
AT + ++G G +G VYK G +A+K + +G G EV L+
Sbjct: 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLR 66
Query: 569 KLQ---HRNLVKLLGCCTQRDER-----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH 620
+L+ H N+V+L+ C L++E++ ++ L ++ D L
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-DQDLRTYL-DKAPPPGLPAETIKD 124
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR 680
++ RGL +LH + I+HRDLK N+L+ + K++DFGLAR + T
Sbjct: 125 LMRQFLRGLDFLHAN---CIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA--LTPV 179
Query: 681 VVGTYGYMSPE 691
VV T Y +PE
Sbjct: 180 VV-TLWYRAPE 189
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 9e-24
Identities = 57/212 (26%), Positives = 93/212 (43%), Gaps = 28/212 (13%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------GSGQGMEEFKNEVLL 566
N D + +LG G F V K G + A K + K G E+ + EV +
Sbjct: 8 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 67
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHII 622
+ ++QH N++ L + + +LI E + L FD + L ++ + +
Sbjct: 68 LKEIQHPNVITLHEVYENKTDVILILELVAGGEL----FDFLAEKESL---TEEEATEFL 120
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEANT 678
I G+ YLH L+I H DLK N++L + P KI DFGLA
Sbjct: 121 KQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---F 174
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
K + GT +++PE +++D++S GV+
Sbjct: 175 KNIFGTPEFVAPEIVNYEPLGLEADMWSIGVI 206
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 3e-23
Identities = 53/215 (24%), Positives = 92/215 (42%), Gaps = 29/215 (13%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLL 579
++ LGEG V + + QE AVK + K G EV ++ + Q HRN+++L+
Sbjct: 18 EDVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVFREVEMLYQCQGHRNVLELI 77
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQD 635
+ D L++E + S+ R ++ S ++ +A L +LH
Sbjct: 78 EFFEEEDRFYLVFEKMRGGSI----LSHIHKRRHF---NELEASVVVQDVASALDFLHN- 129
Query: 636 SRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKR-----VVGTYGY 687
I HRDLK N+L ++ KI DF L L+ + G+ Y
Sbjct: 130 --KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEY 187
Query: 688 MSPE-----YAIDGLFSVKSDVFSFGVLVLEIICG 717
M+PE ++ + D++S GV++ ++ G
Sbjct: 188 MAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSG 222
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 4e-23
Identities = 54/207 (26%), Positives = 95/207 (45%), Gaps = 22/207 (10%)
Query: 513 ANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--GSGQGMEEFKNEVLLIAK 569
T+ + +LG+G F V + + + GQE A ++ S + ++ + E +
Sbjct: 7 TRFTEEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKLSARDHQKLEREARICRL 66
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGI 625
L+H N+V+L ++ LI++ + L F+ R S+ SH I I
Sbjct: 67 LKHPNIVRLHDSISEEGHHYLIFDLVTGGEL----FEDIVAREYY---SEADASHCIQQI 119
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKRVV 682
+L+ HQ + ++HR+LK N+LL + + K++DFGLA +Q
Sbjct: 120 LEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFG--FA 174
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGV 709
GT GY+SPE + D+++ GV
Sbjct: 175 GTPGYLSPEVLRKDPYGKPVDLWACGV 201
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-23
Identities = 50/186 (26%), Positives = 88/186 (47%), Gaps = 20/186 (10%)
Query: 521 EKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVK 577
E K+G G +G VYK + ++ A+K++ +G+G M + E+ L+ +L+H N++
Sbjct: 25 EGCKVGRGTYGHVYKAKRKDGKDDKDYALKQI-EGTGISMSACR-EIALLRELKHPNVIS 82
Query: 578 LLGCCTQRDER--MLIYEYLPN---KSLDYFIFDTTRSKL--LDWSKRSHIIAGIARGLL 630
L +R L+++Y + + + K L ++ I G+
Sbjct: 83 LQKVFLSHADRKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIH 142
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGL-DQTEANTKRVVGTY 685
YLH + ++HRDLK +N+L+ KI+D G AR F + A+ VV T+
Sbjct: 143 YLHAN---WVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTF 199
Query: 686 GYMSPE 691
Y +PE
Sbjct: 200 WYRAPE 205
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 102 bits (255), Expect = 1e-22
Identities = 66/217 (30%), Positives = 98/217 (45%), Gaps = 33/217 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
+ F + LG+GGFG V + ++ A K+L K +G NE ++ K+
Sbjct: 184 NTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNS 243
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-------FDTTRSKLLDWSKRSHIIAG 624
R +V L + + + L+ + L + I F R+ A
Sbjct: 244 RFVVSL-AYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFY--------AAE 294
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
I GL LH R RI++RDLK N+LLD+ + +ISD GLA QT K VGT
Sbjct: 295 ICCGLEDLH---RERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGT 348
Query: 685 YGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIICGK 718
GYM+PE + FS D ++ G L+ E+I G+
Sbjct: 349 VGYMAPE-VVKNERYTFSP--DWWALGCLLYEMIAGQ 382
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 61/207 (29%), Positives = 97/207 (46%), Gaps = 31/207 (14%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+G+G F V ++ G+E+A+K + K + +++ EV ++ L H N+VKL
Sbjct: 23 IGKGNFAKVKLARHILTGREVAIKIIDKTQLNPTSLQKLFREVRIMKILNHPNIVKLFEV 82
Query: 582 CTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDSR 637
LI EY + DY + ++ + RS I++ + Y H +
Sbjct: 83 IETEKTLYLIMEYASGGEVFDYLV---AHGRMKEKEARSKFRQIVSAVQ----YCH---Q 132
Query: 638 LRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE------ 691
RI+HRDLKA N+LLD MN KI+DFG + F + G Y +PE
Sbjct: 133 KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKL---DAFCGAPPYAAPELFQGKK 189
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y DG + DV+S GV++ ++ G
Sbjct: 190 Y--DGP---EVDVWSLGVILYTLVSGS 211
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 98.9 bits (247), Expect = 1e-22
Identities = 52/217 (23%), Positives = 86/217 (39%), Gaps = 36/217 (16%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRN 574
TD + K +G G + + + E AVK + K EE +L+ QH N
Sbjct: 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEE---IEILLRYGQHPN 77
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLL 630
++ L ++ E + L D + S+R S ++ I + +
Sbjct: 78 IITLKDVYDDGKYVYVVTELMKGGEL----LDKILRQKFF---SEREASAVLFTITKTVE 130
Query: 631 YLHQDSRLRIIHRDLKASNVLL----DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
YLH ++HRDLK SN+L N + +I DFG A+ + T T
Sbjct: 131 YLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMT--PCYTAN 185
Query: 687 YMSPE------YAIDGLFSVKSDVFSFGVLVLEIICG 717
+++PE Y D++S GVL+ ++ G
Sbjct: 186 FVAPEVLERQGY------DAACDIWSLGVLLYTMLTG 216
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 97.7 bits (244), Expect = 2e-22
Identities = 52/216 (24%), Positives = 86/216 (39%), Gaps = 40/216 (18%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLVKL- 578
LGEG +G V + + AVK L K G K E+ L+ +L+H+N+++L
Sbjct: 13 LGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLV 72
Query: 579 --LGCCTQRDERMLIY---EYLPNKSLDYFIFD-TTRSKLLDWSKRSH---IIAGIARGL 629
L ++ +Y EY + + D + + +I G+
Sbjct: 73 DVLYNEEKQK----MYMVMEYCVCGMQE--MLDSVPEKRFPVCQAHGYFCQLIDGLE--- 123
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
YLH I+H+D+K N+LL KIS G+A + + + G+ +
Sbjct: 124 -YLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQP 179
Query: 690 PE-------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
PE + G K D++S GV + I G
Sbjct: 180 PEIANGLDTF--SGF---KVDIWSAGVTLYNITTGL 210
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 2e-22
Identities = 62/208 (29%), Positives = 97/208 (46%), Gaps = 12/208 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
D F + LG GGFG V+ + ++ A K+L+K +G + E ++AK+
Sbjct: 185 DWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHS 244
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLL 630
R +V L + + L+ + + Y I++ + + A I GL
Sbjct: 245 RFIVSLA-YAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLE 303
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LHQ II+RDLK NVLLD+ N +ISD GLA QT+ GT G+M+P
Sbjct: 304 HLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTKTKG--YAGTPGFMAP 358
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + + D F+ GV + E+I +
Sbjct: 359 ELLLGEEYDFSVDYFALGVTLYEMIAAR 386
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 98.2 bits (245), Expect = 3e-22
Identities = 58/236 (24%), Positives = 97/236 (41%), Gaps = 27/236 (11%)
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGMLIE- 540
+Y + S + + D I + D S+ ++LG G VY+
Sbjct: 18 LYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGATSIVYRCKQKGT 77
Query: 541 GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSL 600
+ A+K L K + + + E+ ++ +L H N++KL E L+ E + L
Sbjct: 78 QKPYALKVLKKTVDK--KIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGEL 135
Query: 601 DYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL---D 653
FD + S+R + + I + YLH+ I+HRDLK N+L
Sbjct: 136 ----FDRIVEKGYY---SERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPA 185
Query: 654 NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGV 709
KI+DFGL++ K V GT GY +PE + + D++S G+
Sbjct: 186 PDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYCAPEILRGCAYGPEVDMWSVGI 238
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 96.9 bits (242), Expect = 3e-22
Identities = 61/212 (28%), Positives = 93/212 (43%), Gaps = 22/212 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQH 572
++F LGEG F V + A+K L K + E ++++L H
Sbjct: 30 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 89
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
VKL Q DE++ Y N L +I FD T ++ A I
Sbjct: 90 PFFVKLYFTF-QDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFY--------TAEIV 140
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
L YLH IIHRDLK N+LL+ M+ +I+DFG A+ + +A VGT
Sbjct: 141 SALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQ 197
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y+SPE + SD+++ G ++ +++ G
Sbjct: 198 YVSPELLTEKSACKSSDLWALGCIIYQLVAGL 229
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 99.0 bits (247), Expect = 3e-22
Identities = 51/218 (23%), Positives = 88/218 (40%), Gaps = 27/218 (12%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK--------GSGQGMEEFKNEVLL 566
D + LG G G V + +++A++ +SK + E+ +
Sbjct: 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEI 193
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD-TTRSKLLDWSKRSHIIAGI 625
+ KL H ++K+ D ++ E + L FD +K L + +
Sbjct: 194 LKKLNHPCIIKIKNFFDAED-YYIVLELMEGGEL----FDKVVGNKRLKEATCKLYFYQM 248
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEANTKRVV 682
+ YLH+ IIHRDLK NVLL + KI+DFG ++ G + +
Sbjct: 249 LLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLC 302
Query: 683 GTYGYMSPE---YAIDGLFSVKSDVFSFGVLVLEIICG 717
GT Y++PE ++ D +S GV++ + G
Sbjct: 303 GTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 340
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 4e-22
Identities = 60/218 (27%), Positives = 97/218 (44%), Gaps = 34/218 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNE--VL-LIAK 569
++FS +G GGFG VY + ++ A+K L K QG NE +L L++
Sbjct: 189 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 248
Query: 570 LQHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIA 623
+V + +++ I + + L Y + F + A
Sbjct: 249 GDCPFIVCM-SYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFY--------AA 299
Query: 624 GIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
I GL ++H +++RDLK +N+LLD + +ISD GLA F + A VG
Sbjct: 300 EIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHA----SVG 352
Query: 684 TYGYMSPEYAIDGL---FSVKSDVFSFGVLVLEIICGK 718
T+GYM+PE G+ S D FS G ++ +++ G
Sbjct: 353 THGYMAPEVLQKGVAYDSSA--DWFSLGCMLFKLLRGH 388
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 96.2 bits (240), Expect = 7e-22
Identities = 53/229 (23%), Positives = 95/229 (41%), Gaps = 25/229 (10%)
Query: 497 NEKEEMELPIFDLKIIANATDNFSEK-----NKLGEGGFGPVYKGMLIE-GQEIAVKRLS 550
+ + + + + +NF+ +LG G F V + + GQE A K L
Sbjct: 4 HHHHSSGVDLGTENLYFQSMENFNNFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLK 63
Query: 551 K--GSGQGMEEFKNEVLLIAKLQHR-NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDT 607
K E +E+ ++ + ++ L E +LI EY + F
Sbjct: 64 KRRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEI----FSL 119
Query: 608 TRSKLLDW---SKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKIS 661
+L + + +I I G+ YLHQ I+H DLK N+LL + + KI
Sbjct: 120 CLPELAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIV 176
Query: 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVL 710
DFG++R G + ++GT Y++PE + +D+++ G++
Sbjct: 177 DFGMSRKIGHACE---LREIMGTPEYLAPEILNYDPITTATDMWNIGII 222
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 95.8 bits (239), Expect = 9e-22
Identities = 52/224 (23%), Positives = 85/224 (37%), Gaps = 39/224 (17%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE--------FKNEVLL 566
D + LG G G V + +++A+K +SK + E+ +
Sbjct: 9 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEI 68
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIY---EYLPNKSLDYFIFD--TTRSKLLDWSKR--S 619
+ KL H ++K+ D Y E + L FD +L +
Sbjct: 69 LKKLNHPCIIKIKNFFDAED----YYIVLELMEGGEL----FDKVVGNKRL---KEATCK 117
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLARSFGLDQTEA 676
+ + YLH IIHRDLK NVLL + KI+DFG ++ G
Sbjct: 118 LYFYQMLLAVQYLH---ENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL-- 172
Query: 677 NTKRVVGTYGYMSPE---YAIDGLFSVKSDVFSFGVLVLEIICG 717
+ + GT Y++PE ++ D +S GV++ + G
Sbjct: 173 -MRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSG 215
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 95.5 bits (238), Expect = 1e-21
Identities = 57/210 (27%), Positives = 89/210 (42%), Gaps = 30/210 (14%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK------GSGQGMEEFKNEVLLIAKLQHR--NL 575
LG GGFG VY G+ + + +A+K + K G EV+L+ K+ +
Sbjct: 51 LGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGV 110
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
++LL + D +LI E P D F F T R L + R + + + H
Sbjct: 111 IRLLDWFERPDSFVLILER-PEPVQDLFDFITERGALQEELAR-SFFWQVLEAVRHCH-- 166
Query: 636 SRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE--- 691
++HRD+K N+L+D N K+ DFG + GT Y PE
Sbjct: 167 -NCGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWIR 221
Query: 692 ---YAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y G + V+S G+L+ +++CG
Sbjct: 222 YHRY--HGR---SAAVWSLGILLYDMVCGD 246
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 95.6 bits (238), Expect = 2e-21
Identities = 45/219 (20%), Positives = 83/219 (37%), Gaps = 50/219 (22%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK--------GSGQGMEEFKNEVLLIAKLQHRNL 575
LG G FG V+ + + +E+ VK + K + + E+ ++++++H N+
Sbjct: 32 LGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANI 91
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFI----------FD-TTRSKLLDWSKRSHIIAG 624
+K+ + N+ + F R LD S+I
Sbjct: 92 IKV-------------LDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ + YL IIHRD+K N+++ K+ DFG A + GT
Sbjct: 139 LVSAVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKL---FYTFCGT 192
Query: 685 YGYMSPE------YAIDGLFSVKSDVFSFGVLVLEIICG 717
Y +PE Y G + +++S GV + ++
Sbjct: 193 IEYCAPEVLMGNPY--RGP---ELEMWSLGVTLYTLVFE 226
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 94.3 bits (235), Expect = 6e-21
Identities = 56/235 (23%), Positives = 92/235 (39%), Gaps = 55/235 (23%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN----EVLLIA 568
D F + G+G FG V G G +A+K++ + F+N + +A
Sbjct: 20 KEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDP-----RFRNRELQIMQDLA 74
Query: 569 KLQHRNLVKLLGCCTQRDER-------MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS-- 619
L H N+V+L ER ++ EY+P T + R
Sbjct: 75 VLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVP----------DTLHRCCRNYYRRQV 124
Query: 620 -----HI---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFG 670
I + + R + LH S + + HRD+K NVL++ K+ DFG A+
Sbjct: 125 APPPILIKVFLFQLIRSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK-- 181
Query: 671 LDQTEANTKRVVGTYGYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
L +E N + Y Y +PE Y + D++S G + E++ G+
Sbjct: 182 LSPSEPNVAYICSRY-YRAPELIFGNQHY------TTAVDIWSVGCIFAEMMLGE 229
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 7e-21
Identities = 52/205 (25%), Positives = 87/205 (42%), Gaps = 24/205 (11%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLL 579
LGEG F K + + Q AVK +SK + + E+ + + H N+VKL
Sbjct: 16 DKPLGEGSFSICRKCVHKKSNQAFAVKIISK---RMEANTQKEITALKLCEGHPNIVKLH 72
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKR--SHIIAGIARGLLYLHQD 635
+ L+ E L L F+ + S+ S+I+ + + ++H
Sbjct: 73 EVFHDQLHTFLVMELLNGGEL----FERIKKKKHF---SETEASYIMRKLVSAVSHMHD- 124
Query: 636 SRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
+ ++HRDLK N+L ++ + KI DFG AR D T T Y +PE
Sbjct: 125 --VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKT--PCFTLHYAAPEL 180
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICG 717
+ D++S GV++ ++ G
Sbjct: 181 LNQNGYDESCDLWSLGVILYTMLSG 205
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 92.3 bits (230), Expect = 9e-21
Identities = 58/232 (25%), Positives = 97/232 (41%), Gaps = 53/232 (22%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK-------------------------GSGQGME 558
+G+G +G V + A+K LSK +G
Sbjct: 21 IGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPI 80
Query: 559 EF-KNEVLLIAKLQHRNLVKL---LGCCTQRDERMLIYEYLPNKSLDYFIFDT-TRSKLL 613
E E+ ++ KL H N+VKL L D +++E + + + T L
Sbjct: 81 EQVYQEIAILKKLDHPNVVKLVEVLDDPN-EDHLYMVFELVNQGPV----MEVPTLKPLS 135
Query: 614 DWSKRSH---IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
+ R + +I GI YLH +IIHRD+K SN+L+ + KI+DFG++ F
Sbjct: 136 EDQARFYFQDLIKGIE----YLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF- 187
Query: 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSV----KSDVFSFGVLVLEIICGK 718
++A VGT +M+PE ++ + DV++ GV + + G+
Sbjct: 188 -KGSDALLSNTVGTPAFMAPE-SLSETRKIFSGKALDVWAMGVTLYCFVFGQ 237
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 49/206 (23%), Positives = 88/206 (42%), Gaps = 22/206 (10%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK------GSGQGMEEFKNEV----LLIAKLQHR 573
LG+GGFG V+ G L + ++A+K + + EV + A H
Sbjct: 39 LGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHP 98
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
+++LL ++ ML+ E P + D F + T + L + R + + + H
Sbjct: 99 GVIRLLDWFETQEGFMLVLER-PLPAQDLFDYITEKGPLGEGPSR-CFFGQVVAAIQHCH 156
Query: 634 QDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
++HRD+K N+L+D K+ DFG + GT Y PE+
Sbjct: 157 ---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALL----HDEPYTDFDGTRVYSPPEW 209
Query: 693 AIDGLFS-VKSDVFSFGVLVLEIICG 717
+ + + V+S G+L+ +++CG
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCG 235
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 89.7 bits (223), Expect = 2e-19
Identities = 47/214 (21%), Positives = 83/214 (38%), Gaps = 40/214 (18%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEV-LLIAKLQHRNLVKLL 579
K LG G G V + GQ+ A+K L + + EV ++V +L
Sbjct: 34 KQVLGLGVNGKVLECFHRRTGQKCALKLLYD-----SPKARQEVDHHWQASGGPHIVCIL 88
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFI----------FDTTRSKLLDW-SKR--SHIIAGIA 626
+YE + + I F + + ++R + I+ I
Sbjct: 89 D----------VYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIG 138
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLL---DNTMNPKISDFGLARSFGLDQTEANTKRVVG 683
+ +LH I HRD+K N+L + K++DFG A+ T+ +
Sbjct: 139 TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET----TQNALQTPCY 191
Query: 684 TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
T Y++PE + D++S GV++ ++CG
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCG 225
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 88.0 bits (219), Expect = 2e-19
Identities = 59/211 (27%), Positives = 97/211 (45%), Gaps = 38/211 (18%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG G FG V G + G ++AVK L++ S + + K E+ + +H +++KL
Sbjct: 19 LGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQ 78
Query: 581 CCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDS 636
+ + ++ EY+ L DY ++ + R I++ + Y H
Sbjct: 79 VISTPTDFFMVMEYVSGGELFDYIC---KHGRVEEMEARRLFQQILSAVD----YCH--- 128
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSF---GLDQTEANTKRVVGTYGYMSPE-- 691
R ++HRDLK NVLLD MN KI+DFGL+ +T G+ Y +PE
Sbjct: 129 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRT------SCGSPNYAAPEVI 182
Query: 692 ----YAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y G + D++S GV++ ++CG
Sbjct: 183 SGRLY--AGP---EVDIWSCGVILYALLCGT 208
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 2e-19
Identities = 57/253 (22%), Positives = 96/253 (37%), Gaps = 65/253 (25%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN-EVLLIAKLQ 571
++ +S LG G FG V + IE G+ A+K++ + +KN E+ ++ L
Sbjct: 4 TSSKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDP-----RYKNRELDIMKVLD 58
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLD-------------------------YFIF- 605
H N++KL+ + P+ I
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 606 --DTTRSKLLDWSKRS-------HI---IAGIARGLLYLHQDSRLRIIHRDLKASNVLLD 653
T K+L RS I I + R + ++H L I HRD+K N+L++
Sbjct: 119 YVPDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQNLLVN 175
Query: 654 -NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE-------YAIDGLFSVKSDVF 705
K+ DFG A+ L +E + + + Y +PE Y + D++
Sbjct: 176 SKDNTLKLCDFGSAK--KLIPSEPSVAYICSRF-YRAPELMLGATEY------TPSIDLW 226
Query: 706 SFGVLVLEIICGK 718
S G + E+I GK
Sbjct: 227 SIGCVFGELILGK 239
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 7e-19
Identities = 55/208 (26%), Positives = 90/208 (43%), Gaps = 36/208 (17%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQHRNLVKLLGCC 582
+G G FG + + +AVK + +G ++E + E++ L+H N+V+
Sbjct: 28 IGSGNFGVARLMRDKLTKELVAVKYIERG--AAIDENVQREIINHRSLRHPNIVRFKEVI 85
Query: 583 TQRDERMLIYEYLPNKSLDYFIFD--TTRSKLLDWSKRS---HIIAGIARGLLYLHQDSR 637
+I EY L ++ + + R +++G++ Y H
Sbjct: 86 LTPTHLAIIMEYASGGEL----YERICNAGRFSEDEARFFFQQLLSGVS----YCH---S 134
Query: 638 LRIIHRDLKASNVLLD--NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE---- 691
++I HRDLK N LLD KI DFG ++S L K VGT Y++PE
Sbjct: 135 MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQ---PKSTVGTPAYIAPEVLLR 191
Query: 692 --YAIDGLFSVKSDVFSFGVLVLEIICG 717
Y DG +DV+S GV + ++ G
Sbjct: 192 QEY--DGK---IADVWSCGVTLYVMLVG 214
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 1e-18
Identities = 51/243 (20%), Positives = 89/243 (36%), Gaps = 29/243 (11%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAV 546
+ + +K A D LG G G V + ++ A+
Sbjct: 33 AQPPPPPPQQFPQFHVKSGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFAL 92
Query: 547 KRLSKGSGQGMEEFKNEV-LLIAKLQHRNLVKLLGCC-TQRDERMLIY---EYLPNKSLD 601
K L + + EV L Q ++V+++ R + E L L
Sbjct: 93 KMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL- 146
Query: 602 YFIFDTTRSKLLDW-SKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658
F + + ++R S I+ I + YLH + I HRD+K N+L + P
Sbjct: 147 ---FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSK-RP 199
Query: 659 ----KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEI 714
K++DFG A+ + T Y++PE + D++S GV++ +
Sbjct: 200 NAILKLTDFGFAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYIL 256
Query: 715 ICG 717
+CG
Sbjct: 257 LCG 259
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 87.8 bits (218), Expect = 1e-18
Identities = 63/217 (29%), Positives = 99/217 (45%), Gaps = 32/217 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFKN---EVLLIAKLQH 572
D+F +G+G FG V + +++ A+K ++K E +N E+ ++ L+H
Sbjct: 15 DHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEH 74
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
LV L Q +E M ++ + L L Y + F KL I +
Sbjct: 75 PFLVNLW-YSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLF--------ICELV 125
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
L YL RIIHRD+K N+LLD + I+DF +A +T+ T + GT
Sbjct: 126 MALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAML-PRETQITT--MAGTKP 179
Query: 687 YMSPE--YAIDGL---FSVKSDVFSFGVLVLEIICGK 718
YM+PE + G F+V D +S GV E++ G+
Sbjct: 180 YMAPEMFSSRKGAGYSFAV--DWWSLGVTAYELLRGR 214
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 55/217 (25%), Positives = 92/217 (42%), Gaps = 51/217 (23%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LGEG FG V Q++A+K +S+ + E+ + L+H +++KL
Sbjct: 17 LGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKL-- 74
Query: 581 CCTQRDERMLIYEYLPNKSLDYFI--------FD--TTRSKLLDWSKRSH---IIAGIAR 627
Y+ + + + FD + ++ + R II I
Sbjct: 75 -----------YDVITTPTDIVMVIEYAGGELFDYIVEKKRMTEDEGRRFFQQIICAIE- 122
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
Y H R +I+HRDLK N+LLD+ +N KI+DFGL+ T G+ Y
Sbjct: 123 ---YCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF-LKT--SCGSPNY 173
Query: 688 MSPE------YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+PE Y G + DV+S G+++ ++ G+
Sbjct: 174 AAPEVINGKLY--AGP---EVDVWSCGIVLYVMLVGR 205
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 59/208 (28%), Positives = 98/208 (47%), Gaps = 32/208 (15%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRLSK---GSGQGMEEFKNEVLLIAKLQHRNLVKLLG 580
LG G FG V G + G ++AVK L++ S + + + E+ + +H +++KL
Sbjct: 24 LGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQ 83
Query: 581 CCTQRDERMLIYEYLPNKSL-DYFIFDTTRSKLLDWSKRSH---IIAGIARGLLYLHQDS 636
+ + ++ EY+ L DY +L + R I++G+ Y H
Sbjct: 84 VISTPSDIFMVMEYVSGGELFDYIC---KNGRLDEKESRRLFQQILSGVD----YCH--- 133
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE----- 691
R ++HRDLK NVLLD MN KI+DFGL+ + + G+ Y +PE
Sbjct: 134 RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPEVISGR 190
Query: 692 -YAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y G + D++S GV++ ++CG
Sbjct: 191 LY--AGP---EVDIWSSGVILYALLCGT 213
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 2e-18
Identities = 51/217 (23%), Positives = 93/217 (42%), Gaps = 21/217 (9%)
Query: 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLI 567
+ D++ KLG G + V++ + I +++ VK L ++ K E+ ++
Sbjct: 28 HVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVK---KKKIKREIKIL 84
Query: 568 AKLQ-HRNLVKLLGCCTQRDERM--LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAG 624
L+ N++ L R L++E++ N L D+ R +
Sbjct: 85 ENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY-----QTLTDYDIRF-YMYE 138
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVG 683
I + L Y H S I+HRD+K NV++D ++ D+GLA + + RV
Sbjct: 139 ILKALDYCH--SM-GIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFY--HPGQEYNVRVAS 193
Query: 684 TYGYMSPEYAIDGLFSVKS-DVFSFGVLVLEIICGKK 719
Y + PE +D S D++S G ++ +I K+
Sbjct: 194 RY-FKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 229
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 86.1 bits (213), Expect = 3e-18
Identities = 35/91 (38%), Positives = 51/91 (56%), Gaps = 3/91 (3%)
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+A+G+ +L + + IHRDL A N+LL KI DFGLAR D
Sbjct: 202 VAKGMEFL---ASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLP 258
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEII 715
+M+PE D +++++SDV+SFGVL+ EI
Sbjct: 259 LKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 68.8 bits (168), Expect = 1e-12
Identities = 36/162 (22%), Positives = 63/162 (38%), Gaps = 19/162 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSGQG-MEEFKNEVLLIAK 569
D LG G FG V + + +AVK L +G+ +E+ ++
Sbjct: 22 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 81
Query: 570 L-QHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
+ H N+V LLG CT+ M+I E+ +L ++ SKR+ + +
Sbjct: 82 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL----------RSKRNEFVPYKTK 131
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669
G + + I DLK + ++ + S F +S
Sbjct: 132 GARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSL 173
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 2e-17
Identities = 48/219 (21%), Positives = 87/219 (39%), Gaps = 31/219 (14%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
D+F +G G F V + + ++ A+K ++K + F+ E ++
Sbjct: 61 DDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDR 120
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI------FDTTRSKLLDWSKRSHIIAGI 625
R + +L Q + + L+ EY L + ++ +A I
Sbjct: 121 RWITQLH-FAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFY--------LAEI 171
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+ +H+ L +HRD+K N+LLD + +++DFG D T + VGT
Sbjct: 172 VMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT-VRSLVAVGTP 227
Query: 686 GYMSPE-------YAIDGLFSVKSDVFSFGVLVLEIICG 717
Y+SPE G + + D ++ GV E+ G
Sbjct: 228 DYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYG 266
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 83.7 bits (207), Expect = 3e-17
Identities = 50/217 (23%), Positives = 88/217 (40%), Gaps = 29/217 (13%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEE---FKNEVLLIAKLQH 572
++F +G G FG V L ++ A+K L+K E F+ E ++
Sbjct: 74 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDS 133
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI------FDTTRSKLLDWSKRSHIIAGI 625
+ + L Q D + L+ +Y L + ++ +A +
Sbjct: 134 KWITTLH-YAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFY--------LAEM 184
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+ +HQ L +HRD+K N+L+D + +++DFG D T + VGT
Sbjct: 185 VIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT-VQSSVAVGTP 240
Query: 686 GYMSPE-----YAIDGLFSVKSDVFSFGVLVLEIICG 717
Y+SPE G + + D +S GV + E++ G
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYG 277
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 80.4 bits (199), Expect = 2e-16
Identities = 50/231 (21%), Positives = 91/231 (39%), Gaps = 46/231 (19%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ + LG GG G V+ + + +A+K++ + E+
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIV---------LTDPQSVKHALREIK 60
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-YFIFD--------TTRSKLLDWS 616
+I +L H N+VK+ ++ + Y + + L
Sbjct: 61 IIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQGPLLEE 120
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMN--PKISDFGLARSFGLDQT 674
+ + RGL Y+H + ++HRDLK +N+ + NT + KI DFGLAR +
Sbjct: 121 HARLFMYQLLRGLKYIHSAN---VLHRDLKPANLFI-NTEDLVLKIGDFGLARIMDPHYS 176
Query: 675 EAN--TKRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIICGK 718
++ +V T Y SP L S + D+++ G + E++ GK
Sbjct: 177 HKGHLSEGLV-TKWYRSPRL----LLSPNNYTKAIDMWAAGCIFAEMLTGK 222
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 81.3 bits (201), Expect = 2e-16
Identities = 56/204 (27%), Positives = 86/204 (42%), Gaps = 23/204 (11%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQHRNLVKLLG 580
LG+G FG V A+K L K +E E ++ +H L L
Sbjct: 156 LGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALK- 214
Query: 581 CCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
Q +R+ + EY L + + F R++ A I L YLH
Sbjct: 215 YSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFY--------GAEIVSALDYLH- 265
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
S +++RDLK N++LD + KI+DFGL + D T GT Y++PE
Sbjct: 266 -SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKT--FCGTPEYLAPEVLE 322
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
D + D + GV++ E++CG+
Sbjct: 323 DNDYGRAVDWWGLGVVMYEMMCGR 346
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 81.4 bits (201), Expect = 2e-16
Identities = 42/222 (18%), Positives = 92/222 (41%), Gaps = 35/222 (15%)
Query: 487 YRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIA 545
R++ HS++ + + D + ++ +G G +G V + +E + +A
Sbjct: 29 QRKQHHSSKPTASMPRPHSDWQI------PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVA 82
Query: 546 VKRLSKGSGQGMEEFKN---------EVLLIAKLQHRNLVKLLGCCTQRDERM-----LI 591
+K++ + F++ E+ ++ +L H ++VK+L +D ++
Sbjct: 83 IKKILR-------VFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVV 135
Query: 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
E T L + ++ ++ + G+ Y+H S I+HRDLK +N L
Sbjct: 136 LEIAD-SDFKKLF--RTPVYLTELHIKT-LLYNLLVGVKYVH--SA-GILHRDLKPANCL 188
Query: 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
++ + K+ DFGLAR+ + + + M+
Sbjct: 189 VNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTF 230
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 79.7 bits (197), Expect = 4e-16
Identities = 57/226 (25%), Positives = 99/226 (43%), Gaps = 49/226 (21%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ +G G G V I + +A+K+LS+ F+N E++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSR-------PFQNQTHAKRAYRELV 76
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFD--------TTRSKL 612
L+ + H+N++ LL + P KSL+ Y + + + +L
Sbjct: 77 LMKCVNHKNIIGLLNV------------FTPQKSLEEFQDVYIVMELMDANLCQVIQMEL 124
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+ S+++ + G+ +LH IIHRDLK SN+++ + KI DFGLAR+
Sbjct: 125 DH-ERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLART--AG 178
Query: 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
+ T VV T Y +PE + + D++S G ++ E+I G
Sbjct: 179 TSFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 80.1 bits (198), Expect = 4e-16
Identities = 55/241 (22%), Positives = 99/241 (41%), Gaps = 26/241 (10%)
Query: 490 KKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKR 548
+K+ N N + I ++ + +++ +G G FG V +++ A+K
Sbjct: 42 RKNKNIDNFLSRYKDTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKL 101
Query: 549 LSKGSGQGMEE---FKNEVLLIAKLQHRNLVKLLGCCTQRDERM-LIYEYLPN----KSL 600
LSK + F E ++A +V+L Q D + ++ EY+P +
Sbjct: 102 LSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLF-YAFQDDRYLYMVMEYMPGGDLVNLM 160
Query: 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKI 660
+ ++ A + L +H + IHRD+K N+LLD + + K+
Sbjct: 161 SNYDVPEKWARFY--------TAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKL 209
Query: 661 SDFGLARSFGLDQTEANTKRVVGTYGYMSPE----YAIDGLFSVKSDVFSFGVLVLEIIC 716
+DFG + VGT Y+SPE DG + + D +S GV + E++
Sbjct: 210 ADFGTCMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLV 268
Query: 717 G 717
G
Sbjct: 269 G 269
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 79.5 bits (196), Expect = 8e-16
Identities = 56/225 (24%), Positives = 100/225 (44%), Gaps = 47/225 (20%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ +G G G V + + +A+K+LS+ F+N E++
Sbjct: 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR-------PFQNQTHAKRAYRELV 113
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFDTTRSKL-------L 613
L+ + H+N++ LL + P K+L+ Y + + + L L
Sbjct: 114 LMKCVNHKNIISLLNV------------FTPQKTLEEFQDVYLVMELMDANLCQVIQMEL 161
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
D + S+++ + G+ +LH IIHRDLK SN+++ + KI DFGLAR+
Sbjct: 162 DHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLART--AGT 216
Query: 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
+ T VV T Y +PE + + D++S G ++ E++ K
Sbjct: 217 SFMMTPYVV-TRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 9e-16
Identities = 54/227 (23%), Positives = 96/227 (42%), Gaps = 52/227 (22%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ +G G +G V + G+++A+K+LS+ F++ E+L
Sbjct: 23 PKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR-------PFQSEIFAKRAYRELL 75
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFD--------TTRSKL 612
L+ +QH N++ LL + P SL Y + K
Sbjct: 76 LLKHMQHENVIGLLDV------------FTPASSLRNFYDFYLVMPFMQTDLQKIMGLKF 123
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+ K +++ + +GL Y+H ++HRDLK N+ ++ KI DFGLAR +
Sbjct: 124 SE-EKIQYLVYQMLKGLKYIHSAG---VVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
Query: 673 QTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGK 718
T V T Y +PE + ++ D++S G ++ E++ GK
Sbjct: 180 MTG-----YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGK 221
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 2e-15
Identities = 53/231 (22%), Positives = 96/231 (41%), Gaps = 59/231 (25%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ + +G G +G V + G ++A+K+L + F++ E+
Sbjct: 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR-------PFQSELFAKRAYRELR 76
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFD--------TTRSKL 612
L+ ++H N++ LL + P+++LD Y + + +
Sbjct: 77 LLKHMRHENVIGLLDV------------FTPDETLDDFTDFYLVMPFMGTDLGKLMKHEK 124
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
L + ++ + +GL Y+H IIHRDLK N+ ++ KI DFGLAR +
Sbjct: 125 LGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIICGK 718
T V T Y +PE + + D++S G ++ E+I GK
Sbjct: 182 MTGY-----VVTRWYRAPEV----ILNWMRYTQTVDIWSVGCIMAEMITGK 223
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 3e-15
Identities = 50/226 (22%), Positives = 85/226 (37%), Gaps = 38/226 (16%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEE--FKN---------EV 564
++ + + G +G V G+ EG +A+KR+ G + E+
Sbjct: 21 QSPYTVQRFISSGSYGAVCAGVDSEGIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREI 80
Query: 565 LLIAKLQHRNLVKLLGCCTQRDERM-----LIYEYLPNKSLDYFIFDTTRSKLLDWSKRS 619
L+ H N++ L +E L+ E + L I + ++
Sbjct: 81 RLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMRT-DLAQVI--HDQRIVISPQHIQ 137
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ--TEAN 677
+ + I GL LH+ ++HRDL N+LL + + I DF LAR D T
Sbjct: 138 YFMYHILLGLHVLHEAG---VVHRDLHPGNILLADNNDITICDFNLAREDTADANKTH-- 192
Query: 678 TKRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIICGK 718
V Y +PE + K D++S G ++ E+ K
Sbjct: 193 ---YVTHRWYRAPEL----VMQFKGFTKLVDMWSAGCVMAEMFNRK 231
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 3e-15
Identities = 54/204 (26%), Positives = 85/204 (41%), Gaps = 24/204 (11%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQHRNLVKLLG 580
LG+G FG V A+K L K +E E ++ +H L L
Sbjct: 13 LGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALK- 71
Query: 581 CCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
Q +R+ + EY L + + F R++ A I L YLH
Sbjct: 72 YAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFY--------GAEIVSALEYLHS 123
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+++RD+K N++LD + KI+DFGL + D T GT Y++PE
Sbjct: 124 ---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLAPEVLE 178
Query: 695 DGLFSVKSDVFSFGVLVLEIICGK 718
D + D + GV++ E++CG+
Sbjct: 179 DNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 76.6 bits (189), Expect = 4e-15
Identities = 51/225 (22%), Positives = 98/225 (43%), Gaps = 43/225 (19%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN---------EVL 565
++ + +GEG +G V + +A+K++S F++ E+
Sbjct: 26 GPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISP--------FEHQTYCQRTLREIK 77
Query: 566 LIAKLQHRNLVKLLGCCTQRDERM-----LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH 620
++ + +H N++ + ++ + + L + +++ L +
Sbjct: 78 ILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLL----KTQHLSNDHICY 132
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEAN--T 678
+ I RGL Y+H S ++HRDLK SN+LL+ T + KI DFGLAR D T
Sbjct: 133 FLYQILRGLKYIH--SA-NVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLT 189
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKS-----DVFSFGVLVLEIICGK 718
+ V T Y +PE + + K D++S G ++ E++ +
Sbjct: 190 EYVA-TRWYRAPEI----MLNSKGYTKSIDIWSVGCILAEMLSNR 229
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 76.0 bits (188), Expect = 5e-15
Identities = 61/209 (29%), Positives = 101/209 (48%), Gaps = 32/209 (15%)
Query: 525 LGEGGFGPVY---KGMLIEGQEI-AVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKL 578
LG+G FG V+ K + +++ A+K L K + + K E ++ ++ H +VKL
Sbjct: 32 LGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVRTKMERDILVEVNHPFIVKL 91
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
Q + ++ LI ++L L + F K +A +A L +L
Sbjct: 92 H-YAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFY--------LAELALALDHL 142
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H L II+RDLK N+LLD + K++DFGL++ + +A + GT YM+PE
Sbjct: 143 HS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS--FCGTVEYMAPE- 196
Query: 693 AIDGL---FSVKSDVFSFGVLVLEIICGK 718
++ S D +SFGVL+ E++ G
Sbjct: 197 VVNRRGHTQSA--DWWSFGVLMFEMLTGT 223
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 5e-15
Identities = 57/227 (25%), Positives = 98/227 (43%), Gaps = 51/227 (22%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN---------EVL 565
+ + + +G G +G V + G +AVK+LS+ F++ E+
Sbjct: 28 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR-------PFQSIIHAKRTYRELR 80
Query: 566 LIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLD-----YFIFD--------TTRSKL 612
L+ ++H N++ LL + P +SL+ Y + + +
Sbjct: 81 LLKHMKHENVIGLLDV------------FTPARSLEEFNDVYLVTHLMGADLNNIVKCQK 128
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
L +I I RGL Y+H IIHRDLK SN+ ++ KI DFGLAR +
Sbjct: 129 LTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185
Query: 673 QTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGK 718
T V T Y +PE ++ ++ D++S G ++ E++ G+
Sbjct: 186 MTGY-----VATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 227
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.3 bits (186), Expect = 9e-15
Identities = 63/205 (30%), Positives = 96/205 (46%), Gaps = 27/205 (13%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFK-----NEVLLIAKLQHRNLVKL 578
LG+G FG V+ + + A+K L K ++ + VL +A +H L +
Sbjct: 25 LGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLA-WEHPFLTHM 83
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
C Q E + + EYL L Y I FD +R+ A I GL +L
Sbjct: 84 F-CTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATF--------YAAEIILGLQFL 134
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H I++RDLK N+LLD + KI+DFG+ + L + NT GT Y++PE
Sbjct: 135 HS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPEI 189
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICG 717
+ ++ D +SFGVL+ E++ G
Sbjct: 190 LLGQKYNHSVDWWSFGVLLYEMLIG 214
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 75.4 bits (186), Expect = 9e-15
Identities = 51/211 (24%), Positives = 88/211 (41%), Gaps = 27/211 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQH 572
D F LG G FG V E A+K L K +++ NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
LVKL + + + ++ EY+ + + F ++ A I
Sbjct: 101 PFLVKLEFSF-KDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF--------YAAQIV 151
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
YLH L +I+RDLK N+L+D +++DFG A+ + + T + GT
Sbjct: 152 LTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPE 203
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICG 717
++PE + ++ D ++ GVL+ E+ G
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 1e-14
Identities = 53/206 (25%), Positives = 89/206 (43%), Gaps = 27/206 (13%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNE--VLLIAKLQHRNLVKL 578
+G G + V L + I A++ + K E+ + E V A H LV L
Sbjct: 60 IGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 118
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
C Q + R+ + EY+ L + + ++ A I+ L YL
Sbjct: 119 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--------SAEISLALNYL 169
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H+ II+RDLK NVLLD+ + K++D+G+ + +T GT Y++PE
Sbjct: 170 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 224
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++ GVL+ E++ G+
Sbjct: 225 LRGEDYGFSVDWWALGVLMFEMMAGR 250
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 61/206 (29%), Positives = 99/206 (48%), Gaps = 27/206 (13%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEFK-----NEVLLIAKLQHRNLVKL 578
LG+G FG V + E ++ AVK L K ++ + +L +A+ H L +L
Sbjct: 31 LGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLAR-NHPFLTQL 89
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
CC Q +R+ + E++ L + I FD R++ A I L++L
Sbjct: 90 F-CCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARF--------YAAEIISALMFL 140
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H II+RDLK NVLLD+ + K++DFG+ + + T GT Y++PE
Sbjct: 141 HD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNGVTTAT--FCGTPDYIAPEI 195
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ L+ D ++ GVL+ E++CG
Sbjct: 196 LQEMLYGPAVDWWAMGVLLYEMLCGH 221
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-14
Identities = 54/206 (26%), Positives = 89/206 (43%), Gaps = 27/206 (13%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNE--VLLIAKLQHRNLVKL 578
+G G + V L + I A+K + K E+ + E V A H LV L
Sbjct: 17 IGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQA-SNHPFLVGL 75
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
C Q + R+ + EY+ L + + ++ A I+ L YL
Sbjct: 76 H-SCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFY--------SAEISLALNYL 126
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H+ II+RDLK NVLLD+ + K++D+G+ + +T GT Y++PE
Sbjct: 127 HE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTST--FCGTPNYIAPEI 181
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++ GVL+ E++ G+
Sbjct: 182 LRGEDYGFSVDWWALGVLMFEMMAGR 207
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 74.6 bits (184), Expect = 2e-14
Identities = 61/206 (29%), Positives = 90/206 (43%), Gaps = 27/206 (13%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNE--VLLIAKLQHRNLVKL 578
LG+G FG V E+ AVK L K ++ E VL + + L +L
Sbjct: 28 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPG-KPPFLTQL 86
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
C Q +R+ + EY+ L Y I F + A IA GL +L
Sbjct: 87 H-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVF--------YAAEIAIGLFFL 137
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
II+RDLK NV+LD+ + KI+DFG+ + D T GT Y++PE
Sbjct: 138 QS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGTPDYIAPEI 192
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ D ++FGVL+ E++ G+
Sbjct: 193 IAYQPYGKSVDWWAFGVLLYEMLAGQ 218
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 2e-14
Identities = 63/214 (29%), Positives = 93/214 (43%), Gaps = 27/214 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKG---SGQGMEEFKNE--VLLIAKL 570
+F+ LG+G FG V E+ AVK L K +E E VL +
Sbjct: 341 TDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALP-G 399
Query: 571 QHRNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAG 624
+ L +L C Q +R+ + EY+ L Y I F + A
Sbjct: 400 KPPFLTQLH-SCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFY--------AAE 450
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
IA GL +L II+RDLK NV+LD+ + KI+DFG+ + D T GT
Sbjct: 451 IAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKT--FCGT 505
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y++PE + D ++FGVL+ E++ G+
Sbjct: 506 PDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 539
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 73.2 bits (180), Expect = 2e-14
Identities = 20/199 (10%), Positives = 57/199 (28%), Gaps = 41/199 (20%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLL 579
G ++ + +++A+ + ++E + L ++++ + ++L
Sbjct: 38 FHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVL 97
Query: 580 GCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLR 639
R +++ E++ SL + + + +A H R
Sbjct: 98 DVVHTRAGGLVVAEWIRGGSLQ----EVADTSP-SPVGAIRAMQSLAAAADAAH---RAG 149
Query: 640 IIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFS 699
+ S V +S G V+ M +
Sbjct: 150 VALSIDHPSRVR--------VSIDGDV--------------VLAYPATMPDA-------N 180
Query: 700 VKSDVFSFGVLVLEIICGK 718
+ D+ G + ++ +
Sbjct: 181 PQDDIRGIGASLYALLVNR 199
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 73.7 bits (182), Expect = 2e-14
Identities = 58/208 (27%), Positives = 96/208 (46%), Gaps = 28/208 (13%)
Query: 525 LGEGGFGPVY---KGMLIEGQEI-AVKRLSKGS----GQGMEEFKNEVLLIAKLQHRNLV 576
LG+GG+G V+ K +I A+K L K + K E ++ +++H +V
Sbjct: 25 LGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIV 84
Query: 577 KLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLL 630
L+ Q ++ LI EYL L + F + +A I+ L
Sbjct: 85 DLI-YAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY--------LAEISMALG 135
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LHQ II+RDLK N++L++ + K++DFGL + D T +T GT YM+P
Sbjct: 136 HLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGTVTHT--FCGTIEYMAP 190
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + + D +S G L+ +++ G
Sbjct: 191 EILMRSGHNRAVDWWSLGALMYDMLTGA 218
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 40/180 (22%), Positives = 65/180 (36%), Gaps = 36/180 (20%)
Query: 505 PIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNE 563
+K A D LG G G V + ++ A+K L + + E
Sbjct: 6 SGLQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARRE 60
Query: 564 V-LLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI----------FDTTRSKL 612
V L Q ++V+++ +YE L I F + +
Sbjct: 61 VELHWRASQCPHIVRIVD----------VYENLYAGRKCLLIVMECLDGGELFSRIQDRG 110
Query: 613 LDW-SKR--SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT---MNPKISDFGLA 666
++R S I+ I + YLH + I HRD+K N+L + K++DFG A
Sbjct: 111 DQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFA 167
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 73.3 bits (181), Expect = 3e-14
Identities = 56/214 (26%), Positives = 95/214 (44%), Gaps = 33/214 (15%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNEVLLIAKLQH 572
+F LG G FG V+ A+K L K +++ +E L+++ + H
Sbjct: 6 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 65
Query: 573 RNLVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIA 626
++++ G Q +++ +I +Y+ L + F +K A +
Sbjct: 66 PFIIRMWGTF-QDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFY--------AAEVC 116
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYG 686
L YLH II+RDLK N+LLD + KI+DFG A+ T + GT
Sbjct: 117 LALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK-----YVPDVTYTLCGTPD 168
Query: 687 YMSPEYAIDGL---FSVKSDVFSFGVLVLEIICG 717
Y++PE + S+ D +SFG+L+ E++ G
Sbjct: 169 YIAPE-VVSTKPYNKSI--DWWSFGILIYEMLAG 199
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 73.4 bits (181), Expect = 5e-14
Identities = 57/209 (27%), Positives = 93/209 (44%), Gaps = 33/209 (15%)
Query: 525 LGEGGFGPVYKGMLIEGQEI-AVKRLSKGSGQGMEEF---KNE--VLLIAKLQHRNLVKL 578
+G+G FG V + AVK L K + +E +E VLL ++H LV L
Sbjct: 46 IGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKN-VKHPFLVGL 104
Query: 579 LGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARGLLYL 632
Q +++ + +Y+ L Y + F R++ A IA L YL
Sbjct: 105 H-FSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFY--------AAEIASALGYL 155
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H L I++RDLK N+LLD+ + ++DFGL + + +T GT Y++PE
Sbjct: 156 HS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTST--FCGTPEYLAPE- 209
Query: 693 AIDGL---FSVKSDVFSFGVLVLEIICGK 718
+ +V D + G ++ E++ G
Sbjct: 210 VLHKQPYDRTV--DWWCLGAVLYEMLYGL 236
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 6e-14
Identities = 39/240 (16%), Positives = 81/240 (33%), Gaps = 63/240 (26%)
Query: 486 MYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEI 544
M+ HS+ + + DN+ K+ +G G +G VY + +
Sbjct: 1 MHHHHHHSSGRENLYFQGIKNVHV------PDNYIIKHLIGRGSYGYVYLAYDKNTEKNV 54
Query: 545 AVKRLSKGSGQGMEEFKN---------EVLLIAKLQHRNLVKLLGCCTQRDERM-----L 590
A+K++++ F++ E+ ++ +L+ +++L D +
Sbjct: 55 AIKKVNR-------MFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYI 107
Query: 591 IYEYLP---------NKSLD-----YFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+ E L +++ + G ++H
Sbjct: 108 VLEIADSDLKKLFKTPIFLTEEHIKTILYN------------------LLLGENFIH--E 147
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
IIHRDLK +N LL+ + K+ DFGLAR+ ++ + +
Sbjct: 148 S-GIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKK 206
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 71.5 bits (174), Expect = 2e-13
Identities = 35/200 (17%), Positives = 63/200 (31%), Gaps = 46/200 (23%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRL--------SKGSGQGMEEFKNEVLL 566
T+ K+GEG FG V++ + + +A+K + + + EE E+++
Sbjct: 18 PTEKLQRCEKIGEGVFGEVFQTIA-DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIII 76
Query: 567 IAKLQ---------HRNLVKLLGCC-------------------TQRDERMLIYEYLPNK 598
+L + L T+ + ++
Sbjct: 77 SKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQ 136
Query: 599 SLDYFIF-------DTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
F + R+KL + I+ + L LR HRDL NVL
Sbjct: 137 LFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEA--SLRFEHRDLHWGNVL 194
Query: 652 LDNTMNPKISDFGLARSFGL 671
L T K+ +S +
Sbjct: 195 LKKTSLKKLHYTLNGKSSTI 214
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 4e-13
Identities = 47/198 (23%), Positives = 84/198 (42%), Gaps = 34/198 (17%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKN------ 562
+I+ N + +F K+ LGEG +G V G+ +A+K++ F
Sbjct: 4 RIVYNISSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEP--------FDKPLFALR 55
Query: 563 ---EVLLIAKLQHRNLVKLLGCCTQRDERM-----LIYEYLPNKSLDYFIFDTTRSKLLD 614
E+ ++ +H N++ + +I E + L I +++L
Sbjct: 56 TLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVI----STQMLS 110
Query: 615 WSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
+ I R + LH + +IHRDLK SN+L+++ + K+ DFGLAR D++
Sbjct: 111 DDHIQYFIYQTLRAVKVLHGSN---VIHRDLKPSNLLINSNCDLKVCDFGLARII--DES 165
Query: 675 EANTKRVVGTYGYMSPEY 692
A+ G M E+
Sbjct: 166 AADNSEPTGQQSGMV-EF 182
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 69.2 bits (170), Expect = 1e-12
Identities = 56/215 (26%), Positives = 95/215 (44%), Gaps = 38/215 (17%)
Query: 525 LGEGGFGPVY---KGMLIEGQEI-AVKRLSKGS----GQGMEEFKNE--VLLIAKLQHRN 574
LG G +G V+ K + ++ A+K L K + + E + E VL + Q
Sbjct: 62 LGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIR-QSPF 120
Query: 575 LVKLLGCCTQRDERM-LIYEYLPNKSLDYFI-----FDTTRSKLLDWSKRSHIIAGIARG 628
LV L Q + ++ LI +Y+ L + F ++ + I
Sbjct: 121 LVTLH-YAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQI--------YVGEIVLA 171
Query: 629 LLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
L +LH+ L II+RD+K N+LLD+ + ++DFGL++ + GT YM
Sbjct: 172 LEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKE-FVADETERAYDFCGTIEYM 227
Query: 689 SPEYAIDGL-----FSVKSDVFSFGVLVLEIICGK 718
+P+ + G +V D +S GVL+ E++ G
Sbjct: 228 APD-IVRGGDSGHDKAV--DWWSLGVLMYELLTGA 259
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 3e-12
Identities = 48/201 (23%), Positives = 95/201 (47%), Gaps = 28/201 (13%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKN------ 562
++ + + KLG+G +G V+K + G+ +AVK++ F+N
Sbjct: 2 RVDRHVLRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-------FQNSTDAQR 54
Query: 563 ---EVLLIAKLQ-HRNLVKLLGCCT--QRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWS 616
E++++ +L H N+V LL + L+++Y+ L I R+ +L+
Sbjct: 55 TFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVI----RANILEPV 109
Query: 617 KRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676
+ +++ + + + YLH S ++HRD+K SN+LL+ + K++DFGL+RSF +
Sbjct: 110 HKQYVVYQLIKVIKYLH--SG-GLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVT 166
Query: 677 NTKRVVGTYGYMSPEYAIDGL 697
N + + + L
Sbjct: 167 NNIPLSINENTENFDDDQPIL 187
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 1e-11
Identities = 56/248 (22%), Positives = 86/248 (34%), Gaps = 65/248 (26%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRL---SKGSGQGMEEFKNEVLLIAKLQHRNLVKLL 579
KLG G F V+ ++ +A+K + + +E +KLL
Sbjct: 26 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDE----------------IKLL 69
Query: 580 GCCTQRDERMLIYEYLPN--KSLDYFIFDTTRSK------------LLDWSKRSH----- 620
D + K LD+F LL K+
Sbjct: 70 QRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIP 129
Query: 621 --IIAGIAR----GLLYLHQDSRLRIIHRDLKASNVLLDNTMNP------KISDFGLARS 668
+ I++ GL Y+H R IIH D+K NVL++ +P KI+D G A
Sbjct: 130 LIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACW 187
Query: 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGK-----KNRG 722
+ T + T Y SPE + G + +D++S L+ E+I G
Sbjct: 188 YDEHYTN-----SIQTREYRSPE-VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGH 241
Query: 723 FNHADHDH 730
D DH
Sbjct: 242 SYTKDDDH 249
|
| >1kj1_A Lectin I, lecgna 1; BULB lectin, mannose, plant protein; HET: MAN; 2.20A {Allium sativum} SCOP: b.78.1.1 PDB: 1bwu_P* 1kj1_D* 1bwu_Q* 1bwu_A* 1bwu_D* Length = 109 | Back alignment and structure |
|---|
Score = 60.6 bits (147), Expect = 2e-11
Identities = 22/128 (17%), Positives = 47/128 (36%), Gaps = 21/128 (16%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ ++ G+ + G++L E + N + Y T W +N
Sbjct: 2 NLLTNGEGLYAGQSLDV--EPYHFIMQEDCNL------VLYDH---STSVWASNTGIL-- 48
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
+ + +G V+ ++ ++W+S+S V L E GN+V+ +
Sbjct: 49 -GKKGCKAVLQSDGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY-------GS 100
Query: 166 ILWQSFDY 173
+W + Y
Sbjct: 101 DIWSTGTY 108
|
| >3a0c_A Mannose/sialic acid-binding lectin; beta-prism II, sugar binding protein; 2.00A {Polygonatum cyrtonema} PDB: 3a0d_A* 3a0e_A* Length = 110 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 6e-11
Identities = 24/126 (19%), Positives = 46/126 (36%), Gaps = 21/126 (16%)
Query: 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPL 104
++++S S+ G +L S+ L N + Y G W +N
Sbjct: 1 VNSLSSPNSLFTGHSL-EVGPSYRLIMQGDCNF------VLYDS---GKPVWASNTGGLG 50
Query: 105 SDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPD 164
S L NG LV+ + +N +W + ++ V L + N+V+
Sbjct: 51 SGCRLTLHNNGN----LVIYDQSNRVIWQTKTNGKEDHYVLVLQQDRNVVIY-------G 99
Query: 165 NILWQS 170
++W +
Sbjct: 100 PVVWAT 105
|
| >1xd5_A Gastrodianin-1, antifungal protein GAFP-1; monocot mannose binding lectin, monomer, homogeneous beta- sheet; 2.00A {Gastrodia elata} SCOP: b.78.1.1 PDB: 1xd6_A Length = 112 | Back alignment and structure |
|---|
Score = 54.2 bits (130), Expect = 3e-09
Identities = 20/130 (15%), Positives = 45/130 (34%), Gaps = 20/130 (15%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
D ++ G + G +L + + N L ++ W + + S
Sbjct: 2 DRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYDN----NRAVWASGTNGKAS 50
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
++ +G LV+ + + +W+SN++ L N+V+ D +N
Sbjct: 51 GCVLKMQNDGN----LVIYSGSR-AIWASNTNRQNGNYYLILQRDRNVVIYDNS----NN 101
Query: 166 ILWQSFDYPC 175
+W +
Sbjct: 102 AIWATHTNVG 111
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 5e-09
Identities = 44/183 (24%), Positives = 73/183 (39%), Gaps = 32/183 (17%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH-RNLVKLLGC 581
K+G G FG +Y G I G+E+A+K + E + +Q + + C
Sbjct: 16 KIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHPQ--LHIESKIYKMMQGGVGIPTIRWC 73
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---HIIAGIARGLL----YLHQ 634
+ D +++ E L SL+ L ++ R + +A ++ Y+H
Sbjct: 74 GAEGDYNVMVMELL-GPSLED---------LFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPK---ISDFGLARSFGLDQTEA-----NTKRVVGTYG 686
+ IHRD+K N L+ I DFGLA+ + +T K + GT
Sbjct: 124 KN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTAR 180
Query: 687 YMS 689
Y S
Sbjct: 181 YAS 183
|
| >2dpf_A Curculin; sweet taste, taste modifying, plant protein; 1.50A {Curculigo latifolia} PDB: 2d04_B* 2d04_A* Length = 115 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 7e-09
Identities = 25/125 (20%), Positives = 44/125 (35%), Gaps = 22/125 (17%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ + GQ++ +L + ++ L + N + Y+ G W +N D S
Sbjct: 3 NVLLSGQTLHADHSLQAG--AYTLTIQNKCNL------VKYQN---GRQIWASNTDRRGS 51
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
L +G LV+ + N+ VW S K L + G V+
Sbjct: 52 GCRLTLLSDGN----LVIYDHNNNDVWGSACWGDNGKYALVLQKDGRFVIY-------GP 100
Query: 166 ILWQS 170
+LW
Sbjct: 101 VLWSL 105
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 7e-09
Identities = 38/201 (18%), Positives = 71/201 (35%), Gaps = 48/201 (23%)
Query: 524 KLGEGGFGPVYKGMLIEGQEI------AVKRLSKGSGQGMEEFK-----NEVLLIAKLQH 572
+G+GGFG +Y + + + VK +G E K + I K
Sbjct: 42 PIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIR 101
Query: 573 RNLVKLLG----------CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS--- 619
+K LG + R +I + L K+ + + +
Sbjct: 102 TRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQ---------KIYEANAKRFSR 151
Query: 620 HIIAGIARGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPKI--SDFGLARSFGLDQ 673
+ ++ +L Y+H+ +H D+KASN+LL+ ++ D+GLA + +
Sbjct: 152 KTVLQLSLRILDILEYIHEHE---YVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEG 208
Query: 674 T-----EANTKRVVGTYGYMS 689
+ GT + S
Sbjct: 209 VHKAYAADPKRCHDGTIEFTS 229
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 1e-08
Identities = 43/197 (21%), Positives = 71/197 (36%), Gaps = 35/197 (17%)
Query: 511 IIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAK 569
++ NF K+G G FG + G L + +A+K S +
Sbjct: 6 MVGP---NFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRAPQLHLEYRFYKQLG 62
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---HIIAGIA 626
+ ++ ++ E L SL+ L D R+ + IA
Sbjct: 63 -SGDGIPQVYYFGPCGKYNAMVLELL-GPSLED---------LFDLCDRTFSLKTVLMIA 111
Query: 627 RGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPK-----ISDFGLARSFGLDQTEA- 676
L+ Y+H + +I+RD+K N L+ N I DF LA+ + +T+
Sbjct: 112 IQLISRMEYVHSKN---LIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKH 168
Query: 677 ----NTKRVVGTYGYMS 689
K + GT YMS
Sbjct: 169 IPYREHKSLTGTARYMS 185
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 2e-08
Identities = 36/199 (18%), Positives = 67/199 (33%), Gaps = 42/199 (21%)
Query: 523 NKLGEGGFGPVYKGM---------LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHR 573
+ G +Y+ + Q+ ++K L G+ E LQ
Sbjct: 48 SFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLK-LDAKDGRLFNEQNFFQRAAKPLQVN 106
Query: 574 NLVKLLGC------------CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHI 621
KL Q R L+ L +SL D + +L S+RS
Sbjct: 107 KWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQS-ALDVSPKHVL--SERS-- 160
Query: 622 IAGIARGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPKI--SDFGLARSFGLDQT- 674
+ +A LL +LH++ +H ++ A N+ +D ++ + +G A +
Sbjct: 161 VLQVACRLLDALEFLHENE---YVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKH 217
Query: 675 ----EANTKRVVGTYGYMS 689
E + G ++S
Sbjct: 218 VAYVEGSRSPHEGDLEFIS 236
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 41/183 (22%), Positives = 71/183 (38%), Gaps = 32/183 (17%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGC 581
K+G G FG +Y G + +E+A+K + + E + LQ + +
Sbjct: 14 KIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHPQ--LLYESKIYRILQGGTGIPNVRWF 71
Query: 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---HIIAGIARGLL----YLHQ 634
+ D +L+ + L SL+ L ++ R + +A ++ ++H
Sbjct: 72 GVEGDYNVLVMDLL-GPSLED---------LFNFCSRKLSLKTVLMLADQMINRVEFVHS 121
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPK---ISDFGLARSFGLDQTEA-----NTKRVVGTYG 686
S +HRD+K N L+ I DFGLA+ + T K + GT
Sbjct: 122 KS---FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTAR 178
Query: 687 YMS 689
Y S
Sbjct: 179 YAS 181
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 4e-08
Identities = 39/198 (19%), Positives = 79/198 (39%), Gaps = 35/198 (17%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIA 568
++ ++ ++GEG FG +++G L+ Q++A+K + S + +
Sbjct: 6 NVVGV---HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDAPQLRDEYRTYKLL 62
Query: 569 KLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRS---HIIAGI 625
+ + + +L+ + L SL+ LLD R +A
Sbjct: 63 A-GCTGIPNVYYFGQEGLHNVLVIDLLG-PSLED---------LLDLCGRKFSVKTVAMA 111
Query: 626 ARGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPK-----ISDFGLARSFGLDQTEA 676
A+ +L +H+ S +++RD+K N L+ + + DFG+ + + T+
Sbjct: 112 AKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQ 168
Query: 677 -----NTKRVVGTYGYMS 689
K + GT YMS
Sbjct: 169 HIPYREKKNLSGTARYMS 186
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 7e-08
Identities = 42/198 (21%), Positives = 73/198 (36%), Gaps = 45/198 (22%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIA---VKRLSKGSGQGMEEFK-----NEVLLIAKLQHRN 574
K+G GGFG +Y + ++ A VK + +G E K + I K R
Sbjct: 44 KIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK 103
Query: 575 LVKLLG----------CCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR--SHII 622
+ LG R R ++ E L L K+ + +
Sbjct: 104 QLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQ---------KISGQNGTFKKSTV 153
Query: 623 AGIARGLL----YLHQDSRLRIIHRDLKASNVLLDNTMNPKI--SDFGLARSFGLDQT-- 674
+ +L Y+H++ +H D+KA+N+LL ++ +D+GL+ + +
Sbjct: 154 LQLGIRMLDVLEYIHENE---YVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHK 210
Query: 675 ---EANTKRVVGTYGYMS 689
E K GT + S
Sbjct: 211 QYQENPRKGHNGTIEFTS 228
|
| >3dzw_A Agglutinin; lectin, mannobiose, mannose-alpha1, 3-mannose, D sugar binding protein; HET: MAN; 1.70A {Narcissus pseudonarcissus} PDB: 1npl_A* 1jpc_A* 1msa_A* 1niv_A* Length = 109 | Back alignment and structure |
|---|
Score = 49.5 bits (118), Expect = 1e-07
Identities = 20/125 (16%), Positives = 41/125 (32%), Gaps = 22/125 (17%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ + G+++ GE L + + N + Y W N
Sbjct: 2 NILYSGETLSPGEFLNN--GRYVFIMQEDCNL------VLYDV---DKPIWATNTGGLDR 50
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
++ +G LV+ + N+ +W+SN+ V L + N+V+
Sbjct: 51 RCHLSMQSDGN----LVVYSPRNNPIWASNTGGENGNYVCVLQKDRNVVIY-------GT 99
Query: 166 ILWQS 170
W +
Sbjct: 100 ARWAT 104
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 53.4 bits (128), Expect = 2e-07
Identities = 61/294 (20%), Positives = 93/294 (31%), Gaps = 104/294 (35%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
KLG G F V+ + + +A+K + K + E +E+ +LL
Sbjct: 44 KLGWGHFSTVWLSWDIQGKKFVAMK-VVKSAEHYTETALDEI------------RLLKSV 90
Query: 583 TQRDERMLIYEYLPNKSLDYF------------IFDTTRSKLLDWSKRS----------- 619
D E + + LD F +F+ LL W +S
Sbjct: 91 RNSDPNDPNREMVV-QLLDDFKISGVNGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVK 149
Query: 620 HIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL--------------------------- 652
II + +GL YLH ++ RIIH D+K N+LL
Sbjct: 150 KIIQQVLQGLDYLH--TKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSG 207
Query: 653 ----------------------DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+ KI+D G A TE + T Y S
Sbjct: 208 SAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTE-----DIQTRQYRSL 262
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK-----KNRGFNHADHDH-----NLLG 734
E I ++ +D++S + E+ G + D DH LLG
Sbjct: 263 EVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLG 316
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 52.4 bits (126), Expect = 3e-07
Identities = 54/252 (21%), Positives = 98/252 (38%), Gaps = 45/252 (17%)
Query: 488 RRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGM-LIEGQEIAV 546
+ +K N G + + + + + + + + + +G+G FG V K +E + +A+
Sbjct: 28 KERKVYNDGYDDDNYDYIVKNGEKWMD---RYEIDSLIGKGSFGQVVKAYDRVEQEWVAI 84
Query: 547 K---RLSKGSGQGMEEFKNEVLLIAKLQHR------NLVKLLGCCTQRD------ERMLI 591
K Q EV L+ + +V L R+ E +
Sbjct: 85 KIIKNKKAFLNQAQ----IEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLSY 140
Query: 592 --YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASN 649
Y+ L N + + TR + LL+L L IIH DLK N
Sbjct: 141 NLYDLLRNTNFRGVSLNLTR----------KFAQQMCTALLFLA-TPELSIIHCDLKPEN 189
Query: 650 VLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFS 706
+LL N KI DFG + + + + + Y SPE + G+ + + D++S
Sbjct: 190 ILLCNPKRSAIKIVDFGSS----CQLGQRIYQYIQSRF-YRSPE-VLLGMPYDLAIDMWS 243
Query: 707 FGVLVLEIICGK 718
G +++E+ G+
Sbjct: 244 LGCILVEMHTGE 255
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-07
Identities = 52/218 (23%), Positives = 86/218 (39%), Gaps = 50/218 (22%)
Query: 525 LGEGGFGPVYKGM-LIEGQEIAVKRL---SKGSGQGMEEFKNEVLLIAKLQHR------N 574
+G+G FG V K Q +A+K + + Q EE + ++ L+ + N
Sbjct: 105 IGKGSFGQVVKAYDHKVHQHVALKMVRNEKRFHRQAAEEIR----ILEHLRKQDKDNTMN 160
Query: 575 LVKLLGCCTQRD------ERMLI--YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
++ +L T R+ E + + YE + F R I
Sbjct: 161 VIHMLENFTFRNHICMTFELLSMNLYELIKKNKFQGFSLPLVR----------KFAHSIL 210
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGT 684
+ L LH + RIIH DLK N+LL K+ DFG + + Q V T
Sbjct: 211 QCLDALH---KNRIIHCDLKPENILLKQQGRSGIKVIDFGSS-CY-EHQR-------VYT 258
Query: 685 Y----GYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y Y +PE + + + D++S G ++ E++ G
Sbjct: 259 YIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGY 296
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 2e-06
Identities = 45/324 (13%), Positives = 96/324 (29%), Gaps = 66/324 (20%)
Query: 426 FHDLIDIKELPESGQDLFIRMAASELDNVERRRQSKNKKQVMIIITSISLATAV-IFIGG 484
F D D K++ + + + + E+D++ + + + + V F+
Sbjct: 29 FVDNFDCKDVQDMPKSIL---SKEEIDHIIMSKDAVSGTLRLFWTLLSKQEEMVQKFVEE 85
Query: 485 --------LMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKG 536
LM K Q + I + N F++ N V +
Sbjct: 86 VLRINYKFLMSPIKTEQRQ--PSMMTRMYIEQRDRLYNDNQVFAKYN---------VSRL 134
Query: 537 MLIEGQEIAVKRLSKGSG---QGMEEF-K----NEVLLIAKLQHRNLVKL----LGCCTQ 584
A+ L G+ K +V L K+Q + K+ L C
Sbjct: 135 QPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALDVCLSYKVQCKMDFKIFWLNLKNCNS 194
Query: 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRD 644
+ + + + L + D +W+ RS + I + + + R + +
Sbjct: 195 PETVLEMLQKL------LYQIDP------NWTSRSDHSSNIKLRIHSIQAELRRLLKSKP 242
Query: 645 LKASNVLLDNTMNPKISDFGLARSFGL---------DQTEANTKRVVGTYGYMSPEYAID 695
+ ++L N N K +F L + + T ++S ++
Sbjct: 243 YENCLLVLLNVQNAKA-----WNAFNLSCKILLTTRFKQVTD-FLSAATTTHISLDHHSM 296
Query: 696 GLFSVKS-DVFSFGVLVLEIICGK 718
L + + L+
Sbjct: 297 TLTPDEVKSLLL---KYLDCRPQD 317
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 41.8 bits (97), Expect = 8e-04
Identities = 64/386 (16%), Positives = 115/386 (29%), Gaps = 116/386 (30%)
Query: 95 TWVAN---RDAPLSDR--SGVLRIN-GERNG------ILVLLNSTNDTVWSSNSSISAQK 142
TWVA + + + +N N +L L D W+S S S+
Sbjct: 164 TWVALDVCLSYKVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNI 223
Query: 143 PVAA---------LMESGN-----LVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188
+ L++S LV+ + ++ W +F+ C LL
Sbjct: 224 KLRIHSIQAELRRLLKSKPYENCLLVLLNVQNAK----AWNAFNLSCKILL------TTR 273
Query: 189 GTGLNRFLSSWKSTD---DPARGDFT-----------YGLDPRGIPQLVLRKN----SII 230
+ FLS+ +T D T P+ +P+ VL N SII
Sbjct: 274 FKQVTDFLSAATTTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSII 333
Query: 231 --TFRAGSWNGLHWTGVPQLQLNPVYTFEYVS------NEKEAFYTYNLS--NSSVPSRM 280
+ R G W + + + T S E + LS S
Sbjct: 334 AESIRDGL---ATWDNWKHVNCDKLTTIIESSLNVLEPAEYRKMF-DRLSVFPPSAH--- 386
Query: 281 VINPAGTVQRYTWMERTKT-----WTLFSRFSGVTLDQCDS-YALCGAY----ASCN--- 327
I P + W + K+ ++S V +S ++ Y
Sbjct: 387 -I-PTILLSLI-WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSIYLELKVKLENEY 443
Query: 328 ------INS-NSPECECLQGFVPNSQREWDMQYKSGGCVRRTPL-----DCKHGDGFLEH 375
++ N P+ +P ++ + + + +H +
Sbjct: 444 ALHRSIVDHYNIPKTFDSDDLIPPYLDQYFYSH----------IGHHLKNIEHPERMTLF 493
Query: 376 KAVKLPDTRFSWVDKNI----TLWEC 397
+ V L D F ++++ I T W
Sbjct: 494 RMVFL-D--FRFLEQKIRHDSTAWNA 516
|
| >3r0e_A Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 109 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 6e-06
Identities = 28/136 (20%), Positives = 43/136 (31%), Gaps = 30/136 (22%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ + GQ++ L + F+L N Y G W + T RD
Sbjct: 4 NYLLSGQTLDTEGHLKN--GDFDLVMQDDCNL-VLYNGNWQ------SNTANNGRDC--- 51
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
L + G LV+ N TVW S + A + G LVV
Sbjct: 52 ----KLTLTD--YGELVIKNGDGSTVWKSGAQSVKGNYAAVVHPDGRLVVF-------GP 98
Query: 166 ILWQSFDYPCDTLLPG 181
+++ D + G
Sbjct: 99 SVFKI-----DPWVRG 109
|
| >3r0e_B Lectin; carbohydrate binding, carbohydrate, sugar binding protein; 2.40A {Remusatia vivipara} Length = 110 | Back alignment and structure |
|---|
Score = 43.7 bits (103), Expect = 1e-05
Identities = 24/116 (20%), Positives = 43/116 (37%), Gaps = 16/116 (13%)
Query: 40 SAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVAN 99
+ T + + GQ + L + ++ +L N L ++ K + T
Sbjct: 1 NIPFTNNLLFSGQVLYGDGRLTA--KNHQLVMQGDCN-----LVLYGGKYGWQSNTHGNG 53
Query: 100 RDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVV 155
LR+N G L++ + T+WSS SS + V L + G V+
Sbjct: 54 EHC-------FLRLNH--KGELIIKDDDFKTIWSSRSSSKQGEYVLILQDDGFGVI 100
|
| >1b2p_A Protein (lectin); mannose-binding lectin, monocot, aglutinin, bluebell bulbs, carbohydrate interactions, sugar binding protein; 1.70A {Hyacinthoides hispanica} SCOP: b.78.1.1 Length = 119 | Back alignment and structure |
|---|
Score = 43.4 bits (102), Expect = 2e-05
Identities = 23/138 (16%), Positives = 44/138 (31%), Gaps = 24/138 (17%)
Query: 33 SFLFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEG 92
+ +F + +S+ ++ + + N + Y
Sbjct: 2 NIIFSKQPDDNHPQILHATESL----EILFGTHVYRFIMQTDCNL------VLYDN---N 48
Query: 93 TVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGN 152
W N + VL+ +G LV++ + N TVW S + A V L N
Sbjct: 49 NPIWATNTGGLGNGCRAVLQPDGV----LVVITNENVTVWQSPVAGKAGHYVLVLQPDRN 104
Query: 153 LVVKDGKDNNPDNILWQS 170
+V+ + LW +
Sbjct: 105 VVIY-------GDALWAT 115
|
| >3m7h_A Putidacin L1; monocot mannose-binding lectin, bacteriocin, LLPA, pseudomon bacterial toxin, siras, antimicrobial protein; 2.20A {Pseudomonas SP} PDB: 3m7j_A* Length = 276 | Back alignment and structure |
|---|
Score = 43.9 bits (102), Expect = 1e-04
Identities = 29/168 (17%), Positives = 53/168 (31%), Gaps = 14/168 (8%)
Query: 40 SAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVAN 99
+ Q++ G+ L+S + F+L GN L I
Sbjct: 9 FNGVGTSVLPAYQTLSAGQYLLSPNQRFKLLLQGDGN-----LVIQDNGATVWVANEQQP 63
Query: 100 RDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSS-----NSSISAQKPVAALMESGNLV 154
+ + R+ + L + + VW + S+ + L + GN+V
Sbjct: 64 FSSTIPLRNKKAPLAFYVQYGAFLDDYSRRRVWLTDNSTFTSNDQWNRTHLVLQDDGNIV 123
Query: 155 VKDGKD--NNPDNILWQSFDYPCDTLLPGMKL--GINLGTGLNRFLSS 198
+ D N I L PG +L G+ G G ++ +
Sbjct: 124 LVDSLALWNGTPAIPLVPGAIDSLLLAPGSELVQGVVYGAGASKLVFQ 171
|
| >3mez_B Mannose-specific lectin 3 chain 2; heterotetramer, sugar binding protein; 1.94A {Crocus vernus} Length = 113 | Back alignment and structure |
|---|
Score = 40.6 bits (95), Expect = 2e-04
Identities = 21/113 (18%), Positives = 38/113 (33%), Gaps = 13/113 (11%)
Query: 43 RTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDA 102
R + + Q + D L + + L N + K ++ + W +
Sbjct: 4 RVRNVLFSSQVMYDNAQLAT--RDYSLVMRDDCNL------VLTKG-SKTNIVWESGTSG 54
Query: 103 PLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVV 155
L +GE L + + +TV+ SN+ V L +G VV
Sbjct: 55 RGQHCFMRLGHSGE----LDITDDRLNTVFVSNTVGQEGDYVLILQINGQAVV 103
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 6e-04
Identities = 57/276 (20%), Positives = 95/276 (34%), Gaps = 63/276 (22%)
Query: 486 MYRRKKHSNQ-GNEKEEMELPIFDLKIIANATDNFSEK----NKLGEGGFGPVYKGM-LI 539
M+ HS+ N + + I + K+G+G FG V +
Sbjct: 1 MHHHHHHSSGRENLYFQGDDEIVHFSWKKG--MLLNNAFLVIRKMGDGTFGRVLLCQHID 58
Query: 540 EGQEIAVK---RLSKGSGQGMEEFKNEVLLIAKLQHR-----NLVKLLGCCTQRD----- 586
+ AVK + K + E ++ K+Q+ N+VK G D
Sbjct: 59 NKKYYAVKVVRNIKKYTRSAKIEAD----ILKKIQNDDINNNNIVKYHGKFMYYDHMCLI 114
Query: 587 -ERMLI--YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHR 643
E + YE + + + F + + I + L YL ++ + H
Sbjct: 115 FEPLGPSLYEIITRNNYNGFHIEDIK----------LYCIEILKALNYLR---KMSLTHT 161
Query: 644 DLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR--------------------VVG 683
DLK N+LLD+ K + G TK ++
Sbjct: 162 DLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIIN 221
Query: 684 TYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGK 718
T Y +PE I L + V SD++SFG ++ E+ G
Sbjct: 222 TRQYRAPE-VILNLGWDVSSDMWSFGCVLAELYTGS 256
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 738 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-63 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-63 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 4e-59 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-57 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-56 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 6e-56 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-56 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-55 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 2e-55 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-55 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 9e-54 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-53 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-53 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-53 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 3e-53 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 4e-53 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 7e-53 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 9e-53 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-52 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 4e-51 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-51 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 6e-51 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-50 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 4e-50 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 6e-49 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 7e-49 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 6e-48 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-48 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-47 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 7e-46 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-45 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-44 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-44 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 5e-44 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-43 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 1e-43 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-43 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-43 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 1e-42 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 3e-41 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-41 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-41 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-40 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 7e-40 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-39 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 1e-38 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 3e-38 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-38 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-37 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 2e-37 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-36 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-36 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-35 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-34 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-32 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-32 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-31 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-31 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-27 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 9e-24 | |
| d1kj1a_ | 109 | b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium | 1e-18 | |
| d1jpca_ | 108 | b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galan | 5e-14 | |
| d1dlpa2 | 120 | b.78.1.1 (A:116-235) Fetuin-binding protein Scafet | 9e-14 | |
| d1xd5a_ | 112 | b.78.1.1 (A:) Gastrodianin (antifungal protein) {G | 4e-13 | |
| d1b2pa_ | 119 | b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scill | 4e-10 | |
| d1dlpa1 | 115 | b.78.1.1 (A:1-115) Fetuin-binding protein Scafet p | 2e-08 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 2e-63
Identities = 57/206 (27%), Positives = 103/206 (50%), Gaps = 9/206 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+ ++G G FG VYKG + + ++ + Q ++ FKNEV ++ K +H N++
Sbjct: 8 GQITVGQRIGSGSFGTVYKGKWHGDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNIL 67
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+G T + ++ ++ SL + + + K I A+G+ YLH S
Sbjct: 68 LFMGYSTA-PQLAIVTQWCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS 124
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA--- 693
IIHRDLK++N+ L + KI DFGLA +++ G+ +M+PE
Sbjct: 125 ---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQ 181
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGKK 719
+S +SDV++FG+++ E++ G+
Sbjct: 182 DKNPYSFQSDVYAFGIVLYELMTGQL 207
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 210 bits (536), Expect = 9e-63
Identities = 51/206 (24%), Positives = 97/206 (47%), Gaps = 11/206 (5%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQH 572
D+F + ++LG G G V+K G +A K + + + E+ ++ +
Sbjct: 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNS 63
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
+V G E + E++ SLD + ++ + + + +GL YL
Sbjct: 64 PYIVGFYGAFYSDGEISICMEHMDGGSLDQVLK---KAGRIPEQILGKVSIAVIKGLTYL 120
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
+ +I+HRD+K SN+L+++ K+ DFG++ ++ VGT YMSPE
Sbjct: 121 R--EKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQL----IDSMANSFVGTRSYMSPER 174
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+SV+SD++S G+ ++E+ G+
Sbjct: 175 LQGTHYSVQSDIWSMGLSLVEMAVGR 200
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 4e-59
Identities = 75/221 (33%), Positives = 121/221 (54%), Gaps = 17/221 (7%)
Query: 499 KEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGME 558
++E E+P LK++ +LG G FG V+ G ++AVK L +GS +
Sbjct: 5 EDEWEVPRETLKLV----------ERLGAGQFGEVWMGYYNGHTKVAVKSLKQGS-MSPD 53
Query: 559 EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKR 618
F E L+ +LQH+ LV+L TQ + +I EY+ N SL F+ + KL +K
Sbjct: 54 AFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKL-TINKL 111
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
+ A IA G+ ++ + + IHRDL+A+N+L+ +T++ KI+DFGLAR ++ A
Sbjct: 112 LDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYTARE 168
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
+ +PE G F++KSDV+SFG+L+ EI+ +
Sbjct: 169 -GAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 195 bits (497), Expect = 1e-57
Identities = 57/211 (27%), Positives = 101/211 (47%), Gaps = 13/211 (6%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH 572
N D + +LG+G FG VYK E A K + S + +E++ E+ ++A H
Sbjct: 9 NPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDH 68
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
N+VKLL + ++ E+ ++D + + + L S+ + L YL
Sbjct: 69 PNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLE--LERPLTESQIQVVCKQTLDALNYL 126
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H +IIHRDLKA N+L + K++DFG++ ++ +GT +M+PE
Sbjct: 127 HD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQRRDS--FIGTPYWMAPEV 181
Query: 693 AI-----DGLFSVKSDVFSFGVLVLEIICGK 718
+ D + K+DV+S G+ ++E+ +
Sbjct: 182 VMCETSKDRPYDYKADVWSLGITLIEMAEIE 212
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 1e-56
Identities = 59/203 (29%), Positives = 99/203 (48%), Gaps = 7/203 (3%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+ ++G G FG V+ G + ++A+K + +G+ E+F E ++ KL H LV
Sbjct: 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGA-MSEEDFIEEAEVMMKLSHPKLV 63
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+L G C ++ L++E++ + L ++ + L + + G+ YL +
Sbjct: 64 QLYGVCLEQAPICLVFEFMEHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEE-- 119
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
+IHRDL A N L+ K+SDFG+ R F LD ++ + SPE
Sbjct: 120 -ACVIHRDLAARNCLVGENQVIKVSDFGMTR-FVLDDQYTSSTGTKFPVKWASPEVFSFS 177
Query: 697 LFSVKSDVFSFGVLVLEIICGKK 719
+S KSDV+SFGVL+ E+ K
Sbjct: 178 RYSSKSDVWSFGVLMWEVFSEGK 200
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 191 bits (487), Expect = 6e-56
Identities = 61/210 (29%), Positives = 96/210 (45%), Gaps = 19/210 (9%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG---MEEFKNEVLLIAKLQ 571
FS+ ++G G FG VY + + +A+K++S Q ++ EV + KL+
Sbjct: 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLR 73
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H N ++ GC + L+ EY + D K L + + + G +GL Y
Sbjct: 74 HPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEV---HKKPLQEVEIAAVTHGALQGLAY 130
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH +IHRD+KA N+LL K+ DFG A A VGT +M+PE
Sbjct: 131 LHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIM------APANSFVGTPYWMAPE 181
Query: 692 YAI---DGLFSVKSDVFSFGVLVLEIICGK 718
+ +G + K DV+S G+ +E+ K
Sbjct: 182 VILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (483), Expect = 6e-56
Identities = 58/205 (28%), Positives = 92/205 (44%), Gaps = 9/205 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQHRN 574
+++ LGEG +G V + + +AVK + E K E+ + L H N
Sbjct: 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHEN 64
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VK G + + + L EY L I + + G++YLH
Sbjct: 65 VVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIG---MPEPDAQRFFHQLMAGVVYLHG 121
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
+ I HRD+K N+LLD N KISDFGLA F + E ++ GT Y++PE
Sbjct: 122 ---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLK 178
Query: 695 DGLF-SVKSDVFSFGVLVLEIICGK 718
F + DV+S G+++ ++ G+
Sbjct: 179 RREFHAEPVDVWSCGIVLTAMLAGE 203
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 8e-56
Identities = 69/229 (30%), Positives = 115/229 (50%), Gaps = 17/229 (7%)
Query: 491 KHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLS 550
K QG K+ E+P L++ KLG+G FG V+ G +A+K L
Sbjct: 1 KPQTQGLAKDAWEIPRESLRLE----------VKLGQGCFGEVWMGTWNGTTRVAIKTLK 50
Query: 551 KGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRS 610
G+ E F E ++ KL+H LV+L ++ + ++ EY+ SL F+
Sbjct: 51 PGT-MSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGE-TG 107
Query: 611 KLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670
K L + + A IA G+ Y+ + + +HRDL+A+N+L+ + K++DFGLAR
Sbjct: 108 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIE 164
Query: 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
++ A + +PE A+ G F++KSDV+SFG+L+ E+ +
Sbjct: 165 DNEYTARQ-GAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 212
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (482), Expect = 1e-55
Identities = 62/210 (29%), Positives = 94/210 (44%), Gaps = 10/210 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHR 573
+++ +G G +G K G+ + K L GS + +EV L+ +L+H
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHP 63
Query: 574 NLVKLLGCCTQRDERML--IYEYLPNKSLDYFIFDTTRSK-LLDWSKRSHIIAGIARGLL 630
N+V+ R L + EY L I T+ + LD ++ + L
Sbjct: 64 NIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALK 123
Query: 631 YLHQ--DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
H+ D ++HRDLK +NV LD N K+ DFGLAR D + A VGT YM
Sbjct: 124 ECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKA--FVGTPYYM 181
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
SPE ++ KSD++S G L+ E+
Sbjct: 182 SPEQMNRMSYNEKSDIWSLGCLLYELCALM 211
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 188 bits (478), Expect = 2e-55
Identities = 58/203 (28%), Positives = 96/203 (47%), Gaps = 7/203 (3%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+ + +LG G FG V G ++A+K + +GS +EF E ++ L H LV
Sbjct: 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGS-MSEDEFIEEAKVMMNLSHEKLV 62
Query: 577 KLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS 636
+L G CT++ +I EY+ N L ++ + + + + + YL
Sbjct: 63 QLYGVCTKQRPIFIITEYMANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESK- 119
Query: 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDG 696
+ +HRDL A N L+++ K+SDFGL+R D ++ + PE +
Sbjct: 120 --QFLHRDLAARNCLVNDQGVVKVSDFGLSRYVL-DDEYTSSVGSKFPVRWSPPEVLMYS 176
Query: 697 LFSVKSDVFSFGVLVLEIICGKK 719
FS KSD+++FGVL+ EI K
Sbjct: 177 KFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (480), Expect = 4e-55
Identities = 57/208 (27%), Positives = 109/208 (52%), Gaps = 10/208 (4%)
Query: 512 IANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKL 570
+ + ++ K+G+G G VY M + GQE+A+++++ E NE+L++ +
Sbjct: 15 VGDPKKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMREN 74
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
++ N+V L DE ++ EYL SL + +T D + + + + L
Sbjct: 75 KNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCM----DEGQIAAVCRECLQALE 130
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSP 690
+LH ++IHRD+K+ N+LL + K++DFG +Q++ +T +VGT +M+P
Sbjct: 131 FLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRST--MVGTPYWMAP 185
Query: 691 EYAIDGLFSVKSDVFSFGVLVLEIICGK 718
E + K D++S G++ +E+I G+
Sbjct: 186 EVVTRKAYGPKVDIWSLGIMAIEMIEGE 213
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 9e-54
Identities = 61/211 (28%), Positives = 105/211 (49%), Gaps = 12/211 (5%)
Query: 515 ATDNFS-EKNKLGEGGFGPVYKGMLI---EGQEIAVKRLSKGSGQG-MEEFKNEVLLIAK 569
DN +LG G FG V +G+ + ++A+K L +G+ + EE E ++ +
Sbjct: 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQ 65
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
L + +V+L+G C Q + ML+ E L F+ + + + S + ++ ++ G+
Sbjct: 66 LDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGM 122
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR-VVGTYGYM 688
YL + +HRDL A NVLL N KISDFGL+++ G D + + +
Sbjct: 123 KYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
+PE FS +SDV+S+GV + E + +
Sbjct: 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 184 bits (468), Expect = 1e-53
Identities = 63/204 (30%), Positives = 107/204 (52%), Gaps = 7/204 (3%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+ + K+KLG G +G VY+G+ + +AVK L + + + +EEF E ++ +++H NL
Sbjct: 17 TDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTME-VEEFLKEAAVMKEIKHPNL 75
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V+LLG CT+ +I E++ +L ++ + R + + ++ I+ + YL
Sbjct: 76 VQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQE-VSAVVLLYMATQISSAMEYLE-- 132
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
+ IHRDL A N L+ K++DFGL+R D A+ + +PE
Sbjct: 133 -KKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPESLAY 190
Query: 696 GLFSVKSDVFSFGVLVLEIICGKK 719
FS+KSDV++FGVL+ EI
Sbjct: 191 NKFSIKSDVWAFGVLLWEIATYGM 214
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 184 bits (468), Expect = 2e-53
Identities = 60/230 (26%), Positives = 108/230 (46%), Gaps = 22/230 (9%)
Query: 507 FDLKIIANATDNFSEK---------NKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG- 552
F + A F+++ +G G FG V G L +A+K L G
Sbjct: 7 FTFEDPNEAVREFAKEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGY 66
Query: 553 SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL 612
+ + +F +E ++ + H N++ L G T+ M+I E++ N SLD F+
Sbjct: 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQ--NDGQ 124
Query: 613 LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672
+ ++ GIA G+ YL + +HRDL A N+L+++ + K+SDFGL+R D
Sbjct: 125 FTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDD 181
Query: 673 QTEANTKRVVG---TYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
++ +G + +PE F+ SDV+S+G+++ E++ +
Sbjct: 182 TSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (465), Expect = 2e-53
Identities = 58/206 (28%), Positives = 93/206 (45%), Gaps = 14/206 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
++F LG+G FG VY + +A+K L K + + EV + + L+H
Sbjct: 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRH 65
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
N+++L G LI EY P ++ + ++ D + + I +A L Y
Sbjct: 66 PNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSK---FDEQRTATYITELANALSYC 122
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H R+IHRD+K N+LL + KI+DFG + + + GT Y+ PE
Sbjct: 123 HS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEM 175
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ K D++S GVL E + GK
Sbjct: 176 IEGRMHDEKVDLWSLGVLCYEFLVGK 201
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (464), Expect = 3e-53
Identities = 58/223 (26%), Positives = 99/223 (44%), Gaps = 19/223 (8%)
Query: 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKL 578
++G G F VYKG+ E E+A L + + FK E ++ LQH N+V+
Sbjct: 14 DIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRF 73
Query: 579 LGCC----TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+ +L+ E + + +L ++ R K++ I +GL +LH
Sbjct: 74 YDSWESTVKGKKCIVLVTELMTSGTLKTYLK---RFKVMKIKVLRSWCRQILKGLQFLHT 130
Query: 635 DSRLRIIHRDLKASNVLL-DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
+ IIHRDLK N+ + T + KI D GLA K V+GT +M+PE
Sbjct: 131 RTP-PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGTPEFMAPEM- 184
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
+ + DV++FG+ +LE+ + ++ + + V
Sbjct: 185 YEEKYDESVDVYAFGMCMLEMATSE--YPYSECQNAAQIYRRV 225
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 4e-53
Identities = 57/204 (27%), Positives = 90/204 (44%), Gaps = 13/204 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV 576
+G+G FG V G G ++AVK + + + F E ++ +L+H NLV
Sbjct: 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDATA--QAFLAEASVMTQLRHSNLV 63
Query: 577 KLLGCCTQRDERM-LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
+LLG + + ++ EY+ SL ++ R +L + + YL
Sbjct: 64 QLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGR-SVLGGDCLLKFSLDVCEAMEYLE-- 120
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID 695
+HRDL A NVL+ K+SDFGL + Q + +PE +
Sbjct: 121 -GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD-----TGKLPVKWTAPEALRE 174
Query: 696 GLFSVKSDVFSFGVLVLEIICGKK 719
FS KSDV+SFG+L+ EI +
Sbjct: 175 KKFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 183 bits (464), Expect = 7e-53
Identities = 52/226 (23%), Positives = 94/226 (41%), Gaps = 23/226 (10%)
Query: 522 KNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGC 581
+ +G+G FG V++G G+E+AVK S + + E+ L+H N++ +
Sbjct: 8 QESIGKGRFGEVWRGKW-RGEEVAVKIFSSREERS-WFREAEIYQTVMLRHENILGFIAA 65
Query: 582 CTQRD----ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-- 635
+ + + L+ +Y + SL ++ + + A GL +LH +
Sbjct: 66 DNKDNGTWTQLWLVSDYHEHGSLFDYL----NRYTVTVEGMIKLALSTASGLAHLHMEIV 121
Query: 636 ---SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF--GLDQTEANTKRVVGTYGYMSP 690
+ I HRDLK+ N+L+ I+D GLA D + VGT YM+P
Sbjct: 122 GTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAP 181
Query: 691 EYAIDGL------FSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH 730
E D + ++D+++ G++ EI G +
Sbjct: 182 EVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLP 227
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 9e-53
Identities = 57/205 (27%), Positives = 94/205 (45%), Gaps = 13/205 (6%)
Query: 521 EKNKLGEGGFGPVYKGMLIE---GQEIAVKRLSKGSGQG--MEEFKNEVLLIAKLQHRNL 575
E +LG G FG V KG + +AVK L + +E E ++ +L + +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYI 70
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V+++G C + + ML+ E L+ ++ + ++ ++ G+ YL +
Sbjct: 71 VRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRH---VKDKNIIELVHQVSMGMKYLEES 126
Query: 636 SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTK-RVVGTYGYMSPEYAI 694
+HRDL A NVLL KISDFGL+++ D+ + + +PE
Sbjct: 127 ---NFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 695 DGLFSVKSDVFSFGVLVLEIICGKK 719
FS KSDV+SFGVL+ E +
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 181 bits (461), Expect = 2e-52
Identities = 60/248 (24%), Positives = 103/248 (41%), Gaps = 41/248 (16%)
Query: 500 EEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS 553
+E P +N +GEG FG V++ +AVK L + +
Sbjct: 6 LSLEYP----------RNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA 55
Query: 554 GQGME-EFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL 612
M+ +F+ E L+A+ + N+VKLLG C L++EY+ L+ F+ + +
Sbjct: 56 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTV 115
Query: 613 ---------------------LDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVL 651
L +++ I +A G+ YL + + +HRDL N L
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSER---KFVHRDLATRNCL 172
Query: 652 LDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLV 711
+ M KI+DFGL+R+ +M PE ++ +SDV+++GV++
Sbjct: 173 VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVL 232
Query: 712 LEIICGKK 719
EI
Sbjct: 233 WEIFSYGL 240
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (453), Expect = 4e-51
Identities = 63/217 (29%), Positives = 111/217 (51%), Gaps = 14/217 (6%)
Query: 509 LKIIANATDNFSEKNKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKG-SGQGMEEFKN 562
L+I+ T+ F + LG G FG VYKG+ I E +A+K L + S + +E +
Sbjct: 3 LRIL-KETE-FKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILD 60
Query: 563 EVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHII 622
E ++A + + ++ +LLG C LI + +P L ++ + + +
Sbjct: 61 EAYVMASVDNPHVCRLLGIC-LTSTVQLITQLMPFGCLLDYVRE--HKDNIGSQYLLNWC 117
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
IA+G+ YL R++HRDL A NVL+ + KI+DFGLA+ G ++ E + +
Sbjct: 118 VQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGK 174
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
+M+ E + +++ +SDV+S+GV V E++
Sbjct: 175 VPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGS 211
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 5e-51
Identities = 63/221 (28%), Positives = 103/221 (46%), Gaps = 24/221 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEG---QEIAVKRLSK-GSGQGMEEFKNEVLLIAKL-Q 571
++ ++ +GEG FG V K + + + A+KR+ + S +F E+ ++ KL
Sbjct: 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGH 69
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFI-------------FDTTRSKLLDWSKR 618
H N++ LLG C R L EY P+ +L F+ + + L +
Sbjct: 70 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129
Query: 619 SHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT 678
H A +ARG+ YL Q + IHRDL A N+L+ KI+DFGL+R +
Sbjct: 130 LHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQ---EVYVKK 183
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
+M+ E +++ SDV+S+GVL+ EI+
Sbjct: 184 TMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 178 bits (452), Expect = 6e-51
Identities = 63/248 (25%), Positives = 99/248 (39%), Gaps = 32/248 (12%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQG-MEEFKNEVLLIAK 569
+N LG G FG V ++AVK L + + E +E+ ++ +
Sbjct: 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQ 96
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFD--------------------TT 608
L H N+V LLG CT LI+EY L ++
Sbjct: 97 LGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEE 156
Query: 609 RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668
+L + +A+G+ +L +HRDL A NVL+ + KI DFGLAR
Sbjct: 157 DLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARD 213
Query: 669 FGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728
D +M+PE +G++++KSDV+S+G+L+ EI +
Sbjct: 214 IMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGV-NPYPGIPV 272
Query: 729 DHNLLGHV 736
D N +
Sbjct: 273 DANFYKLI 280
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-50
Identities = 60/237 (25%), Positives = 93/237 (39%), Gaps = 26/237 (10%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQG-MEEFKNEVLLIAK 569
+ S LG G FG V + +AVK L + E +E+ +++
Sbjct: 23 NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSY 82
Query: 570 L-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL---------------L 613
L H N+V LLG CT ++I EY L F+ S + L
Sbjct: 83 LGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL 142
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
D +A+G+ +L IHRDL A N+LL + KI DFGLAR D
Sbjct: 143 DLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDS 199
Query: 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDH 730
+M+PE + +++ +SDV+S+G+ + E+ +
Sbjct: 200 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSK 256
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 3e-50
Identities = 61/220 (27%), Positives = 109/220 (49%), Gaps = 12/220 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQE-----IAVKRLSKGSGQGM-EEFKNEVLLIAKL 570
+ + +G G FG VYKGML +A+K L G + +F E ++ +
Sbjct: 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQF 66
Query: 571 QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLL 630
H N+++L G ++ M+I EY+ N +LD F+ + + + ++ GIA G+
Sbjct: 67 SHHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE--KDGEFSVLQLVGMLRGIAAGMK 124
Query: 631 YLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT-KRVVGTYGYMS 689
YL + +HRDL A N+L+++ + K+SDFGL+R D T + +
Sbjct: 125 YLA---NMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTA 181
Query: 690 PEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
PE F+ SDV+SFG+++ E++ + + ++H+
Sbjct: 182 PEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 3e-50
Identities = 58/247 (23%), Positives = 111/247 (44%), Gaps = 23/247 (9%)
Query: 498 EKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS 553
+ + + L + +F+E +G G FG VY G L++ AVK L++ +
Sbjct: 16 AVQHVVIGPSSLIV------HFNEV--IGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT 67
Query: 554 GQG-MEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIFDTTRSK 611
G + +F E +++ H N++ LLG C + + +++ Y+ + L FI + +
Sbjct: 68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRN--ETH 125
Query: 612 LLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671
+A+G+ + + +HRDL A N +LD K++DFGLAR
Sbjct: 126 NPTVKDLIGFGLQVAKGM---KFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYD 182
Query: 672 DQTEANTKR--VVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHD 729
+ ++ + +M+ E F+ KSDV+SFGVL+ E++ +
Sbjct: 183 KEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAP--PYPDVNT 240
Query: 730 HNLLGHV 736
++ ++
Sbjct: 241 FDITVYL 247
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 175 bits (444), Expect = 4e-50
Identities = 57/206 (27%), Positives = 90/206 (43%), Gaps = 10/206 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
++F LGEG F V + +E A+K L K + E ++++L H
Sbjct: 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDH 67
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
VKL ++ Y N L +I + D + A I L YL
Sbjct: 68 PFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIR---KIGSFDETCTRFYTAEIVSALEYL 124
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H IIHRDLK N+LL+ M+ +I+DFG A+ + +A VGT Y+SPE
Sbjct: 125 H---GKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPEL 181
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ SD+++ G ++ +++ G
Sbjct: 182 LTEKSACKSSDLWALGCIIYQLVAGL 207
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 6e-49
Identities = 60/211 (28%), Positives = 87/211 (41%), Gaps = 14/211 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSK---GSGQGMEEFKNEVLLIAK 569
+ KLG+G FG V +G + +AVK L + M++F EV +
Sbjct: 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHS 67
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
L HRNL++L G +M + E P SL + S +A G+
Sbjct: 68 LDHRNLIRLYGVVLTPPMKM-VTELAPLGSLLDRLRK--HQGHFLLGTLSRYAVQVAEGM 124
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE-ANTKRVVGTYGYM 688
YL R IHRDL A N+LL KI DFGL R+ + + + +
Sbjct: 125 GYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWC 181
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
+PE FS SD + FGV + E+ +
Sbjct: 182 APESLKTRTFSHASDTWMFGVTLWEMFTYGQ 212
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 173 bits (440), Expect = 7e-49
Identities = 48/205 (23%), Positives = 86/205 (41%), Gaps = 11/205 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
D++ +LG G FG V++ G A K + E + E+ ++ L+H L
Sbjct: 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTL 85
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
V L +E ++IYE++ L + D + + + + +GL ++H
Sbjct: 86 VNLHDAFEDDNEMVMIYEFMSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMH-- 141
Query: 636 SRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
+H DLK N++ + K+ DFGL + + K GT + +PE A
Sbjct: 142 -ENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHL---DPKQSVKVTTGTAEFAAPEVA 197
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGK 718
+D++S GVL ++ G
Sbjct: 198 EGKPVGYYTDMWSVGVLSYILLSGL 222
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 168 bits (426), Expect = 6e-48
Identities = 58/225 (25%), Positives = 100/225 (44%), Gaps = 14/225 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQ 571
+ +GEG FG V++G+ + +A+K + + E+F E L + +
Sbjct: 7 ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFD 66
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H ++VKL+G T+ + +I E L F+ S LD + ++ L Y
Sbjct: 67 HPHIVKLIGVITE-NPVWIIMELCTLGELRSFLQVRKYS--LDLASLILYAYQLSTALAY 123
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
L R +HRD+ A NVL+ + K+ DFGL+R D T + +M+PE
Sbjct: 124 LE---SKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME-DSTYYKASKGKLPIKWMAPE 179
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
F+ SDV+ FGV + EI+ +++++G +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVK--PFQGVKNNDVIGRI 222
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 171 bits (433), Expect = 6e-48
Identities = 48/205 (23%), Positives = 85/205 (41%), Gaps = 11/205 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
D + +LG G FG V++ + G+ K ++ KNE+ ++ +L H L
Sbjct: 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKL 88
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
+ L + E +LI E+L L I + ++ + + GL ++H
Sbjct: 89 INLHDAFEDKYEMVLILEFLSGGELFDRI--AAEDYKMSEAEVINYMRQACEGLKHMH-- 144
Query: 636 SRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
I+H D+K N++ + KI DFGLA D+ K T + +PE
Sbjct: 145 -EHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEI---VKVTTATAEFAAPEIV 200
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGK 718
+D+++ GVL ++ G
Sbjct: 201 DREPVGFYTDMWAIGVLGYVLLSGL 225
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 4e-47
Identities = 58/217 (26%), Positives = 101/217 (46%), Gaps = 17/217 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGML------IEGQEIAVKRLSKG-SGQGMEEFKNEVLLIAK 569
+ + +LG+G FG VY+G+ +A+K +++ S + EF NE ++ +
Sbjct: 20 EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKE 79
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIF-------DTTRSKLLDWSKRSHII 622
++V+LLG +Q ++I E + L ++ + SK +
Sbjct: 80 FNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMA 139
Query: 623 AGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVV 682
IA G+ YL+ + + +HRDL A N ++ KI DFG+ R + +
Sbjct: 140 GEIADGMAYLNAN---KFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL 196
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
+MSPE DG+F+ SDV+SFGV++ EI +
Sbjct: 197 LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 233
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (417), Expect = 7e-46
Identities = 51/209 (24%), Positives = 95/209 (45%), Gaps = 7/209 (3%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM-EEFKNEVLLIAKLQ 571
+ ++ + +GEG +G V +A+K++S Q + E+ ++ + +
Sbjct: 5 DVGPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFR 64
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H N++ + + YL + ++ +++ L + + I RGL Y
Sbjct: 65 HENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKY 124
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANT-KRVVGTYGYMSP 690
+H ++HRDLK SN+LL+ T + KI DFGLAR D V T Y +P
Sbjct: 125 IHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAP 181
Query: 691 EYAIDGLFSVKS-DVFSFGVLVLEIICGK 718
E ++ KS D++S G ++ E++ +
Sbjct: 182 EIMLNSKGYTKSIDIWSVGCILAEMLSNR 210
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 164 bits (416), Expect = 2e-45
Identities = 57/210 (27%), Positives = 97/210 (46%), Gaps = 18/210 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQ- 571
++FS +G GGFG VY + G+ A+K L K QG NE ++++ +
Sbjct: 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVST 63
Query: 572 --HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
+V + D+ I + + L Y + + + + A I GL
Sbjct: 64 GDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS---QHGVFSEADMRFYAAEIILGL 120
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMS 689
++H +++RDLK +N+LLD + +ISD GLA F + VGT+GYM+
Sbjct: 121 EHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYMA 173
Query: 690 PEYAIDGL-FSVKSDVFSFGVLVLEIICGK 718
PE G+ + +D FS G ++ +++ G
Sbjct: 174 PEVLQKGVAYDSSADWFSLGCMLFKLLRGH 203
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 159 bits (403), Expect = 1e-44
Identities = 53/212 (25%), Positives = 92/212 (43%), Gaps = 15/212 (7%)
Query: 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG---MEEFKNEVLLIAKLQ 571
+D + LG GG V+ + +++AVK L + F+ E A L
Sbjct: 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALN 65
Query: 572 HRNLVKLLGCCTQRDER----MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
H +V + ++ EY+ +L + + + +IA +
Sbjct: 66 HPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGP---MTPKRAIEVIADACQ 122
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE-ANTKRVVGTYG 686
L + H + IIHRD+K +N+++ T K+ DFG+AR+ T V+GT
Sbjct: 123 ALNFSH---QNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179
Query: 687 YMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y+SPE A +SDV+S G ++ E++ G+
Sbjct: 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGE 211
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 2e-44
Identities = 62/225 (27%), Positives = 91/225 (40%), Gaps = 25/225 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGSGQG--MEEFKNEVLLIA 568
D LG G FG V + + +AVK L +G+ +LI
Sbjct: 13 DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIH 72
Query: 569 KLQHRNLVKLLGCCTQRDER-MLIYEYLPNKSLDYFIF-------------DTTRSKLLD 614
H N+V LLG CT+ M+I E+ +L ++ + L
Sbjct: 73 IGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLT 132
Query: 615 WSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674
+A+G+ +L + IHRDL A N+LL KI DFGLAR D
Sbjct: 133 LEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD 189
Query: 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
+M+PE D +++++SDV+SFGVL+ EI
Sbjct: 190 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGA 234
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (402), Expect = 5e-44
Identities = 61/207 (29%), Positives = 96/207 (46%), Gaps = 13/207 (6%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG---QGMEEFKNEV-LLIAKLQ 571
++F LG+G FG V+ + Q A+K L K +E E +L +
Sbjct: 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWE 61
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H L + ++ + EYL L Y I + D S+ + A I GL +
Sbjct: 62 HPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHK---FDLSRATFYAAEIILGLQF 118
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH I++RDLK N+LLD + KI+DFG+ + L + NT GT Y++PE
Sbjct: 119 LH---SKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAKTNT--FCGTPDYIAPE 173
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+ ++ D +SFGVL+ E++ G+
Sbjct: 174 ILLGQKYNHSVDWWSFGVLLYEMLIGQ 200
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 157 bits (399), Expect = 1e-43
Identities = 48/207 (23%), Positives = 82/207 (39%), Gaps = 8/207 (3%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-FKNEVLLIAKLQ 571
+ D + ++ LG G F V + +A+K ++K + +G E +NE+ ++ K++
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIK 65
Query: 572 HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLY 631
H N+V L LI + + L I S +I + + Y
Sbjct: 66 HPNIVALDDIYESGGHLYLIMQLVSGGELFDRI---VEKGFYTERDASRLIFQVLDAVKY 122
Query: 632 LHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE 691
LH + + LD ISDFGL++ GT GY++PE
Sbjct: 123 LHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYVAPE 179
Query: 692 YAIDGLFSVKSDVFSFGVLVLEIICGK 718
+S D +S GV+ ++CG
Sbjct: 180 VLAQKPYSKAVDCWSIGVIAYILLCGY 206
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (397), Expect = 1e-43
Identities = 65/226 (28%), Positives = 97/226 (42%), Gaps = 26/226 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKG-SGQGMEEFKNEVLLI 567
D LGEG FG V I ++AVK L + + + + +E+ ++
Sbjct: 13 DRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMM 72
Query: 568 AKL-QHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKL-------------L 613
+ +H+N++ LLG CTQ +I EY +L ++ L L
Sbjct: 73 KMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQL 132
Query: 614 DWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673
+ARG+ YL + IHRDL A NVL+ KI+DFGLAR
Sbjct: 133 SSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHID 189
Query: 674 TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK 719
T +M+PE D +++ +SDV+SFGVL+ EI
Sbjct: 190 YYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 1e-43
Identities = 44/205 (21%), Positives = 85/205 (41%), Gaps = 12/205 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
+ + LG G FG V++ + + K + G K E+ ++ +HRN+
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV-KGTDQVLVKKEISILNIARHRNI 63
Query: 576 VKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD 635
+ L +E ++I+E++ + I T + L+ + + + L +LH
Sbjct: 64 LHLHESFESMEELVMIFEFISGLDIFERI--NTSAFELNEREIVSYVHQVCEALQFLHS- 120
Query: 636 SRLRIIHRDLKASNVLLDNTMNP--KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
I H D++ N++ + KI +FG AR N + + Y +PE
Sbjct: 121 --HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD---NFRLLFTAPEYYAPEVH 175
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGK 718
+ S +D++S G LV ++ G
Sbjct: 176 QHDVVSTATDMWSLGTLVYVLLSGI 200
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 157 bits (398), Expect = 1e-43
Identities = 55/207 (26%), Positives = 92/207 (44%), Gaps = 15/207 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
+F LG G FG V+ G+ A+K L K + +E +E L+++ + H
Sbjct: 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTH 63
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
++++ G + +I +Y+ L + + R A + L YL
Sbjct: 64 PFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRF---PNPVAKFYAAEVCLALEYL 120
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H II+RDLK N+LLD + KI+DFG A+ T + GT Y++PE
Sbjct: 121 H---SKDIIYRDLKPENILLDKNGHIKITDFGFAKYV-----PDVTYTLCGTPDYIAPEV 172
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGKK 719
++ D +SFG+L+ E++ G
Sbjct: 173 VSTKPYNKSIDWWSFGILIYEMLAGYT 199
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 154 bits (389), Expect = 1e-42
Identities = 53/219 (24%), Positives = 95/219 (43%), Gaps = 26/219 (11%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGM---------EEFKNEVLL 566
+N+ K LG G V + + +E AVK + G E EV +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 567 IAKLQ-HRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+ K+ H N+++L L+++ + L ++ T L + I+ +
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYL---TEKVTLSEKETRKIMRAL 119
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+ LH +L I+HRDLK N+LLD+ MN K++DFG + + + V GT
Sbjct: 120 LEVICALH---KLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGTP 173
Query: 686 GYMSPEYAIDGL------FSVKSDVFSFGVLVLEIICGK 718
Y++PE + + + D++S GV++ ++ G
Sbjct: 174 SYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGS 212
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (384), Expect = 3e-41
Identities = 50/210 (23%), Positives = 92/210 (43%), Gaps = 17/210 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL 575
++++ +G G FG VY+ L + G+ +A+K++ + E+ ++ KL H N+
Sbjct: 20 VSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDK----RFKNRELQIMRKLDHCNI 75
Query: 576 VKLLGCCTQRDERM------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
V+L E+ L+ +Y+P + + L + + R L
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSL 135
Query: 630 LYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
Y+H I HRD+K N+LLD +T K+ DFG A+ + E N + Y
Sbjct: 136 AYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL--VRGEPNVSYICSRYYRA 190
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
++ DV+S G ++ E++ G+
Sbjct: 191 PELIFGATDYTSSIDVWSAGCVLAELLLGQ 220
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 150 bits (378), Expect = 4e-41
Identities = 55/205 (26%), Positives = 95/205 (46%), Gaps = 11/205 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVK--RLSKGSGQGMEEFKNEVLLIAKLQHRN 574
+ + K+GEG +G VYK G+ A+K RL K E+ ++ +L+H N
Sbjct: 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSN 61
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+VKL + +L++E+L L+ + + G+ Y H
Sbjct: 62 IVKLYDVIHTKKRLVLVFEHLDQDLKKLLDV---CEGGLESVTAKSFLLQLLNGIAYCHD 118
Query: 635 DSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAI 694
R++HRDLK N+L++ KI+DFGLAR+FG+ + + T Y +P+ +
Sbjct: 119 ---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVLM 173
Query: 695 -DGLFSVKSDVFSFGVLVLEIICGK 718
+S D++S G + E++ G
Sbjct: 174 GSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 149 bits (376), Expect = 9e-41
Identities = 59/206 (28%), Positives = 96/206 (46%), Gaps = 16/206 (7%)
Query: 521 EK-NKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE-----FKNEVLLIAKLQHR 573
EK + LGEG F VYK Q +A+K++ G ++ E+ L+ +L H
Sbjct: 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHP 60
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N++ LL + L+++++ S +L S + +GL YLH
Sbjct: 61 NIIGLLDAFGHKSNISLVFDFMETDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLH 117
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
Q I+HRDLK +N+LLD K++DFGLA+SFG V T Y +PE
Sbjct: 118 QH---WILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYRAPELL 172
Query: 694 ID-GLFSVKSDVFSFGVLVLEIICGK 718
++ V D+++ G ++ E++
Sbjct: 173 FGARMYGVGVDMWAVGCILAELLLRV 198
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (374), Expect = 2e-40
Identities = 56/206 (27%), Positives = 99/206 (48%), Gaps = 11/206 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+NF + K+GEG +G VYK G+ +A+K++ + E+ L+ +L H
Sbjct: 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHP 61
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+VKLL ++ L++E+L + D + + + + +GL + H
Sbjct: 62 NIVKLLDVIHTENKLYLVFEFLHQDLKKFM--DASALTGIPLPLIKSYLFQLLQGLAFCH 119
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPE-Y 692
R++HRDLK N+L++ K++DFGLAR+FG+ V T Y +PE
Sbjct: 120 SH---RVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH--EVVTLWYRAPEIL 174
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+S D++S G + E++ +
Sbjct: 175 LGCKYYSTAVDIWSLGCIFAEMVTRR 200
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 7e-40
Identities = 55/214 (25%), Positives = 97/214 (45%), Gaps = 16/214 (7%)
Query: 515 ATDNFSEKNKLGEGGFGPVYKGMLIE--GQEIAVKRLSKGSGQGM--EEFKNEVLLIAKL 570
A + ++GEG +G V+K ++ G+ +A+KR+ +G+ EV ++ L
Sbjct: 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHL 64
Query: 571 ---QHRNLVKLLGCCTQRDERMLIYEYLPNKSLD---YFIFDTTRSKLLDWSKRSHIIAG 624
+H N+V+L CT L + +D D + ++
Sbjct: 65 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ 124
Query: 625 IARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGT 684
+ RGL +LH R++HRDLK N+L+ ++ K++DFGLAR + VV T
Sbjct: 125 LLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA---LTSVVVT 178
Query: 685 YGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
Y +PE + ++ D++S G + E+ K
Sbjct: 179 LWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 212
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 145 bits (366), Expect = 2e-39
Identities = 47/235 (20%), Positives = 84/235 (35%), Gaps = 20/235 (8%)
Query: 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLL 566
+L++ + + K+G G FG +Y G I G+E+A+K + + E +
Sbjct: 2 ELRV----GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH--PQLHIESKI 55
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+Q + + C + ++ L SL+ S+ + +
Sbjct: 56 YKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNF--CSRKFSLKTVLLLADQMI 113
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVL---LDNTMNPKISDFGLARSFGLDQTEAN-----T 678
+ Y+H IHRD+K N L I DFGLA+ + +T +
Sbjct: 114 SRIEYIH---SKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYREN 170
Query: 679 KRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLL 733
K + GT Y S + S + D+ S G +++ G A
Sbjct: 171 KNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQKY 225
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 1e-38
Identities = 57/216 (26%), Positives = 95/216 (43%), Gaps = 20/216 (9%)
Query: 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS------GQGMEEFKNEVLL 566
N D + +LG G F V K G + A K + K G E+ + EV +
Sbjct: 7 NVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSI 66
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIA 626
+ ++QH N++ L + + +LI E + L F+ + L + + + I
Sbjct: 67 LKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA---EKESLTEEEATEFLKQIL 123
Query: 627 RGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP----KISDFGLARSFGLDQTEANTKRVV 682
G+ YLH L+I H DLK N++L + P KI DFGLA K +
Sbjct: 124 NGVYYLH---SLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIF 177
Query: 683 GTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
GT +++PE +++D++S GV+ ++ G
Sbjct: 178 GTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 213
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 142 bits (358), Expect = 3e-38
Identities = 37/237 (15%), Positives = 88/237 (37%), Gaps = 21/237 (8%)
Query: 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAK 569
++ ++ ++GEG FG +++G + Q++A+K + S + ++E
Sbjct: 2 VVGV---HYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA--PQLRDEYRTYKL 56
Query: 570 LQHRNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGL 629
L + + Q ++ L SL+ + + + + +
Sbjct: 57 LAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDL--CGRKFSVKTVAMAAKQMLARV 114
Query: 630 LYLHQDSRLRIIHRDLKASNVLLDNTMNP-----KISDFGLARSFGLDQTEAN-----TK 679
+H+ +++RD+K N L+ + + DFG+ + + T+ + K
Sbjct: 115 QSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171
Query: 680 RVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADHDHNLLGHV 736
+ GT YMS + S + D+ + G + + + G A + +
Sbjct: 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERI 228
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (360), Expect = 4e-38
Identities = 53/206 (25%), Positives = 88/206 (42%), Gaps = 12/206 (5%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
++F LG+G FG V G+ A+K L K + + E ++ +H
Sbjct: 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRH 64
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
L L D + EY L + + +R ++ + A I L YL
Sbjct: 65 PFLTALKYAFQTHDRLCFVMEYANGGELFFHL---SRERVFTEERARFYGAEIVSALEYL 121
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H +++RD+K N++LD + KI+DFGL + A K GT Y++PE
Sbjct: 122 H---SRDVVYRDIKLENLMLDKDGHIKITDFGLCKE--GISDGATMKTFCGTPEYLAPEV 176
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
D + D + GV++ E++CG+
Sbjct: 177 LEDNDYGRAVDWWGLGVVMYEMMCGR 202
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (350), Expect = 2e-37
Identities = 49/206 (23%), Positives = 81/206 (39%), Gaps = 20/206 (9%)
Query: 524 KLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEE------FKNEVLLIAKLQ--HRN 574
LG GGFG VY G+ + +A+K + K E EV+L+ K+
Sbjct: 11 LLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSG 70
Query: 575 LVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ 634
+++LL + D +LI E + T L + + + H
Sbjct: 71 VIRLLDWFERPDSFVLILERPEPVQDLFDFI--TERGALQEELARSFFWQVLEAVRHCHN 128
Query: 635 DSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY- 692
++HRD+K N+L+D N K+ DFG + GT Y PE+
Sbjct: 129 ---CGVLHRDIKDENILIDLNRGELKLIDFGSGALL----KDTVYTDFDGTRVYSPPEWI 181
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ V+S G+L+ +++CG
Sbjct: 182 RYHRYHGRSAAVWSLGILLYDMVCGD 207
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (352), Expect = 2e-37
Identities = 50/216 (23%), Positives = 101/216 (46%), Gaps = 20/216 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQG--MEEFKNEVLLIAKLQHR 573
+ + K+G+G FG V+K + GQ++A+K++ + + E+ ++ L+H
Sbjct: 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHE 69
Query: 574 NLVKLLGCCTQRDERM--------LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
N+V L+ C + L++++ + + S+ ++ +
Sbjct: 70 NVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVK---FTLSEIKRVMQML 126
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR--VVG 683
GL Y+H++ +I+HRD+KA+NVL+ K++DFGLAR+F L + + V
Sbjct: 127 LNGLYYIHRN---KILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVV 183
Query: 684 TYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIICGK 718
T Y PE + + + D++ G ++ E+
Sbjct: 184 TLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRS 219
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 137 bits (346), Expect = 3e-36
Identities = 52/221 (23%), Positives = 93/221 (42%), Gaps = 23/221 (10%)
Query: 509 LKIIANA-TDNFSEKNK-LGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVL 565
L+I NA D++ ++ LG G G V + ++ A+K L + + EV
Sbjct: 2 LQIKKNAIIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVE 56
Query: 566 LIAKL-QHRNLVKLLGCC----TQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSH 620
L + Q ++V+++ R +++ E L L I D + + S
Sbjct: 57 LHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDR-GDQAFTEREASE 115
Query: 621 IIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP---KISDFGLARSFGLDQTEAN 677
I+ I + YLH + I HRD+K N+L + K++DFG A+ +
Sbjct: 116 IMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTT 172
Query: 678 TKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
T Y++PE + D++S GV++ ++CG
Sbjct: 173 PCY---TPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 210
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (340), Expect = 6e-36
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 10/206 (4%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHR 573
+ + K+GEG +G V+K E + +A+KR+ E+ L+ +L+H+
Sbjct: 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHK 61
Query: 574 NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLH 633
N+V+L + L++E+ YF + LD + + +GL + H
Sbjct: 62 NIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCH 118
Query: 634 QDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYA 693
++HRDLK N+L++ K+++FGLAR+FG+ + VV +
Sbjct: 119 S---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCY-SAEVVTLWYRPPDVLF 174
Query: 694 IDGLFSVKSDVFSFGVLVLEIICGKK 719
L+S D++S G + E+ +
Sbjct: 175 GAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 136 bits (343), Expect = 1e-35
Identities = 53/206 (25%), Positives = 84/206 (40%), Gaps = 15/206 (7%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQH 572
D F LG G FG V E G A+K L K + +E NE ++ +
Sbjct: 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNF 100
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
LVKL ++ EY+ + + R A I YL
Sbjct: 101 PFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGR---FSEPHARFYAAQIVLTFEYL 157
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEY 692
H L +I+RDLK N+L+D +++DFG A+ + + T + GT ++PE
Sbjct: 158 HS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK-----RVKGRTWTLCGTPEALAPEI 209
Query: 693 AIDGLFSVKSDVFSFGVLVLEIICGK 718
+ ++ D ++ GVL+ E+ G
Sbjct: 210 ILSKGYNKAVDWWALGVLIYEMAAGY 235
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (333), Expect = 2e-34
Identities = 53/214 (24%), Positives = 98/214 (45%), Gaps = 13/214 (6%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLL 566
K + + +G G +G V + G ++A+K+L + S + E+ L
Sbjct: 11 KTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRL 70
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLIYE-YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+ ++H N++ LL T + + YL + + + + L + ++ +
Sbjct: 71 LKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQM 130
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
+GL Y+H IIHRDLK N+ ++ KI DFGLAR Q ++ V T
Sbjct: 131 LKGLRYIH---AAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QADSEMTGYVVTR 182
Query: 686 GYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGK 718
Y +PE ++ + ++ D++S G ++ E+I GK
Sbjct: 183 WYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGK 216
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 126 bits (317), Expect = 1e-32
Identities = 48/242 (19%), Positives = 99/242 (40%), Gaps = 21/242 (8%)
Query: 483 GGLMYRRKKHSNQGNEKEEMELPIFDLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE-G 541
G + R + +++ + + D++ KLG G + V++ + I
Sbjct: 1 GPVPSRARVYTDVNTHRPREYWDYESHVVEWGNQDDYQLVRKLGRGKYSEVFEAINITNN 60
Query: 542 QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERM--LIYEYLPNK 598
+++ VK L ++ K E+ ++ L+ N++ L R L++E++ N
Sbjct: 61 EKVVVKILKPVK---KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNT 117
Query: 599 SLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMN 657
+ L + I + L Y H + I+HRD+K NV++D+
Sbjct: 118 DFKQLY------QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRK 168
Query: 658 PKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIIC 716
++ D+GLA + Q V + + PE +D ++ D++S G ++ +I
Sbjct: 169 LRLIDWGLAEFYHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIF 225
Query: 717 GK 718
K
Sbjct: 226 RK 227
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 125 bits (314), Expect = 3e-32
Identities = 58/213 (27%), Positives = 94/213 (44%), Gaps = 18/213 (8%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS----GQGMEEFKNEVLLIA 568
+NF LG G +G V+ I G+ A+K L K + + E + E ++
Sbjct: 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLE 83
Query: 569 KLQHR-NLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
++ LV L + LI +Y+ L + R + + I
Sbjct: 84 HIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRER---FTEHEVQIYVGEIVL 140
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
L +LH +L II+RD+K N+LLD+ + ++DFGL++ F D+TE GT Y
Sbjct: 141 ALEHLH---KLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIEY 196
Query: 688 MSPEYAIDGL--FSVKSDVFSFGVLVLEIICGK 718
M+P+ G D +S GVL+ E++ G
Sbjct: 197 MAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGA 229
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 123 bits (310), Expect = 2e-31
Identities = 57/214 (26%), Positives = 97/214 (45%), Gaps = 13/214 (6%)
Query: 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLL 566
K I + + + +G G +G V + G +AVK+LS+ S + E+ L
Sbjct: 11 KTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRL 70
Query: 567 IAKLQHRNLVKLLGCCTQRDERMLI-YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGI 625
+ ++H N++ LL T YL + + + + + L +I I
Sbjct: 71 LKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQI 130
Query: 626 ARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTY 685
RGL Y+H IIHRDLK SN+ ++ KI DFGLAR + T T
Sbjct: 131 LRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVA-----TR 182
Query: 686 GYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGK 718
Y +PE ++ + ++ D++S G ++ E++ G+
Sbjct: 183 WYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (311), Expect = 2e-31
Identities = 50/211 (23%), Positives = 92/211 (43%), Gaps = 21/211 (9%)
Query: 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHR 573
+ +G G G V + +A+K+LS+ + + E++L+ + H+
Sbjct: 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHK 76
Query: 574 NLVKLLGCCTQRD------ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIAR 627
N++ LL T + + L+ E + + D + S+++ +
Sbjct: 77 NIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQVIQMEL------DHERMSYLLYQMLC 130
Query: 628 GLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGY 687
G+ +LH IIHRDLK SN+++ + KI DFGLAR+ G V T Y
Sbjct: 131 GIKHLHSA---GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRYY 184
Query: 688 MSPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
+PE + + D++S G ++ E++ K
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMVRHK 215
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 112 bits (279), Expect = 2e-27
Identities = 39/210 (18%), Positives = 78/210 (37%), Gaps = 18/210 (8%)
Query: 524 KLGEGGFGPVYKGM-LIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCC 582
KLG G F V+ ++ +A+K + E ++E+ L+ ++ + K
Sbjct: 20 KLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVY-TEAAEDEIKLLQRVNDADNTKEDSMG 78
Query: 583 TQRDERMLIYEYLPNKSLDYF-------------IFDTTRSKLLDWSKRSHIIAGIARGL 629
++L + + + + + + I + GL
Sbjct: 79 ANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGL 138
Query: 630 LYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYM 688
Y+H+ R IIH D+K NVL++ + +A + + + T Y
Sbjct: 139 DYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYR 196
Query: 689 SPEYAIDGLFSVKSDVFSFGVLVLEIICGK 718
SPE + + +D++S L+ E+I G
Sbjct: 197 SPEVLLGAPWGCGADIWSTACLIFELITGD 226
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 97.2 bits (241), Expect = 9e-24
Identities = 40/202 (19%), Positives = 64/202 (31%), Gaps = 27/202 (13%)
Query: 523 NKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS----------GQGMEEFKNEVLLIAKLQH 572
+GEG V+ + E VK G G F + A+ +
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 573 RNLVKLLGCCTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYL 632
R L KL G + Y + N L I ++ + ++ I +
Sbjct: 66 RALQKLQGLAVPKV-----YAWEGNAVLMELIDAKELYRVRVENPD-EVLDMILEEVAKF 119
Query: 633 HQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKR-VVGTYGYMSPE 691
+ I+H DL NVL+ I DF + G + +R V Y S
Sbjct: 120 YHR---GIVHGDLSQYNVLVSE-EGIWIIDFPQSVEVGEEGWREILERDVRNIITYFSRT 175
Query: 692 YAIDGLFSVKSDVFSFGVLVLE 713
Y + D+ S +L+
Sbjct: 176 Y------RTEKDINSAIDRILQ 191
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} Length = 109 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Score = 79.6 bits (196), Expect = 1e-18
Identities = 20/128 (15%), Positives = 47/128 (36%), Gaps = 21/128 (16%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ ++ G+ + G++L + + L ++ T W +N
Sbjct: 2 NLLTNGEGLYAGQSLDV-------EPYHFIMQEDCNLVLYDH----STSVWASNTGILGK 50
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
+ + +G V+ ++ ++W+S+S V L E GN+V+ +
Sbjct: 51 KGCKAVLQS---DGNFVVYDAEGRSLWASHSVRGNGNYVLVLQEDGNVVIY-------GS 100
Query: 166 ILWQSFDY 173
+W + Y
Sbjct: 101 DIWSTGTY 108
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} Length = 108 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Score = 66.6 bits (162), Expect = 5e-14
Identities = 26/128 (20%), Positives = 45/128 (35%), Gaps = 22/128 (17%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
+ + G+++ GE L SF N L ++ W N
Sbjct: 2 NILYSGETLSTGEFLNYG--SFVFIMQEDCN-----LVLYD----VDKPIWATNTGGL-- 48
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
RS L + + N LV+ N +N +W+SN+ V L + N+V+
Sbjct: 49 SRSCFLSMQTDGN--LVVYNPSNKPIWASNTGGQNGNYVCILQKDRNVVIY-------GT 99
Query: 166 ILWQSFDY 173
W + +
Sbjct: 100 DRWATGTH 107
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 120 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 66.1 bits (161), Expect = 9e-14
Identities = 18/89 (20%), Positives = 32/89 (35%), Gaps = 7/89 (7%)
Query: 84 IWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKP 143
I Y + L L + + LVL + +D VWS+N++
Sbjct: 12 ILYSTQGNDNHPQTLHATQSLQLSPYRLSMET--DCNLVLFDR-DDRVWSTNTAGKGTGC 68
Query: 144 VAALMESGNLVVKDGKDNNPDNILWQSFD 172
A L +G + V + + +W S +
Sbjct: 69 RAVLQPNGRMDVLTNQ----NIAVWTSGN 93
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} Length = 112 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Score = 64.0 bits (155), Expect = 4e-13
Identities = 20/131 (15%), Positives = 44/131 (33%), Gaps = 20/131 (15%)
Query: 46 DTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLS 105
D ++ G + G +L + + N + Y W + + S
Sbjct: 2 DRLNSGHQLDTGGSLAEGG--YLFIIQNDCNL------VLYDN---NRAVWASGTNGKAS 50
Query: 106 DRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDN 165
++ +G + S + +W+SN++ L N+V+ D N +N
Sbjct: 51 GCVLKMQNDGNLV-----IYSGSRAIWASNTNRQNGNYYLILQRDRNVVIYD----NSNN 101
Query: 166 ILWQSFDYPCD 176
+W + +
Sbjct: 102 AIWATHTNVGN 112
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 119 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 55.8 bits (134), Expect = 4e-10
Identities = 22/139 (15%), Positives = 44/139 (31%), Gaps = 24/139 (17%)
Query: 35 LFYIISAARTLDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTV 94
+F + +S+ ++ + + N L ++
Sbjct: 4 IFSKQPDDNHPQILHATESL----EILFGTHVYRFIMQTDCN-----LVLY----DNNNP 50
Query: 95 TWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLV 154
W N + R + +G+LV++ + N TVW S + A V L N+V
Sbjct: 51 IWATNTGGLGNG----CRAVLQPDGVLVVITNENVTVWQSPVAGKAGHYVLVLQPDRNVV 106
Query: 155 VKDGKDNNPDNILWQSFDY 173
+ + LW +
Sbjct: 107 IY-------GDALWATQTV 118
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} Length = 115 | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Score = 50.7 bits (121), Expect = 2e-08
Identities = 20/115 (17%), Positives = 31/115 (26%), Gaps = 35/115 (30%)
Query: 84 IWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERN------------------------- 118
I + EG+ + L S + + N
Sbjct: 3 ILFGLSHEGSHPQTLHAAQSLELSSFRFTMQSDCNLVLFDSDVRVWASNTAGATGCRAVL 62
Query: 119 ---GILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170
G+LV+L + N WSS + S V L + + LW S
Sbjct: 63 QSDGLLVILTAQNTIRWSSGTKGSIGNYVLVLQPDRTVTIY-------GPGLWDS 110
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 738 | |||
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.82 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 99.79 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 99.77 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 99.76 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 99.67 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.52 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.5 | |
| d1dlpa1 | 115 | Fetuin-binding protein Scafet precursor {Bluebell | 99.2 | |
| d1b2pa_ | 119 | Lectin (agglutinin) {Bluebell (Scilla campanulata) | 99.0 | |
| d1dlpa2 | 120 | Fetuin-binding protein Scafet precursor {Bluebell | 98.94 | |
| d1jpca_ | 108 | Lectin (agglutinin) {Snowdrop (Galanthus nivalis) | 98.85 | |
| d1kj1a_ | 109 | Lectin (agglutinin) {Garlic (Allium sativum) [TaxI | 98.8 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.68 | |
| d1xd5a_ | 112 | Gastrodianin (antifungal protein) {Gastrodia elata | 98.62 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.05 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.98 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.42 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.1 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.42 |
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-44 Score=310.88 Aligned_cols=201 Identities=27% Similarity=0.479 Sum_probs=179.5
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEEE
Q ss_conf 079895651055564769974504-6638999981589975668899999999671277723588477417821699841
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 594 (738)
.++|++.+.||+|+||.||++... .++.||+|++........+.+.+|+.++++++||||+++++++.+.+..++||||
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy 98 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEY 98 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEEC
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEEEE
T ss_conf 10538878981285829999999899989999998430172799999999999867999880585779889998999970
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC
Q ss_conf 79999457886138888899999999999999999998739999747479899968984899539995247511498865
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~~ 674 (738)
+++|+|..++.. ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.....
T Consensus 99 ~~gg~L~~~~~~----~~l~~~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~ 171 (293)
T d1yhwa1 99 LAGGSLTDVVTE----TCMDEGQIAAVCRECLQALEFLHSNQ---VIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS 171 (293)
T ss_dssp CTTCBHHHHHHH----SCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC
T ss_pred CCCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCCC
T ss_conf 379808988641----59999999999999999999999879---72267768886887899686425156413213666
Q ss_pred CCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 545333346667455011037988904589999999999993998999999
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
.....+||+.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 172 --~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 220 (293)
T d1yhwa1 172 --KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNEN 220 (293)
T ss_dssp --CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred --CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCC
T ss_conf --4444444777368266447998801203137299999804889989979
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.4e-45 Score=313.91 Aligned_cols=205 Identities=28% Similarity=0.406 Sum_probs=179.4
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEECCCCC-CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEE
Q ss_conf 0798956510555647699745046-6389999815899-7566889999999967127772358847741782169984
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
.++|++.+.||+|+||.||++.... ++.||+|++.... ....+++.+|+.++++++||||+++++++.+.+..++|||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmE 83 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLE 83 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC-------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEEE
T ss_conf 74608998972174809999999999979999998456641279999999999985799888469654046743679886
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 17999945788613888889999999999999999999873999974747989996898489953999524751149886
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~ 673 (738)
|+++|+|.+++. ....+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+......
T Consensus 84 y~~gg~L~~~l~---~~~~l~e~~~~~i~~qi~~al~ylH~~~---IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 84 YCSGGELFDRIE---PDIGMPEPDAQRFFHQLMAGVVYLHGIG---ITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp CCTTEEGGGGSB---TTTBCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred CCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 458980899975---3799999999999999999999999759---8357546899788789987983231422404688
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 5545333346667455011037988-9045899999999999939989999998
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
........+||+.|+|||++.+..+ +.++||||+|+++|||++|+.||.....
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~ 211 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 211 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSST
T ss_pred CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCH
T ss_conf 653111325574742872861899999710161737999999829978888985
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-45 Score=314.47 Aligned_cols=202 Identities=26% Similarity=0.368 Sum_probs=178.2
Q ss_pred HCCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCC-CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEE
Q ss_conf 5079895651055564769974504-6638999981589-9756688999999996712777235884774178216998
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 515 ~~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
..++|++.+.||+|+||+||++... .++.||+|+++.. .....+++.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVm 83 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICM 83 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 75688897897127780999999989996999999875409789999999999998679999994999999899999999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-CCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 4179999457886138888899999999999999999998739-999747479899968984899539995247511498
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-SRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 593 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~ 671 (738)
||+++|+|.+++... ..+++..+..++.|++.||.|||+. + |+||||||+|||+++++.+||+|||+|+....
T Consensus 84 Ey~~gg~L~~~l~~~---~~l~~~~~~~~~~qil~aL~yLH~~~~---IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 84 EHMDGGSLDQVLKKA---GRIPEQILGKVSIAVIKGLTYLREKHK---IMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp ECCTTEEHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHHHC---CCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred ECCCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 767998689987424---999999999999999999999998599---97144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 8655453333466674550110379889045899999999999939989999998
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
......+||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 158 ----~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 158 ----SMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp ----HTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred ----CCCCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf ----862111377141194687589989488899899999999988899899887
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-43 Score=305.48 Aligned_cols=202 Identities=30% Similarity=0.480 Sum_probs=173.9
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEECCCC--CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEE
Q ss_conf 0798956510555647699745046638999981589--97566889999999967127772358847741782169984
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~~g~~VavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
.++|++.+.||+|+||.||+|++. ..||||+++.. .....+.|.+|+.++.+++||||+++++++.+ ...++|||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~--~~vAvK~~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~E 83 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWH--GDVAVKMLNVTAPTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQ 83 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESS--SEEEEEECCCSSCCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEEC--CEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEEE
T ss_conf 451899889830788589999999--989999997346998999999999999984799878645679715-58999996
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 17999945788613888889999999999999999999873999974747989996898489953999524751149886
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~ 673 (738)
|+++|+|.+++.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+......
T Consensus 84 y~~~g~L~~~l~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 84 WCEGSSLYHHLHI--IETKFEMIKLIDIARQTAQGMDYLHAKS---IIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp CCCEEEHHHHHHT--SCCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred CCCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCHHHEEECCCCCEEECCCCCEEECCCCC
T ss_conf 5899888999852--3578999999999999999988875099---9516147899798189978875002213335567
Q ss_pred CCCCCCCCCCCCCCCCHHCCCC---CCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 5545333346667455011037---988904589999999999993998999999
Q 004674 674 TEANTKRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
.........||+.|+|||++.+ ..++.++||||||+++|||+||+.||....
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~ 213 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 213 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 7631256655743179999950568999953151635999999997889989989
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-44 Score=310.14 Aligned_cols=204 Identities=28% Similarity=0.407 Sum_probs=180.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCC---CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEE
Q ss_conf 79895651055564769974504-6638999981589---9756688999999996712777235884774178216998
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|++.+.||+|+||.||++... .++.||+|++.+. .....+.+.+|++++++++||||+++++++.+.+..++||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 41799994578861388888999999999999999999987399997474798999689848995399952475114988
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~ 672 (738)
||+++|+|.+++.. .+.+++..+..++.|++.||+|||+.+ |+||||||+|||+++++.+||+|||+|+.+...
T Consensus 88 Ey~~gg~L~~~~~~---~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~ 161 (288)
T d1uu3a_ 88 SYAKNGELLKYIRK---IGSFDETCTRFYTAEIVSALEYLHGKG---IIHRDLKPENILLNEDMHIQITDFGTAKVLSPE 161 (288)
T ss_dssp CCCTTEEHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECC--
T ss_pred ECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCCCCCCCCCCCEEEECCCCCCEECCCC
T ss_conf 70489877776531---599999999999999999997621650---884767741236688853886032102422567
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 655453333466674550110379889045899999999999939989999998
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
.........+||+.|+|||++.+..++.++||||+|+++|||++|+.||.....
T Consensus 162 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (288)
T d1uu3a_ 162 SKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215 (288)
T ss_dssp --------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCH
T ss_conf 764333555677552584400268989666230456999998038899899599
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=2.5e-43 Score=304.09 Aligned_cols=203 Identities=25% Similarity=0.399 Sum_probs=179.2
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEEE
Q ss_conf 079895651055564769974504-6638999981589975668899999999671277723588477417821699841
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 594 (738)
.++|++.+.||+|+||.||++... .|+.||+|++........+.+.+|+.++.+++||||+++++++.+.+..++||||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 104 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEF 104 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 65758988984076819999998899989999998452431699999999999867997999299999989999999985
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEEECCCCCCCCC
Q ss_conf 79999457886138888899999999999999999998739999747479899968984--8995399952475114988
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~~vkL~DfGla~~~~~~ 672 (738)
+++|+|.+++.. ....+++..+..++.||+.||.|||+++ |+||||||+|||++ .++.+||+|||+++.+...
T Consensus 105 ~~gg~L~~~l~~--~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~ 179 (350)
T d1koaa2 105 MSGGELFEKVAD--EHNKMSEDEAVEYMRQVCKGLCHMHENN---YVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK 179 (350)
T ss_dssp CCSCBHHHHHTC--TTSCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTSCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHH--HCCCCCHHHHHHHHHHHHHHHHHHHHCC---CEEEEECHHHEEECCCCCCEEEEEECCHHEECCCC
T ss_conf 799889999976--2378999999999999999999997569---76000154673641688986999545210442565
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 655453333466674550110379889045899999999999939989999998
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
. ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.....
T Consensus 180 ~---~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 230 (350)
T d1koaa2 180 Q---SVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGEND 230 (350)
T ss_dssp S---CEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred C---CCCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf 4---32000686242188997589987267655465999999859899899799
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.6e-44 Score=307.58 Aligned_cols=203 Identities=28% Similarity=0.421 Sum_probs=178.0
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEEEC
Q ss_conf 798956510555647699745046-6389999815899756688999999996712777235884774178216998417
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 595 (738)
+.|++.+.||+|+||.||++.... +..||+|++........+.+.+|++++++++||||+++++++.+.+..++||||+
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~ 91 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFC 91 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEECC
T ss_conf 37598479930778199999999999399999987289999999999999998679999884988980099589999627
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 99994578861388888999999999999999999987399997474798999689848995399952475114988655
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~~~ 675 (738)
++|+|..++... ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|.......
T Consensus 92 ~~g~L~~~~~~~--~~~l~e~~~~~i~~qi~~gL~ylH~~~---ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~-- 164 (288)
T d2jfla1 92 AGGAVDAVMLEL--ERPLTESQIQVVCKQTLDALNYLHDNK---IIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI-- 164 (288)
T ss_dssp TTEEHHHHHHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECHHHH--
T ss_pred CCCCHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEECCHHHEEECCCCCEEEEECHHHHCCCCCC--
T ss_conf 998188999862--899999999999999999999999889---8871407003148789998997161230357786--
Q ss_pred CCCCCCCCCCCCCCHHCCC-----CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 4533334666745501103-----79889045899999999999939989999998
Q 004674 676 ANTKRVVGTYGYMSPEYAI-----DGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~-----~~~~t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
.......||+.|+|||++. +..++.++||||+|+++|||++|+.||.....
T Consensus 165 ~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~ 220 (288)
T d2jfla1 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNP 220 (288)
T ss_dssp HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred CCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf 41001025626479999832025788888066578789999998208899999899
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.6e-44 Score=307.60 Aligned_cols=204 Identities=30% Similarity=0.443 Sum_probs=177.7
Q ss_pred HHCCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEE
Q ss_conf 750798956510555647699745046-6389999815899756688999999996712777235884774178216998
Q 004674 514 NATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 514 ~~~~~y~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
...++|++.+.||+|+||.||+|.+.. ++.||+|+++.. ....+++.+|+.++++++||||+++++++.+.+..++||
T Consensus 14 i~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~ 92 (287)
T d1opja_ 14 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED-TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIIT 92 (287)
T ss_dssp CCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTT-CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEE
T ss_pred ECHHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEEE
T ss_conf 4579939865982088808999999999969999997776-103999999999998679998826775274578547876
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 41799994578861388888999999999999999999987399997474798999689848995399952475114988
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~ 672 (738)
||+++|+|..++... ....+++..+..++.|++.||.|||+++ |+||||||+|||+++++.+||+|||+++.....
T Consensus 93 E~~~~g~l~~~l~~~-~~~~~~~~~~~~i~~qi~~gL~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 93 EFMTYGNLLDYLREC-NRQEVSAVVLLYMATQISSAMEYLEKKN---FIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp ECCTTCBHHHHHHHS-CTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred ECCCCCCHHHHHHHC-CCCCHHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEECCCC
T ss_conf 314676067775303-5541579999999999999788898789---305760457689989992898324454653788
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 655453333466674550110379889045899999999999939989999
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~ 723 (738)
... ......|+..|+|||++.+..++.++||||||+++|||++|..|+..
T Consensus 169 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~ 218 (287)
T d1opja_ 169 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYP 218 (287)
T ss_dssp SSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred CCE-EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf 722-10355665466692787279998104302178999999867998877
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-43 Score=302.94 Aligned_cols=201 Identities=28% Similarity=0.456 Sum_probs=176.0
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEEEC
Q ss_conf 07989565105556476997450466389999815899756688999999996712777235884774178216998417
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 595 (738)
.++|+..+.||+|+||.||+|.+.+++.||||++... ....++|.+|+.++++++||||++++|++...+..++||||+
T Consensus 4 p~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~ 82 (263)
T d1sm2a_ 4 PSELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREG-AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFM 82 (263)
T ss_dssp CSCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSS-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECC
T ss_pred HHHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEEEC
T ss_conf 6995888898208882999999889999999998788-676899999999999668997565352431599337999836
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 99994578861388888999999999999999999987399997474798999689848995399952475114988655
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~~~ 675 (738)
++|+|.+++.. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 83 ~~g~L~~~l~~--~~~~~~~~~~~~i~~qia~gl~~lH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~ 157 (263)
T d1sm2a_ 83 EHGCLSDYLRT--QRGLFAAETLLGMCLDVCEGMAYLEEAC---VIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT 157 (263)
T ss_dssp TTCBHHHHHHT--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCTTCSGGGEEECGGGCEEECSCC-----------
T ss_pred CCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCHHHEEECCCCCEEECCCCHHEECCCCCCE
T ss_conf 99918997520--1347889999999999999877653164---310443153266668877686553210023688733
Q ss_pred CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCC
Q ss_conf 4533334666745501103798890458999999999999399-89999
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK-KNRGF 723 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~-~p~~~ 723 (738)
......||..|+|||++.+..++.++||||||+++|||+|+. .|+..
T Consensus 158 -~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~ 205 (263)
T d1sm2a_ 158 -SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYEN 205 (263)
T ss_dssp --------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCS
T ss_pred -EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCC
T ss_conf -504300176667857860799984033210599999998789888778
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-44 Score=309.49 Aligned_cols=200 Identities=29% Similarity=0.433 Sum_probs=177.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CCEEEEEECCCC---CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEE
Q ss_conf 798956510555647699745046-638999981589---9756688999999996712777235884774178216998
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|++.+.||+|+||.||++.... ++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.++...++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 41799994578861388888999999999999999999987399997474798999689848995399952475114988
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~ 672 (738)
||+++|+|..++.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||++......
T Consensus 86 Ey~~~g~L~~~l~~---~~~l~e~~~~~i~~qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~ 159 (263)
T d2j4za1 86 EYAPLGTVYRELQK---LSKFDEQRTATYITELANALSYCHSKR---VIHRDIKPENLLLGSAGELKIADFGWSVHAPSS 159 (263)
T ss_dssp ECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC
T ss_pred EECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCCEECCCCCEEECCCCEEEECCCC
T ss_conf 50479858988750---489999999999999999999999889---465220234414668998711555633544888
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 655453333466674550110379889045899999999999939989999998
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 160 ----~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 209 (263)
T d2j4za1 160 ----RRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 209 (263)
T ss_dssp ----CCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ----CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCH
T ss_conf ----52355788763499997589989314404675999998329999888999
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=304.49 Aligned_cols=203 Identities=26% Similarity=0.363 Sum_probs=179.3
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCC---CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEE
Q ss_conf 079895651055564769974504-6638999981589---975668899999999671277723588477417821699
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
.++|++.+.||+|+||.||++... .++.||+|++.+. .....+.+.+|+.++++++||||+++++++.+....++|
T Consensus 4 l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv 83 (337)
T d1o6la_ 4 MNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFV 83 (337)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47428988983176849999999899989999998156544979999999999999867999887787640356421110
Q ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 84179999457886138888899999999999999999998739999747479899968984899539995247511498
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~ 671 (738)
|||+++|+|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+|+....
T Consensus 84 ~ey~~gg~L~~~~~~---~~~~~e~~~~~~~~qil~al~ylH~~~---iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~ 157 (337)
T d1o6la_ 84 MEYANGGELFFHLSR---ERVFTEERARFYGAEIVSALEYLHSRD---VVYRDIKLENLMLDKDGHIKITDFGLCKEGIS 157 (337)
T ss_dssp EECCTTCBHHHHHHH---HSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCSCC
T ss_pred EECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 003579860555532---567759999999999965211343159---62246477784765899888820565200356
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 8655453333466674550110379889045899999999999939989999998
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
... .....+||+.|+|||++.+..++.++||||+|+++|||++|+.||.....
T Consensus 158 ~~~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~ 210 (337)
T d1o6la_ 158 DGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp TTC--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCC--CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCH
T ss_conf 786--20551008899666650489888333102230678899878999999699
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-43 Score=302.72 Aligned_cols=207 Identities=30% Similarity=0.471 Sum_probs=177.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC------CCEEEEEECCCC-CCCCHHHHHHHHHHHHHH-CCCCEEEEEEEEECCCCC
Q ss_conf 798956510555647699745046------638999981589-975668899999999671-277723588477417821
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~~------g~~VavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~ 588 (738)
++|++.+.||+|+||.||+|+... ...||+|.+... .......+.+|+.++.++ +|||||++++++.+....
T Consensus 37 ~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~ 116 (325)
T d1rjba_ 37 ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPI 116 (325)
T ss_dssp GGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSC
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEE
T ss_conf 99397019830788199999985788554204999999663358789999999999999715899686877888629958
Q ss_pred EEEEEECCCCCHHHHHHHCCC--------------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCC
Q ss_conf 699841799994578861388--------------------888999999999999999999987399997474798999
Q 004674 589 MLIYEYLPNKSLDYFIFDTTR--------------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKAS 648 (738)
Q Consensus 589 ~lV~E~~~~gsL~~~l~~~~~--------------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~ 648 (738)
++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+
T Consensus 117 ~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~---IiHRDlKp~ 193 (325)
T d1rjba_ 117 YLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKS---CVHRDLAAR 193 (325)
T ss_dssp EEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTT---EEETTCSGG
T ss_pred EEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHH
T ss_conf 99997279995999998625777510221000012220012577899999999999999999997399---050527032
Q ss_pred CEEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCC
Q ss_conf 68984899539995247511498865545333346667455011037988904589999999999993-9989999998
Q 004674 649 NVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHA 726 (738)
Q Consensus 649 NILl~~~~~vkL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~ellt-G~~p~~~~~~ 726 (738)
|||++.++.+||+|||+|+...............||+.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 194 Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 194 NVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred CCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 1443459828985142222045778615623435787657838872799996330300039999998389999999898
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=5.8e-43 Score=301.66 Aligned_cols=202 Identities=24% Similarity=0.343 Sum_probs=178.2
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEEE
Q ss_conf 079895651055564769974504-6638999981589975668899999999671277723588477417821699841
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 594 (738)
.++|++.+.||+|+||.||++... .++.||+|++........+.+.+|+.++++++||||+++++++.++...++||||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~ 107 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEF 107 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEEEC
T ss_conf 40359989993177829999999899979999998872646799999999999867997989199999989999999982
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCEEEEEECCCCCCCCC
Q ss_conf 79999457886138888899999999999999999998739999747479899968984--8995399952475114988
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD--NTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~--~~~~vkL~DfGla~~~~~~ 672 (738)
+++|+|.+.+. .....+++.++..++.||+.||.|||+.+ |+||||||+|||++ .++.+||+|||+|..+...
T Consensus 108 ~~gg~L~~~~~--~~~~~l~e~~~~~i~~qi~~aL~ylH~~~---iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~ 182 (352)
T d1koba_ 108 LSGGELFDRIA--AEDYKMSEAEVINYMRQACEGLKHMHEHS---IVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD 182 (352)
T ss_dssp CCCCBHHHHTT--CTTCCBCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSTTCCCEEECCCTTCEECCTT
T ss_pred CCCCHHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCCCCCCCCEEEEEECCCCEECCCC
T ss_conf 89980888898--63899899999999999999999999779---26513144553113467884899525630343788
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 65545333346667455011037988904589999999999993998999999
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
. ......|++.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 183 ~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 232 (352)
T d1koba_ 183 E---IVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGED 232 (352)
T ss_dssp S---CEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSS
T ss_pred C---CEEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 7---2010047645348999747998976333898999999996889989979
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-43 Score=302.32 Aligned_cols=201 Identities=33% Similarity=0.506 Sum_probs=172.8
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEEEC
Q ss_conf 07989565105556476997450466389999815899756688999999996712777235884774178216998417
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 595 (738)
.++|++.+.||+|+||.||+|.++.+..||||+++.. ....++|.+|+.++++++||||++++|++.+ +..++||||+
T Consensus 12 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~ 89 (272)
T d1qpca_ 12 RETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQG-SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYM 89 (272)
T ss_dssp GGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECC
T ss_pred HHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEEEEEC
T ss_conf 8993886798107982899999999999999998647-6888999999999986799988578731045-9769999957
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 99994578861388888999999999999999999987399997474798999689848995399952475114988655
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~~~ 675 (738)
++|+|.+++... ....+++..++.++.||++||.|||+.+ |+||||||+|||+++++.+||+|||+|+.+......
T Consensus 90 ~~g~L~~~~~~~-~~~~l~~~~~~~i~~qi~~gl~~lH~~~---ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~~ 165 (272)
T d1qpca_ 90 ENGSLVDFLKTP-SGIKLTINKLLDMAAQIAEGMAFIEERN---YIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT 165 (272)
T ss_dssp TTCBHHHHTTSH-HHHTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE
T ss_pred CCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCEEECCCCCEEECCCCCCC
T ss_conf 898288887514-7898878899999999999999997489---546756422515620244042341014773588644
Q ss_pred CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 453333466674550110379889045899999999999939989999
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~ 723 (738)
......|++.|+|||++.+..++.++||||||+++|||+||.+|+..
T Consensus 166 -~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~ 212 (272)
T d1qpca_ 166 -AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYP 212 (272)
T ss_dssp -CCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred -CCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCC
T ss_conf -20356774444582898379998245645257999999968988888
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=5.6e-43 Score=301.74 Aligned_cols=199 Identities=28% Similarity=0.402 Sum_probs=176.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CCEEEEEECCCC---CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEE
Q ss_conf 798956510555647699745046-638999981589---9756688999999996712777235884774178216998
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|++.+.||+|+||.||++..+. ++.||+|++.+. .....+.+.+|+.+++.++||||+++++++.+....++||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 41799994578861388888999999999999999999987399997474798999689848995399952475114988
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~ 672 (738)
||+++|+|...+.. ...+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+|+.....
T Consensus 84 E~~~gg~l~~~~~~---~~~~~~~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~ 157 (316)
T d1fota_ 84 DYIEGGELFSLLRK---SQRFPNPVAKFYAAEVCLALEYLHSKD---IIYRDLKPENILLDKNGHIKITDFGFAKYVPDV 157 (316)
T ss_dssp CCCCSCBHHHHHHH---TSSCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTSCEEECCCSSCEECSSC
T ss_pred EECCCCCCCCCCCC---CCCCCCCHHHHHHHHHHHHHHHHCCCC---EECCCCCCHHEEECCCCCEEEECCCCCEEECCC
T ss_conf 50378632234322---221110079999999987655412476---770556810503868998898317521671245
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 655453333466674550110379889045899999999999939989999998
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
....+||+.|+|||++.+..++.++||||+|+++|||++|+.||.....
T Consensus 158 -----~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 206 (316)
T d1fota_ 158 -----TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206 (316)
T ss_dssp -----BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred -----CCCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCH
T ss_conf -----6434576343599998389998043046533368999759899999699
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.1e-43 Score=304.65 Aligned_cols=205 Identities=28% Similarity=0.459 Sum_probs=174.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-C---CEEEEEECCCC-CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEE
Q ss_conf 798956510555647699745046-6---38999981589-975668899999999671277723588477417821699
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-G---QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~~-g---~~VavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
++|++.+.||+|+||.||+|.... + ..||+|++... .....++|.+|+.++++++|||||+++|++.+....++|
T Consensus 26 ~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv 105 (299)
T d1jpaa_ 26 SCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMII 105 (299)
T ss_dssp GGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 04278569802788299999995799788999999978445989999999999999857998886189999628877999
Q ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 84179999457886138888899999999999999999998739999747479899968984899539995247511498
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~ 671 (738)
|||+++|+|..++.. ....+++.++..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 106 ~Ey~~~g~L~~~~~~--~~~~l~~~~~~~i~~qia~gl~yLH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~ 180 (299)
T d1jpaa_ 106 TEFMENGSLDSFLRQ--NDGQFTVIQLVGMLRGIAAGMKYLADMN---YVHRDLAARNILVNSNLVCKVSDFGLSRFLED 180 (299)
T ss_dssp EECCTTEEHHHHHHT--TTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCC--------
T ss_pred EEECCCCCCEEEECC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCCEECCC
T ss_conf 972279853002104--5679999999999999999889885279---83576150448988999199888443157567
Q ss_pred CCCCC---CCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCC
Q ss_conf 86554---5333346667455011037988904589999999999993-9989999998
Q 004674 672 DQTEA---NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHA 726 (738)
Q Consensus 672 ~~~~~---~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~ellt-G~~p~~~~~~ 726 (738)
..... ......||+.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 181 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~ 239 (299)
T d1jpaa_ 181 DTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTN 239 (299)
T ss_dssp ---------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH
T ss_conf 77765365025666883003878883699786121445357899998679999999999
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-43 Score=304.41 Aligned_cols=209 Identities=29% Similarity=0.390 Sum_probs=177.7
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEECCCCC--CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECC--CCCEE
Q ss_conf 0798956510555647699745046-6389999815899--75668899999999671277723588477417--82169
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR--DERML 590 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~--~~~~l 590 (738)
.++|++.+.||+|+||.||++.... ++.||+|.+.... ....+.+.+|++++++++||||+++++++.+. ...++
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~i 82 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYI 82 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSCHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 33379967983088919999999999979999998746579799999999999999778999824899999178998999
Q ss_pred EEEECCCCCHHHHHHHCC-CCCCCCHHHHHHHHHHHHHHHHHHHHCCC--CCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf 984179999457886138-88889999999999999999999873999--974747989996898489953999524751
Q 004674 591 IYEYLPNKSLDYFIFDTT-RSKLLDWSKRSHIIAGIARGLLYLHQDSR--LRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 591 V~E~~~~gsL~~~l~~~~-~~~~l~~~~~~~i~~~ia~gL~yLH~~~~--~~ivH~DLkp~NILl~~~~~vkL~DfGla~ 667 (738)
||||+++|+|.+++.... ....+++..++.++.|++.||.|||+.+. .+|+||||||+|||++.++.+||+|||+++
T Consensus 83 vmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~ 162 (269)
T d2java1 83 VMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLAR 162 (269)
T ss_dssp EEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHH
T ss_pred EEECCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCCEE
T ss_conf 99568999389999851545789999999999999999999999716778878858676542574788857980010003
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 14988655453333466674550110379889045899999999999939989999998
Q 004674 668 SFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 668 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
.+..... ......||+.|+|||++.+..++.++||||||+++|||++|+.||.....
T Consensus 163 ~~~~~~~--~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~ 219 (269)
T d2java1 163 ILNHDTS--FAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 219 (269)
T ss_dssp HC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ECCCCCC--CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH
T ss_conf 2245777--55667788232799998399999389887527899998018899899899
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.4e-43 Score=304.25 Aligned_cols=202 Identities=26% Similarity=0.356 Sum_probs=176.6
Q ss_pred HCCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEECCCCC-CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEE
Q ss_conf 50798956510555647699745046-6389999815899-756688999999996712777235884774178216998
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 515 ~~~~y~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
..+.|++.+.||+|+||.||++.... ++.||+|++.... ....+.+.+|+.++..++||||+++++++.+....++||
T Consensus 7 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvm 86 (307)
T d1a06a_ 7 IRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIM 86 (307)
T ss_dssp GGGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC----------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 76666998899406583999999999998999999815773128999999999998679989991989999899888988
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEEECCCCCC
Q ss_conf 4179999457886138888899999999999999999998739999747479899968984---8995399952475114
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARSF 669 (738)
Q Consensus 593 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~vkL~DfGla~~~ 669 (738)
||+++|+|.+++. ....+++..+..++.|++.||.|||+.+ |+||||||+|||+. +++.+||+|||+++..
T Consensus 87 E~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~al~ylH~~~---iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 87 QLVSGGELFDRIV---EKGFYTERDASRLIFQVLDAVKYLHDLG---IVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp CCCCSCBHHHHHH---TCSCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred ECCCCCCHHHHHH---CCCCCCHHHHHHHHHHHHHHHHHHHHCE---EEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf 5268984888653---0367887899999999999987524130---556870463001104688824998315435872
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 98865545333346667455011037988904589999999999993998999999
Q 004674 670 GLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
.... .....+||+.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 213 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEN 213 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCC---EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 5897---0440032842259188737999807873451599999985979999989
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2e-42 Score=298.02 Aligned_cols=197 Identities=30% Similarity=0.483 Sum_probs=171.5
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCC---CHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEE
Q ss_conf 79895651055564769974504-6638999981589975---6688999999996712777235884774178216998
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ---GMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~~~---~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
+.|+..+.||+|+||.||++... +++.||+|++...... ..+.+.+|+.++++++||||+++++++.+....++||
T Consensus 15 ~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 85676279701888099999998999399999984444358899999999999999778999823899999899889999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 41799994578861388888999999999999999999987399997474798999689848995399952475114988
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~ 672 (738)
||+++|+|..++.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+||+|||++.....
T Consensus 95 E~~~~g~l~~~~~~---~~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~- 167 (309)
T d1u5ra_ 95 EYCLGSASDLLEVH---KKPLQEVEIAAVTHGALQGLAYLHSHN---MIHRDVKAGNILLSEPGLVKLGDFGSASIMAP- 167 (309)
T ss_dssp ECCSEEHHHHHHHH---TSCCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCSGGGEEEETTTEEEECCCTTCBSSSS-
T ss_pred EECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCCCEEEECCCCCEEEEECCCCCCCCC-
T ss_conf 80699945789973---799999999999999999999998689---76667884217987999789844365334677-
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCC---CCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 65545333346667455011037---988904589999999999993998999999
Q 004674 673 QTEANTKRVVGTYGYMSPEYAID---GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~---~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
.....||+.|+|||++.+ ..++.++||||||+++|||++|+.||....
T Consensus 168 -----~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~ 218 (309)
T d1u5ra_ 168 -----ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (309)
T ss_dssp -----BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred -----CCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf -----873134766368899834678886721454558999999987889999979
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-42 Score=298.05 Aligned_cols=205 Identities=28% Similarity=0.440 Sum_probs=180.3
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEEEC
Q ss_conf 07989565105556476997450466389999815899756688999999996712777235884774178216998417
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYL 595 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~ 595 (738)
.++|+..++||+|+||.||+|+.++++.||||+++.. ....++|.+|+.++++++||||++++|++.+....++||||+
T Consensus 3 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~-~~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~ 81 (258)
T d1k2pa_ 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEG-SMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYM 81 (258)
T ss_dssp CCCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESS-SSCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECC
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEECC
T ss_conf 6997996898207883999999889989999998747-577899999999999668986015889985078169999704
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 99994578861388888999999999999999999987399997474798999689848995399952475114988655
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~~~ 675 (738)
++|+|..++.. ....+++..+.+++.|+++||+|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 82 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~~LH~~~---iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~~ 156 (258)
T d1k2pa_ 82 ANGCLLNYLRE--MRHRFQTQQLLEMCKDVCEAMEYLESKQ---FLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYT 156 (258)
T ss_dssp TTEEHHHHHHS--GGGCCCHHHHHHHHHHHHHHHHHHHHTT---BCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSCC
T ss_pred CCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCCE
T ss_conf 89938886410--2467768999999999999999875468---434665413588769984798861442023578722
Q ss_pred CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCC
Q ss_conf 45333346667455011037988904589999999999993-99899999988
Q 004674 676 ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHAD 727 (738)
Q Consensus 676 ~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~ellt-G~~p~~~~~~~ 727 (738)
......||..|+|||++.+..++.++||||||+++|||+| |+.||+....+
T Consensus 157 -~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 157 -SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp -CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred -EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHH
T ss_conf -5246578877578078637998852103364324673975599998899999
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.4e-42 Score=299.18 Aligned_cols=198 Identities=25% Similarity=0.323 Sum_probs=176.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCC---CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEE
Q ss_conf 79895651055564769974504-6638999981589---9756688999999996712777235884774178216998
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIY 592 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~ 592 (738)
++|++.+.||+|+||.||++... .++.||+|++.+. .....+.+.+|+.+++.++||||+++++++......++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCC
Q ss_conf 41799994578861388888999999999999999999987399997474798999689848995399952475114988
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLD 672 (738)
Q Consensus 593 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~ 672 (738)
||+.+|+|..++... +.+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.+...
T Consensus 121 e~~~~g~l~~~l~~~---~~l~e~~~~~i~~qi~~aL~yLH~~~---iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~ 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRI---GRFSEPHARFYAAQIVLTFEYLHSLD---LIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR 194 (350)
T ss_dssp ECCTTCBHHHHHHHH---CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTSCEEECCCTTCEECSSC
T ss_pred CCCCCCCHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHCCCCCCCCEEEEECEEEEECCCC
T ss_conf 233466226667515---89899999999999999899998599---861767999936077897886101033322566
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 65545333346667455011037988904589999999999993998999999
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 195 -----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 242 (350)
T d1rdqe_ 195 -----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQ 242 (350)
T ss_dssp -----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred -----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf -----643367635678899717998853311450078999975889989959
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.2e-42 Score=299.62 Aligned_cols=202 Identities=28% Similarity=0.418 Sum_probs=171.0
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEECCCC---CCCCHHHHHHH---HHHHHHHCCCCEEEEEEEEECCCCC
Q ss_conf 0798956510555647699745046-638999981589---97566889999---9999671277723588477417821
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNE---VLLIAKLQHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~---~~~~~~~~~~E---i~~l~~l~H~nIv~l~g~~~~~~~~ 588 (738)
.++|++.+.||+|+||.||++.... ++.||+|++.+. .......+.+| +.++..++||||+++++++.+.+..
T Consensus 3 lddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~ 82 (364)
T d1omwa3 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKL 82 (364)
T ss_dssp STTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
T ss_conf 77685101884288909999999999979999998458754266799999999999998508998588999999989988
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 69984179999457886138888899999999999999999998739999747479899968984899539995247511
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 589 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~ 668 (738)
++||||+++|+|..++.. ...+++..+..++.||+.||.|||+.+ |+||||||+|||++.++.+||+|||+|+.
T Consensus 83 ~ivmE~~~gg~L~~~l~~---~~~~~e~~~~~~~~qi~~aL~ylH~~~---iiHrDlKP~NILl~~~g~iKl~DFGla~~ 156 (364)
T d1omwa3 83 SFILDLMNGGDLHYHLSQ---HGVFSEADMRFYAAEIILGLEHMHNRF---VVYRDLKPANILLDEHGHVRISDLGLACD 156 (364)
T ss_dssp EEEECCCCSCBHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECSSSCEEECCCTTCEE
T ss_pred EEEEEECCCCCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCEEECCCEEEECCCCCEEEEEECEEEE
T ss_conf 999991489838999873---255327899999999999999999779---62204442216785889679822010233
Q ss_pred CCCCCCCCCCCCCCCCCCCCCHHCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 498865545333346667455011037-98890458999999999999399899999988
Q 004674 669 FGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (738)
Q Consensus 669 ~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGviL~elltG~~p~~~~~~~ 727 (738)
..... ....+||+.|+|||++.. ..++.++||||+||++|||++|+.||......
T Consensus 157 ~~~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 157 FSKKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp CSSSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred CCCCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHH
T ss_conf 37886----433113455421687603899984410467789999998599988889989
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-41 Score=292.70 Aligned_cols=202 Identities=27% Similarity=0.415 Sum_probs=176.7
Q ss_pred HCCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCC------CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCC
Q ss_conf 5079895651055564769974504-66389999815899------7566889999999967127772358847741782
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS------GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE 587 (738)
Q Consensus 515 ~~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~------~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~ 587 (738)
..+.|++.+.||+|+||.||++... .++.||+|++.+.. ....+.+.+|+.++++++||||+++++++.+...
T Consensus 8 i~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~ 87 (293)
T d1jksa_ 8 VDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTD 87 (293)
T ss_dssp GGGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSE
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCE
T ss_conf 55677982798117895999999999998999999875663213406899999999999986799899938899997998
Q ss_pred CEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CEEEEEE
Q ss_conf 169984179999457886138888899999999999999999998739999747479899968984899----5399952
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM----NPKISDF 663 (738)
Q Consensus 588 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~----~vkL~Df 663 (738)
.++||||+++|+|.+++... ..+++..+..++.|++.||+|||+.+ |+||||||+|||++.++ .+||+||
T Consensus 88 ~~iv~E~~~gg~L~~~i~~~---~~l~~~~~~~~~~qi~~al~yLH~~~---ivHrDiKp~Nill~~~~~~~~~vkl~Df 161 (293)
T d1jksa_ 88 VILILELVAGGELFDFLAEK---ESLTEEEATEFLKQILNGVYYLHSLQ---IAHFDLKPENIMLLDRNVPKPRIKIIDF 161 (293)
T ss_dssp EEEEEECCCSCBHHHHHHHH---SSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSSSSCCEEECCC
T ss_pred EEEEEECCCCCCCCCHHCCC---CCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEEECCCCCCCCEEECCH
T ss_conf 99999867786431001035---64215578999999999987666254---2211333012798258986664696433
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 47511498865545333346667455011037988904589999999999993998999999
Q 004674 664 GLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 664 Gla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
|++........ .....|++.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 162 G~a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 220 (293)
T d1jksa_ 162 GLAHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220 (293)
T ss_dssp TTCEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHHHHCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCC
T ss_conf 44210577763---122477774309999818999976652214099999970889988999
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-42 Score=297.69 Aligned_cols=204 Identities=30% Similarity=0.502 Sum_probs=172.2
Q ss_pred CCCCCCC-EECCCCCEEEEEEEECC---CCEEEEEECCCCC-CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEE
Q ss_conf 7989565-10555647699745046---6389999815899-75668899999999671277723588477417821699
Q 004674 517 DNFSEKN-KLGEGGFGPVYKGMLIE---GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~y~~~~-~IG~G~fG~Vykg~~~~---g~~VavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
+++.+.+ +||+|+||.||+|.... +..||||+++... ....++|.+|++++.+++||||++++|++.. +..++|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lv 86 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLV 86 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEEEE
T ss_conf 4718878487306080999999960897689999998820397899999999999986799888068656036-807999
Q ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 84179999457886138888899999999999999999998739999747479899968984899539995247511498
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~ 671 (738)
|||+++|+|.+++.. ....+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+..
T Consensus 87 mE~~~~g~L~~~l~~--~~~~l~~~~~~~i~~qi~~gL~ylH~~~---iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~ 161 (285)
T d1u59a_ 87 MEMAGGGPLHKFLVG--KREEIPVSNVAELLHQVSMGMKYLEEKN---FVHRDLAARNVLLVNRHYAKISDFGLSKALGA 161 (285)
T ss_dssp EECCTTEEHHHHHTT--CTTTSCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEEETTEEEECCCTTCEECTT
T ss_pred EEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EECCCCCHHHEEECCCCCEEECCCHHHHCCCC
T ss_conf 980789968997521--2569999999999999999878998688---10576764660454688542033134211554
Q ss_pred CCCC-CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCC
Q ss_conf 8655-45333346667455011037988904589999999999993-9989999998
Q 004674 672 DQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHA 726 (738)
Q Consensus 672 ~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~ellt-G~~p~~~~~~ 726 (738)
.... .......||+.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 162 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~ 218 (285)
T d1u59a_ 162 DDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 218 (285)
T ss_dssp CSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCH
T ss_conf 343211356211374335868872799995412322017899999389999999799
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-42 Score=294.31 Aligned_cols=196 Identities=29% Similarity=0.430 Sum_probs=166.4
Q ss_pred CCCCEECCCCCEEEEEEEECC-CCEEEEEECCCC--CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEEC----CCCCEEEE
Q ss_conf 956510555647699745046-638999981589--97566889999999967127772358847741----78216998
Q 004674 520 SEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ----RDERMLIY 592 (738)
Q Consensus 520 ~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~----~~~~~lV~ 592 (738)
+..++||+|+||+||++.... +..||+|++... .....+.+.+|++++++++||||+++++++.. ....++||
T Consensus 12 ~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivm 91 (270)
T d1t4ha_ 12 KFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVT 91 (270)
T ss_dssp EEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSCHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEE
T ss_pred EEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEEEE
T ss_conf 85169700828499999999999599999985122798999999999999985799985069999840334588899999
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC-CCCCEEEEEECCCCCCCC
Q ss_conf 4179999457886138888899999999999999999998739999747479899968984-899539995247511498
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD-NTMNPKISDFGLARSFGL 671 (738)
Q Consensus 593 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~-~~~~vkL~DfGla~~~~~ 671 (738)
||+++|+|.+++.. ...+++..+..++.|++.||+|||+++ .+|+||||||+|||++ +++.+||+|||+++....
T Consensus 92 E~~~~g~L~~~l~~---~~~~~~~~~~~~~~qi~~gl~yLH~~~-~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~ 167 (270)
T d1t4ha_ 92 ELMTSGTLKTYLKR---FKVMKIKVLRSWCRQILKGLQFLHTRT-PPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA 167 (270)
T ss_dssp ECCCSCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHTSS-SCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCT
T ss_pred ECCCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC-CCEEECCCCHHHCEEECCCCCEEEEECCCCEECCC
T ss_conf 57898948999751---355469999999999999999999789-97996876743511667999889800576542368
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 86554533334666745501103798890458999999999999399899999
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~ 724 (738)
. .....+||+.|+|||++.+ .++.++||||||+++|||++|+.||...
T Consensus 168 ~----~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~ 215 (270)
T d1t4ha_ 168 S----FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSEC 215 (270)
T ss_dssp T----SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred C----CCCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCC
T ss_conf 7----6677553813008988478-9998671100799999998788999876
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.6e-42 Score=294.60 Aligned_cols=206 Identities=30% Similarity=0.506 Sum_probs=176.3
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CC----EEEEEECCCC-CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEE
Q ss_conf 798956510555647699745046-63----8999981589-97566889999999967127772358847741782169
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ----EIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~~-g~----~VavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
++|++.+.||+|+||.||+|.... ++ +||+|++... .....+++.+|+.++++++||||++++|++.++ ..++
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~ 87 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQL 87 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC----CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CEEE
T ss_conf 999783198208992999999958998898999999965134979999999999999867998881589999619-8369
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 98417999945788613888889999999999999999999873999974747989996898489953999524751149
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~ 670 (738)
++|++.+++|.+.+.. ....+++..++.++.|++.||.|||+++ |+||||||+|||++.++.+||+|||+++...
T Consensus 88 v~e~~~~~~l~~~~~~--~~~~~~~~~~~~i~~qi~~gl~yLH~~~---iiHrDlKp~NIll~~~~~~kl~DFGla~~~~ 162 (317)
T d1xkka_ 88 ITQLMPFGCLLDYVRE--HKDNIGSQYLLNWCVQIAKGMNYLEDRR---LVHRDLAARNVLVKTPQHVKITDFGLAKLLG 162 (317)
T ss_dssp EEECCTTCBHHHHHHH--TSSSCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEEEETTEEEECCCSHHHHTT
T ss_pred EEEECCCCCCCCCCCC--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCHHHCCEECCCCCEEEECCCCCEECC
T ss_conf 9984268740101113--3457999999999999999999998769---5047621203116799875860255222335
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCCC
Q ss_conf 8865545333346667455011037988904589999999999993-998999999888
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHADH 728 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~ellt-G~~p~~~~~~~~ 728 (738)
............||..|+|||++.+..++.++||||||+++|||+| |+.||+.....+
T Consensus 163 ~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~ 221 (317)
T d1xkka_ 163 AEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221 (317)
T ss_dssp TTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred CCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
T ss_conf 44453223651058644670887469998356544079999999977999999999899
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=293.12 Aligned_cols=202 Identities=29% Similarity=0.466 Sum_probs=174.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CCEEEEEECCCC---CCCCHHHHHHHHHHHH-HHCCCCEEEEEEEEECCCCCEEE
Q ss_conf 798956510555647699745046-638999981589---9756688999999996-71277723588477417821699
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKG---SGQGMEEFKNEVLLIA-KLQHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~---~~~~~~~~~~Ei~~l~-~l~H~nIv~l~g~~~~~~~~~lV 591 (738)
++|++.+.||+|+||+||+++... ++.||+|++++. .....+.+..|..++. .++||||+++++++.+....++|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCC
Q ss_conf 84179999457886138888899999999999999999998739999747479899968984899539995247511498
Q 004674 592 YEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGL 671 (738)
Q Consensus 592 ~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~ 671 (738)
|||+++|+|..++.. ...+++..+..++.||+.||.|||+++ |+||||||+|||+++++.+||+|||+++....
T Consensus 82 mEy~~~g~L~~~i~~---~~~~~e~~~~~~~~qi~~al~ylH~~~---iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~ 155 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQS---CHKFDLSRATFYAAEIILGLQFLHSKG---IVYRDLKLDNILLDKDGHIKIADFGMCKENML 155 (320)
T ss_dssp EECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---CBCCCCCGGGEEECTTSCEEECCCTTCBCCCC
T ss_pred EEECCCCCHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCEEECCCCCEECCCCCHHHHCCC
T ss_conf 750379808998640---478999999999999999999998689---34034765404444899630155530232356
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 8655453333466674550110379889045899999999999939989999998
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
... ......||+.|+|||++.+..++.++||||+|+++|||++|+.||.....
T Consensus 156 ~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~ 208 (320)
T d1xjda_ 156 GDA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208 (320)
T ss_dssp TTC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CCC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCH
T ss_conf 653--34545787776899998279988323201122789898738899999899
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.8e-42 Score=294.09 Aligned_cols=201 Identities=30% Similarity=0.490 Sum_probs=174.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEEECC
Q ss_conf 79895651055564769974504663899998158997566889999999967127772358847741782169984179
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLP 596 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~ 596 (738)
++|++.+.||+|+||.||+|.+.++..||+|++... ....+.|.+|+.++.+++|+|||++++++.+ +..++||||++
T Consensus 17 ~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~-~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~ 94 (285)
T d1fmka3 17 ESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPG-TMSPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMS 94 (285)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTT-SSCHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCT
T ss_pred HHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCC-CCCHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CCEEEEEEECC
T ss_conf 997984699307980999999999999999998804-4888999999999986666788689999823-97599999447
Q ss_pred CCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCC
Q ss_conf 99945788613888889999999999999999999873999974747989996898489953999524751149886554
Q 004674 597 NKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEA 676 (738)
Q Consensus 597 ~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~~~~ 676 (738)
+|+|..++... ....+++..++.++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++........
T Consensus 95 ~g~l~~~~~~~-~~~~l~~~~~~~i~~~i~~gl~~LH~~~---ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~~- 169 (285)
T d1fmka3 95 KGSLLDFLKGE-TGKYLRLPQLVDMAAQIASGMAYVERMN---YVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT- 169 (285)
T ss_dssp TCBHHHHHSHH-HHTTCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECGGGCEEECCCCTTC---------
T ss_pred CCCHHHHHHHC-CCCCCHHHHHHHHHHHHHHHHHHHHHHH---EECCCCCCEEEEECCCCCEEECCCCHHHHCCCCCCE-
T ss_conf 99435420000-3553059999999999999999875411---433531230799989992998442555425688733-
Q ss_pred CCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 533334666745501103798890458999999999999399899999
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~ 724 (738)
......||+.|+|||++.+..++.++||||||+++|||++|..|+...
T Consensus 170 ~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~ 217 (285)
T d1fmka3 170 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 217 (285)
T ss_dssp ------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTT
T ss_pred EECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCC
T ss_conf 524545566545808983799891774132358999998689999988
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-42 Score=297.46 Aligned_cols=197 Identities=29% Similarity=0.443 Sum_probs=168.4
Q ss_pred CEECCCCCEEEEEEEECC---CCEEEEEECCCC--CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEEECCC
Q ss_conf 510555647699745046---638999981589--975668899999999671277723588477417821699841799
Q 004674 523 NKLGEGGFGPVYKGMLIE---GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEYLPN 597 (738)
Q Consensus 523 ~~IG~G~fG~Vykg~~~~---g~~VavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~~~~ 597 (738)
++||+|+||.||+|.+.. ++.||+|+++.. .....+++.+|+.++++++||||+++++++.. +..++||||+++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~ 91 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEANDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAEL 91 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC-----CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCCC
T ss_conf 7834587829999998169738599999988010898999999999999986799898527777505-977999974788
Q ss_pred CCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC-C
Q ss_conf 994578861388888999999999999999999987399997474798999689848995399952475114988655-4
Q 004674 598 KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE-A 676 (738)
Q Consensus 598 gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~~~-~ 676 (738)
|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||+++.+...... .
T Consensus 92 g~L~~~l~~---~~~l~~~~~~~i~~qi~~gl~ylH~~~---iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 92 GPLNKYLQQ---NRHVKDKNIIELVHQVSMGMKYLEESN---FVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp EEHHHHHHH---CTTCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CCHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCC
T ss_conf 968999752---257899999999999999976687479---55677761131023567512341345331343234432
Q ss_pred CCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCC
Q ss_conf 5333346667455011037988904589999999999993-9989999998
Q 004674 677 NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHA 726 (738)
Q Consensus 677 ~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~ellt-G~~p~~~~~~ 726 (738)
......||+.|+|||++.+..++.++||||||+++|||+| |+.||.....
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~ 216 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred CCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCH
T ss_conf 244567784203916653799984344303403132896589999999899
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-41 Score=291.16 Aligned_cols=202 Identities=30% Similarity=0.489 Sum_probs=172.6
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCC-----CEEEEEECCCCC-CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEE
Q ss_conf 7989565105556476997450466-----389999815899-7566889999999967127772358847741782169
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEG-----QEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~~g-----~~VavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
+.|+..+.||+|+||.||+|.+... ..||||++.... ....++|.+|+.++.+++|||||+++|++.+....++
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~ 86 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMI 86 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCEEE
T ss_conf 99686159811779099999996899878799999998844596899999999999985689878323677833880389
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 98417999945788613888889999999999999999999873999974747989996898489953999524751149
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~ 670 (738)
|+||+.++++.+.+... ...+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||+++.+.
T Consensus 87 v~e~~~~~~l~~~~~~~--~~~~~~~~~~~i~~~i~~gl~~lH~~~---iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~ 161 (283)
T d1mqba_ 87 ITEYMENGALDKFLREK--DGEFSVLQLVGMLRGIAAGMKYLANMN---YVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161 (283)
T ss_dssp EEECCTTEEHHHHHHHT--TTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-----
T ss_pred EEEECCCCCCHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHCCCCC---CCCCCCCCCEEEECCCCEEEECCCCHHHCCC
T ss_conf 99721357402221023--454208999999999998541212123---4257656442788899849984551030035
Q ss_pred CCCCC-CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 88655-453333466674550110379889045899999999999939989999
Q 004674 671 LDQTE-ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 671 ~~~~~-~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~ 723 (738)
..... .......||..|+|||++.+..++.++||||||+++|||++++.|+..
T Consensus 162 ~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp ------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred CCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCC
T ss_conf 787652674267777343488887049999735563448989999967988655
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.3e-41 Score=286.89 Aligned_cols=202 Identities=20% Similarity=0.314 Sum_probs=175.9
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEEE
Q ss_conf 0798956510555647699745046-638999981589975668899999999671277723588477417821699841
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 594 (738)
-++|++.+.||+|+||+||++.... ++.||+|.+.... .....+.+|+.++..++||||+++++++.+....++||||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~-~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~ 82 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG-TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEF 82 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT-HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC-CCHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEEEC
T ss_conf 010588789831778399999998999699999975786-6599999999999857997989098999889988999953
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC--CCCEEEEEECCCCCCCCC
Q ss_conf 799994578861388888999999999999999999987399997474798999689848--995399952475114988
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN--TMNPKISDFGLARSFGLD 672 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~--~~~vkL~DfGla~~~~~~ 672 (738)
+++|+|.+++.. ....+++.++..++.||+.||.|||+.+ |+||||||+|||++. ...+||+|||++......
T Consensus 83 ~~gg~L~~~i~~--~~~~l~e~~~~~i~~qi~~al~yLH~~~---iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~ 157 (321)
T d1tkia_ 83 ISGLDIFERINT--SAFELNEREIVSYVHQVCEALQFLHSHN---IGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157 (321)
T ss_dssp CCCCBHHHHHTS--SSCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEESSSSCCCEEECCCTTCEECCTT
T ss_pred CCCCCHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCCC
T ss_conf 899808899875--3899999999999999999999998769---97513554443443788518997644111003467
Q ss_pred CCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 655453333466674550110379889045899999999999939989999998
Q 004674 673 QTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 673 ~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
.. .....+++.|+|||.+.+..++.++||||+|+++|||++|+.||.....
T Consensus 158 ~~---~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~ 208 (321)
T d1tkia_ 158 DN---FRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp CE---EEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred CC---CCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCH
T ss_conf 75---3212233222340210487778401130279999999828999999899
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=6.9e-42 Score=294.45 Aligned_cols=214 Identities=27% Similarity=0.417 Sum_probs=180.8
Q ss_pred HHHHHHCCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEECCCCCC-CCHHHHHHHHHHHHHHCCCCEEEEEEEE
Q ss_conf 989975079895651055564769974504------663899998158997-5668899999999671277723588477
Q 004674 510 KIIANATDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKLQHRNLVKLLGCC 582 (738)
Q Consensus 510 ~~~~~~~~~y~~~~~IG~G~fG~Vykg~~~------~g~~VavK~l~~~~~-~~~~~~~~Ei~~l~~l~H~nIv~l~g~~ 582 (738)
.+++...++|++.+.||+|+||.||+|... .++.||||++..... ...++|.+|+.+++.++|+||+++++++
T Consensus 6 ~~~e~p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~ 85 (301)
T d1lufa_ 6 LSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVC 85 (301)
T ss_dssp HHTBCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEE
T ss_pred HHCCCCHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCHHHHHHHHHHHHHHHHCCCCCCCCCEEEE
T ss_conf 31138988938867982078839999998887657788299999988210857999999999999966899765524666
Q ss_pred ECCCCCEEEEEECCCCCHHHHHHHCC---------------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEE
Q ss_conf 41782169984179999457886138---------------------888899999999999999999998739999747
Q 004674 583 TQRDERMLIYEYLPNKSLDYFIFDTT---------------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRII 641 (738)
Q Consensus 583 ~~~~~~~lV~E~~~~gsL~~~l~~~~---------------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~iv 641 (738)
......++++||+++|+|.+++.... ....+++..++.++.|++.||+|||+.+ ++
T Consensus 86 ~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~---iv 162 (301)
T d1lufa_ 86 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERK---FV 162 (301)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CC
T ss_pred CCCCCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC---EE
T ss_conf 059803899981589929999985275542100001110012103467889899999999999999855413578---68
Q ss_pred ECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCC-CC
Q ss_conf 47989996898489953999524751149886554533334666745501103798890458999999999999399-89
Q 004674 642 HRDLKASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK-KN 720 (738)
Q Consensus 642 H~DLkp~NILl~~~~~vkL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~-~p 720 (738)
||||||+|||++.++.+||+|||+++...............|++.|+|||.+.+..++.++||||||+++|||++|. +|
T Consensus 163 HrDlKp~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p 242 (301)
T d1lufa_ 163 HRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQP 242 (301)
T ss_dssp CSCCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCT
T ss_pred EEEECCCCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCC
T ss_conf 54884011689899928983314421136776411157777676767989972688980563025236299998068999
Q ss_pred CCCCCC
Q ss_conf 999998
Q 004674 721 RGFNHA 726 (738)
Q Consensus 721 ~~~~~~ 726 (738)
|.....
T Consensus 243 ~~~~~~ 248 (301)
T d1lufa_ 243 YYGMAH 248 (301)
T ss_dssp TTTSCH
T ss_pred CCCCCH
T ss_conf 999899
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=8.8e-41 Score=287.05 Aligned_cols=204 Identities=26% Similarity=0.403 Sum_probs=175.8
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCCC---CCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCC----
Q ss_conf 079895651055564769974504-663899998158997---566889999999967127772358847741782----
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG---QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDE---- 587 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~~---~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~---- 587 (738)
.++|++.+.||+|+||.||++... .++.||+|+++.... ...+.+.+|+.+++.++||||+++++++.....
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred CEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCC
Q ss_conf 16998417999945788613888889999999999999999999873999974747989996898489953999524751
Q 004674 588 RMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLAR 667 (738)
Q Consensus 588 ~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~ 667 (738)
.++||||+++++|..++.. .+.+++.++..++.|++.||.|||+.+ |+||||||+|||++.++..++.|||.+.
T Consensus 86 ~~lvmE~~~g~~L~~~~~~---~~~l~~~~~~~i~~qi~~al~~lH~~~---iiHrDiKP~NIll~~~~~~~l~d~~~~~ 159 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHT---EGPMTPKRAIEVIADACQALNFSHQNG---IIHRDVKPANIMISATNAVKVMDFGIAR 159 (277)
T ss_dssp EEEEEECCCEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTSCEEECCCTTCE
T ss_pred EEEEEECCCCCEEHHHHCC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCEEEHHHHHH
T ss_conf 9999977889871011203---589999999999999999999998579---5276346755665754320100344432
Q ss_pred CCCCCC-CCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 149886-5545333346667455011037988904589999999999993998999999
Q 004674 668 SFGLDQ-TEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 668 ~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
...... ........+||+.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 218 (277)
T d1o6ya_ 160 AIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDS 218 (277)
T ss_dssp ECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred HHCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCC
T ss_conf 21235443333464257624369999839999966320265289999976979989969
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-40 Score=285.77 Aligned_cols=199 Identities=25% Similarity=0.344 Sum_probs=168.8
Q ss_pred CCCCCCCC-EECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHH-CCCCEEEEEEEEEC----CCCC
Q ss_conf 07989565-1055564769974504-6638999981589975668899999999671-27772358847741----7821
Q 004674 516 TDNFSEKN-KLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQ----RDER 588 (738)
Q Consensus 516 ~~~y~~~~-~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~----~~~~ 588 (738)
.++|.+.+ .||+|+||.||++... .++.||+|+++. ...+.+|+.++.++ +||||+++++++.+ ....
T Consensus 10 ~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~-----~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~ 84 (335)
T d2ozaa1 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD-----CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCL 84 (335)
T ss_dssp GGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEC-----SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEE
T ss_pred CCCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECC-----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCCEE
T ss_conf 14879810796545486999999889998999999897-----4779999999998669999782989995034689789
Q ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCEEEEEECC
Q ss_conf 699841799994578861388888999999999999999999987399997474798999689848---99539995247
Q 004674 589 MLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN---TMNPKISDFGL 665 (738)
Q Consensus 589 ~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~---~~~vkL~DfGl 665 (738)
++||||+++|+|.+++... ....+++..+..++.|++.||+|||+.+ |+||||||+|||++. .+.+||+|||+
T Consensus 85 ~ivmEy~~gg~L~~~i~~~-~~~~l~e~~~~~i~~qi~~al~ylH~~~---iiHRDiKp~NIll~~~~~~~~~Kl~DFG~ 160 (335)
T d2ozaa1 85 LIVMECLDGGELFSRIQDR-GDQAFTEREASEIMKSIGEAIQYLHSIN---IAHRDVKPENLLYTSKRPNAILKLTDFGF 160 (335)
T ss_dssp EEEEECCCSEEHHHHHHSC-SCCCEEHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEESCSSTTCCEEECCCTT
T ss_pred EEEEECCCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCCE
T ss_conf 9999778998499999862-7877579999999999999999999769---86444100220113555566311354551
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 5114988655453333466674550110379889045899999999999939989999998
Q 004674 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
++....... .....||+.|+|||++.+..++.++||||+|+++|||++|+.||.....
T Consensus 161 a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 161 AKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp CEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred EEECCCCCC---CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCH
T ss_conf 233368886---4322677563792777489888888887645167788658899889887
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-40 Score=283.84 Aligned_cols=197 Identities=29% Similarity=0.415 Sum_probs=168.3
Q ss_pred CCCEECCCCCEEEEEEEECC-CCEEEEEECCCCCC-----CCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEEE
Q ss_conf 56510555647699745046-63899998158997-----5668899999999671277723588477417821699841
Q 004674 521 EKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSG-----QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 521 ~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~~~-----~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 594 (738)
..+.||+|+||+||++.... ++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++||||
T Consensus 2 ~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~ 81 (299)
T d1ua2a_ 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDF 81 (299)
T ss_dssp EEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEEC
T ss_pred CCEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHH
T ss_conf 56385127282999999999996999999842021245679999999999999867999986898542258740220455
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC
Q ss_conf 79999457886138888899999999999999999998739999747479899968984899539995247511498865
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~~ 674 (738)
+.++.+.... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|||+++.......
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~~~~qil~aL~~lH~~~---iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~ 155 (299)
T d1ua2a_ 82 METDLEVIIK---DNSLVLTPSHIKAYMLMTLQGLEYLHQHW---ILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR 155 (299)
T ss_dssp CSEEHHHHHT---TCCSSCCSSHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC
T ss_pred HCCHHHHHHH---HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCC
T ss_conf 3450776554---12667789999999999999998863163---55035776258853778411465761000578755
Q ss_pred CCCCCCCCCCCCCCCHHCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 545333346667455011037-988904589999999999993998999999
Q 004674 675 EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
.....+||+.|+|||++.+ ..++.++||||+|+++|||++|+.||....
T Consensus 156 --~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 205 (299)
T d1ua2a_ 156 --AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDS 205 (299)
T ss_dssp --CCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred --CCCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCC
T ss_conf --43302047333639997267788805643630428999985969999999
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.2e-40 Score=281.88 Aligned_cols=202 Identities=25% Similarity=0.382 Sum_probs=175.1
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCC---------CHHHHHHHHHHHHHHC-CCCEEEEEEEEEC
Q ss_conf 079895651055564769974504-6638999981589975---------6688999999996712-7772358847741
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQ---------GMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQ 584 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~~~---------~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~ 584 (738)
.++|++.+.||+|+||+||+++.. +++.||+|++...... ..+.+.+|+.++++++ ||||+++++++.+
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred CCCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCC
T ss_conf 66388852884176849999999999989999999624464114788899999999999999985079974799762146
Q ss_pred CCCCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEEC
Q ss_conf 78216998417999945788613888889999999999999999999873999974747989996898489953999524
Q 004674 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (738)
Q Consensus 585 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfG 664 (738)
....++||||+++|+|.+++.. ...+++..+..++.||+.||+|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 82 ~~~~~ivmE~~~~g~L~~~l~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---ivHrDlkp~Nill~~~~~~kl~DFG 155 (277)
T d1phka_ 82 NTFFFLVFDLMKKGELFDYLTE---KVTLSEKETRKIMRALLEVICALHKLN---IVHRDLKPENILLDDDMNIKLTDFG 155 (277)
T ss_dssp SSEEEEEEECCTTCBHHHHHHH---HSSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECTTCCEEECCCT
T ss_pred CCCEEEEEECCCCCHHHHHHHH---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCH
T ss_conf 7605999976898668999986---599999999999999999999998759---9432346254898689983871240
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHCCCC------CCCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 7511498865545333346667455011037------9889045899999999999939989999998
Q 004674 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAID------GLFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
+++....... .....||..|+|||++.+ ..++.++||||+|+++|||++|+.||.....
T Consensus 156 ~a~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~ 220 (277)
T d1phka_ 156 FSCQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220 (277)
T ss_dssp TCEECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HEEECCCCCC---EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCH
T ss_conf 3167268872---1345246788898886053445678899233185656023103228889889999
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-40 Score=282.91 Aligned_cols=215 Identities=29% Similarity=0.423 Sum_probs=175.9
Q ss_pred CHHHHHHHCCCCCCCCEECCCCCEEEEEEEECC------CCEEEEEECCCCC-CCCHHHHHHHHHHHHHH-CCCCEEEEE
Q ss_conf 789899750798956510555647699745046------6389999815899-75668899999999671-277723588
Q 004674 508 DLKIIANATDNFSEKNKLGEGGFGPVYKGMLIE------GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKL-QHRNLVKLL 579 (738)
Q Consensus 508 ~~~~~~~~~~~y~~~~~IG~G~fG~Vykg~~~~------g~~VavK~l~~~~-~~~~~~~~~Ei~~l~~l-~H~nIv~l~ 579 (738)
+...++...++|++.+.||+|+||.||+|.... ++.||+|++.... ....+.+.+|...+.++ +|+||+.++
T Consensus 4 ~~~~wei~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~ 83 (299)
T d1ywna1 4 DASKWEFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLL 83 (299)
T ss_dssp CHHHHBCCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CHHHHHHHHHHHHHHHHHCCCTTBCCEE
T ss_pred CCCCCCCCHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHCCCCEEEEEE
T ss_conf 98252616799798449841678399999986777555783999999860017178999999999988614998499741
Q ss_pred EEEECCC-CCEEEEEECCCCCHHHHHHHCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCC
Q ss_conf 4774178-21699841799994578861388-------------888999999999999999999987399997474798
Q 004674 580 GCCTQRD-ERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDL 645 (738)
Q Consensus 580 g~~~~~~-~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DL 645 (738)
+++.+.+ ..++||||+++|+|.+++..... ...+++..+..++.|++.||.|||+++ |+||||
T Consensus 84 ~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~---ivHrDl 160 (299)
T d1ywna1 84 GACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRK---CIHRDL 160 (299)
T ss_dssp EEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTT---CCCSCC
T ss_pred EEECCCCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCC
T ss_conf 15404797579999845899299999853666665322202332146899999999999999999887379---717867
Q ss_pred CCCCEEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCC
Q ss_conf 9996898489953999524751149886554533334666745501103798890458999999999999399-899999
Q 004674 646 KASNVLLDNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK-KNRGFN 724 (738)
Q Consensus 646 kp~NILl~~~~~vkL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~-~p~~~~ 724 (738)
||+|||+++++.+||+|||+|+...............||+.|+|||++.+..++.++||||||+++|||++|. .||...
T Consensus 161 Kp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~ 240 (299)
T d1ywna1 161 AARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGV 240 (299)
T ss_dssp CGGGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTC
T ss_pred CCCCEEECCCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCC
T ss_conf 73106577998289845752001135665222475166721020368646889966322136789999986889999899
Q ss_pred C
Q ss_conf 9
Q 004674 725 H 725 (738)
Q Consensus 725 ~ 725 (738)
.
T Consensus 241 ~ 241 (299)
T d1ywna1 241 K 241 (299)
T ss_dssp C
T ss_pred C
T ss_conf 9
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-40 Score=281.41 Aligned_cols=201 Identities=27% Similarity=0.450 Sum_probs=172.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCC--CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEE
Q ss_conf 79895651055564769974504-66389999815899--7566889999999967127772358847741782169984
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
++|++.+.||+|+||+||++... .++.||+|+++... ....+++.+|++++++++||||+++++++.+....++|||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e 81 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 81 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99776517723768099999999999799999980222575899999999999986799838874453322432037886
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 17999945788613888889999999999999999999873999974747989996898489953999524751149886
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~ 673 (738)
|+.++.+..... .....+++..+..++.|++.||.|||+++ |+||||||+|||++.+..+||+|||.|+......
T Consensus 82 ~~~~~~~~~~~~--~~~~~l~e~~~~~~~~qil~~L~yLH~~~---IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 82 FLHQDLKKFMDA--SALTGIPLPLIKSYLFQLLQGLAFCHSHR---VLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp CCSEEHHHHHHH--TTTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred ECCCCHHHHHHH--HCCCCCCHHHHHHHHHHHHHHHHHHHCCC---EECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 237744555442--02568888999999999999999865288---9921357114011346762103578613436886
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 554533334666745501103798-890458999999999999399899999
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwSlGviL~elltG~~p~~~~ 724 (738)
. ......||+.|+|||++.... ++.++||||+|+++|||++|+.||...
T Consensus 157 ~--~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~ 206 (298)
T d1gz8a_ 157 R--TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGD 206 (298)
T ss_dssp B--CTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred C--CCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCC
T ss_conf 4--1001036521541122136657774221033331342796687998988
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=279.71 Aligned_cols=207 Identities=29% Similarity=0.411 Sum_probs=176.2
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEECCCCCC-CCHHHHHHHHHHHHHH-CCCCEEEEEEEEECCCC
Q ss_conf 079895651055564769974504------663899998158997-5668899999999671-27772358847741782
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDE 587 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~------~g~~VavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~ 587 (738)
.++|++.+.||+|+||.||+|++. .++.||||+++.... ....++.+|+.++.++ +||||+++++++.+...
T Consensus 22 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~ 101 (311)
T d1t46a_ 22 RNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGP 101 (311)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCE
T ss_conf 89969854982068829999998066447788699999987424877999999999998762699988789989831997
Q ss_pred CEEEEEECCCCCHHHHHHHCC---------------CCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 169984179999457886138---------------88889999999999999999999873999974747989996898
Q 004674 588 RMLIYEYLPNKSLDYFIFDTT---------------RSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (738)
Q Consensus 588 ~~lV~E~~~~gsL~~~l~~~~---------------~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 652 (738)
.++||||+++|+|..++.... ....+++..+..++.||+.||+|||+++ ++||||||+||++
T Consensus 102 ~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~---ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 102 TLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKN---CIHRDLAARNILL 178 (311)
T ss_dssp CEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred EEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCCCCC
T ss_conf 8999973799879999985356654444453322233458899999999999999999887579---2666241021000
Q ss_pred CCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCC
Q ss_conf 489953999524751149886554533334666745501103798890458999999999999399-8999999
Q 004674 653 DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK-KNRGFNH 725 (738)
Q Consensus 653 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~-~p~~~~~ 725 (738)
+.++.+|++|||+++...............||+.|+|||++.+..++.++||||||+++|||+|++ +++....
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~ 252 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCC
T ss_pred CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 02575210234010233678861586201359687677886179999740010258999999858998877899
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-40 Score=283.04 Aligned_cols=205 Identities=27% Similarity=0.380 Sum_probs=173.7
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECC----CCEEEEEECCCCC-CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEE
Q ss_conf 0798956510555647699745046----6389999815899-7566889999999967127772358847741782169
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERML 590 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~~----g~~VavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~l 590 (738)
.++|++.+.||+|+||.||+|.+.. +..||+|.++... ....+.+.+|+.++++++||||+++++++. .+..++
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~i 84 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWI 84 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEE
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEEEE
T ss_conf 8996987799307882999999936996449999999365668799999999999998689999856988995-374799
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCC
Q ss_conf 98417999945788613888889999999999999999999873999974747989996898489953999524751149
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFG 670 (738)
Q Consensus 591 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~ 670 (738)
||||+++|+|..++.. ....+++..++.++.|++.||.|||+.+ ++||||||+||+++.++.+||+|||+++...
T Consensus 85 v~E~~~~g~l~~~~~~--~~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~ 159 (273)
T d1mp8a_ 85 IMELCTLGELRSFLQV--RKYSLDLASLILYAYQLSTALAYLESKR---FVHRDIAARNVLVSSNDCVKLGDFGLSRYME 159 (273)
T ss_dssp EEECCTTEEHHHHHHH--TTTTSCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEEEETTEEEECC--------
T ss_pred EEEECCCCCHHHHHHC--CCCCCCHHHHHHHHHHHHHHHHHHCCCC---EECCCCCHHHEEECCCCCEEECCCHHHEECC
T ss_conf 9984069807765422--4789999999999999987752302267---4414102655320678967876503421336
Q ss_pred CCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCC
Q ss_conf 8865545333346667455011037988904589999999999993-99899999988
Q 004674 671 LDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHAD 727 (738)
Q Consensus 671 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~ellt-G~~p~~~~~~~ 727 (738)
..... ......||+.|+|||++.+..++.++||||||+++|||++ |+.||......
T Consensus 160 ~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~ 216 (273)
T d1mp8a_ 160 DSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216 (273)
T ss_dssp ------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred CCCCE-ECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH
T ss_conf 77623-3054005831032667516998874524442478999982699998889999
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-40 Score=283.19 Aligned_cols=208 Identities=31% Similarity=0.449 Sum_probs=178.2
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECC--------CCEEEEEECCCCCC-CCHHHHHHHHHHHHHH-CCCCEEEEEEEEECC
Q ss_conf 0798956510555647699745046--------63899998158997-5668899999999671-277723588477417
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE--------GQEIAVKRLSKGSG-QGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQR 585 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~~--------g~~VavK~l~~~~~-~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~ 585 (738)
.++|++.+.||+|+||.||++.... +..||+|+++.... ....++.+|...+.++ +||||+++++++.+.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~ 91 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQD 91 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSS
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCHHHHHHHHHHHHHHHHHCCCCEEEECCCCCCCC
T ss_conf 89969700985167828999998578755566754999999881128688999999999999813999697346522018
Q ss_pred CCCEEEEEECCCCCHHHHHHHCCC-------------CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 821699841799994578861388-------------8889999999999999999999873999974747989996898
Q 004674 586 DERMLIYEYLPNKSLDYFIFDTTR-------------SKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLL 652 (738)
Q Consensus 586 ~~~~lV~E~~~~gsL~~~l~~~~~-------------~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl 652 (738)
...++||||+++|+|.+++..... ...+++..++.++.|++.||+|||+.+ |+||||||+|||+
T Consensus 92 ~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~---ivHrDiKp~NiLl 168 (299)
T d1fgka_ 92 GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKK---CIHRDLAARNVLV 168 (299)
T ss_dssp SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEE
T ss_pred CEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECCCCEEE
T ss_conf 8689999736999099999860677643222334574346799999999999999998766379---7863022102245
Q ss_pred CCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCC
Q ss_conf 4899539995247511498865545333346667455011037988904589999999999993-9989999998
Q 004674 653 DNTMNPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHA 726 (738)
Q Consensus 653 ~~~~~vkL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~ellt-G~~p~~~~~~ 726 (738)
+.++.+||+|||+++...............+++.|+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 169 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 169 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred CCCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCH
T ss_conf 478976762211101135555543146678884663266751798882555477588888740179898999999
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9e-40 Score=280.26 Aligned_cols=203 Identities=32% Similarity=0.489 Sum_probs=173.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC-CC--EEEEEECCCC-CCCCHHHHHHHHHHHHHH-CCCCEEEEEEEEECCCCCEEE
Q ss_conf 798956510555647699745046-63--8999981589-975668899999999671-277723588477417821699
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE-GQ--EIAVKRLSKG-SGQGMEEFKNEVLLIAKL-QHRNLVKLLGCCTQRDERMLI 591 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~~-g~--~VavK~l~~~-~~~~~~~~~~Ei~~l~~l-~H~nIv~l~g~~~~~~~~~lV 591 (738)
++|++.+.||+|+||.||+|.+.. +. .||||++... .....+++.+|++++.++ +||||+++++++.++...++|
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV 89 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLA 89 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEEEE
T ss_conf 99688779820788289999998999699999999782338579999999999998622899883678888418736999
Q ss_pred EEECCCCCHHHHHHHC-------------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCE
Q ss_conf 8417999945788613-------------888889999999999999999999873999974747989996898489953
Q 004674 592 YEYLPNKSLDYFIFDT-------------TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNP 658 (738)
Q Consensus 592 ~E~~~~gsL~~~l~~~-------------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~v 658 (738)
|||+++|+|.+++... .....+++..+.+++.|++.||.|||+.+ |+||||||+|||++.++.+
T Consensus 90 ~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~---iiHrDlkp~NIL~~~~~~~ 166 (309)
T d1fvra_ 90 IEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQ---FIHRDLAARNILVGENYVA 166 (309)
T ss_dssp ECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEECGGGCE
T ss_pred EEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCC---CCCCCCCCCEEEECCCCCE
T ss_conf 9802898699998640355555123101234578999999999999999987663089---5455505204898688763
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCC-CCCCCC
Q ss_conf 9995247511498865545333346667455011037988904589999999999993998-999999
Q 004674 659 KISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKK-NRGFNH 725 (738)
Q Consensus 659 kL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~-p~~~~~ 725 (738)
||+|||+++...... ......||..|+|||.+.+..++.++||||||+++|||++|.. ||....
T Consensus 167 kl~DfG~a~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 167 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp EECCTTCEESSCEEC---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred EECCCCCCCCCCCCC---CCCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCC
T ss_conf 874344322444223---45530137755553875269999622153138899999836899999999
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-39 Score=276.53 Aligned_cols=199 Identities=28% Similarity=0.455 Sum_probs=168.4
Q ss_pred CCEECCCCCEEEEEEEECCC----CEEEEEECCCC-CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECC-CCCEEEEEEC
Q ss_conf 65105556476997450466----38999981589-975668899999999671277723588477417-8216998417
Q 004674 522 KNKLGEGGFGPVYKGMLIEG----QEIAVKRLSKG-SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-DERMLIYEYL 595 (738)
Q Consensus 522 ~~~IG~G~fG~Vykg~~~~g----~~VavK~l~~~-~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E~~ 595 (738)
.++||+|+||+||+|.+..+ ..||||+++.. .....++|.+|++++++++||||++++|++.+. ...++||||+
T Consensus 32 ~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~ 111 (311)
T d1r0pa_ 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYM 111 (311)
T ss_dssp EEEEEEETTEEEEEEEECC----CEEEEEEEECCCCCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECC
T ss_pred CEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEEE
T ss_conf 66981368809999999779987999999998843697899999999999986789998678678980699438999874
Q ss_pred CCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCCC
Q ss_conf 99994578861388888999999999999999999987399997474798999689848995399952475114988655
Q 004674 596 PNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQTE 675 (738)
Q Consensus 596 ~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~~~ 675 (738)
++++|.+++.. ....+++..+++++.|+++||.|||+.+ |+||||||+|||+++++.+||+|||+++........
T Consensus 112 ~~g~l~~~~~~--~~~~~~~~~~~~i~~qia~gL~~lH~~~---iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~ 186 (311)
T d1r0pa_ 112 KHGDLRNFIRN--ETHNPTVKDLIGFGLQVAKGMKFLASKK---FVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFD 186 (311)
T ss_dssp TTCBHHHHHHC--TTCCCBHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCC
T ss_pred ECCCHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHCCCC---CCCCCCCHHHEEECCCCCEEEECCCCHHHCCCCCCC
T ss_conf 06741442101--3454048999999999887652003367---625776687576779998899106523225566555
Q ss_pred --CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf --45333346667455011037988904589999999999993998999999
Q 004674 676 --ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 676 --~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
.......||..|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 187 ~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~ 238 (311)
T d1r0pa_ 187 SVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV 238 (311)
T ss_dssp CTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC--
T ss_pred CCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 3100256555645567688743799974574661999999997899998889
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-40 Score=282.37 Aligned_cols=207 Identities=28% Similarity=0.438 Sum_probs=176.4
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC------CCCEEEEEECCCCC-CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCC
Q ss_conf 079895651055564769974504------66389999815899-75668899999999671277723588477417821
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI------EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDER 588 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~------~g~~VavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~ 588 (738)
.++|++.+.||+|+||.||+|.+. .+..||||+++... ......|.+|+.++++++||||+++++++......
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~ 98 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPT 98 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSC
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 89918835982078818999998786447789689999987012868999999999999976999884125478428810
Q ss_pred EEEEEECCCCCHHHHHHHC-------CCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf 6998417999945788613-------888889999999999999999999873999974747989996898489953999
Q 004674 589 MLIYEYLPNKSLDYFIFDT-------TRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (738)
Q Consensus 589 ~lV~E~~~~gsL~~~l~~~-------~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~ 661 (738)
++||||+++|+|.+++... .....+++..+..++.|++.||.|||+.+ |+||||||+|||+++++.+||+
T Consensus 99 ~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~---ivHrDlk~~NiLld~~~~~Kl~ 175 (308)
T d1p4oa_ 99 LVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANK---FVHRDLAARNCMVAEDFTVKIG 175 (308)
T ss_dssp EEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTT---CBCSCCSGGGEEECTTCCEEEC
T ss_pred EEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECEECCCCEEECCCCEEEEE
T ss_conf 6777604899889998750332113444688799999999999999999876479---6543286775403599649994
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCC-CCCCCCC
Q ss_conf 524751149886554533334666745501103798890458999999999999399-8999999
Q 004674 662 DFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGK-KNRGFNH 725 (738)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~-~p~~~~~ 725 (738)
|||+++...............|++.|+|||.+.+..++.++||||||+++|||+||+ .||....
T Consensus 176 DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~ 240 (308)
T d1p4oa_ 176 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLS 240 (308)
T ss_dssp CTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSC
T ss_pred ECCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCC
T ss_conf 24542023577630313402316323788887369988333444378999999968999999989
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.9e-40 Score=282.68 Aligned_cols=200 Identities=28% Similarity=0.429 Sum_probs=172.5
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECC-CCCEEEEEE
Q ss_conf 0798956510555647699745046638999981589975668899999999671277723588477417-821699841
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-DERMLIYEY 594 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-~~~~lV~E~ 594 (738)
.++|++.+.||+|+||.||+|.+ .+..||||+++.. ...+++.+|++++++++||||++++|++.+. ..+++||||
T Consensus 6 ~~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~--~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey 82 (262)
T d1byga_ 6 MKELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKND--ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEY 82 (262)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCC--C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECC
T ss_pred HHHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEEEC
T ss_conf 89948857982079808999999-9909999998857--77999999999998678989854987887238928999963
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC
Q ss_conf 79999457886138888899999999999999999998739999747479899968984899539995247511498865
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~~ 674 (738)
+++|+|.+++... ....+++..+++++.||+.||.|||+.+ ++||||||+|||++.++.+||+|||+++.....
T Consensus 83 ~~~g~L~~~l~~~-~~~~l~~~~~~~i~~~i~~al~ylH~~~---ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-- 156 (262)
T d1byga_ 83 MAKGSLVDYLRSR-GRSVLGGDCLLKFSLDVCEAMEYLEGNN---FVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-- 156 (262)
T ss_dssp CTTEEHHHHHHHH-HHHHCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCSGGGEEECTTSCEEECCCCC---------
T ss_pred CCCCCHHHHHHHC-CCCCCCHHHHHHHHHHHHHHCCCCCCCC---EECCCCCHHHHEECCCCCEEECCCCCCEECCCC--
T ss_conf 6999899998745-7888899999999999985232113376---553666567601468997763245600344787--
Q ss_pred CCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCCCC
Q ss_conf 545333346667455011037988904589999999999993-99899999988
Q 004674 675 EANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNHAD 727 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~ellt-G~~p~~~~~~~ 727 (738)
.....++..|+|||++.+..++.++||||||+++|||+| |+.||......
T Consensus 157 ---~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~ 207 (262)
T d1byga_ 157 ---QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207 (262)
T ss_dssp --------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred ---CCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHH
T ss_conf ---765566646778178727988858877757999999997899999999999
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-39 Score=279.61 Aligned_cols=203 Identities=29% Similarity=0.390 Sum_probs=172.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEECC----CCEEEEEECCCC---CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCE
Q ss_conf 798956510555647699745046----638999981589---9756688999999996712777235884774178216
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIE----GQEIAVKRLSKG---SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERM 589 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~~----g~~VavK~l~~~---~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~ 589 (738)
++|++.+.||+|+||.||+|.... ...||+|++... .....++|.+|+.++++++||||++++|++.+ ...+
T Consensus 8 ~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~ 86 (273)
T d1u46a_ 8 KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMK 86 (273)
T ss_dssp GGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCE
T ss_pred HHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCHH
T ss_conf 891997898038883999999988999079999999983555798999999999999986899998789877740-1001
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCC
Q ss_conf 99841799994578861388888999999999999999999987399997474798999689848995399952475114
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 590 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~ 669 (738)
+|+||++++++.+.+... ...+++..+..++.|+++||.|||+++ |+||||||+|||++.++.+||+|||+++..
T Consensus 87 lv~e~~~~~~l~~~~~~~--~~~l~~~~~~~~~~qi~~gl~ylH~~~---iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 87 MVTELAPLGSLLDRLRKH--QGHFLLGTLSRYAVQVAEGMGYLESKR---FIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEECCTTCBHHHHHHHH--GGGSCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHCC--CCCCCHHHHHHHHHHHHHHHHHHHHCC---EEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf 146542386125444212--689999999999999999998752178---752056688815655654332561155530
Q ss_pred CCCCCCC-CCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHC-CCCCCCCCC
Q ss_conf 9886554-5333346667455011037988904589999999999993-998999999
Q 004674 670 GLDQTEA-NTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIIC-GKKNRGFNH 725 (738)
Q Consensus 670 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~ellt-G~~p~~~~~ 725 (738)
....... ......|+..|+|||++.+..++.++||||||+++|||+| |+.||....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~ 219 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLN 219 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
T ss_conf 3588752654763257310799998379999421566148999999968999999969
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.6e-39 Score=277.19 Aligned_cols=200 Identities=26% Similarity=0.419 Sum_probs=175.1
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEECCCCC--CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEEE
Q ss_conf 7989565105556476997450466389999815899--75668899999999671277723588477417821699841
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYEY 594 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~~g~~VavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E~ 594 (738)
++|++.++||+|+||+||++..+.++.||+|++.... ....+.+.+|+.++++++||||+++++.+...+..++++|+
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~ 81 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEH 81 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSGGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEEC
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEEE
T ss_conf 99634318722778189999968999999999812326858999999999999867998687660120467731589974
Q ss_pred CCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCCC
Q ss_conf 79999457886138888899999999999999999998739999747479899968984899539995247511498865
Q 004674 595 LPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQT 674 (738)
Q Consensus 595 ~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~~ 674 (738)
+.++.+..+. ...+.+++..+..++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||.+........
T Consensus 82 ~~~~~~~~~~---~~~~~l~~~~~~~i~~qi~~~L~~LH~~~---IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 82 LDQDLKKLLD---VCEGGLESVTAKSFLLQLLNGIAYCHDRR---VLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CSEEHHHHHH---TSTTCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EHHHHHHHHH---HHCCCCCHHHHHHHHHHHHHHHHHHCCCC---EEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf 0045678998---60477514456899999999999860574---88267877505686899787323664301146765
Q ss_pred CCCCCCCCCCCCCCCHHCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCC
Q ss_conf 545333346667455011037-98890458999999999999399899999
Q 004674 675 EANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFN 724 (738)
Q Consensus 675 ~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGviL~elltG~~p~~~~ 724 (738)
......+++.|+|||.+.+ ..++.++||||+|+++|||++|+.||...
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~ 204 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred --CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCC
T ss_conf --4101024311013788717888884100211175899997797998988
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-40 Score=281.36 Aligned_cols=201 Identities=25% Similarity=0.404 Sum_probs=163.2
Q ss_pred CCCCCCCEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHH--HHHHHHHHCCCCEEEEEEEEECCC----CCEE
Q ss_conf 7989565105556476997450466389999815899756688999--999996712777235884774178----2169
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKN--EVLLIAKLQHRNLVKLLGCCTQRD----ERML 590 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~~g~~VavK~l~~~~~~~~~~~~~--Ei~~l~~l~H~nIv~l~g~~~~~~----~~~l 590 (738)
+.|...+.||+|+||.||+|++ .|+.||||+++.. ..+++.. |+..+..++||||+++++++.+.. .+++
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~---~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~l 78 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSR---EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWL 78 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGG---GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCC---CHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 6899988982078819999999-9989999998720---04679999999999627998683268899837986048999
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHC-----CCCCEEECCCCCCCEEECCCCCEEEEEECC
Q ss_conf 984179999457886138888899999999999999999998739-----999747479899968984899539995247
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD-----SRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (738)
Q Consensus 591 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~-----~~~~ivH~DLkp~NILl~~~~~vkL~DfGl 665 (738)
||||+++|+|..++.. ..+++..+..++.+++.||+|||+. ...+|+||||||+|||++.++.+||+|||+
T Consensus 79 v~Ey~~~g~L~~~l~~----~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl 154 (303)
T d1vjya_ 79 VSDYHEHGSLFDYLNR----YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGL 154 (303)
T ss_dssp EEECCTTCBHHHHHHH----CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTT
T ss_pred EEECCCCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEECCC
T ss_conf 9964669898999865----899989999999999999999887665204689866153173135786887768876386
Q ss_pred CCCCCCCCC--CCCCCCCCCCCCCCCHHCCCCCC------CCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 511498865--54533334666745501103798------8904589999999999993998999999
Q 004674 666 ARSFGLDQT--EANTKRVVGTYGYMSPEYAIDGL------FSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 666 a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~------~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
++....... ........||+.|+|||++.+.. ++.++||||||++||||+||..|++...
T Consensus 155 ~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~ 222 (303)
T d1vjya_ 155 AVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp CEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred CCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 62346777620013552503547678221056545467776750122015999999962899887663
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-39 Score=274.60 Aligned_cols=203 Identities=26% Similarity=0.423 Sum_probs=168.2
Q ss_pred HCCCCCCCCEECCCCCEEEEEEEEC-C-CCEEEEEECCCC--CCCCHHHHHHHHHHHHHH---CCCCEEEEEEEEEC---
Q ss_conf 5079895651055564769974504-6-638999981589--975668899999999671---27772358847741---
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-E-GQEIAVKRLSKG--SGQGMEEFKNEVLLIAKL---QHRNLVKLLGCCTQ--- 584 (738)
Q Consensus 515 ~~~~y~~~~~IG~G~fG~Vykg~~~-~-g~~VavK~l~~~--~~~~~~~~~~Ei~~l~~l---~H~nIv~l~g~~~~--- 584 (738)
..++|++.+.||+|+||+||++... . ++.||+|++... .......+.+|+.+++.+ +||||+++++++..
T Consensus 5 ~~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 5 ADQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTTSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 75897988899215586999999988899899999980232451679999999999998742589880236632214666
Q ss_pred --CCCCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEE
Q ss_conf --782169984179999457886138888899999999999999999998739999747479899968984899539995
Q 004674 585 --RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISD 662 (738)
Q Consensus 585 --~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~D 662 (738)
....++++|++.++.+..... .....+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+||+|
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~--~~~~~~~~~~~~~~~~qi~~aL~yLH~~~---ivHrDiKp~NILi~~~~~~kl~d 159 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDK--VPEPGVPTETIKDMMFQLLRGLDFLHSHR---VVHRDLKPQNILVTSSGQIKLAD 159 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHH--SCTTCSCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECS
T ss_pred CCCCEEEEEEEECCCCCHHHHHH--CCCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCCCEEEECCCCCEEECC
T ss_conf 66746999997405871444443--03789998999999999999999997588---98357986278985899754210
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 247511498865545333346667455011037988904589999999999993998999999
Q 004674 663 FGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 663 fGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
||++...... .......||+.|+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 160 fg~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~ 219 (305)
T d1blxa_ 160 FGLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSS 219 (305)
T ss_dssp CCSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred HHHHHHHCCC---CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCC
T ss_conf 0010110023---45777654851148310017988811100032899999987879989989
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-38 Score=271.43 Aligned_cols=198 Identities=24% Similarity=0.370 Sum_probs=163.8
Q ss_pred CCCCCCEECCCCCEEEEEEEECC-CCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCEEEEEEEEECC------CCCEE
Q ss_conf 98956510555647699745046-638999981589975668899999999671277723588477417------82169
Q 004674 518 NFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------DERML 590 (738)
Q Consensus 518 ~y~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~~~~l 590 (738)
+|+..++||+|+||+||+++... ++.||+|++..... ...+|+.++++++|+||+++++++... ...++
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~----~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~l 96 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR----FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNL 96 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS----SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH----HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEEEEE
T ss_conf 76751698217683999999999997999999881606----89999999986689898738789974476577318999
Q ss_pred EEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CEEEEEECCCCCC
Q ss_conf 984179999457886138888899999999999999999998739999747479899968984899-5399952475114
Q 004674 591 IYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTM-NPKISDFGLARSF 669 (738)
Q Consensus 591 V~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~-~vkL~DfGla~~~ 669 (738)
||||++++.+............+++..+..++.|++.||+|||+++ |+||||||+|||++.++ .+||+|||++...
T Consensus 97 v~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~---IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~ 173 (350)
T d1q5ka_ 97 VLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFG---ICHRDIKPQNLLLDPDTAVLKLCDFGSAKQL 173 (350)
T ss_dssp EEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECTTTCCEEECCCTTCEEC
T ss_pred EEECCCCCCHHHHHHHHHCCCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEEECCCCCEEEECCCCHHHC
T ss_conf 9841688607888863103689999999999999999999998668---7645788603787358971167336605440
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 98865545333346667455011037-988904589999999999993998999999
Q 004674 670 GLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 670 ~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
..... .....|+..|+|||.+.+ ..++.++||||+|+++|||++|+.||....
T Consensus 174 ~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~ 227 (350)
T d1q5ka_ 174 VRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDS 227 (350)
T ss_dssp CTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSS
T ss_pred CCCCC---CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCC
T ss_conf 47765---3200255555682776404688821000246527785502879989879
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.7e-38 Score=270.41 Aligned_cols=203 Identities=24% Similarity=0.371 Sum_probs=170.6
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCC-CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCC----CCE
Q ss_conf 079895651055564769974504-66389999815899-756688999999996712777235884774178----216
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS-GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----ERM 589 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~-~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----~~~ 589 (738)
+++|++.+.||+|+||+||+|... .++.||||++.... ....+++.+|+.+++.++||||+++++++.... ..+
T Consensus 7 ~~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~ 86 (345)
T d1pmea_ 7 GPRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDV 86 (345)
T ss_dssp CTTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 89859978994064809999999999949999998031095899999999999997689898858889950564554149
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCC
Q ss_conf 99841799994578861388888999999999999999999987399997474798999689848995399952475114
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSF 669 (738)
Q Consensus 590 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~ 669 (738)
++++++.+++|.+++.. ..+++..+..++.|++.||+|||+++ |+||||||+|||+++++.+||+|||++...
T Consensus 87 ~l~~~~~~g~L~~~l~~----~~l~~~~i~~i~~qil~al~yLH~~~---iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 87 YLVTHLMGADLYKLLKT----QHLSNDHICYFLYQILRGLKYIHSAN---VLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEECCCEEHHHHHHH----CCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEECCCCHHHHHHC----CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 99996259865664405----89999999999999999999999789---867778764378879997787545705650
Q ss_pred CCCCCC-CCCCCCCCCCCCCCHHCCC-CCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 988655-4533334666745501103-7988904589999999999993998999999
Q 004674 670 GLDQTE-ANTKRVVGTYGYMSPEYAI-DGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 670 ~~~~~~-~~~~~~~gt~~y~aPE~~~-~~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
...... ......+|++.|+|||++. +..++.++||||+|+++|||++|+.||....
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~ 217 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKH 217 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCC
T ss_conf 4777641010110265200038786047888741010046701337766979978888
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-38 Score=272.65 Aligned_cols=204 Identities=25% Similarity=0.419 Sum_probs=171.8
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCC--CCCCHHHHHHHHHHHHHHCCCCEEEEEEEEEC--------
Q ss_conf 079895651055564769974504-6638999981589--97566889999999967127772358847741--------
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKG--SGQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQ-------- 584 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~--~~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~-------- 584 (738)
.++|++.+.||+|+||+||+++.. .++.||||++... .....+++.+|+.++++++|+|++++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CTTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 27988999972274829999999899979999998422246378999999999999835999660676540246544445
Q ss_pred CCCCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEEC
Q ss_conf 78216998417999945788613888889999999999999999999873999974747989996898489953999524
Q 004674 585 RDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFG 664 (738)
Q Consensus 585 ~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfG 664 (738)
....++||||+.++.+.... .....+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+||+|||
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~---~~~~~~~~~~~~~i~~qil~~l~~lH~~~---ivHrDlKp~NILl~~~~~~kl~dfg 162 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLS---NVLVKFTLSEIKRVMQMLLNGLYYIHRNK---ILHRDMKAANVLITRDGVLKLADFG 162 (318)
T ss_dssp --CEEEEEECCCEEHHHHHT---CTTCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTSCEEECCCT
T ss_pred CCEEEEEEECCCCCCCCHHH---HCCCCCCCHHHHHHHHHHHHHHHHHCCCC---EEECCCCCHHEEECCCCCEEEEECC
T ss_conf 76389998535787410122---20344330899999999999998852299---8856767222036689968763135
Q ss_pred CCCCCCCCCCC--CCCCCCCCCCCCCCHHCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 75114988655--453333466674550110379-88904589999999999993998999999
Q 004674 665 LARSFGLDQTE--ANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 665 la~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
++......... ......+||+.|+|||++.+. .++.++||||+|+++|||++|+.||....
T Consensus 163 ~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~ 226 (318)
T d3blha1 163 LARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNT 226 (318)
T ss_dssp TCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred EEEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCC
T ss_conf 0022355444321135660249787428997079998917870067864661744879989989
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.8e-39 Score=275.40 Aligned_cols=198 Identities=25% Similarity=0.389 Sum_probs=166.7
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCCC------CCHHHHHHHHHHHHHHC--CCCEEEEEEEEECCC
Q ss_conf 079895651055564769974504-663899998158997------56688999999996712--777235884774178
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG------QGMEEFKNEVLLIAKLQ--HRNLVKLLGCCTQRD 586 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~~------~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~ 586 (738)
.++|++.+.||+|+||.||++... +++.||+|++.+... ....++.+|+.++++++ ||||+++++++.+.+
T Consensus 3 ~~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~ 82 (273)
T d1xwsa_ 3 ESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 82 (273)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSS
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECC
T ss_conf 88379967984087839999999999979999998568844334556799999999999974358988127999983099
Q ss_pred CCEEEEEECCC-CCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-CCCEEEEEEC
Q ss_conf 21699841799-994578861388888999999999999999999987399997474798999689848-9953999524
Q 004674 587 ERMLIYEYLPN-KSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-TMNPKISDFG 664 (738)
Q Consensus 587 ~~~lV~E~~~~-gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-~~~vkL~DfG 664 (738)
..++||||+.+ +++..++.. ...+++..+..++.|++.||+|||+.+ |+||||||+|||++. ++.+||+|||
T Consensus 83 ~~~lv~e~~~~~~~l~~~~~~---~~~l~e~~~~~~~~qi~~al~~lH~~~---iiHrDiKp~NIll~~~~~~vkl~DFG 156 (273)
T d1xwsa_ 83 SFVLILERPEPVQDLFDFITE---RGALQEELARSFFWQVLEAVRHCHNCG---VLHRDIKDENILIDLNRGELKLIDFG 156 (273)
T ss_dssp EEEEEEECCSSEEEHHHHHHH---HCSCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCSGGGEEEETTTTEEEECCCT
T ss_pred EEEEEEEECCCCCHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEEECCCCEEEECCCC
T ss_conf 689999833686228999861---589999999999999999999998779---75566761114774478848977546
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCC-CCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 7511498865545333346667455011037988-9045899999999999939989999
Q 004674 665 LARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLF-SVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 665 la~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-t~~sDVwSlGviL~elltG~~p~~~ 723 (738)
++...... ......||+.|+|||++.+..+ +.++||||+|+++|||++|+.||..
T Consensus 157 ~a~~~~~~----~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~ 212 (273)
T d1xwsa_ 157 SGALLKDT----VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEH 212 (273)
T ss_dssp TCEECCSS----CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCS
T ss_pred CCEECCCC----CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCC
T ss_conf 53532444----556656587747999984899788653325540345367568899887
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.6e-38 Score=269.56 Aligned_cols=198 Identities=25% Similarity=0.416 Sum_probs=168.5
Q ss_pred HCCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEECCCCC--CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCC-----
Q ss_conf 50798956510555647699745046-6389999815899--756688999999996712777235884774178-----
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRD----- 586 (738)
Q Consensus 515 ~~~~y~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~----- 586 (738)
..++|++.++||+|+||+||++.... ++.||+|+++... ....+.+.+|+.+++.++||||+++++++....
T Consensus 16 ~~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 16 VRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp CBSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTTSSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 47718998898017781999999999998999999852225969999999999999866898754799986357655554
Q ss_pred -CCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECC
Q ss_conf -2169984179999457886138888899999999999999999998739999747479899968984899539995247
Q 004674 587 -ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGL 665 (738)
Q Consensus 587 -~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGl 665 (738)
..++||||+ +.+|..+.. ...+++..+..++.|++.||.|||+++ |+||||||+|||++.++.+|++|||+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~----~~~l~~~~~~~~~~qi~~aL~~LH~~~---IiHrDiKp~NIL~~~~~~~kl~Dfg~ 167 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMK----HEKLGEDRIQFLVYQMLKGLRYIHAAG---IIHRDLKPGNLAVNEDCELKILDFGL 167 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCCGGGEEECTTCCEEECCCTT
T ss_pred CEEEEEEECC-CCCHHHHHH----HCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCHHHCCCCCCCCCCCCCC
T ss_conf 1599998405-521899987----402269999999999999999987378---76456685111121001221134310
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCHHCCCC-CCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 511498865545333346667455011037-988904589999999999993998999999
Q 004674 666 ARSFGLDQTEANTKRVVGTYGYMSPEYAID-GLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 666 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
++..... .....|++.|+|||++.+ ..++.++||||+|+++|||++|+.||....
T Consensus 168 a~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~ 223 (346)
T d1cm8a_ 168 ARQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSD 223 (346)
T ss_dssp CEECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCC
T ss_conf 2206876-----3102455333588998178789965010300389999997869988897
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.1e-37 Score=263.31 Aligned_cols=204 Identities=19% Similarity=0.270 Sum_probs=171.8
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHCC-CCEEEEEEEEECCCCCEEEEE
Q ss_conf 079895651055564769974504-663899998158997566889999999967127-772358847741782169984
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQH-RNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~~~~lV~E 593 (738)
.++|++.+.||+|+||.||+|+.. .++.||+|.+.... ....+.+|++.+..++| +|++.+++++......++|||
T Consensus 4 g~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~--~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme 81 (293)
T d1csna_ 4 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRS--DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVID 81 (293)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCT--TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCC--CCHHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEEEE
T ss_conf 980699799841788299999998899799999975025--829999999999996489998779999601881179999
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCEEEEEECCCCC
Q ss_conf 1799994578861388888999999999999999999987399997474798999689848-----99539995247511
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDN-----TMNPKISDFGLARS 668 (738)
Q Consensus 594 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~-----~~~vkL~DfGla~~ 668 (738)
|+ +++|.+++.. ....++...+..++.|++.||.|||+.+ |+||||||+|||++. ++.+||+|||+|+.
T Consensus 82 ~~-~~~l~~~~~~--~~~~~~~~~~~~i~~q~~~~l~~lH~~g---iiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~ 155 (293)
T d1csna_ 82 LL-GPSLEDLLDL--CGRKFSVKTVAMAAKQMLARVQSIHEKS---LVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKF 155 (293)
T ss_dssp CC-CCBHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHTTT---EECCCCCGGGEEECCSSSTTTTCEEECCCTTCEE
T ss_pred EC-CCCHHHHHHH--HCCCHHHHHHHHHHHHHHHHHHHHHHCC---CEECCCCCCCEEECCCCCCCCCCEEECCCCEEEE
T ss_conf 64-8887999975--2031106899999999999999999779---6626677131523475434479568723660577
Q ss_pred CCCCCCC-----CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCC
Q ss_conf 4988655-----4533334666745501103798890458999999999999399899999988
Q 004674 669 FGLDQTE-----ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHAD 727 (738)
Q Consensus 669 ~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~~~ 727 (738)
....... ......+||+.|+|||++.+..++.++||||||+++|||++|+.||......
T Consensus 156 ~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~ 219 (293)
T d1csna_ 156 YRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219 (293)
T ss_dssp SBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSC
T ss_pred CCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH
T ss_conf 1467665411102467627751026798964888886999898319999998698767885302
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-38 Score=269.48 Aligned_cols=206 Identities=27% Similarity=0.391 Sum_probs=174.4
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC----CCCEEEEEECCCC----CCCCHHHHHHHHHHHHHHCC-CCEEEEEEEEECCC
Q ss_conf 079895651055564769974504----6638999981589----97566889999999967127-77235884774178
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI----EGQEIAVKRLSKG----SGQGMEEFKNEVLLIAKLQH-RNLVKLLGCCTQRD 586 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~----~g~~VavK~l~~~----~~~~~~~~~~Ei~~l~~l~H-~nIv~l~g~~~~~~ 586 (738)
.++|++.+.||+|+||.||++... .++.||+|++.+. .....+.+.+|++++.+++| |||+++++++.+..
T Consensus 23 l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~ 102 (322)
T d1vzoa_ 23 IENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTET 102 (322)
T ss_dssp GGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETT
T ss_pred HHCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCC
T ss_conf 10259998983287839999998765887948999998367721016899999999999986467983999620002487
Q ss_pred CCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCC
Q ss_conf 21699841799994578861388888999999999999999999987399997474798999689848995399952475
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (738)
Q Consensus 587 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla 666 (738)
..++++||+.+++|..++... ..+++.....++.|++.|+.|||+.+ |+||||||+|||++.++.+||+|||++
T Consensus 103 ~~~~v~e~~~~~~L~~~i~~~---~~~~e~~~~~~~~Qi~~al~~lH~~~---ivHrDiKp~Nill~~~~~vkL~DFG~a 176 (322)
T d1vzoa_ 103 KLHLILDYINGGELFTHLSQR---ERFTEHEVQIYVGEIVLALEHLHKLG---IIYRDIKLENILLDSNGHVVLTDFGLS 176 (322)
T ss_dssp EEEEEECCCCSCBHHHHHHHH---SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTSCEEESCSSEE
T ss_pred CEEEEEECCCCCHHHHHHHHC---CCCCHHHHHHHHHHHHHHHHHHHCCC---EEECCCCCCCEEECCCCCEEEEECCCH
T ss_conf 300123123411799998730---45437888888999999998851499---896547732012469998887413202
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHCCCCC--CCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 114988655453333466674550110379--88904589999999999993998999999888
Q 004674 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDG--LFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728 (738)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~t~~sDVwSlGviL~elltG~~p~~~~~~~~ 728 (738)
+.+...... ......|++.|+|||.+.+. .++.++||||+|++||||++|+.||......+
T Consensus 177 ~~~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 177 KEFVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp EECCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred HHHCCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH
T ss_conf 220344443-221222333331068760577688713251777799999976899988887777
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.7e-37 Score=262.73 Aligned_cols=205 Identities=23% Similarity=0.309 Sum_probs=166.1
Q ss_pred CCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCEE-EEEEEEECCCCCEEEEE
Q ss_conf 079895651055564769974504-6638999981589975668899999999671277723-58847741782169984
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNLV-KLLGCCTQRDERMLIYE 593 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nIv-~l~g~~~~~~~~~lV~E 593 (738)
.++|++.+.||+|+||.||+|... .++.||||.+..... ..++..|+++++.++|++++ .+..+..+....++|||
T Consensus 6 g~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme 83 (299)
T d1ckia_ 6 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTK--HPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVME 83 (299)
T ss_dssp TTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTT--SCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEE
T ss_pred CCEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCC--CHHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEEEE
T ss_conf 8889996898507880999999988998999999721005--88899999999970389960179999951987789998
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCEEEEEECCCCCCC
Q ss_conf 179999457886138888899999999999999999998739999747479899968984---89953999524751149
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLD---NTMNPKISDFGLARSFG 670 (738)
Q Consensus 594 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~---~~~~vkL~DfGla~~~~ 670 (738)
|+.+ ++...+.. ....+++..+..++.|++.||+|||+++ |+||||||+|||++ .+..+||+|||+|+...
T Consensus 84 ~~~~-~l~~~~~~--~~~~~~~~~~~~~~~qi~~~l~~lH~~~---iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~ 157 (299)
T d1ckia_ 84 LLGP-SLEDLFNF--CSRKFSLKTVLLLADQMISRIEYIHSKN---FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYR 157 (299)
T ss_dssp CCCC-BHHHHHHH--TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECSCCCGGGEEECCGGGTTCEEECCCSSCEECB
T ss_pred ECCC-CHHHHHHH--CCCCCCHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHCCCCCCCCCCEEEEECCCCCEECC
T ss_conf 7387-13332443--0688768999999999999999999799---4426678766064335777615650467513425
Q ss_pred CCCCC-----CCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCC
Q ss_conf 88655-----45333346667455011037988904589999999999993998999999888
Q 004674 671 LDQTE-----ANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNHADH 728 (738)
Q Consensus 671 ~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~~~~ 728 (738)
..... .......||+.|+|||++.+..++.++||||||+++|||++|+.||.......
T Consensus 158 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~ 220 (299)
T d1ckia_ 158 DARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAAT 220 (299)
T ss_dssp CTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC---
T ss_pred CCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHH
T ss_conf 544554100013577678735329999918998983218861778999984987665530577
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=9e-37 Score=260.16 Aligned_cols=195 Identities=24% Similarity=0.401 Sum_probs=166.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHC-CCCEEEEEEEEECC--CCCEEEE
Q ss_conf 79895651055564769974504-66389999815899756688999999996712-77723588477417--8216998
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQR--DERMLIY 592 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~--~~~~lV~ 592 (738)
++|++.++||+|+||+||+++.. .++.||+|+++.. ..+++.+|+.++..++ ||||+++++++... ...++||
T Consensus 35 d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~---~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~ 111 (328)
T d3bqca1 35 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV---KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVF 111 (328)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS---CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCEEEEE
T ss_conf 6718978983174819999998899979999998889---9999999999998515799876799999816877126888
Q ss_pred EECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCEEEEEECCCCCCCC
Q ss_conf 417999945788613888889999999999999999999873999974747989996898489-9539995247511498
Q 004674 593 EYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNT-MNPKISDFGLARSFGL 671 (738)
Q Consensus 593 E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~-~~vkL~DfGla~~~~~ 671 (738)
||+.+++|.... +.+++..+..++.||+.||.|||+++ |+||||||+|||++.+ ..+||+|||++.....
T Consensus 112 e~~~~~~L~~~~------~~l~e~~i~~i~~qil~aL~~LH~~g---IvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~ 182 (328)
T d3bqca1 112 EHVNNTDFKQLY------QTLTDYDIRFYMYEILKALDYCHSMG---IMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP 182 (328)
T ss_dssp ECCCSCBGGGTT------TSCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEEETTTTEEEECCGGGCEECCT
T ss_pred EECCCCCHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCEEECCCCCEEEECCCCCCEECCC
T ss_conf 631798589974------68999999999999999998876433---443456441237748998366415654266468
Q ss_pred CCCCCCCCCCCCCCCCCCHHCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCCC
Q ss_conf 8655453333466674550110379-889045899999999999939989999998
Q 004674 672 DQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNHA 726 (738)
Q Consensus 672 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGviL~elltG~~p~~~~~~ 726 (738)
... .....+|..|+|||.+.+. .++.++||||+|++++||++|+.||.....
T Consensus 183 ~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 183 GQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp TCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred CCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCH
T ss_conf 874---44322486424761026888888452323354555876048899988760
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-37 Score=261.93 Aligned_cols=199 Identities=25% Similarity=0.398 Sum_probs=172.4
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCC--CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECCCCCEEEEE
Q ss_conf 79895651055564769974504-66389999815899--7566889999999967127772358847741782169984
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQRDERMLIYE 593 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~~~~~lV~E 593 (738)
++|++.+.||+|+||+||+++.. .++.||+|+++... ....+++.+|+.+++.++|+||+++++++.+....++++|
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~ 81 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCSSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEEE
T ss_conf 99786269712868199999999999699999980321786899999999999985675788821354444431158863
Q ss_pred ECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCCCCCCCCC
Q ss_conf 17999945788613888889999999999999999999873999974747989996898489953999524751149886
Q 004674 594 YLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLARSFGLDQ 673 (738)
Q Consensus 594 ~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~~~~~~ 673 (738)
++.++.+..++. ..+.+++..+..++.|++.||+|||+++ |+||||||+|||++.+..+||+|||.+.......
T Consensus 82 ~~~~~~l~~~~~---~~~~~~~~~~~~~~~q~~~aL~~lH~~~---IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 82 FCDQDLKKYFDS---CNGDLDPEIVKSFLFQLLKGLGFCHSRN---VLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp CCSEEHHHHHHH---TTTCCCHHHHHHHHHHHHHHHHHHHHTT---EECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred ECCCCCCCCCCC---CCCCCCHHHHHHHHHHHHHHHHHHHCCC---EEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 023322211212---3565403678999999999987743399---8600146761211337826652046011046887
Q ss_pred CCCCCCCCCCCCCCCCHHCCCCCC-CCCHHHHHHHHHHHHHHHCCCCCCCC
Q ss_conf 554533334666745501103798-89045899999999999939989999
Q 004674 674 TEANTKRVVGTYGYMSPEYAIDGL-FSVKSDVFSFGVLVLEIICGKKNRGF 723 (738)
Q Consensus 674 ~~~~~~~~~gt~~y~aPE~~~~~~-~t~~sDVwSlGviL~elltG~~p~~~ 723 (738)
.. .....++..|+|||++.... ++.++||||+|+++|||++|+.||..
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~ 204 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred CC--CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCC
T ss_conf 51--00103443101466750698888044402654188998518999988
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-37 Score=260.61 Aligned_cols=198 Identities=26% Similarity=0.353 Sum_probs=169.0
Q ss_pred CCCCCCCCEECCCCCEEEEEEEECC-CCEEEEEECCCCC--CCCHHHHHHHHHHHHHHCCCCEEEEEEEEECC------C
Q ss_conf 0798956510555647699745046-6389999815899--75668899999999671277723588477417------8
Q 004674 516 TDNFSEKNKLGEGGFGPVYKGMLIE-GQEIAVKRLSKGS--GQGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR------D 586 (738)
Q Consensus 516 ~~~y~~~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~~~--~~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~------~ 586 (738)
.++|++.++||+|+||+||+|.... ++.||||++.... ....+++.+|+.++++++||||+++++++... .
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 37759988962175859999999999989999998823369799999999999998648987648998970256434576
Q ss_pred CCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCC
Q ss_conf 21699841799994578861388888999999999999999999987399997474798999689848995399952475
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (738)
Q Consensus 587 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla 666 (738)
..++||||+.++.+.... ..+++..+..++.|++.||.|||+.+ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~iv~Ey~~~~l~~~~~------~~~~~~~i~~~~~qil~gl~~LH~~g---iiHrDlKP~Nil~~~~~~~kl~df~~~ 166 (355)
T d2b1pa1 96 DVYLVMELMDANLCQVIQ------MELDHERMSYLLYQMLCGIKHLHSAG---IIHRDLKPSNIVVKSDCTLKILDFGLA 166 (355)
T ss_dssp EEEEEEECCSEEHHHHHT------SCCCHHHHHHHHHHHHHHHHHHHHTT---CCCSCCCGGGEEECTTCCEEECCCCC-
T ss_pred EEEEEEECCCHHHHHHHH------CCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCEEEECHHHH
T ss_conf 269998414467787650------38999999999999999998865221---124567763211365443132010232
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 11498865545333346667455011037988904589999999999993998999999
Q 004674 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
+...... ......+|+.|+|||++.+..++.++||||+|++++||++|+.||...+
T Consensus 167 ~~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~ 222 (355)
T d2b1pa1 167 RTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_dssp -----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HCCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCC
T ss_conf 1146665---5332214655558133147777877433356625789865989988897
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-37 Score=260.34 Aligned_cols=199 Identities=27% Similarity=0.412 Sum_probs=168.6
Q ss_pred HCCCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCCC--CCHHHHHHHHHHHHHHCCCCEEEEEEEEECC-----C
Q ss_conf 5079895651055564769974504-663899998158997--5668899999999671277723588477417-----8
Q 004674 515 ATDNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSG--QGMEEFKNEVLLIAKLQHRNLVKLLGCCTQR-----D 586 (738)
Q Consensus 515 ~~~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~~--~~~~~~~~Ei~~l~~l~H~nIv~l~g~~~~~-----~ 586 (738)
..++|++.+.||+|+||+||++... .++.||+|+++.... ...+++.+|+.+++.++|+|++++++++... .
T Consensus 16 ~~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 16 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp EETTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTSSHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCC
T ss_conf 89871888898317883999999999997999999882002868999999999999866898742599999634645668
Q ss_pred CCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEEEECCC
Q ss_conf 21699841799994578861388888999999999999999999987399997474798999689848995399952475
Q 004674 587 ERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKISDFGLA 666 (738)
Q Consensus 587 ~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~DfGla 666 (738)
..+++++++.+++|.+++. .+.+++..+..++.|++.||+|||+++ |+||||||+|||++.++.+|++|||++
T Consensus 96 ~~~~i~~~~~gg~L~~~~~----~~~l~e~~~~~i~~qil~aL~~LH~~g---iiHrDiKp~NILi~~~~~~kl~dfg~a 168 (348)
T d2gfsa1 96 NDVYLVTHLMGADLNNIVK----CQKLTDDHVQFLIYQILRGLKYIHSAD---IIHRDLKPSNLAVNEDCELKILDFGLA 168 (348)
T ss_dssp CCCEEEEECCSEEHHHHHT----TCCCCHHHHHHHHHHHHHHHHHHHHTT---CCCCCCCGGGEEECTTCCEEECCC---
T ss_pred CEEEEEEEECCCCHHHHCC----CCCCCHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf 6499999625886232002----245309999999999999999997388---765166776334554322001321000
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCHHCCCCC-CCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf 114988655453333466674550110379-88904589999999999993998999999
Q 004674 667 RSFGLDQTEANTKRVVGTYGYMSPEYAIDG-LFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 667 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
..... ......|+..|+|||+..+. .++.++||||+|+++|||++|+.||...+
T Consensus 169 ~~~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~ 223 (348)
T d2gfsa1 169 RHTDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 223 (348)
T ss_dssp -CCTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CCCCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCC
T ss_conf 12575-----44443454355583553377567855124320589999976889978898
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.7e-32 Score=231.56 Aligned_cols=200 Identities=22% Similarity=0.298 Sum_probs=160.7
Q ss_pred CCCCCCCEECCCCCEEEEEEEEC-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHC-----------CCCEEEEEEEEEC
Q ss_conf 79895651055564769974504-66389999815899756688999999996712-----------7772358847741
Q 004674 517 DNFSEKNKLGEGGFGPVYKGMLI-EGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-----------HRNLVKLLGCCTQ 584 (738)
Q Consensus 517 ~~y~~~~~IG~G~fG~Vykg~~~-~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~-----------H~nIv~l~g~~~~ 584 (738)
++|++.++||+|+||+||+++.. .++.||||++.... ...+.+.+|+.+++.++ |+||+++++++..
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~-~~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~ 91 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK-VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNH 91 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH-HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCC-CCHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 85799899750778189999999999799999983431-33689999999999840145555542276764789987631
Q ss_pred C--CCCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHH-CCCCCEEECCCCCCCEEECCCC-----
Q ss_conf 7--8216998417999945788613888889999999999999999999873-9999747479899968984899-----
Q 004674 585 R--DERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQ-DSRLRIIHRDLKASNVLLDNTM----- 656 (738)
Q Consensus 585 ~--~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~-~~~~~ivH~DLkp~NILl~~~~----- 656 (738)
. ...++++++...+..............+++..+..++.|++.||+|||+ .+ |+||||||+|||++.++
T Consensus 92 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~---IvHrDlKp~NIll~~~~~~~~~ 168 (362)
T d1q8ya_ 92 KGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG---IIHTDIKPENVLMEIVDSPENL 168 (362)
T ss_dssp EETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTC---EECSCCSGGGEEEEEEETTTTE
T ss_pred CCCCCEEEEEEECCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHCC---CCCCCCCHHHEEEECCCCCCCC
T ss_conf 2565202343200035420000012234678689999999999999888764058---6465677057056305765644
Q ss_pred -CEEEEEECCCCCCCCCCCCCCCCCCCCCCCCCCHHCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf -539995247511498865545333346667455011037988904589999999999993998999999
Q 004674 657 -NPKISDFGLARSFGLDQTEANTKRVVGTYGYMSPEYAIDGLFSVKSDVFSFGVLVLEIICGKKNRGFNH 725 (738)
Q Consensus 657 -~vkL~DfGla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~t~~sDVwSlGviL~elltG~~p~~~~~ 725 (738)
.++++|||.+..... ......|++.|+|||++.+..++.++||||+|++++||++|+.||....
T Consensus 169 ~~~kl~dfg~s~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 169 IQIKIADLGNACWYDE-----HYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp EEEEECCCTTCEETTB-----CCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred CEEEEEECCCCCCCCC-----CCCCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCC
T ss_conf 3056753144212344-----5422366521057132146677764320123789999987889989875
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.82 E-value=2.9e-20 Score=149.58 Aligned_cols=164 Identities=20% Similarity=0.207 Sum_probs=117.9
Q ss_pred CCCCEECCCCCEEEEEEEECCCCEEEEEECCCCCC------------------CCHHHHHHHHHHHHHHCCCCEEEEEEE
Q ss_conf 95651055564769974504663899998158997------------------566889999999967127772358847
Q 004674 520 SEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSG------------------QGMEEFKNEVLLIAKLQHRNLVKLLGC 581 (738)
Q Consensus 520 ~~~~~IG~G~fG~Vykg~~~~g~~VavK~l~~~~~------------------~~~~~~~~Ei~~l~~l~H~nIv~l~g~ 581 (738)
.+.++||+|+||.||+|...+|+.||+|.++.... ........|...+.++.|.+++..++.
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EECCCCCEEEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCEEEE
Q ss_conf 74178216998417999945788613888889999999999999999999873999974747989996898489953999
Q 004674 582 CTQRDERMLIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDSRLRIIHRDLKASNVLLDNTMNPKIS 661 (738)
Q Consensus 582 ~~~~~~~~lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~~~~ivH~DLkp~NILl~~~~~vkL~ 661 (738)
. ..+++||++++..+.. ++......++.|++.+++|||+.+ |+||||||+|||++++ .++|+
T Consensus 83 ~----~~~lvme~~~~~~~~~----------l~~~~~~~i~~ql~~~l~~lH~~g---iiHrDiKP~NILv~~~-~~~li 144 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR----------VRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSEE-GIWII 144 (191)
T ss_dssp E----TTEEEEECCCCEEGGG----------CCCSCHHHHHHHHHHHHHHHHHTT---EECSCCSTTSEEEETT-EEEEC
T ss_pred C----CCEEEEEEECCCCCCC----------HHHHHHHHHHHHHHHHHHHHHHCC---EEECCCCHHHEEEECC-CEEEE
T ss_conf 2----8889999504565420----------015789999999999999982688---8983689036114289-89998
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCCH------HCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 52475114988655453333466674550------1103798890458999999999
Q 004674 662 DFGLARSFGLDQTEANTKRVVGTYGYMSP------EYAIDGLFSVKSDVFSFGVLVL 712 (738)
Q Consensus 662 DfGla~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~t~~sDVwSlGviL~ 712 (738)
|||.|.....+... .|... +.+ ...|..++|+||..--++
T Consensus 145 DFG~a~~~~~~~~~----------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~~ 190 (191)
T d1zara2 145 DFPQSVEVGEEGWR----------EILERDVRNIITYF-SRTYRTEKDINSAIDRIL 190 (191)
T ss_dssp CCTTCEETTSTTHH----------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHHH
T ss_pred ECCCCCCCCCCCCH----------HHHHHHHHHHHHHH-CCCCCCCCCHHHHHHHHH
T ss_conf 77884308998709----------99987799999997-578998446899999874
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=99.79 E-value=9e-19 Score=139.55 Aligned_cols=112 Identities=20% Similarity=0.413 Sum_probs=91.8
Q ss_pred CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEEECCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEEEE
Q ss_conf 46557898457999696089938997645899986158786542689808996359998756986089943178149997
Q 004674 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (738)
Q Consensus 45 ~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~lvl~ 124 (738)
+|+|.+||.|.+|++|+| |.|.|.|+..++ |.++. ..++||.||++.|.. .+.+.++ .||+|||+
T Consensus 1 tDtL~~gq~L~~g~~l~~--g~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~~--~~~l~l~--~dGnLvl~ 65 (112)
T d1xd5a_ 1 SDRLNSGHQLDTGGSLAE--GGYLFIIQNDCN-----LVLYD----NNRAVWASGTNGKAS--GCVLKMQ--NDGNLVIY 65 (112)
T ss_dssp CCEEETTEEECTTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSCS--SEEEEEC--TTSCEEEE
T ss_pred CCEECCCCEECCCCEEEE--CCEEEEECCCCC-----EEEEC----CCCEEEECCCCCCCC--CCEEEEE--CCCCEEEE
T ss_conf 989069999559999987--879999817998-----89873----983899846734788--8579996--15349999
Q ss_pred CCCCCEEEEECCCCCCCCCEEEEECCCCEEEECCCCCCCCCEEEEECCCCCC
Q ss_conf 7999769984488887753699905986899439899998604531468977
Q 004674 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCD 176 (738)
Q Consensus 125 ~~~~~~~Ws~~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~WqSFd~PtD 176 (738)
+. +..+|++++.......+|+|+|+|||||++.. +.++|||+.+|++
T Consensus 66 ~~-~~~~w~s~t~~~~~~~~l~L~ddGNlvly~~~----~~~~W~S~t~~~n 112 (112)
T d1xd5a_ 66 SG-SRAIWASNTNRQNGNYYLILQRDRNVVIYDNS----NNAIWATHTNVGN 112 (112)
T ss_dssp ET-TEEEEECCCCCSCCCCEEEECTTSCEEEECTT----SCEEEECCCCCCC
T ss_pred EC-CCEEEEEEECCCCCCEEEEECCCCCEEEECCC----CCEEECCCCCCCC
T ss_conf 34-87499983036887259999678999999899----9679618885698
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=99.77 E-value=5e-18 Score=134.58 Aligned_cols=108 Identities=20% Similarity=0.373 Sum_probs=88.8
Q ss_pred CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEEECCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEEEE
Q ss_conf 46557898457999696089938997645899986158786542689808996359998756986089943178149997
Q 004674 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (738)
Q Consensus 45 ~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~lvl~ 124 (738)
.|+|.+|+.|.+|++|.+ |.|.|+|...++ |.++. ..++||+||++.|... .+.|.++ .||+|||.
T Consensus 1 ~~~L~~g~~L~~g~~l~~--g~~~l~~q~dgn-----Lvl~~----~~~~vW~ant~~~~~~-~~~l~l~--~dGnLvl~ 66 (109)
T d1kj1a_ 1 RNLLTNGEGLYAGQSLDV--EPYHFIMQEDCN-----LVLYD----HSTSVWASNTGILGKK-GCKAVLQ--SDGNFVVY 66 (109)
T ss_dssp CCEEETTCEEETTCEEEE--TTEEEEECTTSC-----EEEEE----TTEEEEECCCCCTTCC-CCEEEEC--TTSCEEEE
T ss_pred CCCCCCCCEEECCCEEEE--CCEEEEECCCCE-----EEEEE----CCEEEEEECCCCCCCE-EEEEEEC--CCCEEEEE
T ss_conf 989259998828998983--788999448986-----99986----9989998378998751-0799993--79609999
Q ss_pred CCCCCEEEEECCCCCCCCCEEEEECCCCEEEECCCCCCCCCEEEEECCC
Q ss_conf 7999769984488887753699905986899439899998604531468
Q 004674 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDY 173 (738)
Q Consensus 125 ~~~~~~~Ws~~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~WqSFd~ 173 (738)
|+++.++|+|+++......+|+|+|+|||||+++ .+|||+-|
T Consensus 67 ~~~g~~vW~s~t~~~~~~~~l~L~ddGNlvly~~-------~~W~S~t~ 108 (109)
T d1kj1a_ 67 DAEGRSLWASHSVRGNGNYVLVLQEDGNVVIYGS-------DIWSTGTY 108 (109)
T ss_dssp CSSSCEEEECCCCCCSSCCEEEECTTSCEEEECC-------EEEECCCC
T ss_pred ECCCCEEEEEEEECCCCCEEEEEECCCCEEEECC-------CEECCCCC
T ss_conf 0898679997308899977999947975999799-------87217985
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=99.76 E-value=3e-18 Score=136.08 Aligned_cols=107 Identities=24% Similarity=0.344 Sum_probs=89.3
Q ss_pred CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEEECCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEEEE
Q ss_conf 46557898457999696089938997645899986158786542689808996359998756986089943178149997
Q 004674 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (738)
Q Consensus 45 ~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~lvl~ 124 (738)
+|+|.+||.|.+|++|. +|.|.|.|+..++ |.|+. ..++||.||++.|- +.+.+.+. .+|+|+|.
T Consensus 1 ~~~L~~g~~L~~G~~l~--ng~~~l~~q~DGN-----Lvly~----~~~~vW~s~~~~~~--~~~~l~l~--~~Gnlvl~ 65 (108)
T d1jpca_ 1 DNILYSGETLSTGEFLN--YGSFVFIMQEDCN-----LVLYD----VDKPIWATNTGGLS--RSCFLSMQ--TDGNLVVY 65 (108)
T ss_dssp CCEEETTEEECTTCEEE--ETTEEEEECTTSC-----EEEEE----TTEEEEECCCTTSC--SSCEEEEC--TTSCEEEE
T ss_pred CCCCCCCCEECCCCEEE--CCCEEEEECCCCE-----EEEEE----CCCEEEEECCCCCC--CCCEEEEE--CCCEEEEE
T ss_conf 99956997726999897--2888999878980-----99970----99021570788998--75479981--26039997
Q ss_pred CCCCCEEEEECCCCCCCCCEEEEECCCCEEEECCCCCCCCCEEEEECCC
Q ss_conf 7999769984488887753699905986899439899998604531468
Q 004674 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDY 173 (738)
Q Consensus 125 ~~~~~~~Ws~~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~WqSFd~ 173 (738)
++++.++|+|++.......+|+|+|+|||||++. .+||||+|
T Consensus 66 ~~~g~~vWsS~t~~~~~~~~l~L~ddGNlVly~~-------~~W~S~t~ 107 (108)
T d1jpca_ 66 NPSNKPIWASNTGGQNGNYVCILQKDRNVVIYGT-------DRWATGTH 107 (108)
T ss_dssp CTTCCEEEECCCCCSCSCEEEEECTTSCEEEEEC-------CCCCCCCC
T ss_pred CCCCCCEEECCCCCCCCCEEEEECCCCCEEEECC-------CCCCCCCC
T ss_conf 7985512770455888767999968889999699-------84568888
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.67 E-value=1e-16 Score=125.81 Aligned_cols=103 Identities=20% Similarity=0.312 Sum_probs=87.9
Q ss_pred EEEEEECCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEEEECCCCCEEEEECCCCCCCCCEEEEECCCCEEEECCCCCC
Q ss_conf 78654268980899635999875698608994317814999779997699844888877536999059868994398999
Q 004674 83 GIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNN 162 (738)
Q Consensus 83 giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~lvl~~~~~~~~Ws~~~~~~~~~~~a~l~d~GNlVl~~~~~~~ 162 (738)
-|||.++++++.+|++|++.|+......|.+. .||||||++. +.++|++++.+......|.|+|+|||||++.+
T Consensus 11 ~il~~~~~~~~~~~~l~~~q~l~~g~y~L~~q--~DGNLvL~~~-~~~vW~s~t~~~~~~~~~~l~~~GnLvl~d~~--- 84 (120)
T d1dlpa2 11 SILYSTQGNDNHPQTLHATQSLQLSPYRLSME--TDCNLVLFDR-DDRVWSTNTAGKGTGCRAVLQPNGRMDVLTNQ--- 84 (120)
T ss_dssp EECCCC--CCCCCCEECSSCCCBCSSCEEEEE--TTTEEEEEBT-TBCCSCCCCCSSCSSCEEEEETTTEEEEEETT---
T ss_pred EEEECCCCCCCCCCEECCCCEEECCCEEEEEC--CCCCEEEECC-CCEEEEECCCCCCCCEEEEEECCEEEEEECCC---
T ss_conf 69982898888562883997217488799996--8983899649-96899975224777479999077649999299---
Q ss_pred CCCEEEEECCCCCCCCCCCCEEEEEECCCCCEEEEEECCCCCCCCCCEEEECCCCCCCEEE
Q ss_conf 9860453146897776899923213238973389980249999997527501899975679
Q 004674 163 PDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLV 223 (738)
Q Consensus 163 ~~~~~WqSFd~PtDtlLpgq~l~~~~~~~~~~~l~s~~s~~dps~G~~~~~~~~~g~~~~~ 223 (738)
++++||||. +.++|.|.+.+|++|++.+|
T Consensus 85 -~~~lW~S~t-------------------------------~~~~~~~~l~Lq~DGnlvlY 113 (120)
T d1dlpa2 85 -NIAVWTSGN-------------------------------SRSAGRYVFVLQPDRNLAIY 113 (120)
T ss_dssp -TEEEEECCC-------------------------------CCSSSCCEEEECSSSCEEEE
T ss_pred -CCEEEEECC-------------------------------CCCCCCEEEEECCCCCEEEE
T ss_conf -988998199-------------------------------99998489998889869996
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.52 E-value=1e-13 Score=105.74 Aligned_cols=105 Identities=20% Similarity=0.336 Sum_probs=80.2
Q ss_pred CCCCCCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEEECCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEEEE
Q ss_conf 46557898457999696089938997645899986158786542689808996359998756986089943178149997
Q 004674 45 LDTISLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLL 124 (738)
Q Consensus 45 ~~~~~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~lvl~ 124 (738)
..+|.++|+| ...+..|.|.|.|...|+ |.+ |. ..++||.||+..+.. ...|.+. .||+|+|.
T Consensus 14 ~~~l~~~q~l----~~~~~~~~y~l~mQ~DGN-----LVL-y~---~~~~vWssnt~~~~~--~~~l~l~--~dGnLvL~ 76 (119)
T d1b2pa_ 14 PQILHATESL----EILFGTHVYRFIMQTDCN-----LVL-YD---NNNPIWATNTGGLGN--GCRAVLQ--PDGVLVVI 76 (119)
T ss_dssp CCEEETTCEE----EEEETTEEEEEEECTTSC-----EEE-EE---TTEEEEECCCTTSCS--SCEEEEC--TTSCEEEE
T ss_pred CCEEECCCEE----EEECCCCEEEEEECCCCC-----EEE-EE---CCEEEEEECCCCCCC--CEEEEEE--ECCCEEEE
T ss_conf 8888289758----870478538999889982-----999-97---996799946788774--1699998--37779998
Q ss_pred CCCCCEEEEECCCCCCCCCEEEEECCCCEEEECCCCCCCCCEEEEECCC
Q ss_conf 7999769984488887753699905986899439899998604531468
Q 004674 125 NSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDY 173 (738)
Q Consensus 125 ~~~~~~~Ws~~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~WqSFd~ 173 (738)
|+++.++|++++.+.....+++|+|+|||||++ ..+|||..+
T Consensus 77 d~~g~~vWsS~t~~~~~~~~l~Lq~DGNlvlYg-------~~~W~S~T~ 118 (119)
T d1b2pa_ 77 TNENVTVWQSPVAGKAGHYVLVLQPDRNVVIYG-------DALWATQTV 118 (119)
T ss_dssp CTTCCEEEECSCCCCSSCEEEEECTTSCEEEEE-------SEEEECCCC
T ss_pred CCCCCEEEECCCCCCCCCEEEEECCCCCEEEEC-------CCEECCCCC
T ss_conf 999857997887699886599996998899979-------988416974
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.50 E-value=1.2e-14 Score=111.91 Aligned_cols=112 Identities=22% Similarity=0.293 Sum_probs=88.1
Q ss_pred EEEEEECCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEEEECCCCCEEEEECCCCCCCCCEEEEECCCCEEEECCCCCC
Q ss_conf 78654268980899635999875698608994317814999779997699844888877536999059868994398999
Q 004674 83 GIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNN 162 (738)
Q Consensus 83 giw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~lvl~~~~~~~~Ws~~~~~~~~~~~a~l~d~GNlVl~~~~~~~ 162 (738)
.|||.-.++.+..|..+.+.++......|.+. .||||||++ ++.++|++++.+ ..+..+.|+|+|||||++.+
T Consensus 2 ~~~~~~~~~~~~~~tl~~~~~l~~g~~~l~~q--~DGNLvL~~-~~~~vW~s~t~~-~~~~~l~l~~dGNLvl~d~~--- 74 (115)
T d1dlpa1 2 NILFGLSHEGSHPQTLHAAQSLELSSFRFTMQ--SDCNLVLFD-SDVRVWASNTAG-ATGCRAVLQSDGLLVILTAQ--- 74 (115)
T ss_dssp CCCBCSSSSSCSCSCCCTTCEECSTTEEEEEC--TTSCEEEEE-SSSEEECCCCCS-CSCCBCCBCSSSCBCCBCTT---
T ss_pred CEEEECCCCCCCCCEECCCCCEECCCEEEEEC--CCCEEEEEC-CCEEEEECCCCC-CCCEEEEEECCCCEEEECCC---
T ss_conf 67786478998821246998177598899997--998399981-990689711689-97568999446789999058---
Q ss_pred CCCEEEEECCCCCCCCCCCCEEEEEECCCCCEEEEEECCCCCCCCCCEEEECCCCCCCEEEEEECCEEEEEECCC
Q ss_conf 986045314689777689992321323897338998024999999752750189997567994088489971998
Q 004674 163 PDNILWQSFDYPCDTLLPGMKLGINLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSW 237 (738)
Q Consensus 163 ~~~~~WqSFd~PtDtlLpgq~l~~~~~~~~~~~l~s~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~~ 237 (738)
++++|||+. +.+.|.|.+.|+++|++.++ +.++|.+|.-
T Consensus 75 -~~~vWsS~t-------------------------------~~~~g~y~l~Lq~DGNlvlY----~~~~Wssgt~ 113 (115)
T d1dlpa1 75 -NTIRWSSGT-------------------------------KGSIGNYVLVLQPDRTVTIY----GPGLWDSGTS 113 (115)
T ss_dssp -TCCSCCCCC-------------------------------CCCSSCCEEEECSSSCEEEE----CSEEEECSCC
T ss_pred -CCEEEECCC-------------------------------CCCCCCEEEEECCCCCEEEE----CCCEECCCCC
T ss_conf -978998188-------------------------------89999789999899869996----8976438898
|
| >d1dlpa1 b.78.1.1 (A:1-115) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.20 E-value=3e-11 Score=89.12 Aligned_cols=101 Identities=24% Similarity=0.345 Sum_probs=75.5
Q ss_pred CCCCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEEECCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEEEECCCC
Q ss_conf 78984579996960899389976458999861587865426898089963599987569860899431781499977999
Q 004674 49 SLGQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTN 128 (738)
Q Consensus 49 ~~~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~lvl~~~~~ 128 (738)
+..|+|.+++.| .+|.|.|.|...|+ |.++. ...+||.+|...+ ..+.+.+. .+|+|||.|..+
T Consensus 12 ~~~~tl~~~~~l--~~g~~~l~~q~DGN-----LvL~~----~~~~vW~s~t~~~---~~~~l~l~--~dGNLvl~d~~~ 75 (115)
T d1dlpa1 12 SHPQTLHAAQSL--ELSSFRFTMQSDCN-----LVLFD----SDVRVWASNTAGA---TGCRAVLQ--SDGLLVILTAQN 75 (115)
T ss_dssp CSCSCCCTTCEE--CSTTEEEEECTTSC-----EEEEE----SSSEEECCCCCSC---SCCBCCBC--SSSCBCCBCTTT
T ss_pred CCCCEECCCCCE--ECCCEEEEECCCCE-----EEEEC----CCEEEEECCCCCC---CCEEEEEE--CCCCEEEECCCC
T ss_conf 882124699817--75988999979983-----99981----9906897116899---75689994--467899990589
Q ss_pred CEEEEECCCCCCCCCEEEEECCCCEEEECCCCCCCCCEEEEECC
Q ss_conf 76998448888775369990598689943989999860453146
Q 004674 129 DTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFD 172 (738)
Q Consensus 129 ~~~Ws~~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~WqSFd 172 (738)
.++|++.+.......+++|+++|||||++ ..+|+|-.
T Consensus 76 ~~vWsS~t~~~~g~y~l~Lq~DGNlvlY~-------~~~Wssgt 112 (115)
T d1dlpa1 76 TIRWSSGTKGSIGNYVLVLQPDRTVTIYG-------PGLWDSGT 112 (115)
T ss_dssp CCSCCCCCCCCSSCCEEEECSSSCEEEEC-------SEEEECSC
T ss_pred CEEEECCCCCCCCCEEEEECCCCCEEEEC-------CCEECCCC
T ss_conf 78998188899997899998998699968-------97643889
|
| >d1b2pa_ b.78.1.1 (A:) Lectin (agglutinin) {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=99.00 E-value=3e-09 Score=75.71 Aligned_cols=90 Identities=22% Similarity=0.294 Sum_probs=68.7
Q ss_pred CCCCEEEEECCCCEEEEECCCCCEEEEECCCCCCCCCEEEEECCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCEEEE
Q ss_conf 98608994317814999779997699844888877536999059868994398999986045314689777689992321
Q 004674 107 RSGVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGI 186 (738)
Q Consensus 107 ~~~~l~~~~~~~g~lvl~~~~~~~~Ws~~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgq~l~~ 186 (738)
+++..+|.++.||||||+++ +.++|++++.+......+.|.++|||||++.. +.++|+|.-
T Consensus 28 ~~~~y~l~mQ~DGNLVLy~~-~~~vWssnt~~~~~~~~l~l~~dGnLvL~d~~----g~~vWsS~t-------------- 88 (119)
T d1b2pa_ 28 GTHVYRFIMQTDCNLVLYDN-NNPIWATNTGGLGNGCRAVLQPDGVLVVITNE----NVTVWQSPV-------------- 88 (119)
T ss_dssp TTEEEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEECSC--------------
T ss_pred CCCEEEEEECCCCCEEEEEC-CEEEEEECCCCCCCCEEEEEEECCCEEEECCC----CCEEEECCC--------------
T ss_conf 78538999889982999979-96799946788774169999837779998999----857997887--------------
Q ss_pred EECCCCCEEEEEECCCCCCCCCCEEEECCCCCCCEEEEEECCEEEEEECC
Q ss_conf 32389733899802499999975275018999756799408848997199
Q 004674 187 NLGTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGS 236 (738)
Q Consensus 187 ~~~~~~~~~l~s~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~ 236 (738)
.-+.|.|.+.|+++|++.++ . .+.|.++.
T Consensus 89 -----------------~~~~~~~~l~Lq~DGNlvlY--g--~~~W~S~T 117 (119)
T d1b2pa_ 89 -----------------AGKAGHYVLVLQPDRNVVIY--G--DALWATQT 117 (119)
T ss_dssp -----------------CCCSSCEEEEECTTSCEEEE--E--SEEEECCC
T ss_pred -----------------CCCCCCEEEEECCCCCEEEE--C--CCEECCCC
T ss_conf -----------------69988659999699889997--9--98841697
|
| >d1dlpa2 b.78.1.1 (A:116-235) Fetuin-binding protein Scafet precursor {Bluebell (Scilla campanulata) [TaxId: 81759]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Fetuin-binding protein Scafet precursor species: Bluebell (Scilla campanulata) [TaxId: 81759]
Probab=98.94 E-value=2.9e-09 Score=75.89 Aligned_cols=98 Identities=24% Similarity=0.390 Sum_probs=66.1
Q ss_pred CCCCCCCCEEEECCCEEEEEEECCCCCCCEEEEEEEEECCCCCEEEEECCCCCCCCCCCCEEEEECCCCEEEEECCCCCE
Q ss_conf 98457999696089938997645899986158786542689808996359998756986089943178149997799976
Q 004674 51 GQSIKDGETLVSAKESFELGFFSPGNSKSRYLGIWYKKIAEGTVTWVANRDAPLSDRSGVLRINGERNGILVLLNSTNDT 130 (738)
Q Consensus 51 ~~~l~~~~~l~s~~g~f~~gf~~~~~~~~~ylgiw~~~~~~~t~vW~Anr~~p~~~~~~~l~~~~~~~g~lvl~~~~~~~ 130 (738)
.+.|.+++.+. .|.|.|.|...++ |.++. ...+||.+|-.. .+....+.|. .+|+|||.|.++.+
T Consensus 23 ~~~l~~~q~l~--~g~y~L~~q~DGN-----LvL~~----~~~~vW~s~t~~--~~~~~~~~l~--~~GnLvl~d~~~~~ 87 (120)
T d1dlpa2 23 PQTLHATQSLQ--LSPYRLSMETDCN-----LVLFD----RDDRVWSTNTAG--KGTGCRAVLQ--PNGRMDVLTNQNIA 87 (120)
T ss_dssp CCEECSSCCCB--CSSCEEEEETTTE-----EEEEB----TTBCCSCCCCCS--SCSSCEEEEE--TTTEEEEEETTTEE
T ss_pred CCEECCCCEEE--CCCEEEEECCCCC-----EEEEC----CCCEEEEECCCC--CCCCEEEEEE--CCEEEEEECCCCCE
T ss_conf 62883997217--4887999968983-----89964----996899975224--7774799990--77649999299988
Q ss_pred EEEECCCCCCCCCEEEEECCCCEEEECCCCCCCCCEEEEE
Q ss_conf 9984488887753699905986899439899998604531
Q 004674 131 VWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQS 170 (738)
Q Consensus 131 ~Ws~~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~WqS 170 (738)
+|+|++........++|+++|||||++. .+|.|
T Consensus 88 lW~S~t~~~~~~~~l~Lq~DGnlvlY~~-------~~W~t 120 (120)
T d1dlpa2 88 VWTSGNSRSAGRYVFVLQPDRNLAIYGG-------ALWTT 120 (120)
T ss_dssp EEECCCCCSSSCCEEEECSSSCEEEECC-------CCCBC
T ss_pred EEEECCCCCCCCEEEEECCCCCEEEECC-------CCCCC
T ss_conf 9981999999848999888986999689-------74349
|
| >d1jpca_ b.78.1.1 (A:) Lectin (agglutinin) {Snowdrop (Galanthus nivalis) [TaxId: 4670]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Snowdrop (Galanthus nivalis) [TaxId: 4670]
Probab=98.85 E-value=1e-08 Score=72.17 Aligned_cols=79 Identities=19% Similarity=0.347 Sum_probs=59.5
Q ss_pred CCEEEEECCCCEEEEECCCCCEEEEECCCCCCCCCEEEEECCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCEEEEEE
Q ss_conf 60899431781499977999769984488887753699905986899439899998604531468977768999232132
Q 004674 109 GVLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (738)
Q Consensus 109 ~~l~~~~~~~g~lvl~~~~~~~~Ws~~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgq~l~~~~ 188 (738)
+..++.++.||||||++. +.++|++++........+.|.++|||||++.+ ++++|+|
T Consensus 19 g~~~l~~q~DGNLvly~~-~~~vW~s~~~~~~~~~~l~l~~~Gnlvl~~~~----g~~vWsS------------------ 75 (108)
T d1jpca_ 19 GSFVFIMQEDCNLVLYDV-DKPIWATNTGGLSRSCFLSMQTDGNLVVYNPS----NKPIWAS------------------ 75 (108)
T ss_dssp TTEEEEECTTSCEEEEET-TEEEEECCCTTSCSSCEEEECTTSCEEEECTT----CCEEEEC------------------
T ss_pred CCEEEEECCCCEEEEEEC-CCEEEEECCCCCCCCCEEEEECCCEEEEECCC----CCCEEEC------------------
T ss_conf 888999878980999709-90215707889987547998126039997798----5512770------------------
Q ss_pred CCCCCEEEEEECCCCCCCCCCEEEECCCCCCCEEE
Q ss_conf 38973389980249999997527501899975679
Q 004674 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLV 223 (738)
Q Consensus 189 ~~~~~~~l~s~~s~~dps~G~~~~~~~~~g~~~~~ 223 (738)
.+..+.+.|.+.|+++|++.++
T Consensus 76 -------------~t~~~~~~~~l~L~ddGNlVly 97 (108)
T d1jpca_ 76 -------------NTGGQNGNYVCILQKDRNVVIY 97 (108)
T ss_dssp -------------CCCCSCSCEEEEECTTSCEEEE
T ss_pred -------------CCCCCCCCEEEEECCCCCEEEE
T ss_conf -------------4558887679999688899996
|
| >d1kj1a_ b.78.1.1 (A:) Lectin (agglutinin) {Garlic (Allium sativum) [TaxId: 4682]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Lectin (agglutinin) species: Garlic (Allium sativum) [TaxId: 4682]
Probab=98.80 E-value=4.7e-08 Score=67.72 Aligned_cols=88 Identities=25% Similarity=0.396 Sum_probs=63.1
Q ss_pred CEEEEECCCCEEEEECCCCCEEEEECCCCC-CCCCEEEEECCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCEEEEEE
Q ss_conf 089943178149997799976998448888-7753699905986899439899998604531468977768999232132
Q 004674 110 VLRINGERNGILVLLNSTNDTVWSSNSSIS-AQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINL 188 (738)
Q Consensus 110 ~l~~~~~~~g~lvl~~~~~~~~Ws~~~~~~-~~~~~a~l~d~GNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgq~l~~~~ 188 (738)
...+.++.||||||++ .+.++|++++... .....+.|.++|||||++++ +.++|+|-
T Consensus 20 ~~~l~~q~dgnLvl~~-~~~~vW~ant~~~~~~~~~l~l~~dGnLvl~~~~----g~~vW~s~----------------- 77 (109)
T d1kj1a_ 20 PYHFIMQEDCNLVLYD-HSTSVWASNTGILGKKGCKAVLQSDGNFVVYDAE----GRSLWASH----------------- 77 (109)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCCCTTCCCCEEEECTTSCEEEECSS----SCEEEECC-----------------
T ss_pred CEEEEECCCCEEEEEE-CCEEEEEECCCCCCCEEEEEEECCCCEEEEEECC----CCEEEEEE-----------------
T ss_conf 8899944898699986-9989998378998751079999379609999089----86799973-----------------
Q ss_pred CCCCCEEEEEECCCCCCCCCCEEEECCCCCCCEEEEEECCEEEEEECCC
Q ss_conf 3897338998024999999752750189997567994088489971998
Q 004674 189 GTGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSW 237 (738)
Q Consensus 189 ~~~~~~~l~s~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~~ 237 (738)
+..+.|.|.+.|+++|++.++ + ...|.++.+
T Consensus 78 --------------t~~~~~~~~l~L~ddGNlvly--~--~~~W~S~t~ 108 (109)
T d1kj1a_ 78 --------------SVRGNGNYVLVLQEDGNVVIY--G--SDIWSTGTY 108 (109)
T ss_dssp --------------CCCCSSCCEEEECTTSCEEEE--C--CEEEECCCC
T ss_pred --------------EECCCCCEEEEEECCCCEEEE--C--CCEECCCCC
T ss_conf --------------088999779999479759997--9--987217985
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.68 E-value=1.4e-07 Score=64.52 Aligned_cols=149 Identities=15% Similarity=0.089 Sum_probs=100.0
Q ss_pred HHHHHCCCCCCCCEECCCCCEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHC-CCCEEEEEEEEECCCCCE
Q ss_conf 8997507989565105556476997450466389999815899756688999999996712-777235884774178216
Q 004674 511 IIANATDNFSEKNKLGEGGFGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ-HRNLVKLLGCCTQRDERM 589 (738)
Q Consensus 511 ~~~~~~~~y~~~~~IG~G~fG~Vykg~~~~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~-H~nIv~l~g~~~~~~~~~ 589 (738)
++....+.|...+..+.+....||+... +++.+.+|+...........+.+|...+..+. +--+.+++.+.......+
T Consensus 8 ~l~~~~~~~~~~~~~~G~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~ 86 (263)
T d1j7la_ 8 ELKKLIEKYRCVKDTEGMSPAKVYKLVG-ENENLYLKMTDSRYKGTTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSN 86 (263)
T ss_dssp HHHHHHTTSEEEECSCCCSSSEEEEEEC-SSCEEEEEEECGGGTTSTTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEE
T ss_pred HHHHHHHCEEEEECCCCCCCCCEEEEEE-CCCEEEEEECCCCCCCCHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEE
T ss_conf 9997513527997678998771899990-898699998488765325569999999998760699872899975089649
Q ss_pred EEEEECCCCCHHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHCC---------------------------------
Q ss_conf 99841799994578861388888999999999999999999987399---------------------------------
Q 004674 590 LIYEYLPNKSLDYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQDS--------------------------------- 636 (738)
Q Consensus 590 lV~E~~~~gsL~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~~--------------------------------- 636 (738)
+||+++++.++....... .. ...++.++++.++.||+..
T Consensus 87 lv~~~l~G~~~~~~~~~~-----~~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 158 (263)
T d1j7la_ 87 LLMSEADGVLCSEEYEDE-----QS---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENW 158 (263)
T ss_dssp EEEECCSSEEHHHHTTTC-----SC---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGG
T ss_pred EEEEECCCCCCCCCCCCC-----CC---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCC
T ss_conf 999860433435433440-----26---9999998999999985568421435764465655577899877655554303
Q ss_pred -----------------------CCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf -----------------------99747479899968984899539995247511
Q 004674 637 -----------------------RLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 637 -----------------------~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~ 668 (738)
...++|+|+.|.||+++++..+.|.||+.+..
T Consensus 159 ~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 159 EEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp STTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCHHHHHHHHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 3232005799999999844986781789860047642364996599960231441
|
| >d1xd5a_ b.78.1.1 (A:) Gastrodianin (antifungal protein) {Gastrodia elata [TaxId: 91201]} | Back information, alignment and structure |
|---|
class: All beta proteins fold: beta-Prism II superfamily: alpha-D-mannose-specific plant lectins family: alpha-D-mannose-specific plant lectins domain: Gastrodianin (antifungal protein) species: Gastrodia elata [TaxId: 91201]
Probab=98.62 E-value=3.9e-07 Score=61.61 Aligned_cols=90 Identities=20% Similarity=0.295 Sum_probs=61.1
Q ss_pred CEEEEECCCCEEEEECCCCCEEEEECCCCCCCCCEEEEECCCCEEEECCCCCCCCCEEEEECCCCCCCCCCCCEEEEEEC
Q ss_conf 08994317814999779997699844888877536999059868994398999986045314689777689992321323
Q 004674 110 VLRINGERNGILVLLNSTNDTVWSSNSSISAQKPVAALMESGNLVVKDGKDNNPDNILWQSFDYPCDTLLPGMKLGINLG 189 (738)
Q Consensus 110 ~l~~~~~~~g~lvl~~~~~~~~Ws~~~~~~~~~~~a~l~d~GNlVl~~~~~~~~~~~~WqSFd~PtDtlLpgq~l~~~~~ 189 (738)
..+|.++.||||||++ .+.++|++++........+.|..+|||||++. ++.+|.|
T Consensus 20 ~~~l~~q~DGNLvly~-~~~~vW~s~~~~~~~~~~l~l~~dGnLvl~~~-----~~~~w~s------------------- 74 (112)
T d1xd5a_ 20 GYLFIIQNDCNLVLYD-NNRAVWASGTNGKASGCVLKMQNDGNLVIYSG-----SRAIWAS------------------- 74 (112)
T ss_dssp TEEEEECTTSCEEEEE-TTEEEEECCCTTSCSSEEEEECTTSCEEEEET-----TEEEEEC-------------------
T ss_pred CEEEEECCCCCEEEEC-CCCEEEECCCCCCCCCCEEEEECCCCEEEEEC-----CCEEEEE-------------------
T ss_conf 7999981799889873-98389984673478885799961534999934-----8749998-------------------
Q ss_pred CCCCEEEEEECCCCCCCCCCEEEECCCCCCCEEEEEECCEEEEEECCC
Q ss_conf 897338998024999999752750189997567994088489971998
Q 004674 190 TGLNRFLSSWKSTDDPARGDFTYGLDPRGIPQLVLRKNSIITFRAGSW 237 (738)
Q Consensus 190 ~~~~~~l~s~~s~~dps~G~~~~~~~~~g~~~~~~~~~~~~~~~~g~~ 237 (738)
...-..|.+.+.++.+|++.++ .....+.|.++.-
T Consensus 75 ------------~t~~~~~~~~l~L~ddGNlvly-~~~~~~~W~S~t~ 109 (112)
T d1xd5a_ 75 ------------NTNRQNGNYYLILQRDRNVVIY-DNSNNAIWATHTN 109 (112)
T ss_dssp ------------CCCCSCCCCEEEECTTSCEEEE-CTTSCEEEECCCC
T ss_pred ------------EECCCCCCEEEEECCCCCEEEE-CCCCCEEECCCCC
T ss_conf ------------3036887259999678999999-8999679618885
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.05 E-value=2.3e-05 Score=49.68 Aligned_cols=131 Identities=18% Similarity=0.172 Sum_probs=85.1
Q ss_pred EECCCCC-EEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHC--CCCEEEEEEEEECCCCCEEEEEECCCCCH
Q ss_conf 1055564-76997450466389999815899756688999999996712--77723588477417821699841799994
Q 004674 524 KLGEGGF-GPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQ--HRNLVKLLGCCTQRDERMLIYEYLPNKSL 600 (738)
Q Consensus 524 ~IG~G~f-G~Vykg~~~~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~--H~nIv~l~g~~~~~~~~~lV~E~~~~gsL 600 (738)
.+..|.. ..||+.....+..+.+|...... ...+..|...+..+. ...+.+++.+..+....++||+++++.++
T Consensus 17 ~~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~---~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSAQGRPVLFVKTDLSGA---LNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp ECSCTTSSCEEEEEECTTSCCEEEEEECSCT---TSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred ECCCCCCCCEEEEEEECCCCEEEEEECCCCC---HHHHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECCCC
T ss_conf 7678654775899993898789999589667---7689999999999986599988613222456615999874413554
Q ss_pred HHHHHHCCCCCCCCHHHHHHHHHHHHHHHHHHHHC---------------------------------------------
Q ss_conf 57886138888899999999999999999998739---------------------------------------------
Q 004674 601 DYFIFDTTRSKLLDWSKRSHIIAGIARGLLYLHQD--------------------------------------------- 635 (738)
Q Consensus 601 ~~~l~~~~~~~~l~~~~~~~i~~~ia~gL~yLH~~--------------------------------------------- 635 (738)
.... .... ..+.++++.|+-||..
T Consensus 94 ~~~~--------~~~~---~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (255)
T d1nd4a_ 94 LSSH--------LAPA---EKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELF 162 (255)
T ss_dssp TTSC--------CCHH---HHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHH
T ss_pred CCCC--------CCHH---HHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHH
T ss_conf 3221--------2689---9999999999987368854488755412468899999987541101134011213799999
Q ss_pred ----------CCCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf ----------999747479899968984899539995247511
Q 004674 636 ----------SRLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 636 ----------~~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~ 668 (738)
....++|+|+.|.||+++++..+.|+||+.+..
T Consensus 163 ~~l~~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 163 ARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHCCCCCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 9998718765795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.98 E-value=7.2e-05 Score=46.41 Aligned_cols=77 Identities=12% Similarity=0.183 Sum_probs=49.9
Q ss_pred CCEECCCCCEEEEEEEECC-CCEEEEEECCC------C-CCCCHHHHHHHHHHHHHHC-C--CCEEEEEEEEECCCCCEE
Q ss_conf 6510555647699745046-63899998158------9-9756688999999996712-7--772358847741782169
Q 004674 522 KNKLGEGGFGPVYKGMLIE-GQEIAVKRLSK------G-SGQGMEEFKNEVLLIAKLQ-H--RNLVKLLGCCTQRDERML 590 (738)
Q Consensus 522 ~~~IG~G~fG~Vykg~~~~-g~~VavK~l~~------~-~~~~~~~~~~Ei~~l~~l~-H--~nIv~l~g~~~~~~~~~l 590 (738)
.+.||.|....||+..... ++.+++|.-.. . ......+...|.+.++.+. + ..+.+++.+ ++...++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEEECCCCCH
Q ss_conf 9841799994
Q 004674 591 IYEYLPNKSL 600 (738)
Q Consensus 591 V~E~~~~gsL 600 (738)
|||++++..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEECCCCCCC
T ss_conf 8713577653
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.42 E-value=0.0017 Score=37.19 Aligned_cols=136 Identities=12% Similarity=0.119 Sum_probs=70.6
Q ss_pred CEEEEEEEECCCCEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCE--EEEEE-----EEECCCCCEEEEEECCCCCHHH
Q ss_conf 4769974504663899998158997566889999999967127772--35884-----7741782169984179999457
Q 004674 530 FGPVYKGMLIEGQEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL--VKLLG-----CCTQRDERMLIYEYLPNKSLDY 602 (738)
Q Consensus 530 fG~Vykg~~~~g~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI--v~l~g-----~~~~~~~~~lV~E~~~~gsL~~ 602 (738)
.-.||+....+|..+++|..+.. ....+++..|...+..+....+ +..+. ........+.+++++++..+..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~-~~s~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~~~~ 113 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPE-RWTADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQFEA 113 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTT-TSCHHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEECCS
T ss_pred CCEEEEEECCCCCEEEEEEECCC-CCCHHHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCCCCC
T ss_conf 20269998389997999984787-78899999999999999855998787520689805665347999986527768899
Q ss_pred -----HH---------HH------CCCCCCCCH----------------------HHHHHHHHHHHHHHHHH-HHCCCCC
Q ss_conf -----88---------61------388888999----------------------99999999999999998-7399997
Q 004674 603 -----FI---------FD------TTRSKLLDW----------------------SKRSHIIAGIARGLLYL-HQDSRLR 639 (738)
Q Consensus 603 -----~l---------~~------~~~~~~l~~----------------------~~~~~i~~~ia~gL~yL-H~~~~~~ 639 (738)
.. +. .......+. ......+..+...+.-. .+..+..
T Consensus 114 ~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~p~~ 193 (325)
T d1zyla1 114 DNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDFTVL 193 (325)
T ss_dssp SCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCSCCE
T ss_pred CCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCE
T ss_conf 99999999899999988630357865567789788766568999874769988989999999999999998454568712
Q ss_pred EEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 47479899968984899539995247511
Q 004674 640 IIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 640 ivH~DLkp~NILl~~~~~vkL~DfGla~~ 668 (738)
++|+|+.+.|||++++ ..++||+.+..
T Consensus 194 liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 194 RLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp ECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred EECCCCCCCCEEEECC--CEEEECHHCCC
T ss_conf 0247888042878389--35886520146
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.10 E-value=0.0034 Score=35.18 Aligned_cols=74 Identities=19% Similarity=0.284 Sum_probs=46.4
Q ss_pred CCEECCCCCEEEEEEEECCC--------CEEEEEECCCCCCCCHHHHHHHHHHHHHHCCCCE-EEEEEEEECCCCCEEEE
Q ss_conf 65105556476997450466--------3899998158997566889999999967127772-35884774178216998
Q 004674 522 KNKLGEGGFGPVYKGMLIEG--------QEIAVKRLSKGSGQGMEEFKNEVLLIAKLQHRNL-VKLLGCCTQRDERMLIY 592 (738)
Q Consensus 522 ~~~IG~G~fG~Vykg~~~~g--------~~VavK~l~~~~~~~~~~~~~Ei~~l~~l~H~nI-v~l~g~~~~~~~~~lV~ 592 (738)
.+.|..|-.-.+|++...++ +.|.+++... ........+|..+++.+.-.++ .++++++.. .+|+
T Consensus 47 v~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~--~~~~idr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~ 120 (395)
T d1nw1a_ 47 ISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFN--PETESHLVAESVIFTLLSERHLGPKLYGIFSG----GRLE 120 (395)
T ss_dssp EEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECS--CCCHHHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEE
T ss_pred EEECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECCC--CCHHHHHHHHHHHHHHHHHCCCCCEEEEECCC----CEEE
T ss_conf 99917853343489996887754457898179996599--61165899999999999757999808998189----5699
Q ss_pred EECCCCCHH
Q ss_conf 417999945
Q 004674 593 EYLPNKSLD 601 (738)
Q Consensus 593 E~~~~gsL~ 601 (738)
||+++..+.
T Consensus 121 efi~g~~l~ 129 (395)
T d1nw1a_ 121 EYIPSRPLS 129 (395)
T ss_dssp CCCCEEECC
T ss_pred EEECCCCCC
T ss_conf 973455488
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.42 E-value=0.056 Score=27.04 Aligned_cols=32 Identities=28% Similarity=0.301 Sum_probs=27.3
Q ss_pred CCCEEECCCCCCCEEECCCCCEEEEEECCCCC
Q ss_conf 99747479899968984899539995247511
Q 004674 637 RLRIIHRDLKASNVLLDNTMNPKISDFGLARS 668 (738)
Q Consensus 637 ~~~ivH~DLkp~NILl~~~~~vkL~DfGla~~ 668 (738)
+.+++|+|+.++||+++.+...-|.||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 45033378636564020454126742221236
|